data_2jpr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jpr _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.48 0.686 0 N-CA-C 112.997 0.345 . . . . 20.0 112.997 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.99 135.01 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.473 1.109 . . . . 20.0 108.448 163.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.81 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 20.0 109.686 170.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.47 116.7 32.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.531 0.733 . . . . 20.0 109.17 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.503 0.668 . . . . 20.0 112.495 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.82 -26.57 68.81 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.432 1.271 . . . . 20.0 114.432 -173.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 20.0 113.03 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.0 3.07 85.68 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.475 1.036 . . . . 20.0 114.058 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.22 35.46 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.847 1.323 . . . . 20.0 109.731 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.52 29.47 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.453 -0.573 . . . . 20.0 109.453 168.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.9 123.39 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.014 1.326 . . . . 20.0 108.648 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 20.0 111.213 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.67 141.12 48.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.511 1.924 . . . . 20.0 107.935 169.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.37 20.84 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.949 0.795 . . . . 20.0 111.191 170.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.53 136.81 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.625 -0.672 . . . . 20.0 111.61 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.62 129.96 93.29 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.084 0.553 . . . . 20.0 111.137 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.05 -34.48 67.98 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.868 2.378 . . . . 20.0 113.542 167.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.51 -38.09 86.46 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.453 -0.779 . . . . 20.0 112.56 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.99 -44.21 97.74 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 20.0 111.354 171.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.58 -44.45 94.02 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.341 0.519 . . . . 20.0 112.256 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.08 -47.19 86.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.076 0.55 . . . . 20.0 111.402 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.2 95.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.64 0.776 . . . . 20.0 111.881 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -60.29 -46.89 88.26 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.81 0.844 . . . . 20.0 112.781 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.9 t -57.0 -54.24 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.412 0.551 . . . . 20.0 110.355 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.8 -37.25 78.59 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.374 1.07 . . . . 20.0 113.229 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.22 -52.31 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.206 1.403 . . . . 20.0 111.233 170.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.08 -36.14 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.022 0.529 . . . . 20.0 111.405 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -58.55 -23.85 59.37 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.978 1.103 . . . . 20.0 113.978 175.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.47 -25.47 11.38 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.04 1.126 . . . . 20.0 114.04 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -136.19 16.09 3.24 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.367 1.247 . . . . 20.0 114.367 -165.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.08 -36.78 2.71 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.478 2.029 . . . . 20.0 116.478 -175.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.48 15.34 13.78 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.492 1.117 . . . . 20.0 113.098 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -114.87 153.01 47.0 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.961 0.904 . . . . 20.0 111.456 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.96 -30.6 59.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.218 2.612 . . . . 20.0 115.238 -172.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.17 -20.74 64.45 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.173 1.175 . . . . 20.0 114.173 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.88 -31.82 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.468 1.031 . . . . 20.0 112.548 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.7 mt -71.47 -54.98 6.26 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.927 1.291 . . . . 20.0 113.01 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.89 -30.16 49.16 Favored 'Trans proline' 0 C--N 1.351 0.686 0 CA-C-N 121.673 1.633 . . . . 20.0 112.633 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -68.96 -40.26 79.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.867 1.212 . . . . 20.0 112.674 172.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.3 -46.44 83.17 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.476 0.711 . . . . 20.0 111.576 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.0 m -61.12 -44.53 97.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.608 0.596 . . . . 20.0 112.608 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.8 -31.88 71.26 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.28 1.032 . . . . 20.0 113.315 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.52 4.57 53.07 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.364 1.466 . . . . 20.0 113.499 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.5 p -133.1 22.88 4.14 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.437 1.273 . . . . 20.0 114.437 -176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.63 120.27 5.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.485 -1.384 . . . . 20.0 111.47 168.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.6 11.59 60.19 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 115.365 0.906 . . . . 20.0 115.365 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.45 130.82 46.9 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.542 1.671 . . . . 20.0 112.48 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.33 159.66 84.37 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.706 0.802 . . . . 20.0 110.68 167.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.57 -35.47 37.43 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.144 1.896 . . . . 20.0 115.406 168.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.04 -40.17 87.11 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.098 0.777 . . . . 20.0 113.098 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.42 -45.26 94.26 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.629 -0.669 . . . . 20.0 111.047 172.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.56 -44.28 94.58 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.32 1.048 . . . . 20.0 112.115 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -59.25 -41.39 88.66 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.618 0.644 . . . . 20.0 112.008 171.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.9 m -60.3 -45.28 93.93 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.597 0.635 . . . . 20.0 111.066 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.38 -48.98 77.64 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.218 0.917 . . . . 20.0 112.114 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.04 -38.34 90.8 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.827 0.677 . . . . 20.0 112.827 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.04 -33.66 71.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.89 0.7 . . . . 20.0 112.89 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.8 p -73.1 -12.81 61.04 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.662 1.356 . . . . 20.0 114.662 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.03 7.78 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.357 1.063 . . . . 20.0 113.868 -174.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.09 -5.43 10.05 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 117.46 1.744 . . . . 20.0 117.46 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.05 -35.42 69.21 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 119.32 1.56 . . . . 20.0 115.282 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -85.28 77.84 9.91 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 123.053 1.406 . . . . 20.0 110.56 171.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.98 -35.61 34.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.624 1.57 . . . . 20.0 115.225 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.58 -41.42 72.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.226 1.375 . . . . 20.0 112.306 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.32 -43.59 85.75 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.777 -0.577 . . . . 20.0 111.37 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -63.13 -39.98 96.26 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.475 -0.766 . . . . 20.0 112.239 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -57.05 -49.94 74.27 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.05 -1.031 . . . . 20.0 111.548 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.95 -45.46 78.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 20.0 112.239 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.96 -48.73 79.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.27 0.628 . . . . 20.0 112.034 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.73 -38.37 90.85 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 20.0 112.403 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.78 -45.59 91.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.807 0.73 . . . . 20.0 112.048 170.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.5 m -62.67 -42.41 99.6 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.724 0.693 . . . . 20.0 112.118 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.78 -46.1 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.431 -0.793 . . . . 20.0 111.093 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.12 -39.48 94.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.788 0.722 . . . . 20.0 112.715 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -60.77 -47.45 86.28 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.716 0.806 . . . . 20.0 111.958 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.09 -34.3 72.97 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.901 0.704 . . . . 20.0 112.901 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.59 91.73 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.434 -0.791 . . . . 20.0 112.369 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.11 98.57 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.264 0.625 . . . . 20.0 111.781 172.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.12 -42.27 99.5 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 20.0 112.163 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.81 -48.49 79.57 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.661 0.664 . . . . 20.0 111.669 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.06 -30.33 71.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.906 0.706 . . . . 20.0 112.906 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.17 -38.99 79.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.331 1.052 . . . . 20.0 112.457 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.4 -27.58 41.81 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.807 1.243 . . . . 20.0 113.306 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.1 54.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.587 1.955 . . . . 20.0 111.217 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.0 120.13 7.4 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.483 2.122 . . . . 20.0 110.242 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.41 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.366 1.466 . . . . 20.0 112.158 -169.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.09 160.47 25.76 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.103 0.561 . . . . 20.0 110.903 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -19.97 65.05 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.367 1.247 . . . . 20.0 114.367 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.88 174.81 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.064 1.316 . . . . 20.0 112.68 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.57 169.17 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.66 2.907 . . . . 20.0 112.906 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.73 -39.05 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.843 1.257 . . . . 20.0 111.82 -175.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.55 161.85 28.7 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.877 1.671 . . . . 20.0 110.603 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.92 133.45 22.9 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.473 2.782 . . . . 20.0 113.132 168.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.94 -15.02 60.35 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.567 1.08 . . . . 20.0 115.001 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -78.14 143.36 37.35 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.978 1.389 . . . . 20.0 110.187 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.14 145.58 54.24 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.719 -0.613 . . . . 20.0 110.826 168.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.51 152.69 45.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.717 0.807 . . . . 20.0 111.616 171.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.21 131.73 84.9 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.917 -0.563 . . . . 20.0 109.834 170.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.42 140.27 43.55 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.096 1.864 . . . . 20.0 112.451 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -74.92 171.62 13.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.743 1.617 . . . . 20.0 111.872 163.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.87 94.09 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.935 -0.478 . . . . 20.0 112.998 168.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.75 -25.83 64.93 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.059 1.133 . . . . 20.0 114.059 175.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.6 64.98 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.062 -1.024 . . . . 20.0 111.742 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.65 -42.72 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.731 0.812 . . . . 20.0 110.812 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.29 14.06 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.87 1.063 . . . . 20.0 113.87 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.26 74.28 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 120.865 -1.147 . . . . 20.0 115.393 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.41 19.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.11 1.455 . . . . 20.0 113.263 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.6 p -126.22 -1.46 7.02 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.273 1.212 . . . . 20.0 114.273 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.67 149.96 24.46 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.032 0.933 . . . . 20.0 111.824 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.8 p -82.02 162.43 22.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.347 0.594 . . . . 20.0 110.797 170.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.71 -39.5 73.97 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.404 -0.81 . . . . 20.0 111.454 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.5 -38.95 93.08 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.512 -0.742 . . . . 20.0 112.648 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.55 -42.78 95.47 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.637 -0.665 . . . . 20.0 112.084 171.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.63 -46.36 90.59 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.603 0.761 . . . . 20.0 112.156 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.47 -46.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.091 0.956 . . . . 20.0 110.288 172.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.07 54.18 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 20.0 112.869 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 20.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 20.0 114.434 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.91 8.36 20.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.645 1.178 . . . . 20.0 113.033 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.38 162.3 1.58 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.027 1.331 . . . . 20.0 111.396 165.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.59 103.32 48.95 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.071 0.949 . . . . 20.0 110.837 176.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.13 163.84 89.13 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.462 0.844 . . . . 20.0 111.701 -6.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -50.03 141.37 30.02 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 20.0 114.168 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.3 mt -96.11 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 20.0 104.858 163.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.98 54.57 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 20.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.89 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.029 1.122 . . . . 20.0 114.029 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.27 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.688 0.676 . . . . 20.0 112.958 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.86 -36.86 75.85 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.289 -1.124 . . . . 20.0 112.693 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.89 -44.62 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.808 -0.557 . . . . 20.0 109.952 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.41 91.65 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.303 -0.873 . . . . 20.0 112.533 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -41.97 74.91 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.395 -0.816 . . . . 20.0 112.287 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.74 -45.19 82.13 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.889 0.768 . . . . 20.0 112.12 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.37 -40.54 85.74 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.287 0.635 . . . . 20.0 112.227 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.58 -47.23 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.039 0.536 . . . . 20.0 110.235 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.05 -37.39 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.749 1.22 . . . . 20.0 112.308 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.87 98.53 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.01 0.823 . . . . 20.0 111.194 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.53 -45.02 91.88 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.832 0.729 . . . . 20.0 113.26 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.42 -42.49 87.37 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.002 0.901 . . . . 20.0 111.056 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.5 -50.12 70.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.795 0.838 . . . . 20.0 112.449 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.79 -43.35 76.74 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.915 0.78 . . . . 20.0 111.996 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.6 mt -64.28 -48.32 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.26 0.624 . . . . 20.0 111.366 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.54 -31.48 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.791 1.178 . . . . 20.0 112.981 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -61.43 -42.14 98.29 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.102 0.864 . . . . 20.0 111.642 171.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.3 ttp -80.6 -36.29 32.96 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.726 1.61 . . . . 20.0 113.884 -174.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 1.103 ' OXT' ' C ' ' A' ' 145' ' ' TYR . 70.5 m-85 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 127.784 2.434 . . . . 20.0 114.432 -168.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 N--CA 1.479 0.661 0 N-CA-C 113.01 0.35 . . . . 0.0 113.01 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.58 135.04 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.47 1.108 . . . . 0.0 108.413 163.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -126.07 155.0 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.633 170.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -104.84 116.81 32.64 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.465 0.706 . . . . 0.0 109.143 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.48 178.03 6.93 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.587 0.708 . . . . 0.0 112.441 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.94 -26.43 68.81 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.11 57.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.794 1.237 . . . . 0.0 113.011 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.91 85.85 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.514 1.054 . . . . 0.0 114.128 -175.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.63 128.29 35.68 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.816 1.308 . . . . 0.0 109.695 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.73 29.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 168.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -126.09 123.32 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.075 1.35 . . . . 0.0 108.68 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.57 139.69 38.58 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.18 48.48 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.513 1.925 . . . . 0.0 107.979 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.24 152.35 20.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.202 170.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.86 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.453 0.644 . . . . 0.0 111.555 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 129.96 93.26 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.164 0.585 . . . . 0.0 111.095 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.97 -34.67 68.08 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.907 2.405 . . . . 0.0 113.572 167.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.39 -38.02 86.58 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.508 -0.745 . . . . 0.0 112.594 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.0 -44.31 97.61 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.716 0.689 . . . . 0.0 111.356 171.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.5 -44.33 94.64 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.296 0.498 . . . . 0.0 112.256 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.23 -47.32 85.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.079 0.551 . . . . 0.0 111.417 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.14 96.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.599 0.76 . . . . 0.0 111.896 176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -60.07 -47.5 85.63 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.844 0.858 . . . . 0.0 112.711 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.2 t -56.7 -54.55 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.4 0.545 . . . . 0.0 110.404 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.5 -37.6 78.69 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.348 1.059 . . . . 0.0 113.221 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.61 -51.99 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.945 1.298 . . . . 0.0 111.329 170.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.52 -35.94 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.416 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.64 -23.98 60.21 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.2 -25.85 11.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.8 16.25 3.32 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -166.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.05 -38.49 2.34 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -118.06 15.79 14.16 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.36 1.064 . . . . 0.0 113.055 -171.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 p -114.93 152.7 46.76 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.98 0.912 . . . . 0.0 111.464 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.77 -30.68 57.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.282 2.655 . . . . 0.0 115.205 -172.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.69 64.26 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.643 1.177 . . . . 0.0 114.173 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.93 -31.81 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.424 1.011 . . . . 0.0 112.515 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.1 mt -71.45 -55.05 6.23 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.987 1.315 . . . . 0.0 112.972 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.85 -30.14 49.5 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.685 1.637 . . . . 0.0 112.652 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.6 mtm -69.06 -40.24 78.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.894 1.225 . . . . 0.0 112.65 172.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.22 -46.55 82.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.768 0.713 . . . . 0.0 111.522 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -60.94 -44.69 96.9 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -32.27 71.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.279 1.031 . . . . 0.0 113.246 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.1 4.48 53.65 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.406 1.482 . . . . 0.0 113.539 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.7 p -133.0 22.78 4.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.52 120.35 6.02 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.473 -1.392 . . . . 0.0 111.483 168.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.44 11.63 59.86 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.447 0.939 . . . . 0.0 115.447 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.57 130.88 47.06 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.525 1.663 . . . . 0.0 112.528 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.3 p -73.28 159.66 84.42 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.722 0.809 . . . . 0.0 110.711 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.58 -35.38 37.25 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.134 1.89 . . . . 0.0 115.47 168.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -67.19 -40.2 86.48 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.28 -45.25 93.97 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.626 -0.671 . . . . 0.0 111.098 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.5 mt -63.71 -44.32 93.97 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.351 1.06 . . . . 0.0 112.127 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -59.15 -41.48 88.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.642 0.656 . . . . 0.0 111.984 171.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 m -60.18 -45.28 93.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.599 0.636 . . . . 0.0 111.11 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.42 -48.86 78.01 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.246 0.93 . . . . 0.0 112.153 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.16 -38.44 91.19 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.84 -33.23 70.19 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 p -73.88 -12.44 60.67 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.5 m -122.19 8.14 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.28 -4.5 6.51 Favored Glycine 0 CA--C 1.542 1.753 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.8 -33.51 56.01 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 119.256 1.528 . . . . 0.0 115.389 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -91.18 78.29 5.86 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.802 1.301 . . . . 0.0 110.55 171.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.77 -35.92 34.21 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.95 74.73 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 120.023 1.283 . . . . 0.0 112.303 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.44 -43.54 85.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.194 0.597 . . . . 0.0 111.353 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -62.99 -40.17 96.93 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.545 -0.722 . . . . 0.0 112.263 175.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.95 -49.99 73.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.314 1.045 . . . . 0.0 111.565 173.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.1 tpp -56.04 -45.43 79.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.096 0.958 . . . . 0.0 112.205 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.85 -48.77 79.05 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.289 0.636 . . . . 0.0 112.087 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.72 -38.37 90.84 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.45 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.86 -45.56 92.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.698 0.681 . . . . 0.0 112.014 170.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.9 m -62.56 -42.41 99.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.777 0.717 . . . . 0.0 112.128 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.81 -46.2 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.514 -0.741 . . . . 0.0 111.041 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.07 -39.45 94.09 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.829 0.741 . . . . 0.0 112.759 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.78 -47.46 86.24 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.78 0.832 . . . . 0.0 111.964 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -70.07 -34.41 73.16 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.24 91.71 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.437 -0.789 . . . . 0.0 112.403 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.14 98.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.232 0.613 . . . . 0.0 111.781 172.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.19 99.59 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.834 -0.541 . . . . 0.0 112.183 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.85 -48.69 79.06 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.648 0.658 . . . . 0.0 111.665 173.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.95 -30.13 71.33 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.21 -39.22 78.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.399 1.08 . . . . 0.0 112.443 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.49 42.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.739 1.216 . . . . 0.0 113.32 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.81 60.92 53.35 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 126.675 1.99 . . . . 0.0 111.249 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.94 119.99 7.21 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.509 2.139 . . . . 0.0 110.306 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.24 136.16 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.342 1.457 . . . . 0.0 112.144 -169.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -79.92 160.43 26.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.101 0.561 . . . . 0.0 110.861 168.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.31 -19.8 64.93 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.03 174.68 41.65 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.083 1.325 . . . . 0.0 112.653 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.49 169.11 14.8 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.644 2.896 . . . . 0.0 112.954 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.7 mt -57.65 -39.11 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.894 1.278 . . . . 0.0 111.739 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.54 161.92 28.55 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.841 1.656 . . . . 0.0 110.584 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.96 133.47 23.1 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.479 2.786 . . . . 0.0 113.116 168.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.05 60.32 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.605 1.098 . . . . 0.0 115.019 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.15 143.31 37.37 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.946 1.373 . . . . 0.0 110.234 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.12 145.44 54.38 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.729 -0.607 . . . . 0.0 110.805 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -68.65 153.07 44.46 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.641 0.776 . . . . 0.0 111.673 171.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -72.16 131.7 85.01 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.858 170.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.37 140.53 44.38 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.137 1.891 . . . . 0.0 112.383 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 67.8 mtp85 -75.31 171.59 13.93 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.727 1.611 . . . . 0.0 111.859 163.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.37 -43.72 93.75 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 123.274 0.464 . . . . 0.0 113.04 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.5 p -69.15 -25.64 64.47 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -72.72 -41.66 64.98 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.02 -1.05 . . . . 0.0 111.71 171.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.73 -42.74 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.648 0.779 . . . . 0.0 110.824 173.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.11 -1.16 13.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.0 18.03 74.16 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.953 -1.092 . . . . 0.0 115.453 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.62 19.18 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.147 1.473 . . . . 0.0 113.259 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.2 p -125.9 -0.86 7.26 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.9 p -104.59 149.06 25.84 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.045 0.938 . . . . 0.0 111.798 173.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.4 p -80.95 162.18 23.99 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.348 0.595 . . . . 0.0 110.747 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.2 tp -56.85 -39.32 74.05 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.423 -0.798 . . . . 0.0 111.397 169.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.62 -39.06 93.41 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.558 -0.714 . . . . 0.0 112.644 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -64.37 -42.83 95.97 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.666 -0.646 . . . . 0.0 112.028 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -60.68 -46.35 90.7 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.677 0.791 . . . . 0.0 112.192 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.34 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 110.305 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.43 -51.17 53.36 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.83 0.729 . . . . 0.0 112.913 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.19 -50.08 73.23 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.788 0.794 . . . . 0.0 112.526 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.69 -18.5 64.27 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.1 p -111.81 8.33 20.5 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.675 1.19 . . . . 0.0 113.018 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.36 162.31 1.56 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.009 1.324 . . . . 0.0 111.433 165.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.52 103.38 49.02 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.089 0.956 . . . . 0.0 110.787 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.03 163.83 89.2 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.477 0.849 . . . . 0.0 111.746 -6.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -50.01 141.42 29.71 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.208 2.606 . . . . 0.0 114.173 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.19 96.36 2.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.97 54.6 3.5 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.326 2.684 . . . . 0.0 112.89 -152.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.61 -34.89 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.44 -46.16 94.4 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 118.641 0.655 . . . . 0.0 113.004 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.74 -36.96 76.29 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.313 -1.11 . . . . 0.0 112.667 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.88 -44.63 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.802 -0.561 . . . . 0.0 109.94 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.85 -40.42 91.7 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.327 -0.858 . . . . 0.0 112.547 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -42.02 74.98 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.395 -0.816 . . . . 0.0 112.259 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.72 -45.24 82.0 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.945 0.793 . . . . 0.0 112.093 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.26 -40.53 86.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.308 0.643 . . . . 0.0 112.251 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.68 -47.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.032 0.533 . . . . 0.0 110.279 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.19 -37.37 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.698 1.199 . . . . 0.0 112.263 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.75 98.36 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.039 0.836 . . . . 0.0 111.245 171.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.5 -45.2 91.08 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.879 0.752 . . . . 0.0 113.235 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.4 -42.28 86.81 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.019 0.91 . . . . 0.0 111.114 173.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.52 -50.2 70.6 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.788 0.835 . . . . 0.0 112.43 173.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -55.84 -43.0 76.62 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.872 0.76 . . . . 0.0 112.062 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.0 mt -64.47 -48.64 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.332 0.653 . . . . 0.0 111.361 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.28 -31.61 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.8 1.182 . . . . 0.0 112.978 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.98 -39.64 90.38 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.057 0.844 . . . . 0.0 111.877 171.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.4 ttp -84.45 -33.36 23.66 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.758 1.623 . . . . 0.0 113.976 -173.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 . . . . . 0 C--O 1.255 1.351 0 C-N-CA 127.599 2.36 . . . . 0.0 114.287 -169.744 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.697 0 N-CA-C 112.967 0.333 . . . . 0.0 112.967 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -92.01 135.02 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.51 1.124 . . . . 0.0 108.448 163.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.04 154.69 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.067 1.347 . . . . 0.0 109.709 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.29 116.62 32.47 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.555 0.742 . . . . 0.0 109.166 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.44 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.573 0.702 . . . . 0.0 112.476 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.87 -26.5 68.8 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -85.68 -2.13 57.88 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.792 1.237 . . . . 0.0 112.998 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.21 85.8 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.426 1.012 . . . . 0.0 114.094 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.14 35.13 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.883 1.342 . . . . 0.0 109.695 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.88 125.53 29.48 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 168.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.86 123.39 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.077 1.351 . . . . 0.0 108.648 -174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.7 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.1 48.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.36 20.98 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.988 0.813 . . . . 0.0 111.217 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.46 136.84 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.605 -0.684 . . . . 0.0 111.537 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.03 93.23 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.1 -34.54 68.75 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.86 2.373 . . . . 0.0 113.572 167.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.48 -38.06 86.47 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.464 -0.773 . . . . 0.0 112.521 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.98 -44.2 97.72 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.805 0.729 . . . . 0.0 111.382 171.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.65 -44.28 94.3 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.341 0.519 . . . . 0.0 112.292 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.26 -47.16 86.39 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.149 0.58 . . . . 0.0 111.338 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.26 95.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.621 0.768 . . . . 0.0 111.856 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -60.31 -46.73 88.83 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.835 0.854 . . . . 0.0 112.818 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.87 -54.53 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.443 0.565 . . . . 0.0 110.31 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.76 -37.23 78.44 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.332 1.053 . . . . 0.0 113.256 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.82 -52.33 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.227 1.411 . . . . 0.0 111.202 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -65.42 -36.08 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.016 0.526 . . . . 0.0 111.484 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.54 -24.05 59.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.2 -25.47 11.5 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.17 16.07 3.24 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -165.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.97 -37.22 2.82 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -175.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.14 15.37 14.09 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.539 1.136 . . . . 0.0 113.087 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -114.9 152.88 46.9 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.937 0.895 . . . . 0.0 111.458 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.75 -30.83 58.42 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.253 2.636 . . . . 0.0 115.222 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -61.93 -20.88 64.27 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.89 -31.84 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.448 1.022 . . . . 0.0 112.512 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.44 -55.07 6.24 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.97 1.308 . . . . 0.0 112.961 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.87 -30.08 49.42 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.72 1.65 . . . . 0.0 112.685 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -68.99 -40.24 78.87 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.849 1.204 . . . . 0.0 112.63 172.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.33 -46.48 83.21 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.771 0.714 . . . . 0.0 111.585 169.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.1 m -61.09 -44.44 97.36 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.76 71.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.281 1.033 . . . . 0.0 113.261 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.61 4.54 53.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.372 1.469 . . . . 0.0 113.508 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.9 p -133.09 22.83 4.14 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -176.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.57 120.31 5.99 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.422 -1.424 . . . . 0.0 111.45 168.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.67 60.04 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.5 130.79 46.75 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.498 1.649 . . . . 0.0 112.53 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.0 p -73.28 159.63 84.51 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.741 0.816 . . . . 0.0 110.666 167.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.46 -35.58 36.67 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.183 1.922 . . . . 0.0 115.422 168.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.96 -40.27 87.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.32 -45.38 93.6 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.662 -0.649 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.53 -44.22 94.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.342 1.057 . . . . 0.0 112.162 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -59.3 -41.35 88.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.587 0.63 . . . . 0.0 112.008 171.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.32 -45.33 93.8 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.65 0.659 . . . . 0.0 111.098 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.29 -48.96 77.57 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.175 0.898 . . . . 0.0 112.143 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.04 -38.6 91.83 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.84 -33.96 71.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.6 p -73.1 -12.64 60.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 m -122.25 7.53 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.68 -5.35 5.08 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 117.094 1.598 . . . . 0.0 117.094 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.56 56.15 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 119.1 1.45 . . . . 0.0 115.519 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -91.22 79.59 5.68 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.977 1.388 . . . . 0.0 110.594 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.82 -36.18 47.1 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.04 -41.21 71.11 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.131 1.332 . . . . 0.0 112.328 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.6 86.3 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.772 -0.58 . . . . 0.0 111.296 172.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.06 -40.07 96.6 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.538 -0.726 . . . . 0.0 112.239 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.91 -50.1 73.6 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.087 -1.008 . . . . 0.0 111.538 173.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.3 tpp -55.99 -45.41 79.01 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.051 0.941 . . . . 0.0 112.231 174.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.93 -48.73 79.14 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.307 0.643 . . . . 0.0 112.109 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.63 -38.31 90.65 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.455 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.03 -45.43 92.85 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 112.019 170.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.6 m -62.67 -42.4 99.6 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.842 0.746 . . . . 0.0 112.113 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.92 -46.04 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.472 -0.768 . . . . 0.0 111.063 174.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.11 -39.44 94.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.876 0.762 . . . . 0.0 112.757 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -60.87 -47.4 86.53 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.714 0.806 . . . . 0.0 111.95 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.12 -34.3 72.92 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.71 -41.79 91.89 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.447 -0.783 . . . . 0.0 112.33 172.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.02 98.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.248 0.619 . . . . 0.0 111.799 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.19 -42.23 99.3 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.812 -0.555 . . . . 0.0 112.211 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.82 -48.38 79.9 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.696 0.68 . . . . 0.0 111.675 173.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -63.16 -30.33 71.5 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.13 -38.96 79.13 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.306 1.042 . . . . 0.0 112.489 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.31 -27.64 42.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.833 1.253 . . . . 0.0 113.346 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.79 61.04 54.13 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.583 1.953 . . . . 0.0 111.22 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.95 120.12 7.39 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.452 2.102 . . . . 0.0 110.266 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.42 136.56 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.283 1.433 . . . . 0.0 112.119 -169.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.07 160.49 25.78 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.098 0.559 . . . . 0.0 110.905 168.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.26 -19.92 64.99 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 174.8 41.62 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.018 1.294 . . . . 0.0 112.602 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.62 169.16 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.944 177.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.61 -39.21 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.88 1.272 . . . . 0.0 111.801 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.49 161.93 28.54 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.817 1.647 . . . . 0.0 110.549 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.441 2.761 . . . . 0.0 113.132 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -15.03 60.34 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.577 1.084 . . . . 0.0 115.065 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.35 37.47 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.928 1.364 . . . . 0.0 110.198 173.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.2 145.62 54.14 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.753 -0.592 . . . . 0.0 110.835 168.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.51 152.72 44.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.717 0.807 . . . . 0.0 111.653 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.27 131.75 84.78 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.886 -0.578 . . . . 0.0 109.797 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.46 140.25 43.31 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.122 1.881 . . . . 0.0 112.414 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.3 mtp85 -74.86 171.58 13.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.716 1.607 . . . . 0.0 111.849 163.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.52 -43.87 93.97 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.934 -0.479 . . . . 0.0 113.029 168.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.73 -25.83 64.95 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 175.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.75 -41.6 64.93 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.986 -1.071 . . . . 0.0 111.739 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.68 -42.69 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.716 0.806 . . . . 0.0 110.756 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.91 -1.32 13.94 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 173.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.91 18.17 74.14 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.603 1.096 . . . . 0.0 115.488 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.3 -19.38 19.31 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.073 1.436 . . . . 0.0 113.284 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.0 p -126.23 -1.48 7.01 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.71 149.99 24.46 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.024 0.93 . . . . 0.0 111.737 173.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 p -81.89 162.32 22.81 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.293 0.568 . . . . 0.0 110.811 170.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.74 -39.49 74.06 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.424 -0.798 . . . . 0.0 111.425 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.59 -38.82 92.59 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.518 -0.739 . . . . 0.0 112.657 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -64.67 -42.75 95.15 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.622 -0.673 . . . . 0.0 111.997 171.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.3 90.87 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.58 0.752 . . . . 0.0 112.146 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.5 -46.4 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.151 0.981 . . . . 0.0 110.256 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.45 -51.04 54.34 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.793 0.711 . . . . 0.0 112.881 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.828 0.814 . . . . 0.0 112.485 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.68 -18.39 64.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.96 8.35 20.24 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.664 1.186 . . . . 0.0 113.033 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.43 162.31 1.6 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.978 1.311 . . . . 0.0 111.412 165.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.36 48.93 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.005 0.922 . . . . 0.0 110.836 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.14 163.81 89.19 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-N 119.462 0.844 . . . . 0.0 111.715 -6.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -49.95 141.29 29.56 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.205 2.604 . . . . 0.0 114.169 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.13 96.49 2.49 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 163.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.92 54.52 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.257 2.638 . . . . 0.0 112.909 -152.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.83 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.26 94.22 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.985 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.91 -36.78 75.65 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.358 -1.084 . . . . 0.0 112.648 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.03 -44.46 99.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.745 -0.597 . . . . 0.0 109.951 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.93 -40.42 91.4 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.313 -0.867 . . . . 0.0 112.489 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -41.96 74.96 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.8 -45.29 82.31 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.912 0.778 . . . . 0.0 112.093 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.25 -40.51 86.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.233 0.613 . . . . 0.0 112.279 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.57 -47.37 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.23 174.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -61.91 -37.29 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.707 1.203 . . . . 0.0 112.355 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.88 -42.83 98.73 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.057 0.844 . . . . 0.0 111.187 171.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.58 -44.99 91.83 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.87 0.748 . . . . 0.0 113.257 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.24 -42.69 86.88 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.876 0.87 . . . . 0.0 110.997 173.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.17 70.6 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.791 0.836 . . . . 0.0 112.454 173.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.74 -43.41 76.58 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 118.87 0.759 . . . . 0.0 111.992 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.1 mt -64.47 -48.19 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.342 0.657 . . . . 0.0 111.361 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.44 -31.66 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.73 1.15 . . . . 0.0 112.983 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -61.67 -43.58 98.58 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.168 0.895 . . . . 0.0 111.649 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.9 ttp -77.11 -35.75 56.12 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.726 1.61 . . . . 0.0 113.696 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 127.641 2.376 . . . . 0.0 114.205 -168.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 N--CA 1.48 0.686 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.81 135.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.03 154.89 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.665 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.61 116.71 32.53 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.521 0.729 . . . . 0.0 109.19 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.46 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.507 0.67 . . . . 0.0 112.474 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.54 68.79 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.58 -2.18 57.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.851 1.26 . . . . 0.0 113.043 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.94 3.1 85.8 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.458 1.028 . . . . 0.0 114.08 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.2 35.34 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.883 1.342 . . . . 0.0 109.727 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.85 125.55 29.51 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.94 123.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.074 1.349 . . . . 0.0 108.629 -174.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.58 139.66 38.57 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.487 0.66 . . . . 0.0 111.239 170.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.07 48.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.491 1.916 . . . . 0.0 107.921 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.2 152.37 20.77 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.019 0.827 . . . . 0.0 111.259 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.87 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.462 0.649 . . . . 0.0 111.579 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.01 93.24 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.99 -34.56 67.76 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.907 2.405 . . . . 0.0 113.604 167.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.48 -38.06 86.47 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.457 -0.777 . . . . 0.0 112.594 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 m -60.93 -44.31 97.41 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.691 0.678 . . . . 0.0 111.401 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.52 -44.39 94.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.251 0.478 . . . . 0.0 112.256 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.18 -47.3 85.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.115 0.566 . . . . 0.0 111.366 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.23 95.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.672 0.789 . . . . 0.0 111.908 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -60.16 -47.16 87.08 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.806 0.842 . . . . 0.0 112.783 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.75 -54.57 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.443 0.565 . . . . 0.0 110.375 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.62 -37.36 78.4 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.296 1.039 . . . . 0.0 113.234 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.43 -52.16 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.094 1.358 . . . . 0.0 111.296 170.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -64.8 -35.86 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 122.909 0.484 . . . . 0.0 111.471 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.74 -23.82 60.56 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.38 -25.64 11.35 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.06 16.16 3.26 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -166.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.42 -37.95 2.57 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -118.17 15.66 14.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.438 1.095 . . . . 0.0 113.057 -172.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.0 p -115.0 152.86 46.97 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.966 0.907 . . . . 0.0 111.463 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.88 -30.61 58.75 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.262 2.641 . . . . 0.0 115.208 -172.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.19 -20.67 64.41 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.87 -31.84 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.41 1.005 . . . . 0.0 112.548 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.6 mt -71.47 -55.05 6.21 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.966 1.307 . . . . 0.0 112.971 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.88 -30.05 49.34 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.653 1.626 . . . . 0.0 112.641 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.16 -40.16 78.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.867 1.212 . . . . 0.0 112.602 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.25 -46.46 83.01 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.808 0.731 . . . . 0.0 111.576 169.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.6 m -61.12 -44.42 97.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.0 71.51 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.333 1.053 . . . . 0.0 113.208 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.41 4.5 53.27 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.367 1.467 . . . . 0.0 113.488 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.5 p -133.01 22.8 4.16 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.68 120.31 6.05 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 120.477 -1.389 . . . . 0.0 111.477 168.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.63 11.57 60.24 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.377 0.911 . . . . 0.0 115.377 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.52 130.88 47.14 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.575 1.687 . . . . 0.0 112.464 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.39 159.64 84.35 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.758 0.823 . . . . 0.0 110.685 167.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.61 -35.4 37.6 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.144 1.896 . . . . 0.0 115.4 168.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -66.99 -40.29 87.36 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 174.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.35 93.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.039 172.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.56 -44.26 94.64 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 112.133 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -59.17 -41.49 88.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.618 0.645 . . . . 0.0 112.031 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.8 m -60.29 -45.22 94.1 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.582 0.628 . . . . 0.0 111.074 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.37 -48.91 77.8 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.254 0.934 . . . . 0.0 112.179 174.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.13 -38.45 91.24 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.89 -33.45 70.54 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.4 p -73.65 -12.5 60.76 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 m -122.19 7.88 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.72 -4.62 5.77 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 117.159 1.624 . . . . 0.0 117.159 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.88 -33.13 56.19 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 119.224 1.512 . . . . 0.0 115.423 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -91.32 78.7 5.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.892 1.346 . . . . 0.0 110.605 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.26 -35.82 39.1 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -173.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.41 -41.1 73.38 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.086 1.312 . . . . 0.0 112.315 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.28 -43.56 86.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.167 0.587 . . . . 0.0 111.337 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.3 tpp -63.1 -40.1 96.65 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.565 -0.709 . . . . 0.0 112.229 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.93 -50.02 73.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.218 1.007 . . . . 0.0 111.539 173.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.95 -45.5 78.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.044 0.938 . . . . 0.0 112.233 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -61.88 -48.77 79.01 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.276 0.63 . . . . 0.0 112.055 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.64 -38.28 90.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.845 0.858 . . . . 0.0 112.479 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.98 -45.45 92.67 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.668 0.667 . . . . 0.0 112.048 170.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.7 -42.39 99.61 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.815 0.734 . . . . 0.0 112.082 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.85 -46.1 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.441 -0.787 . . . . 0.0 111.059 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.08 -39.46 94.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.831 0.741 . . . . 0.0 112.736 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.84 -47.37 86.69 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.667 0.787 . . . . 0.0 111.971 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -70.13 -34.3 72.89 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.68 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.43 -0.794 . . . . 0.0 112.361 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.11 98.68 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.231 0.613 . . . . 0.0 111.781 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.21 99.57 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 0.0 112.218 174.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.85 -48.55 79.47 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.667 0.667 . . . . 0.0 111.726 173.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.04 -30.25 71.46 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.12 -39.18 79.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.343 1.057 . . . . 0.0 112.499 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.64 42.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 113.29 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.72 61.01 54.1 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.67 1.988 . . . . 0.0 111.247 -174.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.9 120.17 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.452 2.101 . . . . 0.0 110.315 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.36 136.31 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.377 1.471 . . . . 0.0 112.136 -169.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.97 160.45 25.92 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.124 0.57 . . . . 0.0 110.855 168.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.91 65.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.99 174.77 41.63 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.059 1.314 . . . . 0.0 112.64 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.58 169.15 14.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.682 2.921 . . . . 0.0 112.878 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.68 -39.15 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.873 1.269 . . . . 0.0 111.787 -175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.51 161.9 28.6 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.856 1.662 . . . . 0.0 110.561 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.83 133.42 22.44 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.519 2.812 . . . . 0.0 113.132 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.89 -15.0 60.33 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.551 1.072 . . . . 0.0 115.001 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.11 143.39 37.38 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.996 1.398 . . . . 0.0 110.214 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.24 145.52 54.19 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.664 -0.647 . . . . 0.0 110.793 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.52 152.78 44.91 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.674 0.79 . . . . 0.0 111.617 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.23 131.68 84.9 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.883 -0.58 . . . . 0.0 109.821 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.37 140.4 44.03 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.076 1.851 . . . . 0.0 112.426 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -75.08 171.66 13.72 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.679 1.592 . . . . 0.0 111.89 163.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.78 94.19 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.912 -0.493 . . . . 0.0 113.04 168.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.1 p -68.81 -25.78 64.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.7 64.98 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.989 -1.069 . . . . 0.0 111.727 171.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.6 -42.74 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.704 0.801 . . . . 0.0 110.771 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.2 13.79 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.92 18.11 74.09 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.897 -1.127 . . . . 0.0 115.496 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.47 19.29 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.073 1.436 . . . . 0.0 113.29 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -126.18 -1.38 7.04 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.67 149.91 24.51 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.14 0.976 . . . . 0.0 111.763 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.0 p -81.86 162.27 22.87 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.319 0.581 . . . . 0.0 110.778 170.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.74 -39.4 73.89 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.415 -0.803 . . . . 0.0 111.404 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.55 -38.97 93.16 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.481 -0.762 . . . . 0.0 112.659 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.77 95.55 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.39 90.54 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.119 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.4 -46.39 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.203 1.001 . . . . 0.0 110.285 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.01 54.55 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.753 0.692 . . . . 0.0 112.945 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.32 -50.01 73.34 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.751 0.776 . . . . 0.0 112.537 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.69 -18.49 64.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.93 8.42 20.32 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.651 1.18 . . . . 0.0 113.035 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.45 162.31 1.62 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.989 1.316 . . . . 0.0 111.414 165.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.451 0.84 . . . . 0.0 111.701 -6.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.99 141.33 29.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.258 2.639 . . . . 0.0 114.136 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.3 mt -96.15 96.49 2.5 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 163.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -86.02 54.59 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.289 2.659 . . . . 0.0 112.86 -152.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.84 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.36 -46.34 94.07 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 118.605 0.639 . . . . 0.0 112.958 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.82 -36.8 75.93 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.313 -1.11 . . . . 0.0 112.678 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.97 -44.56 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.732 -0.605 . . . . 0.0 109.942 174.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.46 91.67 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.292 -0.88 . . . . 0.0 112.504 176.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.04 75.08 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.275 173.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.67 -45.23 81.82 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.901 0.773 . . . . 0.0 112.12 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.31 -40.5 86.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.296 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.62 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.044 0.538 . . . . 0.0 110.291 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.03 -37.35 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.683 1.193 . . . . 0.0 112.355 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.75 98.19 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.03 0.832 . . . . 0.0 111.275 171.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.67 -45.0 91.52 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.828 0.727 . . . . 0.0 113.23 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.4 -42.42 87.11 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.075 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.21 70.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.811 0.844 . . . . 0.0 112.425 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.79 -43.28 76.68 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.892 0.769 . . . . 0.0 111.968 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.37 -48.36 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.337 0.655 . . . . 0.0 111.415 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.34 -31.74 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 119.725 1.148 . . . . 0.0 113.012 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -61.14 -41.76 97.31 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.074 0.852 . . . . 0.0 111.722 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.7 ttp -80.96 -34.43 33.16 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.738 1.615 . . . . 0.0 113.935 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 127.614 2.366 . . . . 0.0 114.236 -169.036 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.81 135.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.08 154.81 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.685 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.55 116.74 32.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.488 0.715 . . . . 0.0 109.191 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.84 -26.49 68.78 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -173.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.58 -2.21 57.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.852 1.261 . . . . 0.0 112.991 175.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.02 85.77 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.5 1.048 . . . . 0.0 114.144 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.7 128.23 35.47 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.801 1.301 . . . . 0.0 109.678 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.89 125.57 29.55 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.88 123.39 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.11 1.364 . . . . 0.0 108.7 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.71 38.55 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.72 141.11 48.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.465 1.906 . . . . 0.0 107.929 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.27 152.4 20.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.217 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.9 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.607 -0.683 . . . . 0.0 111.579 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.66 130.01 93.24 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.068 0.547 . . . . 0.0 111.125 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.887 2.391 . . . . 0.0 113.575 167.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.41 -38.05 86.6 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.451 -0.78 . . . . 0.0 112.587 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.8 m -60.96 -44.32 97.48 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.747 0.703 . . . . 0.0 111.386 171.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.54 -44.37 94.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.258 0.481 . . . . 0.0 112.244 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.22 -47.27 85.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.115 0.566 . . . . 0.0 111.37 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.96 -45.26 95.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.67 0.788 . . . . 0.0 111.914 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.22 -47.09 87.42 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.868 0.867 . . . . 0.0 112.774 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.8 t -56.82 -54.55 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.489 0.586 . . . . 0.0 110.31 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.61 -37.4 78.47 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.35 1.06 . . . . 0.0 113.247 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.36 -52.17 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.092 1.357 . . . . 0.0 111.302 170.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.82 -35.99 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.996 0.518 . . . . 0.0 111.407 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.69 -23.86 60.3 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.34 -25.62 11.38 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -136.03 16.15 3.27 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -166.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.47 -37.91 2.61 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -118.08 15.62 14.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.478 1.111 . . . . 0.0 113.107 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.7 p -114.91 152.87 46.9 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.959 0.903 . . . . 0.0 111.49 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.86 -30.63 58.77 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.238 2.625 . . . . 0.0 115.276 -172.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.11 -20.73 64.36 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.81 -31.96 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 119.466 1.03 . . . . 0.0 112.479 176.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.36 -55.07 6.34 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.957 1.303 . . . . 0.0 112.995 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.88 -30.08 49.28 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.681 1.636 . . . . 0.0 112.671 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.05 -40.2 78.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.914 1.234 . . . . 0.0 112.665 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.3 -46.48 83.12 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.421 0.689 . . . . 0.0 111.576 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -61.07 -44.45 97.36 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.85 -32.03 71.45 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.284 1.034 . . . . 0.0 113.278 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.36 4.47 53.36 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.355 1.462 . . . . 0.0 113.484 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -133.03 22.84 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.58 120.3 5.99 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.456 -1.402 . . . . 0.0 111.432 168.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.67 60.04 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 130.88 47.14 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.498 1.649 . . . . 0.0 112.482 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.35 159.66 84.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.753 0.821 . . . . 0.0 110.666 167.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.22 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.34 -45.33 93.83 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.66 -0.65 . . . . 0.0 111.1 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -59.28 -41.34 88.68 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.692 -0.63 . . . . 0.0 112.02 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.27 -45.32 93.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.596 0.634 . . . . 0.0 111.097 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.32 -48.91 77.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.233 0.924 . . . . 0.0 112.179 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.11 -38.46 91.27 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.91 -33.56 70.69 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.9 p -73.5 -12.54 60.82 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.24 7.85 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.54 -4.69 5.55 Favored Glycine 0 CA--C 1.541 1.684 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.96 -32.99 56.57 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.186 1.493 . . . . 0.0 115.435 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -91.28 78.76 5.74 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.918 1.359 . . . . 0.0 110.619 171.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.36 -35.92 40.74 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.43 -41.15 73.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.137 1.335 . . . . 0.0 112.293 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.51 86.07 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.139 0.576 . . . . 0.0 111.329 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.09 -40.12 96.71 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.514 -0.741 . . . . 0.0 112.198 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.98 -49.97 74.1 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.202 1.001 . . . . 0.0 111.518 173.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.97 -45.46 78.92 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.094 0.958 . . . . 0.0 112.245 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.91 -48.77 78.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.331 0.652 . . . . 0.0 112.055 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.66 -38.27 90.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.453 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.01 -45.48 92.62 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.664 0.665 . . . . 0.0 112.048 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.65 -42.37 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.118 175.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.85 -46.14 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.441 -0.787 . . . . 0.0 111.03 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.06 -39.46 94.13 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.842 0.746 . . . . 0.0 112.736 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -60.78 -47.49 86.1 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.943 174.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.06 -34.33 73.07 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.69 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.408 -0.808 . . . . 0.0 112.361 172.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.09 98.7 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.215 0.606 . . . . 0.0 111.751 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.12 -42.25 99.49 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.86 -0.525 . . . . 0.0 112.138 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.81 -48.52 79.5 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.666 0.666 . . . . 0.0 111.722 173.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.11 -30.19 71.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.22 -39.06 78.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.354 1.062 . . . . 0.0 112.482 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.3 -27.6 42.18 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.791 1.236 . . . . 0.0 113.29 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.78 60.99 53.88 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.639 1.976 . . . . 0.0 111.22 -174.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.92 120.21 7.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.481 2.12 . . . . 0.0 110.24 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.46 136.37 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.287 1.435 . . . . 0.0 112.13 -169.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.04 160.47 25.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.075 0.55 . . . . 0.0 110.915 168.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.92 65.01 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.11 1.338 . . . . 0.0 112.655 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.59 169.15 14.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.687 2.925 . . . . 0.0 112.878 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.68 -39.19 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.903 1.281 . . . . 0.0 111.749 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.44 161.97 28.44 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.817 1.647 . . . . 0.0 110.573 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.97 133.45 23.18 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.477 2.785 . . . . 0.0 113.149 168.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.99 60.34 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.613 1.101 . . . . 0.0 115.051 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.38 37.45 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.952 1.376 . . . . 0.0 110.198 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.51 54.26 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.66 -0.65 . . . . 0.0 110.842 168.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.48 152.73 44.98 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.684 0.794 . . . . 0.0 111.653 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.23 131.65 84.93 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.33 140.35 44.06 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -75.02 171.61 13.79 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.733 1.613 . . . . 0.0 111.867 163.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.57 -43.9 94.05 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.876 -0.515 . . . . 0.0 113.021 168.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.79 -25.78 64.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.69 -41.69 65.03 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.064 -1.022 . . . . 0.0 111.757 171.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.54 -42.84 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.73 0.812 . . . . 0.0 110.798 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.95 -1.26 13.83 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.98 18.15 74.24 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.626 1.107 . . . . 0.0 115.445 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.38 19.3 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.131 1.466 . . . . 0.0 113.301 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -126.2 -1.48 7.03 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.66 149.96 24.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.052 0.941 . . . . 0.0 111.788 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.5 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.293 0.568 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.83 -39.4 74.15 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.441 -0.787 . . . . 0.0 111.374 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.52 -38.93 93.02 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.531 -0.73 . . . . 0.0 112.685 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.64 -42.73 95.27 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 112.031 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.66 -46.37 90.58 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.651 0.78 . . . . 0.0 112.143 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.32 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.301 172.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.45 -51.06 54.19 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.782 0.706 . . . . 0.0 112.884 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 0.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.64 -18.49 64.3 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.87 8.36 20.4 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.703 1.201 . . . . 0.0 113.051 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.44 162.31 1.61 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.995 1.318 . . . . 0.0 111.447 165.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.34 48.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.035 0.934 . . . . 0.0 110.837 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.447 0.838 . . . . 0.0 111.701 -6.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.99 141.33 29.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.258 2.639 . . . . 0.0 114.136 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.17 96.48 2.51 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 163.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -86.0 54.56 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.257 2.638 . . . . 0.0 112.86 -152.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.56 -34.83 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.26 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.999 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.83 -36.87 75.95 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.91 -44.6 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.709 -0.62 . . . . 0.0 109.942 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.78 -40.5 92.02 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.307 -0.871 . . . . 0.0 112.559 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.78 -41.97 74.85 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.468 -0.77 . . . . 0.0 112.287 173.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.76 -45.22 82.2 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.889 0.768 . . . . 0.0 112.093 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.31 -40.5 86.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.296 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.62 -47.19 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.067 0.547 . . . . 0.0 110.272 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.15 -37.35 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.682 1.193 . . . . 0.0 112.292 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.82 -42.76 98.3 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.011 0.823 . . . . 0.0 111.244 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.59 -45.03 91.61 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.87 0.748 . . . . 0.0 113.252 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.4 -42.42 87.11 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.075 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.49 -50.16 70.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.811 0.844 . . . . 0.0 112.453 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.81 -43.27 76.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.875 0.762 . . . . 0.0 112.005 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.37 -48.36 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.337 0.655 . . . . 0.0 111.415 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.34 -31.81 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 119.725 1.148 . . . . 0.0 113.012 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -61.03 -42.07 97.76 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.058 0.845 . . . . 0.0 111.721 171.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.1 ttp -80.47 -34.64 35.73 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.761 1.624 . . . . 0.0 113.901 -174.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 127.621 2.368 . . . . 0.0 114.251 -168.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.998 0.345 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.9 mm -92.07 135.01 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.484 1.114 . . . . 0.0 108.489 163.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.03 154.6 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.076 1.35 . . . . 0.0 109.662 170.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.22 116.74 32.71 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.554 0.742 . . . . 0.0 109.201 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.53 177.98 7.01 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.557 0.694 . . . . 0.0 112.436 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.84 -26.54 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.63 -2.2 57.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.81 1.244 . . . . 0.0 113.047 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.97 3.17 85.66 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.418 1.009 . . . . 0.0 114.096 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.14 35.11 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.857 1.328 . . . . 0.0 109.726 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.84 125.55 29.52 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 168.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.84 123.38 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.077 1.351 . . . . 0.0 108.679 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.53 139.63 38.62 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.236 170.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.71 141.16 48.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.431 1.892 . . . . 0.0 107.897 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.28 152.44 20.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.803 . . . . 0.0 111.221 170.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.51 136.86 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.65 -0.656 . . . . 0.0 111.563 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.65 129.96 93.27 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.07 0.548 . . . . 0.0 111.155 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.05 -34.46 67.9 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.864 2.376 . . . . 0.0 113.597 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.55 -38.06 86.32 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.453 -0.779 . . . . 0.0 112.521 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.02 -44.13 97.86 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.805 0.729 . . . . 0.0 111.372 171.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.66 -44.37 93.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.354 0.525 . . . . 0.0 112.311 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.18 -47.11 86.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.424 0.556 . . . . 0.0 111.38 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.05 -45.34 95.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.612 0.765 . . . . 0.0 111.866 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -60.41 -46.39 90.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.808 0.843 . . . . 0.0 112.846 177.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.04 -54.51 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 118.458 0.572 . . . . 0.0 110.302 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.77 -37.11 78.14 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.404 1.082 . . . . 0.0 113.289 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.61 -52.41 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.398 1.479 . . . . 0.0 111.223 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.64 -36.2 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.069 0.548 . . . . 0.0 111.479 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.51 -24.24 60.03 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 175.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -106.93 -25.38 11.67 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -136.32 15.7 3.21 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -165.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.62 -37.36 2.53 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -117.23 12.5 14.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.478 1.111 . . . . 0.0 113.198 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.9 p -111.63 153.21 44.37 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.876 0.87 . . . . 0.0 111.497 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.83 -30.87 59.54 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.284 2.656 . . . . 0.0 115.173 -172.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.09 -20.98 64.59 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.61 -32.13 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.437 1.017 . . . . 0.0 112.458 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.41 -57.17 5.92 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.718 1.207 . . . . 0.0 112.538 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.89 -29.5 58.21 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 121.885 1.709 . . . . 0.0 112.786 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.13 -40.13 78.46 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.779 1.172 . . . . 0.0 112.698 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.25 -47.08 82.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.848 0.749 . . . . 0.0 111.546 169.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m -60.88 -44.11 97.53 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 175.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.54 70.96 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.249 1.019 . . . . 0.0 113.252 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -96.0 4.69 52.44 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.382 1.473 . . . . 0.0 113.491 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.8 p -133.17 22.78 4.11 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -53.57 120.25 5.92 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.437 -1.414 . . . . 0.0 111.42 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.6 11.68 60.35 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 115.391 0.916 . . . . 0.0 115.391 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.84 46.9 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.516 1.658 . . . . 0.0 112.481 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.27 159.68 84.4 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.718 0.807 . . . . 0.0 110.7 167.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.53 -35.5 37.15 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.144 1.896 . . . . 0.0 115.412 168.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.98 -40.32 87.4 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 174.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.29 -45.33 93.72 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.062 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.5 mt -63.53 -44.24 94.79 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.31 1.044 . . . . 0.0 112.151 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -59.26 -41.36 88.61 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.663 -0.648 . . . . 0.0 112.024 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.6 m -60.33 -45.43 93.45 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.626 0.648 . . . . 0.0 111.078 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.17 -49.01 77.29 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.218 0.917 . . . . 0.0 112.17 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.7 mt -63.04 -38.62 91.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.95 -34.2 71.49 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.3 p -72.88 -12.52 61.0 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.44 7.49 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.44 -5.75 5.23 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 117.102 1.601 . . . . 0.0 117.102 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.96 56.42 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 119.053 1.427 . . . . 0.0 115.526 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -90.23 79.8 6.33 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.029 1.414 . . . . 0.0 110.607 171.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -52.1 -36.28 50.44 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.23 -41.32 70.32 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.203 1.365 . . . . 0.0 112.348 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.17 -43.52 86.66 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.784 -0.573 . . . . 0.0 111.335 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -63.15 -40.03 96.38 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.566 -0.708 . . . . 0.0 112.204 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.88 -50.07 73.6 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.072 -1.017 . . . . 0.0 111.538 172.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.03 -45.38 79.19 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.056 0.942 . . . . 0.0 112.22 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.8 tp -61.96 -48.78 78.82 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.295 0.638 . . . . 0.0 112.045 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.71 -38.12 89.9 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.832 0.853 . . . . 0.0 112.45 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.06 -45.53 92.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.653 0.661 . . . . 0.0 112.001 170.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.61 -42.42 99.57 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.806 0.73 . . . . 0.0 112.114 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.9 -46.04 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.506 -0.747 . . . . 0.0 111.037 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -64.16 -39.44 94.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.887 0.767 . . . . 0.0 112.684 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -60.84 -47.44 86.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.934 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -70.05 -34.38 73.14 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.63 -41.98 92.02 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.49 -0.756 . . . . 0.0 112.299 172.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.57 -42.04 98.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.231 0.613 . . . . 0.0 111.784 172.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.15 -42.35 99.44 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.825 -0.547 . . . . 0.0 112.189 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -57.72 -48.48 79.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.677 0.671 . . . . 0.0 111.653 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.06 -30.4 71.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.09 -38.95 79.26 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.359 1.064 . . . . 0.0 112.488 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.44 -27.61 41.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.803 1.241 . . . . 0.0 113.318 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 60.98 53.81 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.583 1.953 . . . . 0.0 111.22 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.89 120.17 7.46 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.456 2.104 . . . . 0.0 110.296 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.52 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.335 1.454 . . . . 0.0 112.154 -169.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.12 160.46 25.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.1 0.56 . . . . 0.0 110.845 168.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.19 -19.96 64.98 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 174.7 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.069 1.319 . . . . 0.0 112.647 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.55 169.2 14.71 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.624 2.883 . . . . 0.0 112.944 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.65 -39.26 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.897 1.279 . . . . 0.0 111.762 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.45 161.91 28.56 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.862 1.665 . . . . 0.0 110.597 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.92 133.42 22.9 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.473 2.782 . . . . 0.0 113.132 168.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -15.05 60.3 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.531 1.063 . . . . 0.0 115.037 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.03 143.35 37.56 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.942 1.371 . . . . 0.0 110.197 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.14 145.64 54.17 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.663 -0.648 . . . . 0.0 110.793 168.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -68.59 152.67 45.05 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.677 0.791 . . . . 0.0 111.69 171.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -72.22 131.78 84.83 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.848 170.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.38 140.26 43.63 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.15 1.9 . . . . 0.0 112.465 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -74.87 171.65 13.65 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.707 1.603 . . . . 0.0 111.879 163.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.54 -44.0 93.95 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.921 -0.487 . . . . 0.0 112.955 168.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.66 -25.9 65.05 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.67 -41.61 65.19 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.057 -1.027 . . . . 0.0 111.777 171.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.66 -42.65 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.737 0.815 . . . . 0.0 110.819 173.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.98 -1.28 13.99 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.93 18.28 74.27 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.899 -1.126 . . . . 0.0 115.437 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.38 -19.39 19.24 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.115 1.458 . . . . 0.0 113.301 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 p -126.21 -1.55 7.02 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.3 p -103.43 150.05 24.22 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.099 0.96 . . . . 0.0 111.783 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.2 p -81.96 162.45 22.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.268 0.556 . . . . 0.0 110.848 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.87 -39.4 74.27 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.444 -0.785 . . . . 0.0 111.445 169.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.52 -38.87 92.8 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.513 -0.742 . . . . 0.0 112.688 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -64.59 -42.8 95.35 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.584 -0.698 . . . . 0.0 112.069 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.68 -46.3 90.87 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.574 0.75 . . . . 0.0 112.155 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.5 -46.36 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.122 0.969 . . . . 0.0 110.288 172.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.42 -51.01 54.42 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.806 0.717 . . . . 0.0 112.945 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.3 -50.09 73.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.751 0.776 . . . . 0.0 112.48 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.66 -18.35 64.26 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -112.01 8.39 20.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.628 1.171 . . . . 0.0 113.035 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.46 162.33 1.62 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.921 1.288 . . . . 0.0 111.461 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.93 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.065 0.946 . . . . 0.0 110.758 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.84 89.15 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.461 0.843 . . . . 0.0 111.713 -6.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -50.0 141.28 29.98 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.216 2.611 . . . . 0.0 114.206 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 74.9 mt -96.1 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 163.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.91 54.48 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.295 2.663 . . . . 0.0 112.884 -152.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.54 -34.85 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.26 94.22 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.985 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.91 -36.84 75.68 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.358 -1.083 . . . . 0.0 112.645 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.92 -44.61 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.753 -0.592 . . . . 0.0 109.987 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.79 -40.39 91.9 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.352 -0.842 . . . . 0.0 112.572 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -55.84 -41.99 75.11 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.476 -0.765 . . . . 0.0 112.287 173.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.76 -45.24 82.16 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.888 0.767 . . . . 0.0 112.125 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.27 -40.56 86.17 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.273 0.629 . . . . 0.0 112.246 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.48 -47.53 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 122.987 0.515 . . . . 0.0 110.216 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.97 -37.12 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.708 1.203 . . . . 0.0 112.326 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.85 98.55 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.107 0.867 . . . . 0.0 111.264 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.85 91.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.838 0.733 . . . . 0.0 113.199 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -58.1 -42.93 86.74 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.02 0.91 . . . . 0.0 110.987 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.24 70.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.842 0.857 . . . . 0.0 112.458 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -55.72 -43.44 76.55 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.894 0.77 . . . . 0.0 111.987 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.9 mt -64.57 -47.48 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 118.707 -0.663 . . . . 0.0 111.452 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.61 -32.99 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 119.918 1.235 . . . . 0.0 112.881 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -60.87 -46.46 90.51 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.949 0.9 . . . . 0.0 111.468 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.4 ttp -72.23 -38.38 68.95 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.588 1.555 . . . . 0.0 113.082 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.7 t80 . . . . . 0 C--O 1.251 1.156 0 C-N-CA 128.345 2.658 . . . . 0.0 114.73 -174.362 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.017 0.353 . . . . 0.0 113.017 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -92.0 135.05 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.51 1.124 . . . . 0.0 108.471 163.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.08 154.66 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.685 170.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.36 116.63 32.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.519 0.728 . . . . 0.0 109.181 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.4 177.97 6.92 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.55 0.69 . . . . 0.0 112.474 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.61 68.82 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.59 -2.12 57.83 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.746 1.219 . . . . 0.0 113.046 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.25 85.75 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.5 1.048 . . . . 0.0 114.066 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.82 128.16 35.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.848 1.324 . . . . 0.0 109.715 174.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.81 125.46 29.38 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 168.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.89 123.39 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.053 1.341 . . . . 0.0 108.659 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.66 141.1 48.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.513 1.925 . . . . 0.0 107.959 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.3 152.38 21.16 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.98 0.809 . . . . 0.0 111.274 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.49 136.85 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.645 -0.659 . . . . 0.0 111.61 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.0 93.24 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.02 -34.56 68.04 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.918 2.412 . . . . 0.0 113.569 167.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.46 -38.08 86.55 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.457 -0.777 . . . . 0.0 112.545 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.98 -44.21 97.7 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.718 0.69 . . . . 0.0 111.425 171.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.58 -44.42 94.11 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.291 0.496 . . . . 0.0 112.256 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.15 -47.17 86.26 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.441 0.564 . . . . 0.0 111.398 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.14 95.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.606 0.763 . . . . 0.0 111.879 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.7 t-105 -60.38 -46.83 88.57 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.734 0.813 . . . . 0.0 112.85 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.98 -54.16 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.436 0.562 . . . . 0.0 110.343 174.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.89 -37.14 78.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.391 1.076 . . . . 0.0 113.249 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.26 -52.46 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.236 1.414 . . . . 0.0 111.236 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.8 t -64.98 -36.09 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.023 0.529 . . . . 0.0 111.441 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.39 -24.04 58.86 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.51 -25.29 11.45 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -136.36 15.98 3.2 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -165.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.05 -36.98 2.77 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 -175.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -117.89 13.61 14.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.415 1.086 . . . . 0.0 113.114 -172.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.4 p -113.03 153.09 45.4 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.944 0.898 . . . . 0.0 111.55 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.88 -30.77 59.6 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.303 2.669 . . . . 0.0 115.181 -172.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -62.05 -20.82 64.36 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.81 -31.83 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.404 1.002 . . . . 0.0 112.525 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.49 -55.02 6.2 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 124.904 1.282 . . . . 0.0 112.968 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.84 -30.15 49.58 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.718 1.649 . . . . 0.0 112.633 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.0 -40.25 78.83 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.911 1.232 . . . . 0.0 112.669 172.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -57.23 -46.53 82.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.716 0.689 . . . . 0.0 111.592 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.2 m -61.04 -44.45 97.39 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.83 71.34 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.317 1.047 . . . . 0.0 113.229 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.54 4.5 53.13 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.455 1.502 . . . . 0.0 113.522 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -133.03 22.76 4.16 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.55 120.26 5.92 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.44 -1.413 . . . . 0.0 111.517 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.52 11.72 60.23 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.57 130.84 46.89 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.546 1.673 . . . . 0.0 112.437 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.31 159.68 84.36 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.7 167.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.53 -35.53 37.25 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.144 1.896 . . . . 0.0 115.412 168.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.96 -40.26 87.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.37 -45.31 93.95 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.695 -0.628 . . . . 0.0 111.038 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -59.18 -41.49 88.61 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.696 -0.628 . . . . 0.0 112.031 171.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.2 m -60.23 -45.28 93.77 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.582 0.628 . . . . 0.0 111.11 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.34 -48.99 77.56 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.246 0.93 . . . . 0.0 112.165 174.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -62.98 -38.38 90.9 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.01 -33.42 70.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.9 p -73.49 -12.72 60.88 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.6 m -122.53 6.98 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.22 -4.1 7.78 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 117.414 1.726 . . . . 0.0 117.414 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.59 -35.58 67.49 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 119.353 1.576 . . . . 0.0 115.173 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -85.35 77.89 9.86 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.944 1.354 . . . . 0.0 110.5 170.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.86 -35.51 32.96 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.597 1.559 . . . . 0.0 115.165 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.6 -41.33 72.45 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.142 1.337 . . . . 0.0 112.345 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.61 86.14 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.767 -0.583 . . . . 0.0 111.362 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -63.11 -40.02 96.4 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.576 -0.702 . . . . 0.0 112.228 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.02 -49.94 74.26 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.018 -1.051 . . . . 0.0 111.523 173.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.97 -45.41 78.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.066 0.946 . . . . 0.0 112.251 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.6 tp -61.94 -48.77 78.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.307 0.643 . . . . 0.0 112.071 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.72 -38.28 90.51 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 0.0 112.44 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.98 -45.49 92.55 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.715 0.689 . . . . 0.0 112.034 170.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.62 -42.43 99.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.793 0.724 . . . . 0.0 112.109 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.82 -46.11 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.426 -0.796 . . . . 0.0 111.03 174.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.12 -39.43 94.03 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.869 0.759 . . . . 0.0 112.724 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -60.82 -47.4 86.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.721 0.808 . . . . 0.0 111.961 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -70.15 -34.3 72.85 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.81 91.08 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.44 -0.788 . . . . 0.0 112.468 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.18 99.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.211 0.604 . . . . 0.0 111.737 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -62.91 -42.12 99.68 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.907 -0.496 . . . . 0.0 112.13 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -58.17 -48.81 79.14 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.641 -0.662 . . . . 0.0 111.751 173.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -62.76 -29.7 70.88 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.73 -39.48 76.78 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.398 1.079 . . . . 0.0 112.52 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.06 -27.59 43.1 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.731 1.212 . . . . 0.0 113.337 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.76 61.1 54.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.675 1.99 . . . . 0.0 111.229 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.77 120.22 7.53 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.484 2.123 . . . . 0.0 110.313 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.38 135.97 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.325 1.45 . . . . 0.0 112.079 -169.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -79.74 160.48 26.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.062 0.545 . . . . 0.0 110.908 168.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.99 65.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 174.78 41.62 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.115 1.34 . . . . 0.0 112.677 174.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.62 169.14 14.95 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.642 2.895 . . . . 0.0 112.906 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.6 -39.22 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.887 1.275 . . . . 0.0 111.787 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.91 28.56 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.845 1.658 . . . . 0.0 110.597 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.89 133.45 22.75 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.473 2.782 . . . . 0.0 113.114 168.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.91 -15.0 60.36 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.577 1.084 . . . . 0.0 115.056 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.32 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.906 1.353 . . . . 0.0 110.198 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.15 145.58 54.22 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.719 -0.613 . . . . 0.0 110.868 168.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -68.39 152.58 45.21 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.682 0.793 . . . . 0.0 111.616 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.07 131.58 85.27 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.805 170.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.26 140.47 44.63 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.051 1.834 . . . . 0.0 112.362 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -75.23 171.83 13.49 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.654 1.582 . . . . 0.0 111.99 162.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.78 -43.98 94.39 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 123.36 0.505 . . . . 0.0 113.012 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.71 -25.89 65.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -72.65 -41.67 65.2 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.977 -1.077 . . . . 0.0 111.764 171.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -62.52 -42.81 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.788 0.835 . . . . 0.0 110.76 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.99 -1.32 14.12 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.92 18.27 74.25 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.827 -1.17 . . . . 0.0 115.423 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.6 p -96.19 -19.53 19.27 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.13 1.465 . . . . 0.0 113.394 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 61.8 p -126.23 -1.55 7.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.613 1.165 . . . . 0.0 114.072 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -103.27 150.21 23.96 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.758 0.823 . . . . 0.0 112.25 173.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.8 p -82.53 162.4 22.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.361 0.601 . . . . 0.0 110.793 170.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.9 tp -56.57 -39.61 73.77 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.52 -0.737 . . . . 0.0 111.368 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.28 -39.0 93.34 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.547 -0.721 . . . . 0.0 112.63 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -64.68 -42.6 95.22 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.478 -0.764 . . . . 0.0 112.152 171.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -60.66 -46.34 90.69 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.618 0.767 . . . . 0.0 112.133 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.38 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.122 0.969 . . . . 0.0 110.288 172.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.43 -51.05 54.14 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.819 0.723 . . . . 0.0 112.9 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.22 -50.14 72.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.866 0.833 . . . . 0.0 112.517 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.63 -18.39 64.29 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.94 8.35 20.26 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.671 1.189 . . . . 0.0 113.051 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.43 162.33 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.978 1.311 . . . . 0.0 111.447 165.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.29 49.02 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.065 0.946 . . . . 0.0 110.821 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.1 163.84 89.14 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.497 0.856 . . . . 0.0 111.713 -6.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -50.01 141.26 30.1 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.231 2.621 . . . . 0.0 114.148 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.04 96.46 2.44 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.84 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.36 -46.24 94.28 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.638 0.654 . . . . 0.0 112.985 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.88 -36.89 75.83 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.362 -1.081 . . . . 0.0 112.645 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.88 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.722 -0.611 . . . . 0.0 109.947 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.92 -40.38 91.38 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.282 -0.886 . . . . 0.0 112.521 176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -42.02 75.05 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.71 -45.19 82.0 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.924 0.784 . . . . 0.0 112.12 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -67.41 -40.49 85.59 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.248 0.619 . . . . 0.0 112.292 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.57 -47.23 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 122.997 0.519 . . . . 0.0 110.235 174.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.05 -37.37 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.749 1.22 . . . . 0.0 112.308 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.85 -42.84 98.63 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.038 0.836 . . . . 0.0 111.216 171.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.55 -45.03 91.75 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.821 0.724 . . . . 0.0 113.252 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.37 -42.48 87.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.055 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.46 -50.17 70.57 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.811 0.844 . . . . 0.0 112.5 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.88 -43.33 77.09 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.855 0.752 . . . . 0.0 111.984 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.2 mt -64.43 -47.62 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.443 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.75 -32.91 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.952 1.251 . . . . 0.0 112.889 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -60.45 -45.86 92.16 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.901 0.88 . . . . 0.0 111.448 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.9 ttp -73.57 -38.43 65.17 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.564 1.546 . . . . 0.0 113.313 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.9 t80 . . . . . 0 C--O 1.255 1.39 0 C-N-CA 128.43 2.692 . . . . 0.0 114.714 -172.964 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.81 135.01 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.92 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.686 170.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.62 116.69 32.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.57 0.748 . . . . 0.0 109.17 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.46 178.06 6.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.46 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.95 -26.44 68.82 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.62 -2.16 57.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.818 1.247 . . . . 0.0 113.03 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.0 85.7 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.67 128.26 35.58 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.858 1.329 . . . . 0.0 109.726 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.92 125.62 29.62 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.99 123.4 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.07 1.348 . . . . 0.0 108.629 -174.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.73 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.75 141.14 48.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.477 1.911 . . . . 0.0 107.948 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.28 152.45 20.89 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.196 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.58 136.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.6 -0.687 . . . . 0.0 111.544 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.69 130.01 93.2 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.068 0.547 . . . . 0.0 111.106 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.05 -34.52 68.15 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.794 2.329 . . . . 0.0 113.607 167.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.46 -38.08 86.54 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.448 -0.783 . . . . 0.0 112.56 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.98 -44.29 97.58 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.753 0.706 . . . . 0.0 111.362 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.45 -44.42 94.56 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.277 0.49 . . . . 0.0 112.275 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.17 -47.28 85.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.162 0.585 . . . . 0.0 111.386 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.17 95.87 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.611 0.764 . . . . 0.0 111.856 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -60.14 -47.46 85.82 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.809 0.843 . . . . 0.0 112.748 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.8 -54.16 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.426 0.557 . . . . 0.0 110.384 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.8 -37.47 79.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.297 1.039 . . . . 0.0 113.207 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.87 -52.08 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.962 1.305 . . . . 0.0 111.281 170.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.58 -35.81 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.414 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.84 -23.51 60.72 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.72 -25.6 11.21 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -135.78 16.36 3.32 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -166.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.12 -38.35 2.38 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -175.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -118.01 14.08 14.04 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.49 1.116 . . . . 0.0 113.024 -171.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 p -113.13 152.91 45.43 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.997 0.919 . . . . 0.0 111.523 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.83 -30.95 59.87 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.296 2.664 . . . . 0.0 115.214 -172.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.08 -20.94 64.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.59 -32.17 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.413 1.006 . . . . 0.0 112.485 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.37 -57.16 5.98 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.715 1.206 . . . . 0.0 112.555 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.87 -29.43 58.45 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 121.833 1.69 . . . . 0.0 112.809 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.3 -40.1 77.91 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.841 1.2 . . . . 0.0 112.703 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.12 -47.05 82.06 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.885 0.766 . . . . 0.0 111.537 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -60.88 -44.17 97.46 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.84 -31.66 71.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.178 0.991 . . . . 0.0 113.261 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.76 4.59 52.79 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.362 1.465 . . . . 0.0 113.514 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.5 p -133.12 22.86 4.13 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.59 120.34 6.04 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.47 -1.394 . . . . 0.0 111.472 168.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.49 11.69 60.08 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.371 0.909 . . . . 0.0 115.371 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.87 47.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.565 1.683 . . . . 0.0 112.481 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.0 p -73.32 159.67 84.36 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.732 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.57 -35.43 37.32 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.144 1.896 . . . . 0.0 115.406 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.0 -40.34 87.33 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.28 -45.3 93.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.627 -0.671 . . . . 0.0 111.1 172.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.62 -44.23 94.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.343 1.057 . . . . 0.0 112.085 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.3 -41.31 88.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.649 0.659 . . . . 0.0 112.02 171.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.27 -45.41 93.42 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.611 0.642 . . . . 0.0 111.071 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.37 -48.66 78.44 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.192 0.906 . . . . 0.0 112.151 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.1 mt -63.23 -38.36 90.85 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.03 -34.36 71.82 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.627 -0.671 . . . . 0.0 112.776 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.2 p -72.4 -13.39 61.45 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 m -118.19 11.16 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.367 1.067 . . . . 0.0 113.391 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.75 -10.59 4.74 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 117.141 1.616 . . . . 0.0 117.141 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.85 9.5 2.78 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 125.811 1.672 . . . . 0.0 117.009 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -127.85 79.11 1.87 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.232 1.516 . . . . 0.0 110.0 162.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -52.17 -36.0 50.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -171.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.87 -40.9 75.44 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.127 1.331 . . . . 0.0 112.147 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.58 83.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.298 0.639 . . . . 0.0 111.351 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.0 tpp -62.88 -40.3 97.09 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.531 -0.73 . . . . 0.0 112.281 175.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.02 -50.0 74.06 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.267 1.027 . . . . 0.0 111.544 173.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.8 tpp -56.04 -45.45 79.19 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.098 0.959 . . . . 0.0 112.184 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.87 -48.82 78.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.337 0.655 . . . . 0.0 112.017 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.67 -38.31 90.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.905 0.882 . . . . 0.0 112.49 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -60.0 -45.44 92.74 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.689 0.677 . . . . 0.0 112.048 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.64 -42.36 99.56 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.827 0.739 . . . . 0.0 112.118 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.86 -46.11 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.472 -0.768 . . . . 0.0 111.03 174.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.11 -39.43 94.02 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.869 0.759 . . . . 0.0 112.738 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.85 -47.42 86.43 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.758 0.823 . . . . 0.0 111.892 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.09 -34.38 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.47 91.54 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.484 -0.76 . . . . 0.0 112.327 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.11 98.64 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.256 0.622 . . . . 0.0 111.781 172.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.12 -42.22 99.49 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.872 -0.517 . . . . 0.0 112.191 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.71 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.05 -30.24 71.44 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -39.1 78.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.397 1.079 . . . . 0.0 112.45 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.79 60.98 53.75 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.91 120.14 7.42 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.424 2.083 . . . . 0.0 110.315 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.35 136.29 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.332 1.453 . . . . 0.0 112.129 -169.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -80.01 160.47 25.86 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.054 0.541 . . . . 0.0 110.915 168.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.92 65.01 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.11 1.338 . . . . 0.0 112.686 174.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.6 169.19 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.658 2.905 . . . . 0.0 112.889 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.66 -39.2 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.904 1.282 . . . . 0.0 111.753 -175.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.61 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 110.585 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.89 133.38 22.73 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.487 2.791 . . . . 0.0 113.15 168.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.94 -15.04 60.29 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.567 1.08 . . . . 0.0 115.001 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.992 1.396 . . . . 0.0 110.198 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.22 145.58 54.16 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.691 -0.631 . . . . 0.0 110.793 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.54 152.82 44.85 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.655 0.782 . . . . 0.0 111.67 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.27 131.65 84.85 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.29 140.41 44.36 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.11 1.873 . . . . 0.0 112.442 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -75.18 171.62 13.84 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.697 1.599 . . . . 0.0 111.893 163.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.83 94.0 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.971 -0.455 . . . . 0.0 113.03 168.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.85 -25.75 64.8 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.66 64.9 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.03 -1.044 . . . . 0.0 111.779 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.59 -42.76 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 110.82 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.26 14.03 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.16 74.31 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.927 -1.108 . . . . 0.0 115.447 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.34 -19.39 19.27 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.074 1.437 . . . . 0.0 113.284 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.2 p -126.18 -1.44 7.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.71 149.96 24.49 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.036 0.935 . . . . 0.0 111.788 173.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.2 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.282 0.563 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.86 -39.37 74.17 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.451 -0.781 . . . . 0.0 111.394 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.49 -38.98 93.21 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.554 -0.716 . . . . 0.0 112.701 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.82 95.52 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.58 -46.44 90.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.636 0.774 . . . . 0.0 112.142 176.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.43 -46.36 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.158 0.983 . . . . 0.0 110.304 172.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.04 54.4 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.81 0.719 . . . . 0.0 112.93 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.79 0.795 . . . . 0.0 112.485 174.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.9 8.32 20.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.66 1.184 . . . . 0.0 113.033 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.39 162.29 1.59 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.041 1.336 . . . . 0.0 111.39 165.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.36 48.92 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.042 0.937 . . . . 0.0 110.758 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.09 163.83 89.17 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.509 0.86 . . . . 0.0 111.746 -6.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -49.98 141.36 29.67 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.253 2.635 . . . . 0.0 114.117 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.2 96.42 2.49 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -85.96 54.56 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.27 2.647 . . . . 0.0 112.86 -152.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.78 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.19 94.34 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.61 0.641 . . . . 0.0 113.011 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.87 -36.87 75.83 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.326 -1.102 . . . . 0.0 112.634 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.94 -44.56 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.808 -0.557 . . . . 0.0 109.949 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.36 91.58 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.303 -0.873 . . . . 0.0 112.557 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.85 -42.07 75.26 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.472 -0.767 . . . . 0.0 112.217 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -56.59 -45.26 81.49 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 112.087 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.39 -40.41 85.66 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.248 0.619 . . . . 0.0 112.286 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.73 -46.97 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.093 0.557 . . . . 0.0 110.286 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.38 -37.27 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.648 1.179 . . . . 0.0 112.32 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.85 -42.8 98.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.036 0.835 . . . . 0.0 111.176 171.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.24 91.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.878 0.751 . . . . 0.0 113.181 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.48 -42.21 87.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.035 0.918 . . . . 0.0 111.113 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.24 70.44 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.774 0.83 . . . . 0.0 112.399 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.83 -43.06 76.62 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.884 0.765 . . . . 0.0 112.027 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.64 -47.96 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.371 0.668 . . . . 0.0 111.451 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.46 -32.83 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 119.894 1.225 . . . . 0.0 112.895 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.11 -43.85 95.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.867 0.867 . . . . 0.0 111.512 171.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.6 ttp -76.99 -36.27 56.54 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.644 1.577 . . . . 0.0 113.606 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.255 1.375 0 C-N-CA 128.35 2.66 . . . . 0.0 114.599 -172.764 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.75 134.99 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.501 1.121 . . . . 0.0 108.436 163.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.98 154.96 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.114 1.366 . . . . 0.0 109.665 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.7 116.69 32.48 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.555 0.742 . . . . 0.0 109.222 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.46 178.07 6.89 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.604 0.716 . . . . 0.0 112.46 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.87 -26.57 68.84 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.08 57.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.746 1.219 . . . . 0.0 113.002 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.0 85.78 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.487 1.042 . . . . 0.0 114.091 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.75 128.29 35.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.858 1.329 . . . . 0.0 109.714 174.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.86 125.64 29.65 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 168.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.9 t -126.04 123.28 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.103 1.361 . . . . 0.0 108.712 -174.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.53 139.71 38.62 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.15 48.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.465 1.906 . . . . 0.0 107.922 169.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.34 20.89 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.015 0.825 . . . . 0.0 111.233 170.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.57 136.88 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.607 -0.683 . . . . 0.0 111.579 176.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.63 130.02 93.27 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.112 0.565 . . . . 0.0 111.139 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.04 -34.54 68.22 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.864 2.376 . . . . 0.0 113.607 167.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.44 -38.03 86.47 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.463 -0.773 . . . . 0.0 112.588 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 m -60.93 -44.33 97.38 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.722 0.692 . . . . 0.0 111.401 171.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.53 -44.17 95.02 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.3 -47.29 85.96 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.167 0.587 . . . . 0.0 111.416 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.13 95.91 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.626 0.77 . . . . 0.0 111.897 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -60.21 -47.26 86.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.86 0.864 . . . . 0.0 112.73 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.51 -54.95 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 118.471 0.578 . . . . 0.0 110.345 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.48 -37.3 77.87 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.272 1.029 . . . . 0.0 113.178 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.47 -52.16 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.028 1.331 . . . . 0.0 111.29 170.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.68 -36.02 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 119.016 -0.516 . . . . 0.0 111.452 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -58.53 -24.17 59.96 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.04 -25.81 11.43 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.91 15.97 3.31 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -165.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.08 -38.92 2.54 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -116.62 13.73 15.3 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.379 1.072 . . . . 0.0 113.154 -172.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.1 p -112.87 152.95 45.27 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 123.941 0.897 . . . . 0.0 111.544 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.82 -30.77 58.93 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.299 2.666 . . . . 0.0 115.233 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.02 -20.74 64.24 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.8 -31.86 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.435 1.016 . . . . 0.0 112.548 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.45 -55.05 6.24 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.907 1.283 . . . . 0.0 112.956 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.83 -30.12 49.72 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.688 1.639 . . . . 0.0 112.661 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.07 -40.22 78.61 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.86 1.209 . . . . 0.0 112.64 172.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -57.27 -46.49 83.04 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.719 0.69 . . . . 0.0 111.579 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -61.04 -44.48 97.33 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.07 71.51 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.341 1.056 . . . . 0.0 113.225 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.23 4.44 53.53 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.4 1.48 . . . . 0.0 113.522 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.9 p -133.03 22.82 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.61 120.27 5.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.44 -1.413 . . . . 0.0 111.484 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.59 11.6 60.19 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.422 0.929 . . . . 0.0 115.422 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.51 130.87 47.09 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.525 1.663 . . . . 0.0 112.498 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.35 159.68 84.3 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.758 0.823 . . . . 0.0 110.697 167.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.65 -35.41 37.95 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.204 1.936 . . . . 0.0 115.366 168.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.0 -40.27 87.29 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.33 -45.31 93.88 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.596 -0.69 . . . . 0.0 111.044 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.6 -44.21 94.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.318 1.047 . . . . 0.0 112.175 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -59.24 -41.48 88.82 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.649 -0.657 . . . . 0.0 111.973 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.2 m -60.23 -45.28 93.77 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.614 0.643 . . . . 0.0 111.11 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -57.33 -49.01 77.48 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.246 0.93 . . . . 0.0 112.193 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.02 -38.54 91.59 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.87 -33.22 70.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.9 p -73.68 -13.37 60.97 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.6 m -122.45 6.2 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.5 -4.36 6.65 Favored Glycine 0 CA--C 1.541 1.67 0 N-CA-C 117.243 1.657 . . . . 0.0 117.243 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.75 -35.28 57.61 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 119.179 1.489 . . . . 0.0 115.177 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -86.18 77.95 9.47 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.838 1.304 . . . . 0.0 110.551 170.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.95 -35.91 35.96 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.36 -41.18 73.47 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.047 1.294 . . . . 0.0 112.301 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.36 -43.55 85.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.137 0.575 . . . . 0.0 111.33 173.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 59.8 tpp -63.25 -39.96 96.08 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.47 -0.769 . . . . 0.0 112.223 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -50.0 73.98 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.079 -1.013 . . . . 0.0 111.521 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -56.0 -45.43 79.04 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.88 -48.81 78.85 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.314 0.646 . . . . 0.0 112.055 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.7 -38.21 90.26 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.835 0.854 . . . . 0.0 112.448 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.99 -45.53 92.42 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.664 0.665 . . . . 0.0 112.027 170.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -62.64 -42.37 99.55 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.149 175.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.86 -46.1 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.47 -0.769 . . . . 0.0 111.059 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.08 -39.46 94.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.831 0.741 . . . . 0.0 112.736 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.82 -47.4 86.51 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.958 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.1 -34.32 72.97 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.584 -0.697 . . . . 0.0 112.835 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.92 -41.47 91.35 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.441 -0.787 . . . . 0.0 112.307 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.12 98.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.238 0.615 . . . . 0.0 111.772 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.09 -42.28 99.58 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.915 -0.491 . . . . 0.0 112.138 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -57.8 -48.58 79.32 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.661 0.664 . . . . 0.0 111.71 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.06 -30.24 71.44 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.2 -39.13 78.84 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.391 1.076 . . . . 0.0 112.48 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.26 -27.6 42.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.812 1.245 . . . . 0.0 113.302 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.8 61.02 54.01 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.668 1.987 . . . . 0.0 111.228 -174.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.9 120.13 7.4 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.507 2.138 . . . . 0.0 110.285 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.45 136.23 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.298 1.439 . . . . 0.0 112.121 -169.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -79.85 160.43 26.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.087 0.555 . . . . 0.0 110.915 168.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.27 -19.97 65.05 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.74 41.58 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.048 1.309 . . . . 0.0 112.64 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.58 169.23 14.72 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.611 2.874 . . . . 0.0 112.882 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.66 -39.22 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.925 1.29 . . . . 0.0 111.806 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.62 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.884 1.674 . . . . 0.0 110.631 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.91 133.41 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.456 2.77 . . . . 0.0 113.116 168.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.05 60.34 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 115.005 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.1 143.42 37.36 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.006 1.403 . . . . 0.0 110.185 173.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.2 145.56 54.2 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.721 -0.612 . . . . 0.0 110.842 168.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.49 152.73 44.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.748 0.819 . . . . 0.0 111.666 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -72.26 131.72 84.81 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.808 170.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.33 140.41 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -75.2 171.66 13.77 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.697 1.599 . . . . 0.0 111.889 163.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.5 -43.94 93.9 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.934 -0.479 . . . . 0.0 113.03 168.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.81 -25.73 64.83 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.78 -41.63 64.8 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.05 -1.032 . . . . 0.0 111.728 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.77 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.77 0.828 . . . . 0.0 110.771 173.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.26 13.94 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.2 74.23 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.596 1.093 . . . . 0.0 115.449 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.43 19.26 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.157 1.478 . . . . 0.0 113.283 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.19 -1.42 7.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.74 149.84 24.62 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.082 0.953 . . . . 0.0 111.799 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.5 p -81.78 162.32 22.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.291 0.567 . . . . 0.0 110.779 170.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.74 -39.38 73.85 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.448 -0.783 . . . . 0.0 111.445 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.54 -38.98 93.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.554 -0.716 . . . . 0.0 112.685 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.77 95.55 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.68 -46.35 90.69 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.119 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.33 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 110.268 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.04 54.46 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.795 0.712 . . . . 0.0 112.92 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.29 -50.05 73.22 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.812 0.806 . . . . 0.0 112.537 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.48 64.29 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.87 8.36 20.4 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.703 1.201 . . . . 0.0 113.051 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.5 162.33 1.64 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.991 1.316 . . . . 0.0 111.399 165.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.35 48.98 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.066 0.946 . . . . 0.0 110.813 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.82 89.2 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-N 119.429 0.832 . . . . 0.0 111.69 -6.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.94 141.39 29.27 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.187 2.591 . . . . 0.0 114.171 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.23 96.49 2.54 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 163.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.05 54.62 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.214 2.61 . . . . 0.0 112.83 -152.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.81 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.17 94.4 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.638 0.654 . . . . 0.0 113.011 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.89 -36.84 75.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.296 -1.12 . . . . 0.0 112.634 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.8 mt -62.95 -44.62 99.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.799 -0.563 . . . . 0.0 109.914 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.87 -40.35 91.57 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.327 -0.858 . . . . 0.0 112.521 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -55.86 -42.04 75.25 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.439 -0.788 . . . . 0.0 112.246 173.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.72 -45.23 82.04 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.924 0.784 . . . . 0.0 112.125 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.26 -40.57 86.22 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.294 0.638 . . . . 0.0 112.244 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.57 -47.33 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.23 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.98 -37.36 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.695 1.198 . . . . 0.0 112.301 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.84 -42.77 98.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.039 0.836 . . . . 0.0 111.217 171.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.62 -44.98 91.71 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 123.855 0.74 . . . . 0.0 113.214 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.35 -42.57 87.17 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.007 0.903 . . . . 0.0 110.992 173.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.24 70.37 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.807 0.843 . . . . 0.0 112.483 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.82 -43.28 76.81 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.88 0.764 . . . . 0.0 111.961 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.52 -47.8 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.334 0.654 . . . . 0.0 111.418 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.93 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 119.911 1.232 . . . . 0.0 112.893 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -60.36 -44.86 95.18 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.949 0.9 . . . . 0.0 111.428 171.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.4 ttp -74.89 -35.72 62.25 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.683 1.593 . . . . 0.0 113.422 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.0 t80 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 128.341 2.656 . . . . 0.0 114.546 -173.291 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.042 0.362 . . . . 0.0 113.042 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.97 135.05 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.468 1.107 . . . . 0.0 108.466 163.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.06 154.71 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.662 170.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.4 116.65 32.5 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.534 0.734 . . . . 0.0 109.17 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.41 177.97 6.93 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.557 0.694 . . . . 0.0 112.474 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.55 68.79 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.67 -2.1 57.85 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.798 1.239 . . . . 0.0 113.001 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.12 85.87 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.454 1.026 . . . . 0.0 114.133 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.75 128.17 35.24 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.826 1.313 . . . . 0.0 109.695 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.85 125.5 29.43 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.89 123.39 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.077 1.351 . . . . 0.0 108.674 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.56 139.71 38.58 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.1 48.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.4 20.87 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.988 0.813 . . . . 0.0 111.217 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.53 136.86 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.644 -0.66 . . . . 0.0 111.544 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.68 130.0 93.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.11 0.564 . . . . 0.0 111.137 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.99 -34.6 67.98 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.894 2.396 . . . . 0.0 113.602 167.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -66.44 -38.03 86.49 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.425 -0.797 . . . . 0.0 112.56 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -61.04 -44.26 97.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.747 0.703 . . . . 0.0 111.337 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.54 -44.42 94.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.302 0.501 . . . . 0.0 112.256 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.12 -47.18 86.21 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.121 0.569 . . . . 0.0 111.396 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.19 95.75 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.667 0.787 . . . . 0.0 111.874 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.28 -46.95 88.04 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.779 0.831 . . . . 0.0 112.811 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.8 t -56.9 -54.26 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.4 0.546 . . . . 0.0 110.368 174.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.77 -37.17 78.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.412 1.085 . . . . 0.0 113.287 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.41 -52.35 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.206 1.402 . . . . 0.0 111.209 170.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.96 -36.06 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.958 0.503 . . . . 0.0 111.405 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.48 -24.0 59.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.48 -25.33 11.44 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.23 15.83 3.23 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -165.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.9 -37.07 2.67 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -117.88 13.84 14.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.385 1.074 . . . . 0.0 113.151 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.0 p -113.11 153.11 45.46 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.968 0.907 . . . . 0.0 111.474 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.86 -30.87 59.77 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.25 2.633 . . . . 0.0 115.185 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.11 -20.99 64.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.52 -32.24 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.396 0.998 . . . . 0.0 112.452 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.36 -57.16 6.0 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.726 1.21 . . . . 0.0 112.578 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.88 -29.46 58.31 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.928 1.724 . . . . 0.0 112.764 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.29 -40.09 77.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.866 1.212 . . . . 0.0 112.661 172.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -57.2 -46.98 82.39 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.873 0.76 . . . . 0.0 111.555 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.2 m -60.86 -44.26 97.26 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.65 70.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.248 1.019 . . . . 0.0 113.251 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.85 4.59 52.7 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.436 1.494 . . . . 0.0 113.528 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.9 p -133.13 22.85 4.13 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -176.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.56 120.28 5.96 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.501 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.54 60.17 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.377 0.911 . . . . 0.0 115.377 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 130.82 46.9 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.565 1.682 . . . . 0.0 112.53 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.28 159.71 84.31 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.699 167.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.6 -35.46 37.64 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.209 1.94 . . . . 0.0 115.39 168.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.98 -40.25 87.39 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.45 -45.22 94.48 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.569 -0.707 . . . . 0.0 111.055 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.62 -44.21 94.61 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.307 1.043 . . . . 0.0 112.115 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -59.25 -41.47 88.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.649 0.659 . . . . 0.0 111.965 171.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.9 m -60.25 -45.22 94.03 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.601 0.637 . . . . 0.0 111.066 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.46 -48.88 77.99 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.196 0.907 . . . . 0.0 112.174 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -63.07 -38.34 90.8 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.99 -33.33 70.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.3 p -73.58 -12.72 60.85 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -122.43 7.21 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -174.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.42 -4.06 8.36 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 117.413 1.725 . . . . 0.0 117.413 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.71 -35.2 66.46 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.394 1.597 . . . . 0.0 115.17 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -85.94 77.81 9.61 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.006 1.384 . . . . 0.0 110.537 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.71 -35.55 31.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.663 1.585 . . . . 0.0 115.223 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.48 -41.32 72.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.129 1.331 . . . . 0.0 112.332 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.63 85.94 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.776 -0.577 . . . . 0.0 111.348 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.15 -39.97 96.22 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.548 -0.72 . . . . 0.0 112.22 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.98 -49.97 74.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.223 1.009 . . . . 0.0 111.569 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.96 -45.44 78.87 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 0.0 112.212 174.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.6 tp -61.92 -48.77 78.98 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.344 0.657 . . . . 0.0 112.071 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.71 -38.27 90.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.873 0.869 . . . . 0.0 112.488 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.96 -45.58 92.19 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.684 0.675 . . . . 0.0 111.966 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.2 m -62.54 -42.46 99.54 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.828 0.74 . . . . 0.0 112.155 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.6 mt -58.8 -46.1 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.453 -0.78 . . . . 0.0 111.093 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.36 93.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.847 0.749 . . . . 0.0 112.759 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.93 -47.42 86.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.756 0.822 . . . . 0.0 111.908 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.12 -34.3 72.92 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.72 -41.73 91.91 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.447 -0.783 . . . . 0.0 112.328 172.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -41.98 98.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.139 0.576 . . . . 0.0 111.817 172.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.17 -42.26 99.37 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.918 -0.489 . . . . 0.0 112.163 174.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.8 -48.47 79.62 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.68 0.673 . . . . 0.0 111.694 173.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -63.13 -30.34 71.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.06 -39.09 79.31 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.342 1.057 . . . . 0.0 112.482 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.32 -27.57 42.13 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.796 1.239 . . . . 0.0 113.325 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.74 60.97 53.77 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.653 1.981 . . . . 0.0 111.274 -174.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.86 120.13 7.41 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.483 2.122 . . . . 0.0 110.323 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.294 1.438 . . . . 0.0 112.115 -169.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -80.2 160.52 25.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.07 0.548 . . . . 0.0 110.857 168.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.19 -20.02 65.03 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.7 41.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.096 1.332 . . . . 0.0 112.631 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.52 169.2 14.66 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.624 2.883 . . . . 0.0 112.917 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.66 -39.19 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.874 1.27 . . . . 0.0 111.791 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.94 28.52 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.93 133.38 22.92 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.441 2.761 . . . . 0.0 113.163 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -14.95 60.55 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.648 1.118 . . . . 0.0 115.042 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.38 37.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.952 1.376 . . . . 0.0 110.198 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.64 54.14 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.726 -0.608 . . . . 0.0 110.793 168.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -68.64 152.77 44.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.648 0.779 . . . . 0.0 111.618 171.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.26 131.72 84.81 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-O 118.888 -0.577 . . . . 0.0 109.831 170.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.4 140.32 43.71 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.063 1.842 . . . . 0.0 112.442 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -74.94 171.61 13.76 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.8 1.64 . . . . 0.0 111.817 163.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.61 -43.86 94.12 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.913 -0.492 . . . . 0.0 112.979 168.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.75 -25.88 64.96 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.71 -41.53 65.13 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.076 -1.015 . . . . 0.0 111.778 171.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.73 -42.63 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.719 0.807 . . . . 0.0 110.812 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.02 -1.29 14.12 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.03 18.13 74.33 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.929 -1.107 . . . . 0.0 115.445 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.25 -19.42 19.31 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.073 1.436 . . . . 0.0 113.289 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.2 -1.58 7.02 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.57 150.04 24.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.067 0.947 . . . . 0.0 111.773 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.4 p -81.95 162.44 22.7 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.321 0.582 . . . . 0.0 110.797 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.88 -39.36 74.23 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.414 -0.804 . . . . 0.0 111.445 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.62 -38.84 92.65 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.557 -0.715 . . . . 0.0 112.635 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -64.62 -42.8 95.27 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.628 -0.67 . . . . 0.0 112.033 171.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.61 -46.46 90.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.648 0.779 . . . . 0.0 112.097 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.38 -46.39 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.142 0.977 . . . . 0.0 110.317 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.42 -51.01 54.42 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.806 0.717 . . . . 0.0 112.945 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.3 -50.09 73.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.751 0.776 . . . . 0.0 112.48 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.0 p -111.93 8.43 20.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.637 1.175 . . . . 0.0 113.027 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.46 162.34 1.61 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.939 1.295 . . . . 0.0 111.434 165.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.63 103.35 48.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.054 0.942 . . . . 0.0 110.758 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.79 89.26 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.451 0.84 . . . . 0.0 111.701 -6.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -49.98 141.37 29.62 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.176 2.584 . . . . 0.0 114.168 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.12 96.53 2.51 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -86.03 54.54 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.232 2.621 . . . . 0.0 112.882 -152.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.54 -34.86 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.46 -46.2 94.31 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.605 0.639 . . . . 0.0 112.947 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.86 -36.9 75.9 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.259 -1.142 . . . . 0.0 112.645 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.88 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.785 -0.572 . . . . 0.0 109.98 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.44 91.68 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.356 -0.84 . . . . 0.0 112.576 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -55.78 -41.99 74.88 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.468 -0.77 . . . . 0.0 112.287 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.71 -45.24 81.98 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.888 0.767 . . . . 0.0 112.134 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.26 -40.59 86.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.308 0.643 . . . . 0.0 112.251 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.55 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.083 0.553 . . . . 0.0 110.261 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.13 -37.33 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.72 1.208 . . . . 0.0 112.322 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.82 98.32 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.047 0.84 . . . . 0.0 111.275 171.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.05 91.66 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.847 0.737 . . . . 0.0 113.242 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.4 -42.47 87.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.954 0.877 . . . . 0.0 111.032 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.48 -50.21 70.48 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.811 0.844 . . . . 0.0 112.45 173.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.79 -43.42 76.81 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 118.853 0.751 . . . . 0.0 111.956 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.43 -47.68 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.406 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.67 -32.89 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.992 1.269 . . . . 0.0 112.907 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -60.43 -45.36 93.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.899 0.88 . . . . 0.0 111.5 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.3 ttp -74.51 -38.24 62.88 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.597 1.559 . . . . 0.0 113.336 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.3 t80 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 128.483 2.713 . . . . 0.0 114.671 -172.571 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 N--CA 1.479 0.666 0 N-CA-C 112.965 0.333 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.22 134.86 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.46 1.104 . . . . 0.0 108.451 163.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.91 154.92 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.136 1.374 . . . . 0.0 109.665 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.67 116.72 32.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.48 0.712 . . . . 0.0 109.171 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.43 177.97 6.95 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.514 0.673 . . . . 0.0 112.511 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.87 -26.49 68.8 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.56 -2.24 57.94 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.825 1.25 . . . . 0.0 113.024 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.07 2.94 85.6 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.467 1.032 . . . . 0.0 114.142 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.74 128.29 35.73 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.815 1.308 . . . . 0.0 109.7 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.69 29.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.01 123.4 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.066 1.347 . . . . 0.0 108.648 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.68 139.68 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.572 0.701 . . . . 0.0 111.21 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.64 141.17 48.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.488 1.915 . . . . 0.0 107.922 169.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.17 152.31 20.77 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.977 0.808 . . . . 0.0 111.237 170.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.62 136.83 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.651 -0.656 . . . . 0.0 111.571 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.59 129.98 93.32 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.167 0.587 . . . . 0.0 111.157 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.07 -34.57 68.66 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.86 2.373 . . . . 0.0 113.543 167.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.39 -38.13 86.81 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.475 -0.765 . . . . 0.0 112.55 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.88 -44.4 97.12 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.728 0.695 . . . . 0.0 111.383 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.45 -44.42 94.55 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.251 0.478 . . . . 0.0 112.211 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.12 -47.25 85.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.087 0.555 . . . . 0.0 111.441 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.1 -45.19 95.73 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.633 0.773 . . . . 0.0 111.892 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -59.98 -47.53 85.43 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.806 0.842 . . . . 0.0 112.729 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.7 t -56.85 -54.13 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.408 0.549 . . . . 0.0 110.493 174.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.72 -37.36 78.68 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.344 1.058 . . . . 0.0 113.214 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -58.24 -52.11 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.917 1.287 . . . . 0.0 111.345 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.19 -35.98 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 122.948 0.499 . . . . 0.0 111.336 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.66 -23.45 59.25 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.98 -25.72 11.04 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -135.87 16.03 3.31 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.46 -37.83 2.57 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -117.86 14.56 14.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.374 1.07 . . . . 0.0 113.141 -172.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.5 p -113.64 152.95 45.89 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.008 0.923 . . . . 0.0 111.513 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.85 -30.81 59.43 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.216 2.61 . . . . 0.0 115.249 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.06 -20.93 64.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.54 -32.19 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.424 1.011 . . . . 0.0 112.482 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.7 mt -70.36 -57.2 5.97 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.76 1.224 . . . . 0.0 112.561 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.81 -29.57 58.95 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.859 1.699 . . . . 0.0 112.793 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.25 -40.07 78.08 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.838 1.199 . . . . 0.0 112.733 172.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -57.15 -47.08 82.05 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.877 0.762 . . . . 0.0 111.507 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m -60.79 -44.24 97.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.65 71.05 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.233 1.013 . . . . 0.0 113.264 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.8 4.59 52.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.389 1.476 . . . . 0.0 113.514 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.7 p -133.1 22.79 4.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.54 120.23 5.87 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.49 -1.381 . . . . 0.0 111.491 168.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.64 11.59 60.3 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 115.367 0.907 . . . . 0.0 115.367 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.49 131.04 47.83 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.567 1.683 . . . . 0.0 112.487 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.7 p -73.47 159.81 83.85 Favored Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 123.667 0.787 . . . . 0.0 110.722 167.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.63 -35.35 37.62 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.161 1.908 . . . . 0.0 115.429 168.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.1 -40.24 86.89 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -60.26 -45.35 93.59 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.66 -0.65 . . . . 0.0 111.089 172.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.62 -44.27 94.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.328 1.051 . . . . 0.0 112.146 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -59.18 -41.43 88.44 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.672 -0.642 . . . . 0.0 112.03 171.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.6 m -60.25 -45.25 93.91 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.561 0.619 . . . . 0.0 111.059 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.47 -48.86 78.08 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.196 0.907 . . . . 0.0 112.16 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.18 -38.13 89.97 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.11 -32.82 70.18 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.3 p -74.14 -12.29 60.55 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.11 8.28 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.81 -3.78 11.77 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 117.446 1.739 . . . . 0.0 117.446 -175.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.32 -32.79 64.32 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 119.556 1.678 . . . . 0.0 115.279 -177.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -89.75 77.36 7.08 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 123.06 1.409 . . . . 0.0 110.481 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.33 -35.08 26.12 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.859 1.664 . . . . 0.0 115.416 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.9 -40.9 75.36 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 120.159 1.345 . . . . 0.0 112.312 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.64 -43.45 84.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.158 0.583 . . . . 0.0 111.366 173.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.14 -40.13 96.68 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.494 -0.754 . . . . 0.0 112.246 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.83 74.6 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.257 1.023 . . . . 0.0 111.541 173.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.04 -45.5 79.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.092 0.957 . . . . 0.0 112.189 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.3 tp -61.85 -48.77 79.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.332 0.653 . . . . 0.0 112.08 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.79 -38.18 90.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.861 0.865 . . . . 0.0 112.483 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.01 -45.52 92.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.664 0.665 . . . . 0.0 112.034 170.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.54 -42.47 99.55 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.792 0.724 . . . . 0.0 112.105 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.81 -46.14 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.491 -0.755 . . . . 0.0 111.077 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.1 -39.45 94.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.819 0.736 . . . . 0.0 112.717 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -60.83 -47.36 86.69 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.77 0.828 . . . . 0.0 111.98 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.17 -34.3 72.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.56 91.79 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.451 -0.781 . . . . 0.0 112.371 172.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.04 98.56 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.202 0.601 . . . . 0.0 111.832 172.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.09 -42.27 99.57 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.905 -0.497 . . . . 0.0 112.221 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.8 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.615 0.643 . . . . 0.0 111.649 173.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.03 -30.31 71.5 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.14 -39.1 79.05 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.324 1.05 . . . . 0.0 112.52 173.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.17 -27.66 42.67 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.785 1.234 . . . . 0.0 113.307 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -132.78 61.03 54.11 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.646 1.978 . . . . 0.0 111.276 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.92 120.16 7.44 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.48 2.12 . . . . 0.0 110.277 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.23 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.363 1.465 . . . . 0.0 112.151 -169.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.98 160.37 25.94 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.13 0.572 . . . . 0.0 110.861 168.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.15 -20.03 65.02 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 174.77 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.048 1.309 . . . . 0.0 112.656 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.55 169.17 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.66 2.907 . . . . 0.0 112.93 177.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.62 -39.2 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.867 1.267 . . . . 0.0 111.841 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.62 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.884 1.674 . . . . 0.0 110.631 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.91 133.41 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.456 2.77 . . . . 0.0 113.116 168.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.99 -15.04 60.37 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.562 1.077 . . . . 0.0 115.013 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -78.09 143.41 37.39 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.928 1.364 . . . . 0.0 110.218 173.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.51 54.2 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.726 -0.608 . . . . 0.0 110.826 168.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -68.55 152.89 44.74 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.694 0.798 . . . . 0.0 111.669 171.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -72.3 131.69 84.77 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.917 -0.563 . . . . 0.0 109.858 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.33 140.41 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -75.19 171.67 13.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.72 1.608 . . . . 0.0 111.862 163.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.51 -43.93 93.93 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.968 -0.458 . . . . 0.0 113.006 168.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.83 -25.77 64.83 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.67 -41.65 65.13 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.064 -1.022 . . . . 0.0 111.765 171.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.65 -42.72 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.712 0.805 . . . . 0.0 110.801 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.3 14.11 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.13 74.17 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.626 1.107 . . . . 0.0 115.458 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.6 p -96.22 -19.43 19.33 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.09 1.445 . . . . 0.0 113.255 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.2 p -126.16 -1.5 7.05 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.4 p -103.64 149.8 24.6 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.034 0.934 . . . . 0.0 111.778 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.1 p -81.68 162.34 23.06 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.341 0.591 . . . . 0.0 110.775 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.72 -39.44 73.91 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.448 -0.783 . . . . 0.0 111.429 169.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.51 -39.01 93.32 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.531 -0.731 . . . . 0.0 112.636 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -64.6 -42.65 95.42 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.72 -46.42 90.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.652 0.781 . . . . 0.0 112.119 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.42 -46.35 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.12 0.968 . . . . 0.0 110.301 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.07 54.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.806 0.717 . . . . 0.0 112.889 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.24 -50.09 73.12 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.831 0.816 . . . . 0.0 112.48 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.2 mtp -68.62 -18.52 64.32 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.92 8.41 20.33 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.665 1.186 . . . . 0.0 113.072 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.42 162.3 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.971 1.309 . . . . 0.0 111.461 165.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.32 48.97 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.15 163.8 89.21 Favored 'Cis proline' 0 CA--C 1.544 1.021 0 CA-C-N 119.466 0.845 . . . . 0.0 111.735 -6.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -49.93 141.34 29.28 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.184 2.59 . . . . 0.0 114.207 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.21 96.44 2.51 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 163.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.97 54.67 3.51 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.65 -34.84 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.24 94.25 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 118.656 0.662 . . . . 0.0 112.991 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -69.73 -36.98 76.32 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.281 -1.129 . . . . 0.0 112.609 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.93 -44.6 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.762 -0.586 . . . . 0.0 109.949 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.85 -40.37 91.64 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.352 -0.842 . . . . 0.0 112.543 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.04 75.12 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.455 -0.778 . . . . 0.0 112.243 173.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -56.7 -45.17 81.99 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.933 0.788 . . . . 0.0 112.098 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.33 -40.55 85.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.29 0.636 . . . . 0.0 112.251 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.69 -46.94 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.062 0.545 . . . . 0.0 110.321 174.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.34 -37.31 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.688 1.195 . . . . 0.0 112.314 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.81 98.3 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.019 0.827 . . . . 0.0 111.223 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.11 91.4 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.796 0.712 . . . . 0.0 113.265 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.49 -42.24 87.15 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.01 0.905 . . . . 0.0 111.092 173.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.39 -50.25 70.22 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.766 0.826 . . . . 0.0 112.461 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.93 -43.1 77.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.823 0.738 . . . . 0.0 112.011 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.44 -48.13 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.721 -0.656 . . . . 0.0 111.372 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -69.38 -32.83 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 119.973 1.261 . . . . 0.0 112.89 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.95 -42.79 94.8 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.931 0.892 . . . . 0.0 111.552 171.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.0 ttp -79.02 -35.65 42.4 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.718 1.607 . . . . 0.0 113.704 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 t80 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 128.383 2.673 . . . . 0.0 114.513 -172.013 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.656 0 N-CA-C 112.952 0.328 . . . . 0.0 112.952 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.89 135.17 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.48 1.112 . . . . 0.0 108.438 163.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.12 154.89 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.113 1.365 . . . . 0.0 109.698 170.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.62 116.71 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.522 0.729 . . . . 0.0 109.128 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -76.57 177.73 7.23 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.604 0.716 . . . . 0.0 112.408 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.53 -26.53 68.61 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -173.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -85.64 -2.22 57.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.76 1.224 . . . . 0.0 113.037 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.99 3.13 85.65 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.53 1.062 . . . . 0.0 114.049 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.71 128.19 35.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.877 1.338 . . . . 0.0 109.726 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.6 29.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.99 123.42 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.045 1.338 . . . . 0.0 108.674 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.56 139.65 38.59 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.52 0.676 . . . . 0.0 111.222 170.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.61 141.06 48.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.476 1.91 . . . . 0.0 107.909 169.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.18 152.34 20.76 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.974 0.806 . . . . 0.0 111.244 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.54 136.86 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.492 0.663 . . . . 0.0 111.575 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.68 129.96 93.23 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.112 0.565 . . . . 0.0 111.18 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -52.91 -34.69 67.57 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.865 2.377 . . . . 0.0 113.589 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -66.33 -38.14 86.99 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.419 -0.801 . . . . 0.0 112.572 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.91 -44.39 97.24 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.749 0.704 . . . . 0.0 111.359 171.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.43 -44.48 94.46 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.29 0.495 . . . . 0.0 112.275 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.05 -47.25 85.91 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.113 0.565 . . . . 0.0 111.42 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.99 96.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.614 0.766 . . . . 0.0 111.914 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -60.14 -47.47 85.77 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.828 0.851 . . . . 0.0 112.754 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.4 t -56.74 -54.15 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 118.392 0.542 . . . . 0.0 110.418 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.79 -37.38 78.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.3 1.04 . . . . 0.0 113.227 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.85 -52.09 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.035 1.334 . . . . 0.0 111.278 170.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.6 -35.96 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 122.99 0.516 . . . . 0.0 111.362 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -58.61 -23.43 58.85 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -108.06 -25.48 11.11 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -136.07 15.67 3.28 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -166.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.41 -37.53 2.37 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -117.73 14.45 14.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.436 1.095 . . . . 0.0 113.093 -172.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 p -113.92 152.96 46.14 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.078 0.951 . . . . 0.0 111.659 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.84 -31.17 60.96 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.287 2.658 . . . . 0.0 115.292 -172.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -61.69 -21.01 64.09 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.33 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.387 0.994 . . . . 0.0 112.472 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.33 -57.12 6.07 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.717 1.207 . . . . 0.0 112.633 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.78 -29.61 59.2 Favored 'Trans proline' 0 C--N 1.351 0.709 0 CA-C-N 121.901 1.715 . . . . 0.0 112.783 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.18 -40.21 78.25 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.809 1.186 . . . . 0.0 112.683 172.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -57.04 -46.85 82.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.836 0.744 . . . . 0.0 111.544 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -61.03 -44.43 97.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.368 0.667 . . . . 0.0 112.784 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.57 -31.64 70.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.242 1.017 . . . . 0.0 113.26 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.87 4.88 52.44 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.384 1.474 . . . . 0.0 113.523 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.8 p -133.46 22.8 4.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -53.41 120.36 5.97 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.468 -1.395 . . . . 0.0 111.48 168.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.4 11.6 59.71 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.46 130.84 47.01 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.517 1.659 . . . . 0.0 112.449 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.5 p -73.45 159.55 84.48 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 123.701 0.801 . . . . 0.0 110.65 167.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.58 -35.52 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.198 1.932 . . . . 0.0 115.388 168.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.84 -40.43 87.94 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -60.21 -45.31 93.62 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.64 -0.663 . . . . 0.0 111.049 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.58 -44.29 94.48 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.288 1.035 . . . . 0.0 112.164 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -59.19 -41.4 88.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.578 0.626 . . . . 0.0 112.05 171.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.3 m -60.24 -45.19 94.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.55 0.614 . . . . 0.0 111.161 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.41 -48.88 77.92 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.196 0.907 . . . . 0.0 112.185 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.6 mt -63.12 -38.46 91.28 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.78 -33.03 69.85 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.4 p -73.87 -12.47 60.68 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.34 7.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.02 -3.7 9.3 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 117.506 1.762 . . . . 0.0 117.506 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.98 -34.08 65.07 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 119.501 1.651 . . . . 0.0 115.226 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -88.27 77.45 8.22 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.062 1.411 . . . . 0.0 110.485 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -50.36 -35.3 27.36 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.826 1.65 . . . . 0.0 115.341 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.24 74.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.118 1.327 . . . . 0.0 112.249 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.39 -43.53 85.62 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.128 0.571 . . . . 0.0 111.35 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.07 -40.16 96.86 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.592 -0.692 . . . . 0.0 112.271 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.93 -50.12 73.54 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.262 1.025 . . . . 0.0 111.539 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -55.77 -45.4 78.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.067 0.947 . . . . 0.0 112.241 174.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.3 tp -61.98 -48.71 79.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.363 0.665 . . . . 0.0 112.064 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.73 -38.23 90.32 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.857 0.863 . . . . 0.0 112.514 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.12 -45.52 92.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.623 0.647 . . . . 0.0 112.058 170.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.62 -42.34 99.53 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.768 0.713 . . . . 0.0 112.186 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.83 -46.0 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.462 -0.774 . . . . 0.0 111.051 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.17 -39.55 94.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.776 0.716 . . . . 0.0 112.738 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -60.55 -47.66 85.21 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.739 0.816 . . . . 0.0 111.968 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -70.0 -34.33 73.19 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.75 -41.53 92.02 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.44 -0.787 . . . . 0.0 112.391 172.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.85 98.25 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.123 0.569 . . . . 0.0 111.781 172.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -63.58 -42.11 98.31 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.856 -0.528 . . . . 0.0 112.182 175.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.67 -48.51 79.3 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.564 0.62 . . . . 0.0 111.744 172.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.28 -30.07 71.28 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -69.28 -39.1 78.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.363 1.065 . . . . 0.0 112.432 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.2 -27.77 42.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.796 1.239 . . . . 0.0 113.337 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.62 61.03 54.4 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.635 1.974 . . . . 0.0 111.216 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.91 120.14 7.42 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.424 2.083 . . . . 0.0 110.315 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.44 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.292 1.437 . . . . 0.0 112.158 -169.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -80.1 160.39 25.78 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.174 0.59 . . . . 0.0 110.894 168.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.17 -19.88 64.9 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.11 174.7 41.71 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.048 1.309 . . . . 0.0 112.606 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.55 169.17 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.631 2.887 . . . . 0.0 112.906 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.69 -39.0 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.874 1.269 . . . . 0.0 111.785 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.71 161.83 28.75 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.888 1.675 . . . . 0.0 110.592 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.93 133.46 22.94 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.479 2.786 . . . . 0.0 113.098 168.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.89 -14.97 60.41 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.566 1.079 . . . . 0.0 115.062 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.2 143.45 37.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.95 1.375 . . . . 0.0 110.164 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.3 145.63 54.04 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.742 -0.599 . . . . 0.0 110.869 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -68.49 152.5 45.3 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.76 0.824 . . . . 0.0 111.615 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -72.25 131.64 84.91 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-O 118.898 -0.572 . . . . 0.0 109.814 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.49 140.23 43.17 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.062 1.841 . . . . 0.0 112.401 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -74.8 171.28 14.26 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.773 1.629 . . . . 0.0 111.891 163.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.46 -43.81 93.88 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 123.33 0.491 . . . . 0.0 113.035 168.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.3 p -68.71 -25.73 64.91 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -72.97 -41.44 64.38 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.034 -1.041 . . . . 0.0 111.78 172.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.69 -42.84 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.839 0.856 . . . . 0.0 110.761 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.82 -1.52 14.41 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 173.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.11 18.15 74.49 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.922 -1.111 . . . . 0.0 115.406 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.9 p -96.02 -19.31 19.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.067 1.433 . . . . 0.0 113.287 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.9 p -126.62 -1.69 6.75 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -103.25 150.38 23.78 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.164 0.986 . . . . 0.0 111.554 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.2 p -82.48 162.61 22.0 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.342 0.591 . . . . 0.0 110.781 169.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.6 tp -56.57 -39.54 73.66 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.501 -0.749 . . . . 0.0 111.541 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.45 -38.95 93.12 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.454 -0.779 . . . . 0.0 112.666 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -64.71 -42.69 95.09 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.612 -0.68 . . . . 0.0 111.988 171.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.58 -46.35 90.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.678 0.791 . . . . 0.0 112.097 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.64 -46.16 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.167 0.987 . . . . 0.0 110.312 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.62 -50.98 55.39 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.852 0.739 . . . . 0.0 112.876 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.35 -50.04 73.16 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 117.74 0.77 . . . . 0.0 112.532 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.6 64.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.1 p -111.83 8.32 20.44 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.677 1.191 . . . . 0.0 113.033 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.3 162.31 1.53 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.045 1.338 . . . . 0.0 111.451 165.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.64 103.32 48.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.046 0.938 . . . . 0.0 110.778 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.1 163.81 89.21 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.466 0.845 . . . . 0.0 111.713 -6.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -49.93 141.38 29.26 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.199 2.6 . . . . 0.0 114.186 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.25 96.42 2.51 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 163.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.02 54.59 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.255 2.637 . . . . 0.0 112.852 -152.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.52 -35.11 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -61.91 -46.57 93.85 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.595 0.634 . . . . 0.0 113.031 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -69.88 -36.69 75.66 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.281 -1.129 . . . . 0.0 112.636 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.3 mt -62.94 -44.66 99.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.757 -0.589 . . . . 0.0 109.902 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -65.81 -40.37 91.78 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.265 -0.897 . . . . 0.0 112.497 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -55.89 -42.04 75.37 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.472 -0.767 . . . . 0.0 112.232 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.7 -45.22 81.93 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.892 0.769 . . . . 0.0 112.134 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.25 -40.66 86.3 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.242 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.55 -47.05 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.041 0.536 . . . . 0.0 110.283 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.33 -37.27 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.672 1.189 . . . . 0.0 112.261 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.86 -42.76 98.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.027 0.83 . . . . 0.0 111.235 171.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.49 -45.26 90.84 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.863 0.744 . . . . 0.0 113.176 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.41 -42.34 86.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.039 0.919 . . . . 0.0 111.112 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -55.34 -50.2 70.26 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.815 0.846 . . . . 0.0 112.473 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -55.95 -43.16 77.19 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.865 0.757 . . . . 0.0 111.971 175.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.44 -48.06 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.338 0.655 . . . . 0.0 111.448 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.52 -32.69 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.916 1.235 . . . . 0.0 112.952 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.3 -43.91 95.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.901 0.88 . . . . 0.0 111.498 171.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.7 ttp -76.99 -37.1 55.8 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.66 1.584 . . . . 0.0 113.48 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 C--O 1.252 1.192 0 C-N-CA 128.377 2.671 . . . . 0.0 114.48 -172.057 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.82 135.0 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.467 1.107 . . . . 0.0 108.402 163.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.92 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.686 170.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.62 116.68 32.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.57 0.748 . . . . 0.0 109.18 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.47 178.07 6.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.58 0.705 . . . . 0.0 112.451 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.95 -26.45 68.83 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.59 -2.19 57.9 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.776 1.231 . . . . 0.0 113.0 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.02 85.69 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.76 128.28 35.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.823 1.311 . . . . 0.0 109.745 174.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.89 125.62 29.62 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.99 123.4 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.07 1.348 . . . . 0.0 108.629 -174.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.7 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.71 141.15 48.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.5 1.92 . . . . 0.0 107.929 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 21.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.998 0.817 . . . . 0.0 111.191 170.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.53 136.84 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.607 -0.683 . . . . 0.0 111.544 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.64 130.03 93.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.059 0.544 . . . . 0.0 111.169 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.09 -34.5 68.53 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.86 2.373 . . . . 0.0 113.575 167.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.53 -38.04 86.32 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.508 -0.745 . . . . 0.0 112.562 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.91 -44.31 97.34 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.767 0.712 . . . . 0.0 111.377 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.53 -44.33 94.55 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.328 0.513 . . . . 0.0 112.321 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.17 -47.33 85.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.136 0.574 . . . . 0.0 111.359 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.35 95.19 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.644 0.778 . . . . 0.0 111.883 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.7 t-105 -60.02 -47.42 85.93 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.855 0.862 . . . . 0.0 112.763 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.68 -55.0 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.465 0.575 . . . . 0.0 110.273 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.04 -37.82 77.89 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.396 1.079 . . . . 0.0 113.243 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.33 -51.9 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.031 1.332 . . . . 0.0 111.329 170.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.65 -35.88 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.435 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -58.98 -23.1 61.44 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.707 1.139 . . . . 0.0 114.038 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.73 -25.94 11.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -135.86 16.3 3.31 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -166.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.53 -37.68 2.57 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -118.25 14.73 13.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.392 1.077 . . . . 0.0 113.149 -172.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -113.93 152.94 46.13 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 111.566 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.85 -30.75 59.21 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.257 2.638 . . . . 0.0 115.276 -172.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.05 -20.67 64.2 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.82 -31.97 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.376 0.989 . . . . 0.0 112.528 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.1 mt -71.34 -55.08 6.35 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.943 1.297 . . . . 0.0 112.961 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.83 -30.12 49.72 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.688 1.639 . . . . 0.0 112.661 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.6 mtm -69.06 -40.22 78.64 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.86 1.209 . . . . 0.0 112.623 172.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.23 -46.53 82.87 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.816 0.735 . . . . 0.0 111.581 169.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.7 m -61.01 -44.52 97.3 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 175.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.82 -32.09 71.47 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.255 1.022 . . . . 0.0 113.207 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.29 4.44 53.47 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.39 1.476 . . . . 0.0 113.522 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.4 p -132.98 22.83 4.18 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.62 120.3 6.0 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.47 -1.394 . . . . 0.0 111.491 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.54 60.16 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.42 130.84 47.06 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.565 1.682 . . . . 0.0 112.499 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.39 159.69 84.21 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.714 0.806 . . . . 0.0 110.661 167.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.28 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -60.4 -45.29 94.11 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.663 -0.648 . . . . 0.0 111.025 172.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.51 -44.34 94.57 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 112.103 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -59.11 -41.58 88.5 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.635 0.652 . . . . 0.0 111.994 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.13 -45.31 93.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.594 0.633 . . . . 0.0 111.084 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.43 -48.81 78.15 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.209 0.913 . . . . 0.0 112.188 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.18 -38.27 90.53 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.98 -33.63 70.9 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -73.29 -12.76 60.96 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.15 9.21 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.23 -5.51 8.22 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 117.328 1.691 . . . . 0.0 117.328 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.36 -31.3 59.55 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 119.336 1.568 . . . . 0.0 115.563 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -93.61 78.12 4.32 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.003 1.402 . . . . 0.0 110.652 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.79 -35.78 33.68 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -173.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.05 -41.02 74.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.123 1.328 . . . . 0.0 112.246 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.5 -43.5 85.14 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.164 0.585 . . . . 0.0 111.371 173.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.7 tpp -63.06 -40.14 96.82 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.521 -0.737 . . . . 0.0 112.263 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.99 -49.93 74.24 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.235 1.014 . . . . 0.0 111.521 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.02 -45.47 79.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.091 0.956 . . . . 0.0 112.188 174.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -61.91 -48.72 79.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.277 0.631 . . . . 0.0 112.088 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.7 -38.28 90.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 0.0 112.479 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.99 -45.49 92.54 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 112.02 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.6 m -62.61 -42.38 99.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.848 0.749 . . . . 0.0 112.149 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.9 -46.04 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 121.472 -0.768 . . . . 0.0 111.097 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.49 94.13 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.876 0.762 . . . . 0.0 112.684 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -60.78 -47.39 86.53 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.741 0.816 . . . . 0.0 111.94 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.13 -34.35 72.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.53 91.62 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.484 -0.76 . . . . 0.0 112.322 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.11 98.61 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.224 0.61 . . . . 0.0 111.781 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.17 -42.11 99.33 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.84 -0.538 . . . . 0.0 112.207 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -57.88 -48.55 79.52 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.673 0.67 . . . . 0.0 111.694 173.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.01 -30.35 71.53 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.11 -39.06 79.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.354 1.062 . . . . 0.0 112.482 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.79 60.98 53.75 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.85 120.1 7.36 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.451 2.101 . . . . 0.0 110.341 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.29 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.351 1.461 . . . . 0.0 112.142 -169.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.0 160.47 25.88 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.053 0.541 . . . . 0.0 110.903 168.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.91 65.0 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.74 41.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.096 1.332 . . . . 0.0 112.631 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.56 169.2 14.73 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.601 2.867 . . . . 0.0 112.917 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.66 -39.2 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.904 1.282 . . . . 0.0 111.753 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.61 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 110.585 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -47.94 133.42 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.479 2.786 . . . . 0.0 113.106 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.93 -14.96 60.48 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.567 1.08 . . . . 0.0 115.037 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.13 143.32 37.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.95 1.375 . . . . 0.0 110.214 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.11 145.48 54.35 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.654 -0.654 . . . . 0.0 110.843 168.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.47 152.82 44.86 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.27 131.69 84.83 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.916 -0.564 . . . . 0.0 109.872 170.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.35 140.36 44.03 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.107 1.871 . . . . 0.0 112.435 -177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -75.14 171.65 13.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.705 1.602 . . . . 0.0 111.805 163.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.6 -43.78 94.15 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.916 -0.49 . . . . 0.0 113.035 168.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.89 -25.78 64.78 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.65 65.03 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.989 -1.069 . . . . 0.0 111.749 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.65 -42.7 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.686 0.794 . . . . 0.0 110.812 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.06 -1.26 14.09 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 173.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.23 74.26 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 120.865 -1.147 . . . . 0.0 115.444 174.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.5 19.21 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.079 1.439 . . . . 0.0 113.263 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 p -126.13 -1.28 7.08 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.76 149.84 24.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.08 0.952 . . . . 0.0 111.789 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.5 p -81.81 162.32 22.91 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.288 0.566 . . . . 0.0 110.73 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.81 -39.37 74.04 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.529 -0.732 . . . . 0.0 111.438 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.5 -38.99 93.24 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.576 -0.702 . . . . 0.0 112.675 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.6 95.45 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.573 -0.705 . . . . 0.0 112.085 171.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.77 -46.47 90.36 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.626 0.77 . . . . 0.0 112.092 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.33 -46.35 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.126 0.971 . . . . 0.0 110.35 172.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.03 54.41 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.753 0.692 . . . . 0.0 112.945 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.79 0.795 . . . . 0.0 112.485 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.9 8.36 20.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.66 1.184 . . . . 0.0 113.033 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.46 162.31 1.62 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.029 1.332 . . . . 0.0 111.361 165.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.34 48.99 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.035 0.934 . . . . 0.0 110.811 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.14 163.78 89.25 Favored 'Cis proline' 0 CA--C 1.543 0.951 0 CA-C-N 119.466 0.845 . . . . 0.0 111.735 -6.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -49.9 141.39 29.0 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.205 2.604 . . . . 0.0 114.171 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.19 96.38 2.46 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 163.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.96 54.56 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.27 2.647 . . . . 0.0 112.86 -152.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.57 -34.83 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.39 -46.26 94.22 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.638 0.654 . . . . 0.0 112.967 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.83 -36.86 75.94 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.91 -44.56 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.732 -0.605 . . . . 0.0 110.004 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.37 91.6 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.307 -0.871 . . . . 0.0 112.557 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.83 -41.97 75.03 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.489 -0.757 . . . . 0.0 112.287 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -56.71 -45.27 81.94 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.889 0.768 . . . . 0.0 112.08 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.32 -40.46 85.98 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.236 0.614 . . . . 0.0 112.315 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.7 -46.98 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.044 0.538 . . . . 0.0 110.34 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.23 -37.39 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.686 1.195 . . . . 0.0 112.3 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.81 98.3 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.011 0.823 . . . . 0.0 111.223 171.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.49 -45.19 91.19 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.796 0.712 . . . . 0.0 113.26 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.42 -42.26 86.87 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.003 0.901 . . . . 0.0 111.113 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.45 -50.22 70.41 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.772 0.829 . . . . 0.0 112.453 173.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.18 76.94 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.856 0.753 . . . . 0.0 111.973 175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.48 -48.01 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.377 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.47 -32.84 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.988 1.267 . . . . 0.0 112.945 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.96 -43.23 95.18 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.877 0.871 . . . . 0.0 111.562 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.8 ttp -78.41 -36.71 45.37 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.72 1.608 . . . . 0.0 113.619 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.3 t80 . . . . . 0 C--O 1.252 1.219 0 C-N-CA 128.423 2.689 . . . . 0.0 114.629 -171.91 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.93 135.02 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.453 1.101 . . . . 0.0 108.425 163.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.92 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.62 116.7 32.52 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.521 0.729 . . . . 0.0 109.201 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.41 178.04 6.88 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.598 0.713 . . . . 0.0 112.441 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.94 -26.5 68.85 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.13 57.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.97 2.99 85.8 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.458 1.028 . . . . 0.0 114.12 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.73 128.3 35.75 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.801 1.301 . . . . 0.0 109.683 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.6 29.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 168.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -126.0 123.39 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.046 1.338 . . . . 0.0 108.659 -174.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.65 141.14 48.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.491 1.916 . . . . 0.0 107.914 169.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 21.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.015 0.825 . . . . 0.0 111.191 170.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.47 136.83 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.601 -0.687 . . . . 0.0 111.58 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.7 130.06 93.18 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.11 0.564 . . . . 0.0 111.088 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.09 -34.54 68.73 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.86 2.373 . . . . 0.0 113.575 167.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.43 -38.03 86.5 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.526 -0.734 . . . . 0.0 112.622 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.94 -44.32 97.43 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.691 0.678 . . . . 0.0 111.373 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.55 -44.36 94.39 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.251 0.478 . . . . 0.0 112.266 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.19 -47.21 86.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.105 0.562 . . . . 0.0 111.432 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.14 95.91 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.683 0.793 . . . . 0.0 111.879 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.19 -47.23 86.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.861 0.864 . . . . 0.0 112.766 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.8 -54.44 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.397 0.544 . . . . 0.0 110.369 174.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.71 -37.34 78.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.347 1.059 . . . . 0.0 113.2 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.54 -52.15 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.058 1.343 . . . . 0.0 111.288 170.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.75 -35.9 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.406 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -58.7 -23.86 60.34 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.37 -25.65 11.35 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.93 16.12 3.3 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -166.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.19 -38.22 2.41 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -117.56 13.97 14.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.415 1.086 . . . . 0.0 113.105 -172.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.5 p -113.2 152.97 45.54 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.027 0.931 . . . . 0.0 111.582 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.9 -30.76 59.7 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.277 2.651 . . . . 0.0 115.229 -172.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.02 -20.69 64.19 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.85 -31.89 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.431 1.014 . . . . 0.0 112.548 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.38 -55.07 6.31 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.957 1.303 . . . . 0.0 113.011 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.88 -30.08 49.31 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.653 1.626 . . . . 0.0 112.641 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.06 -40.16 78.67 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.901 1.228 . . . . 0.0 112.673 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -57.27 -46.51 83.01 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.758 0.708 . . . . 0.0 111.583 169.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -61.05 -44.48 97.33 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.86 -31.98 71.42 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.284 1.034 . . . . 0.0 113.292 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.34 4.44 53.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.344 1.458 . . . . 0.0 113.508 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.6 p -132.91 22.75 4.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.54 120.31 5.98 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.474 -1.391 . . . . 0.0 111.47 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.66 60.1 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.362 0.905 . . . . 0.0 115.362 -177.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.51 130.82 46.87 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.554 1.677 . . . . 0.0 112.53 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.33 159.66 84.35 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.718 167.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.61 -35.31 37.27 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.15 1.9 . . . . 0.0 115.454 168.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.16 -40.19 86.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.34 -45.3 93.95 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.6 -0.687 . . . . 0.0 111.1 172.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.52 -44.37 94.44 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.364 1.066 . . . . 0.0 112.134 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.13 -41.51 88.42 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.658 -0.651 . . . . 0.0 112.031 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.18 -45.35 93.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.622 0.646 . . . . 0.0 111.084 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.36 -48.87 77.9 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.179 0.9 . . . . 0.0 112.19 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -63.15 -38.44 91.17 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.95 -33.36 70.53 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.0 p -73.67 -12.5 60.75 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.25 7.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.87 -4.49 5.86 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.82 -33.19 55.8 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 119.249 1.524 . . . . 0.0 115.425 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -91.23 78.63 5.78 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.84 1.32 . . . . 0.0 110.613 171.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.16 -35.86 38.06 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.39 -41.1 73.48 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 120.107 1.322 . . . . 0.0 112.299 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.28 -43.61 85.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.202 0.601 . . . . 0.0 111.335 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.05 -40.1 96.71 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.514 -0.741 . . . . 0.0 112.255 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -50.02 73.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.251 1.02 . . . . 0.0 111.539 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -56.0 -45.39 79.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.97 -48.72 79.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.338 0.655 . . . . 0.0 112.055 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.75 -38.27 90.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.411 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.95 -45.48 92.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.735 0.698 . . . . 0.0 112.046 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.64 -42.37 99.55 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.149 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.84 -46.07 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.507 -0.745 . . . . 0.0 111.093 174.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.19 -39.33 93.76 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.816 0.734 . . . . 0.0 112.738 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.89 -47.4 86.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.745 0.818 . . . . 0.0 111.964 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.16 -34.33 72.87 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.48 91.66 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.481 -0.762 . . . . 0.0 112.355 173.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.16 98.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.2 0.6 . . . . 0.0 111.787 172.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.03 -42.28 99.74 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.888 -0.508 . . . . 0.0 112.166 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.676 0.671 . . . . 0.0 111.71 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.07 -30.2 71.41 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.22 -39.1 78.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.397 1.079 . . . . 0.0 112.45 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.0 53.92 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.88 120.08 7.34 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.479 2.119 . . . . 0.0 110.312 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.26 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.35 1.46 . . . . 0.0 112.179 -169.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.98 160.47 25.9 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.079 0.552 . . . . 0.0 110.903 168.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.98 65.01 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.77 41.6 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.053 1.311 . . . . 0.0 112.647 174.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.62 169.16 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.944 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.61 -39.2 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.91 1.284 . . . . 0.0 111.799 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.47 161.94 28.51 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.884 1.674 . . . . 0.0 110.587 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.94 133.42 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.479 2.786 . . . . 0.0 113.106 168.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.98 -15.08 60.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.567 1.08 . . . . 0.0 115.01 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.6 54.12 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.694 -0.629 . . . . 0.0 110.824 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.48 152.7 45.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.765 0.826 . . . . 0.0 111.626 171.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -72.25 131.7 84.85 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.912 -0.565 . . . . 0.0 109.835 170.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.38 140.43 44.06 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.074 1.849 . . . . 0.0 112.442 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -75.1 171.61 13.83 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.763 1.625 . . . . 0.0 111.871 163.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.87 94.1 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.895 -0.503 . . . . 0.0 113.035 168.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.0 p -68.81 -25.68 64.8 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.82 -41.6 64.72 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.03 -1.044 . . . . 0.0 111.733 171.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.67 -42.71 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.742 0.817 . . . . 0.0 110.787 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.23 13.99 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.98 18.11 74.21 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.626 1.107 . . . . 0.0 115.413 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.21 -19.36 19.39 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.141 1.471 . . . . 0.0 113.312 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.25 -1.52 6.99 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.56 150.01 24.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.063 0.945 . . . . 0.0 111.773 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.9 p -82.01 162.3 22.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.311 0.577 . . . . 0.0 110.806 169.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.66 -39.45 73.76 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.431 -0.793 . . . . 0.0 111.427 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.49 -38.93 93.03 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.533 -0.729 . . . . 0.0 112.701 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -64.67 -42.75 95.15 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 111.997 171.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.6 -46.41 90.36 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.575 0.75 . . . . 0.0 112.152 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.47 -46.29 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.106 0.962 . . . . 0.0 110.338 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.1 54.01 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 0.0 112.869 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.07 73.19 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.512 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.95 8.42 20.29 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.6 1.16 . . . . 0.0 113.046 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.39 162.28 1.6 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.991 1.316 . . . . 0.0 111.403 165.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.54 103.37 48.97 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.035 0.934 . . . . 0.0 110.792 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.14 163.87 89.05 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.509 0.86 . . . . 0.0 111.676 -6.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -50.04 141.36 30.06 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 0.0 114.205 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.11 96.41 2.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.97 54.6 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.54 -34.89 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.24 94.26 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.633 0.652 . . . . 0.0 112.999 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.8 -36.87 76.02 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.348 -1.09 . . . . 0.0 112.723 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.92 -44.56 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.732 -0.605 . . . . 0.0 109.987 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.89 -40.39 91.53 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.307 -0.871 . . . . 0.0 112.521 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.83 -41.98 75.06 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.431 -0.793 . . . . 0.0 112.259 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.74 -45.23 82.12 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.956 0.798 . . . . 0.0 112.044 174.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.3 -40.57 86.06 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.257 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.53 -47.22 93.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.065 0.546 . . . . 0.0 110.295 174.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.09 -37.39 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.68 1.192 . . . . 0.0 112.3 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.78 98.35 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.011 0.823 . . . . 0.0 111.224 171.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.07 91.47 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.844 0.735 . . . . 0.0 113.252 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.35 -42.42 86.86 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.988 0.894 . . . . 0.0 111.076 173.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.18 70.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.9 -43.23 77.07 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.83 0.741 . . . . 0.0 111.975 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.51 -47.79 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.43 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.56 -32.91 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.963 1.256 . . . . 0.0 112.911 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.23 -44.79 94.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.933 0.893 . . . . 0.0 111.487 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.2 ttp -75.42 -36.34 60.81 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.631 1.573 . . . . 0.0 113.442 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.252 1.196 0 C-N-CA 128.394 2.678 . . . . 0.0 114.54 -172.815 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.009 0.35 . . . . 0.0 113.009 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.76 135.02 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.472 1.109 . . . . 0.0 108.436 163.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.96 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.72 116.74 32.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.501 0.72 . . . . 0.0 109.195 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.452 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.89 -26.46 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -173.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.19 57.93 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.809 1.244 . . . . 0.0 112.988 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.04 2.94 85.67 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.504 1.05 . . . . 0.0 114.103 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.64 128.29 35.68 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.866 1.333 . . . . 0.0 109.745 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.61 29.61 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 168.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.0 t -125.97 123.34 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.045 1.338 . . . . 0.0 108.723 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.5 139.73 38.64 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.512 0.672 . . . . 0.0 111.206 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.76 141.17 48.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.477 1.911 . . . . 0.0 107.897 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.38 20.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.804 . . . . 0.0 111.238 170.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.5 136.79 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.611 -0.681 . . . . 0.0 111.591 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.64 130.01 93.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 123.114 0.566 . . . . 0.0 111.151 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.887 2.391 . . . . 0.0 113.575 167.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.4 -38.09 86.69 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 112.579 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.0 -44.28 97.65 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.687 0.676 . . . . 0.0 111.347 171.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.55 -44.23 94.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.328 0.513 . . . . 0.0 112.309 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.28 -47.28 85.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.124 0.569 . . . . 0.0 111.392 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.2 95.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.658 0.783 . . . . 0.0 111.9 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.17 -47.23 86.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.809 0.844 . . . . 0.0 112.77 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.76 -54.52 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.455 0.57 . . . . 0.0 110.397 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.59 -37.44 78.54 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.354 1.062 . . . . 0.0 113.191 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.59 -52.1 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.026 1.33 . . . . 0.0 111.295 170.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.64 -35.92 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.915 0.486 . . . . 0.0 111.399 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -58.72 -23.95 60.63 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.21 -25.73 11.39 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.88 16.13 3.31 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.16 -38.38 2.44 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -117.48 14.1 14.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.404 1.081 . . . . 0.0 113.115 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.9 p -113.18 153.02 45.54 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 123.952 0.901 . . . . 0.0 111.565 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.89 -30.66 59.12 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.289 2.659 . . . . 0.0 115.27 -172.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.12 -20.74 64.37 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.73 -32.01 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.387 0.994 . . . . 0.0 112.539 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.33 -55.05 6.39 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.943 1.297 . . . . 0.0 113.011 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.89 -30.08 49.23 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.685 1.637 . . . . 0.0 112.655 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.08 -40.21 78.58 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.876 1.216 . . . . 0.0 112.598 172.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -57.28 -46.52 83.03 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.776 0.716 . . . . 0.0 111.522 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.2 m -61.11 -44.4 97.4 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.9 -32.02 71.5 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.268 1.027 . . . . 0.0 113.27 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.23 4.43 53.55 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.4 1.48 . . . . 0.0 113.536 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -133.03 22.8 4.16 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.62 120.34 6.06 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.491 168.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.69 60.06 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.9 47.19 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.565 1.683 . . . . 0.0 112.481 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.37 159.66 84.33 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 123.748 0.819 . . . . 0.0 110.705 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -49.54 -35.48 37.11 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.3 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.36 -45.26 94.12 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.049 172.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.54 -44.37 94.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.386 1.074 . . . . 0.0 112.134 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -59.13 -41.51 88.42 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.658 -0.651 . . . . 0.0 112.031 171.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.5 m -60.23 -45.28 93.78 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.622 0.646 . . . . 0.0 111.073 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.44 -48.85 78.06 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.254 0.934 . . . . 0.0 112.191 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.13 -38.45 91.24 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.87 -33.43 70.48 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.1 p -73.66 -12.52 60.76 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.4 m -122.2 7.84 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.93 -4.54 6.0 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 117.193 1.637 . . . . 0.0 117.193 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.83 -33.22 55.93 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.257 1.528 . . . . 0.0 115.404 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -91.18 78.49 5.83 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.875 1.338 . . . . 0.0 110.605 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.06 -35.86 36.88 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.35 -41.09 73.61 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.094 1.315 . . . . 0.0 112.242 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.54 85.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.174 0.59 . . . . 0.0 111.311 173.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.05 -40.13 96.77 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.514 -0.741 . . . . 0.0 112.265 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -49.92 74.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.198 0.999 . . . . 0.0 111.58 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.99 -45.52 78.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.091 0.956 . . . . 0.0 112.199 174.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.2 tp -61.87 -48.81 78.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.326 0.65 . . . . 0.0 112.055 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.63 -38.28 90.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.842 0.857 . . . . 0.0 112.49 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.99 -45.55 92.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 111.985 170.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.3 m -62.51 -42.45 99.51 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.87 0.759 . . . . 0.0 112.155 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.86 -46.08 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.478 -0.764 . . . . 0.0 111.059 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.18 -39.37 93.85 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.858 0.754 . . . . 0.0 112.752 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.81 -47.48 86.13 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.925 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.09 -34.32 73.0 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.582 -0.699 . . . . 0.0 112.85 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.69 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.408 -0.808 . . . . 0.0 112.361 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.09 98.7 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.215 0.606 . . . . 0.0 111.751 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.25 99.58 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 0.0 112.218 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.77 -48.57 79.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.737 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.05 -30.23 71.43 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.24 -39.11 78.71 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.337 1.055 . . . . 0.0 112.482 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.24 -27.58 42.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.76 1.224 . . . . 0.0 113.327 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.76 61.03 54.17 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.646 1.978 . . . . 0.0 111.247 -174.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.92 120.14 7.41 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.509 2.139 . . . . 0.0 110.261 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.42 136.3 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.298 1.439 . . . . 0.0 112.108 -169.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.97 160.37 25.95 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.116 0.567 . . . . 0.0 110.922 168.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.97 65.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 174.77 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.048 1.309 . . . . 0.0 112.656 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 169.16 14.85 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.66 2.907 . . . . 0.0 112.896 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.64 -39.18 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.926 1.29 . . . . 0.0 111.762 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.55 161.87 28.65 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.858 1.663 . . . . 0.0 110.561 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.93 133.44 22.94 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.403 2.735 . . . . 0.0 113.141 168.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.08 60.29 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.562 1.077 . . . . 0.0 114.978 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.22 145.5 54.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.694 -0.629 . . . . 0.0 110.815 168.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -68.54 152.83 44.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.658 0.783 . . . . 0.0 111.668 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.18 131.64 85.03 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.83 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.37 140.44 44.13 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.076 1.851 . . . . 0.0 112.426 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -75.12 171.58 13.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.74 1.616 . . . . 0.0 111.906 163.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.51 -43.87 93.96 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.971 -0.455 . . . . 0.0 113.049 168.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.85 -25.7 64.78 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.68 64.88 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.068 -1.02 . . . . 0.0 111.727 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.63 -42.69 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 110.817 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.29 14.23 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.16 74.31 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.605 1.098 . . . . 0.0 115.447 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.31 -19.46 19.24 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.074 1.437 . . . . 0.0 113.263 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 p -126.14 -1.34 7.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.86 149.81 24.73 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.095 0.958 . . . . 0.0 111.752 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.6 p -81.73 162.27 23.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.303 0.573 . . . . 0.0 110.799 170.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.72 -39.38 73.81 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.466 -0.771 . . . . 0.0 111.445 169.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.58 -38.91 92.91 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.554 -0.716 . . . . 0.0 112.706 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.57 -42.79 95.41 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.542 -0.724 . . . . 0.0 112.011 171.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.62 -46.43 90.3 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.68 0.792 . . . . 0.0 112.144 176.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.46 -46.35 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.106 0.962 . . . . 0.0 110.301 172.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.39 -51.11 53.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.872 0.748 . . . . 0.0 112.882 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 0.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.62 -18.56 64.33 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.86 8.42 20.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.624 1.17 . . . . 0.0 113.064 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.41 162.3 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.952 1.301 . . . . 0.0 111.461 165.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.39 48.92 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.035 0.934 . . . . 0.0 110.811 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.07 163.84 89.16 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.429 0.832 . . . . 0.0 111.701 -6.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -50.04 141.35 30.07 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 0.0 114.205 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.13 96.48 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.05 54.58 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.274 2.649 . . . . 0.0 112.827 -152.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.59 -34.77 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.48 -46.2 94.31 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.637 0.653 . . . . 0.0 112.996 173.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.8 -36.92 76.07 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.293 -1.122 . . . . 0.0 112.665 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.0 mt -62.93 -44.57 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.808 -0.557 . . . . 0.0 109.921 174.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.42 91.66 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.303 -0.873 . . . . 0.0 112.489 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.84 -41.99 75.1 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.294 173.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -56.7 -45.24 81.95 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.926 0.784 . . . . 0.0 112.071 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -67.34 -40.48 85.9 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.266 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.62 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.044 0.538 . . . . 0.0 110.291 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.03 -37.35 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.683 1.193 . . . . 0.0 112.355 177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.77 98.4 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.03 0.832 . . . . 0.0 111.224 171.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.09 91.41 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.796 0.712 . . . . 0.0 113.242 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.38 -42.35 86.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 117.986 0.893 . . . . 0.0 111.097 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.55 -50.17 70.73 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.798 0.839 . . . . 0.0 112.445 173.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.26 77.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.86 0.755 . . . . 0.0 111.991 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.4 -47.9 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.335 0.654 . . . . 0.0 111.44 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.92 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.924 1.238 . . . . 0.0 112.9 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.17 -44.54 94.94 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.884 0.874 . . . . 0.0 111.473 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.78 -35.86 59.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.655 1.582 . . . . 0.0 113.468 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 128.39 2.676 . . . . 0.0 114.59 -172.737 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.998 0.345 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.9 135.09 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.457 1.103 . . . . 0.0 108.402 163.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.13 154.83 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.063 1.345 . . . . 0.0 109.627 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.7 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.9 -26.45 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.61 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.825 1.25 . . . . 0.0 113.03 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.02 85.77 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.5 1.048 . . . . 0.0 114.144 -175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.7 128.22 35.43 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.801 1.301 . . . . 0.0 109.745 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.63 29.63 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 168.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -125.95 123.36 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.107 1.363 . . . . 0.0 108.669 -174.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.56 139.71 38.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.543 0.687 . . . . 0.0 111.191 170.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.72 141.11 48.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.465 1.906 . . . . 0.0 107.929 169.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.36 21.02 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.254 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.5 136.89 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.492 0.663 . . . . 0.0 111.572 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.69 129.96 93.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.068 0.547 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.01 -34.56 68.05 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.868 2.378 . . . . 0.0 113.56 167.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.41 -38.07 86.64 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.451 -0.78 . . . . 0.0 112.587 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.97 -44.3 97.55 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.779 0.718 . . . . 0.0 111.377 171.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.54 -44.37 94.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.29 0.496 . . . . 0.0 112.244 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.22 -47.25 86.04 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.115 0.566 . . . . 0.0 111.37 176.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.24 95.61 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.651 0.78 . . . . 0.0 111.897 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.24 -47.01 87.79 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.771 0.829 . . . . 0.0 112.812 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.78 -54.55 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.439 0.563 . . . . 0.0 110.344 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.66 -37.36 78.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.343 1.057 . . . . 0.0 113.219 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.38 -52.22 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.138 1.375 . . . . 0.0 111.253 170.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.82 -36.02 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.996 0.518 . . . . 0.0 111.407 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.66 -23.89 60.13 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.3 -25.62 11.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.98 16.08 3.29 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -165.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.37 -38.13 2.59 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -117.44 13.8 14.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.345 1.058 . . . . 0.0 113.127 -172.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -112.99 153.0 45.38 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.96 0.904 . . . . 0.0 111.566 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.88 -30.74 59.39 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.311 2.674 . . . . 0.0 115.218 -172.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.02 -20.74 64.25 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.88 -31.88 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.414 1.006 . . . . 0.0 112.488 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.41 -55.01 6.32 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.957 1.303 . . . . 0.0 112.989 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.93 -30.08 48.9 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 121.678 1.635 . . . . 0.0 112.641 174.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.06 -40.21 78.65 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.901 1.228 . . . . 0.0 112.673 172.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.27 -46.47 83.05 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.765 0.711 . . . . 0.0 111.569 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -61.09 -44.44 97.36 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -32.0 71.51 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.268 1.027 . . . . 0.0 113.257 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.3 4.48 53.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.325 1.45 . . . . 0.0 113.511 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -133.03 22.8 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.54 120.31 5.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.478 -1.389 . . . . 0.0 111.468 168.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.63 60.04 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.46 130.88 47.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.573 1.687 . . . . 0.0 112.482 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.35 159.66 84.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.753 0.821 . . . . 0.0 110.666 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.22 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.41 -45.22 94.38 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.66 -0.65 . . . . 0.0 111.108 172.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.57 -44.26 94.62 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 112.163 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.3 -41.35 88.78 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.696 -0.628 . . . . 0.0 111.989 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.26 -45.33 93.68 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.629 0.65 . . . . 0.0 111.091 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.33 -48.91 77.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.205 0.911 . . . . 0.0 112.179 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.11 -38.49 91.38 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.91 -33.56 70.69 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 p -73.57 -12.46 60.77 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.34 7.73 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.57 -4.8 5.73 Favored Glycine 0 CA--C 1.541 1.702 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.71 -33.32 55.25 Favored Glycine 0 CA--C 1.537 1.433 0 CA-C-N 119.183 1.491 . . . . 0.0 115.462 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -90.81 78.77 6.06 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.836 1.318 . . . . 0.0 110.634 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.32 -35.94 40.43 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.49 -41.2 73.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.094 1.315 . . . . 0.0 112.293 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.57 86.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.155 0.582 . . . . 0.0 111.337 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.13 -40.04 96.44 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.555 -0.716 . . . . 0.0 112.224 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.99 -50.0 74.03 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.056 -1.028 . . . . 0.0 111.521 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.0 -45.42 79.05 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 tp -61.88 -48.75 79.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.277 0.631 . . . . 0.0 112.105 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.77 -38.21 90.26 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.836 0.854 . . . . 0.0 112.463 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.97 -45.48 92.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.699 0.681 . . . . 0.0 112.075 170.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.65 -42.37 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.118 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.85 -46.14 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.477 -0.765 . . . . 0.0 111.03 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.09 -39.43 94.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.842 0.746 . . . . 0.0 112.757 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.75 -47.46 86.2 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.703 0.801 . . . . 0.0 111.975 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.09 -34.38 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.87 -41.42 91.63 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.467 -0.771 . . . . 0.0 112.341 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.08 98.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.184 0.594 . . . . 0.0 111.772 172.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.14 -42.21 99.44 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.924 -0.485 . . . . 0.0 112.135 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.84 -48.58 79.38 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.682 0.674 . . . . 0.0 111.699 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.04 -30.19 71.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.16 -39.18 78.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.361 1.065 . . . . 0.0 112.499 173.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.61 42.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 113.29 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.76 61.03 54.13 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.696 1.998 . . . . 0.0 111.225 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.9 120.16 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.481 2.12 . . . . 0.0 110.277 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.46 136.23 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.318 1.447 . . . . 0.0 112.121 -169.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.92 160.49 25.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.05 0.54 . . . . 0.0 110.903 168.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.9 64.99 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.98 174.71 41.62 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.099 1.333 . . . . 0.0 112.653 174.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.63 169.14 14.96 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.658 2.905 . . . . 0.0 112.915 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.6 -39.23 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.94 1.296 . . . . 0.0 111.762 -175.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.44 161.93 28.53 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.817 1.647 . . . . 0.0 110.573 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.95 133.47 23.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.441 2.761 . . . . 0.0 113.132 168.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.99 60.33 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.613 1.101 . . . . 0.0 115.056 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.36 37.46 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.946 1.373 . . . . 0.0 110.198 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.11 145.54 54.29 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.693 -0.63 . . . . 0.0 110.858 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.51 152.7 45.02 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.728 0.811 . . . . 0.0 111.653 171.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.21 131.66 84.96 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.34 140.38 44.09 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.134 1.889 . . . . 0.0 112.416 -177.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -75.11 171.66 13.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.709 1.604 . . . . 0.0 111.89 163.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.91 94.07 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.895 -0.503 . . . . 0.0 112.991 168.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.6 p -68.78 -25.77 64.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.76 -41.59 64.92 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.027 -1.046 . . . . 0.0 111.778 171.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.65 -42.69 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.718 0.807 . . . . 0.0 110.793 173.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.26 13.93 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 173.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.91 18.16 74.12 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.922 -1.111 . . . . 0.0 115.477 175.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.3 -19.35 19.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.131 1.466 . . . . 0.0 113.305 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.0 p -126.27 -1.51 6.98 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.6 149.97 24.41 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.103 0.961 . . . . 0.0 111.824 173.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.6 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.318 0.58 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.81 -39.44 74.16 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.418 -0.801 . . . . 0.0 111.372 169.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.5 -38.93 93.03 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.576 -0.702 . . . . 0.0 112.685 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.8 95.31 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.602 -0.686 . . . . 0.0 112.008 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.61 -46.39 90.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.648 0.779 . . . . 0.0 112.097 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.35 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.301 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.05 54.33 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.85 0.738 . . . . 0.0 112.866 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.14 72.91 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.828 0.814 . . . . 0.0 112.517 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.62 -18.48 64.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.4 p -111.88 8.36 20.39 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.688 1.195 . . . . 0.0 113.051 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.43 162.31 1.6 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.989 1.316 . . . . 0.0 111.434 165.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.34 48.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.035 0.934 . . . . 0.0 110.837 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.85 89.11 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.447 0.838 . . . . 0.0 111.701 -6.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -50.06 141.37 30.24 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.21 2.607 . . . . 0.0 114.135 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.14 96.49 2.5 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 163.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.0 54.59 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.251 2.634 . . . . 0.0 112.86 -152.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.63 -34.81 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.26 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.999 173.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.83 -36.87 75.95 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.91 -44.6 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.709 -0.62 . . . . 0.0 109.942 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.82 -40.46 91.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.307 -0.871 . . . . 0.0 112.54 176.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -42.03 74.99 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.455 -0.778 . . . . 0.0 112.287 173.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.68 -45.21 81.9 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.865 0.757 . . . . 0.0 112.147 174.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.35 -40.47 85.83 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.272 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.64 -47.27 93.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.085 0.554 . . . . 0.0 110.206 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.05 -37.36 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.634 1.174 . . . . 0.0 112.322 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.74 -42.87 98.24 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.095 0.861 . . . . 0.0 111.233 171.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.55 -45.07 91.56 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.821 0.724 . . . . 0.0 113.252 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.28 -42.49 86.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.988 0.894 . . . . 0.0 111.102 173.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.5 -50.16 70.67 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.772 0.829 . . . . 0.0 112.503 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.86 -43.27 76.95 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.864 0.756 . . . . 0.0 112.027 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.46 -47.74 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.337 0.655 . . . . 0.0 111.467 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.64 -32.89 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.923 1.238 . . . . 0.0 112.874 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.34 -45.11 94.6 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.958 0.903 . . . . 0.0 111.463 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.3 ttp -74.74 -36.7 62.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.666 1.586 . . . . 0.0 113.362 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 128.417 2.687 . . . . 0.0 114.655 -173.026 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.81 135.01 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.458 1.103 . . . . 0.0 108.437 163.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.02 154.94 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.1 1.36 . . . . 0.0 109.648 170.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.66 116.69 32.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.516 0.726 . . . . 0.0 109.17 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.604 0.716 . . . . 0.0 112.452 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.89 -26.45 68.79 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.63 -2.19 57.92 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.767 1.227 . . . . 0.0 112.988 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.03 85.67 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.78 128.27 35.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.861 1.331 . . . . 0.0 109.664 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.61 29.61 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 168.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.97 123.35 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.046 1.338 . . . . 0.0 108.678 -174.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.52 139.65 38.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.236 170.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.13 48.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.468 1.907 . . . . 0.0 107.94 169.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.24 152.37 20.91 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.221 170.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.54 136.9 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.65 -0.656 . . . . 0.0 111.509 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.71 130.01 93.19 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 123.098 0.559 . . . . 0.0 111.151 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.99 -34.6 67.96 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.907 2.405 . . . . 0.0 113.604 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.43 -38.06 86.57 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 112.594 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.94 -44.32 97.43 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.691 0.678 . . . . 0.0 111.373 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.57 -44.29 94.53 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.251 0.478 . . . . 0.0 112.254 175.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.23 -47.27 85.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.079 0.551 . . . . 0.0 111.399 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.23 95.63 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.663 0.785 . . . . 0.0 111.882 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.11 -47.27 86.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.801 0.84 . . . . 0.0 112.801 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.8 -54.4 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.431 0.559 . . . . 0.0 110.397 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.7 -37.36 78.63 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.301 1.04 . . . . 0.0 113.218 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.55 -52.19 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.027 1.331 . . . . 0.0 111.318 170.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.61 -35.96 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.417 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -58.66 -23.96 60.27 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.2 -25.73 11.39 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.83 15.91 3.33 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -166.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.05 -38.22 2.24 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -117.61 14.05 14.4 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.402 1.081 . . . . 0.0 113.141 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 p -113.14 152.97 45.49 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.982 0.913 . . . . 0.0 111.523 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.74 -30.96 58.98 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.258 2.639 . . . . 0.0 115.203 -172.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.01 -21.01 64.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.16 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.41 1.005 . . . . 0.0 112.485 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.36 -57.18 5.98 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.76 1.224 . . . . 0.0 112.561 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.84 -29.52 58.68 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.891 1.711 . . . . 0.0 112.814 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.25 -40.16 78.03 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.781 1.173 . . . . 0.0 112.705 172.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.09 -47.02 82.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.847 0.748 . . . . 0.0 111.53 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -60.92 -44.2 97.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.68 71.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.227 1.011 . . . . 0.0 113.225 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.76 4.53 52.85 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.373 1.469 . . . . 0.0 113.47 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.5 p -133.08 22.79 4.14 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -53.56 120.33 6.01 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.508 -1.37 . . . . 0.0 111.454 168.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.62 60.02 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.447 0.939 . . . . 0.0 115.447 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.89 47.15 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.489 1.644 . . . . 0.0 112.515 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.32 159.68 84.33 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.771 0.828 . . . . 0.0 110.665 167.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.57 -35.48 37.46 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.227 1.951 . . . . 0.0 115.381 168.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.3 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.33 -45.3 93.9 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.062 172.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.57 -44.29 94.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.354 1.062 . . . . 0.0 112.134 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -59.21 -41.49 88.74 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.682 -0.636 . . . . 0.0 111.973 171.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.25 -45.24 93.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.654 0.661 . . . . 0.0 111.08 175.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.38 -48.87 77.92 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.254 0.934 . . . . 0.0 112.202 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.0 mt -63.13 -38.47 91.32 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.91 -33.41 70.51 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.4 p -73.66 -12.52 60.76 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.2 m -122.14 7.79 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -174.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.77 -4.64 5.87 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.85 -32.94 55.83 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 119.236 1.518 . . . . 0.0 115.411 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -91.57 78.62 5.56 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.875 1.337 . . . . 0.0 110.585 171.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.18 -35.92 38.59 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.33 -41.06 73.73 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.12 1.327 . . . . 0.0 112.315 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.6 86.01 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.16 0.584 . . . . 0.0 111.361 173.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.04 -40.18 96.95 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.476 -0.765 . . . . 0.0 112.255 175.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.9 -50.0 73.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.237 1.015 . . . . 0.0 111.548 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.99 -45.42 79.02 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.095 0.958 . . . . 0.0 112.21 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.97 -48.72 79.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.338 0.655 . . . . 0.0 112.055 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -63.75 -38.24 90.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.448 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.98 -45.53 92.42 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.684 0.675 . . . . 0.0 112.046 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.54 -42.42 99.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.848 0.749 . . . . 0.0 112.164 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.84 -46.1 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.507 -0.745 . . . . 0.0 111.093 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.13 -39.4 93.94 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.847 0.749 . . . . 0.0 112.759 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.8 -47.46 86.23 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.948 174.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.11 -34.32 72.96 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.46 91.76 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.408 -0.808 . . . . 0.0 112.376 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.12 98.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.208 0.603 . . . . 0.0 111.772 172.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.0 -42.32 99.81 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.869 -0.519 . . . . 0.0 112.165 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.77 -48.63 79.11 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.645 0.657 . . . . 0.0 111.676 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.02 -30.25 71.45 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -39.1 78.79 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.326 1.05 . . . . 0.0 112.451 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.22 -27.61 42.5 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 113.339 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.76 61.01 54.03 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.646 1.978 . . . . 0.0 111.247 -174.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.89 120.16 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.51 2.14 . . . . 0.0 110.261 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.45 136.24 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.383 1.473 . . . . 0.0 112.086 -169.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -79.94 160.43 25.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.082 0.553 . . . . 0.0 110.909 168.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.98 65.02 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.016 1.293 . . . . 0.0 112.617 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 169.2 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.917 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.65 -39.17 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.897 1.279 . . . . 0.0 111.799 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.51 161.9 28.59 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.911 1.684 . . . . 0.0 110.599 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.427 2.751 . . . . 0.0 113.132 168.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.07 60.28 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 115.005 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.021 1.41 . . . . 0.0 110.198 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.5 54.27 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.726 -0.608 . . . . 0.0 110.848 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.53 152.77 44.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.666 0.787 . . . . 0.0 111.664 171.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.24 131.73 84.85 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.883 -0.58 . . . . 0.0 109.821 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.42 140.44 43.95 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.037 1.825 . . . . 0.0 112.426 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -75.1 171.62 13.8 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.74 1.616 . . . . 0.0 111.898 163.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.55 -43.94 94.0 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 121.895 -0.503 . . . . 0.0 112.986 168.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.5 p -68.77 -25.73 64.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.8 -41.61 64.76 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.068 -1.02 . . . . 0.0 111.721 171.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.75 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.784 0.834 . . . . 0.0 110.782 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.05 -1.25 14.05 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.97 18.13 74.21 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.879 -1.138 . . . . 0.0 115.485 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.34 -19.3 19.33 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.092 1.446 . . . . 0.0 113.313 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.26 -1.5 6.99 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.63 149.95 24.45 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.055 0.942 . . . . 0.0 111.799 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.1 p -81.79 162.42 22.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.309 0.576 . . . . 0.0 110.773 169.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.81 -39.41 74.13 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.454 -0.778 . . . . 0.0 111.431 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.52 -38.91 92.93 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.518 -0.739 . . . . 0.0 112.674 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.62 -42.75 95.3 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.628 -0.67 . . . . 0.0 112.033 171.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.35 90.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.62 0.768 . . . . 0.0 112.11 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.51 -46.33 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.151 0.981 . . . . 0.0 110.255 172.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.09 54.06 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.823 0.725 . . . . 0.0 112.884 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.22 -50.1 73.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.517 174.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.61 -18.58 64.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.9 8.41 20.37 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.581 1.153 . . . . 0.0 113.046 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.41 162.3 1.59 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.935 1.294 . . . . 0.0 111.461 165.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.87 89.08 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.451 0.84 . . . . 0.0 111.713 -6.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -50.08 141.4 30.3 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.189 2.593 . . . . 0.0 114.135 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.16 96.43 2.48 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.97 54.63 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.66 -34.78 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.44 -46.2 94.33 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.666 0.666 . . . . 0.0 112.996 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.84 -36.89 75.93 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.259 -1.142 . . . . 0.0 112.679 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.89 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.802 -0.561 . . . . 0.0 109.98 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.9 -40.4 91.47 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.313 -0.867 . . . . 0.0 112.521 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -42.04 75.07 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.69 -45.28 81.88 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.924 0.784 . . . . 0.0 112.058 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.3 -40.54 86.04 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.305 0.642 . . . . 0.0 112.227 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.64 -47.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.279 174.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.25 -37.29 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.685 1.194 . . . . 0.0 112.282 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.8 -42.78 98.31 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.112 0.869 . . . . 0.0 111.245 171.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.06 91.55 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.796 0.712 . . . . 0.0 113.242 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.41 -42.4 87.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.019 0.91 . . . . 0.0 111.078 173.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.19 70.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.26 77.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.86 0.755 . . . . 0.0 111.991 175.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.43 -47.94 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.402 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.48 -32.88 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.951 1.251 . . . . 0.0 112.911 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.24 -44.55 95.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.902 0.881 . . . . 0.0 111.474 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.77 -36.2 59.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.69 1.596 . . . . 0.0 113.437 -177.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.5 t80 . . . . . 0 C--O 1.251 1.16 0 C-N-CA 128.415 2.686 . . . . 0.0 114.504 -172.665 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.85 135.0 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.504 1.121 . . . . 0.0 108.402 163.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.7 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.88 -26.5 68.81 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.0 3.05 85.7 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.475 1.036 . . . . 0.0 114.092 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.19 35.32 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.87 1.335 . . . . 0.0 109.741 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.85 125.52 29.47 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 168.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.9 t -125.9 123.36 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.063 1.345 . . . . 0.0 108.659 -174.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.54 139.67 38.61 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.177 170.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.16 48.41 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 20.99 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.803 . . . . 0.0 111.191 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.53 136.91 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.472 0.653 . . . . 0.0 111.578 176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.71 130.0 93.19 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.108 0.563 . . . . 0.0 111.137 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.873 2.382 . . . . 0.0 113.575 167.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.44 -38.09 86.61 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.464 -0.773 . . . . 0.0 112.56 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.92 -44.32 97.35 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 0.0 111.373 171.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.53 -44.31 94.6 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.24 -47.26 86.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.079 0.551 . . . . 0.0 111.366 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.18 95.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.626 0.77 . . . . 0.0 111.91 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.11 -47.14 87.12 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.833 0.853 . . . . 0.0 112.786 176.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.0 t -56.89 -54.26 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.381 0.537 . . . . 0.0 110.474 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.83 -37.26 78.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.358 1.063 . . . . 0.0 113.19 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.45 -52.3 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.096 1.358 . . . . 0.0 111.257 170.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.83 -35.85 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 119.053 -0.499 . . . . 0.0 111.466 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.73 -23.71 60.31 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.49 -25.62 11.3 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.92 16.11 3.3 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -166.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.39 -37.5 2.34 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -118.23 13.84 13.79 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.475 1.11 . . . . 0.0 113.148 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.9 p -113.05 153.06 45.42 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.971 0.908 . . . . 0.0 111.568 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.89 -30.88 60.16 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.256 2.638 . . . . 0.0 115.182 -172.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.95 64.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.17 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.41 1.005 . . . . 0.0 112.462 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.6 mt -70.35 -57.18 6.0 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.743 1.217 . . . . 0.0 112.561 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.88 -29.45 58.36 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.891 1.711 . . . . 0.0 112.816 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.24 -40.17 78.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.831 1.196 . . . . 0.0 112.709 172.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.12 -47.01 82.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.83 0.741 . . . . 0.0 111.562 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -60.91 -44.2 97.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.73 -31.68 70.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.228 1.011 . . . . 0.0 113.251 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.87 4.62 52.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.419 1.488 . . . . 0.0 113.458 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.1 p -133.11 22.86 4.14 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.61 120.3 6.0 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.453 -1.404 . . . . 0.0 111.465 168.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.71 60.16 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.59 130.91 47.18 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.478 1.639 . . . . 0.0 112.453 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.35 159.65 84.37 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.771 0.828 . . . . 0.0 110.653 167.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.58 -35.44 37.43 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.171 1.914 . . . . 0.0 115.372 168.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.07 -40.24 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -60.32 -45.32 93.81 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.662 -0.649 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.57 -44.27 94.59 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 112.163 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -59.21 -41.43 88.58 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.682 -0.636 . . . . 0.0 111.996 171.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.6 m -60.25 -45.42 93.33 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.583 0.629 . . . . 0.0 111.028 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.28 -48.85 77.85 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.228 0.922 . . . . 0.0 112.179 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.8 mt -63.18 -38.29 90.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 178.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.07 -34.2 71.69 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -72.81 -12.93 61.18 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.4 13.11 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.267 1.027 . . . . 0.0 113.505 -175.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.48 -5.91 4.1 Favored Glycine 0 CA--C 1.543 1.835 0 N-CA-C 117.067 1.587 . . . . 0.0 117.067 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.67 -0.13 6.21 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 125.84 1.686 . . . . 0.0 116.919 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -124.78 79.79 1.81 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.339 1.57 . . . . 0.0 110.347 166.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.81 -36.08 46.59 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -172.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.17 -41.01 74.33 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.118 1.326 . . . . 0.0 112.19 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.47 -43.68 84.82 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.19 0.596 . . . . 0.0 111.317 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.2 tpp -62.86 -40.3 97.04 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.508 -0.745 . . . . 0.0 112.2 175.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.97 74.18 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.296 1.038 . . . . 0.0 111.536 173.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -56.02 -45.43 79.1 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.101 0.961 . . . . 0.0 112.206 174.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.8 tp -61.88 -48.81 78.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.289 0.636 . . . . 0.0 112.055 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.63 -38.31 90.65 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.455 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.02 -45.45 92.75 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.668 0.667 . . . . 0.0 112.013 170.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.61 -42.45 99.58 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.848 0.749 . . . . 0.0 112.094 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.8 -46.11 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.535 -0.728 . . . . 0.0 111.053 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.16 -39.4 93.94 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.865 0.757 . . . . 0.0 112.717 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -60.84 -47.44 86.35 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.964 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.1 -34.3 72.96 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.55 91.78 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.451 -0.781 . . . . 0.0 112.369 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.01 98.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.201 0.6 . . . . 0.0 111.784 172.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.1 -42.28 99.54 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.864 -0.523 . . . . 0.0 112.19 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.88 -48.45 79.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.646 0.657 . . . . 0.0 111.687 173.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.09 -30.3 71.49 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.08 -39.12 79.26 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.361 1.064 . . . . 0.0 112.499 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.29 -27.6 42.21 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.776 1.23 . . . . 0.0 113.302 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.83 61.03 54.02 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.672 1.989 . . . . 0.0 111.241 -174.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.93 120.16 7.44 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.421 2.08 . . . . 0.0 110.258 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.4 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.34 1.456 . . . . 0.0 112.152 -169.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.05 160.47 25.81 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.043 0.537 . . . . 0.0 110.909 168.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.26 -19.97 65.03 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.71 41.58 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.048 1.309 . . . . 0.0 112.61 174.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.45 169.17 14.61 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.668 2.912 . . . . 0.0 112.954 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.74 -39.17 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.909 1.284 . . . . 0.0 111.742 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.94 28.52 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -47.91 133.42 22.84 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.479 2.786 . . . . 0.0 113.089 168.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.06 60.35 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.562 1.077 . . . . 0.0 114.978 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.35 37.47 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.96 1.38 . . . . 0.0 110.198 173.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.17 145.57 54.21 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.717 -0.614 . . . . 0.0 110.826 168.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.56 152.73 44.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.709 0.804 . . . . 0.0 111.614 171.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.25 131.73 84.82 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.916 -0.564 . . . . 0.0 109.835 170.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.42 140.39 43.83 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.099 1.866 . . . . 0.0 112.442 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.7 mtp85 -75.02 171.63 13.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.737 1.615 . . . . 0.0 111.852 163.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.68 -43.82 94.27 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.942 -0.474 . . . . 0.0 112.954 168.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.77 -25.86 64.92 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.56 65.11 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.041 -1.037 . . . . 0.0 111.756 171.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.66 -42.69 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.731 0.812 . . . . 0.0 110.827 173.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.29 14.03 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 173.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.11 74.16 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.934 -1.104 . . . . 0.0 115.477 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.39 19.35 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.11 1.455 . . . . 0.0 113.292 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.6 p -126.21 -1.54 7.02 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.57 149.99 24.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.067 0.947 . . . . 0.0 111.773 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.9 p -81.85 162.37 22.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.307 0.575 . . . . 0.0 110.794 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.81 -39.45 74.19 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.484 -0.76 . . . . 0.0 111.4 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.59 -38.83 92.62 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.556 -0.715 . . . . 0.0 112.683 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.63 -42.76 95.25 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.628 -0.67 . . . . 0.0 112.047 171.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.63 -46.42 90.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.61 0.764 . . . . 0.0 112.11 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.39 -46.33 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.142 0.977 . . . . 0.0 110.354 172.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.12 53.81 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.81 0.719 . . . . 0.0 112.902 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.21 -50.07 73.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.778 0.789 . . . . 0.0 112.512 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.1 p -111.95 8.42 20.29 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.6 1.16 . . . . 0.0 113.009 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.44 162.31 1.61 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.952 1.301 . . . . 0.0 111.441 165.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.85 89.12 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.451 0.84 . . . . 0.0 111.762 -6.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -49.97 141.31 29.73 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.238 2.625 . . . . 0.0 114.174 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.12 96.48 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.81 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.17 94.4 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.638 0.654 . . . . 0.0 113.011 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.89 -36.86 75.76 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.296 -1.12 . . . . 0.0 112.634 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.92 -44.58 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.785 -0.572 . . . . 0.0 109.954 173.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.89 -40.38 91.52 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.303 -0.873 . . . . 0.0 112.521 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.05 75.1 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.275 173.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.65 -45.21 81.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.901 0.773 . . . . 0.0 112.147 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.28 -40.53 86.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.69 -47.04 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.05 0.54 . . . . 0.0 110.286 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.29 -37.3 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.636 1.174 . . . . 0.0 112.282 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.82 -42.77 98.35 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.051 0.842 . . . . 0.0 111.215 171.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.17 90.96 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.836 0.731 . . . . 0.0 113.184 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.43 -42.29 86.97 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.045 0.922 . . . . 0.0 111.073 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.26 70.4 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.424 173.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.77 -43.26 76.57 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.874 0.761 . . . . 0.0 111.961 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.2 mt -64.6 -47.76 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.431 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.56 -32.89 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.965 1.257 . . . . 0.0 112.9 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.25 -44.84 94.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.939 0.895 . . . . 0.0 111.468 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.39 -36.87 60.82 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.683 1.593 . . . . 0.0 113.428 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 128.425 2.69 . . . . 0.0 114.577 -172.73 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.89 135.06 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.482 1.113 . . . . 0.0 108.402 163.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -126.07 154.84 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.092 1.357 . . . . 0.0 109.688 170.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.56 116.7 32.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.519 0.728 . . . . 0.0 109.139 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.46 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.514 0.673 . . . . 0.0 112.474 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.85 -26.53 68.8 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -173.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.87 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.81 1.244 . . . . 0.0 113.019 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.94 3.09 85.81 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.458 1.028 . . . . 0.0 114.08 -175.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.21 35.39 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.823 1.312 . . . . 0.0 109.683 174.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.53 29.49 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 168.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.9 123.31 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.086 1.354 . . . . 0.0 108.698 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.58 139.66 38.57 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.555 0.693 . . . . 0.0 111.23 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.09 48.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.491 1.916 . . . . 0.0 107.921 169.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.4 20.9 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.248 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.56 136.85 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.605 -0.685 . . . . 0.0 111.555 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.65 129.98 93.26 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.136 0.575 . . . . 0.0 111.149 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.02 -34.58 68.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.907 2.405 . . . . 0.0 113.586 167.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.44 -38.08 86.6 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.513 -0.742 . . . . 0.0 112.588 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.87 -44.34 97.19 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.767 0.712 . . . . 0.0 111.386 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.52 -44.33 94.57 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.296 0.498 . . . . 0.0 112.267 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.23 -47.22 86.14 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.139 0.576 . . . . 0.0 111.4 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.24 95.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.664 0.786 . . . . 0.0 111.899 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.14 -47.12 87.25 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.795 0.838 . . . . 0.0 112.772 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.1 t -56.91 -54.3 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.392 0.542 . . . . 0.0 110.41 174.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.81 -37.18 78.42 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.324 1.05 . . . . 0.0 113.247 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.57 -52.19 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.044 1.338 . . . . 0.0 111.286 170.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.91 -35.86 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.972 0.509 . . . . 0.0 111.412 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -58.66 -23.79 59.96 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.52 -25.58 11.31 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -135.94 16.12 3.29 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.42 -37.4 2.33 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -175.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -118.31 13.91 13.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.473 1.109 . . . . 0.0 113.148 -172.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.1 p -113.15 153.02 45.52 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.962 0.905 . . . . 0.0 111.515 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.82 -30.91 59.64 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.287 2.658 . . . . 0.0 115.218 -172.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.91 64.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.61 -32.24 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.406 1.003 . . . . 0.0 112.422 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.6 mt -70.33 -57.15 6.05 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.684 1.194 . . . . 0.0 112.572 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.86 -29.45 58.49 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.896 1.713 . . . . 0.0 112.816 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.29 -40.08 77.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.818 1.19 . . . . 0.0 112.694 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -57.17 -47.05 82.18 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.878 0.763 . . . . 0.0 111.537 169.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -60.88 -44.21 97.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.79 -31.61 70.97 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.193 0.997 . . . . 0.0 113.297 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.88 4.74 52.54 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.368 1.467 . . . . 0.0 113.55 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.0 p -133.15 22.73 4.12 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.57 120.29 5.96 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.474 -1.391 . . . . 0.0 111.456 168.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.53 60.15 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.47 130.82 46.91 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.528 1.664 . . . . 0.0 112.53 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.28 159.66 84.43 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.718 0.807 . . . . 0.0 110.692 167.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.61 -35.37 37.49 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.144 1.896 . . . . 0.0 115.4 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.03 -40.3 87.18 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.3 93.89 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.066 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.55 -44.28 94.62 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.329 1.051 . . . . 0.0 112.175 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -59.24 -41.37 88.58 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.612 -0.68 . . . . 0.0 112.047 171.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.2 -45.41 93.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.597 0.635 . . . . 0.0 111.115 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.28 -48.85 77.84 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.187 0.903 . . . . 0.0 112.176 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.0 mt -63.18 -38.33 90.73 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.06 -34.16 71.62 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -72.78 -12.98 61.21 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.36 13.15 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.315 1.046 . . . . 0.0 113.557 -175.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.48 -5.92 4.11 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 117.055 1.582 . . . . 0.0 117.055 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.71 -0.2 6.38 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 125.909 1.719 . . . . 0.0 116.845 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -124.71 79.76 1.8 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.347 1.574 . . . . 0.0 110.385 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.87 -36.03 47.07 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.718 1.607 . . . . 0.0 115.304 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.2 -40.98 74.29 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.154 1.343 . . . . 0.0 112.191 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.44 -43.75 84.73 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.254 0.622 . . . . 0.0 111.315 173.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.2 tpp -62.77 -40.3 96.87 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.491 -0.756 . . . . 0.0 112.257 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.05 -49.95 74.26 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.292 1.037 . . . . 0.0 111.544 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -56.0 -45.42 79.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.101 0.961 . . . . 0.0 112.234 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.88 -48.84 78.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.308 0.643 . . . . 0.0 112.054 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.69 -38.3 90.58 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.873 0.869 . . . . 0.0 112.424 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.95 -45.49 92.49 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.705 0.684 . . . . 0.0 112.034 170.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.7 m -62.65 -42.36 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.793 0.724 . . . . 0.0 112.118 175.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.87 -46.08 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.507 -0.745 . . . . 0.0 111.045 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.4 93.96 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.838 0.745 . . . . 0.0 112.717 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -60.84 -47.41 86.48 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.743 0.817 . . . . 0.0 111.958 174.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.12 -34.34 72.96 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.593 -0.692 . . . . 0.0 112.859 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.56 91.81 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.484 -0.76 . . . . 0.0 112.371 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.09 98.58 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.246 0.619 . . . . 0.0 111.766 172.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.17 -42.22 99.37 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.864 -0.523 . . . . 0.0 112.191 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.71 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.06 -30.22 71.43 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.19 -39.06 78.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.342 1.057 . . . . 0.0 112.488 173.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.57 42.28 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.796 1.239 . . . . 0.0 113.354 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.0 53.92 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.94 120.15 7.43 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.452 2.101 . . . . 0.0 110.285 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.44 136.36 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.372 1.469 . . . . 0.0 112.077 -169.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -80.0 160.47 25.87 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.048 0.539 . . . . 0.0 110.909 168.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.24 -19.98 65.03 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.91 174.81 41.58 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.075 1.322 . . . . 0.0 112.625 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.64 169.18 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.635 2.89 . . . . 0.0 112.889 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.68 -39.19 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.903 1.281 . . . . 0.0 111.749 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.46 161.89 28.6 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.842 1.657 . . . . 0.0 110.551 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.427 2.751 . . . . 0.0 113.132 168.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.98 -15.08 60.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.567 1.08 . . . . 0.0 115.01 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.23 145.48 54.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.691 -0.631 . . . . 0.0 110.859 168.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.47 152.82 44.86 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.2 131.69 84.94 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.83 170.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.44 140.36 43.69 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.097 1.864 . . . . 0.0 112.426 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -75.04 171.62 13.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.649 1.58 . . . . 0.0 111.89 163.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.55 -43.85 94.02 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.949 -0.469 . . . . 0.0 113.035 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.76 -25.85 64.94 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.63 -41.63 65.32 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.061 -1.025 . . . . 0.0 111.795 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.75 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.784 0.834 . . . . 0.0 110.782 173.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.26 14.02 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 173.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.93 18.16 74.16 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.908 -1.12 . . . . 0.0 115.491 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.26 -19.46 19.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.053 1.426 . . . . 0.0 113.263 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.0 p -126.1 -1.49 7.09 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.67 149.89 24.53 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.052 0.941 . . . . 0.0 111.814 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.0 p -81.76 162.31 22.97 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.318 0.58 . . . . 0.0 110.827 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.75 -39.43 73.97 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.446 -0.784 . . . . 0.0 111.43 169.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.56 -38.9 92.89 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.516 -0.74 . . . . 0.0 112.706 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.76 95.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 112.008 171.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.68 -46.36 90.66 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.156 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.47 -46.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.091 0.956 . . . . 0.0 110.288 172.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.1 54.01 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 0.0 112.869 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.07 73.19 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.512 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.61 -18.53 64.33 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.91 8.36 20.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.645 1.178 . . . . 0.0 112.996 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.44 162.33 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.995 1.318 . . . . 0.0 111.447 165.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.6 103.34 48.91 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.065 0.946 . . . . 0.0 110.778 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.451 0.84 . . . . 0.0 111.762 -6.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -50.0 141.36 29.81 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.155 2.57 . . . . 0.0 114.205 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.11 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.56 -34.84 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -173.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.21 94.29 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.605 0.639 . . . . 0.0 112.996 173.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.84 -36.9 75.95 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.289 -1.124 . . . . 0.0 112.645 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.9 -44.57 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.745 -0.597 . . . . 0.0 109.914 173.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.91 -40.35 91.4 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.282 -0.886 . . . . 0.0 112.521 176.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.87 -42.07 75.34 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.439 -0.788 . . . . 0.0 112.204 173.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.63 -45.25 81.66 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.899 0.772 . . . . 0.0 112.093 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.28 -40.53 86.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.66 -47.08 94.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.085 0.554 . . . . 0.0 110.285 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.26 -37.32 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.645 1.178 . . . . 0.0 112.298 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.82 98.41 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.028 0.831 . . . . 0.0 111.185 171.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.48 -45.21 91.12 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.878 0.751 . . . . 0.0 113.228 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.38 -42.3 86.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.003 0.901 . . . . 0.0 111.14 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.26 70.4 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.424 173.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.83 -43.19 76.74 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.874 0.761 . . . . 0.0 111.975 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.6 -47.79 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.344 0.658 . . . . 0.0 111.431 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.89 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.961 1.255 . . . . 0.0 112.9 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -60.26 -44.87 94.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.939 0.895 . . . . 0.0 111.461 171.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.33 -36.95 60.99 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.672 1.589 . . . . 0.0 113.45 -177.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 128.454 2.702 . . . . 0.0 114.562 -172.701 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.85 135.0 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.488 1.115 . . . . 0.0 108.482 163.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.65 32.46 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.43 178.06 6.88 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 121.529 0.68 . . . . 0.0 112.46 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.88 -26.56 68.84 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.03 3.02 85.65 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.475 1.036 . . . . 0.0 114.07 -175.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.71 128.2 35.35 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.893 1.347 . . . . 0.0 109.712 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.55 29.51 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 168.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.94 123.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.074 1.349 . . . . 0.0 108.629 -174.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.65 141.14 48.49 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.488 1.915 . . . . 0.0 107.89 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.29 21.03 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.023 0.829 . . . . 0.0 111.254 170.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.48 136.85 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.523 0.678 . . . . 0.0 111.55 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.69 130.0 93.21 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.068 0.547 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.02 -34.58 68.22 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.894 2.396 . . . . 0.0 113.583 167.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.44 -38.06 86.55 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.437 -0.789 . . . . 0.0 112.588 174.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.95 -44.31 97.47 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 0.0 111.349 171.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.57 -44.35 94.36 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.29 0.496 . . . . 0.0 112.309 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.12 -47.31 85.73 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.142 0.577 . . . . 0.0 111.388 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.32 95.29 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.604 0.761 . . . . 0.0 111.896 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -60.07 -47.29 86.47 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.849 0.859 . . . . 0.0 112.791 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.6 t -56.74 -54.94 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 118.417 0.553 . . . . 0.0 110.254 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.15 -37.71 77.98 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.371 1.068 . . . . 0.0 113.237 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.21 -51.96 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.064 1.346 . . . . 0.0 111.28 170.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.81 -35.87 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.993 0.517 . . . . 0.0 111.485 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -58.94 -23.29 61.29 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.709 1.141 . . . . 0.0 113.972 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.55 -25.91 11.15 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -135.9 16.26 3.3 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -165.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.65 -37.47 2.6 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -118.3 14.58 13.86 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.39 1.076 . . . . 0.0 113.1 -172.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -113.77 153.02 46.05 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.004 0.922 . . . . 0.0 111.526 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.9 -30.79 59.87 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.274 2.649 . . . . 0.0 115.224 -172.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.09 -20.64 64.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.78 -31.96 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.397 0.998 . . . . 0.0 112.539 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.38 -55.08 6.3 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.974 1.31 . . . . 0.0 112.944 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.85 -30.07 49.59 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.658 1.628 . . . . 0.0 112.669 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.04 -40.3 78.68 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.921 1.237 . . . . 0.0 112.606 172.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.25 -46.46 82.99 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.735 0.698 . . . . 0.0 111.576 169.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -61.1 -44.47 97.31 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.84 -31.95 71.37 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.317 1.047 . . . . 0.0 113.25 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.47 4.58 53.13 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.333 1.453 . . . . 0.0 113.526 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.1 p -133.09 22.8 4.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.58 120.34 6.04 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.47 168.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.69 60.07 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.371 0.909 . . . . 0.0 115.371 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.54 130.89 47.14 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.565 1.683 . . . . 0.0 112.515 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.33 159.69 84.29 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 123.748 0.819 . . . . 0.0 110.718 167.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.61 -35.44 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.204 1.936 . . . . 0.0 115.372 168.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.24 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.35 93.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -59.2 -41.49 88.66 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.696 -0.628 . . . . 0.0 112.024 171.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.22 -45.33 93.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.569 0.622 . . . . 0.0 111.091 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.33 -48.86 77.88 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.205 0.911 . . . . 0.0 112.164 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.19 -38.33 90.76 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.06 -33.7 71.09 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.4 p -73.07 -12.92 61.09 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.17 8.9 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -174.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.86 -5.55 7.55 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 117.267 1.667 . . . . 0.0 117.267 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.23 -31.24 59.12 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.318 1.559 . . . . 0.0 115.648 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -93.42 78.44 4.41 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.962 1.381 . . . . 0.0 110.536 172.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.07 -35.8 36.64 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.03 73.96 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.154 1.343 . . . . 0.0 112.243 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.58 85.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.199 0.599 . . . . 0.0 111.35 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.06 -40.08 96.64 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.53 -0.732 . . . . 0.0 112.238 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.96 74.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.247 1.019 . . . . 0.0 111.529 173.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -55.9 -45.5 78.63 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.1 0.96 . . . . 0.0 112.228 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.92 -48.77 78.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.265 0.626 . . . . 0.0 112.035 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.69 -38.31 90.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.873 0.869 . . . . 0.0 112.49 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.96 -45.49 92.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.689 0.677 . . . . 0.0 112.02 170.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.6 -42.43 99.57 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.848 0.749 . . . . 0.0 112.13 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.83 -46.08 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.535 -0.728 . . . . 0.0 111.059 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.21 -39.35 93.79 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.858 0.754 . . . . 0.0 112.731 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.84 -47.39 86.59 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.964 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.19 -34.27 72.74 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.6 91.91 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.451 -0.781 . . . . 0.0 112.333 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -42.04 98.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.224 0.61 . . . . 0.0 111.783 172.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.19 -42.26 99.33 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.855 -0.528 . . . . 0.0 112.191 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.74 -48.55 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.625 0.648 . . . . 0.0 111.71 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -63.04 -30.3 71.49 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -38.99 78.83 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.33 1.052 . . . . 0.0 112.458 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.36 -27.5 41.95 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.776 1.23 . . . . 0.0 113.313 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.84 61.02 53.98 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.622 1.969 . . . . 0.0 111.241 -174.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -63.91 120.12 7.38 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.479 2.119 . . . . 0.0 110.293 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.39 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.32 1.448 . . . . 0.0 112.135 -169.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.03 160.49 25.83 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.083 0.553 . . . . 0.0 110.897 168.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -19.93 65.01 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.94 174.77 41.59 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.032 1.301 . . . . 0.0 112.656 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.57 169.17 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.66 2.907 . . . . 0.0 112.906 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.69 -39.14 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.843 1.257 . . . . 0.0 111.824 -175.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.91 28.57 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.83 133.41 22.44 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.519 2.812 . . . . 0.0 113.132 168.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.9 -15.0 60.33 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.607 1.099 . . . . 0.0 114.992 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.992 1.396 . . . . 0.0 110.198 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.52 54.19 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.694 -0.629 . . . . 0.0 110.787 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.47 152.84 44.83 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.3 131.73 84.73 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 118.945 -0.55 . . . . 0.0 109.824 170.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.38 140.38 43.93 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.074 1.849 . . . . 0.0 112.442 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -74.98 171.61 13.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.761 1.625 . . . . 0.0 111.872 163.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.64 -43.82 94.19 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.912 -0.493 . . . . 0.0 112.974 168.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.5 p -68.74 -25.85 64.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.72 -41.64 65.0 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.082 -1.011 . . . . 0.0 111.725 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.63 -42.69 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.718 0.807 . . . . 0.0 110.827 173.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.96 -1.34 14.13 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.21 74.24 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 120.877 -1.139 . . . . 0.0 115.463 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.31 -19.46 19.24 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.099 1.449 . . . . 0.0 113.263 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.12 -1.42 7.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.7 149.87 24.57 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.073 0.949 . . . . 0.0 111.788 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.1 p -81.76 162.33 22.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.318 0.58 . . . . 0.0 110.827 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.78 -39.47 74.14 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.418 -0.801 . . . . 0.0 111.347 169.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.52 -38.9 92.89 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.554 -0.716 . . . . 0.0 112.722 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.62 -42.76 95.3 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.584 -0.698 . . . . 0.0 112.033 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.65 -46.39 90.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.687 0.795 . . . . 0.0 112.097 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.29 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.338 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.51 -51.02 54.73 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.81 0.719 . . . . 0.0 112.927 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.27 -50.04 73.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.819 0.81 . . . . 0.0 112.542 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.69 -18.49 64.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.0 p -111.93 8.46 20.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.643 1.177 . . . . 0.0 113.062 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.45 162.31 1.62 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.989 1.316 . . . . 0.0 111.441 165.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.37 48.93 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.029 0.932 . . . . 0.0 110.758 176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.06 163.81 89.24 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.494 0.855 . . . . 0.0 111.713 -6.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -49.93 141.36 29.3 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.199 2.6 . . . . 0.0 114.149 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.16 96.45 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 163.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -86.0 54.56 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.251 2.634 . . . . 0.0 112.86 -152.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.56 -34.86 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.22 94.31 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.638 0.654 . . . . 0.0 112.999 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -69.9 -36.83 75.72 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.327 -1.102 . . . . 0.0 112.688 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.87 -44.64 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.795 -0.566 . . . . 0.0 109.912 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.88 -40.34 91.52 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.303 -0.873 . . . . 0.0 112.564 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.88 -41.98 75.26 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.412 -0.805 . . . . 0.0 112.253 173.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.69 -45.16 81.95 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.924 0.784 . . . . 0.0 112.147 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.33 -40.53 85.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.29 0.636 . . . . 0.0 112.251 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.67 -47.09 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.085 0.554 . . . . 0.0 110.249 174.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.19 -37.39 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.674 1.19 . . . . 0.0 112.3 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.8 -42.79 98.31 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.011 0.823 . . . . 0.0 111.253 171.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.11 91.4 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.796 0.712 . . . . 0.0 113.265 175.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.46 -42.3 87.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.01 0.905 . . . . 0.0 111.092 173.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.19 70.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.23 77.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.86 0.755 . . . . 0.0 111.986 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.41 -47.91 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.415 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -69.64 -32.8 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.0 1.273 . . . . 0.0 112.86 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.11 -44.02 95.18 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.863 0.865 . . . . 0.0 111.505 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.3 ttp -77.04 -37.36 54.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.652 1.581 . . . . 0.0 113.558 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.251 1.177 0 C-N-CA 128.427 2.691 . . . . 0.0 114.649 -172.059 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.48 0.686 0 N-CA-C 112.997 0.345 . . . . 20.0 112.997 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.99 135.01 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.473 1.109 . . . . 20.0 108.448 163.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.81 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 20.0 109.686 170.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.47 116.7 32.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.531 0.733 . . . . 20.0 109.17 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.503 0.668 . . . . 20.0 112.495 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.82 -26.57 68.81 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.432 1.271 . . . . 20.0 114.432 -173.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 20.0 113.03 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.0 3.07 85.68 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.475 1.036 . . . . 20.0 114.058 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.22 35.46 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.847 1.323 . . . . 20.0 109.731 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.52 29.47 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.453 -0.573 . . . . 20.0 109.453 168.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.9 123.39 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.014 1.326 . . . . 20.0 108.648 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 20.0 111.213 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.67 141.12 48.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.511 1.924 . . . . 20.0 107.935 169.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.37 20.84 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.949 0.795 . . . . 20.0 111.191 170.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.53 136.81 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.625 -0.672 . . . . 20.0 111.61 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.62 129.96 93.29 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.084 0.553 . . . . 20.0 111.137 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.05 -34.48 67.98 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.868 2.378 . . . . 20.0 113.542 167.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.51 -38.09 86.46 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.453 -0.779 . . . . 20.0 112.56 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.99 -44.21 97.74 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 20.0 111.354 171.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.58 -44.45 94.02 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.341 0.519 . . . . 20.0 112.256 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.08 -47.19 86.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.076 0.55 . . . . 20.0 111.402 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.2 95.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.64 0.776 . . . . 20.0 111.881 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -60.29 -46.89 88.26 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.81 0.844 . . . . 20.0 112.781 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.9 t -57.0 -54.24 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.412 0.551 . . . . 20.0 110.355 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.8 -37.25 78.59 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.374 1.07 . . . . 20.0 113.229 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.22 -52.31 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.206 1.403 . . . . 20.0 111.233 170.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.08 -36.14 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.022 0.529 . . . . 20.0 111.405 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -58.55 -23.85 59.37 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.978 1.103 . . . . 20.0 113.978 175.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.47 -25.47 11.38 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.04 1.126 . . . . 20.0 114.04 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -136.19 16.09 3.24 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.367 1.247 . . . . 20.0 114.367 -165.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.08 -36.78 2.71 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.478 2.029 . . . . 20.0 116.478 -175.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.48 15.34 13.78 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.492 1.117 . . . . 20.0 113.098 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -114.87 153.01 47.0 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.961 0.904 . . . . 20.0 111.456 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.96 -30.6 59.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.218 2.612 . . . . 20.0 115.238 -172.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.17 -20.74 64.45 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.173 1.175 . . . . 20.0 114.173 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.88 -31.82 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.468 1.031 . . . . 20.0 112.548 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.7 mt -71.47 -54.98 6.26 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.927 1.291 . . . . 20.0 113.01 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.89 -30.16 49.16 Favored 'Trans proline' 0 C--N 1.351 0.686 0 CA-C-N 121.673 1.633 . . . . 20.0 112.633 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -68.96 -40.26 79.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.867 1.212 . . . . 20.0 112.674 172.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.3 -46.44 83.17 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.476 0.711 . . . . 20.0 111.576 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.0 m -61.12 -44.53 97.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.608 0.596 . . . . 20.0 112.608 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.8 -31.88 71.26 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.28 1.032 . . . . 20.0 113.315 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.52 4.57 53.07 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.364 1.466 . . . . 20.0 113.499 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.5 p -133.1 22.88 4.14 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.437 1.273 . . . . 20.0 114.437 -176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.63 120.27 5.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.485 -1.384 . . . . 20.0 111.47 168.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.6 11.59 60.19 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 115.365 0.906 . . . . 20.0 115.365 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.45 130.82 46.9 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.542 1.671 . . . . 20.0 112.48 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.33 159.66 84.37 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.706 0.802 . . . . 20.0 110.68 167.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.57 -35.47 37.43 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.144 1.896 . . . . 20.0 115.406 168.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.04 -40.17 87.11 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.098 0.777 . . . . 20.0 113.098 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.42 -45.26 94.26 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.629 -0.669 . . . . 20.0 111.047 172.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.56 -44.28 94.58 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.32 1.048 . . . . 20.0 112.115 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -59.25 -41.39 88.66 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.618 0.644 . . . . 20.0 112.008 171.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.9 m -60.3 -45.28 93.93 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.597 0.635 . . . . 20.0 111.066 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.38 -48.98 77.64 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.218 0.917 . . . . 20.0 112.114 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.04 -38.34 90.8 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.827 0.677 . . . . 20.0 112.827 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.04 -33.66 71.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.89 0.7 . . . . 20.0 112.89 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.8 p -73.1 -12.81 61.04 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.662 1.356 . . . . 20.0 114.662 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.03 7.78 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.357 1.063 . . . . 20.0 113.868 -174.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.09 -5.43 10.05 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 117.46 1.744 . . . . 20.0 117.46 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.05 -35.42 69.21 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 119.32 1.56 . . . . 20.0 115.282 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -85.28 77.84 9.91 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 123.053 1.406 . . . . 20.0 110.56 171.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.98 -35.61 34.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.624 1.57 . . . . 20.0 115.225 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.58 -41.42 72.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.226 1.375 . . . . 20.0 112.306 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.32 -43.59 85.75 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.777 -0.577 . . . . 20.0 111.37 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -63.13 -39.98 96.26 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.475 -0.766 . . . . 20.0 112.239 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -57.05 -49.94 74.27 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.05 -1.031 . . . . 20.0 111.548 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.95 -45.46 78.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 20.0 112.239 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.96 -48.73 79.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.27 0.628 . . . . 20.0 112.034 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.73 -38.37 90.85 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 20.0 112.403 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.78 -45.59 91.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.807 0.73 . . . . 20.0 112.048 170.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.5 m -62.67 -42.41 99.6 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.724 0.693 . . . . 20.0 112.118 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.78 -46.1 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.431 -0.793 . . . . 20.0 111.093 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.12 -39.48 94.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.788 0.722 . . . . 20.0 112.715 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -60.77 -47.45 86.28 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.716 0.806 . . . . 20.0 111.958 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.09 -34.3 72.97 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.901 0.704 . . . . 20.0 112.901 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.59 91.73 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.434 -0.791 . . . . 20.0 112.369 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.11 98.57 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.264 0.625 . . . . 20.0 111.781 172.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.12 -42.27 99.5 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 20.0 112.163 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.81 -48.49 79.57 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.661 0.664 . . . . 20.0 111.669 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.06 -30.33 71.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.906 0.706 . . . . 20.0 112.906 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.17 -38.99 79.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.331 1.052 . . . . 20.0 112.457 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.4 -27.58 41.81 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.807 1.243 . . . . 20.0 113.306 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.1 54.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.587 1.955 . . . . 20.0 111.217 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.0 120.13 7.4 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.483 2.122 . . . . 20.0 110.242 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.41 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.366 1.466 . . . . 20.0 112.158 -169.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.09 160.47 25.76 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.103 0.561 . . . . 20.0 110.903 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -19.97 65.05 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.367 1.247 . . . . 20.0 114.367 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.88 174.81 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.064 1.316 . . . . 20.0 112.68 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.57 169.17 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.66 2.907 . . . . 20.0 112.906 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.73 -39.05 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.843 1.257 . . . . 20.0 111.82 -175.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.55 161.85 28.7 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.877 1.671 . . . . 20.0 110.603 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.92 133.45 22.9 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.473 2.782 . . . . 20.0 113.132 168.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.94 -15.02 60.35 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.567 1.08 . . . . 20.0 115.001 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -78.14 143.36 37.35 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.978 1.389 . . . . 20.0 110.187 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.14 145.58 54.24 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.719 -0.613 . . . . 20.0 110.826 168.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.51 152.69 45.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.717 0.807 . . . . 20.0 111.616 171.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.21 131.73 84.9 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.917 -0.563 . . . . 20.0 109.834 170.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.42 140.27 43.55 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.096 1.864 . . . . 20.0 112.451 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -74.92 171.62 13.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.743 1.617 . . . . 20.0 111.872 163.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.87 94.09 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.935 -0.478 . . . . 20.0 112.998 168.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.75 -25.83 64.93 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.059 1.133 . . . . 20.0 114.059 175.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.6 64.98 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.062 -1.024 . . . . 20.0 111.742 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.65 -42.72 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.731 0.812 . . . . 20.0 110.812 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.29 14.06 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.87 1.063 . . . . 20.0 113.87 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.26 74.28 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 120.865 -1.147 . . . . 20.0 115.393 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.41 19.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.11 1.455 . . . . 20.0 113.263 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.6 p -126.22 -1.46 7.02 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.273 1.212 . . . . 20.0 114.273 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.67 149.96 24.46 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.032 0.933 . . . . 20.0 111.824 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.8 p -82.02 162.43 22.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.347 0.594 . . . . 20.0 110.797 170.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.71 -39.5 73.97 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.404 -0.81 . . . . 20.0 111.454 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.5 -38.95 93.08 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.512 -0.742 . . . . 20.0 112.648 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.55 -42.78 95.47 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.637 -0.665 . . . . 20.0 112.084 171.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.63 -46.36 90.59 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.603 0.761 . . . . 20.0 112.156 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.47 -46.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.091 0.956 . . . . 20.0 110.288 172.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.07 54.18 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 20.0 112.869 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 20.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 20.0 114.434 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.91 8.36 20.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.645 1.178 . . . . 20.0 113.033 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.38 162.3 1.58 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.027 1.331 . . . . 20.0 111.396 165.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.59 103.32 48.95 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.071 0.949 . . . . 20.0 110.837 176.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.13 163.84 89.13 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.462 0.844 . . . . 20.0 111.701 -6.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -50.03 141.37 30.02 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 20.0 114.168 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.3 mt -96.11 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 20.0 104.858 163.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.98 54.57 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 20.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.89 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.029 1.122 . . . . 20.0 114.029 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.27 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.688 0.676 . . . . 20.0 112.958 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.86 -36.86 75.85 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.289 -1.124 . . . . 20.0 112.693 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.89 -44.62 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.808 -0.557 . . . . 20.0 109.952 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.41 91.65 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.303 -0.873 . . . . 20.0 112.533 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -41.97 74.91 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.395 -0.816 . . . . 20.0 112.287 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.74 -45.19 82.13 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.889 0.768 . . . . 20.0 112.12 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.37 -40.54 85.74 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.287 0.635 . . . . 20.0 112.227 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.58 -47.23 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.039 0.536 . . . . 20.0 110.235 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.05 -37.39 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.749 1.22 . . . . 20.0 112.308 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.87 98.53 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.01 0.823 . . . . 20.0 111.194 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.53 -45.02 91.88 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.832 0.729 . . . . 20.0 113.26 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.42 -42.49 87.37 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.002 0.901 . . . . 20.0 111.056 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.5 -50.12 70.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.795 0.838 . . . . 20.0 112.449 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.79 -43.35 76.74 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.915 0.78 . . . . 20.0 111.996 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.6 mt -64.28 -48.32 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.26 0.624 . . . . 20.0 111.366 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.54 -31.48 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.791 1.178 . . . . 20.0 112.981 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -61.43 -42.14 98.29 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.102 0.864 . . . . 20.0 111.642 171.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.3 ttp -80.6 -36.29 32.96 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.726 1.61 . . . . 20.0 113.884 -174.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 1.103 ' OXT' ' C ' ' A' ' 145' ' ' TYR . 70.5 m-85 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 127.784 2.434 . . . . 20.0 114.432 -168.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 N--CA 1.479 0.661 0 N-CA-C 113.01 0.35 . . . . 0.0 113.01 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.58 135.04 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.47 1.108 . . . . 0.0 108.413 163.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -126.07 155.0 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.633 170.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -104.84 116.81 32.64 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.465 0.706 . . . . 0.0 109.143 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.48 178.03 6.93 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.587 0.708 . . . . 0.0 112.441 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.94 -26.43 68.81 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.11 57.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.794 1.237 . . . . 0.0 113.011 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.91 85.85 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.514 1.054 . . . . 0.0 114.128 -175.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.63 128.29 35.68 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.816 1.308 . . . . 0.0 109.695 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.73 29.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 168.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -126.09 123.32 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.075 1.35 . . . . 0.0 108.68 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.57 139.69 38.58 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.18 48.48 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.513 1.925 . . . . 0.0 107.979 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.24 152.35 20.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.202 170.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.86 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.453 0.644 . . . . 0.0 111.555 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 129.96 93.26 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.164 0.585 . . . . 0.0 111.095 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.97 -34.67 68.08 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.907 2.405 . . . . 0.0 113.572 167.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.39 -38.02 86.58 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.508 -0.745 . . . . 0.0 112.594 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.0 -44.31 97.61 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.716 0.689 . . . . 0.0 111.356 171.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.5 -44.33 94.64 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.296 0.498 . . . . 0.0 112.256 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.23 -47.32 85.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.079 0.551 . . . . 0.0 111.417 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.14 96.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.599 0.76 . . . . 0.0 111.896 176.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -60.07 -47.5 85.63 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.844 0.858 . . . . 0.0 112.711 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.2 t -56.7 -54.55 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.4 0.545 . . . . 0.0 110.404 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.5 -37.6 78.69 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.348 1.059 . . . . 0.0 113.221 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.61 -51.99 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.945 1.298 . . . . 0.0 111.329 170.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.52 -35.94 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.416 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.64 -23.98 60.21 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.2 -25.85 11.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.8 16.25 3.32 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -166.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.05 -38.49 2.34 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -118.06 15.79 14.16 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.36 1.064 . . . . 0.0 113.055 -171.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 p -114.93 152.7 46.76 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.98 0.912 . . . . 0.0 111.464 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.77 -30.68 57.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.282 2.655 . . . . 0.0 115.205 -172.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.69 64.26 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.643 1.177 . . . . 0.0 114.173 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.93 -31.81 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.424 1.011 . . . . 0.0 112.515 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.1 mt -71.45 -55.05 6.23 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.987 1.315 . . . . 0.0 112.972 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.85 -30.14 49.5 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.685 1.637 . . . . 0.0 112.652 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.6 mtm -69.06 -40.24 78.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.894 1.225 . . . . 0.0 112.65 172.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.22 -46.55 82.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.768 0.713 . . . . 0.0 111.522 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -60.94 -44.69 96.9 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -32.27 71.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.279 1.031 . . . . 0.0 113.246 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.1 4.48 53.65 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.406 1.482 . . . . 0.0 113.539 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.7 p -133.0 22.78 4.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.52 120.35 6.02 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.473 -1.392 . . . . 0.0 111.483 168.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.44 11.63 59.86 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.447 0.939 . . . . 0.0 115.447 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.57 130.88 47.06 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.525 1.663 . . . . 0.0 112.528 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.3 p -73.28 159.66 84.42 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.722 0.809 . . . . 0.0 110.711 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.58 -35.38 37.25 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.134 1.89 . . . . 0.0 115.47 168.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -67.19 -40.2 86.48 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.28 -45.25 93.97 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.626 -0.671 . . . . 0.0 111.098 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.5 mt -63.71 -44.32 93.97 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.351 1.06 . . . . 0.0 112.127 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -59.15 -41.48 88.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.642 0.656 . . . . 0.0 111.984 171.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 m -60.18 -45.28 93.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.599 0.636 . . . . 0.0 111.11 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.42 -48.86 78.01 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.246 0.93 . . . . 0.0 112.153 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.16 -38.44 91.19 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.84 -33.23 70.19 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 p -73.88 -12.44 60.67 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.5 m -122.19 8.14 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.28 -4.5 6.51 Favored Glycine 0 CA--C 1.542 1.753 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.8 -33.51 56.01 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 119.256 1.528 . . . . 0.0 115.389 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -91.18 78.29 5.86 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.802 1.301 . . . . 0.0 110.55 171.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.77 -35.92 34.21 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.95 74.73 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 120.023 1.283 . . . . 0.0 112.303 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.44 -43.54 85.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.194 0.597 . . . . 0.0 111.353 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -62.99 -40.17 96.93 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.545 -0.722 . . . . 0.0 112.263 175.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.95 -49.99 73.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.314 1.045 . . . . 0.0 111.565 173.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.1 tpp -56.04 -45.43 79.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.096 0.958 . . . . 0.0 112.205 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.85 -48.77 79.05 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.289 0.636 . . . . 0.0 112.087 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.72 -38.37 90.84 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.45 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.86 -45.56 92.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.698 0.681 . . . . 0.0 112.014 170.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.9 m -62.56 -42.41 99.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.777 0.717 . . . . 0.0 112.128 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.81 -46.2 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.514 -0.741 . . . . 0.0 111.041 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.07 -39.45 94.09 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.829 0.741 . . . . 0.0 112.759 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.78 -47.46 86.24 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.78 0.832 . . . . 0.0 111.964 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -70.07 -34.41 73.16 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.24 91.71 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.437 -0.789 . . . . 0.0 112.403 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.14 98.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.232 0.613 . . . . 0.0 111.781 172.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.19 99.59 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.834 -0.541 . . . . 0.0 112.183 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.85 -48.69 79.06 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.648 0.658 . . . . 0.0 111.665 173.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.95 -30.13 71.33 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.21 -39.22 78.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.399 1.08 . . . . 0.0 112.443 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.49 42.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.739 1.216 . . . . 0.0 113.32 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.81 60.92 53.35 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 126.675 1.99 . . . . 0.0 111.249 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.94 119.99 7.21 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.509 2.139 . . . . 0.0 110.306 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.24 136.16 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.342 1.457 . . . . 0.0 112.144 -169.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -79.92 160.43 26.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.101 0.561 . . . . 0.0 110.861 168.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.31 -19.8 64.93 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.03 174.68 41.65 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.083 1.325 . . . . 0.0 112.653 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.49 169.11 14.8 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.644 2.896 . . . . 0.0 112.954 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.7 mt -57.65 -39.11 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.894 1.278 . . . . 0.0 111.739 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.54 161.92 28.55 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.841 1.656 . . . . 0.0 110.584 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.96 133.47 23.1 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.479 2.786 . . . . 0.0 113.116 168.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.05 60.32 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.605 1.098 . . . . 0.0 115.019 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.15 143.31 37.37 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.946 1.373 . . . . 0.0 110.234 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.12 145.44 54.38 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.729 -0.607 . . . . 0.0 110.805 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -68.65 153.07 44.46 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.641 0.776 . . . . 0.0 111.673 171.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -72.16 131.7 85.01 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.858 170.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.37 140.53 44.38 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.137 1.891 . . . . 0.0 112.383 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 67.8 mtp85 -75.31 171.59 13.93 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.727 1.611 . . . . 0.0 111.859 163.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.37 -43.72 93.75 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 123.274 0.464 . . . . 0.0 113.04 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.5 p -69.15 -25.64 64.47 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -72.72 -41.66 64.98 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.02 -1.05 . . . . 0.0 111.71 171.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.73 -42.74 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.648 0.779 . . . . 0.0 110.824 173.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.11 -1.16 13.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.0 18.03 74.16 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.953 -1.092 . . . . 0.0 115.453 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.62 19.18 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.147 1.473 . . . . 0.0 113.259 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.2 p -125.9 -0.86 7.26 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.9 p -104.59 149.06 25.84 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.045 0.938 . . . . 0.0 111.798 173.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.4 p -80.95 162.18 23.99 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.348 0.595 . . . . 0.0 110.747 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.2 tp -56.85 -39.32 74.05 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.423 -0.798 . . . . 0.0 111.397 169.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.62 -39.06 93.41 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.558 -0.714 . . . . 0.0 112.644 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -64.37 -42.83 95.97 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.666 -0.646 . . . . 0.0 112.028 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -60.68 -46.35 90.7 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.677 0.791 . . . . 0.0 112.192 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.34 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 110.305 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.43 -51.17 53.36 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.83 0.729 . . . . 0.0 112.913 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.19 -50.08 73.23 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.788 0.794 . . . . 0.0 112.526 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.69 -18.5 64.27 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.1 p -111.81 8.33 20.5 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.675 1.19 . . . . 0.0 113.018 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.36 162.31 1.56 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.009 1.324 . . . . 0.0 111.433 165.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.52 103.38 49.02 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.089 0.956 . . . . 0.0 110.787 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.03 163.83 89.2 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.477 0.849 . . . . 0.0 111.746 -6.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -50.01 141.42 29.71 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.208 2.606 . . . . 0.0 114.173 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.19 96.36 2.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.97 54.6 3.5 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.326 2.684 . . . . 0.0 112.89 -152.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.61 -34.89 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.44 -46.16 94.4 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 118.641 0.655 . . . . 0.0 113.004 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.74 -36.96 76.29 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.313 -1.11 . . . . 0.0 112.667 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.88 -44.63 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.802 -0.561 . . . . 0.0 109.94 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.85 -40.42 91.7 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.327 -0.858 . . . . 0.0 112.547 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -42.02 74.98 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.395 -0.816 . . . . 0.0 112.259 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.72 -45.24 82.0 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.945 0.793 . . . . 0.0 112.093 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.26 -40.53 86.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.308 0.643 . . . . 0.0 112.251 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.68 -47.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.032 0.533 . . . . 0.0 110.279 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.19 -37.37 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.698 1.199 . . . . 0.0 112.263 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.75 98.36 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.039 0.836 . . . . 0.0 111.245 171.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.5 -45.2 91.08 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.879 0.752 . . . . 0.0 113.235 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.4 -42.28 86.81 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.019 0.91 . . . . 0.0 111.114 173.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.52 -50.2 70.6 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.788 0.835 . . . . 0.0 112.43 173.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -55.84 -43.0 76.62 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.872 0.76 . . . . 0.0 112.062 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.0 mt -64.47 -48.64 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.332 0.653 . . . . 0.0 111.361 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.28 -31.61 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.8 1.182 . . . . 0.0 112.978 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.98 -39.64 90.38 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.057 0.844 . . . . 0.0 111.877 171.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.4 ttp -84.45 -33.36 23.66 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.758 1.623 . . . . 0.0 113.976 -173.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 . . . . . 0 C--O 1.255 1.351 0 C-N-CA 127.599 2.36 . . . . 0.0 114.287 -169.744 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.697 0 N-CA-C 112.967 0.333 . . . . 0.0 112.967 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -92.01 135.02 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.51 1.124 . . . . 0.0 108.448 163.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.04 154.69 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.067 1.347 . . . . 0.0 109.709 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.29 116.62 32.47 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.555 0.742 . . . . 0.0 109.166 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.44 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.573 0.702 . . . . 0.0 112.476 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.87 -26.5 68.8 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -85.68 -2.13 57.88 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.792 1.237 . . . . 0.0 112.998 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.21 85.8 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.426 1.012 . . . . 0.0 114.094 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.14 35.13 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.883 1.342 . . . . 0.0 109.695 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.88 125.53 29.48 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 168.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.86 123.39 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.077 1.351 . . . . 0.0 108.648 -174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.7 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.1 48.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.36 20.98 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.988 0.813 . . . . 0.0 111.217 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.46 136.84 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.605 -0.684 . . . . 0.0 111.537 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.03 93.23 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.1 -34.54 68.75 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.86 2.373 . . . . 0.0 113.572 167.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.48 -38.06 86.47 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.464 -0.773 . . . . 0.0 112.521 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.98 -44.2 97.72 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.805 0.729 . . . . 0.0 111.382 171.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.65 -44.28 94.3 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.341 0.519 . . . . 0.0 112.292 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.26 -47.16 86.39 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.149 0.58 . . . . 0.0 111.338 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.26 95.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.621 0.768 . . . . 0.0 111.856 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -60.31 -46.73 88.83 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.835 0.854 . . . . 0.0 112.818 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.87 -54.53 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.443 0.565 . . . . 0.0 110.31 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.76 -37.23 78.44 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.332 1.053 . . . . 0.0 113.256 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.82 -52.33 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.227 1.411 . . . . 0.0 111.202 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -65.42 -36.08 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.016 0.526 . . . . 0.0 111.484 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.54 -24.05 59.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.2 -25.47 11.5 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.17 16.07 3.24 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -165.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.97 -37.22 2.82 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -175.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.14 15.37 14.09 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.539 1.136 . . . . 0.0 113.087 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -114.9 152.88 46.9 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.937 0.895 . . . . 0.0 111.458 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.75 -30.83 58.42 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.253 2.636 . . . . 0.0 115.222 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -61.93 -20.88 64.27 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.89 -31.84 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.448 1.022 . . . . 0.0 112.512 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.44 -55.07 6.24 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.97 1.308 . . . . 0.0 112.961 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.87 -30.08 49.42 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.72 1.65 . . . . 0.0 112.685 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -68.99 -40.24 78.87 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.849 1.204 . . . . 0.0 112.63 172.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.33 -46.48 83.21 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.771 0.714 . . . . 0.0 111.585 169.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.1 m -61.09 -44.44 97.36 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.76 71.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.281 1.033 . . . . 0.0 113.261 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.61 4.54 53.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.372 1.469 . . . . 0.0 113.508 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.9 p -133.09 22.83 4.14 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -176.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.57 120.31 5.99 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.422 -1.424 . . . . 0.0 111.45 168.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.67 60.04 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.5 130.79 46.75 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.498 1.649 . . . . 0.0 112.53 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.0 p -73.28 159.63 84.51 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.741 0.816 . . . . 0.0 110.666 167.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.46 -35.58 36.67 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.183 1.922 . . . . 0.0 115.422 168.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.96 -40.27 87.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.32 -45.38 93.6 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.662 -0.649 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.53 -44.22 94.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.342 1.057 . . . . 0.0 112.162 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -59.3 -41.35 88.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.587 0.63 . . . . 0.0 112.008 171.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.32 -45.33 93.8 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.65 0.659 . . . . 0.0 111.098 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.29 -48.96 77.57 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.175 0.898 . . . . 0.0 112.143 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.04 -38.6 91.83 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.84 -33.96 71.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.6 p -73.1 -12.64 60.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 m -122.25 7.53 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.68 -5.35 5.08 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 117.094 1.598 . . . . 0.0 117.094 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.56 56.15 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 119.1 1.45 . . . . 0.0 115.519 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -91.22 79.59 5.68 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.977 1.388 . . . . 0.0 110.594 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.82 -36.18 47.1 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.04 -41.21 71.11 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.131 1.332 . . . . 0.0 112.328 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.6 86.3 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.772 -0.58 . . . . 0.0 111.296 172.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.06 -40.07 96.6 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.538 -0.726 . . . . 0.0 112.239 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.91 -50.1 73.6 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.087 -1.008 . . . . 0.0 111.538 173.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.3 tpp -55.99 -45.41 79.01 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.051 0.941 . . . . 0.0 112.231 174.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.93 -48.73 79.14 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.307 0.643 . . . . 0.0 112.109 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.63 -38.31 90.65 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.455 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.03 -45.43 92.85 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 112.019 170.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.6 m -62.67 -42.4 99.6 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.842 0.746 . . . . 0.0 112.113 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.92 -46.04 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.472 -0.768 . . . . 0.0 111.063 174.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.11 -39.44 94.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.876 0.762 . . . . 0.0 112.757 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -60.87 -47.4 86.53 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.714 0.806 . . . . 0.0 111.95 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.12 -34.3 72.92 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.71 -41.79 91.89 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.447 -0.783 . . . . 0.0 112.33 172.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.02 98.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.248 0.619 . . . . 0.0 111.799 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.19 -42.23 99.3 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.812 -0.555 . . . . 0.0 112.211 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.82 -48.38 79.9 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.696 0.68 . . . . 0.0 111.675 173.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -63.16 -30.33 71.5 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.13 -38.96 79.13 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.306 1.042 . . . . 0.0 112.489 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.31 -27.64 42.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.833 1.253 . . . . 0.0 113.346 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.79 61.04 54.13 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.583 1.953 . . . . 0.0 111.22 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.95 120.12 7.39 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.452 2.102 . . . . 0.0 110.266 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.42 136.56 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.283 1.433 . . . . 0.0 112.119 -169.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.07 160.49 25.78 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.098 0.559 . . . . 0.0 110.905 168.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.26 -19.92 64.99 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 174.8 41.62 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.018 1.294 . . . . 0.0 112.602 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.62 169.16 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.944 177.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.61 -39.21 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.88 1.272 . . . . 0.0 111.801 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.49 161.93 28.54 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.817 1.647 . . . . 0.0 110.549 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.441 2.761 . . . . 0.0 113.132 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -15.03 60.34 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.577 1.084 . . . . 0.0 115.065 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.35 37.47 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.928 1.364 . . . . 0.0 110.198 173.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.2 145.62 54.14 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.753 -0.592 . . . . 0.0 110.835 168.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.51 152.72 44.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.717 0.807 . . . . 0.0 111.653 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.27 131.75 84.78 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.886 -0.578 . . . . 0.0 109.797 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.46 140.25 43.31 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.122 1.881 . . . . 0.0 112.414 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.3 mtp85 -74.86 171.58 13.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.716 1.607 . . . . 0.0 111.849 163.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.52 -43.87 93.97 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.934 -0.479 . . . . 0.0 113.029 168.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.73 -25.83 64.95 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 175.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.75 -41.6 64.93 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.986 -1.071 . . . . 0.0 111.739 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.68 -42.69 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.716 0.806 . . . . 0.0 110.756 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.91 -1.32 13.94 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 173.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.91 18.17 74.14 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.603 1.096 . . . . 0.0 115.488 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.3 -19.38 19.31 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.073 1.436 . . . . 0.0 113.284 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.0 p -126.23 -1.48 7.01 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.71 149.99 24.46 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.024 0.93 . . . . 0.0 111.737 173.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 p -81.89 162.32 22.81 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.293 0.568 . . . . 0.0 110.811 170.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.74 -39.49 74.06 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.424 -0.798 . . . . 0.0 111.425 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.59 -38.82 92.59 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.518 -0.739 . . . . 0.0 112.657 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -64.67 -42.75 95.15 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.622 -0.673 . . . . 0.0 111.997 171.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.3 90.87 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.58 0.752 . . . . 0.0 112.146 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.5 -46.4 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.151 0.981 . . . . 0.0 110.256 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.45 -51.04 54.34 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.793 0.711 . . . . 0.0 112.881 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.828 0.814 . . . . 0.0 112.485 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.68 -18.39 64.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.96 8.35 20.24 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.664 1.186 . . . . 0.0 113.033 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.43 162.31 1.6 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.978 1.311 . . . . 0.0 111.412 165.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.36 48.93 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.005 0.922 . . . . 0.0 110.836 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.14 163.81 89.19 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-N 119.462 0.844 . . . . 0.0 111.715 -6.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -49.95 141.29 29.56 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.205 2.604 . . . . 0.0 114.169 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.13 96.49 2.49 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 163.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.92 54.52 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.257 2.638 . . . . 0.0 112.909 -152.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.83 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.26 94.22 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.985 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.91 -36.78 75.65 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.358 -1.084 . . . . 0.0 112.648 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.03 -44.46 99.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.745 -0.597 . . . . 0.0 109.951 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.93 -40.42 91.4 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.313 -0.867 . . . . 0.0 112.489 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -41.96 74.96 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.8 -45.29 82.31 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.912 0.778 . . . . 0.0 112.093 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.25 -40.51 86.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.233 0.613 . . . . 0.0 112.279 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.57 -47.37 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.23 174.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -61.91 -37.29 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.707 1.203 . . . . 0.0 112.355 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.88 -42.83 98.73 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.057 0.844 . . . . 0.0 111.187 171.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.58 -44.99 91.83 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.87 0.748 . . . . 0.0 113.257 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.24 -42.69 86.88 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.876 0.87 . . . . 0.0 110.997 173.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.17 70.6 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.791 0.836 . . . . 0.0 112.454 173.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.74 -43.41 76.58 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 118.87 0.759 . . . . 0.0 111.992 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.1 mt -64.47 -48.19 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.342 0.657 . . . . 0.0 111.361 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.44 -31.66 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.73 1.15 . . . . 0.0 112.983 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -61.67 -43.58 98.58 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.168 0.895 . . . . 0.0 111.649 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.9 ttp -77.11 -35.75 56.12 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.726 1.61 . . . . 0.0 113.696 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 127.641 2.376 . . . . 0.0 114.205 -168.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 N--CA 1.48 0.686 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.81 135.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.03 154.89 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.665 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.61 116.71 32.53 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.521 0.729 . . . . 0.0 109.19 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.46 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.507 0.67 . . . . 0.0 112.474 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.54 68.79 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.58 -2.18 57.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.851 1.26 . . . . 0.0 113.043 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.94 3.1 85.8 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.458 1.028 . . . . 0.0 114.08 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.2 35.34 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.883 1.342 . . . . 0.0 109.727 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.85 125.55 29.51 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.94 123.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.074 1.349 . . . . 0.0 108.629 -174.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.58 139.66 38.57 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.487 0.66 . . . . 0.0 111.239 170.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.07 48.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.491 1.916 . . . . 0.0 107.921 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.2 152.37 20.77 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.019 0.827 . . . . 0.0 111.259 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.87 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.462 0.649 . . . . 0.0 111.579 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.01 93.24 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.99 -34.56 67.76 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.907 2.405 . . . . 0.0 113.604 167.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.48 -38.06 86.47 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.457 -0.777 . . . . 0.0 112.594 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 m -60.93 -44.31 97.41 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.691 0.678 . . . . 0.0 111.401 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.52 -44.39 94.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.251 0.478 . . . . 0.0 112.256 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.18 -47.3 85.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.115 0.566 . . . . 0.0 111.366 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.23 95.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.672 0.789 . . . . 0.0 111.908 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -60.16 -47.16 87.08 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.806 0.842 . . . . 0.0 112.783 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.75 -54.57 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.443 0.565 . . . . 0.0 110.375 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.62 -37.36 78.4 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.296 1.039 . . . . 0.0 113.234 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.43 -52.16 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.094 1.358 . . . . 0.0 111.296 170.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -64.8 -35.86 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 122.909 0.484 . . . . 0.0 111.471 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.74 -23.82 60.56 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.38 -25.64 11.35 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.06 16.16 3.26 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -166.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.42 -37.95 2.57 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -118.17 15.66 14.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.438 1.095 . . . . 0.0 113.057 -172.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.0 p -115.0 152.86 46.97 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.966 0.907 . . . . 0.0 111.463 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.88 -30.61 58.75 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.262 2.641 . . . . 0.0 115.208 -172.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.19 -20.67 64.41 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.87 -31.84 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.41 1.005 . . . . 0.0 112.548 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.6 mt -71.47 -55.05 6.21 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.966 1.307 . . . . 0.0 112.971 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.88 -30.05 49.34 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.653 1.626 . . . . 0.0 112.641 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.16 -40.16 78.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.867 1.212 . . . . 0.0 112.602 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.25 -46.46 83.01 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.808 0.731 . . . . 0.0 111.576 169.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.6 m -61.12 -44.42 97.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.0 71.51 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.333 1.053 . . . . 0.0 113.208 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.41 4.5 53.27 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.367 1.467 . . . . 0.0 113.488 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.5 p -133.01 22.8 4.16 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.68 120.31 6.05 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 120.477 -1.389 . . . . 0.0 111.477 168.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.63 11.57 60.24 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.377 0.911 . . . . 0.0 115.377 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.52 130.88 47.14 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.575 1.687 . . . . 0.0 112.464 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.39 159.64 84.35 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.758 0.823 . . . . 0.0 110.685 167.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.61 -35.4 37.6 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.144 1.896 . . . . 0.0 115.4 168.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -66.99 -40.29 87.36 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 174.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.35 93.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.039 172.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.56 -44.26 94.64 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 112.133 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -59.17 -41.49 88.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.618 0.645 . . . . 0.0 112.031 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.8 m -60.29 -45.22 94.1 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.582 0.628 . . . . 0.0 111.074 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.37 -48.91 77.8 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.254 0.934 . . . . 0.0 112.179 174.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.13 -38.45 91.24 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.89 -33.45 70.54 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.4 p -73.65 -12.5 60.76 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 m -122.19 7.88 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.72 -4.62 5.77 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 117.159 1.624 . . . . 0.0 117.159 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.88 -33.13 56.19 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 119.224 1.512 . . . . 0.0 115.423 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -91.32 78.7 5.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.892 1.346 . . . . 0.0 110.605 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.26 -35.82 39.1 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -173.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.41 -41.1 73.38 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.086 1.312 . . . . 0.0 112.315 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.28 -43.56 86.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.167 0.587 . . . . 0.0 111.337 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.3 tpp -63.1 -40.1 96.65 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.565 -0.709 . . . . 0.0 112.229 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.93 -50.02 73.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.218 1.007 . . . . 0.0 111.539 173.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.95 -45.5 78.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.044 0.938 . . . . 0.0 112.233 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -61.88 -48.77 79.01 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.276 0.63 . . . . 0.0 112.055 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.64 -38.28 90.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.845 0.858 . . . . 0.0 112.479 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.98 -45.45 92.67 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.668 0.667 . . . . 0.0 112.048 170.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.7 -42.39 99.61 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.815 0.734 . . . . 0.0 112.082 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.85 -46.1 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.441 -0.787 . . . . 0.0 111.059 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.08 -39.46 94.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.831 0.741 . . . . 0.0 112.736 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.84 -47.37 86.69 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.667 0.787 . . . . 0.0 111.971 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -70.13 -34.3 72.89 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.68 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.43 -0.794 . . . . 0.0 112.361 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.11 98.68 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.231 0.613 . . . . 0.0 111.781 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.21 99.57 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 0.0 112.218 174.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.85 -48.55 79.47 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.667 0.667 . . . . 0.0 111.726 173.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.04 -30.25 71.46 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.12 -39.18 79.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.343 1.057 . . . . 0.0 112.499 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.64 42.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 113.29 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.72 61.01 54.1 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.67 1.988 . . . . 0.0 111.247 -174.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.9 120.17 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.452 2.101 . . . . 0.0 110.315 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.36 136.31 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.377 1.471 . . . . 0.0 112.136 -169.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.97 160.45 25.92 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.124 0.57 . . . . 0.0 110.855 168.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.91 65.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.99 174.77 41.63 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.059 1.314 . . . . 0.0 112.64 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.58 169.15 14.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.682 2.921 . . . . 0.0 112.878 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.68 -39.15 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.873 1.269 . . . . 0.0 111.787 -175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.51 161.9 28.6 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.856 1.662 . . . . 0.0 110.561 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.83 133.42 22.44 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.519 2.812 . . . . 0.0 113.132 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.89 -15.0 60.33 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.551 1.072 . . . . 0.0 115.001 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.11 143.39 37.38 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.996 1.398 . . . . 0.0 110.214 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.24 145.52 54.19 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.664 -0.647 . . . . 0.0 110.793 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.52 152.78 44.91 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.674 0.79 . . . . 0.0 111.617 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.23 131.68 84.9 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.883 -0.58 . . . . 0.0 109.821 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.37 140.4 44.03 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.076 1.851 . . . . 0.0 112.426 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -75.08 171.66 13.72 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.679 1.592 . . . . 0.0 111.89 163.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.78 94.19 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.912 -0.493 . . . . 0.0 113.04 168.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.1 p -68.81 -25.78 64.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.7 64.98 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.989 -1.069 . . . . 0.0 111.727 171.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.6 -42.74 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.704 0.801 . . . . 0.0 110.771 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.2 13.79 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.92 18.11 74.09 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.897 -1.127 . . . . 0.0 115.496 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.47 19.29 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.073 1.436 . . . . 0.0 113.29 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -126.18 -1.38 7.04 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.67 149.91 24.51 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.14 0.976 . . . . 0.0 111.763 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.0 p -81.86 162.27 22.87 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.319 0.581 . . . . 0.0 110.778 170.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.74 -39.4 73.89 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.415 -0.803 . . . . 0.0 111.404 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.55 -38.97 93.16 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.481 -0.762 . . . . 0.0 112.659 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.77 95.55 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.39 90.54 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.119 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.4 -46.39 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.203 1.001 . . . . 0.0 110.285 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.01 54.55 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.753 0.692 . . . . 0.0 112.945 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.32 -50.01 73.34 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.751 0.776 . . . . 0.0 112.537 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.69 -18.49 64.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.93 8.42 20.32 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.651 1.18 . . . . 0.0 113.035 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.45 162.31 1.62 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.989 1.316 . . . . 0.0 111.414 165.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.451 0.84 . . . . 0.0 111.701 -6.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.99 141.33 29.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.258 2.639 . . . . 0.0 114.136 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.3 mt -96.15 96.49 2.5 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 163.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -86.02 54.59 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.289 2.659 . . . . 0.0 112.86 -152.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.84 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.36 -46.34 94.07 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 118.605 0.639 . . . . 0.0 112.958 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.82 -36.8 75.93 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.313 -1.11 . . . . 0.0 112.678 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.97 -44.56 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.732 -0.605 . . . . 0.0 109.942 174.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.46 91.67 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.292 -0.88 . . . . 0.0 112.504 176.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.04 75.08 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.275 173.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.67 -45.23 81.82 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.901 0.773 . . . . 0.0 112.12 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.31 -40.5 86.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.296 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.62 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.044 0.538 . . . . 0.0 110.291 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.03 -37.35 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.683 1.193 . . . . 0.0 112.355 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.75 98.19 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.03 0.832 . . . . 0.0 111.275 171.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.67 -45.0 91.52 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.828 0.727 . . . . 0.0 113.23 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.4 -42.42 87.11 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.075 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.21 70.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.811 0.844 . . . . 0.0 112.425 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.79 -43.28 76.68 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.892 0.769 . . . . 0.0 111.968 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.37 -48.36 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.337 0.655 . . . . 0.0 111.415 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.34 -31.74 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 119.725 1.148 . . . . 0.0 113.012 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -61.14 -41.76 97.31 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.074 0.852 . . . . 0.0 111.722 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.7 ttp -80.96 -34.43 33.16 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.738 1.615 . . . . 0.0 113.935 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 127.614 2.366 . . . . 0.0 114.236 -169.036 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.81 135.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.08 154.81 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.685 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.55 116.74 32.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.488 0.715 . . . . 0.0 109.191 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.84 -26.49 68.78 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -173.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.58 -2.21 57.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.852 1.261 . . . . 0.0 112.991 175.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.02 85.77 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.5 1.048 . . . . 0.0 114.144 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.7 128.23 35.47 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.801 1.301 . . . . 0.0 109.678 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.89 125.57 29.55 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.88 123.39 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.11 1.364 . . . . 0.0 108.7 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.71 38.55 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.72 141.11 48.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.465 1.906 . . . . 0.0 107.929 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.27 152.4 20.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.217 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.9 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.607 -0.683 . . . . 0.0 111.579 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.66 130.01 93.24 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.068 0.547 . . . . 0.0 111.125 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.887 2.391 . . . . 0.0 113.575 167.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.41 -38.05 86.6 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.451 -0.78 . . . . 0.0 112.587 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.8 m -60.96 -44.32 97.48 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.747 0.703 . . . . 0.0 111.386 171.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.54 -44.37 94.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.258 0.481 . . . . 0.0 112.244 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.22 -47.27 85.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.115 0.566 . . . . 0.0 111.37 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.96 -45.26 95.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.67 0.788 . . . . 0.0 111.914 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.22 -47.09 87.42 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.868 0.867 . . . . 0.0 112.774 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.8 t -56.82 -54.55 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.489 0.586 . . . . 0.0 110.31 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.61 -37.4 78.47 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.35 1.06 . . . . 0.0 113.247 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.36 -52.17 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.092 1.357 . . . . 0.0 111.302 170.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.82 -35.99 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.996 0.518 . . . . 0.0 111.407 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.69 -23.86 60.3 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.34 -25.62 11.38 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -136.03 16.15 3.27 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -166.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.47 -37.91 2.61 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -118.08 15.62 14.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.478 1.111 . . . . 0.0 113.107 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.7 p -114.91 152.87 46.9 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.959 0.903 . . . . 0.0 111.49 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.86 -30.63 58.77 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.238 2.625 . . . . 0.0 115.276 -172.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.11 -20.73 64.36 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.81 -31.96 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 119.466 1.03 . . . . 0.0 112.479 176.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.36 -55.07 6.34 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.957 1.303 . . . . 0.0 112.995 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.88 -30.08 49.28 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.681 1.636 . . . . 0.0 112.671 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.05 -40.2 78.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.914 1.234 . . . . 0.0 112.665 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.3 -46.48 83.12 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.421 0.689 . . . . 0.0 111.576 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -61.07 -44.45 97.36 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.85 -32.03 71.45 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.284 1.034 . . . . 0.0 113.278 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.36 4.47 53.36 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.355 1.462 . . . . 0.0 113.484 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -133.03 22.84 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.58 120.3 5.99 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.456 -1.402 . . . . 0.0 111.432 168.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.67 60.04 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 130.88 47.14 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.498 1.649 . . . . 0.0 112.482 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.35 159.66 84.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.753 0.821 . . . . 0.0 110.666 167.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.22 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.34 -45.33 93.83 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.66 -0.65 . . . . 0.0 111.1 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -59.28 -41.34 88.68 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.692 -0.63 . . . . 0.0 112.02 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.27 -45.32 93.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.596 0.634 . . . . 0.0 111.097 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.32 -48.91 77.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.233 0.924 . . . . 0.0 112.179 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.11 -38.46 91.27 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.91 -33.56 70.69 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.9 p -73.5 -12.54 60.82 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.24 7.85 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.54 -4.69 5.55 Favored Glycine 0 CA--C 1.541 1.684 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.96 -32.99 56.57 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.186 1.493 . . . . 0.0 115.435 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -91.28 78.76 5.74 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.918 1.359 . . . . 0.0 110.619 171.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.36 -35.92 40.74 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.43 -41.15 73.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.137 1.335 . . . . 0.0 112.293 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.51 86.07 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.139 0.576 . . . . 0.0 111.329 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.09 -40.12 96.71 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.514 -0.741 . . . . 0.0 112.198 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.98 -49.97 74.1 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.202 1.001 . . . . 0.0 111.518 173.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.97 -45.46 78.92 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.094 0.958 . . . . 0.0 112.245 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.91 -48.77 78.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.331 0.652 . . . . 0.0 112.055 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.66 -38.27 90.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.453 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.01 -45.48 92.62 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.664 0.665 . . . . 0.0 112.048 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.65 -42.37 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.118 175.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.85 -46.14 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.441 -0.787 . . . . 0.0 111.03 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.06 -39.46 94.13 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.842 0.746 . . . . 0.0 112.736 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -60.78 -47.49 86.1 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.943 174.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.06 -34.33 73.07 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.69 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.408 -0.808 . . . . 0.0 112.361 172.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.09 98.7 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.215 0.606 . . . . 0.0 111.751 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.12 -42.25 99.49 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.86 -0.525 . . . . 0.0 112.138 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.81 -48.52 79.5 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.666 0.666 . . . . 0.0 111.722 173.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.11 -30.19 71.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.22 -39.06 78.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.354 1.062 . . . . 0.0 112.482 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.3 -27.6 42.18 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.791 1.236 . . . . 0.0 113.29 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.78 60.99 53.88 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.639 1.976 . . . . 0.0 111.22 -174.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.92 120.21 7.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.481 2.12 . . . . 0.0 110.24 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.46 136.37 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.287 1.435 . . . . 0.0 112.13 -169.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.04 160.47 25.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.075 0.55 . . . . 0.0 110.915 168.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.92 65.01 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.11 1.338 . . . . 0.0 112.655 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.59 169.15 14.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.687 2.925 . . . . 0.0 112.878 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.68 -39.19 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.903 1.281 . . . . 0.0 111.749 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.44 161.97 28.44 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.817 1.647 . . . . 0.0 110.573 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.97 133.45 23.18 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.477 2.785 . . . . 0.0 113.149 168.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.99 60.34 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.613 1.101 . . . . 0.0 115.051 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.38 37.45 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.952 1.376 . . . . 0.0 110.198 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.51 54.26 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.66 -0.65 . . . . 0.0 110.842 168.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.48 152.73 44.98 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.684 0.794 . . . . 0.0 111.653 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.23 131.65 84.93 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.33 140.35 44.06 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -75.02 171.61 13.79 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.733 1.613 . . . . 0.0 111.867 163.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.57 -43.9 94.05 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.876 -0.515 . . . . 0.0 113.021 168.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.79 -25.78 64.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.69 -41.69 65.03 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.064 -1.022 . . . . 0.0 111.757 171.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.54 -42.84 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.73 0.812 . . . . 0.0 110.798 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.95 -1.26 13.83 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.98 18.15 74.24 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.626 1.107 . . . . 0.0 115.445 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.38 19.3 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.131 1.466 . . . . 0.0 113.301 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -126.2 -1.48 7.03 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.66 149.96 24.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.052 0.941 . . . . 0.0 111.788 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.5 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.293 0.568 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.83 -39.4 74.15 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.441 -0.787 . . . . 0.0 111.374 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.52 -38.93 93.02 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.531 -0.73 . . . . 0.0 112.685 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.64 -42.73 95.27 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 112.031 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.66 -46.37 90.58 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.651 0.78 . . . . 0.0 112.143 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.32 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.301 172.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.45 -51.06 54.19 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.782 0.706 . . . . 0.0 112.884 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 0.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.64 -18.49 64.3 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.87 8.36 20.4 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.703 1.201 . . . . 0.0 113.051 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.44 162.31 1.61 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.995 1.318 . . . . 0.0 111.447 165.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.34 48.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.035 0.934 . . . . 0.0 110.837 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.447 0.838 . . . . 0.0 111.701 -6.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.99 141.33 29.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.258 2.639 . . . . 0.0 114.136 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.17 96.48 2.51 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 163.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -86.0 54.56 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.257 2.638 . . . . 0.0 112.86 -152.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.56 -34.83 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.26 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.999 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.83 -36.87 75.95 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.91 -44.6 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.709 -0.62 . . . . 0.0 109.942 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.78 -40.5 92.02 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.307 -0.871 . . . . 0.0 112.559 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.78 -41.97 74.85 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.468 -0.77 . . . . 0.0 112.287 173.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.76 -45.22 82.2 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.889 0.768 . . . . 0.0 112.093 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.31 -40.5 86.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.296 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.62 -47.19 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.067 0.547 . . . . 0.0 110.272 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.15 -37.35 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.682 1.193 . . . . 0.0 112.292 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.82 -42.76 98.3 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.011 0.823 . . . . 0.0 111.244 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.59 -45.03 91.61 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.87 0.748 . . . . 0.0 113.252 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.4 -42.42 87.11 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.075 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.49 -50.16 70.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.811 0.844 . . . . 0.0 112.453 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.81 -43.27 76.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.875 0.762 . . . . 0.0 112.005 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.37 -48.36 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.337 0.655 . . . . 0.0 111.415 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.34 -31.81 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 119.725 1.148 . . . . 0.0 113.012 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -61.03 -42.07 97.76 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.058 0.845 . . . . 0.0 111.721 171.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.1 ttp -80.47 -34.64 35.73 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.761 1.624 . . . . 0.0 113.901 -174.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 127.621 2.368 . . . . 0.0 114.251 -168.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.998 0.345 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.9 mm -92.07 135.01 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.484 1.114 . . . . 0.0 108.489 163.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.03 154.6 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.076 1.35 . . . . 0.0 109.662 170.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.22 116.74 32.71 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.554 0.742 . . . . 0.0 109.201 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.53 177.98 7.01 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.557 0.694 . . . . 0.0 112.436 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.84 -26.54 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.63 -2.2 57.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.81 1.244 . . . . 0.0 113.047 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.97 3.17 85.66 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.418 1.009 . . . . 0.0 114.096 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.14 35.11 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.857 1.328 . . . . 0.0 109.726 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.84 125.55 29.52 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 168.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.84 123.38 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.077 1.351 . . . . 0.0 108.679 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.53 139.63 38.62 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.236 170.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.71 141.16 48.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.431 1.892 . . . . 0.0 107.897 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.28 152.44 20.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.803 . . . . 0.0 111.221 170.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.51 136.86 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.65 -0.656 . . . . 0.0 111.563 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.65 129.96 93.27 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.07 0.548 . . . . 0.0 111.155 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.05 -34.46 67.9 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.864 2.376 . . . . 0.0 113.597 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.55 -38.06 86.32 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.453 -0.779 . . . . 0.0 112.521 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.02 -44.13 97.86 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.805 0.729 . . . . 0.0 111.372 171.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.66 -44.37 93.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.354 0.525 . . . . 0.0 112.311 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.18 -47.11 86.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.424 0.556 . . . . 0.0 111.38 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.05 -45.34 95.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.612 0.765 . . . . 0.0 111.866 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -60.41 -46.39 90.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.808 0.843 . . . . 0.0 112.846 177.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.04 -54.51 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 118.458 0.572 . . . . 0.0 110.302 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.77 -37.11 78.14 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.404 1.082 . . . . 0.0 113.289 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.61 -52.41 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.398 1.479 . . . . 0.0 111.223 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.64 -36.2 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.069 0.548 . . . . 0.0 111.479 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.51 -24.24 60.03 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 175.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -106.93 -25.38 11.67 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -136.32 15.7 3.21 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -165.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.62 -37.36 2.53 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -117.23 12.5 14.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.478 1.111 . . . . 0.0 113.198 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.9 p -111.63 153.21 44.37 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.876 0.87 . . . . 0.0 111.497 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.83 -30.87 59.54 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.284 2.656 . . . . 0.0 115.173 -172.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.09 -20.98 64.59 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.61 -32.13 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.437 1.017 . . . . 0.0 112.458 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.41 -57.17 5.92 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.718 1.207 . . . . 0.0 112.538 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.89 -29.5 58.21 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 121.885 1.709 . . . . 0.0 112.786 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.13 -40.13 78.46 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.779 1.172 . . . . 0.0 112.698 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.25 -47.08 82.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.848 0.749 . . . . 0.0 111.546 169.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m -60.88 -44.11 97.53 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 175.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.54 70.96 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.249 1.019 . . . . 0.0 113.252 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -96.0 4.69 52.44 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.382 1.473 . . . . 0.0 113.491 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.8 p -133.17 22.78 4.11 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -53.57 120.25 5.92 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.437 -1.414 . . . . 0.0 111.42 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.6 11.68 60.35 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 115.391 0.916 . . . . 0.0 115.391 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.84 46.9 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.516 1.658 . . . . 0.0 112.481 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.27 159.68 84.4 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.718 0.807 . . . . 0.0 110.7 167.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.53 -35.5 37.15 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.144 1.896 . . . . 0.0 115.412 168.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.98 -40.32 87.4 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 174.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.29 -45.33 93.72 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.062 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.5 mt -63.53 -44.24 94.79 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.31 1.044 . . . . 0.0 112.151 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -59.26 -41.36 88.61 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.663 -0.648 . . . . 0.0 112.024 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.6 m -60.33 -45.43 93.45 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.626 0.648 . . . . 0.0 111.078 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.17 -49.01 77.29 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.218 0.917 . . . . 0.0 112.17 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.7 mt -63.04 -38.62 91.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.95 -34.2 71.49 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.3 p -72.88 -12.52 61.0 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.44 7.49 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.44 -5.75 5.23 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 117.102 1.601 . . . . 0.0 117.102 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.96 56.42 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 119.053 1.427 . . . . 0.0 115.526 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -90.23 79.8 6.33 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.029 1.414 . . . . 0.0 110.607 171.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -52.1 -36.28 50.44 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.23 -41.32 70.32 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.203 1.365 . . . . 0.0 112.348 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.17 -43.52 86.66 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.784 -0.573 . . . . 0.0 111.335 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -63.15 -40.03 96.38 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.566 -0.708 . . . . 0.0 112.204 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.88 -50.07 73.6 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.072 -1.017 . . . . 0.0 111.538 172.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.03 -45.38 79.19 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.056 0.942 . . . . 0.0 112.22 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.8 tp -61.96 -48.78 78.82 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.295 0.638 . . . . 0.0 112.045 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.71 -38.12 89.9 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.832 0.853 . . . . 0.0 112.45 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.06 -45.53 92.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.653 0.661 . . . . 0.0 112.001 170.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.61 -42.42 99.57 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.806 0.73 . . . . 0.0 112.114 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.9 -46.04 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.506 -0.747 . . . . 0.0 111.037 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -64.16 -39.44 94.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.887 0.767 . . . . 0.0 112.684 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -60.84 -47.44 86.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.934 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -70.05 -34.38 73.14 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.63 -41.98 92.02 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.49 -0.756 . . . . 0.0 112.299 172.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.57 -42.04 98.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.231 0.613 . . . . 0.0 111.784 172.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.15 -42.35 99.44 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.825 -0.547 . . . . 0.0 112.189 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -57.72 -48.48 79.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.677 0.671 . . . . 0.0 111.653 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.06 -30.4 71.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.09 -38.95 79.26 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.359 1.064 . . . . 0.0 112.488 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.44 -27.61 41.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.803 1.241 . . . . 0.0 113.318 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 60.98 53.81 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.583 1.953 . . . . 0.0 111.22 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.89 120.17 7.46 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.456 2.104 . . . . 0.0 110.296 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.52 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.335 1.454 . . . . 0.0 112.154 -169.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.12 160.46 25.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.1 0.56 . . . . 0.0 110.845 168.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.19 -19.96 64.98 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 174.7 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.069 1.319 . . . . 0.0 112.647 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.55 169.2 14.71 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.624 2.883 . . . . 0.0 112.944 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.65 -39.26 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.897 1.279 . . . . 0.0 111.762 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.45 161.91 28.56 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.862 1.665 . . . . 0.0 110.597 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.92 133.42 22.9 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.473 2.782 . . . . 0.0 113.132 168.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -15.05 60.3 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.531 1.063 . . . . 0.0 115.037 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.03 143.35 37.56 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.942 1.371 . . . . 0.0 110.197 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.14 145.64 54.17 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.663 -0.648 . . . . 0.0 110.793 168.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -68.59 152.67 45.05 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.677 0.791 . . . . 0.0 111.69 171.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -72.22 131.78 84.83 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.848 170.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.38 140.26 43.63 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.15 1.9 . . . . 0.0 112.465 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -74.87 171.65 13.65 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.707 1.603 . . . . 0.0 111.879 163.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.54 -44.0 93.95 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.921 -0.487 . . . . 0.0 112.955 168.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.66 -25.9 65.05 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.67 -41.61 65.19 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.057 -1.027 . . . . 0.0 111.777 171.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.66 -42.65 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.737 0.815 . . . . 0.0 110.819 173.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.98 -1.28 13.99 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.93 18.28 74.27 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.899 -1.126 . . . . 0.0 115.437 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.38 -19.39 19.24 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.115 1.458 . . . . 0.0 113.301 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 p -126.21 -1.55 7.02 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.3 p -103.43 150.05 24.22 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.099 0.96 . . . . 0.0 111.783 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.2 p -81.96 162.45 22.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.268 0.556 . . . . 0.0 110.848 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.87 -39.4 74.27 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.444 -0.785 . . . . 0.0 111.445 169.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.52 -38.87 92.8 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.513 -0.742 . . . . 0.0 112.688 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -64.59 -42.8 95.35 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.584 -0.698 . . . . 0.0 112.069 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.68 -46.3 90.87 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.574 0.75 . . . . 0.0 112.155 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.5 -46.36 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.122 0.969 . . . . 0.0 110.288 172.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.42 -51.01 54.42 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.806 0.717 . . . . 0.0 112.945 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.3 -50.09 73.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.751 0.776 . . . . 0.0 112.48 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.66 -18.35 64.26 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -112.01 8.39 20.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.628 1.171 . . . . 0.0 113.035 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.46 162.33 1.62 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.921 1.288 . . . . 0.0 111.461 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.93 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.065 0.946 . . . . 0.0 110.758 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.84 89.15 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.461 0.843 . . . . 0.0 111.713 -6.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -50.0 141.28 29.98 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.216 2.611 . . . . 0.0 114.206 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 74.9 mt -96.1 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 163.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.91 54.48 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.295 2.663 . . . . 0.0 112.884 -152.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.54 -34.85 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.26 94.22 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.985 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.91 -36.84 75.68 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.358 -1.083 . . . . 0.0 112.645 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.92 -44.61 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.753 -0.592 . . . . 0.0 109.987 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.79 -40.39 91.9 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.352 -0.842 . . . . 0.0 112.572 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -55.84 -41.99 75.11 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.476 -0.765 . . . . 0.0 112.287 173.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.76 -45.24 82.16 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.888 0.767 . . . . 0.0 112.125 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.27 -40.56 86.17 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.273 0.629 . . . . 0.0 112.246 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.48 -47.53 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 122.987 0.515 . . . . 0.0 110.216 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.97 -37.12 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.708 1.203 . . . . 0.0 112.326 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.85 98.55 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.107 0.867 . . . . 0.0 111.264 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.85 91.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.838 0.733 . . . . 0.0 113.199 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -58.1 -42.93 86.74 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.02 0.91 . . . . 0.0 110.987 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.24 70.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.842 0.857 . . . . 0.0 112.458 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -55.72 -43.44 76.55 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.894 0.77 . . . . 0.0 111.987 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.9 mt -64.57 -47.48 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 118.707 -0.663 . . . . 0.0 111.452 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.61 -32.99 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 119.918 1.235 . . . . 0.0 112.881 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -60.87 -46.46 90.51 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.949 0.9 . . . . 0.0 111.468 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.4 ttp -72.23 -38.38 68.95 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.588 1.555 . . . . 0.0 113.082 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.7 t80 . . . . . 0 C--O 1.251 1.156 0 C-N-CA 128.345 2.658 . . . . 0.0 114.73 -174.362 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.017 0.353 . . . . 0.0 113.017 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -92.0 135.05 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.51 1.124 . . . . 0.0 108.471 163.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.08 154.66 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.685 170.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.36 116.63 32.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.519 0.728 . . . . 0.0 109.181 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.4 177.97 6.92 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.55 0.69 . . . . 0.0 112.474 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.61 68.82 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.59 -2.12 57.83 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.746 1.219 . . . . 0.0 113.046 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.25 85.75 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.5 1.048 . . . . 0.0 114.066 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.82 128.16 35.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.848 1.324 . . . . 0.0 109.715 174.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.81 125.46 29.38 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 168.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.89 123.39 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.053 1.341 . . . . 0.0 108.659 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.66 141.1 48.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.513 1.925 . . . . 0.0 107.959 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.3 152.38 21.16 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.98 0.809 . . . . 0.0 111.274 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.49 136.85 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.645 -0.659 . . . . 0.0 111.61 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.0 93.24 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.02 -34.56 68.04 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.918 2.412 . . . . 0.0 113.569 167.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.46 -38.08 86.55 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.457 -0.777 . . . . 0.0 112.545 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.98 -44.21 97.7 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.718 0.69 . . . . 0.0 111.425 171.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.58 -44.42 94.11 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.291 0.496 . . . . 0.0 112.256 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.15 -47.17 86.26 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.441 0.564 . . . . 0.0 111.398 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.14 95.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.606 0.763 . . . . 0.0 111.879 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.7 t-105 -60.38 -46.83 88.57 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.734 0.813 . . . . 0.0 112.85 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.98 -54.16 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.436 0.562 . . . . 0.0 110.343 174.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.89 -37.14 78.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.391 1.076 . . . . 0.0 113.249 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.26 -52.46 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.236 1.414 . . . . 0.0 111.236 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.8 t -64.98 -36.09 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.023 0.529 . . . . 0.0 111.441 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.39 -24.04 58.86 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.51 -25.29 11.45 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -136.36 15.98 3.2 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -165.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.05 -36.98 2.77 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 -175.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -117.89 13.61 14.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.415 1.086 . . . . 0.0 113.114 -172.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.4 p -113.03 153.09 45.4 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.944 0.898 . . . . 0.0 111.55 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.88 -30.77 59.6 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.303 2.669 . . . . 0.0 115.181 -172.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -62.05 -20.82 64.36 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.81 -31.83 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.404 1.002 . . . . 0.0 112.525 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.49 -55.02 6.2 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 124.904 1.282 . . . . 0.0 112.968 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.84 -30.15 49.58 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.718 1.649 . . . . 0.0 112.633 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.0 -40.25 78.83 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.911 1.232 . . . . 0.0 112.669 172.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -57.23 -46.53 82.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.716 0.689 . . . . 0.0 111.592 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.2 m -61.04 -44.45 97.39 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.83 71.34 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.317 1.047 . . . . 0.0 113.229 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.54 4.5 53.13 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.455 1.502 . . . . 0.0 113.522 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -133.03 22.76 4.16 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.55 120.26 5.92 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.44 -1.413 . . . . 0.0 111.517 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.52 11.72 60.23 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.57 130.84 46.89 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.546 1.673 . . . . 0.0 112.437 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.31 159.68 84.36 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.7 167.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.53 -35.53 37.25 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.144 1.896 . . . . 0.0 115.412 168.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.96 -40.26 87.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.37 -45.31 93.95 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.695 -0.628 . . . . 0.0 111.038 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -59.18 -41.49 88.61 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.696 -0.628 . . . . 0.0 112.031 171.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.2 m -60.23 -45.28 93.77 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.582 0.628 . . . . 0.0 111.11 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.34 -48.99 77.56 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.246 0.93 . . . . 0.0 112.165 174.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -62.98 -38.38 90.9 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.01 -33.42 70.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.9 p -73.49 -12.72 60.88 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.6 m -122.53 6.98 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.22 -4.1 7.78 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 117.414 1.726 . . . . 0.0 117.414 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.59 -35.58 67.49 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 119.353 1.576 . . . . 0.0 115.173 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -85.35 77.89 9.86 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.944 1.354 . . . . 0.0 110.5 170.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.86 -35.51 32.96 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.597 1.559 . . . . 0.0 115.165 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.6 -41.33 72.45 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.142 1.337 . . . . 0.0 112.345 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.61 86.14 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.767 -0.583 . . . . 0.0 111.362 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -63.11 -40.02 96.4 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.576 -0.702 . . . . 0.0 112.228 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.02 -49.94 74.26 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.018 -1.051 . . . . 0.0 111.523 173.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.97 -45.41 78.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.066 0.946 . . . . 0.0 112.251 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.6 tp -61.94 -48.77 78.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.307 0.643 . . . . 0.0 112.071 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.72 -38.28 90.51 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 0.0 112.44 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.98 -45.49 92.55 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.715 0.689 . . . . 0.0 112.034 170.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.62 -42.43 99.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.793 0.724 . . . . 0.0 112.109 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.82 -46.11 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.426 -0.796 . . . . 0.0 111.03 174.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.12 -39.43 94.03 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.869 0.759 . . . . 0.0 112.724 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -60.82 -47.4 86.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.721 0.808 . . . . 0.0 111.961 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -70.15 -34.3 72.85 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.81 91.08 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.44 -0.788 . . . . 0.0 112.468 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.18 99.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.211 0.604 . . . . 0.0 111.737 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -62.91 -42.12 99.68 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.907 -0.496 . . . . 0.0 112.13 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -58.17 -48.81 79.14 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.641 -0.662 . . . . 0.0 111.751 173.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -62.76 -29.7 70.88 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.73 -39.48 76.78 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.398 1.079 . . . . 0.0 112.52 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.06 -27.59 43.1 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.731 1.212 . . . . 0.0 113.337 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.76 61.1 54.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.675 1.99 . . . . 0.0 111.229 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.77 120.22 7.53 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.484 2.123 . . . . 0.0 110.313 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.38 135.97 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.325 1.45 . . . . 0.0 112.079 -169.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -79.74 160.48 26.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.062 0.545 . . . . 0.0 110.908 168.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.99 65.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 174.78 41.62 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.115 1.34 . . . . 0.0 112.677 174.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.62 169.14 14.95 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.642 2.895 . . . . 0.0 112.906 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.6 -39.22 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.887 1.275 . . . . 0.0 111.787 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.91 28.56 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.845 1.658 . . . . 0.0 110.597 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.89 133.45 22.75 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.473 2.782 . . . . 0.0 113.114 168.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.91 -15.0 60.36 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.577 1.084 . . . . 0.0 115.056 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.32 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.906 1.353 . . . . 0.0 110.198 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.15 145.58 54.22 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.719 -0.613 . . . . 0.0 110.868 168.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -68.39 152.58 45.21 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.682 0.793 . . . . 0.0 111.616 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.07 131.58 85.27 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.805 170.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.26 140.47 44.63 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.051 1.834 . . . . 0.0 112.362 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -75.23 171.83 13.49 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.654 1.582 . . . . 0.0 111.99 162.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.78 -43.98 94.39 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 123.36 0.505 . . . . 0.0 113.012 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.71 -25.89 65.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -72.65 -41.67 65.2 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.977 -1.077 . . . . 0.0 111.764 171.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -62.52 -42.81 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.788 0.835 . . . . 0.0 110.76 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.99 -1.32 14.12 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.92 18.27 74.25 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.827 -1.17 . . . . 0.0 115.423 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.6 p -96.19 -19.53 19.27 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.13 1.465 . . . . 0.0 113.394 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 61.8 p -126.23 -1.55 7.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.613 1.165 . . . . 0.0 114.072 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -103.27 150.21 23.96 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.758 0.823 . . . . 0.0 112.25 173.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.8 p -82.53 162.4 22.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.361 0.601 . . . . 0.0 110.793 170.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.9 tp -56.57 -39.61 73.77 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.52 -0.737 . . . . 0.0 111.368 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.28 -39.0 93.34 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.547 -0.721 . . . . 0.0 112.63 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -64.68 -42.6 95.22 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.478 -0.764 . . . . 0.0 112.152 171.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -60.66 -46.34 90.69 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.618 0.767 . . . . 0.0 112.133 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.38 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.122 0.969 . . . . 0.0 110.288 172.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.43 -51.05 54.14 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.819 0.723 . . . . 0.0 112.9 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.22 -50.14 72.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.866 0.833 . . . . 0.0 112.517 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.63 -18.39 64.29 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.94 8.35 20.26 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.671 1.189 . . . . 0.0 113.051 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.43 162.33 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.978 1.311 . . . . 0.0 111.447 165.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.29 49.02 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.065 0.946 . . . . 0.0 110.821 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.1 163.84 89.14 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.497 0.856 . . . . 0.0 111.713 -6.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -50.01 141.26 30.1 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.231 2.621 . . . . 0.0 114.148 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.04 96.46 2.44 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.84 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.36 -46.24 94.28 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.638 0.654 . . . . 0.0 112.985 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.88 -36.89 75.83 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.362 -1.081 . . . . 0.0 112.645 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.88 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.722 -0.611 . . . . 0.0 109.947 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.92 -40.38 91.38 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.282 -0.886 . . . . 0.0 112.521 176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -42.02 75.05 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.71 -45.19 82.0 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.924 0.784 . . . . 0.0 112.12 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -67.41 -40.49 85.59 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.248 0.619 . . . . 0.0 112.292 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.57 -47.23 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 122.997 0.519 . . . . 0.0 110.235 174.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.05 -37.37 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.749 1.22 . . . . 0.0 112.308 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.85 -42.84 98.63 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.038 0.836 . . . . 0.0 111.216 171.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.55 -45.03 91.75 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.821 0.724 . . . . 0.0 113.252 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.37 -42.48 87.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.055 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.46 -50.17 70.57 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.811 0.844 . . . . 0.0 112.5 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.88 -43.33 77.09 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.855 0.752 . . . . 0.0 111.984 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.2 mt -64.43 -47.62 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.443 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.75 -32.91 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.952 1.251 . . . . 0.0 112.889 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -60.45 -45.86 92.16 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.901 0.88 . . . . 0.0 111.448 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.9 ttp -73.57 -38.43 65.17 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.564 1.546 . . . . 0.0 113.313 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.9 t80 . . . . . 0 C--O 1.255 1.39 0 C-N-CA 128.43 2.692 . . . . 0.0 114.714 -172.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.81 135.01 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.92 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.686 170.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.62 116.69 32.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.57 0.748 . . . . 0.0 109.17 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.46 178.06 6.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.46 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.95 -26.44 68.82 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.62 -2.16 57.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.818 1.247 . . . . 0.0 113.03 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.0 85.7 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.67 128.26 35.58 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.858 1.329 . . . . 0.0 109.726 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.92 125.62 29.62 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.99 123.4 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.07 1.348 . . . . 0.0 108.629 -174.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.73 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.75 141.14 48.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.477 1.911 . . . . 0.0 107.948 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.28 152.45 20.89 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.196 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.58 136.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.6 -0.687 . . . . 0.0 111.544 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.69 130.01 93.2 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.068 0.547 . . . . 0.0 111.106 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.05 -34.52 68.15 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.794 2.329 . . . . 0.0 113.607 167.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.46 -38.08 86.54 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.448 -0.783 . . . . 0.0 112.56 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.98 -44.29 97.58 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.753 0.706 . . . . 0.0 111.362 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.45 -44.42 94.56 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.277 0.49 . . . . 0.0 112.275 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.17 -47.28 85.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.162 0.585 . . . . 0.0 111.386 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.17 95.87 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.611 0.764 . . . . 0.0 111.856 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -60.14 -47.46 85.82 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.809 0.843 . . . . 0.0 112.748 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.8 -54.16 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.426 0.557 . . . . 0.0 110.384 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.8 -37.47 79.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.297 1.039 . . . . 0.0 113.207 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.87 -52.08 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.962 1.305 . . . . 0.0 111.281 170.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.58 -35.81 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.414 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.84 -23.51 60.72 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.72 -25.6 11.21 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -135.78 16.36 3.32 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -166.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.12 -38.35 2.38 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -175.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -118.01 14.08 14.04 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.49 1.116 . . . . 0.0 113.024 -171.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 p -113.13 152.91 45.43 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.997 0.919 . . . . 0.0 111.523 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.83 -30.95 59.87 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.296 2.664 . . . . 0.0 115.214 -172.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.08 -20.94 64.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.59 -32.17 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.413 1.006 . . . . 0.0 112.485 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.37 -57.16 5.98 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.715 1.206 . . . . 0.0 112.555 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.87 -29.43 58.45 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 121.833 1.69 . . . . 0.0 112.809 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.3 -40.1 77.91 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.841 1.2 . . . . 0.0 112.703 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.12 -47.05 82.06 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.885 0.766 . . . . 0.0 111.537 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -60.88 -44.17 97.46 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.84 -31.66 71.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.178 0.991 . . . . 0.0 113.261 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.76 4.59 52.79 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.362 1.465 . . . . 0.0 113.514 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.5 p -133.12 22.86 4.13 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.59 120.34 6.04 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.47 -1.394 . . . . 0.0 111.472 168.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.49 11.69 60.08 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.371 0.909 . . . . 0.0 115.371 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.87 47.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.565 1.683 . . . . 0.0 112.481 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.0 p -73.32 159.67 84.36 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.732 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.57 -35.43 37.32 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.144 1.896 . . . . 0.0 115.406 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.0 -40.34 87.33 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.28 -45.3 93.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.627 -0.671 . . . . 0.0 111.1 172.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.62 -44.23 94.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.343 1.057 . . . . 0.0 112.085 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.3 -41.31 88.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.649 0.659 . . . . 0.0 112.02 171.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.27 -45.41 93.42 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.611 0.642 . . . . 0.0 111.071 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.37 -48.66 78.44 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.192 0.906 . . . . 0.0 112.151 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.1 mt -63.23 -38.36 90.85 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.03 -34.36 71.82 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.627 -0.671 . . . . 0.0 112.776 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.2 p -72.4 -13.39 61.45 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 m -118.19 11.16 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.367 1.067 . . . . 0.0 113.391 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.75 -10.59 4.74 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 117.141 1.616 . . . . 0.0 117.141 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.85 9.5 2.78 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 125.811 1.672 . . . . 0.0 117.009 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -127.85 79.11 1.87 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.232 1.516 . . . . 0.0 110.0 162.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -52.17 -36.0 50.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -171.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.87 -40.9 75.44 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.127 1.331 . . . . 0.0 112.147 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.58 83.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.298 0.639 . . . . 0.0 111.351 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.0 tpp -62.88 -40.3 97.09 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.531 -0.73 . . . . 0.0 112.281 175.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.02 -50.0 74.06 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.267 1.027 . . . . 0.0 111.544 173.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.8 tpp -56.04 -45.45 79.19 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.098 0.959 . . . . 0.0 112.184 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.87 -48.82 78.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.337 0.655 . . . . 0.0 112.017 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.67 -38.31 90.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.905 0.882 . . . . 0.0 112.49 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -60.0 -45.44 92.74 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.689 0.677 . . . . 0.0 112.048 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.64 -42.36 99.56 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.827 0.739 . . . . 0.0 112.118 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.86 -46.11 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.472 -0.768 . . . . 0.0 111.03 174.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.11 -39.43 94.02 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.869 0.759 . . . . 0.0 112.738 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.85 -47.42 86.43 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.758 0.823 . . . . 0.0 111.892 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.09 -34.38 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.47 91.54 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.484 -0.76 . . . . 0.0 112.327 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.11 98.64 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.256 0.622 . . . . 0.0 111.781 172.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.12 -42.22 99.49 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.872 -0.517 . . . . 0.0 112.191 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.71 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.05 -30.24 71.44 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -39.1 78.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.397 1.079 . . . . 0.0 112.45 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.79 60.98 53.75 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.91 120.14 7.42 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.424 2.083 . . . . 0.0 110.315 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.35 136.29 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.332 1.453 . . . . 0.0 112.129 -169.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -80.01 160.47 25.86 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.054 0.541 . . . . 0.0 110.915 168.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.92 65.01 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.11 1.338 . . . . 0.0 112.686 174.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.6 169.19 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.658 2.905 . . . . 0.0 112.889 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.66 -39.2 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.904 1.282 . . . . 0.0 111.753 -175.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.61 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 110.585 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.89 133.38 22.73 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.487 2.791 . . . . 0.0 113.15 168.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.94 -15.04 60.29 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.567 1.08 . . . . 0.0 115.001 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.992 1.396 . . . . 0.0 110.198 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.22 145.58 54.16 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.691 -0.631 . . . . 0.0 110.793 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.54 152.82 44.85 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.655 0.782 . . . . 0.0 111.67 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.27 131.65 84.85 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.29 140.41 44.36 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.11 1.873 . . . . 0.0 112.442 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -75.18 171.62 13.84 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.697 1.599 . . . . 0.0 111.893 163.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.83 94.0 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.971 -0.455 . . . . 0.0 113.03 168.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.85 -25.75 64.8 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.66 64.9 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.03 -1.044 . . . . 0.0 111.779 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.59 -42.76 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 110.82 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.26 14.03 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.16 74.31 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.927 -1.108 . . . . 0.0 115.447 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.34 -19.39 19.27 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.074 1.437 . . . . 0.0 113.284 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.2 p -126.18 -1.44 7.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.71 149.96 24.49 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.036 0.935 . . . . 0.0 111.788 173.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.2 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.282 0.563 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.86 -39.37 74.17 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.451 -0.781 . . . . 0.0 111.394 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.49 -38.98 93.21 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.554 -0.716 . . . . 0.0 112.701 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.82 95.52 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.58 -46.44 90.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.636 0.774 . . . . 0.0 112.142 176.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.43 -46.36 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.158 0.983 . . . . 0.0 110.304 172.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.04 54.4 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.81 0.719 . . . . 0.0 112.93 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.79 0.795 . . . . 0.0 112.485 174.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.9 8.32 20.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.66 1.184 . . . . 0.0 113.033 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.39 162.29 1.59 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.041 1.336 . . . . 0.0 111.39 165.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.36 48.92 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.042 0.937 . . . . 0.0 110.758 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.09 163.83 89.17 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.509 0.86 . . . . 0.0 111.746 -6.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -49.98 141.36 29.67 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.253 2.635 . . . . 0.0 114.117 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.2 96.42 2.49 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -85.96 54.56 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.27 2.647 . . . . 0.0 112.86 -152.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.78 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.19 94.34 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.61 0.641 . . . . 0.0 113.011 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.87 -36.87 75.83 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.326 -1.102 . . . . 0.0 112.634 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.94 -44.56 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.808 -0.557 . . . . 0.0 109.949 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.36 91.58 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.303 -0.873 . . . . 0.0 112.557 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.85 -42.07 75.26 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.472 -0.767 . . . . 0.0 112.217 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -56.59 -45.26 81.49 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 112.087 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.39 -40.41 85.66 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.248 0.619 . . . . 0.0 112.286 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.73 -46.97 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.093 0.557 . . . . 0.0 110.286 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.38 -37.27 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.648 1.179 . . . . 0.0 112.32 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.85 -42.8 98.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.036 0.835 . . . . 0.0 111.176 171.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.24 91.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.878 0.751 . . . . 0.0 113.181 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.48 -42.21 87.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.035 0.918 . . . . 0.0 111.113 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.24 70.44 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.774 0.83 . . . . 0.0 112.399 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.83 -43.06 76.62 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.884 0.765 . . . . 0.0 112.027 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.64 -47.96 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.371 0.668 . . . . 0.0 111.451 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.46 -32.83 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 119.894 1.225 . . . . 0.0 112.895 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.11 -43.85 95.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.867 0.867 . . . . 0.0 111.512 171.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.6 ttp -76.99 -36.27 56.54 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.644 1.577 . . . . 0.0 113.606 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.255 1.375 0 C-N-CA 128.35 2.66 . . . . 0.0 114.599 -172.764 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.75 134.99 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.501 1.121 . . . . 0.0 108.436 163.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.98 154.96 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.114 1.366 . . . . 0.0 109.665 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.7 116.69 32.48 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.555 0.742 . . . . 0.0 109.222 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.46 178.07 6.89 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.604 0.716 . . . . 0.0 112.46 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.87 -26.57 68.84 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.08 57.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.746 1.219 . . . . 0.0 113.002 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.0 85.78 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.487 1.042 . . . . 0.0 114.091 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.75 128.29 35.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.858 1.329 . . . . 0.0 109.714 174.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.86 125.64 29.65 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 168.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.9 t -126.04 123.28 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.103 1.361 . . . . 0.0 108.712 -174.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.53 139.71 38.62 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.15 48.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.465 1.906 . . . . 0.0 107.922 169.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.34 20.89 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.015 0.825 . . . . 0.0 111.233 170.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.57 136.88 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.607 -0.683 . . . . 0.0 111.579 176.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.63 130.02 93.27 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.112 0.565 . . . . 0.0 111.139 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.04 -34.54 68.22 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.864 2.376 . . . . 0.0 113.607 167.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.44 -38.03 86.47 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.463 -0.773 . . . . 0.0 112.588 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 m -60.93 -44.33 97.38 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.722 0.692 . . . . 0.0 111.401 171.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.53 -44.17 95.02 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.3 -47.29 85.96 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.167 0.587 . . . . 0.0 111.416 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.13 95.91 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.626 0.77 . . . . 0.0 111.897 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -60.21 -47.26 86.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.86 0.864 . . . . 0.0 112.73 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.51 -54.95 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 118.471 0.578 . . . . 0.0 110.345 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.48 -37.3 77.87 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.272 1.029 . . . . 0.0 113.178 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.47 -52.16 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.028 1.331 . . . . 0.0 111.29 170.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.68 -36.02 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 119.016 -0.516 . . . . 0.0 111.452 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -58.53 -24.17 59.96 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.04 -25.81 11.43 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.91 15.97 3.31 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -165.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.08 -38.92 2.54 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -116.62 13.73 15.3 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.379 1.072 . . . . 0.0 113.154 -172.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.1 p -112.87 152.95 45.27 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 123.941 0.897 . . . . 0.0 111.544 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.82 -30.77 58.93 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.299 2.666 . . . . 0.0 115.233 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.02 -20.74 64.24 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.8 -31.86 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.435 1.016 . . . . 0.0 112.548 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.45 -55.05 6.24 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.907 1.283 . . . . 0.0 112.956 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.83 -30.12 49.72 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.688 1.639 . . . . 0.0 112.661 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.07 -40.22 78.61 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.86 1.209 . . . . 0.0 112.64 172.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -57.27 -46.49 83.04 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.719 0.69 . . . . 0.0 111.579 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -61.04 -44.48 97.33 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.07 71.51 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.341 1.056 . . . . 0.0 113.225 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.23 4.44 53.53 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.4 1.48 . . . . 0.0 113.522 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.9 p -133.03 22.82 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.61 120.27 5.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.44 -1.413 . . . . 0.0 111.484 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.59 11.6 60.19 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.422 0.929 . . . . 0.0 115.422 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.51 130.87 47.09 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.525 1.663 . . . . 0.0 112.498 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.35 159.68 84.3 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.758 0.823 . . . . 0.0 110.697 167.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.65 -35.41 37.95 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.204 1.936 . . . . 0.0 115.366 168.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.0 -40.27 87.29 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.33 -45.31 93.88 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.596 -0.69 . . . . 0.0 111.044 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.6 -44.21 94.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.318 1.047 . . . . 0.0 112.175 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -59.24 -41.48 88.82 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.649 -0.657 . . . . 0.0 111.973 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.2 m -60.23 -45.28 93.77 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.614 0.643 . . . . 0.0 111.11 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -57.33 -49.01 77.48 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.246 0.93 . . . . 0.0 112.193 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.02 -38.54 91.59 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.87 -33.22 70.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.9 p -73.68 -13.37 60.97 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.6 m -122.45 6.2 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.5 -4.36 6.65 Favored Glycine 0 CA--C 1.541 1.67 0 N-CA-C 117.243 1.657 . . . . 0.0 117.243 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.75 -35.28 57.61 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 119.179 1.489 . . . . 0.0 115.177 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -86.18 77.95 9.47 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.838 1.304 . . . . 0.0 110.551 170.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.95 -35.91 35.96 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.36 -41.18 73.47 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.047 1.294 . . . . 0.0 112.301 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.36 -43.55 85.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.137 0.575 . . . . 0.0 111.33 173.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 59.8 tpp -63.25 -39.96 96.08 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.47 -0.769 . . . . 0.0 112.223 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -50.0 73.98 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.079 -1.013 . . . . 0.0 111.521 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -56.0 -45.43 79.04 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.88 -48.81 78.85 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.314 0.646 . . . . 0.0 112.055 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.7 -38.21 90.26 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.835 0.854 . . . . 0.0 112.448 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.99 -45.53 92.42 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.664 0.665 . . . . 0.0 112.027 170.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -62.64 -42.37 99.55 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.149 175.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.86 -46.1 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.47 -0.769 . . . . 0.0 111.059 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.08 -39.46 94.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.831 0.741 . . . . 0.0 112.736 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.82 -47.4 86.51 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.958 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.1 -34.32 72.97 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.584 -0.697 . . . . 0.0 112.835 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.92 -41.47 91.35 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.441 -0.787 . . . . 0.0 112.307 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.12 98.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.238 0.615 . . . . 0.0 111.772 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.09 -42.28 99.58 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.915 -0.491 . . . . 0.0 112.138 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -57.8 -48.58 79.32 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.661 0.664 . . . . 0.0 111.71 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.06 -30.24 71.44 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.2 -39.13 78.84 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.391 1.076 . . . . 0.0 112.48 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.26 -27.6 42.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.812 1.245 . . . . 0.0 113.302 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.8 61.02 54.01 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.668 1.987 . . . . 0.0 111.228 -174.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.9 120.13 7.4 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.507 2.138 . . . . 0.0 110.285 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.45 136.23 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.298 1.439 . . . . 0.0 112.121 -169.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -79.85 160.43 26.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.087 0.555 . . . . 0.0 110.915 168.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.27 -19.97 65.05 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.74 41.58 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.048 1.309 . . . . 0.0 112.64 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.58 169.23 14.72 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.611 2.874 . . . . 0.0 112.882 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.66 -39.22 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.925 1.29 . . . . 0.0 111.806 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.62 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.884 1.674 . . . . 0.0 110.631 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.91 133.41 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.456 2.77 . . . . 0.0 113.116 168.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.05 60.34 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 115.005 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.1 143.42 37.36 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.006 1.403 . . . . 0.0 110.185 173.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.2 145.56 54.2 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.721 -0.612 . . . . 0.0 110.842 168.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.49 152.73 44.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.748 0.819 . . . . 0.0 111.666 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -72.26 131.72 84.81 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.808 170.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.33 140.41 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -75.2 171.66 13.77 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.697 1.599 . . . . 0.0 111.889 163.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.5 -43.94 93.9 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.934 -0.479 . . . . 0.0 113.03 168.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.81 -25.73 64.83 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.78 -41.63 64.8 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.05 -1.032 . . . . 0.0 111.728 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.77 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.77 0.828 . . . . 0.0 110.771 173.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.26 13.94 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.2 74.23 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.596 1.093 . . . . 0.0 115.449 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.43 19.26 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.157 1.478 . . . . 0.0 113.283 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.19 -1.42 7.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.74 149.84 24.62 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.082 0.953 . . . . 0.0 111.799 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.5 p -81.78 162.32 22.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.291 0.567 . . . . 0.0 110.779 170.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.74 -39.38 73.85 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.448 -0.783 . . . . 0.0 111.445 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.54 -38.98 93.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.554 -0.716 . . . . 0.0 112.685 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.77 95.55 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.68 -46.35 90.69 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.119 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.33 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 110.268 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.04 54.46 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.795 0.712 . . . . 0.0 112.92 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.29 -50.05 73.22 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.812 0.806 . . . . 0.0 112.537 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.48 64.29 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.87 8.36 20.4 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.703 1.201 . . . . 0.0 113.051 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.5 162.33 1.64 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.991 1.316 . . . . 0.0 111.399 165.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.35 48.98 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.066 0.946 . . . . 0.0 110.813 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.82 89.2 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-N 119.429 0.832 . . . . 0.0 111.69 -6.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.94 141.39 29.27 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.187 2.591 . . . . 0.0 114.171 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.23 96.49 2.54 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 163.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.05 54.62 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.214 2.61 . . . . 0.0 112.83 -152.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.81 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.17 94.4 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.638 0.654 . . . . 0.0 113.011 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.89 -36.84 75.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.296 -1.12 . . . . 0.0 112.634 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.8 mt -62.95 -44.62 99.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.799 -0.563 . . . . 0.0 109.914 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.87 -40.35 91.57 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.327 -0.858 . . . . 0.0 112.521 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -55.86 -42.04 75.25 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.439 -0.788 . . . . 0.0 112.246 173.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.72 -45.23 82.04 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.924 0.784 . . . . 0.0 112.125 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.26 -40.57 86.22 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.294 0.638 . . . . 0.0 112.244 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.57 -47.33 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.23 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.98 -37.36 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.695 1.198 . . . . 0.0 112.301 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.84 -42.77 98.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.039 0.836 . . . . 0.0 111.217 171.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.62 -44.98 91.71 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 123.855 0.74 . . . . 0.0 113.214 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.35 -42.57 87.17 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.007 0.903 . . . . 0.0 110.992 173.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.24 70.37 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.807 0.843 . . . . 0.0 112.483 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.82 -43.28 76.81 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.88 0.764 . . . . 0.0 111.961 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.52 -47.8 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.334 0.654 . . . . 0.0 111.418 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.93 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 119.911 1.232 . . . . 0.0 112.893 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -60.36 -44.86 95.18 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.949 0.9 . . . . 0.0 111.428 171.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.4 ttp -74.89 -35.72 62.25 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.683 1.593 . . . . 0.0 113.422 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.0 t80 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 128.341 2.656 . . . . 0.0 114.546 -173.291 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.042 0.362 . . . . 0.0 113.042 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.97 135.05 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.468 1.107 . . . . 0.0 108.466 163.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.06 154.71 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.662 170.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.4 116.65 32.5 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.534 0.734 . . . . 0.0 109.17 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.41 177.97 6.93 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.557 0.694 . . . . 0.0 112.474 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.55 68.79 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.67 -2.1 57.85 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.798 1.239 . . . . 0.0 113.001 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.12 85.87 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.454 1.026 . . . . 0.0 114.133 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.75 128.17 35.24 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.826 1.313 . . . . 0.0 109.695 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.85 125.5 29.43 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.89 123.39 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.077 1.351 . . . . 0.0 108.674 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.56 139.71 38.58 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.1 48.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.4 20.87 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.988 0.813 . . . . 0.0 111.217 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.53 136.86 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.644 -0.66 . . . . 0.0 111.544 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.68 130.0 93.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.11 0.564 . . . . 0.0 111.137 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.99 -34.6 67.98 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.894 2.396 . . . . 0.0 113.602 167.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -66.44 -38.03 86.49 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.425 -0.797 . . . . 0.0 112.56 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -61.04 -44.26 97.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.747 0.703 . . . . 0.0 111.337 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.54 -44.42 94.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.302 0.501 . . . . 0.0 112.256 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.12 -47.18 86.21 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.121 0.569 . . . . 0.0 111.396 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.19 95.75 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.667 0.787 . . . . 0.0 111.874 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.28 -46.95 88.04 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.779 0.831 . . . . 0.0 112.811 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.8 t -56.9 -54.26 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.4 0.546 . . . . 0.0 110.368 174.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.77 -37.17 78.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.412 1.085 . . . . 0.0 113.287 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.41 -52.35 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.206 1.402 . . . . 0.0 111.209 170.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.96 -36.06 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.958 0.503 . . . . 0.0 111.405 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.48 -24.0 59.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.48 -25.33 11.44 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.23 15.83 3.23 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -165.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.9 -37.07 2.67 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -117.88 13.84 14.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.385 1.074 . . . . 0.0 113.151 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.0 p -113.11 153.11 45.46 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.968 0.907 . . . . 0.0 111.474 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.86 -30.87 59.77 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.25 2.633 . . . . 0.0 115.185 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.11 -20.99 64.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.52 -32.24 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.396 0.998 . . . . 0.0 112.452 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.36 -57.16 6.0 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.726 1.21 . . . . 0.0 112.578 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.88 -29.46 58.31 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.928 1.724 . . . . 0.0 112.764 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.29 -40.09 77.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.866 1.212 . . . . 0.0 112.661 172.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -57.2 -46.98 82.39 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.873 0.76 . . . . 0.0 111.555 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.2 m -60.86 -44.26 97.26 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.65 70.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.248 1.019 . . . . 0.0 113.251 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.85 4.59 52.7 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.436 1.494 . . . . 0.0 113.528 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.9 p -133.13 22.85 4.13 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -176.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.56 120.28 5.96 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.501 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.54 60.17 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.377 0.911 . . . . 0.0 115.377 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 130.82 46.9 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.565 1.682 . . . . 0.0 112.53 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.28 159.71 84.31 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.699 167.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.6 -35.46 37.64 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.209 1.94 . . . . 0.0 115.39 168.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.98 -40.25 87.39 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.45 -45.22 94.48 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.569 -0.707 . . . . 0.0 111.055 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.62 -44.21 94.61 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.307 1.043 . . . . 0.0 112.115 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -59.25 -41.47 88.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.649 0.659 . . . . 0.0 111.965 171.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.9 m -60.25 -45.22 94.03 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.601 0.637 . . . . 0.0 111.066 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.46 -48.88 77.99 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.196 0.907 . . . . 0.0 112.174 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -63.07 -38.34 90.8 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.99 -33.33 70.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.3 p -73.58 -12.72 60.85 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -122.43 7.21 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -174.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.42 -4.06 8.36 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 117.413 1.725 . . . . 0.0 117.413 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.71 -35.2 66.46 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.394 1.597 . . . . 0.0 115.17 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -85.94 77.81 9.61 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.006 1.384 . . . . 0.0 110.537 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.71 -35.55 31.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.663 1.585 . . . . 0.0 115.223 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.48 -41.32 72.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.129 1.331 . . . . 0.0 112.332 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.63 85.94 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.776 -0.577 . . . . 0.0 111.348 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.15 -39.97 96.22 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.548 -0.72 . . . . 0.0 112.22 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.98 -49.97 74.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.223 1.009 . . . . 0.0 111.569 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.96 -45.44 78.87 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 0.0 112.212 174.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.6 tp -61.92 -48.77 78.98 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.344 0.657 . . . . 0.0 112.071 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.71 -38.27 90.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.873 0.869 . . . . 0.0 112.488 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.96 -45.58 92.19 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.684 0.675 . . . . 0.0 111.966 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.2 m -62.54 -42.46 99.54 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.828 0.74 . . . . 0.0 112.155 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.6 mt -58.8 -46.1 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.453 -0.78 . . . . 0.0 111.093 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.36 93.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.847 0.749 . . . . 0.0 112.759 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.93 -47.42 86.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.756 0.822 . . . . 0.0 111.908 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.12 -34.3 72.92 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.72 -41.73 91.91 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.447 -0.783 . . . . 0.0 112.328 172.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -41.98 98.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.139 0.576 . . . . 0.0 111.817 172.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.17 -42.26 99.37 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.918 -0.489 . . . . 0.0 112.163 174.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.8 -48.47 79.62 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.68 0.673 . . . . 0.0 111.694 173.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -63.13 -30.34 71.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.06 -39.09 79.31 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.342 1.057 . . . . 0.0 112.482 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.32 -27.57 42.13 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.796 1.239 . . . . 0.0 113.325 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.74 60.97 53.77 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.653 1.981 . . . . 0.0 111.274 -174.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.86 120.13 7.41 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.483 2.122 . . . . 0.0 110.323 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.294 1.438 . . . . 0.0 112.115 -169.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -80.2 160.52 25.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.07 0.548 . . . . 0.0 110.857 168.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.19 -20.02 65.03 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.7 41.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.096 1.332 . . . . 0.0 112.631 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.52 169.2 14.66 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.624 2.883 . . . . 0.0 112.917 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.66 -39.19 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.874 1.27 . . . . 0.0 111.791 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.94 28.52 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.93 133.38 22.92 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.441 2.761 . . . . 0.0 113.163 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -14.95 60.55 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.648 1.118 . . . . 0.0 115.042 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.38 37.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.952 1.376 . . . . 0.0 110.198 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.64 54.14 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.726 -0.608 . . . . 0.0 110.793 168.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -68.64 152.77 44.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.648 0.779 . . . . 0.0 111.618 171.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.26 131.72 84.81 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-O 118.888 -0.577 . . . . 0.0 109.831 170.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.4 140.32 43.71 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.063 1.842 . . . . 0.0 112.442 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -74.94 171.61 13.76 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.8 1.64 . . . . 0.0 111.817 163.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.61 -43.86 94.12 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.913 -0.492 . . . . 0.0 112.979 168.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.75 -25.88 64.96 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.71 -41.53 65.13 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.076 -1.015 . . . . 0.0 111.778 171.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.73 -42.63 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.719 0.807 . . . . 0.0 110.812 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.02 -1.29 14.12 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.03 18.13 74.33 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.929 -1.107 . . . . 0.0 115.445 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.25 -19.42 19.31 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.073 1.436 . . . . 0.0 113.289 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.2 -1.58 7.02 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.57 150.04 24.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.067 0.947 . . . . 0.0 111.773 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.4 p -81.95 162.44 22.7 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.321 0.582 . . . . 0.0 110.797 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.88 -39.36 74.23 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.414 -0.804 . . . . 0.0 111.445 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.62 -38.84 92.65 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.557 -0.715 . . . . 0.0 112.635 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -64.62 -42.8 95.27 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.628 -0.67 . . . . 0.0 112.033 171.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.61 -46.46 90.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.648 0.779 . . . . 0.0 112.097 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.38 -46.39 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.142 0.977 . . . . 0.0 110.317 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.42 -51.01 54.42 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.806 0.717 . . . . 0.0 112.945 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.3 -50.09 73.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.751 0.776 . . . . 0.0 112.48 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.0 p -111.93 8.43 20.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.637 1.175 . . . . 0.0 113.027 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.46 162.34 1.61 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.939 1.295 . . . . 0.0 111.434 165.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.63 103.35 48.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.054 0.942 . . . . 0.0 110.758 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.79 89.26 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.451 0.84 . . . . 0.0 111.701 -6.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -49.98 141.37 29.62 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.176 2.584 . . . . 0.0 114.168 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.12 96.53 2.51 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -86.03 54.54 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.232 2.621 . . . . 0.0 112.882 -152.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.54 -34.86 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.46 -46.2 94.31 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.605 0.639 . . . . 0.0 112.947 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.86 -36.9 75.9 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.259 -1.142 . . . . 0.0 112.645 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.88 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.785 -0.572 . . . . 0.0 109.98 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.44 91.68 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.356 -0.84 . . . . 0.0 112.576 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -55.78 -41.99 74.88 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.468 -0.77 . . . . 0.0 112.287 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.71 -45.24 81.98 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.888 0.767 . . . . 0.0 112.134 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.26 -40.59 86.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.308 0.643 . . . . 0.0 112.251 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.55 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.083 0.553 . . . . 0.0 110.261 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.13 -37.33 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.72 1.208 . . . . 0.0 112.322 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.82 98.32 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.047 0.84 . . . . 0.0 111.275 171.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.05 91.66 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.847 0.737 . . . . 0.0 113.242 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.4 -42.47 87.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.954 0.877 . . . . 0.0 111.032 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.48 -50.21 70.48 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.811 0.844 . . . . 0.0 112.45 173.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.79 -43.42 76.81 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 118.853 0.751 . . . . 0.0 111.956 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.43 -47.68 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.406 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.67 -32.89 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.992 1.269 . . . . 0.0 112.907 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -60.43 -45.36 93.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.899 0.88 . . . . 0.0 111.5 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.3 ttp -74.51 -38.24 62.88 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.597 1.559 . . . . 0.0 113.336 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.3 t80 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 128.483 2.713 . . . . 0.0 114.671 -172.571 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 N--CA 1.479 0.666 0 N-CA-C 112.965 0.333 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.22 134.86 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.46 1.104 . . . . 0.0 108.451 163.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.91 154.92 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.136 1.374 . . . . 0.0 109.665 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.67 116.72 32.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.48 0.712 . . . . 0.0 109.171 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.43 177.97 6.95 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.514 0.673 . . . . 0.0 112.511 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.87 -26.49 68.8 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.56 -2.24 57.94 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.825 1.25 . . . . 0.0 113.024 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.07 2.94 85.6 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.467 1.032 . . . . 0.0 114.142 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.74 128.29 35.73 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.815 1.308 . . . . 0.0 109.7 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.69 29.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.01 123.4 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.066 1.347 . . . . 0.0 108.648 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.68 139.68 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.572 0.701 . . . . 0.0 111.21 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.64 141.17 48.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.488 1.915 . . . . 0.0 107.922 169.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.17 152.31 20.77 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.977 0.808 . . . . 0.0 111.237 170.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.62 136.83 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.651 -0.656 . . . . 0.0 111.571 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.59 129.98 93.32 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.167 0.587 . . . . 0.0 111.157 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.07 -34.57 68.66 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.86 2.373 . . . . 0.0 113.543 167.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.39 -38.13 86.81 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.475 -0.765 . . . . 0.0 112.55 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.88 -44.4 97.12 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.728 0.695 . . . . 0.0 111.383 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.45 -44.42 94.55 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.251 0.478 . . . . 0.0 112.211 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.12 -47.25 85.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.087 0.555 . . . . 0.0 111.441 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.1 -45.19 95.73 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.633 0.773 . . . . 0.0 111.892 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -59.98 -47.53 85.43 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.806 0.842 . . . . 0.0 112.729 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.7 t -56.85 -54.13 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.408 0.549 . . . . 0.0 110.493 174.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.72 -37.36 78.68 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.344 1.058 . . . . 0.0 113.214 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -58.24 -52.11 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.917 1.287 . . . . 0.0 111.345 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.19 -35.98 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 122.948 0.499 . . . . 0.0 111.336 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.66 -23.45 59.25 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.98 -25.72 11.04 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -135.87 16.03 3.31 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.46 -37.83 2.57 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -117.86 14.56 14.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.374 1.07 . . . . 0.0 113.141 -172.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.5 p -113.64 152.95 45.89 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.008 0.923 . . . . 0.0 111.513 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.85 -30.81 59.43 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.216 2.61 . . . . 0.0 115.249 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.06 -20.93 64.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.54 -32.19 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.424 1.011 . . . . 0.0 112.482 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.7 mt -70.36 -57.2 5.97 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.76 1.224 . . . . 0.0 112.561 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.81 -29.57 58.95 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.859 1.699 . . . . 0.0 112.793 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.25 -40.07 78.08 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.838 1.199 . . . . 0.0 112.733 172.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -57.15 -47.08 82.05 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.877 0.762 . . . . 0.0 111.507 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m -60.79 -44.24 97.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.65 71.05 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.233 1.013 . . . . 0.0 113.264 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.8 4.59 52.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.389 1.476 . . . . 0.0 113.514 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.7 p -133.1 22.79 4.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.54 120.23 5.87 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.49 -1.381 . . . . 0.0 111.491 168.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.64 11.59 60.3 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 115.367 0.907 . . . . 0.0 115.367 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.49 131.04 47.83 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.567 1.683 . . . . 0.0 112.487 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.7 p -73.47 159.81 83.85 Favored Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 123.667 0.787 . . . . 0.0 110.722 167.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.63 -35.35 37.62 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.161 1.908 . . . . 0.0 115.429 168.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.1 -40.24 86.89 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -60.26 -45.35 93.59 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.66 -0.65 . . . . 0.0 111.089 172.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.62 -44.27 94.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.328 1.051 . . . . 0.0 112.146 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -59.18 -41.43 88.44 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.672 -0.642 . . . . 0.0 112.03 171.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.6 m -60.25 -45.25 93.91 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.561 0.619 . . . . 0.0 111.059 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.47 -48.86 78.08 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.196 0.907 . . . . 0.0 112.16 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.18 -38.13 89.97 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.11 -32.82 70.18 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.3 p -74.14 -12.29 60.55 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.11 8.28 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.81 -3.78 11.77 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 117.446 1.739 . . . . 0.0 117.446 -175.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.32 -32.79 64.32 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 119.556 1.678 . . . . 0.0 115.279 -177.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -89.75 77.36 7.08 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 123.06 1.409 . . . . 0.0 110.481 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.33 -35.08 26.12 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.859 1.664 . . . . 0.0 115.416 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.9 -40.9 75.36 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 120.159 1.345 . . . . 0.0 112.312 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.64 -43.45 84.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.158 0.583 . . . . 0.0 111.366 173.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.14 -40.13 96.68 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.494 -0.754 . . . . 0.0 112.246 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.83 74.6 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.257 1.023 . . . . 0.0 111.541 173.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.04 -45.5 79.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.092 0.957 . . . . 0.0 112.189 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.3 tp -61.85 -48.77 79.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.332 0.653 . . . . 0.0 112.08 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.79 -38.18 90.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.861 0.865 . . . . 0.0 112.483 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.01 -45.52 92.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.664 0.665 . . . . 0.0 112.034 170.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.54 -42.47 99.55 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.792 0.724 . . . . 0.0 112.105 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.81 -46.14 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.491 -0.755 . . . . 0.0 111.077 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.1 -39.45 94.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.819 0.736 . . . . 0.0 112.717 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -60.83 -47.36 86.69 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.77 0.828 . . . . 0.0 111.98 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.17 -34.3 72.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.56 91.79 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.451 -0.781 . . . . 0.0 112.371 172.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.04 98.56 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.202 0.601 . . . . 0.0 111.832 172.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.09 -42.27 99.57 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.905 -0.497 . . . . 0.0 112.221 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.8 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.615 0.643 . . . . 0.0 111.649 173.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.03 -30.31 71.5 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.14 -39.1 79.05 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.324 1.05 . . . . 0.0 112.52 173.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.17 -27.66 42.67 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.785 1.234 . . . . 0.0 113.307 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -132.78 61.03 54.11 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.646 1.978 . . . . 0.0 111.276 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.92 120.16 7.44 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.48 2.12 . . . . 0.0 110.277 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.23 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.363 1.465 . . . . 0.0 112.151 -169.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.98 160.37 25.94 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.13 0.572 . . . . 0.0 110.861 168.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.15 -20.03 65.02 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 174.77 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.048 1.309 . . . . 0.0 112.656 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.55 169.17 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.66 2.907 . . . . 0.0 112.93 177.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.62 -39.2 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.867 1.267 . . . . 0.0 111.841 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.62 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.884 1.674 . . . . 0.0 110.631 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.91 133.41 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.456 2.77 . . . . 0.0 113.116 168.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.99 -15.04 60.37 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.562 1.077 . . . . 0.0 115.013 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -78.09 143.41 37.39 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.928 1.364 . . . . 0.0 110.218 173.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.51 54.2 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.726 -0.608 . . . . 0.0 110.826 168.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -68.55 152.89 44.74 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.694 0.798 . . . . 0.0 111.669 171.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -72.3 131.69 84.77 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.917 -0.563 . . . . 0.0 109.858 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.33 140.41 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -75.19 171.67 13.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.72 1.608 . . . . 0.0 111.862 163.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.51 -43.93 93.93 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.968 -0.458 . . . . 0.0 113.006 168.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.83 -25.77 64.83 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.67 -41.65 65.13 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.064 -1.022 . . . . 0.0 111.765 171.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.65 -42.72 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.712 0.805 . . . . 0.0 110.801 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.3 14.11 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.13 74.17 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.626 1.107 . . . . 0.0 115.458 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.6 p -96.22 -19.43 19.33 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.09 1.445 . . . . 0.0 113.255 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.2 p -126.16 -1.5 7.05 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.4 p -103.64 149.8 24.6 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.034 0.934 . . . . 0.0 111.778 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.1 p -81.68 162.34 23.06 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.341 0.591 . . . . 0.0 110.775 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.72 -39.44 73.91 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.448 -0.783 . . . . 0.0 111.429 169.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.51 -39.01 93.32 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.531 -0.731 . . . . 0.0 112.636 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -64.6 -42.65 95.42 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.72 -46.42 90.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.652 0.781 . . . . 0.0 112.119 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.42 -46.35 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.12 0.968 . . . . 0.0 110.301 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.07 54.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.806 0.717 . . . . 0.0 112.889 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.24 -50.09 73.12 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.831 0.816 . . . . 0.0 112.48 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.2 mtp -68.62 -18.52 64.32 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.92 8.41 20.33 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.665 1.186 . . . . 0.0 113.072 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.42 162.3 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.971 1.309 . . . . 0.0 111.461 165.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.32 48.97 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.15 163.8 89.21 Favored 'Cis proline' 0 CA--C 1.544 1.021 0 CA-C-N 119.466 0.845 . . . . 0.0 111.735 -6.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -49.93 141.34 29.28 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.184 2.59 . . . . 0.0 114.207 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.21 96.44 2.51 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 163.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.97 54.67 3.51 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.65 -34.84 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.24 94.25 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 118.656 0.662 . . . . 0.0 112.991 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -69.73 -36.98 76.32 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.281 -1.129 . . . . 0.0 112.609 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.93 -44.6 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.762 -0.586 . . . . 0.0 109.949 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.85 -40.37 91.64 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.352 -0.842 . . . . 0.0 112.543 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.04 75.12 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.455 -0.778 . . . . 0.0 112.243 173.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -56.7 -45.17 81.99 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.933 0.788 . . . . 0.0 112.098 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.33 -40.55 85.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.29 0.636 . . . . 0.0 112.251 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.69 -46.94 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.062 0.545 . . . . 0.0 110.321 174.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.34 -37.31 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.688 1.195 . . . . 0.0 112.314 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.81 98.3 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.019 0.827 . . . . 0.0 111.223 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.11 91.4 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.796 0.712 . . . . 0.0 113.265 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.49 -42.24 87.15 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.01 0.905 . . . . 0.0 111.092 173.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.39 -50.25 70.22 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.766 0.826 . . . . 0.0 112.461 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.93 -43.1 77.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.823 0.738 . . . . 0.0 112.011 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.44 -48.13 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.721 -0.656 . . . . 0.0 111.372 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -69.38 -32.83 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 119.973 1.261 . . . . 0.0 112.89 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.95 -42.79 94.8 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.931 0.892 . . . . 0.0 111.552 171.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.0 ttp -79.02 -35.65 42.4 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.718 1.607 . . . . 0.0 113.704 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 t80 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 128.383 2.673 . . . . 0.0 114.513 -172.013 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.656 0 N-CA-C 112.952 0.328 . . . . 0.0 112.952 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.89 135.17 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.48 1.112 . . . . 0.0 108.438 163.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.12 154.89 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.113 1.365 . . . . 0.0 109.698 170.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.62 116.71 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.522 0.729 . . . . 0.0 109.128 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -76.57 177.73 7.23 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.604 0.716 . . . . 0.0 112.408 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.53 -26.53 68.61 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -173.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -85.64 -2.22 57.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.76 1.224 . . . . 0.0 113.037 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.99 3.13 85.65 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.53 1.062 . . . . 0.0 114.049 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.71 128.19 35.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.877 1.338 . . . . 0.0 109.726 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.6 29.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.99 123.42 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.045 1.338 . . . . 0.0 108.674 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.56 139.65 38.59 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.52 0.676 . . . . 0.0 111.222 170.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.61 141.06 48.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.476 1.91 . . . . 0.0 107.909 169.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.18 152.34 20.76 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.974 0.806 . . . . 0.0 111.244 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.54 136.86 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.492 0.663 . . . . 0.0 111.575 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.68 129.96 93.23 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.112 0.565 . . . . 0.0 111.18 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -52.91 -34.69 67.57 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.865 2.377 . . . . 0.0 113.589 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -66.33 -38.14 86.99 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.419 -0.801 . . . . 0.0 112.572 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.91 -44.39 97.24 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.749 0.704 . . . . 0.0 111.359 171.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.43 -44.48 94.46 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.29 0.495 . . . . 0.0 112.275 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.05 -47.25 85.91 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.113 0.565 . . . . 0.0 111.42 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.99 96.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.614 0.766 . . . . 0.0 111.914 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -60.14 -47.47 85.77 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.828 0.851 . . . . 0.0 112.754 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.4 t -56.74 -54.15 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 118.392 0.542 . . . . 0.0 110.418 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.79 -37.38 78.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.3 1.04 . . . . 0.0 113.227 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.85 -52.09 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.035 1.334 . . . . 0.0 111.278 170.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.6 -35.96 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 122.99 0.516 . . . . 0.0 111.362 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -58.61 -23.43 58.85 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -108.06 -25.48 11.11 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -136.07 15.67 3.28 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -166.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.41 -37.53 2.37 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -117.73 14.45 14.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.436 1.095 . . . . 0.0 113.093 -172.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 p -113.92 152.96 46.14 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.078 0.951 . . . . 0.0 111.659 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.84 -31.17 60.96 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.287 2.658 . . . . 0.0 115.292 -172.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -61.69 -21.01 64.09 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.33 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.387 0.994 . . . . 0.0 112.472 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.33 -57.12 6.07 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.717 1.207 . . . . 0.0 112.633 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.78 -29.61 59.2 Favored 'Trans proline' 0 C--N 1.351 0.709 0 CA-C-N 121.901 1.715 . . . . 0.0 112.783 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.18 -40.21 78.25 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.809 1.186 . . . . 0.0 112.683 172.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -57.04 -46.85 82.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.836 0.744 . . . . 0.0 111.544 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -61.03 -44.43 97.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.368 0.667 . . . . 0.0 112.784 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.57 -31.64 70.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.242 1.017 . . . . 0.0 113.26 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.87 4.88 52.44 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.384 1.474 . . . . 0.0 113.523 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.8 p -133.46 22.8 4.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -53.41 120.36 5.97 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.468 -1.395 . . . . 0.0 111.48 168.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.4 11.6 59.71 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.46 130.84 47.01 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.517 1.659 . . . . 0.0 112.449 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.5 p -73.45 159.55 84.48 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 123.701 0.801 . . . . 0.0 110.65 167.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.58 -35.52 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.198 1.932 . . . . 0.0 115.388 168.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.84 -40.43 87.94 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -60.21 -45.31 93.62 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.64 -0.663 . . . . 0.0 111.049 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.58 -44.29 94.48 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.288 1.035 . . . . 0.0 112.164 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -59.19 -41.4 88.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.578 0.626 . . . . 0.0 112.05 171.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.3 m -60.24 -45.19 94.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.55 0.614 . . . . 0.0 111.161 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.41 -48.88 77.92 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.196 0.907 . . . . 0.0 112.185 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.6 mt -63.12 -38.46 91.28 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.78 -33.03 69.85 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.4 p -73.87 -12.47 60.68 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.34 7.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.02 -3.7 9.3 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 117.506 1.762 . . . . 0.0 117.506 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.98 -34.08 65.07 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 119.501 1.651 . . . . 0.0 115.226 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -88.27 77.45 8.22 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.062 1.411 . . . . 0.0 110.485 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -50.36 -35.3 27.36 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.826 1.65 . . . . 0.0 115.341 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.24 74.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.118 1.327 . . . . 0.0 112.249 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.39 -43.53 85.62 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.128 0.571 . . . . 0.0 111.35 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.07 -40.16 96.86 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.592 -0.692 . . . . 0.0 112.271 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.93 -50.12 73.54 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.262 1.025 . . . . 0.0 111.539 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -55.77 -45.4 78.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.067 0.947 . . . . 0.0 112.241 174.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.3 tp -61.98 -48.71 79.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.363 0.665 . . . . 0.0 112.064 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.73 -38.23 90.32 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.857 0.863 . . . . 0.0 112.514 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.12 -45.52 92.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.623 0.647 . . . . 0.0 112.058 170.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.62 -42.34 99.53 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.768 0.713 . . . . 0.0 112.186 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.83 -46.0 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.462 -0.774 . . . . 0.0 111.051 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.17 -39.55 94.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.776 0.716 . . . . 0.0 112.738 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -60.55 -47.66 85.21 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.739 0.816 . . . . 0.0 111.968 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -70.0 -34.33 73.19 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.75 -41.53 92.02 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.44 -0.787 . . . . 0.0 112.391 172.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.85 98.25 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.123 0.569 . . . . 0.0 111.781 172.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -63.58 -42.11 98.31 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.856 -0.528 . . . . 0.0 112.182 175.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.67 -48.51 79.3 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.564 0.62 . . . . 0.0 111.744 172.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.28 -30.07 71.28 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -69.28 -39.1 78.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.363 1.065 . . . . 0.0 112.432 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.2 -27.77 42.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.796 1.239 . . . . 0.0 113.337 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.62 61.03 54.4 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.635 1.974 . . . . 0.0 111.216 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.91 120.14 7.42 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.424 2.083 . . . . 0.0 110.315 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.44 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.292 1.437 . . . . 0.0 112.158 -169.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -80.1 160.39 25.78 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.174 0.59 . . . . 0.0 110.894 168.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.17 -19.88 64.9 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.11 174.7 41.71 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.048 1.309 . . . . 0.0 112.606 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.55 169.17 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.631 2.887 . . . . 0.0 112.906 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.69 -39.0 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.874 1.269 . . . . 0.0 111.785 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.71 161.83 28.75 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.888 1.675 . . . . 0.0 110.592 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.93 133.46 22.94 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.479 2.786 . . . . 0.0 113.098 168.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.89 -14.97 60.41 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.566 1.079 . . . . 0.0 115.062 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.2 143.45 37.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.95 1.375 . . . . 0.0 110.164 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.3 145.63 54.04 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.742 -0.599 . . . . 0.0 110.869 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -68.49 152.5 45.3 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.76 0.824 . . . . 0.0 111.615 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -72.25 131.64 84.91 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-O 118.898 -0.572 . . . . 0.0 109.814 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.49 140.23 43.17 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.062 1.841 . . . . 0.0 112.401 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -74.8 171.28 14.26 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.773 1.629 . . . . 0.0 111.891 163.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.46 -43.81 93.88 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 123.33 0.491 . . . . 0.0 113.035 168.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.3 p -68.71 -25.73 64.91 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -72.97 -41.44 64.38 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.034 -1.041 . . . . 0.0 111.78 172.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.69 -42.84 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.839 0.856 . . . . 0.0 110.761 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.82 -1.52 14.41 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 173.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.11 18.15 74.49 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.922 -1.111 . . . . 0.0 115.406 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.9 p -96.02 -19.31 19.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.067 1.433 . . . . 0.0 113.287 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.9 p -126.62 -1.69 6.75 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -103.25 150.38 23.78 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.164 0.986 . . . . 0.0 111.554 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.2 p -82.48 162.61 22.0 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.342 0.591 . . . . 0.0 110.781 169.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.6 tp -56.57 -39.54 73.66 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.501 -0.749 . . . . 0.0 111.541 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.45 -38.95 93.12 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.454 -0.779 . . . . 0.0 112.666 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -64.71 -42.69 95.09 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.612 -0.68 . . . . 0.0 111.988 171.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.58 -46.35 90.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.678 0.791 . . . . 0.0 112.097 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.64 -46.16 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.167 0.987 . . . . 0.0 110.312 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.62 -50.98 55.39 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.852 0.739 . . . . 0.0 112.876 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.35 -50.04 73.16 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 117.74 0.77 . . . . 0.0 112.532 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.6 64.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.1 p -111.83 8.32 20.44 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.677 1.191 . . . . 0.0 113.033 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.3 162.31 1.53 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.045 1.338 . . . . 0.0 111.451 165.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.64 103.32 48.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.046 0.938 . . . . 0.0 110.778 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.1 163.81 89.21 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.466 0.845 . . . . 0.0 111.713 -6.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -49.93 141.38 29.26 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.199 2.6 . . . . 0.0 114.186 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.25 96.42 2.51 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 163.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.02 54.59 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.255 2.637 . . . . 0.0 112.852 -152.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.52 -35.11 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -61.91 -46.57 93.85 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.595 0.634 . . . . 0.0 113.031 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -69.88 -36.69 75.66 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.281 -1.129 . . . . 0.0 112.636 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.3 mt -62.94 -44.66 99.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.757 -0.589 . . . . 0.0 109.902 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -65.81 -40.37 91.78 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.265 -0.897 . . . . 0.0 112.497 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -55.89 -42.04 75.37 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.472 -0.767 . . . . 0.0 112.232 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.7 -45.22 81.93 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.892 0.769 . . . . 0.0 112.134 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.25 -40.66 86.3 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.242 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.55 -47.05 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.041 0.536 . . . . 0.0 110.283 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.33 -37.27 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.672 1.189 . . . . 0.0 112.261 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.86 -42.76 98.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.027 0.83 . . . . 0.0 111.235 171.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.49 -45.26 90.84 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.863 0.744 . . . . 0.0 113.176 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.41 -42.34 86.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.039 0.919 . . . . 0.0 111.112 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -55.34 -50.2 70.26 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.815 0.846 . . . . 0.0 112.473 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -55.95 -43.16 77.19 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.865 0.757 . . . . 0.0 111.971 175.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.44 -48.06 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.338 0.655 . . . . 0.0 111.448 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.52 -32.69 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.916 1.235 . . . . 0.0 112.952 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.3 -43.91 95.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.901 0.88 . . . . 0.0 111.498 171.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.7 ttp -76.99 -37.1 55.8 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.66 1.584 . . . . 0.0 113.48 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 C--O 1.252 1.192 0 C-N-CA 128.377 2.671 . . . . 0.0 114.48 -172.057 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.82 135.0 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.467 1.107 . . . . 0.0 108.402 163.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.92 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.686 170.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.62 116.68 32.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.57 0.748 . . . . 0.0 109.18 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.47 178.07 6.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.58 0.705 . . . . 0.0 112.451 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.95 -26.45 68.83 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.59 -2.19 57.9 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.776 1.231 . . . . 0.0 113.0 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.02 85.69 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.76 128.28 35.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.823 1.311 . . . . 0.0 109.745 174.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.89 125.62 29.62 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.99 123.4 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.07 1.348 . . . . 0.0 108.629 -174.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.7 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.71 141.15 48.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.5 1.92 . . . . 0.0 107.929 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 21.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.998 0.817 . . . . 0.0 111.191 170.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.53 136.84 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.607 -0.683 . . . . 0.0 111.544 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.64 130.03 93.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.059 0.544 . . . . 0.0 111.169 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.09 -34.5 68.53 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.86 2.373 . . . . 0.0 113.575 167.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.53 -38.04 86.32 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.508 -0.745 . . . . 0.0 112.562 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.91 -44.31 97.34 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.767 0.712 . . . . 0.0 111.377 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.53 -44.33 94.55 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.328 0.513 . . . . 0.0 112.321 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.17 -47.33 85.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.136 0.574 . . . . 0.0 111.359 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.35 95.19 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.644 0.778 . . . . 0.0 111.883 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.7 t-105 -60.02 -47.42 85.93 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.855 0.862 . . . . 0.0 112.763 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.68 -55.0 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.465 0.575 . . . . 0.0 110.273 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.04 -37.82 77.89 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.396 1.079 . . . . 0.0 113.243 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.33 -51.9 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.031 1.332 . . . . 0.0 111.329 170.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.65 -35.88 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.435 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -58.98 -23.1 61.44 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.707 1.139 . . . . 0.0 114.038 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.73 -25.94 11.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -135.86 16.3 3.31 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -166.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.53 -37.68 2.57 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -118.25 14.73 13.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.392 1.077 . . . . 0.0 113.149 -172.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -113.93 152.94 46.13 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 111.566 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.85 -30.75 59.21 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.257 2.638 . . . . 0.0 115.276 -172.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.05 -20.67 64.2 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.82 -31.97 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.376 0.989 . . . . 0.0 112.528 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.1 mt -71.34 -55.08 6.35 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.943 1.297 . . . . 0.0 112.961 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.83 -30.12 49.72 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.688 1.639 . . . . 0.0 112.661 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.6 mtm -69.06 -40.22 78.64 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.86 1.209 . . . . 0.0 112.623 172.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.23 -46.53 82.87 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.816 0.735 . . . . 0.0 111.581 169.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.7 m -61.01 -44.52 97.3 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 175.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.82 -32.09 71.47 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.255 1.022 . . . . 0.0 113.207 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.29 4.44 53.47 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.39 1.476 . . . . 0.0 113.522 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.4 p -132.98 22.83 4.18 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.62 120.3 6.0 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.47 -1.394 . . . . 0.0 111.491 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.54 60.16 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.42 130.84 47.06 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.565 1.682 . . . . 0.0 112.499 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.39 159.69 84.21 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.714 0.806 . . . . 0.0 110.661 167.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.28 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -60.4 -45.29 94.11 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.663 -0.648 . . . . 0.0 111.025 172.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.51 -44.34 94.57 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 112.103 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -59.11 -41.58 88.5 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.635 0.652 . . . . 0.0 111.994 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.13 -45.31 93.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.594 0.633 . . . . 0.0 111.084 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.43 -48.81 78.15 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.209 0.913 . . . . 0.0 112.188 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.18 -38.27 90.53 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.98 -33.63 70.9 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -73.29 -12.76 60.96 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.15 9.21 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.23 -5.51 8.22 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 117.328 1.691 . . . . 0.0 117.328 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.36 -31.3 59.55 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 119.336 1.568 . . . . 0.0 115.563 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -93.61 78.12 4.32 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.003 1.402 . . . . 0.0 110.652 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.79 -35.78 33.68 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -173.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.05 -41.02 74.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.123 1.328 . . . . 0.0 112.246 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.5 -43.5 85.14 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.164 0.585 . . . . 0.0 111.371 173.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.7 tpp -63.06 -40.14 96.82 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.521 -0.737 . . . . 0.0 112.263 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.99 -49.93 74.24 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.235 1.014 . . . . 0.0 111.521 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.02 -45.47 79.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.091 0.956 . . . . 0.0 112.188 174.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -61.91 -48.72 79.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.277 0.631 . . . . 0.0 112.088 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.7 -38.28 90.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 0.0 112.479 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.99 -45.49 92.54 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 112.02 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.6 m -62.61 -42.38 99.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.848 0.749 . . . . 0.0 112.149 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.9 -46.04 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 121.472 -0.768 . . . . 0.0 111.097 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.49 94.13 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.876 0.762 . . . . 0.0 112.684 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -60.78 -47.39 86.53 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.741 0.816 . . . . 0.0 111.94 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.13 -34.35 72.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.53 91.62 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.484 -0.76 . . . . 0.0 112.322 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.11 98.61 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.224 0.61 . . . . 0.0 111.781 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.17 -42.11 99.33 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.84 -0.538 . . . . 0.0 112.207 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -57.88 -48.55 79.52 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.673 0.67 . . . . 0.0 111.694 173.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.01 -30.35 71.53 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.11 -39.06 79.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.354 1.062 . . . . 0.0 112.482 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.79 60.98 53.75 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.85 120.1 7.36 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.451 2.101 . . . . 0.0 110.341 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.29 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.351 1.461 . . . . 0.0 112.142 -169.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.0 160.47 25.88 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.053 0.541 . . . . 0.0 110.903 168.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.91 65.0 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.74 41.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.096 1.332 . . . . 0.0 112.631 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.56 169.2 14.73 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.601 2.867 . . . . 0.0 112.917 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.66 -39.2 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.904 1.282 . . . . 0.0 111.753 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.61 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 110.585 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -47.94 133.42 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.479 2.786 . . . . 0.0 113.106 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.93 -14.96 60.48 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.567 1.08 . . . . 0.0 115.037 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.13 143.32 37.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.95 1.375 . . . . 0.0 110.214 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.11 145.48 54.35 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.654 -0.654 . . . . 0.0 110.843 168.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.47 152.82 44.86 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.27 131.69 84.83 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.916 -0.564 . . . . 0.0 109.872 170.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.35 140.36 44.03 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.107 1.871 . . . . 0.0 112.435 -177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -75.14 171.65 13.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.705 1.602 . . . . 0.0 111.805 163.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.6 -43.78 94.15 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.916 -0.49 . . . . 0.0 113.035 168.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.89 -25.78 64.78 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.65 65.03 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.989 -1.069 . . . . 0.0 111.749 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.65 -42.7 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.686 0.794 . . . . 0.0 110.812 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.06 -1.26 14.09 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 173.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.23 74.26 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 120.865 -1.147 . . . . 0.0 115.444 174.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.5 19.21 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.079 1.439 . . . . 0.0 113.263 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 p -126.13 -1.28 7.08 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.76 149.84 24.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.08 0.952 . . . . 0.0 111.789 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.5 p -81.81 162.32 22.91 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.288 0.566 . . . . 0.0 110.73 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.81 -39.37 74.04 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.529 -0.732 . . . . 0.0 111.438 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.5 -38.99 93.24 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.576 -0.702 . . . . 0.0 112.675 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.6 95.45 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.573 -0.705 . . . . 0.0 112.085 171.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.77 -46.47 90.36 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.626 0.77 . . . . 0.0 112.092 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.33 -46.35 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.126 0.971 . . . . 0.0 110.35 172.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.03 54.41 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.753 0.692 . . . . 0.0 112.945 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.79 0.795 . . . . 0.0 112.485 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.9 8.36 20.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.66 1.184 . . . . 0.0 113.033 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.46 162.31 1.62 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.029 1.332 . . . . 0.0 111.361 165.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.34 48.99 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.035 0.934 . . . . 0.0 110.811 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.14 163.78 89.25 Favored 'Cis proline' 0 CA--C 1.543 0.951 0 CA-C-N 119.466 0.845 . . . . 0.0 111.735 -6.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -49.9 141.39 29.0 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.205 2.604 . . . . 0.0 114.171 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.19 96.38 2.46 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 163.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.96 54.56 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.27 2.647 . . . . 0.0 112.86 -152.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.57 -34.83 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.39 -46.26 94.22 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.638 0.654 . . . . 0.0 112.967 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.83 -36.86 75.94 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.91 -44.56 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.732 -0.605 . . . . 0.0 110.004 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.37 91.6 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.307 -0.871 . . . . 0.0 112.557 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.83 -41.97 75.03 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.489 -0.757 . . . . 0.0 112.287 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -56.71 -45.27 81.94 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.889 0.768 . . . . 0.0 112.08 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.32 -40.46 85.98 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.236 0.614 . . . . 0.0 112.315 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.7 -46.98 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.044 0.538 . . . . 0.0 110.34 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.23 -37.39 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.686 1.195 . . . . 0.0 112.3 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.81 98.3 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.011 0.823 . . . . 0.0 111.223 171.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.49 -45.19 91.19 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.796 0.712 . . . . 0.0 113.26 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.42 -42.26 86.87 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.003 0.901 . . . . 0.0 111.113 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.45 -50.22 70.41 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.772 0.829 . . . . 0.0 112.453 173.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.18 76.94 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.856 0.753 . . . . 0.0 111.973 175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.48 -48.01 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.377 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.47 -32.84 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.988 1.267 . . . . 0.0 112.945 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.96 -43.23 95.18 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.877 0.871 . . . . 0.0 111.562 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.8 ttp -78.41 -36.71 45.37 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.72 1.608 . . . . 0.0 113.619 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.3 t80 . . . . . 0 C--O 1.252 1.219 0 C-N-CA 128.423 2.689 . . . . 0.0 114.629 -171.91 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.93 135.02 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.453 1.101 . . . . 0.0 108.425 163.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.92 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.62 116.7 32.52 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.521 0.729 . . . . 0.0 109.201 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.41 178.04 6.88 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.598 0.713 . . . . 0.0 112.441 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.94 -26.5 68.85 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.13 57.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.97 2.99 85.8 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.458 1.028 . . . . 0.0 114.12 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.73 128.3 35.75 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.801 1.301 . . . . 0.0 109.683 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.6 29.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 168.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -126.0 123.39 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.046 1.338 . . . . 0.0 108.659 -174.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.65 141.14 48.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.491 1.916 . . . . 0.0 107.914 169.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 21.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.015 0.825 . . . . 0.0 111.191 170.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.47 136.83 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.601 -0.687 . . . . 0.0 111.58 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.7 130.06 93.18 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.11 0.564 . . . . 0.0 111.088 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.09 -34.54 68.73 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.86 2.373 . . . . 0.0 113.575 167.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.43 -38.03 86.5 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.526 -0.734 . . . . 0.0 112.622 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.94 -44.32 97.43 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.691 0.678 . . . . 0.0 111.373 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.55 -44.36 94.39 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.251 0.478 . . . . 0.0 112.266 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.19 -47.21 86.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.105 0.562 . . . . 0.0 111.432 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.14 95.91 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.683 0.793 . . . . 0.0 111.879 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.19 -47.23 86.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.861 0.864 . . . . 0.0 112.766 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.8 -54.44 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.397 0.544 . . . . 0.0 110.369 174.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.71 -37.34 78.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.347 1.059 . . . . 0.0 113.2 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.54 -52.15 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.058 1.343 . . . . 0.0 111.288 170.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.75 -35.9 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.406 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -58.7 -23.86 60.34 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.37 -25.65 11.35 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.93 16.12 3.3 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -166.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.19 -38.22 2.41 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -117.56 13.97 14.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.415 1.086 . . . . 0.0 113.105 -172.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.5 p -113.2 152.97 45.54 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.027 0.931 . . . . 0.0 111.582 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.9 -30.76 59.7 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.277 2.651 . . . . 0.0 115.229 -172.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.02 -20.69 64.19 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.85 -31.89 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.431 1.014 . . . . 0.0 112.548 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.38 -55.07 6.31 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.957 1.303 . . . . 0.0 113.011 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.88 -30.08 49.31 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.653 1.626 . . . . 0.0 112.641 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.06 -40.16 78.67 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.901 1.228 . . . . 0.0 112.673 172.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -57.27 -46.51 83.01 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.758 0.708 . . . . 0.0 111.583 169.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -61.05 -44.48 97.33 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.86 -31.98 71.42 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.284 1.034 . . . . 0.0 113.292 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.34 4.44 53.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.344 1.458 . . . . 0.0 113.508 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.6 p -132.91 22.75 4.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.54 120.31 5.98 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.474 -1.391 . . . . 0.0 111.47 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.66 60.1 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.362 0.905 . . . . 0.0 115.362 -177.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.51 130.82 46.87 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.554 1.677 . . . . 0.0 112.53 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.33 159.66 84.35 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.718 167.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.61 -35.31 37.27 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.15 1.9 . . . . 0.0 115.454 168.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.16 -40.19 86.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.34 -45.3 93.95 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.6 -0.687 . . . . 0.0 111.1 172.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.52 -44.37 94.44 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.364 1.066 . . . . 0.0 112.134 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.13 -41.51 88.42 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.658 -0.651 . . . . 0.0 112.031 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.18 -45.35 93.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.622 0.646 . . . . 0.0 111.084 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.36 -48.87 77.9 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.179 0.9 . . . . 0.0 112.19 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -63.15 -38.44 91.17 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.95 -33.36 70.53 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.0 p -73.67 -12.5 60.75 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.25 7.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.87 -4.49 5.86 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.82 -33.19 55.8 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 119.249 1.524 . . . . 0.0 115.425 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -91.23 78.63 5.78 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.84 1.32 . . . . 0.0 110.613 171.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.16 -35.86 38.06 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.39 -41.1 73.48 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 120.107 1.322 . . . . 0.0 112.299 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.28 -43.61 85.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.202 0.601 . . . . 0.0 111.335 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.05 -40.1 96.71 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.514 -0.741 . . . . 0.0 112.255 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -50.02 73.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.251 1.02 . . . . 0.0 111.539 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -56.0 -45.39 79.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.97 -48.72 79.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.338 0.655 . . . . 0.0 112.055 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.75 -38.27 90.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.411 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.95 -45.48 92.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.735 0.698 . . . . 0.0 112.046 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.64 -42.37 99.55 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.149 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.84 -46.07 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.507 -0.745 . . . . 0.0 111.093 174.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.19 -39.33 93.76 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.816 0.734 . . . . 0.0 112.738 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.89 -47.4 86.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.745 0.818 . . . . 0.0 111.964 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.16 -34.33 72.87 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.48 91.66 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.481 -0.762 . . . . 0.0 112.355 173.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.16 98.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.2 0.6 . . . . 0.0 111.787 172.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.03 -42.28 99.74 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.888 -0.508 . . . . 0.0 112.166 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.676 0.671 . . . . 0.0 111.71 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.07 -30.2 71.41 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.22 -39.1 78.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.397 1.079 . . . . 0.0 112.45 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.0 53.92 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.88 120.08 7.34 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.479 2.119 . . . . 0.0 110.312 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.26 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.35 1.46 . . . . 0.0 112.179 -169.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.98 160.47 25.9 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.079 0.552 . . . . 0.0 110.903 168.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.98 65.01 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.77 41.6 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.053 1.311 . . . . 0.0 112.647 174.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.62 169.16 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.944 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.61 -39.2 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.91 1.284 . . . . 0.0 111.799 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.47 161.94 28.51 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.884 1.674 . . . . 0.0 110.587 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.94 133.42 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.479 2.786 . . . . 0.0 113.106 168.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.98 -15.08 60.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.567 1.08 . . . . 0.0 115.01 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.6 54.12 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.694 -0.629 . . . . 0.0 110.824 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.48 152.7 45.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.765 0.826 . . . . 0.0 111.626 171.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -72.25 131.7 84.85 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.912 -0.565 . . . . 0.0 109.835 170.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.38 140.43 44.06 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.074 1.849 . . . . 0.0 112.442 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -75.1 171.61 13.83 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.763 1.625 . . . . 0.0 111.871 163.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.87 94.1 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.895 -0.503 . . . . 0.0 113.035 168.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.0 p -68.81 -25.68 64.8 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.82 -41.6 64.72 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.03 -1.044 . . . . 0.0 111.733 171.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.67 -42.71 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.742 0.817 . . . . 0.0 110.787 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.23 13.99 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.98 18.11 74.21 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.626 1.107 . . . . 0.0 115.413 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.21 -19.36 19.39 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.141 1.471 . . . . 0.0 113.312 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.25 -1.52 6.99 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.56 150.01 24.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.063 0.945 . . . . 0.0 111.773 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.9 p -82.01 162.3 22.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.311 0.577 . . . . 0.0 110.806 169.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.66 -39.45 73.76 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.431 -0.793 . . . . 0.0 111.427 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.49 -38.93 93.03 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.533 -0.729 . . . . 0.0 112.701 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -64.67 -42.75 95.15 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 111.997 171.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.6 -46.41 90.36 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.575 0.75 . . . . 0.0 112.152 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.47 -46.29 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.106 0.962 . . . . 0.0 110.338 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.1 54.01 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 0.0 112.869 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.07 73.19 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.512 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.95 8.42 20.29 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.6 1.16 . . . . 0.0 113.046 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.39 162.28 1.6 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.991 1.316 . . . . 0.0 111.403 165.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.54 103.37 48.97 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.035 0.934 . . . . 0.0 110.792 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.14 163.87 89.05 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.509 0.86 . . . . 0.0 111.676 -6.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -50.04 141.36 30.06 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 0.0 114.205 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.11 96.41 2.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.97 54.6 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.54 -34.89 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.24 94.26 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.633 0.652 . . . . 0.0 112.999 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.8 -36.87 76.02 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.348 -1.09 . . . . 0.0 112.723 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.92 -44.56 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.732 -0.605 . . . . 0.0 109.987 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.89 -40.39 91.53 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.307 -0.871 . . . . 0.0 112.521 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.83 -41.98 75.06 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.431 -0.793 . . . . 0.0 112.259 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.74 -45.23 82.12 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.956 0.798 . . . . 0.0 112.044 174.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.3 -40.57 86.06 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.257 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.53 -47.22 93.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.065 0.546 . . . . 0.0 110.295 174.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.09 -37.39 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.68 1.192 . . . . 0.0 112.3 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.78 98.35 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.011 0.823 . . . . 0.0 111.224 171.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.07 91.47 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.844 0.735 . . . . 0.0 113.252 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.35 -42.42 86.86 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.988 0.894 . . . . 0.0 111.076 173.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.18 70.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.9 -43.23 77.07 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.83 0.741 . . . . 0.0 111.975 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.51 -47.79 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.43 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.56 -32.91 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.963 1.256 . . . . 0.0 112.911 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.23 -44.79 94.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.933 0.893 . . . . 0.0 111.487 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.2 ttp -75.42 -36.34 60.81 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.631 1.573 . . . . 0.0 113.442 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.252 1.196 0 C-N-CA 128.394 2.678 . . . . 0.0 114.54 -172.815 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.009 0.35 . . . . 0.0 113.009 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.76 135.02 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.472 1.109 . . . . 0.0 108.436 163.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.96 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.72 116.74 32.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.501 0.72 . . . . 0.0 109.195 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.452 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.89 -26.46 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -173.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.19 57.93 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.809 1.244 . . . . 0.0 112.988 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.04 2.94 85.67 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.504 1.05 . . . . 0.0 114.103 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.64 128.29 35.68 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.866 1.333 . . . . 0.0 109.745 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.61 29.61 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 168.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.0 t -125.97 123.34 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.045 1.338 . . . . 0.0 108.723 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.5 139.73 38.64 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.512 0.672 . . . . 0.0 111.206 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.76 141.17 48.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.477 1.911 . . . . 0.0 107.897 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.38 20.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.804 . . . . 0.0 111.238 170.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.5 136.79 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.611 -0.681 . . . . 0.0 111.591 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.64 130.01 93.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 123.114 0.566 . . . . 0.0 111.151 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.887 2.391 . . . . 0.0 113.575 167.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.4 -38.09 86.69 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 112.579 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.0 -44.28 97.65 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.687 0.676 . . . . 0.0 111.347 171.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.55 -44.23 94.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.328 0.513 . . . . 0.0 112.309 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.28 -47.28 85.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.124 0.569 . . . . 0.0 111.392 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.2 95.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.658 0.783 . . . . 0.0 111.9 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.17 -47.23 86.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.809 0.844 . . . . 0.0 112.77 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.76 -54.52 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.455 0.57 . . . . 0.0 110.397 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.59 -37.44 78.54 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.354 1.062 . . . . 0.0 113.191 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.59 -52.1 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.026 1.33 . . . . 0.0 111.295 170.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.64 -35.92 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.915 0.486 . . . . 0.0 111.399 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -58.72 -23.95 60.63 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.21 -25.73 11.39 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.88 16.13 3.31 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.16 -38.38 2.44 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -117.48 14.1 14.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.404 1.081 . . . . 0.0 113.115 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.9 p -113.18 153.02 45.54 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 123.952 0.901 . . . . 0.0 111.565 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.89 -30.66 59.12 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.289 2.659 . . . . 0.0 115.27 -172.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.12 -20.74 64.37 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.73 -32.01 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.387 0.994 . . . . 0.0 112.539 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.33 -55.05 6.39 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.943 1.297 . . . . 0.0 113.011 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.89 -30.08 49.23 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.685 1.637 . . . . 0.0 112.655 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.08 -40.21 78.58 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.876 1.216 . . . . 0.0 112.598 172.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -57.28 -46.52 83.03 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.776 0.716 . . . . 0.0 111.522 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.2 m -61.11 -44.4 97.4 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.9 -32.02 71.5 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.268 1.027 . . . . 0.0 113.27 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.23 4.43 53.55 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.4 1.48 . . . . 0.0 113.536 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -133.03 22.8 4.16 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.62 120.34 6.06 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.491 168.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.69 60.06 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.9 47.19 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.565 1.683 . . . . 0.0 112.481 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.37 159.66 84.33 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 123.748 0.819 . . . . 0.0 110.705 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -49.54 -35.48 37.11 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.3 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.36 -45.26 94.12 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.049 172.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.54 -44.37 94.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.386 1.074 . . . . 0.0 112.134 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -59.13 -41.51 88.42 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.658 -0.651 . . . . 0.0 112.031 171.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.5 m -60.23 -45.28 93.78 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.622 0.646 . . . . 0.0 111.073 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.44 -48.85 78.06 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.254 0.934 . . . . 0.0 112.191 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.13 -38.45 91.24 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.87 -33.43 70.48 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.1 p -73.66 -12.52 60.76 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.4 m -122.2 7.84 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.93 -4.54 6.0 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 117.193 1.637 . . . . 0.0 117.193 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.83 -33.22 55.93 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.257 1.528 . . . . 0.0 115.404 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -91.18 78.49 5.83 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.875 1.338 . . . . 0.0 110.605 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.06 -35.86 36.88 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.35 -41.09 73.61 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.094 1.315 . . . . 0.0 112.242 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.54 85.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.174 0.59 . . . . 0.0 111.311 173.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.05 -40.13 96.77 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.514 -0.741 . . . . 0.0 112.265 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -49.92 74.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.198 0.999 . . . . 0.0 111.58 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.99 -45.52 78.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.091 0.956 . . . . 0.0 112.199 174.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.2 tp -61.87 -48.81 78.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.326 0.65 . . . . 0.0 112.055 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.63 -38.28 90.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.842 0.857 . . . . 0.0 112.49 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.99 -45.55 92.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 111.985 170.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.3 m -62.51 -42.45 99.51 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.87 0.759 . . . . 0.0 112.155 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.86 -46.08 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.478 -0.764 . . . . 0.0 111.059 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.18 -39.37 93.85 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.858 0.754 . . . . 0.0 112.752 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.81 -47.48 86.13 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.925 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.09 -34.32 73.0 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.582 -0.699 . . . . 0.0 112.85 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.69 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.408 -0.808 . . . . 0.0 112.361 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.09 98.7 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.215 0.606 . . . . 0.0 111.751 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.25 99.58 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 0.0 112.218 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.77 -48.57 79.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.737 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.05 -30.23 71.43 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.24 -39.11 78.71 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.337 1.055 . . . . 0.0 112.482 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.24 -27.58 42.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.76 1.224 . . . . 0.0 113.327 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.76 61.03 54.17 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.646 1.978 . . . . 0.0 111.247 -174.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.92 120.14 7.41 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.509 2.139 . . . . 0.0 110.261 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.42 136.3 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.298 1.439 . . . . 0.0 112.108 -169.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.97 160.37 25.95 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.116 0.567 . . . . 0.0 110.922 168.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.97 65.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 174.77 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.048 1.309 . . . . 0.0 112.656 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 169.16 14.85 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.66 2.907 . . . . 0.0 112.896 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.64 -39.18 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.926 1.29 . . . . 0.0 111.762 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.55 161.87 28.65 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.858 1.663 . . . . 0.0 110.561 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.93 133.44 22.94 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.403 2.735 . . . . 0.0 113.141 168.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.08 60.29 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.562 1.077 . . . . 0.0 114.978 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.22 145.5 54.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.694 -0.629 . . . . 0.0 110.815 168.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -68.54 152.83 44.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.658 0.783 . . . . 0.0 111.668 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.18 131.64 85.03 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.83 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.37 140.44 44.13 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.076 1.851 . . . . 0.0 112.426 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -75.12 171.58 13.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.74 1.616 . . . . 0.0 111.906 163.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.51 -43.87 93.96 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.971 -0.455 . . . . 0.0 113.049 168.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.85 -25.7 64.78 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.68 64.88 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.068 -1.02 . . . . 0.0 111.727 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.63 -42.69 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 110.817 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.29 14.23 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.16 74.31 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.605 1.098 . . . . 0.0 115.447 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.31 -19.46 19.24 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.074 1.437 . . . . 0.0 113.263 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 p -126.14 -1.34 7.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.86 149.81 24.73 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.095 0.958 . . . . 0.0 111.752 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.6 p -81.73 162.27 23.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.303 0.573 . . . . 0.0 110.799 170.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.72 -39.38 73.81 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.466 -0.771 . . . . 0.0 111.445 169.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.58 -38.91 92.91 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.554 -0.716 . . . . 0.0 112.706 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.57 -42.79 95.41 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.542 -0.724 . . . . 0.0 112.011 171.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.62 -46.43 90.3 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.68 0.792 . . . . 0.0 112.144 176.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.46 -46.35 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.106 0.962 . . . . 0.0 110.301 172.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.39 -51.11 53.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.872 0.748 . . . . 0.0 112.882 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 0.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.62 -18.56 64.33 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.86 8.42 20.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.624 1.17 . . . . 0.0 113.064 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.41 162.3 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.952 1.301 . . . . 0.0 111.461 165.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.39 48.92 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.035 0.934 . . . . 0.0 110.811 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.07 163.84 89.16 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.429 0.832 . . . . 0.0 111.701 -6.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -50.04 141.35 30.07 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 0.0 114.205 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.13 96.48 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.05 54.58 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.274 2.649 . . . . 0.0 112.827 -152.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.59 -34.77 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.48 -46.2 94.31 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.637 0.653 . . . . 0.0 112.996 173.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.8 -36.92 76.07 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.293 -1.122 . . . . 0.0 112.665 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.0 mt -62.93 -44.57 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.808 -0.557 . . . . 0.0 109.921 174.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.42 91.66 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.303 -0.873 . . . . 0.0 112.489 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.84 -41.99 75.1 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.294 173.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -56.7 -45.24 81.95 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.926 0.784 . . . . 0.0 112.071 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -67.34 -40.48 85.9 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.266 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.62 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.044 0.538 . . . . 0.0 110.291 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.03 -37.35 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.683 1.193 . . . . 0.0 112.355 177.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.77 98.4 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.03 0.832 . . . . 0.0 111.224 171.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.09 91.41 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.796 0.712 . . . . 0.0 113.242 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.38 -42.35 86.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 117.986 0.893 . . . . 0.0 111.097 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.55 -50.17 70.73 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.798 0.839 . . . . 0.0 112.445 173.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.26 77.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.86 0.755 . . . . 0.0 111.991 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.4 -47.9 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.335 0.654 . . . . 0.0 111.44 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.92 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.924 1.238 . . . . 0.0 112.9 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.17 -44.54 94.94 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.884 0.874 . . . . 0.0 111.473 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.78 -35.86 59.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.655 1.582 . . . . 0.0 113.468 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 128.39 2.676 . . . . 0.0 114.59 -172.737 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.998 0.345 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.9 135.09 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.457 1.103 . . . . 0.0 108.402 163.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.13 154.83 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.063 1.345 . . . . 0.0 109.627 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.7 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.9 -26.45 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.61 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.825 1.25 . . . . 0.0 113.03 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.02 85.77 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.5 1.048 . . . . 0.0 114.144 -175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.7 128.22 35.43 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.801 1.301 . . . . 0.0 109.745 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.63 29.63 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 168.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -125.95 123.36 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.107 1.363 . . . . 0.0 108.669 -174.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.56 139.71 38.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.543 0.687 . . . . 0.0 111.191 170.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.72 141.11 48.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.465 1.906 . . . . 0.0 107.929 169.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.36 21.02 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.254 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.5 136.89 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.492 0.663 . . . . 0.0 111.572 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.69 129.96 93.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.068 0.547 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.01 -34.56 68.05 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.868 2.378 . . . . 0.0 113.56 167.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.41 -38.07 86.64 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.451 -0.78 . . . . 0.0 112.587 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.97 -44.3 97.55 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.779 0.718 . . . . 0.0 111.377 171.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.54 -44.37 94.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.29 0.496 . . . . 0.0 112.244 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.22 -47.25 86.04 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.115 0.566 . . . . 0.0 111.37 176.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.24 95.61 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.651 0.78 . . . . 0.0 111.897 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.24 -47.01 87.79 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.771 0.829 . . . . 0.0 112.812 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.78 -54.55 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.439 0.563 . . . . 0.0 110.344 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.66 -37.36 78.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.343 1.057 . . . . 0.0 113.219 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.38 -52.22 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.138 1.375 . . . . 0.0 111.253 170.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.82 -36.02 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.996 0.518 . . . . 0.0 111.407 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.66 -23.89 60.13 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.3 -25.62 11.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.98 16.08 3.29 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -165.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.37 -38.13 2.59 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -117.44 13.8 14.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.345 1.058 . . . . 0.0 113.127 -172.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -112.99 153.0 45.38 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.96 0.904 . . . . 0.0 111.566 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.88 -30.74 59.39 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.311 2.674 . . . . 0.0 115.218 -172.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.02 -20.74 64.25 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.88 -31.88 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.414 1.006 . . . . 0.0 112.488 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.41 -55.01 6.32 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.957 1.303 . . . . 0.0 112.989 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.93 -30.08 48.9 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 121.678 1.635 . . . . 0.0 112.641 174.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.06 -40.21 78.65 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.901 1.228 . . . . 0.0 112.673 172.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.27 -46.47 83.05 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.765 0.711 . . . . 0.0 111.569 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -61.09 -44.44 97.36 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -32.0 71.51 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.268 1.027 . . . . 0.0 113.257 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.3 4.48 53.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.325 1.45 . . . . 0.0 113.511 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -133.03 22.8 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.54 120.31 5.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.478 -1.389 . . . . 0.0 111.468 168.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.63 60.04 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.46 130.88 47.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.573 1.687 . . . . 0.0 112.482 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.35 159.66 84.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.753 0.821 . . . . 0.0 110.666 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.22 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.41 -45.22 94.38 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.66 -0.65 . . . . 0.0 111.108 172.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.57 -44.26 94.62 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 112.163 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.3 -41.35 88.78 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.696 -0.628 . . . . 0.0 111.989 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.26 -45.33 93.68 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.629 0.65 . . . . 0.0 111.091 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.33 -48.91 77.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.205 0.911 . . . . 0.0 112.179 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.11 -38.49 91.38 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.91 -33.56 70.69 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 p -73.57 -12.46 60.77 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.34 7.73 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.57 -4.8 5.73 Favored Glycine 0 CA--C 1.541 1.702 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.71 -33.32 55.25 Favored Glycine 0 CA--C 1.537 1.433 0 CA-C-N 119.183 1.491 . . . . 0.0 115.462 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -90.81 78.77 6.06 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.836 1.318 . . . . 0.0 110.634 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.32 -35.94 40.43 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.49 -41.2 73.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.094 1.315 . . . . 0.0 112.293 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.57 86.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.155 0.582 . . . . 0.0 111.337 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.13 -40.04 96.44 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.555 -0.716 . . . . 0.0 112.224 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.99 -50.0 74.03 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.056 -1.028 . . . . 0.0 111.521 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.0 -45.42 79.05 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 tp -61.88 -48.75 79.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.277 0.631 . . . . 0.0 112.105 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.77 -38.21 90.26 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.836 0.854 . . . . 0.0 112.463 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.97 -45.48 92.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.699 0.681 . . . . 0.0 112.075 170.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.65 -42.37 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.118 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.85 -46.14 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.477 -0.765 . . . . 0.0 111.03 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.09 -39.43 94.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.842 0.746 . . . . 0.0 112.757 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.75 -47.46 86.2 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.703 0.801 . . . . 0.0 111.975 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.09 -34.38 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.87 -41.42 91.63 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.467 -0.771 . . . . 0.0 112.341 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.08 98.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.184 0.594 . . . . 0.0 111.772 172.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.14 -42.21 99.44 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.924 -0.485 . . . . 0.0 112.135 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.84 -48.58 79.38 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.682 0.674 . . . . 0.0 111.699 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.04 -30.19 71.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.16 -39.18 78.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.361 1.065 . . . . 0.0 112.499 173.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.61 42.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 113.29 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.76 61.03 54.13 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.696 1.998 . . . . 0.0 111.225 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.9 120.16 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.481 2.12 . . . . 0.0 110.277 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.46 136.23 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.318 1.447 . . . . 0.0 112.121 -169.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.92 160.49 25.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.05 0.54 . . . . 0.0 110.903 168.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.9 64.99 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.98 174.71 41.62 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.099 1.333 . . . . 0.0 112.653 174.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.63 169.14 14.96 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.658 2.905 . . . . 0.0 112.915 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.6 -39.23 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.94 1.296 . . . . 0.0 111.762 -175.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.44 161.93 28.53 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.817 1.647 . . . . 0.0 110.573 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.95 133.47 23.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.441 2.761 . . . . 0.0 113.132 168.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.99 60.33 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.613 1.101 . . . . 0.0 115.056 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.36 37.46 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.946 1.373 . . . . 0.0 110.198 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.11 145.54 54.29 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.693 -0.63 . . . . 0.0 110.858 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.51 152.7 45.02 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.728 0.811 . . . . 0.0 111.653 171.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.21 131.66 84.96 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.34 140.38 44.09 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.134 1.889 . . . . 0.0 112.416 -177.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -75.11 171.66 13.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.709 1.604 . . . . 0.0 111.89 163.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.91 94.07 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.895 -0.503 . . . . 0.0 112.991 168.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.6 p -68.78 -25.77 64.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.76 -41.59 64.92 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.027 -1.046 . . . . 0.0 111.778 171.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.65 -42.69 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.718 0.807 . . . . 0.0 110.793 173.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.26 13.93 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 173.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.91 18.16 74.12 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.922 -1.111 . . . . 0.0 115.477 175.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.3 -19.35 19.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.131 1.466 . . . . 0.0 113.305 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.0 p -126.27 -1.51 6.98 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.6 149.97 24.41 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.103 0.961 . . . . 0.0 111.824 173.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.6 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.318 0.58 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.81 -39.44 74.16 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.418 -0.801 . . . . 0.0 111.372 169.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.5 -38.93 93.03 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.576 -0.702 . . . . 0.0 112.685 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.8 95.31 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.602 -0.686 . . . . 0.0 112.008 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.61 -46.39 90.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.648 0.779 . . . . 0.0 112.097 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.35 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.301 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.05 54.33 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.85 0.738 . . . . 0.0 112.866 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.14 72.91 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.828 0.814 . . . . 0.0 112.517 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.62 -18.48 64.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.4 p -111.88 8.36 20.39 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.688 1.195 . . . . 0.0 113.051 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.43 162.31 1.6 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.989 1.316 . . . . 0.0 111.434 165.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.34 48.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.035 0.934 . . . . 0.0 110.837 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.85 89.11 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.447 0.838 . . . . 0.0 111.701 -6.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -50.06 141.37 30.24 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.21 2.607 . . . . 0.0 114.135 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.14 96.49 2.5 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 163.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.0 54.59 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.251 2.634 . . . . 0.0 112.86 -152.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.63 -34.81 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.26 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.999 173.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.83 -36.87 75.95 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.91 -44.6 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.709 -0.62 . . . . 0.0 109.942 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.82 -40.46 91.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.307 -0.871 . . . . 0.0 112.54 176.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -42.03 74.99 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.455 -0.778 . . . . 0.0 112.287 173.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.68 -45.21 81.9 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.865 0.757 . . . . 0.0 112.147 174.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.35 -40.47 85.83 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.272 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.64 -47.27 93.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.085 0.554 . . . . 0.0 110.206 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.05 -37.36 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.634 1.174 . . . . 0.0 112.322 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.74 -42.87 98.24 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.095 0.861 . . . . 0.0 111.233 171.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.55 -45.07 91.56 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.821 0.724 . . . . 0.0 113.252 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.28 -42.49 86.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.988 0.894 . . . . 0.0 111.102 173.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.5 -50.16 70.67 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.772 0.829 . . . . 0.0 112.503 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.86 -43.27 76.95 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.864 0.756 . . . . 0.0 112.027 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.46 -47.74 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.337 0.655 . . . . 0.0 111.467 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.64 -32.89 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.923 1.238 . . . . 0.0 112.874 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.34 -45.11 94.6 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.958 0.903 . . . . 0.0 111.463 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.3 ttp -74.74 -36.7 62.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.666 1.586 . . . . 0.0 113.362 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 128.417 2.687 . . . . 0.0 114.655 -173.026 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.81 135.01 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.458 1.103 . . . . 0.0 108.437 163.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.02 154.94 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.1 1.36 . . . . 0.0 109.648 170.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.66 116.69 32.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.516 0.726 . . . . 0.0 109.17 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.604 0.716 . . . . 0.0 112.452 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.89 -26.45 68.79 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.63 -2.19 57.92 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.767 1.227 . . . . 0.0 112.988 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.03 85.67 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.78 128.27 35.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.861 1.331 . . . . 0.0 109.664 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.61 29.61 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 168.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.97 123.35 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.046 1.338 . . . . 0.0 108.678 -174.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.52 139.65 38.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.236 170.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.13 48.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.468 1.907 . . . . 0.0 107.94 169.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.24 152.37 20.91 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.221 170.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.54 136.9 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.65 -0.656 . . . . 0.0 111.509 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.71 130.01 93.19 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 123.098 0.559 . . . . 0.0 111.151 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.99 -34.6 67.96 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.907 2.405 . . . . 0.0 113.604 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.43 -38.06 86.57 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 112.594 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.94 -44.32 97.43 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.691 0.678 . . . . 0.0 111.373 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.57 -44.29 94.53 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.251 0.478 . . . . 0.0 112.254 175.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.23 -47.27 85.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.079 0.551 . . . . 0.0 111.399 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.23 95.63 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.663 0.785 . . . . 0.0 111.882 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.11 -47.27 86.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.801 0.84 . . . . 0.0 112.801 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.8 -54.4 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.431 0.559 . . . . 0.0 110.397 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.7 -37.36 78.63 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.301 1.04 . . . . 0.0 113.218 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.55 -52.19 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.027 1.331 . . . . 0.0 111.318 170.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.61 -35.96 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.417 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -58.66 -23.96 60.27 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.2 -25.73 11.39 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.83 15.91 3.33 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -166.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.05 -38.22 2.24 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -117.61 14.05 14.4 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.402 1.081 . . . . 0.0 113.141 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 p -113.14 152.97 45.49 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.982 0.913 . . . . 0.0 111.523 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.74 -30.96 58.98 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.258 2.639 . . . . 0.0 115.203 -172.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.01 -21.01 64.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.16 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.41 1.005 . . . . 0.0 112.485 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.36 -57.18 5.98 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.76 1.224 . . . . 0.0 112.561 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.84 -29.52 58.68 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.891 1.711 . . . . 0.0 112.814 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.25 -40.16 78.03 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.781 1.173 . . . . 0.0 112.705 172.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.09 -47.02 82.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.847 0.748 . . . . 0.0 111.53 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -60.92 -44.2 97.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.68 71.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.227 1.011 . . . . 0.0 113.225 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.76 4.53 52.85 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.373 1.469 . . . . 0.0 113.47 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.5 p -133.08 22.79 4.14 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -53.56 120.33 6.01 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.508 -1.37 . . . . 0.0 111.454 168.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.62 60.02 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.447 0.939 . . . . 0.0 115.447 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.89 47.15 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.489 1.644 . . . . 0.0 112.515 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.32 159.68 84.33 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.771 0.828 . . . . 0.0 110.665 167.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.57 -35.48 37.46 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.227 1.951 . . . . 0.0 115.381 168.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.3 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.33 -45.3 93.9 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.062 172.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.57 -44.29 94.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.354 1.062 . . . . 0.0 112.134 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -59.21 -41.49 88.74 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.682 -0.636 . . . . 0.0 111.973 171.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.25 -45.24 93.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.654 0.661 . . . . 0.0 111.08 175.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.38 -48.87 77.92 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.254 0.934 . . . . 0.0 112.202 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.0 mt -63.13 -38.47 91.32 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.91 -33.41 70.51 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.4 p -73.66 -12.52 60.76 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.2 m -122.14 7.79 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -174.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.77 -4.64 5.87 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.85 -32.94 55.83 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 119.236 1.518 . . . . 0.0 115.411 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -91.57 78.62 5.56 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.875 1.337 . . . . 0.0 110.585 171.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.18 -35.92 38.59 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.33 -41.06 73.73 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.12 1.327 . . . . 0.0 112.315 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.6 86.01 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.16 0.584 . . . . 0.0 111.361 173.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.04 -40.18 96.95 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.476 -0.765 . . . . 0.0 112.255 175.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.9 -50.0 73.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.237 1.015 . . . . 0.0 111.548 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.99 -45.42 79.02 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.095 0.958 . . . . 0.0 112.21 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.97 -48.72 79.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.338 0.655 . . . . 0.0 112.055 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -63.75 -38.24 90.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.448 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.98 -45.53 92.42 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.684 0.675 . . . . 0.0 112.046 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.54 -42.42 99.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.848 0.749 . . . . 0.0 112.164 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.84 -46.1 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.507 -0.745 . . . . 0.0 111.093 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.13 -39.4 93.94 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.847 0.749 . . . . 0.0 112.759 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.8 -47.46 86.23 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.948 174.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.11 -34.32 72.96 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.46 91.76 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.408 -0.808 . . . . 0.0 112.376 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.12 98.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.208 0.603 . . . . 0.0 111.772 172.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.0 -42.32 99.81 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.869 -0.519 . . . . 0.0 112.165 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.77 -48.63 79.11 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.645 0.657 . . . . 0.0 111.676 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.02 -30.25 71.45 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -39.1 78.79 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.326 1.05 . . . . 0.0 112.451 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.22 -27.61 42.5 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 113.339 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.76 61.01 54.03 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.646 1.978 . . . . 0.0 111.247 -174.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.89 120.16 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.51 2.14 . . . . 0.0 110.261 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.45 136.24 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.383 1.473 . . . . 0.0 112.086 -169.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -79.94 160.43 25.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.082 0.553 . . . . 0.0 110.909 168.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.98 65.02 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.016 1.293 . . . . 0.0 112.617 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 169.2 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.917 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.65 -39.17 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.897 1.279 . . . . 0.0 111.799 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.51 161.9 28.59 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.911 1.684 . . . . 0.0 110.599 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.427 2.751 . . . . 0.0 113.132 168.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.07 60.28 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 115.005 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.021 1.41 . . . . 0.0 110.198 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.5 54.27 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.726 -0.608 . . . . 0.0 110.848 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.53 152.77 44.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.666 0.787 . . . . 0.0 111.664 171.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.24 131.73 84.85 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.883 -0.58 . . . . 0.0 109.821 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.42 140.44 43.95 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.037 1.825 . . . . 0.0 112.426 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -75.1 171.62 13.8 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.74 1.616 . . . . 0.0 111.898 163.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.55 -43.94 94.0 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 121.895 -0.503 . . . . 0.0 112.986 168.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.5 p -68.77 -25.73 64.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.8 -41.61 64.76 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.068 -1.02 . . . . 0.0 111.721 171.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.75 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.784 0.834 . . . . 0.0 110.782 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.05 -1.25 14.05 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.97 18.13 74.21 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.879 -1.138 . . . . 0.0 115.485 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.34 -19.3 19.33 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.092 1.446 . . . . 0.0 113.313 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.26 -1.5 6.99 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.63 149.95 24.45 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.055 0.942 . . . . 0.0 111.799 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.1 p -81.79 162.42 22.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.309 0.576 . . . . 0.0 110.773 169.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.81 -39.41 74.13 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.454 -0.778 . . . . 0.0 111.431 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.52 -38.91 92.93 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.518 -0.739 . . . . 0.0 112.674 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.62 -42.75 95.3 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.628 -0.67 . . . . 0.0 112.033 171.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.35 90.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.62 0.768 . . . . 0.0 112.11 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.51 -46.33 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.151 0.981 . . . . 0.0 110.255 172.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.09 54.06 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.823 0.725 . . . . 0.0 112.884 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.22 -50.1 73.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.517 174.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.61 -18.58 64.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.9 8.41 20.37 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.581 1.153 . . . . 0.0 113.046 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.41 162.3 1.59 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.935 1.294 . . . . 0.0 111.461 165.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.87 89.08 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.451 0.84 . . . . 0.0 111.713 -6.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -50.08 141.4 30.3 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.189 2.593 . . . . 0.0 114.135 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.16 96.43 2.48 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.97 54.63 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.66 -34.78 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.44 -46.2 94.33 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.666 0.666 . . . . 0.0 112.996 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.84 -36.89 75.93 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.259 -1.142 . . . . 0.0 112.679 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.89 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.802 -0.561 . . . . 0.0 109.98 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.9 -40.4 91.47 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.313 -0.867 . . . . 0.0 112.521 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -42.04 75.07 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.69 -45.28 81.88 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.924 0.784 . . . . 0.0 112.058 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.3 -40.54 86.04 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.305 0.642 . . . . 0.0 112.227 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.64 -47.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.279 174.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.25 -37.29 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.685 1.194 . . . . 0.0 112.282 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.8 -42.78 98.31 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.112 0.869 . . . . 0.0 111.245 171.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.06 91.55 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.796 0.712 . . . . 0.0 113.242 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.41 -42.4 87.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.019 0.91 . . . . 0.0 111.078 173.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.19 70.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.26 77.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.86 0.755 . . . . 0.0 111.991 175.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.43 -47.94 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.402 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.48 -32.88 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.951 1.251 . . . . 0.0 112.911 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.24 -44.55 95.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.902 0.881 . . . . 0.0 111.474 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.77 -36.2 59.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.69 1.596 . . . . 0.0 113.437 -177.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.5 t80 . . . . . 0 C--O 1.251 1.16 0 C-N-CA 128.415 2.686 . . . . 0.0 114.504 -172.665 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.85 135.0 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.504 1.121 . . . . 0.0 108.402 163.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.7 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.88 -26.5 68.81 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.0 3.05 85.7 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.475 1.036 . . . . 0.0 114.092 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.19 35.32 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.87 1.335 . . . . 0.0 109.741 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.85 125.52 29.47 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 168.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.9 t -125.9 123.36 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.063 1.345 . . . . 0.0 108.659 -174.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.54 139.67 38.61 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.177 170.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.16 48.41 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 20.99 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.803 . . . . 0.0 111.191 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.53 136.91 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.472 0.653 . . . . 0.0 111.578 176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.71 130.0 93.19 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.108 0.563 . . . . 0.0 111.137 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.873 2.382 . . . . 0.0 113.575 167.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.44 -38.09 86.61 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.464 -0.773 . . . . 0.0 112.56 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.92 -44.32 97.35 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 0.0 111.373 171.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.53 -44.31 94.6 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.24 -47.26 86.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.079 0.551 . . . . 0.0 111.366 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.18 95.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.626 0.77 . . . . 0.0 111.91 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.11 -47.14 87.12 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.833 0.853 . . . . 0.0 112.786 176.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.0 t -56.89 -54.26 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.381 0.537 . . . . 0.0 110.474 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.83 -37.26 78.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.358 1.063 . . . . 0.0 113.19 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.45 -52.3 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.096 1.358 . . . . 0.0 111.257 170.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.83 -35.85 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 119.053 -0.499 . . . . 0.0 111.466 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.73 -23.71 60.31 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.49 -25.62 11.3 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.92 16.11 3.3 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -166.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.39 -37.5 2.34 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -118.23 13.84 13.79 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.475 1.11 . . . . 0.0 113.148 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.9 p -113.05 153.06 45.42 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.971 0.908 . . . . 0.0 111.568 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.89 -30.88 60.16 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.256 2.638 . . . . 0.0 115.182 -172.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.95 64.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.17 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.41 1.005 . . . . 0.0 112.462 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.6 mt -70.35 -57.18 6.0 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.743 1.217 . . . . 0.0 112.561 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.88 -29.45 58.36 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.891 1.711 . . . . 0.0 112.816 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.24 -40.17 78.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.831 1.196 . . . . 0.0 112.709 172.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.12 -47.01 82.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.83 0.741 . . . . 0.0 111.562 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -60.91 -44.2 97.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.73 -31.68 70.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.228 1.011 . . . . 0.0 113.251 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.87 4.62 52.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.419 1.488 . . . . 0.0 113.458 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.1 p -133.11 22.86 4.14 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.61 120.3 6.0 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.453 -1.404 . . . . 0.0 111.465 168.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.71 60.16 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.59 130.91 47.18 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.478 1.639 . . . . 0.0 112.453 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.35 159.65 84.37 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.771 0.828 . . . . 0.0 110.653 167.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.58 -35.44 37.43 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.171 1.914 . . . . 0.0 115.372 168.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.07 -40.24 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -60.32 -45.32 93.81 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.662 -0.649 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.57 -44.27 94.59 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 112.163 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -59.21 -41.43 88.58 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.682 -0.636 . . . . 0.0 111.996 171.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.6 m -60.25 -45.42 93.33 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.583 0.629 . . . . 0.0 111.028 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.28 -48.85 77.85 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.228 0.922 . . . . 0.0 112.179 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.8 mt -63.18 -38.29 90.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 178.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.07 -34.2 71.69 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -72.81 -12.93 61.18 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.4 13.11 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.267 1.027 . . . . 0.0 113.505 -175.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.48 -5.91 4.1 Favored Glycine 0 CA--C 1.543 1.835 0 N-CA-C 117.067 1.587 . . . . 0.0 117.067 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.67 -0.13 6.21 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 125.84 1.686 . . . . 0.0 116.919 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -124.78 79.79 1.81 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.339 1.57 . . . . 0.0 110.347 166.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.81 -36.08 46.59 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -172.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.17 -41.01 74.33 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.118 1.326 . . . . 0.0 112.19 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.47 -43.68 84.82 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.19 0.596 . . . . 0.0 111.317 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.2 tpp -62.86 -40.3 97.04 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.508 -0.745 . . . . 0.0 112.2 175.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.97 74.18 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.296 1.038 . . . . 0.0 111.536 173.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -56.02 -45.43 79.1 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.101 0.961 . . . . 0.0 112.206 174.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.8 tp -61.88 -48.81 78.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.289 0.636 . . . . 0.0 112.055 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.63 -38.31 90.65 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.455 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.02 -45.45 92.75 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.668 0.667 . . . . 0.0 112.013 170.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.61 -42.45 99.58 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.848 0.749 . . . . 0.0 112.094 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.8 -46.11 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.535 -0.728 . . . . 0.0 111.053 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.16 -39.4 93.94 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.865 0.757 . . . . 0.0 112.717 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -60.84 -47.44 86.35 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.964 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.1 -34.3 72.96 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.55 91.78 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.451 -0.781 . . . . 0.0 112.369 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.01 98.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.201 0.6 . . . . 0.0 111.784 172.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.1 -42.28 99.54 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.864 -0.523 . . . . 0.0 112.19 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.88 -48.45 79.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.646 0.657 . . . . 0.0 111.687 173.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.09 -30.3 71.49 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.08 -39.12 79.26 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.361 1.064 . . . . 0.0 112.499 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.29 -27.6 42.21 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.776 1.23 . . . . 0.0 113.302 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.83 61.03 54.02 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.672 1.989 . . . . 0.0 111.241 -174.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.93 120.16 7.44 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.421 2.08 . . . . 0.0 110.258 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.4 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.34 1.456 . . . . 0.0 112.152 -169.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.05 160.47 25.81 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.043 0.537 . . . . 0.0 110.909 168.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.26 -19.97 65.03 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.71 41.58 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.048 1.309 . . . . 0.0 112.61 174.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.45 169.17 14.61 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.668 2.912 . . . . 0.0 112.954 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.74 -39.17 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.909 1.284 . . . . 0.0 111.742 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.94 28.52 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -47.91 133.42 22.84 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.479 2.786 . . . . 0.0 113.089 168.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.06 60.35 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.562 1.077 . . . . 0.0 114.978 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.35 37.47 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.96 1.38 . . . . 0.0 110.198 173.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.17 145.57 54.21 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.717 -0.614 . . . . 0.0 110.826 168.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.56 152.73 44.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.709 0.804 . . . . 0.0 111.614 171.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.25 131.73 84.82 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.916 -0.564 . . . . 0.0 109.835 170.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.42 140.39 43.83 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.099 1.866 . . . . 0.0 112.442 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.7 mtp85 -75.02 171.63 13.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.737 1.615 . . . . 0.0 111.852 163.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.68 -43.82 94.27 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.942 -0.474 . . . . 0.0 112.954 168.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.77 -25.86 64.92 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.56 65.11 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.041 -1.037 . . . . 0.0 111.756 171.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.66 -42.69 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.731 0.812 . . . . 0.0 110.827 173.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.29 14.03 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 173.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.11 74.16 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.934 -1.104 . . . . 0.0 115.477 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.39 19.35 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.11 1.455 . . . . 0.0 113.292 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.6 p -126.21 -1.54 7.02 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.57 149.99 24.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.067 0.947 . . . . 0.0 111.773 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.9 p -81.85 162.37 22.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.307 0.575 . . . . 0.0 110.794 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.81 -39.45 74.19 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.484 -0.76 . . . . 0.0 111.4 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.59 -38.83 92.62 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.556 -0.715 . . . . 0.0 112.683 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.63 -42.76 95.25 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.628 -0.67 . . . . 0.0 112.047 171.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.63 -46.42 90.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.61 0.764 . . . . 0.0 112.11 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.39 -46.33 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.142 0.977 . . . . 0.0 110.354 172.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.12 53.81 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.81 0.719 . . . . 0.0 112.902 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.21 -50.07 73.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.778 0.789 . . . . 0.0 112.512 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.1 p -111.95 8.42 20.29 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.6 1.16 . . . . 0.0 113.009 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.44 162.31 1.61 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.952 1.301 . . . . 0.0 111.441 165.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.85 89.12 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.451 0.84 . . . . 0.0 111.762 -6.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -49.97 141.31 29.73 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.238 2.625 . . . . 0.0 114.174 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.12 96.48 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.81 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.17 94.4 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.638 0.654 . . . . 0.0 113.011 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.89 -36.86 75.76 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.296 -1.12 . . . . 0.0 112.634 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.92 -44.58 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.785 -0.572 . . . . 0.0 109.954 173.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.89 -40.38 91.52 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.303 -0.873 . . . . 0.0 112.521 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.05 75.1 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.275 173.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.65 -45.21 81.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.901 0.773 . . . . 0.0 112.147 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.28 -40.53 86.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.69 -47.04 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.05 0.54 . . . . 0.0 110.286 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.29 -37.3 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.636 1.174 . . . . 0.0 112.282 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.82 -42.77 98.35 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.051 0.842 . . . . 0.0 111.215 171.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.17 90.96 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.836 0.731 . . . . 0.0 113.184 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.43 -42.29 86.97 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.045 0.922 . . . . 0.0 111.073 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.26 70.4 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.424 173.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.77 -43.26 76.57 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.874 0.761 . . . . 0.0 111.961 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.2 mt -64.6 -47.76 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.431 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.56 -32.89 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.965 1.257 . . . . 0.0 112.9 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.25 -44.84 94.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.939 0.895 . . . . 0.0 111.468 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.39 -36.87 60.82 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.683 1.593 . . . . 0.0 113.428 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 128.425 2.69 . . . . 0.0 114.577 -172.73 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.89 135.06 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.482 1.113 . . . . 0.0 108.402 163.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -126.07 154.84 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.092 1.357 . . . . 0.0 109.688 170.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.56 116.7 32.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.519 0.728 . . . . 0.0 109.139 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.46 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.514 0.673 . . . . 0.0 112.474 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.85 -26.53 68.8 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -173.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.87 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.81 1.244 . . . . 0.0 113.019 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.94 3.09 85.81 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.458 1.028 . . . . 0.0 114.08 -175.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.21 35.39 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.823 1.312 . . . . 0.0 109.683 174.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.53 29.49 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 168.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.9 123.31 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.086 1.354 . . . . 0.0 108.698 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.58 139.66 38.57 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.555 0.693 . . . . 0.0 111.23 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.09 48.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.491 1.916 . . . . 0.0 107.921 169.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.4 20.9 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.248 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.56 136.85 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.605 -0.685 . . . . 0.0 111.555 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.65 129.98 93.26 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.136 0.575 . . . . 0.0 111.149 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.02 -34.58 68.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.907 2.405 . . . . 0.0 113.586 167.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.44 -38.08 86.6 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.513 -0.742 . . . . 0.0 112.588 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.87 -44.34 97.19 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.767 0.712 . . . . 0.0 111.386 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.52 -44.33 94.57 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.296 0.498 . . . . 0.0 112.267 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.23 -47.22 86.14 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.139 0.576 . . . . 0.0 111.4 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.24 95.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.664 0.786 . . . . 0.0 111.899 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.14 -47.12 87.25 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.795 0.838 . . . . 0.0 112.772 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.1 t -56.91 -54.3 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.392 0.542 . . . . 0.0 110.41 174.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.81 -37.18 78.42 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.324 1.05 . . . . 0.0 113.247 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.57 -52.19 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.044 1.338 . . . . 0.0 111.286 170.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.91 -35.86 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.972 0.509 . . . . 0.0 111.412 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -58.66 -23.79 59.96 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.52 -25.58 11.31 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -135.94 16.12 3.29 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.42 -37.4 2.33 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -175.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -118.31 13.91 13.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.473 1.109 . . . . 0.0 113.148 -172.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.1 p -113.15 153.02 45.52 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.962 0.905 . . . . 0.0 111.515 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.82 -30.91 59.64 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.287 2.658 . . . . 0.0 115.218 -172.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.91 64.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.61 -32.24 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.406 1.003 . . . . 0.0 112.422 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.6 mt -70.33 -57.15 6.05 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.684 1.194 . . . . 0.0 112.572 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.86 -29.45 58.49 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.896 1.713 . . . . 0.0 112.816 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.29 -40.08 77.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.818 1.19 . . . . 0.0 112.694 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -57.17 -47.05 82.18 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.878 0.763 . . . . 0.0 111.537 169.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -60.88 -44.21 97.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.79 -31.61 70.97 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.193 0.997 . . . . 0.0 113.297 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.88 4.74 52.54 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.368 1.467 . . . . 0.0 113.55 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.0 p -133.15 22.73 4.12 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.57 120.29 5.96 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.474 -1.391 . . . . 0.0 111.456 168.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.53 60.15 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.47 130.82 46.91 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.528 1.664 . . . . 0.0 112.53 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.28 159.66 84.43 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.718 0.807 . . . . 0.0 110.692 167.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.61 -35.37 37.49 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.144 1.896 . . . . 0.0 115.4 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.03 -40.3 87.18 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.3 93.89 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.066 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.55 -44.28 94.62 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.329 1.051 . . . . 0.0 112.175 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -59.24 -41.37 88.58 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.612 -0.68 . . . . 0.0 112.047 171.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.2 -45.41 93.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.597 0.635 . . . . 0.0 111.115 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.28 -48.85 77.84 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.187 0.903 . . . . 0.0 112.176 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.0 mt -63.18 -38.33 90.73 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.06 -34.16 71.62 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -72.78 -12.98 61.21 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.36 13.15 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.315 1.046 . . . . 0.0 113.557 -175.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.48 -5.92 4.11 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 117.055 1.582 . . . . 0.0 117.055 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.71 -0.2 6.38 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 125.909 1.719 . . . . 0.0 116.845 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -124.71 79.76 1.8 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.347 1.574 . . . . 0.0 110.385 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.87 -36.03 47.07 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.718 1.607 . . . . 0.0 115.304 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.2 -40.98 74.29 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.154 1.343 . . . . 0.0 112.191 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.44 -43.75 84.73 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.254 0.622 . . . . 0.0 111.315 173.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.2 tpp -62.77 -40.3 96.87 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.491 -0.756 . . . . 0.0 112.257 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.05 -49.95 74.26 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.292 1.037 . . . . 0.0 111.544 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -56.0 -45.42 79.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.101 0.961 . . . . 0.0 112.234 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.88 -48.84 78.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.308 0.643 . . . . 0.0 112.054 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.69 -38.3 90.58 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.873 0.869 . . . . 0.0 112.424 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.95 -45.49 92.49 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.705 0.684 . . . . 0.0 112.034 170.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.7 m -62.65 -42.36 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.793 0.724 . . . . 0.0 112.118 175.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.87 -46.08 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.507 -0.745 . . . . 0.0 111.045 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.4 93.96 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.838 0.745 . . . . 0.0 112.717 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -60.84 -47.41 86.48 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.743 0.817 . . . . 0.0 111.958 174.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.12 -34.34 72.96 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.593 -0.692 . . . . 0.0 112.859 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.56 91.81 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.484 -0.76 . . . . 0.0 112.371 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.09 98.58 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.246 0.619 . . . . 0.0 111.766 172.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.17 -42.22 99.37 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.864 -0.523 . . . . 0.0 112.191 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.71 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.06 -30.22 71.43 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.19 -39.06 78.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.342 1.057 . . . . 0.0 112.488 173.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.57 42.28 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.796 1.239 . . . . 0.0 113.354 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.0 53.92 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.94 120.15 7.43 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.452 2.101 . . . . 0.0 110.285 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.44 136.36 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.372 1.469 . . . . 0.0 112.077 -169.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -80.0 160.47 25.87 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.048 0.539 . . . . 0.0 110.909 168.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.24 -19.98 65.03 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.91 174.81 41.58 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.075 1.322 . . . . 0.0 112.625 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.64 169.18 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.635 2.89 . . . . 0.0 112.889 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.68 -39.19 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.903 1.281 . . . . 0.0 111.749 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.46 161.89 28.6 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.842 1.657 . . . . 0.0 110.551 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.427 2.751 . . . . 0.0 113.132 168.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.98 -15.08 60.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.567 1.08 . . . . 0.0 115.01 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.23 145.48 54.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.691 -0.631 . . . . 0.0 110.859 168.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.47 152.82 44.86 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.2 131.69 84.94 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.83 170.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.44 140.36 43.69 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.097 1.864 . . . . 0.0 112.426 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -75.04 171.62 13.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.649 1.58 . . . . 0.0 111.89 163.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.55 -43.85 94.02 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.949 -0.469 . . . . 0.0 113.035 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.76 -25.85 64.94 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.63 -41.63 65.32 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.061 -1.025 . . . . 0.0 111.795 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.75 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.784 0.834 . . . . 0.0 110.782 173.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.26 14.02 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 173.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.93 18.16 74.16 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.908 -1.12 . . . . 0.0 115.491 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.26 -19.46 19.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.053 1.426 . . . . 0.0 113.263 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.0 p -126.1 -1.49 7.09 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.67 149.89 24.53 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.052 0.941 . . . . 0.0 111.814 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.0 p -81.76 162.31 22.97 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.318 0.58 . . . . 0.0 110.827 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.75 -39.43 73.97 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.446 -0.784 . . . . 0.0 111.43 169.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.56 -38.9 92.89 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.516 -0.74 . . . . 0.0 112.706 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.76 95.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 112.008 171.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.68 -46.36 90.66 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.156 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.47 -46.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.091 0.956 . . . . 0.0 110.288 172.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.1 54.01 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 0.0 112.869 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.07 73.19 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.512 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.61 -18.53 64.33 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.91 8.36 20.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.645 1.178 . . . . 0.0 112.996 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.44 162.33 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.995 1.318 . . . . 0.0 111.447 165.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.6 103.34 48.91 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.065 0.946 . . . . 0.0 110.778 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.451 0.84 . . . . 0.0 111.762 -6.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -50.0 141.36 29.81 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.155 2.57 . . . . 0.0 114.205 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.11 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.56 -34.84 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -173.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.21 94.29 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.605 0.639 . . . . 0.0 112.996 173.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.84 -36.9 75.95 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.289 -1.124 . . . . 0.0 112.645 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.9 -44.57 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.745 -0.597 . . . . 0.0 109.914 173.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.91 -40.35 91.4 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.282 -0.886 . . . . 0.0 112.521 176.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.87 -42.07 75.34 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.439 -0.788 . . . . 0.0 112.204 173.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.63 -45.25 81.66 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.899 0.772 . . . . 0.0 112.093 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.28 -40.53 86.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.66 -47.08 94.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.085 0.554 . . . . 0.0 110.285 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.26 -37.32 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.645 1.178 . . . . 0.0 112.298 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.82 98.41 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.028 0.831 . . . . 0.0 111.185 171.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.48 -45.21 91.12 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.878 0.751 . . . . 0.0 113.228 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.38 -42.3 86.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.003 0.901 . . . . 0.0 111.14 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.26 70.4 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.424 173.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.83 -43.19 76.74 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.874 0.761 . . . . 0.0 111.975 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.6 -47.79 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.344 0.658 . . . . 0.0 111.431 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.89 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.961 1.255 . . . . 0.0 112.9 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -60.26 -44.87 94.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.939 0.895 . . . . 0.0 111.461 171.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.33 -36.95 60.99 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.672 1.589 . . . . 0.0 113.45 -177.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 128.454 2.702 . . . . 0.0 114.562 -172.701 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.85 135.0 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.488 1.115 . . . . 0.0 108.482 163.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.65 32.46 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.43 178.06 6.88 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 121.529 0.68 . . . . 0.0 112.46 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.88 -26.56 68.84 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.03 3.02 85.65 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.475 1.036 . . . . 0.0 114.07 -175.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.71 128.2 35.35 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.893 1.347 . . . . 0.0 109.712 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.55 29.51 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 168.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.94 123.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.074 1.349 . . . . 0.0 108.629 -174.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.65 141.14 48.49 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.488 1.915 . . . . 0.0 107.89 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.29 21.03 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.023 0.829 . . . . 0.0 111.254 170.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.48 136.85 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.523 0.678 . . . . 0.0 111.55 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.69 130.0 93.21 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.068 0.547 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.02 -34.58 68.22 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.894 2.396 . . . . 0.0 113.583 167.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.44 -38.06 86.55 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.437 -0.789 . . . . 0.0 112.588 174.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.95 -44.31 97.47 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 0.0 111.349 171.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.57 -44.35 94.36 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.29 0.496 . . . . 0.0 112.309 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.12 -47.31 85.73 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.142 0.577 . . . . 0.0 111.388 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.32 95.29 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.604 0.761 . . . . 0.0 111.896 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -60.07 -47.29 86.47 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.849 0.859 . . . . 0.0 112.791 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.6 t -56.74 -54.94 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 118.417 0.553 . . . . 0.0 110.254 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.15 -37.71 77.98 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.371 1.068 . . . . 0.0 113.237 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.21 -51.96 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.064 1.346 . . . . 0.0 111.28 170.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.81 -35.87 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.993 0.517 . . . . 0.0 111.485 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -58.94 -23.29 61.29 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.709 1.141 . . . . 0.0 113.972 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.55 -25.91 11.15 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -135.9 16.26 3.3 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -165.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.65 -37.47 2.6 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -118.3 14.58 13.86 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.39 1.076 . . . . 0.0 113.1 -172.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -113.77 153.02 46.05 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.004 0.922 . . . . 0.0 111.526 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.9 -30.79 59.87 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.274 2.649 . . . . 0.0 115.224 -172.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.09 -20.64 64.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.78 -31.96 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.397 0.998 . . . . 0.0 112.539 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.38 -55.08 6.3 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.974 1.31 . . . . 0.0 112.944 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.85 -30.07 49.59 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.658 1.628 . . . . 0.0 112.669 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.04 -40.3 78.68 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.921 1.237 . . . . 0.0 112.606 172.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.25 -46.46 82.99 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.735 0.698 . . . . 0.0 111.576 169.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -61.1 -44.47 97.31 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.84 -31.95 71.37 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.317 1.047 . . . . 0.0 113.25 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.47 4.58 53.13 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.333 1.453 . . . . 0.0 113.526 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.1 p -133.09 22.8 4.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.58 120.34 6.04 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.47 168.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.69 60.07 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.371 0.909 . . . . 0.0 115.371 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.54 130.89 47.14 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.565 1.683 . . . . 0.0 112.515 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.33 159.69 84.29 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 123.748 0.819 . . . . 0.0 110.718 167.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.61 -35.44 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.204 1.936 . . . . 0.0 115.372 168.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.24 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.35 93.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -59.2 -41.49 88.66 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.696 -0.628 . . . . 0.0 112.024 171.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.22 -45.33 93.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.569 0.622 . . . . 0.0 111.091 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.33 -48.86 77.88 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.205 0.911 . . . . 0.0 112.164 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.19 -38.33 90.76 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.06 -33.7 71.09 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.4 p -73.07 -12.92 61.09 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.17 8.9 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -174.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.86 -5.55 7.55 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 117.267 1.667 . . . . 0.0 117.267 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.23 -31.24 59.12 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.318 1.559 . . . . 0.0 115.648 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -93.42 78.44 4.41 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.962 1.381 . . . . 0.0 110.536 172.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.07 -35.8 36.64 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.03 73.96 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.154 1.343 . . . . 0.0 112.243 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.58 85.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.199 0.599 . . . . 0.0 111.35 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.06 -40.08 96.64 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.53 -0.732 . . . . 0.0 112.238 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.96 74.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.247 1.019 . . . . 0.0 111.529 173.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -55.9 -45.5 78.63 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.1 0.96 . . . . 0.0 112.228 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.92 -48.77 78.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.265 0.626 . . . . 0.0 112.035 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.69 -38.31 90.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.873 0.869 . . . . 0.0 112.49 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.96 -45.49 92.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.689 0.677 . . . . 0.0 112.02 170.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.6 -42.43 99.57 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.848 0.749 . . . . 0.0 112.13 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.83 -46.08 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.535 -0.728 . . . . 0.0 111.059 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.21 -39.35 93.79 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.858 0.754 . . . . 0.0 112.731 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.84 -47.39 86.59 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.964 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.19 -34.27 72.74 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.6 91.91 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.451 -0.781 . . . . 0.0 112.333 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -42.04 98.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.224 0.61 . . . . 0.0 111.783 172.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.19 -42.26 99.33 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.855 -0.528 . . . . 0.0 112.191 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.74 -48.55 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.625 0.648 . . . . 0.0 111.71 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -63.04 -30.3 71.49 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -38.99 78.83 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.33 1.052 . . . . 0.0 112.458 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.36 -27.5 41.95 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.776 1.23 . . . . 0.0 113.313 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.84 61.02 53.98 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.622 1.969 . . . . 0.0 111.241 -174.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -63.91 120.12 7.38 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.479 2.119 . . . . 0.0 110.293 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.39 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.32 1.448 . . . . 0.0 112.135 -169.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.03 160.49 25.83 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.083 0.553 . . . . 0.0 110.897 168.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -19.93 65.01 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.94 174.77 41.59 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.032 1.301 . . . . 0.0 112.656 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.57 169.17 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.66 2.907 . . . . 0.0 112.906 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.69 -39.14 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.843 1.257 . . . . 0.0 111.824 -175.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.91 28.57 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.83 133.41 22.44 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.519 2.812 . . . . 0.0 113.132 168.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.9 -15.0 60.33 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.607 1.099 . . . . 0.0 114.992 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.992 1.396 . . . . 0.0 110.198 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.52 54.19 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.694 -0.629 . . . . 0.0 110.787 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.47 152.84 44.83 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.3 131.73 84.73 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 118.945 -0.55 . . . . 0.0 109.824 170.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.38 140.38 43.93 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.074 1.849 . . . . 0.0 112.442 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -74.98 171.61 13.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.761 1.625 . . . . 0.0 111.872 163.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.64 -43.82 94.19 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.912 -0.493 . . . . 0.0 112.974 168.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.5 p -68.74 -25.85 64.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.72 -41.64 65.0 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.082 -1.011 . . . . 0.0 111.725 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.63 -42.69 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.718 0.807 . . . . 0.0 110.827 173.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.96 -1.34 14.13 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.21 74.24 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 120.877 -1.139 . . . . 0.0 115.463 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.31 -19.46 19.24 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.099 1.449 . . . . 0.0 113.263 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.12 -1.42 7.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.7 149.87 24.57 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.073 0.949 . . . . 0.0 111.788 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.1 p -81.76 162.33 22.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.318 0.58 . . . . 0.0 110.827 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.78 -39.47 74.14 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.418 -0.801 . . . . 0.0 111.347 169.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.52 -38.9 92.89 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.554 -0.716 . . . . 0.0 112.722 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.62 -42.76 95.3 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.584 -0.698 . . . . 0.0 112.033 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.65 -46.39 90.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.687 0.795 . . . . 0.0 112.097 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.29 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.338 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.51 -51.02 54.73 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.81 0.719 . . . . 0.0 112.927 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.27 -50.04 73.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.819 0.81 . . . . 0.0 112.542 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.69 -18.49 64.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.0 p -111.93 8.46 20.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.643 1.177 . . . . 0.0 113.062 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.45 162.31 1.62 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.989 1.316 . . . . 0.0 111.441 165.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.37 48.93 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.029 0.932 . . . . 0.0 110.758 176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.06 163.81 89.24 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.494 0.855 . . . . 0.0 111.713 -6.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -49.93 141.36 29.3 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.199 2.6 . . . . 0.0 114.149 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.16 96.45 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 163.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -86.0 54.56 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.251 2.634 . . . . 0.0 112.86 -152.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.56 -34.86 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.22 94.31 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.638 0.654 . . . . 0.0 112.999 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -69.9 -36.83 75.72 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.327 -1.102 . . . . 0.0 112.688 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.87 -44.64 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.795 -0.566 . . . . 0.0 109.912 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.88 -40.34 91.52 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.303 -0.873 . . . . 0.0 112.564 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.88 -41.98 75.26 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.412 -0.805 . . . . 0.0 112.253 173.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.69 -45.16 81.95 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.924 0.784 . . . . 0.0 112.147 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.33 -40.53 85.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.29 0.636 . . . . 0.0 112.251 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.67 -47.09 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.085 0.554 . . . . 0.0 110.249 174.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.19 -37.39 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.674 1.19 . . . . 0.0 112.3 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.8 -42.79 98.31 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.011 0.823 . . . . 0.0 111.253 171.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.11 91.4 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.796 0.712 . . . . 0.0 113.265 175.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.46 -42.3 87.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.01 0.905 . . . . 0.0 111.092 173.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.19 70.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.23 77.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.86 0.755 . . . . 0.0 111.986 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.41 -47.91 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.415 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -69.64 -32.8 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.0 1.273 . . . . 0.0 112.86 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.11 -44.02 95.18 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.863 0.865 . . . . 0.0 111.505 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.3 ttp -77.04 -37.36 54.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.652 1.581 . . . . 0.0 113.558 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.251 1.177 0 C-N-CA 128.427 2.691 . . . . 0.0 114.649 -172.059 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.48 0.686 0 N-CA-C 112.997 0.345 . . . . 20.0 112.997 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.99 135.01 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.473 1.109 . . . . 20.0 108.448 163.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.81 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 20.0 109.686 170.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.47 116.7 32.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.531 0.733 . . . . 20.0 109.17 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.503 0.668 . . . . 20.0 112.495 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.82 -26.57 68.81 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.432 1.271 . . . . 20.0 114.432 -173.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 20.0 113.03 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.0 3.07 85.68 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.475 1.036 . . . . 20.0 114.058 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.22 35.46 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.847 1.323 . . . . 20.0 109.731 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.52 29.47 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.453 -0.573 . . . . 20.0 109.453 168.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.9 123.39 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.014 1.326 . . . . 20.0 108.648 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 20.0 111.213 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.67 141.12 48.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.511 1.924 . . . . 20.0 107.935 169.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.37 20.84 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.949 0.795 . . . . 20.0 111.191 170.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.53 136.81 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.625 -0.672 . . . . 20.0 111.61 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.62 129.96 93.29 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.084 0.553 . . . . 20.0 111.137 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.05 -34.48 67.98 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.868 2.378 . . . . 20.0 113.542 167.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.51 -38.09 86.46 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.453 -0.779 . . . . 20.0 112.56 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.99 -44.21 97.74 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 20.0 111.354 171.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.58 -44.45 94.02 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.341 0.519 . . . . 20.0 112.256 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.08 -47.19 86.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.076 0.55 . . . . 20.0 111.402 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.2 95.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.64 0.776 . . . . 20.0 111.881 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -60.29 -46.89 88.26 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.81 0.844 . . . . 20.0 112.781 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.9 t -57.0 -54.24 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.412 0.551 . . . . 20.0 110.355 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.8 -37.25 78.59 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.374 1.07 . . . . 20.0 113.229 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.22 -52.31 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.206 1.403 . . . . 20.0 111.233 170.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.08 -36.14 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.022 0.529 . . . . 20.0 111.405 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -58.55 -23.85 59.37 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.978 1.103 . . . . 20.0 113.978 175.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.47 -25.47 11.38 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.04 1.126 . . . . 20.0 114.04 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -136.19 16.09 3.24 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.367 1.247 . . . . 20.0 114.367 -165.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.08 -36.78 2.71 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.478 2.029 . . . . 20.0 116.478 -175.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.48 15.34 13.78 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.492 1.117 . . . . 20.0 113.098 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -114.87 153.01 47.0 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.961 0.904 . . . . 20.0 111.456 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.96 -30.6 59.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.218 2.612 . . . . 20.0 115.238 -172.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.17 -20.74 64.45 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.173 1.175 . . . . 20.0 114.173 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.88 -31.82 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.468 1.031 . . . . 20.0 112.548 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.7 mt -71.47 -54.98 6.26 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.927 1.291 . . . . 20.0 113.01 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.89 -30.16 49.16 Favored 'Trans proline' 0 C--N 1.351 0.686 0 CA-C-N 121.673 1.633 . . . . 20.0 112.633 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -68.96 -40.26 79.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.867 1.212 . . . . 20.0 112.674 172.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.3 -46.44 83.17 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.476 0.711 . . . . 20.0 111.576 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.0 m -61.12 -44.53 97.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.608 0.596 . . . . 20.0 112.608 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.8 -31.88 71.26 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.28 1.032 . . . . 20.0 113.315 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.52 4.57 53.07 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.364 1.466 . . . . 20.0 113.499 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.5 p -133.1 22.88 4.14 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.437 1.273 . . . . 20.0 114.437 -176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.63 120.27 5.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.485 -1.384 . . . . 20.0 111.47 168.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.6 11.59 60.19 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 115.365 0.906 . . . . 20.0 115.365 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.45 130.82 46.9 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.542 1.671 . . . . 20.0 112.48 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.33 159.66 84.37 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.706 0.802 . . . . 20.0 110.68 167.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.57 -35.47 37.43 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.144 1.896 . . . . 20.0 115.406 168.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.04 -40.17 87.11 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.098 0.777 . . . . 20.0 113.098 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.42 -45.26 94.26 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.629 -0.669 . . . . 20.0 111.047 172.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.56 -44.28 94.58 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.32 1.048 . . . . 20.0 112.115 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -59.25 -41.39 88.66 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.618 0.644 . . . . 20.0 112.008 171.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.9 m -60.3 -45.28 93.93 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.597 0.635 . . . . 20.0 111.066 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.38 -48.98 77.64 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.218 0.917 . . . . 20.0 112.114 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.04 -38.34 90.8 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.827 0.677 . . . . 20.0 112.827 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.04 -33.66 71.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.89 0.7 . . . . 20.0 112.89 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.8 p -73.1 -12.81 61.04 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.662 1.356 . . . . 20.0 114.662 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.03 7.78 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.357 1.063 . . . . 20.0 113.868 -174.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.09 -5.43 10.05 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 117.46 1.744 . . . . 20.0 117.46 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.05 -35.42 69.21 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 119.32 1.56 . . . . 20.0 115.282 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -85.28 77.84 9.91 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 123.053 1.406 . . . . 20.0 110.56 171.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.98 -35.61 34.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.624 1.57 . . . . 20.0 115.225 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.58 -41.42 72.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.226 1.375 . . . . 20.0 112.306 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.32 -43.59 85.75 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.777 -0.577 . . . . 20.0 111.37 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -63.13 -39.98 96.26 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.475 -0.766 . . . . 20.0 112.239 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -57.05 -49.94 74.27 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.05 -1.031 . . . . 20.0 111.548 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.95 -45.46 78.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 20.0 112.239 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.96 -48.73 79.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.27 0.628 . . . . 20.0 112.034 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.73 -38.37 90.85 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 20.0 112.403 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.78 -45.59 91.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.807 0.73 . . . . 20.0 112.048 170.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.5 m -62.67 -42.41 99.6 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.724 0.693 . . . . 20.0 112.118 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.78 -46.1 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.431 -0.793 . . . . 20.0 111.093 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.12 -39.48 94.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.788 0.722 . . . . 20.0 112.715 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -60.77 -47.45 86.28 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.716 0.806 . . . . 20.0 111.958 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.09 -34.3 72.97 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.901 0.704 . . . . 20.0 112.901 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.59 91.73 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.434 -0.791 . . . . 20.0 112.369 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.11 98.57 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.264 0.625 . . . . 20.0 111.781 172.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.12 -42.27 99.5 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 20.0 112.163 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.81 -48.49 79.57 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.661 0.664 . . . . 20.0 111.669 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.06 -30.33 71.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.906 0.706 . . . . 20.0 112.906 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.17 -38.99 79.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.331 1.052 . . . . 20.0 112.457 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.4 -27.58 41.81 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.807 1.243 . . . . 20.0 113.306 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.1 54.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.587 1.955 . . . . 20.0 111.217 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.0 120.13 7.4 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.483 2.122 . . . . 20.0 110.242 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.41 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.366 1.466 . . . . 20.0 112.158 -169.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.09 160.47 25.76 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.103 0.561 . . . . 20.0 110.903 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -19.97 65.05 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.367 1.247 . . . . 20.0 114.367 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.88 174.81 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.064 1.316 . . . . 20.0 112.68 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.57 169.17 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.66 2.907 . . . . 20.0 112.906 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.73 -39.05 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.843 1.257 . . . . 20.0 111.82 -175.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.55 161.85 28.7 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.877 1.671 . . . . 20.0 110.603 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.92 133.45 22.9 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.473 2.782 . . . . 20.0 113.132 168.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.94 -15.02 60.35 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.567 1.08 . . . . 20.0 115.001 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -78.14 143.36 37.35 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.978 1.389 . . . . 20.0 110.187 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.14 145.58 54.24 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.719 -0.613 . . . . 20.0 110.826 168.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.51 152.69 45.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.717 0.807 . . . . 20.0 111.616 171.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.21 131.73 84.9 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.917 -0.563 . . . . 20.0 109.834 170.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.42 140.27 43.55 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.096 1.864 . . . . 20.0 112.451 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -74.92 171.62 13.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.743 1.617 . . . . 20.0 111.872 163.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.87 94.09 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.935 -0.478 . . . . 20.0 112.998 168.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.75 -25.83 64.93 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.059 1.133 . . . . 20.0 114.059 175.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.6 64.98 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.062 -1.024 . . . . 20.0 111.742 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.65 -42.72 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.731 0.812 . . . . 20.0 110.812 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.29 14.06 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.87 1.063 . . . . 20.0 113.87 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.26 74.28 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 120.865 -1.147 . . . . 20.0 115.393 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.41 19.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.11 1.455 . . . . 20.0 113.263 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.6 p -126.22 -1.46 7.02 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.273 1.212 . . . . 20.0 114.273 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.67 149.96 24.46 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.032 0.933 . . . . 20.0 111.824 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.8 p -82.02 162.43 22.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.347 0.594 . . . . 20.0 110.797 170.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.71 -39.5 73.97 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.404 -0.81 . . . . 20.0 111.454 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.5 -38.95 93.08 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.512 -0.742 . . . . 20.0 112.648 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.55 -42.78 95.47 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.637 -0.665 . . . . 20.0 112.084 171.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.63 -46.36 90.59 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.603 0.761 . . . . 20.0 112.156 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.47 -46.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.091 0.956 . . . . 20.0 110.288 172.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.07 54.18 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 20.0 112.869 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 20.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 20.0 114.434 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.91 8.36 20.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.645 1.178 . . . . 20.0 113.033 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.38 162.3 1.58 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.027 1.331 . . . . 20.0 111.396 165.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.59 103.32 48.95 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.071 0.949 . . . . 20.0 110.837 176.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.13 163.84 89.13 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.462 0.844 . . . . 20.0 111.701 -6.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -50.03 141.37 30.02 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 20.0 114.168 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.3 mt -96.11 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 20.0 104.858 163.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.98 54.57 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 20.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.89 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.029 1.122 . . . . 20.0 114.029 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.27 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.688 0.676 . . . . 20.0 112.958 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.86 -36.86 75.85 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.289 -1.124 . . . . 20.0 112.693 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.89 -44.62 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.808 -0.557 . . . . 20.0 109.952 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.41 91.65 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.303 -0.873 . . . . 20.0 112.533 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -41.97 74.91 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.395 -0.816 . . . . 20.0 112.287 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.74 -45.19 82.13 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.889 0.768 . . . . 20.0 112.12 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.37 -40.54 85.74 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.287 0.635 . . . . 20.0 112.227 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.58 -47.23 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.039 0.536 . . . . 20.0 110.235 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.05 -37.39 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.749 1.22 . . . . 20.0 112.308 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.87 98.53 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.01 0.823 . . . . 20.0 111.194 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.53 -45.02 91.88 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.832 0.729 . . . . 20.0 113.26 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.42 -42.49 87.37 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.002 0.901 . . . . 20.0 111.056 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.5 -50.12 70.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.795 0.838 . . . . 20.0 112.449 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.79 -43.35 76.74 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.915 0.78 . . . . 20.0 111.996 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.6 mt -64.28 -48.32 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.26 0.624 . . . . 20.0 111.366 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.54 -31.48 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.791 1.178 . . . . 20.0 112.981 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -61.43 -42.14 98.29 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.102 0.864 . . . . 20.0 111.642 171.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.3 ttp -80.6 -36.29 32.96 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.726 1.61 . . . . 20.0 113.884 -174.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 1.103 ' OXT' ' C ' ' A' ' 145' ' ' TYR . 70.5 m-85 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 127.784 2.434 . . . . 20.0 114.432 -168.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 N--CA 1.479 0.661 0 N-CA-C 113.01 0.35 . . . . 0.0 113.01 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.58 135.04 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.47 1.108 . . . . 0.0 108.413 163.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -126.07 155.0 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.633 170.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -104.84 116.81 32.64 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.465 0.706 . . . . 0.0 109.143 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.48 178.03 6.93 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.587 0.708 . . . . 0.0 112.441 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.94 -26.43 68.81 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.11 57.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.794 1.237 . . . . 0.0 113.011 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.91 85.85 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.514 1.054 . . . . 0.0 114.128 -175.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.63 128.29 35.68 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.816 1.308 . . . . 0.0 109.695 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.73 29.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 168.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -126.09 123.32 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.075 1.35 . . . . 0.0 108.68 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.57 139.69 38.58 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.18 48.48 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.513 1.925 . . . . 0.0 107.979 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.24 152.35 20.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.202 170.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.86 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.453 0.644 . . . . 0.0 111.555 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 129.96 93.26 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.164 0.585 . . . . 0.0 111.095 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.97 -34.67 68.08 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.907 2.405 . . . . 0.0 113.572 167.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.39 -38.02 86.58 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.508 -0.745 . . . . 0.0 112.594 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.0 -44.31 97.61 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.716 0.689 . . . . 0.0 111.356 171.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.5 -44.33 94.64 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.296 0.498 . . . . 0.0 112.256 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.23 -47.32 85.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.079 0.551 . . . . 0.0 111.417 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.14 96.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.599 0.76 . . . . 0.0 111.896 176.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -60.07 -47.5 85.63 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.844 0.858 . . . . 0.0 112.711 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.2 t -56.7 -54.55 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.4 0.545 . . . . 0.0 110.404 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.5 -37.6 78.69 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.348 1.059 . . . . 0.0 113.221 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.411 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.61 -51.99 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.945 1.298 . . . . 0.0 111.329 170.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.52 -35.94 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.416 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.64 -23.98 60.21 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.2 -25.85 11.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.8 16.25 3.32 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -166.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.05 -38.49 2.34 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -118.06 15.79 14.16 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.36 1.064 . . . . 0.0 113.055 -171.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 p -114.93 152.7 46.76 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.98 0.912 . . . . 0.0 111.464 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.77 -30.68 57.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.282 2.655 . . . . 0.0 115.205 -172.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.69 64.26 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.643 1.177 . . . . 0.0 114.173 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.93 -31.81 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.424 1.011 . . . . 0.0 112.515 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.1 mt -71.45 -55.05 6.23 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.987 1.315 . . . . 0.0 112.972 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.85 -30.14 49.5 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.685 1.637 . . . . 0.0 112.652 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.411 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.6 mtm -69.06 -40.24 78.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.894 1.225 . . . . 0.0 112.65 172.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.22 -46.55 82.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.768 0.713 . . . . 0.0 111.522 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -60.94 -44.69 96.9 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -32.27 71.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.279 1.031 . . . . 0.0 113.246 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.1 4.48 53.65 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.406 1.482 . . . . 0.0 113.539 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.7 p -133.0 22.78 4.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.52 120.35 6.02 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.473 -1.392 . . . . 0.0 111.483 168.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.44 11.63 59.86 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.447 0.939 . . . . 0.0 115.447 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.57 130.88 47.06 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.525 1.663 . . . . 0.0 112.528 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.3 p -73.28 159.66 84.42 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.722 0.809 . . . . 0.0 110.711 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.58 -35.38 37.25 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.134 1.89 . . . . 0.0 115.47 168.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -67.19 -40.2 86.48 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.28 -45.25 93.97 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.626 -0.671 . . . . 0.0 111.098 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.5 mt -63.71 -44.32 93.97 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.351 1.06 . . . . 0.0 112.127 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -59.15 -41.48 88.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.642 0.656 . . . . 0.0 111.984 171.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 m -60.18 -45.28 93.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.599 0.636 . . . . 0.0 111.11 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.42 -48.86 78.01 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.246 0.93 . . . . 0.0 112.153 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.16 -38.44 91.19 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.84 -33.23 70.19 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 p -73.88 -12.44 60.67 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.5 m -122.19 8.14 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.28 -4.5 6.51 Favored Glycine 0 CA--C 1.542 1.753 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.8 -33.51 56.01 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 119.256 1.528 . . . . 0.0 115.389 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -91.18 78.29 5.86 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.802 1.301 . . . . 0.0 110.55 171.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.77 -35.92 34.21 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.95 74.73 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 120.023 1.283 . . . . 0.0 112.303 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.44 -43.54 85.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.194 0.597 . . . . 0.0 111.353 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -62.99 -40.17 96.93 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.545 -0.722 . . . . 0.0 112.263 175.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.95 -49.99 73.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.314 1.045 . . . . 0.0 111.565 173.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.1 tpp -56.04 -45.43 79.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.096 0.958 . . . . 0.0 112.205 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.85 -48.77 79.05 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.289 0.636 . . . . 0.0 112.087 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.72 -38.37 90.84 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.45 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.86 -45.56 92.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.698 0.681 . . . . 0.0 112.014 170.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.9 m -62.56 -42.41 99.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.777 0.717 . . . . 0.0 112.128 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.81 -46.2 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.514 -0.741 . . . . 0.0 111.041 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.07 -39.45 94.09 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.829 0.741 . . . . 0.0 112.759 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.78 -47.46 86.24 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.78 0.832 . . . . 0.0 111.964 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -70.07 -34.41 73.16 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.24 91.71 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.437 -0.789 . . . . 0.0 112.403 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.14 98.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.232 0.613 . . . . 0.0 111.781 172.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.19 99.59 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.834 -0.541 . . . . 0.0 112.183 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.85 -48.69 79.06 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.648 0.658 . . . . 0.0 111.665 173.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.95 -30.13 71.33 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.21 -39.22 78.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.399 1.08 . . . . 0.0 112.443 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.49 42.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.739 1.216 . . . . 0.0 113.32 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.81 60.92 53.35 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 126.675 1.99 . . . . 0.0 111.249 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.94 119.99 7.21 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.509 2.139 . . . . 0.0 110.306 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.24 136.16 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.342 1.457 . . . . 0.0 112.144 -169.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -79.92 160.43 26.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.101 0.561 . . . . 0.0 110.861 168.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.31 -19.8 64.93 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.03 174.68 41.65 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.083 1.325 . . . . 0.0 112.653 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.49 169.11 14.8 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.644 2.896 . . . . 0.0 112.954 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.7 mt -57.65 -39.11 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.894 1.278 . . . . 0.0 111.739 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.54 161.92 28.55 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.841 1.656 . . . . 0.0 110.584 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.96 133.47 23.1 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.479 2.786 . . . . 0.0 113.116 168.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.05 60.32 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.605 1.098 . . . . 0.0 115.019 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.15 143.31 37.37 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.946 1.373 . . . . 0.0 110.234 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.12 145.44 54.38 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.729 -0.607 . . . . 0.0 110.805 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -68.65 153.07 44.46 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.641 0.776 . . . . 0.0 111.673 171.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -72.16 131.7 85.01 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.858 170.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.37 140.53 44.38 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.137 1.891 . . . . 0.0 112.383 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 67.8 mtp85 -75.31 171.59 13.93 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.727 1.611 . . . . 0.0 111.859 163.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.37 -43.72 93.75 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 123.274 0.464 . . . . 0.0 113.04 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.5 p -69.15 -25.64 64.47 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -72.72 -41.66 64.98 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.02 -1.05 . . . . 0.0 111.71 171.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.73 -42.74 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.648 0.779 . . . . 0.0 110.824 173.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.11 -1.16 13.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.0 18.03 74.16 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.953 -1.092 . . . . 0.0 115.453 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.62 19.18 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.147 1.473 . . . . 0.0 113.259 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.2 p -125.9 -0.86 7.26 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.9 p -104.59 149.06 25.84 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.045 0.938 . . . . 0.0 111.798 173.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.4 p -80.95 162.18 23.99 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.348 0.595 . . . . 0.0 110.747 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.2 tp -56.85 -39.32 74.05 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.423 -0.798 . . . . 0.0 111.397 169.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.62 -39.06 93.41 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.558 -0.714 . . . . 0.0 112.644 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -64.37 -42.83 95.97 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.666 -0.646 . . . . 0.0 112.028 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -60.68 -46.35 90.7 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.677 0.791 . . . . 0.0 112.192 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.34 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 110.305 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.43 -51.17 53.36 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.83 0.729 . . . . 0.0 112.913 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.19 -50.08 73.23 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.788 0.794 . . . . 0.0 112.526 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.69 -18.5 64.27 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.1 p -111.81 8.33 20.5 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.675 1.19 . . . . 0.0 113.018 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.36 162.31 1.56 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.009 1.324 . . . . 0.0 111.433 165.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.52 103.38 49.02 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.089 0.956 . . . . 0.0 110.787 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.03 163.83 89.2 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.477 0.849 . . . . 0.0 111.746 -6.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -50.01 141.42 29.71 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.208 2.606 . . . . 0.0 114.173 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.19 96.36 2.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.97 54.6 3.5 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.326 2.684 . . . . 0.0 112.89 -152.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.61 -34.89 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.44 -46.16 94.4 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 118.641 0.655 . . . . 0.0 113.004 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.74 -36.96 76.29 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.313 -1.11 . . . . 0.0 112.667 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.88 -44.63 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.802 -0.561 . . . . 0.0 109.94 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.85 -40.42 91.7 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.327 -0.858 . . . . 0.0 112.547 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -42.02 74.98 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.395 -0.816 . . . . 0.0 112.259 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.72 -45.24 82.0 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.945 0.793 . . . . 0.0 112.093 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.26 -40.53 86.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.308 0.643 . . . . 0.0 112.251 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.68 -47.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.032 0.533 . . . . 0.0 110.279 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.19 -37.37 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.698 1.199 . . . . 0.0 112.263 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.75 98.36 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.039 0.836 . . . . 0.0 111.245 171.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.5 -45.2 91.08 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.879 0.752 . . . . 0.0 113.235 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.4 -42.28 86.81 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.019 0.91 . . . . 0.0 111.114 173.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.52 -50.2 70.6 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.788 0.835 . . . . 0.0 112.43 173.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -55.84 -43.0 76.62 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.872 0.76 . . . . 0.0 112.062 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.0 mt -64.47 -48.64 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.332 0.653 . . . . 0.0 111.361 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.28 -31.61 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.8 1.182 . . . . 0.0 112.978 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.98 -39.64 90.38 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.057 0.844 . . . . 0.0 111.877 171.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.4 ttp -84.45 -33.36 23.66 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.758 1.623 . . . . 0.0 113.976 -173.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 . . . . . 0 C--O 1.255 1.351 0 C-N-CA 127.599 2.36 . . . . 0.0 114.287 -169.744 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.697 0 N-CA-C 112.967 0.333 . . . . 0.0 112.967 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -92.01 135.02 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.51 1.124 . . . . 0.0 108.448 163.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.04 154.69 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.067 1.347 . . . . 0.0 109.709 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.29 116.62 32.47 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.555 0.742 . . . . 0.0 109.166 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.44 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.573 0.702 . . . . 0.0 112.476 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.87 -26.5 68.8 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -85.68 -2.13 57.88 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.792 1.237 . . . . 0.0 112.998 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.21 85.8 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.426 1.012 . . . . 0.0 114.094 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.14 35.13 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.883 1.342 . . . . 0.0 109.695 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.88 125.53 29.48 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 168.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.86 123.39 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.077 1.351 . . . . 0.0 108.648 -174.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.7 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.1 48.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.36 20.98 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.988 0.813 . . . . 0.0 111.217 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.46 136.84 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.605 -0.684 . . . . 0.0 111.537 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.03 93.23 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.1 -34.54 68.75 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.86 2.373 . . . . 0.0 113.572 167.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.48 -38.06 86.47 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.464 -0.773 . . . . 0.0 112.521 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.98 -44.2 97.72 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.805 0.729 . . . . 0.0 111.382 171.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.65 -44.28 94.3 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.341 0.519 . . . . 0.0 112.292 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.26 -47.16 86.39 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.149 0.58 . . . . 0.0 111.338 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.26 95.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.621 0.768 . . . . 0.0 111.856 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -60.31 -46.73 88.83 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.835 0.854 . . . . 0.0 112.818 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.87 -54.53 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.443 0.565 . . . . 0.0 110.31 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.76 -37.23 78.44 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.332 1.053 . . . . 0.0 113.256 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.82 -52.33 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.227 1.411 . . . . 0.0 111.202 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -65.42 -36.08 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.016 0.526 . . . . 0.0 111.484 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.54 -24.05 59.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.2 -25.47 11.5 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.17 16.07 3.24 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -165.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.97 -37.22 2.82 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -175.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.14 15.37 14.09 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.539 1.136 . . . . 0.0 113.087 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -114.9 152.88 46.9 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.937 0.895 . . . . 0.0 111.458 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.75 -30.83 58.42 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.253 2.636 . . . . 0.0 115.222 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -61.93 -20.88 64.27 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.89 -31.84 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.448 1.022 . . . . 0.0 112.512 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.44 -55.07 6.24 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.97 1.308 . . . . 0.0 112.961 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.87 -30.08 49.42 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.72 1.65 . . . . 0.0 112.685 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -68.99 -40.24 78.87 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.849 1.204 . . . . 0.0 112.63 172.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.33 -46.48 83.21 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.771 0.714 . . . . 0.0 111.585 169.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.1 m -61.09 -44.44 97.36 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.76 71.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.281 1.033 . . . . 0.0 113.261 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.61 4.54 53.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.372 1.469 . . . . 0.0 113.508 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.9 p -133.09 22.83 4.14 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -176.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.57 120.31 5.99 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.422 -1.424 . . . . 0.0 111.45 168.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.67 60.04 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.5 130.79 46.75 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.498 1.649 . . . . 0.0 112.53 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.0 p -73.28 159.63 84.51 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.741 0.816 . . . . 0.0 110.666 167.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.46 -35.58 36.67 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.183 1.922 . . . . 0.0 115.422 168.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.96 -40.27 87.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.32 -45.38 93.6 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.662 -0.649 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.53 -44.22 94.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.342 1.057 . . . . 0.0 112.162 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -59.3 -41.35 88.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.587 0.63 . . . . 0.0 112.008 171.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.32 -45.33 93.8 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.65 0.659 . . . . 0.0 111.098 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.29 -48.96 77.57 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.175 0.898 . . . . 0.0 112.143 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.04 -38.6 91.83 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.84 -33.96 71.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.6 p -73.1 -12.64 60.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 m -122.25 7.53 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.68 -5.35 5.08 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 117.094 1.598 . . . . 0.0 117.094 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.56 56.15 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 119.1 1.45 . . . . 0.0 115.519 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -91.22 79.59 5.68 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.977 1.388 . . . . 0.0 110.594 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.82 -36.18 47.1 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.04 -41.21 71.11 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.131 1.332 . . . . 0.0 112.328 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.6 86.3 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.772 -0.58 . . . . 0.0 111.296 172.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.06 -40.07 96.6 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.538 -0.726 . . . . 0.0 112.239 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.91 -50.1 73.6 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.087 -1.008 . . . . 0.0 111.538 173.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.3 tpp -55.99 -45.41 79.01 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.051 0.941 . . . . 0.0 112.231 174.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.93 -48.73 79.14 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.307 0.643 . . . . 0.0 112.109 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.63 -38.31 90.65 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.455 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.03 -45.43 92.85 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 112.019 170.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.6 m -62.67 -42.4 99.6 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.842 0.746 . . . . 0.0 112.113 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.92 -46.04 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.472 -0.768 . . . . 0.0 111.063 174.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.11 -39.44 94.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.876 0.762 . . . . 0.0 112.757 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -60.87 -47.4 86.53 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.714 0.806 . . . . 0.0 111.95 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.12 -34.3 72.92 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.71 -41.79 91.89 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.447 -0.783 . . . . 0.0 112.33 172.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.02 98.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.248 0.619 . . . . 0.0 111.799 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.19 -42.23 99.3 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.812 -0.555 . . . . 0.0 112.211 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.82 -48.38 79.9 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.696 0.68 . . . . 0.0 111.675 173.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -63.16 -30.33 71.5 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.13 -38.96 79.13 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.306 1.042 . . . . 0.0 112.489 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.31 -27.64 42.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.833 1.253 . . . . 0.0 113.346 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.79 61.04 54.13 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.583 1.953 . . . . 0.0 111.22 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.95 120.12 7.39 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.452 2.102 . . . . 0.0 110.266 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.42 136.56 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.283 1.433 . . . . 0.0 112.119 -169.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.07 160.49 25.78 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.098 0.559 . . . . 0.0 110.905 168.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.26 -19.92 64.99 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 174.8 41.62 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.018 1.294 . . . . 0.0 112.602 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.62 169.16 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.944 177.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.61 -39.21 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.88 1.272 . . . . 0.0 111.801 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.49 161.93 28.54 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.817 1.647 . . . . 0.0 110.549 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.441 2.761 . . . . 0.0 113.132 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -15.03 60.34 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.577 1.084 . . . . 0.0 115.065 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.35 37.47 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.928 1.364 . . . . 0.0 110.198 173.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.2 145.62 54.14 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.753 -0.592 . . . . 0.0 110.835 168.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.51 152.72 44.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.717 0.807 . . . . 0.0 111.653 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.27 131.75 84.78 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.886 -0.578 . . . . 0.0 109.797 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.46 140.25 43.31 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.122 1.881 . . . . 0.0 112.414 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.3 mtp85 -74.86 171.58 13.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.716 1.607 . . . . 0.0 111.849 163.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.52 -43.87 93.97 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.934 -0.479 . . . . 0.0 113.029 168.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.73 -25.83 64.95 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 175.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.75 -41.6 64.93 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.986 -1.071 . . . . 0.0 111.739 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.68 -42.69 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.716 0.806 . . . . 0.0 110.756 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.91 -1.32 13.94 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 173.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.91 18.17 74.14 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.603 1.096 . . . . 0.0 115.488 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.3 -19.38 19.31 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.073 1.436 . . . . 0.0 113.284 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.0 p -126.23 -1.48 7.01 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.71 149.99 24.46 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.024 0.93 . . . . 0.0 111.737 173.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 p -81.89 162.32 22.81 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.293 0.568 . . . . 0.0 110.811 170.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.74 -39.49 74.06 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.424 -0.798 . . . . 0.0 111.425 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.59 -38.82 92.59 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.518 -0.739 . . . . 0.0 112.657 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -64.67 -42.75 95.15 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.622 -0.673 . . . . 0.0 111.997 171.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.3 90.87 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.58 0.752 . . . . 0.0 112.146 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.5 -46.4 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.151 0.981 . . . . 0.0 110.256 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.45 -51.04 54.34 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.793 0.711 . . . . 0.0 112.881 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.828 0.814 . . . . 0.0 112.485 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.68 -18.39 64.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.96 8.35 20.24 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.664 1.186 . . . . 0.0 113.033 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.43 162.31 1.6 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.978 1.311 . . . . 0.0 111.412 165.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.36 48.93 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.005 0.922 . . . . 0.0 110.836 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.14 163.81 89.19 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-N 119.462 0.844 . . . . 0.0 111.715 -6.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -49.95 141.29 29.56 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.205 2.604 . . . . 0.0 114.169 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.13 96.49 2.49 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 163.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.92 54.52 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.257 2.638 . . . . 0.0 112.909 -152.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.83 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.26 94.22 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.985 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.91 -36.78 75.65 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.358 -1.084 . . . . 0.0 112.648 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.03 -44.46 99.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.745 -0.597 . . . . 0.0 109.951 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.93 -40.42 91.4 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.313 -0.867 . . . . 0.0 112.489 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -41.96 74.96 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.8 -45.29 82.31 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.912 0.778 . . . . 0.0 112.093 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.25 -40.51 86.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.233 0.613 . . . . 0.0 112.279 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.57 -47.37 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.23 174.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -61.91 -37.29 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.707 1.203 . . . . 0.0 112.355 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.88 -42.83 98.73 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.057 0.844 . . . . 0.0 111.187 171.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.58 -44.99 91.83 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.87 0.748 . . . . 0.0 113.257 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.24 -42.69 86.88 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.876 0.87 . . . . 0.0 110.997 173.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.17 70.6 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.791 0.836 . . . . 0.0 112.454 173.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.74 -43.41 76.58 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 118.87 0.759 . . . . 0.0 111.992 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.1 mt -64.47 -48.19 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.342 0.657 . . . . 0.0 111.361 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.44 -31.66 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.73 1.15 . . . . 0.0 112.983 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -61.67 -43.58 98.58 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.168 0.895 . . . . 0.0 111.649 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.9 ttp -77.11 -35.75 56.12 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.726 1.61 . . . . 0.0 113.696 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 127.641 2.376 . . . . 0.0 114.205 -168.979 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 N--CA 1.48 0.686 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.81 135.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.03 154.89 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.665 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.61 116.71 32.53 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.521 0.729 . . . . 0.0 109.19 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.46 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.507 0.67 . . . . 0.0 112.474 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.54 68.79 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.58 -2.18 57.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.851 1.26 . . . . 0.0 113.043 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.94 3.1 85.8 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.458 1.028 . . . . 0.0 114.08 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.2 35.34 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.883 1.342 . . . . 0.0 109.727 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.85 125.55 29.51 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.94 123.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.074 1.349 . . . . 0.0 108.629 -174.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.58 139.66 38.57 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.487 0.66 . . . . 0.0 111.239 170.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.07 48.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.491 1.916 . . . . 0.0 107.921 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.2 152.37 20.77 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.019 0.827 . . . . 0.0 111.259 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.87 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.462 0.649 . . . . 0.0 111.579 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.01 93.24 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.99 -34.56 67.76 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.907 2.405 . . . . 0.0 113.604 167.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.48 -38.06 86.47 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.457 -0.777 . . . . 0.0 112.594 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 m -60.93 -44.31 97.41 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.691 0.678 . . . . 0.0 111.401 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.52 -44.39 94.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.251 0.478 . . . . 0.0 112.256 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.18 -47.3 85.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.115 0.566 . . . . 0.0 111.366 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.23 95.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.672 0.789 . . . . 0.0 111.908 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -60.16 -47.16 87.08 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.806 0.842 . . . . 0.0 112.783 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.75 -54.57 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.443 0.565 . . . . 0.0 110.375 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.62 -37.36 78.4 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.296 1.039 . . . . 0.0 113.234 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.401 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.43 -52.16 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.094 1.358 . . . . 0.0 111.296 170.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -64.8 -35.86 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 122.909 0.484 . . . . 0.0 111.471 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.74 -23.82 60.56 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.38 -25.64 11.35 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.06 16.16 3.26 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -166.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.42 -37.95 2.57 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -118.17 15.66 14.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.438 1.095 . . . . 0.0 113.057 -172.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.0 p -115.0 152.86 46.97 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.966 0.907 . . . . 0.0 111.463 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.88 -30.61 58.75 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.262 2.641 . . . . 0.0 115.208 -172.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.19 -20.67 64.41 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.87 -31.84 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.41 1.005 . . . . 0.0 112.548 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.6 mt -71.47 -55.05 6.21 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.966 1.307 . . . . 0.0 112.971 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.88 -30.05 49.34 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.653 1.626 . . . . 0.0 112.641 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.401 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.16 -40.16 78.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.867 1.212 . . . . 0.0 112.602 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.25 -46.46 83.01 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.808 0.731 . . . . 0.0 111.576 169.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.6 m -61.12 -44.42 97.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.0 71.51 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.333 1.053 . . . . 0.0 113.208 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.41 4.5 53.27 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.367 1.467 . . . . 0.0 113.488 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.5 p -133.01 22.8 4.16 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.68 120.31 6.05 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 120.477 -1.389 . . . . 0.0 111.477 168.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.63 11.57 60.24 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.377 0.911 . . . . 0.0 115.377 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.52 130.88 47.14 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.575 1.687 . . . . 0.0 112.464 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.39 159.64 84.35 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.758 0.823 . . . . 0.0 110.685 167.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.61 -35.4 37.6 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.144 1.896 . . . . 0.0 115.4 168.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -66.99 -40.29 87.36 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 174.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.35 93.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.039 172.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.56 -44.26 94.64 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 112.133 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -59.17 -41.49 88.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.618 0.645 . . . . 0.0 112.031 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.8 m -60.29 -45.22 94.1 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.582 0.628 . . . . 0.0 111.074 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.37 -48.91 77.8 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.254 0.934 . . . . 0.0 112.179 174.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.13 -38.45 91.24 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.89 -33.45 70.54 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.4 p -73.65 -12.5 60.76 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 m -122.19 7.88 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.72 -4.62 5.77 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 117.159 1.624 . . . . 0.0 117.159 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.88 -33.13 56.19 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 119.224 1.512 . . . . 0.0 115.423 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -91.32 78.7 5.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.892 1.346 . . . . 0.0 110.605 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.26 -35.82 39.1 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -173.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.41 -41.1 73.38 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.086 1.312 . . . . 0.0 112.315 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.28 -43.56 86.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.167 0.587 . . . . 0.0 111.337 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.3 tpp -63.1 -40.1 96.65 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.565 -0.709 . . . . 0.0 112.229 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.93 -50.02 73.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.218 1.007 . . . . 0.0 111.539 173.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.95 -45.5 78.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.044 0.938 . . . . 0.0 112.233 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -61.88 -48.77 79.01 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.276 0.63 . . . . 0.0 112.055 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.64 -38.28 90.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.845 0.858 . . . . 0.0 112.479 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.98 -45.45 92.67 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.668 0.667 . . . . 0.0 112.048 170.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.7 -42.39 99.61 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.815 0.734 . . . . 0.0 112.082 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.85 -46.1 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.441 -0.787 . . . . 0.0 111.059 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.08 -39.46 94.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.831 0.741 . . . . 0.0 112.736 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.84 -47.37 86.69 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.667 0.787 . . . . 0.0 111.971 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -70.13 -34.3 72.89 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.68 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.43 -0.794 . . . . 0.0 112.361 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.11 98.68 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.231 0.613 . . . . 0.0 111.781 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.21 99.57 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 0.0 112.218 174.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.85 -48.55 79.47 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.667 0.667 . . . . 0.0 111.726 173.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.04 -30.25 71.46 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.12 -39.18 79.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.343 1.057 . . . . 0.0 112.499 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.64 42.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 113.29 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.72 61.01 54.1 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.67 1.988 . . . . 0.0 111.247 -174.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.9 120.17 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.452 2.101 . . . . 0.0 110.315 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.36 136.31 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.377 1.471 . . . . 0.0 112.136 -169.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.97 160.45 25.92 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.124 0.57 . . . . 0.0 110.855 168.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.91 65.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.99 174.77 41.63 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.059 1.314 . . . . 0.0 112.64 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.58 169.15 14.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.682 2.921 . . . . 0.0 112.878 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.68 -39.15 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.873 1.269 . . . . 0.0 111.787 -175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.51 161.9 28.6 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.856 1.662 . . . . 0.0 110.561 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.83 133.42 22.44 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.519 2.812 . . . . 0.0 113.132 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.89 -15.0 60.33 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.551 1.072 . . . . 0.0 115.001 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.11 143.39 37.38 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.996 1.398 . . . . 0.0 110.214 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.24 145.52 54.19 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.664 -0.647 . . . . 0.0 110.793 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.52 152.78 44.91 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.674 0.79 . . . . 0.0 111.617 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.23 131.68 84.9 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.883 -0.58 . . . . 0.0 109.821 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.37 140.4 44.03 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.076 1.851 . . . . 0.0 112.426 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -75.08 171.66 13.72 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.679 1.592 . . . . 0.0 111.89 163.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.78 94.19 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.912 -0.493 . . . . 0.0 113.04 168.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.1 p -68.81 -25.78 64.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.7 64.98 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.989 -1.069 . . . . 0.0 111.727 171.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.6 -42.74 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.704 0.801 . . . . 0.0 110.771 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.2 13.79 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.92 18.11 74.09 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.897 -1.127 . . . . 0.0 115.496 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.47 19.29 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.073 1.436 . . . . 0.0 113.29 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -126.18 -1.38 7.04 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.67 149.91 24.51 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.14 0.976 . . . . 0.0 111.763 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.0 p -81.86 162.27 22.87 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.319 0.581 . . . . 0.0 110.778 170.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.74 -39.4 73.89 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.415 -0.803 . . . . 0.0 111.404 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.55 -38.97 93.16 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.481 -0.762 . . . . 0.0 112.659 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.77 95.55 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.39 90.54 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.119 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.4 -46.39 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.203 1.001 . . . . 0.0 110.285 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.01 54.55 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.753 0.692 . . . . 0.0 112.945 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.32 -50.01 73.34 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.751 0.776 . . . . 0.0 112.537 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.69 -18.49 64.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.93 8.42 20.32 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.651 1.18 . . . . 0.0 113.035 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.45 162.31 1.62 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.989 1.316 . . . . 0.0 111.414 165.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.451 0.84 . . . . 0.0 111.701 -6.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.99 141.33 29.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.258 2.639 . . . . 0.0 114.136 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.3 mt -96.15 96.49 2.5 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 163.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -86.02 54.59 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.289 2.659 . . . . 0.0 112.86 -152.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.84 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.36 -46.34 94.07 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 118.605 0.639 . . . . 0.0 112.958 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.82 -36.8 75.93 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.313 -1.11 . . . . 0.0 112.678 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.97 -44.56 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.732 -0.605 . . . . 0.0 109.942 174.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.46 91.67 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.292 -0.88 . . . . 0.0 112.504 176.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.04 75.08 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.275 173.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.67 -45.23 81.82 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.901 0.773 . . . . 0.0 112.12 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.31 -40.5 86.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.296 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.62 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.044 0.538 . . . . 0.0 110.291 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.03 -37.35 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.683 1.193 . . . . 0.0 112.355 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.75 98.19 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.03 0.832 . . . . 0.0 111.275 171.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.67 -45.0 91.52 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.828 0.727 . . . . 0.0 113.23 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.4 -42.42 87.11 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.075 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.21 70.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.811 0.844 . . . . 0.0 112.425 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.79 -43.28 76.68 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.892 0.769 . . . . 0.0 111.968 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.37 -48.36 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.337 0.655 . . . . 0.0 111.415 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.34 -31.74 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 119.725 1.148 . . . . 0.0 113.012 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -61.14 -41.76 97.31 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.074 0.852 . . . . 0.0 111.722 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.7 ttp -80.96 -34.43 33.16 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.738 1.615 . . . . 0.0 113.935 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 127.614 2.366 . . . . 0.0 114.236 -169.036 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.81 135.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.08 154.81 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.685 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.55 116.74 32.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.488 0.715 . . . . 0.0 109.191 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.84 -26.49 68.78 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -173.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.58 -2.21 57.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.852 1.261 . . . . 0.0 112.991 175.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.02 85.77 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.5 1.048 . . . . 0.0 114.144 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.7 128.23 35.47 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.801 1.301 . . . . 0.0 109.678 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.89 125.57 29.55 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.88 123.39 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.11 1.364 . . . . 0.0 108.7 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.71 38.55 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.72 141.11 48.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.465 1.906 . . . . 0.0 107.929 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.27 152.4 20.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.217 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.9 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.607 -0.683 . . . . 0.0 111.579 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.66 130.01 93.24 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.068 0.547 . . . . 0.0 111.125 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.887 2.391 . . . . 0.0 113.575 167.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.41 -38.05 86.6 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.451 -0.78 . . . . 0.0 112.587 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.8 m -60.96 -44.32 97.48 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.747 0.703 . . . . 0.0 111.386 171.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.54 -44.37 94.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.258 0.481 . . . . 0.0 112.244 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.22 -47.27 85.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.115 0.566 . . . . 0.0 111.37 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.96 -45.26 95.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.67 0.788 . . . . 0.0 111.914 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.22 -47.09 87.42 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.868 0.867 . . . . 0.0 112.774 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.8 t -56.82 -54.55 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.489 0.586 . . . . 0.0 110.31 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.61 -37.4 78.47 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.35 1.06 . . . . 0.0 113.247 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.36 -52.17 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.092 1.357 . . . . 0.0 111.302 170.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.82 -35.99 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.996 0.518 . . . . 0.0 111.407 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.69 -23.86 60.3 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.34 -25.62 11.38 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -136.03 16.15 3.27 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -166.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.47 -37.91 2.61 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -118.08 15.62 14.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.478 1.111 . . . . 0.0 113.107 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.7 p -114.91 152.87 46.9 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.959 0.903 . . . . 0.0 111.49 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.86 -30.63 58.77 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.238 2.625 . . . . 0.0 115.276 -172.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.11 -20.73 64.36 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.81 -31.96 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 119.466 1.03 . . . . 0.0 112.479 176.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.36 -55.07 6.34 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.957 1.303 . . . . 0.0 112.995 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.88 -30.08 49.28 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.681 1.636 . . . . 0.0 112.671 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.05 -40.2 78.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.914 1.234 . . . . 0.0 112.665 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.3 -46.48 83.12 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.421 0.689 . . . . 0.0 111.576 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -61.07 -44.45 97.36 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.85 -32.03 71.45 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.284 1.034 . . . . 0.0 113.278 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.36 4.47 53.36 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.355 1.462 . . . . 0.0 113.484 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -133.03 22.84 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.58 120.3 5.99 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.456 -1.402 . . . . 0.0 111.432 168.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.67 60.04 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 130.88 47.14 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.498 1.649 . . . . 0.0 112.482 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.35 159.66 84.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.753 0.821 . . . . 0.0 110.666 167.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.22 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.34 -45.33 93.83 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.66 -0.65 . . . . 0.0 111.1 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -59.28 -41.34 88.68 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.692 -0.63 . . . . 0.0 112.02 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.27 -45.32 93.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.596 0.634 . . . . 0.0 111.097 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.32 -48.91 77.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.233 0.924 . . . . 0.0 112.179 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.11 -38.46 91.27 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.91 -33.56 70.69 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.9 p -73.5 -12.54 60.82 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.24 7.85 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.54 -4.69 5.55 Favored Glycine 0 CA--C 1.541 1.684 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.96 -32.99 56.57 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.186 1.493 . . . . 0.0 115.435 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -91.28 78.76 5.74 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.918 1.359 . . . . 0.0 110.619 171.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.36 -35.92 40.74 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.43 -41.15 73.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.137 1.335 . . . . 0.0 112.293 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.51 86.07 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.139 0.576 . . . . 0.0 111.329 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.09 -40.12 96.71 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.514 -0.741 . . . . 0.0 112.198 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.98 -49.97 74.1 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.202 1.001 . . . . 0.0 111.518 173.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.97 -45.46 78.92 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.094 0.958 . . . . 0.0 112.245 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.91 -48.77 78.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.331 0.652 . . . . 0.0 112.055 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.66 -38.27 90.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.453 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.01 -45.48 92.62 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.664 0.665 . . . . 0.0 112.048 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.65 -42.37 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.118 175.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.85 -46.14 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.441 -0.787 . . . . 0.0 111.03 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.06 -39.46 94.13 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.842 0.746 . . . . 0.0 112.736 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -60.78 -47.49 86.1 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.943 174.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.06 -34.33 73.07 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.69 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.408 -0.808 . . . . 0.0 112.361 172.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.09 98.7 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.215 0.606 . . . . 0.0 111.751 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.12 -42.25 99.49 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.86 -0.525 . . . . 0.0 112.138 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.81 -48.52 79.5 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.666 0.666 . . . . 0.0 111.722 173.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.11 -30.19 71.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.22 -39.06 78.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.354 1.062 . . . . 0.0 112.482 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.3 -27.6 42.18 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.791 1.236 . . . . 0.0 113.29 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.78 60.99 53.88 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.639 1.976 . . . . 0.0 111.22 -174.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.92 120.21 7.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.481 2.12 . . . . 0.0 110.24 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.46 136.37 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.287 1.435 . . . . 0.0 112.13 -169.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.04 160.47 25.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.075 0.55 . . . . 0.0 110.915 168.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.92 65.01 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.11 1.338 . . . . 0.0 112.655 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.59 169.15 14.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.687 2.925 . . . . 0.0 112.878 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.68 -39.19 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.903 1.281 . . . . 0.0 111.749 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.44 161.97 28.44 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.817 1.647 . . . . 0.0 110.573 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.97 133.45 23.18 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.477 2.785 . . . . 0.0 113.149 168.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.99 60.34 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.613 1.101 . . . . 0.0 115.051 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.38 37.45 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.952 1.376 . . . . 0.0 110.198 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.51 54.26 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.66 -0.65 . . . . 0.0 110.842 168.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.48 152.73 44.98 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.684 0.794 . . . . 0.0 111.653 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.23 131.65 84.93 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.33 140.35 44.06 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -75.02 171.61 13.79 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.733 1.613 . . . . 0.0 111.867 163.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.57 -43.9 94.05 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.876 -0.515 . . . . 0.0 113.021 168.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.79 -25.78 64.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.69 -41.69 65.03 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.064 -1.022 . . . . 0.0 111.757 171.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.54 -42.84 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.73 0.812 . . . . 0.0 110.798 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.95 -1.26 13.83 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.98 18.15 74.24 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.626 1.107 . . . . 0.0 115.445 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.38 19.3 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.131 1.466 . . . . 0.0 113.301 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -126.2 -1.48 7.03 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.66 149.96 24.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.052 0.941 . . . . 0.0 111.788 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.5 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.293 0.568 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.83 -39.4 74.15 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.441 -0.787 . . . . 0.0 111.374 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.52 -38.93 93.02 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.531 -0.73 . . . . 0.0 112.685 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.64 -42.73 95.27 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 112.031 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.66 -46.37 90.58 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.651 0.78 . . . . 0.0 112.143 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.32 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.301 172.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.45 -51.06 54.19 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.782 0.706 . . . . 0.0 112.884 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 0.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.64 -18.49 64.3 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.87 8.36 20.4 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.703 1.201 . . . . 0.0 113.051 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.44 162.31 1.61 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.995 1.318 . . . . 0.0 111.447 165.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.34 48.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.035 0.934 . . . . 0.0 110.837 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.447 0.838 . . . . 0.0 111.701 -6.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.99 141.33 29.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.258 2.639 . . . . 0.0 114.136 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.17 96.48 2.51 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 163.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -86.0 54.56 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.257 2.638 . . . . 0.0 112.86 -152.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.56 -34.83 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.26 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.999 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.83 -36.87 75.95 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.91 -44.6 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.709 -0.62 . . . . 0.0 109.942 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.78 -40.5 92.02 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.307 -0.871 . . . . 0.0 112.559 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.78 -41.97 74.85 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.468 -0.77 . . . . 0.0 112.287 173.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.76 -45.22 82.2 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.889 0.768 . . . . 0.0 112.093 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.31 -40.5 86.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.296 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.62 -47.19 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.067 0.547 . . . . 0.0 110.272 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.15 -37.35 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.682 1.193 . . . . 0.0 112.292 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.82 -42.76 98.3 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.011 0.823 . . . . 0.0 111.244 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.59 -45.03 91.61 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.87 0.748 . . . . 0.0 113.252 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.4 -42.42 87.11 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.075 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.49 -50.16 70.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.811 0.844 . . . . 0.0 112.453 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.81 -43.27 76.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.875 0.762 . . . . 0.0 112.005 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.37 -48.36 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.337 0.655 . . . . 0.0 111.415 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.34 -31.81 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 119.725 1.148 . . . . 0.0 113.012 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -61.03 -42.07 97.76 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.058 0.845 . . . . 0.0 111.721 171.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.1 ttp -80.47 -34.64 35.73 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.761 1.624 . . . . 0.0 113.901 -174.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 127.621 2.368 . . . . 0.0 114.251 -168.981 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.998 0.345 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.9 mm -92.07 135.01 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.484 1.114 . . . . 0.0 108.489 163.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.03 154.6 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.076 1.35 . . . . 0.0 109.662 170.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.22 116.74 32.71 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.554 0.742 . . . . 0.0 109.201 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.53 177.98 7.01 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.557 0.694 . . . . 0.0 112.436 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.84 -26.54 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.63 -2.2 57.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.81 1.244 . . . . 0.0 113.047 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.97 3.17 85.66 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.418 1.009 . . . . 0.0 114.096 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.14 35.11 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.857 1.328 . . . . 0.0 109.726 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.84 125.55 29.52 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 168.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.84 123.38 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.077 1.351 . . . . 0.0 108.679 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.53 139.63 38.62 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.236 170.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.71 141.16 48.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.431 1.892 . . . . 0.0 107.897 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.28 152.44 20.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.803 . . . . 0.0 111.221 170.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.51 136.86 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.65 -0.656 . . . . 0.0 111.563 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.65 129.96 93.27 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.07 0.548 . . . . 0.0 111.155 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.05 -34.46 67.9 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.864 2.376 . . . . 0.0 113.597 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.55 -38.06 86.32 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.453 -0.779 . . . . 0.0 112.521 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.02 -44.13 97.86 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.805 0.729 . . . . 0.0 111.372 171.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.66 -44.37 93.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.354 0.525 . . . . 0.0 112.311 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.18 -47.11 86.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.424 0.556 . . . . 0.0 111.38 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.05 -45.34 95.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.612 0.765 . . . . 0.0 111.866 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -60.41 -46.39 90.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.808 0.843 . . . . 0.0 112.846 177.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.04 -54.51 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 118.458 0.572 . . . . 0.0 110.302 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.77 -37.11 78.14 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.404 1.082 . . . . 0.0 113.289 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.61 -52.41 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.398 1.479 . . . . 0.0 111.223 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.64 -36.2 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.069 0.548 . . . . 0.0 111.479 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.51 -24.24 60.03 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 175.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -106.93 -25.38 11.67 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -136.32 15.7 3.21 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -165.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.62 -37.36 2.53 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -117.23 12.5 14.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.478 1.111 . . . . 0.0 113.198 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.9 p -111.63 153.21 44.37 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.876 0.87 . . . . 0.0 111.497 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.83 -30.87 59.54 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.284 2.656 . . . . 0.0 115.173 -172.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.09 -20.98 64.59 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.61 -32.13 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.437 1.017 . . . . 0.0 112.458 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.41 -57.17 5.92 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.718 1.207 . . . . 0.0 112.538 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.89 -29.5 58.21 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 121.885 1.709 . . . . 0.0 112.786 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.13 -40.13 78.46 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.779 1.172 . . . . 0.0 112.698 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.25 -47.08 82.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.848 0.749 . . . . 0.0 111.546 169.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m -60.88 -44.11 97.53 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 175.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.54 70.96 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.249 1.019 . . . . 0.0 113.252 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -96.0 4.69 52.44 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.382 1.473 . . . . 0.0 113.491 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.8 p -133.17 22.78 4.11 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -53.57 120.25 5.92 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.437 -1.414 . . . . 0.0 111.42 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.6 11.68 60.35 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 115.391 0.916 . . . . 0.0 115.391 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.84 46.9 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.516 1.658 . . . . 0.0 112.481 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.27 159.68 84.4 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.718 0.807 . . . . 0.0 110.7 167.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.53 -35.5 37.15 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.144 1.896 . . . . 0.0 115.412 168.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.98 -40.32 87.4 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 174.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.29 -45.33 93.72 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.062 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.5 mt -63.53 -44.24 94.79 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.31 1.044 . . . . 0.0 112.151 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -59.26 -41.36 88.61 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.663 -0.648 . . . . 0.0 112.024 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.6 m -60.33 -45.43 93.45 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.626 0.648 . . . . 0.0 111.078 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.17 -49.01 77.29 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.218 0.917 . . . . 0.0 112.17 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.7 mt -63.04 -38.62 91.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.95 -34.2 71.49 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.3 p -72.88 -12.52 61.0 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.44 7.49 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.44 -5.75 5.23 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 117.102 1.601 . . . . 0.0 117.102 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.96 56.42 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 119.053 1.427 . . . . 0.0 115.526 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -90.23 79.8 6.33 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.029 1.414 . . . . 0.0 110.607 171.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -52.1 -36.28 50.44 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.23 -41.32 70.32 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.203 1.365 . . . . 0.0 112.348 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.17 -43.52 86.66 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.784 -0.573 . . . . 0.0 111.335 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -63.15 -40.03 96.38 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.566 -0.708 . . . . 0.0 112.204 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.88 -50.07 73.6 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.072 -1.017 . . . . 0.0 111.538 172.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.03 -45.38 79.19 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.056 0.942 . . . . 0.0 112.22 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.8 tp -61.96 -48.78 78.82 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.295 0.638 . . . . 0.0 112.045 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.71 -38.12 89.9 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.832 0.853 . . . . 0.0 112.45 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.06 -45.53 92.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.653 0.661 . . . . 0.0 112.001 170.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.61 -42.42 99.57 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.806 0.73 . . . . 0.0 112.114 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.9 -46.04 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.506 -0.747 . . . . 0.0 111.037 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -64.16 -39.44 94.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.887 0.767 . . . . 0.0 112.684 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -60.84 -47.44 86.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.934 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -70.05 -34.38 73.14 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.63 -41.98 92.02 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.49 -0.756 . . . . 0.0 112.299 172.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.57 -42.04 98.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.231 0.613 . . . . 0.0 111.784 172.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.15 -42.35 99.44 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.825 -0.547 . . . . 0.0 112.189 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -57.72 -48.48 79.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.677 0.671 . . . . 0.0 111.653 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.06 -30.4 71.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.09 -38.95 79.26 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.359 1.064 . . . . 0.0 112.488 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.44 -27.61 41.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.803 1.241 . . . . 0.0 113.318 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 60.98 53.81 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.583 1.953 . . . . 0.0 111.22 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.89 120.17 7.46 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.456 2.104 . . . . 0.0 110.296 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.52 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.335 1.454 . . . . 0.0 112.154 -169.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.12 160.46 25.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.1 0.56 . . . . 0.0 110.845 168.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.19 -19.96 64.98 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 174.7 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.069 1.319 . . . . 0.0 112.647 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.55 169.2 14.71 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.624 2.883 . . . . 0.0 112.944 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.65 -39.26 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.897 1.279 . . . . 0.0 111.762 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.45 161.91 28.56 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.862 1.665 . . . . 0.0 110.597 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.92 133.42 22.9 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.473 2.782 . . . . 0.0 113.132 168.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -15.05 60.3 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.531 1.063 . . . . 0.0 115.037 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.03 143.35 37.56 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.942 1.371 . . . . 0.0 110.197 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.14 145.64 54.17 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.663 -0.648 . . . . 0.0 110.793 168.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -68.59 152.67 45.05 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.677 0.791 . . . . 0.0 111.69 171.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -72.22 131.78 84.83 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.848 170.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.38 140.26 43.63 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.15 1.9 . . . . 0.0 112.465 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -74.87 171.65 13.65 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.707 1.603 . . . . 0.0 111.879 163.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.54 -44.0 93.95 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.921 -0.487 . . . . 0.0 112.955 168.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.66 -25.9 65.05 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.67 -41.61 65.19 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.057 -1.027 . . . . 0.0 111.777 171.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.66 -42.65 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.737 0.815 . . . . 0.0 110.819 173.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.98 -1.28 13.99 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.93 18.28 74.27 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.899 -1.126 . . . . 0.0 115.437 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.38 -19.39 19.24 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.115 1.458 . . . . 0.0 113.301 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 p -126.21 -1.55 7.02 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.3 p -103.43 150.05 24.22 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.099 0.96 . . . . 0.0 111.783 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.2 p -81.96 162.45 22.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.268 0.556 . . . . 0.0 110.848 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.87 -39.4 74.27 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.444 -0.785 . . . . 0.0 111.445 169.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.52 -38.87 92.8 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.513 -0.742 . . . . 0.0 112.688 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -64.59 -42.8 95.35 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.584 -0.698 . . . . 0.0 112.069 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.68 -46.3 90.87 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.574 0.75 . . . . 0.0 112.155 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.5 -46.36 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.122 0.969 . . . . 0.0 110.288 172.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.42 -51.01 54.42 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.806 0.717 . . . . 0.0 112.945 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.3 -50.09 73.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.751 0.776 . . . . 0.0 112.48 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.66 -18.35 64.26 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -112.01 8.39 20.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.628 1.171 . . . . 0.0 113.035 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.46 162.33 1.62 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.921 1.288 . . . . 0.0 111.461 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.93 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.065 0.946 . . . . 0.0 110.758 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.84 89.15 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.461 0.843 . . . . 0.0 111.713 -6.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -50.0 141.28 29.98 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.216 2.611 . . . . 0.0 114.206 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 74.9 mt -96.1 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 163.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.91 54.48 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.295 2.663 . . . . 0.0 112.884 -152.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.54 -34.85 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.26 94.22 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.985 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.91 -36.84 75.68 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.358 -1.083 . . . . 0.0 112.645 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.92 -44.61 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.753 -0.592 . . . . 0.0 109.987 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.79 -40.39 91.9 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.352 -0.842 . . . . 0.0 112.572 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -55.84 -41.99 75.11 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.476 -0.765 . . . . 0.0 112.287 173.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.76 -45.24 82.16 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.888 0.767 . . . . 0.0 112.125 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.27 -40.56 86.17 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.273 0.629 . . . . 0.0 112.246 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.48 -47.53 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 122.987 0.515 . . . . 0.0 110.216 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.97 -37.12 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.708 1.203 . . . . 0.0 112.326 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.85 98.55 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.107 0.867 . . . . 0.0 111.264 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.85 91.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.838 0.733 . . . . 0.0 113.199 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -58.1 -42.93 86.74 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.02 0.91 . . . . 0.0 110.987 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.24 70.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.842 0.857 . . . . 0.0 112.458 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -55.72 -43.44 76.55 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.894 0.77 . . . . 0.0 111.987 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.9 mt -64.57 -47.48 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 118.707 -0.663 . . . . 0.0 111.452 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.61 -32.99 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 119.918 1.235 . . . . 0.0 112.881 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -60.87 -46.46 90.51 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.949 0.9 . . . . 0.0 111.468 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.4 ttp -72.23 -38.38 68.95 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.588 1.555 . . . . 0.0 113.082 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.7 t80 . . . . . 0 C--O 1.251 1.156 0 C-N-CA 128.345 2.658 . . . . 0.0 114.73 -174.362 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.017 0.353 . . . . 0.0 113.017 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -92.0 135.05 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.51 1.124 . . . . 0.0 108.471 163.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.08 154.66 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.685 170.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.36 116.63 32.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.519 0.728 . . . . 0.0 109.181 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.4 177.97 6.92 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.55 0.69 . . . . 0.0 112.474 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.61 68.82 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.59 -2.12 57.83 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.746 1.219 . . . . 0.0 113.046 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.25 85.75 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.5 1.048 . . . . 0.0 114.066 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.82 128.16 35.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.848 1.324 . . . . 0.0 109.715 174.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.81 125.46 29.38 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 168.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.89 123.39 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.053 1.341 . . . . 0.0 108.659 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.66 141.1 48.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.513 1.925 . . . . 0.0 107.959 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.3 152.38 21.16 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.98 0.809 . . . . 0.0 111.274 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.49 136.85 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.645 -0.659 . . . . 0.0 111.61 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.0 93.24 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.02 -34.56 68.04 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.918 2.412 . . . . 0.0 113.569 167.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.46 -38.08 86.55 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.457 -0.777 . . . . 0.0 112.545 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.98 -44.21 97.7 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.718 0.69 . . . . 0.0 111.425 171.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.58 -44.42 94.11 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.291 0.496 . . . . 0.0 112.256 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.15 -47.17 86.26 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.441 0.564 . . . . 0.0 111.398 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.14 95.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.606 0.763 . . . . 0.0 111.879 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.7 t-105 -60.38 -46.83 88.57 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.734 0.813 . . . . 0.0 112.85 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.98 -54.16 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.436 0.562 . . . . 0.0 110.343 174.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.89 -37.14 78.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.391 1.076 . . . . 0.0 113.249 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.26 -52.46 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.236 1.414 . . . . 0.0 111.236 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.8 t -64.98 -36.09 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.023 0.529 . . . . 0.0 111.441 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.39 -24.04 58.86 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.51 -25.29 11.45 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -136.36 15.98 3.2 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -165.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.05 -36.98 2.77 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 -175.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -117.89 13.61 14.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.415 1.086 . . . . 0.0 113.114 -172.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.4 p -113.03 153.09 45.4 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.944 0.898 . . . . 0.0 111.55 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.88 -30.77 59.6 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.303 2.669 . . . . 0.0 115.181 -172.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -62.05 -20.82 64.36 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.81 -31.83 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.404 1.002 . . . . 0.0 112.525 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.49 -55.02 6.2 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 124.904 1.282 . . . . 0.0 112.968 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.84 -30.15 49.58 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.718 1.649 . . . . 0.0 112.633 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.0 -40.25 78.83 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.911 1.232 . . . . 0.0 112.669 172.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -57.23 -46.53 82.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.716 0.689 . . . . 0.0 111.592 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.2 m -61.04 -44.45 97.39 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.83 71.34 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.317 1.047 . . . . 0.0 113.229 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.54 4.5 53.13 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.455 1.502 . . . . 0.0 113.522 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -133.03 22.76 4.16 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.55 120.26 5.92 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.44 -1.413 . . . . 0.0 111.517 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.52 11.72 60.23 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.57 130.84 46.89 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.546 1.673 . . . . 0.0 112.437 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.31 159.68 84.36 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.7 167.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.53 -35.53 37.25 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.144 1.896 . . . . 0.0 115.412 168.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.96 -40.26 87.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.37 -45.31 93.95 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.695 -0.628 . . . . 0.0 111.038 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -59.18 -41.49 88.61 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.696 -0.628 . . . . 0.0 112.031 171.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.2 m -60.23 -45.28 93.77 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.582 0.628 . . . . 0.0 111.11 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.34 -48.99 77.56 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.246 0.93 . . . . 0.0 112.165 174.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -62.98 -38.38 90.9 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.01 -33.42 70.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.9 p -73.49 -12.72 60.88 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.6 m -122.53 6.98 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.22 -4.1 7.78 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 117.414 1.726 . . . . 0.0 117.414 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.59 -35.58 67.49 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 119.353 1.576 . . . . 0.0 115.173 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -85.35 77.89 9.86 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.944 1.354 . . . . 0.0 110.5 170.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.86 -35.51 32.96 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.597 1.559 . . . . 0.0 115.165 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.6 -41.33 72.45 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.142 1.337 . . . . 0.0 112.345 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.61 86.14 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.767 -0.583 . . . . 0.0 111.362 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -63.11 -40.02 96.4 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.576 -0.702 . . . . 0.0 112.228 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.02 -49.94 74.26 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.018 -1.051 . . . . 0.0 111.523 173.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.97 -45.41 78.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.066 0.946 . . . . 0.0 112.251 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.6 tp -61.94 -48.77 78.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.307 0.643 . . . . 0.0 112.071 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.72 -38.28 90.51 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 0.0 112.44 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.98 -45.49 92.55 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.715 0.689 . . . . 0.0 112.034 170.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.62 -42.43 99.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.793 0.724 . . . . 0.0 112.109 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.82 -46.11 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.426 -0.796 . . . . 0.0 111.03 174.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.12 -39.43 94.03 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.869 0.759 . . . . 0.0 112.724 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -60.82 -47.4 86.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.721 0.808 . . . . 0.0 111.961 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -70.15 -34.3 72.85 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.81 91.08 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.44 -0.788 . . . . 0.0 112.468 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.18 99.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.211 0.604 . . . . 0.0 111.737 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -62.91 -42.12 99.68 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.907 -0.496 . . . . 0.0 112.13 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -58.17 -48.81 79.14 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.641 -0.662 . . . . 0.0 111.751 173.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -62.76 -29.7 70.88 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.73 -39.48 76.78 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.398 1.079 . . . . 0.0 112.52 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.06 -27.59 43.1 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.731 1.212 . . . . 0.0 113.337 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.76 61.1 54.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.675 1.99 . . . . 0.0 111.229 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.77 120.22 7.53 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.484 2.123 . . . . 0.0 110.313 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.38 135.97 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.325 1.45 . . . . 0.0 112.079 -169.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -79.74 160.48 26.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.062 0.545 . . . . 0.0 110.908 168.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.99 65.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 174.78 41.62 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.115 1.34 . . . . 0.0 112.677 174.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.62 169.14 14.95 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.642 2.895 . . . . 0.0 112.906 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.6 -39.22 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.887 1.275 . . . . 0.0 111.787 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.91 28.56 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.845 1.658 . . . . 0.0 110.597 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.89 133.45 22.75 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.473 2.782 . . . . 0.0 113.114 168.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.91 -15.0 60.36 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.577 1.084 . . . . 0.0 115.056 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.32 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.906 1.353 . . . . 0.0 110.198 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.15 145.58 54.22 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.719 -0.613 . . . . 0.0 110.868 168.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -68.39 152.58 45.21 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.682 0.793 . . . . 0.0 111.616 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.07 131.58 85.27 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.805 170.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.26 140.47 44.63 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.051 1.834 . . . . 0.0 112.362 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -75.23 171.83 13.49 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.654 1.582 . . . . 0.0 111.99 162.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.78 -43.98 94.39 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 123.36 0.505 . . . . 0.0 113.012 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.71 -25.89 65.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -72.65 -41.67 65.2 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.977 -1.077 . . . . 0.0 111.764 171.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -62.52 -42.81 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.788 0.835 . . . . 0.0 110.76 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.99 -1.32 14.12 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.92 18.27 74.25 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.827 -1.17 . . . . 0.0 115.423 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.6 p -96.19 -19.53 19.27 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.13 1.465 . . . . 0.0 113.394 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 61.8 p -126.23 -1.55 7.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.613 1.165 . . . . 0.0 114.072 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -103.27 150.21 23.96 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.758 0.823 . . . . 0.0 112.25 173.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.8 p -82.53 162.4 22.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.361 0.601 . . . . 0.0 110.793 170.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.9 tp -56.57 -39.61 73.77 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.52 -0.737 . . . . 0.0 111.368 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.28 -39.0 93.34 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.547 -0.721 . . . . 0.0 112.63 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -64.68 -42.6 95.22 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.478 -0.764 . . . . 0.0 112.152 171.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -60.66 -46.34 90.69 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.618 0.767 . . . . 0.0 112.133 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.38 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.122 0.969 . . . . 0.0 110.288 172.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.43 -51.05 54.14 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.819 0.723 . . . . 0.0 112.9 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.22 -50.14 72.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.866 0.833 . . . . 0.0 112.517 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.63 -18.39 64.29 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.94 8.35 20.26 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.671 1.189 . . . . 0.0 113.051 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.43 162.33 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.978 1.311 . . . . 0.0 111.447 165.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.29 49.02 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.065 0.946 . . . . 0.0 110.821 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.1 163.84 89.14 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.497 0.856 . . . . 0.0 111.713 -6.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -50.01 141.26 30.1 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.231 2.621 . . . . 0.0 114.148 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.04 96.46 2.44 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.84 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.36 -46.24 94.28 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.638 0.654 . . . . 0.0 112.985 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.88 -36.89 75.83 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.362 -1.081 . . . . 0.0 112.645 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.88 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.722 -0.611 . . . . 0.0 109.947 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.92 -40.38 91.38 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.282 -0.886 . . . . 0.0 112.521 176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -42.02 75.05 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.71 -45.19 82.0 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.924 0.784 . . . . 0.0 112.12 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -67.41 -40.49 85.59 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.248 0.619 . . . . 0.0 112.292 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.57 -47.23 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 122.997 0.519 . . . . 0.0 110.235 174.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.05 -37.37 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.749 1.22 . . . . 0.0 112.308 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.85 -42.84 98.63 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.038 0.836 . . . . 0.0 111.216 171.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.55 -45.03 91.75 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.821 0.724 . . . . 0.0 113.252 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.37 -42.48 87.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.055 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.46 -50.17 70.57 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.811 0.844 . . . . 0.0 112.5 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.88 -43.33 77.09 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.855 0.752 . . . . 0.0 111.984 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.2 mt -64.43 -47.62 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.443 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.75 -32.91 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.952 1.251 . . . . 0.0 112.889 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -60.45 -45.86 92.16 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.901 0.88 . . . . 0.0 111.448 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.9 ttp -73.57 -38.43 65.17 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.564 1.546 . . . . 0.0 113.313 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.9 t80 . . . . . 0 C--O 1.255 1.39 0 C-N-CA 128.43 2.692 . . . . 0.0 114.714 -172.964 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.81 135.01 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.92 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.686 170.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.62 116.69 32.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.57 0.748 . . . . 0.0 109.17 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.46 178.06 6.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.46 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.95 -26.44 68.82 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.62 -2.16 57.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.818 1.247 . . . . 0.0 113.03 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.0 85.7 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.67 128.26 35.58 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.858 1.329 . . . . 0.0 109.726 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.92 125.62 29.62 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.99 123.4 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.07 1.348 . . . . 0.0 108.629 -174.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.73 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.75 141.14 48.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.477 1.911 . . . . 0.0 107.948 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.28 152.45 20.89 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.196 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.58 136.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.6 -0.687 . . . . 0.0 111.544 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.69 130.01 93.2 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.068 0.547 . . . . 0.0 111.106 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.05 -34.52 68.15 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.794 2.329 . . . . 0.0 113.607 167.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.46 -38.08 86.54 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.448 -0.783 . . . . 0.0 112.56 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.98 -44.29 97.58 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.753 0.706 . . . . 0.0 111.362 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.45 -44.42 94.56 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.277 0.49 . . . . 0.0 112.275 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.17 -47.28 85.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.162 0.585 . . . . 0.0 111.386 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.17 95.87 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.611 0.764 . . . . 0.0 111.856 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -60.14 -47.46 85.82 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.809 0.843 . . . . 0.0 112.748 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.8 -54.16 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.426 0.557 . . . . 0.0 110.384 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.8 -37.47 79.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.297 1.039 . . . . 0.0 113.207 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.409 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.87 -52.08 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.962 1.305 . . . . 0.0 111.281 170.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.58 -35.81 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.414 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.84 -23.51 60.72 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.72 -25.6 11.21 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -135.78 16.36 3.32 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -166.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.12 -38.35 2.38 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -175.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -118.01 14.08 14.04 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.49 1.116 . . . . 0.0 113.024 -171.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 p -113.13 152.91 45.43 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.997 0.919 . . . . 0.0 111.523 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.83 -30.95 59.87 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.296 2.664 . . . . 0.0 115.214 -172.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.08 -20.94 64.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.59 -32.17 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.413 1.006 . . . . 0.0 112.485 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.37 -57.16 5.98 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.715 1.206 . . . . 0.0 112.555 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.87 -29.43 58.45 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 121.833 1.69 . . . . 0.0 112.809 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.409 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.3 -40.1 77.91 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.841 1.2 . . . . 0.0 112.703 172.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.12 -47.05 82.06 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.885 0.766 . . . . 0.0 111.537 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -60.88 -44.17 97.46 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.84 -31.66 71.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.178 0.991 . . . . 0.0 113.261 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.76 4.59 52.79 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.362 1.465 . . . . 0.0 113.514 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.5 p -133.12 22.86 4.13 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.59 120.34 6.04 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.47 -1.394 . . . . 0.0 111.472 168.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.49 11.69 60.08 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.371 0.909 . . . . 0.0 115.371 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.87 47.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.565 1.683 . . . . 0.0 112.481 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.0 p -73.32 159.67 84.36 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.732 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.57 -35.43 37.32 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.144 1.896 . . . . 0.0 115.406 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.0 -40.34 87.33 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.28 -45.3 93.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.627 -0.671 . . . . 0.0 111.1 172.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.62 -44.23 94.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.343 1.057 . . . . 0.0 112.085 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.3 -41.31 88.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.649 0.659 . . . . 0.0 112.02 171.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.27 -45.41 93.42 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.611 0.642 . . . . 0.0 111.071 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.37 -48.66 78.44 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.192 0.906 . . . . 0.0 112.151 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.1 mt -63.23 -38.36 90.85 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.03 -34.36 71.82 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.627 -0.671 . . . . 0.0 112.776 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.2 p -72.4 -13.39 61.45 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 m -118.19 11.16 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.367 1.067 . . . . 0.0 113.391 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.75 -10.59 4.74 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 117.141 1.616 . . . . 0.0 117.141 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.85 9.5 2.78 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 125.811 1.672 . . . . 0.0 117.009 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -127.85 79.11 1.87 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.232 1.516 . . . . 0.0 110.0 162.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -52.17 -36.0 50.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -171.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.87 -40.9 75.44 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.127 1.331 . . . . 0.0 112.147 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.58 83.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.298 0.639 . . . . 0.0 111.351 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.0 tpp -62.88 -40.3 97.09 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.531 -0.73 . . . . 0.0 112.281 175.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.02 -50.0 74.06 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.267 1.027 . . . . 0.0 111.544 173.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.8 tpp -56.04 -45.45 79.19 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.098 0.959 . . . . 0.0 112.184 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.87 -48.82 78.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.337 0.655 . . . . 0.0 112.017 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.67 -38.31 90.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.905 0.882 . . . . 0.0 112.49 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -60.0 -45.44 92.74 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.689 0.677 . . . . 0.0 112.048 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.64 -42.36 99.56 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.827 0.739 . . . . 0.0 112.118 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.86 -46.11 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.472 -0.768 . . . . 0.0 111.03 174.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.11 -39.43 94.02 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.869 0.759 . . . . 0.0 112.738 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.85 -47.42 86.43 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.758 0.823 . . . . 0.0 111.892 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.09 -34.38 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.47 91.54 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.484 -0.76 . . . . 0.0 112.327 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.11 98.64 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.256 0.622 . . . . 0.0 111.781 172.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.12 -42.22 99.49 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.872 -0.517 . . . . 0.0 112.191 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.71 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.05 -30.24 71.44 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -39.1 78.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.397 1.079 . . . . 0.0 112.45 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.79 60.98 53.75 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.91 120.14 7.42 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.424 2.083 . . . . 0.0 110.315 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.35 136.29 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.332 1.453 . . . . 0.0 112.129 -169.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -80.01 160.47 25.86 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.054 0.541 . . . . 0.0 110.915 168.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.92 65.01 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.11 1.338 . . . . 0.0 112.686 174.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.6 169.19 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.658 2.905 . . . . 0.0 112.889 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.66 -39.2 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.904 1.282 . . . . 0.0 111.753 -175.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.61 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 110.585 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.89 133.38 22.73 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.487 2.791 . . . . 0.0 113.15 168.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.94 -15.04 60.29 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.567 1.08 . . . . 0.0 115.001 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.992 1.396 . . . . 0.0 110.198 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.22 145.58 54.16 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.691 -0.631 . . . . 0.0 110.793 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.54 152.82 44.85 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.655 0.782 . . . . 0.0 111.67 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.27 131.65 84.85 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.29 140.41 44.36 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.11 1.873 . . . . 0.0 112.442 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -75.18 171.62 13.84 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.697 1.599 . . . . 0.0 111.893 163.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.83 94.0 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.971 -0.455 . . . . 0.0 113.03 168.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.85 -25.75 64.8 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.66 64.9 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.03 -1.044 . . . . 0.0 111.779 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.59 -42.76 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 110.82 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.26 14.03 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.16 74.31 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.927 -1.108 . . . . 0.0 115.447 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.34 -19.39 19.27 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.074 1.437 . . . . 0.0 113.284 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.2 p -126.18 -1.44 7.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.71 149.96 24.49 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.036 0.935 . . . . 0.0 111.788 173.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.2 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.282 0.563 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.86 -39.37 74.17 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.451 -0.781 . . . . 0.0 111.394 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.49 -38.98 93.21 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.554 -0.716 . . . . 0.0 112.701 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.82 95.52 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.58 -46.44 90.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.636 0.774 . . . . 0.0 112.142 176.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.43 -46.36 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.158 0.983 . . . . 0.0 110.304 172.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.04 54.4 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.81 0.719 . . . . 0.0 112.93 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.79 0.795 . . . . 0.0 112.485 174.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.9 8.32 20.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.66 1.184 . . . . 0.0 113.033 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.39 162.29 1.59 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.041 1.336 . . . . 0.0 111.39 165.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.36 48.92 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.042 0.937 . . . . 0.0 110.758 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.09 163.83 89.17 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.509 0.86 . . . . 0.0 111.746 -6.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -49.98 141.36 29.67 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.253 2.635 . . . . 0.0 114.117 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.2 96.42 2.49 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -85.96 54.56 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.27 2.647 . . . . 0.0 112.86 -152.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.78 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.19 94.34 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.61 0.641 . . . . 0.0 113.011 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.87 -36.87 75.83 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.326 -1.102 . . . . 0.0 112.634 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.94 -44.56 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.808 -0.557 . . . . 0.0 109.949 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.36 91.58 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.303 -0.873 . . . . 0.0 112.557 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.85 -42.07 75.26 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.472 -0.767 . . . . 0.0 112.217 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -56.59 -45.26 81.49 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 112.087 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.39 -40.41 85.66 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.248 0.619 . . . . 0.0 112.286 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.73 -46.97 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.093 0.557 . . . . 0.0 110.286 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.38 -37.27 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.648 1.179 . . . . 0.0 112.32 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.85 -42.8 98.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.036 0.835 . . . . 0.0 111.176 171.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.24 91.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.878 0.751 . . . . 0.0 113.181 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.48 -42.21 87.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.035 0.918 . . . . 0.0 111.113 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.24 70.44 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.774 0.83 . . . . 0.0 112.399 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.83 -43.06 76.62 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.884 0.765 . . . . 0.0 112.027 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.64 -47.96 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.371 0.668 . . . . 0.0 111.451 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.46 -32.83 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 119.894 1.225 . . . . 0.0 112.895 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.11 -43.85 95.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.867 0.867 . . . . 0.0 111.512 171.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.6 ttp -76.99 -36.27 56.54 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.644 1.577 . . . . 0.0 113.606 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.255 1.375 0 C-N-CA 128.35 2.66 . . . . 0.0 114.599 -172.764 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.75 134.99 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.501 1.121 . . . . 0.0 108.436 163.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.98 154.96 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.114 1.366 . . . . 0.0 109.665 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.7 116.69 32.48 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.555 0.742 . . . . 0.0 109.222 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.46 178.07 6.89 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.604 0.716 . . . . 0.0 112.46 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.87 -26.57 68.84 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.08 57.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.746 1.219 . . . . 0.0 113.002 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.0 85.78 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.487 1.042 . . . . 0.0 114.091 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.75 128.29 35.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.858 1.329 . . . . 0.0 109.714 174.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.86 125.64 29.65 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 168.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.9 t -126.04 123.28 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.103 1.361 . . . . 0.0 108.712 -174.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.53 139.71 38.62 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.15 48.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.465 1.906 . . . . 0.0 107.922 169.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.34 20.89 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.015 0.825 . . . . 0.0 111.233 170.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.57 136.88 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.607 -0.683 . . . . 0.0 111.579 176.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.63 130.02 93.27 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.112 0.565 . . . . 0.0 111.139 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.04 -34.54 68.22 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.864 2.376 . . . . 0.0 113.607 167.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.44 -38.03 86.47 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.463 -0.773 . . . . 0.0 112.588 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 m -60.93 -44.33 97.38 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.722 0.692 . . . . 0.0 111.401 171.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.53 -44.17 95.02 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.3 -47.29 85.96 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.167 0.587 . . . . 0.0 111.416 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.13 95.91 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.626 0.77 . . . . 0.0 111.897 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -60.21 -47.26 86.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.86 0.864 . . . . 0.0 112.73 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.51 -54.95 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 118.471 0.578 . . . . 0.0 110.345 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.48 -37.3 77.87 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.272 1.029 . . . . 0.0 113.178 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.47 -52.16 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.028 1.331 . . . . 0.0 111.29 170.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.68 -36.02 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 119.016 -0.516 . . . . 0.0 111.452 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -58.53 -24.17 59.96 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.04 -25.81 11.43 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.91 15.97 3.31 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -165.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.08 -38.92 2.54 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -116.62 13.73 15.3 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.379 1.072 . . . . 0.0 113.154 -172.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.1 p -112.87 152.95 45.27 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 123.941 0.897 . . . . 0.0 111.544 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.82 -30.77 58.93 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.299 2.666 . . . . 0.0 115.233 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.02 -20.74 64.24 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.8 -31.86 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.435 1.016 . . . . 0.0 112.548 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.45 -55.05 6.24 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.907 1.283 . . . . 0.0 112.956 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.83 -30.12 49.72 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.688 1.639 . . . . 0.0 112.661 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.403 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.07 -40.22 78.61 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.86 1.209 . . . . 0.0 112.64 172.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -57.27 -46.49 83.04 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.719 0.69 . . . . 0.0 111.579 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -61.04 -44.48 97.33 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.07 71.51 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.341 1.056 . . . . 0.0 113.225 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.23 4.44 53.53 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.4 1.48 . . . . 0.0 113.522 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.9 p -133.03 22.82 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.61 120.27 5.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.44 -1.413 . . . . 0.0 111.484 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.59 11.6 60.19 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.422 0.929 . . . . 0.0 115.422 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.51 130.87 47.09 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.525 1.663 . . . . 0.0 112.498 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.35 159.68 84.3 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.758 0.823 . . . . 0.0 110.697 167.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.65 -35.41 37.95 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.204 1.936 . . . . 0.0 115.366 168.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.0 -40.27 87.29 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.33 -45.31 93.88 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.596 -0.69 . . . . 0.0 111.044 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.6 -44.21 94.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.318 1.047 . . . . 0.0 112.175 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -59.24 -41.48 88.82 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.649 -0.657 . . . . 0.0 111.973 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.2 m -60.23 -45.28 93.77 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.614 0.643 . . . . 0.0 111.11 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -57.33 -49.01 77.48 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.246 0.93 . . . . 0.0 112.193 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.02 -38.54 91.59 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.87 -33.22 70.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.9 p -73.68 -13.37 60.97 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.6 m -122.45 6.2 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.5 -4.36 6.65 Favored Glycine 0 CA--C 1.541 1.67 0 N-CA-C 117.243 1.657 . . . . 0.0 117.243 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.75 -35.28 57.61 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 119.179 1.489 . . . . 0.0 115.177 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -86.18 77.95 9.47 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.838 1.304 . . . . 0.0 110.551 170.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.95 -35.91 35.96 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.36 -41.18 73.47 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.047 1.294 . . . . 0.0 112.301 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.36 -43.55 85.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.137 0.575 . . . . 0.0 111.33 173.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 59.8 tpp -63.25 -39.96 96.08 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.47 -0.769 . . . . 0.0 112.223 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -50.0 73.98 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.079 -1.013 . . . . 0.0 111.521 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -56.0 -45.43 79.04 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.88 -48.81 78.85 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.314 0.646 . . . . 0.0 112.055 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.7 -38.21 90.26 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.835 0.854 . . . . 0.0 112.448 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.99 -45.53 92.42 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.664 0.665 . . . . 0.0 112.027 170.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -62.64 -42.37 99.55 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.149 175.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.86 -46.1 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.47 -0.769 . . . . 0.0 111.059 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.08 -39.46 94.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.831 0.741 . . . . 0.0 112.736 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.82 -47.4 86.51 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.958 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.1 -34.32 72.97 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.584 -0.697 . . . . 0.0 112.835 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.92 -41.47 91.35 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.441 -0.787 . . . . 0.0 112.307 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.12 98.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.238 0.615 . . . . 0.0 111.772 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.09 -42.28 99.58 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.915 -0.491 . . . . 0.0 112.138 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -57.8 -48.58 79.32 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.661 0.664 . . . . 0.0 111.71 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.06 -30.24 71.44 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.2 -39.13 78.84 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.391 1.076 . . . . 0.0 112.48 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.26 -27.6 42.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.812 1.245 . . . . 0.0 113.302 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.8 61.02 54.01 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.668 1.987 . . . . 0.0 111.228 -174.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.9 120.13 7.4 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.507 2.138 . . . . 0.0 110.285 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.45 136.23 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.298 1.439 . . . . 0.0 112.121 -169.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -79.85 160.43 26.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.087 0.555 . . . . 0.0 110.915 168.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.27 -19.97 65.05 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.74 41.58 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.048 1.309 . . . . 0.0 112.64 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.58 169.23 14.72 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.611 2.874 . . . . 0.0 112.882 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.66 -39.22 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.925 1.29 . . . . 0.0 111.806 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.62 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.884 1.674 . . . . 0.0 110.631 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.91 133.41 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.456 2.77 . . . . 0.0 113.116 168.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.05 60.34 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 115.005 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.1 143.42 37.36 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.006 1.403 . . . . 0.0 110.185 173.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.2 145.56 54.2 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.721 -0.612 . . . . 0.0 110.842 168.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.49 152.73 44.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.748 0.819 . . . . 0.0 111.666 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -72.26 131.72 84.81 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.808 170.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.33 140.41 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -75.2 171.66 13.77 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.697 1.599 . . . . 0.0 111.889 163.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.5 -43.94 93.9 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.934 -0.479 . . . . 0.0 113.03 168.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.81 -25.73 64.83 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.78 -41.63 64.8 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.05 -1.032 . . . . 0.0 111.728 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.77 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.77 0.828 . . . . 0.0 110.771 173.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.26 13.94 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.2 74.23 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.596 1.093 . . . . 0.0 115.449 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.43 19.26 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.157 1.478 . . . . 0.0 113.283 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.19 -1.42 7.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.74 149.84 24.62 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.082 0.953 . . . . 0.0 111.799 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.5 p -81.78 162.32 22.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.291 0.567 . . . . 0.0 110.779 170.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.74 -39.38 73.85 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.448 -0.783 . . . . 0.0 111.445 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.54 -38.98 93.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.554 -0.716 . . . . 0.0 112.685 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.77 95.55 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.68 -46.35 90.69 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.119 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.33 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 110.268 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.04 54.46 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.795 0.712 . . . . 0.0 112.92 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.29 -50.05 73.22 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.812 0.806 . . . . 0.0 112.537 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.48 64.29 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.87 8.36 20.4 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.703 1.201 . . . . 0.0 113.051 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.5 162.33 1.64 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.991 1.316 . . . . 0.0 111.399 165.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.35 48.98 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.066 0.946 . . . . 0.0 110.813 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.82 89.2 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-N 119.429 0.832 . . . . 0.0 111.69 -6.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.94 141.39 29.27 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.187 2.591 . . . . 0.0 114.171 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.23 96.49 2.54 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 163.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.05 54.62 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.214 2.61 . . . . 0.0 112.83 -152.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.81 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.17 94.4 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.638 0.654 . . . . 0.0 113.011 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.89 -36.84 75.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.296 -1.12 . . . . 0.0 112.634 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.8 mt -62.95 -44.62 99.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.799 -0.563 . . . . 0.0 109.914 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.87 -40.35 91.57 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.327 -0.858 . . . . 0.0 112.521 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -55.86 -42.04 75.25 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.439 -0.788 . . . . 0.0 112.246 173.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.72 -45.23 82.04 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.924 0.784 . . . . 0.0 112.125 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.26 -40.57 86.22 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.294 0.638 . . . . 0.0 112.244 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.57 -47.33 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.23 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.98 -37.36 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.695 1.198 . . . . 0.0 112.301 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.84 -42.77 98.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.039 0.836 . . . . 0.0 111.217 171.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.62 -44.98 91.71 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 123.855 0.74 . . . . 0.0 113.214 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.35 -42.57 87.17 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.007 0.903 . . . . 0.0 110.992 173.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.24 70.37 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.807 0.843 . . . . 0.0 112.483 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.82 -43.28 76.81 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.88 0.764 . . . . 0.0 111.961 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.52 -47.8 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.334 0.654 . . . . 0.0 111.418 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.93 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 119.911 1.232 . . . . 0.0 112.893 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -60.36 -44.86 95.18 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.949 0.9 . . . . 0.0 111.428 171.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.4 ttp -74.89 -35.72 62.25 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.683 1.593 . . . . 0.0 113.422 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.0 t80 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 128.341 2.656 . . . . 0.0 114.546 -173.291 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.042 0.362 . . . . 0.0 113.042 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.97 135.05 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.468 1.107 . . . . 0.0 108.466 163.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.06 154.71 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.662 170.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.4 116.65 32.5 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.534 0.734 . . . . 0.0 109.17 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.41 177.97 6.93 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.557 0.694 . . . . 0.0 112.474 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.55 68.79 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.67 -2.1 57.85 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.798 1.239 . . . . 0.0 113.001 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.12 85.87 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.454 1.026 . . . . 0.0 114.133 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.75 128.17 35.24 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.826 1.313 . . . . 0.0 109.695 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.85 125.5 29.43 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.89 123.39 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.077 1.351 . . . . 0.0 108.674 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.56 139.71 38.58 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.1 48.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.4 20.87 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.988 0.813 . . . . 0.0 111.217 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.53 136.86 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.644 -0.66 . . . . 0.0 111.544 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.68 130.0 93.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.11 0.564 . . . . 0.0 111.137 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.99 -34.6 67.98 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.894 2.396 . . . . 0.0 113.602 167.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -66.44 -38.03 86.49 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.425 -0.797 . . . . 0.0 112.56 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -61.04 -44.26 97.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.747 0.703 . . . . 0.0 111.337 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.54 -44.42 94.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.302 0.501 . . . . 0.0 112.256 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.12 -47.18 86.21 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.121 0.569 . . . . 0.0 111.396 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.19 95.75 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.667 0.787 . . . . 0.0 111.874 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.28 -46.95 88.04 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.779 0.831 . . . . 0.0 112.811 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.8 t -56.9 -54.26 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.4 0.546 . . . . 0.0 110.368 174.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.77 -37.17 78.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.412 1.085 . . . . 0.0 113.287 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.41 -52.35 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.206 1.402 . . . . 0.0 111.209 170.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.96 -36.06 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.958 0.503 . . . . 0.0 111.405 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.48 -24.0 59.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.48 -25.33 11.44 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.23 15.83 3.23 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -165.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.9 -37.07 2.67 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -117.88 13.84 14.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.385 1.074 . . . . 0.0 113.151 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.0 p -113.11 153.11 45.46 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.968 0.907 . . . . 0.0 111.474 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.86 -30.87 59.77 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.25 2.633 . . . . 0.0 115.185 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.11 -20.99 64.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.52 -32.24 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.396 0.998 . . . . 0.0 112.452 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.36 -57.16 6.0 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.726 1.21 . . . . 0.0 112.578 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.88 -29.46 58.31 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.928 1.724 . . . . 0.0 112.764 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.29 -40.09 77.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.866 1.212 . . . . 0.0 112.661 172.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -57.2 -46.98 82.39 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.873 0.76 . . . . 0.0 111.555 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.2 m -60.86 -44.26 97.26 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.65 70.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.248 1.019 . . . . 0.0 113.251 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.85 4.59 52.7 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.436 1.494 . . . . 0.0 113.528 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.9 p -133.13 22.85 4.13 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -176.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.56 120.28 5.96 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.501 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.54 60.17 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.377 0.911 . . . . 0.0 115.377 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 130.82 46.9 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.565 1.682 . . . . 0.0 112.53 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.28 159.71 84.31 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.699 167.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.6 -35.46 37.64 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.209 1.94 . . . . 0.0 115.39 168.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.98 -40.25 87.39 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.45 -45.22 94.48 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.569 -0.707 . . . . 0.0 111.055 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.62 -44.21 94.61 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.307 1.043 . . . . 0.0 112.115 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -59.25 -41.47 88.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.649 0.659 . . . . 0.0 111.965 171.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.9 m -60.25 -45.22 94.03 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.601 0.637 . . . . 0.0 111.066 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.46 -48.88 77.99 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.196 0.907 . . . . 0.0 112.174 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -63.07 -38.34 90.8 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.99 -33.33 70.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.3 p -73.58 -12.72 60.85 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -122.43 7.21 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -174.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.42 -4.06 8.36 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 117.413 1.725 . . . . 0.0 117.413 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.71 -35.2 66.46 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.394 1.597 . . . . 0.0 115.17 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -85.94 77.81 9.61 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.006 1.384 . . . . 0.0 110.537 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.71 -35.55 31.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.663 1.585 . . . . 0.0 115.223 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.48 -41.32 72.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.129 1.331 . . . . 0.0 112.332 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.63 85.94 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.776 -0.577 . . . . 0.0 111.348 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.15 -39.97 96.22 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.548 -0.72 . . . . 0.0 112.22 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.98 -49.97 74.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.223 1.009 . . . . 0.0 111.569 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.96 -45.44 78.87 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 0.0 112.212 174.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.6 tp -61.92 -48.77 78.98 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.344 0.657 . . . . 0.0 112.071 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.71 -38.27 90.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.873 0.869 . . . . 0.0 112.488 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.96 -45.58 92.19 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.684 0.675 . . . . 0.0 111.966 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.2 m -62.54 -42.46 99.54 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.828 0.74 . . . . 0.0 112.155 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.6 mt -58.8 -46.1 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.453 -0.78 . . . . 0.0 111.093 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.36 93.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.847 0.749 . . . . 0.0 112.759 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.93 -47.42 86.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.756 0.822 . . . . 0.0 111.908 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.12 -34.3 72.92 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.72 -41.73 91.91 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.447 -0.783 . . . . 0.0 112.328 172.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -41.98 98.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.139 0.576 . . . . 0.0 111.817 172.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.17 -42.26 99.37 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.918 -0.489 . . . . 0.0 112.163 174.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.8 -48.47 79.62 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.68 0.673 . . . . 0.0 111.694 173.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -63.13 -30.34 71.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.06 -39.09 79.31 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.342 1.057 . . . . 0.0 112.482 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.32 -27.57 42.13 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.796 1.239 . . . . 0.0 113.325 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.74 60.97 53.77 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.653 1.981 . . . . 0.0 111.274 -174.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.86 120.13 7.41 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.483 2.122 . . . . 0.0 110.323 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.294 1.438 . . . . 0.0 112.115 -169.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -80.2 160.52 25.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.07 0.548 . . . . 0.0 110.857 168.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.19 -20.02 65.03 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.7 41.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.096 1.332 . . . . 0.0 112.631 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.52 169.2 14.66 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.624 2.883 . . . . 0.0 112.917 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.66 -39.19 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.874 1.27 . . . . 0.0 111.791 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.94 28.52 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.93 133.38 22.92 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.441 2.761 . . . . 0.0 113.163 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -14.95 60.55 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.648 1.118 . . . . 0.0 115.042 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.38 37.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.952 1.376 . . . . 0.0 110.198 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.64 54.14 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.726 -0.608 . . . . 0.0 110.793 168.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -68.64 152.77 44.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.648 0.779 . . . . 0.0 111.618 171.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.26 131.72 84.81 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-O 118.888 -0.577 . . . . 0.0 109.831 170.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.4 140.32 43.71 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.063 1.842 . . . . 0.0 112.442 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -74.94 171.61 13.76 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.8 1.64 . . . . 0.0 111.817 163.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.61 -43.86 94.12 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.913 -0.492 . . . . 0.0 112.979 168.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.75 -25.88 64.96 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.71 -41.53 65.13 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.076 -1.015 . . . . 0.0 111.778 171.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.73 -42.63 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.719 0.807 . . . . 0.0 110.812 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.02 -1.29 14.12 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.03 18.13 74.33 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.929 -1.107 . . . . 0.0 115.445 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.25 -19.42 19.31 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.073 1.436 . . . . 0.0 113.289 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.2 -1.58 7.02 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.57 150.04 24.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.067 0.947 . . . . 0.0 111.773 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.4 p -81.95 162.44 22.7 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.321 0.582 . . . . 0.0 110.797 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.88 -39.36 74.23 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.414 -0.804 . . . . 0.0 111.445 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.62 -38.84 92.65 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.557 -0.715 . . . . 0.0 112.635 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -64.62 -42.8 95.27 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.628 -0.67 . . . . 0.0 112.033 171.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.61 -46.46 90.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.648 0.779 . . . . 0.0 112.097 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.38 -46.39 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.142 0.977 . . . . 0.0 110.317 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.42 -51.01 54.42 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.806 0.717 . . . . 0.0 112.945 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.3 -50.09 73.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.751 0.776 . . . . 0.0 112.48 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.0 p -111.93 8.43 20.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.637 1.175 . . . . 0.0 113.027 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.46 162.34 1.61 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.939 1.295 . . . . 0.0 111.434 165.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.63 103.35 48.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.054 0.942 . . . . 0.0 110.758 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.79 89.26 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.451 0.84 . . . . 0.0 111.701 -6.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -49.98 141.37 29.62 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.176 2.584 . . . . 0.0 114.168 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.12 96.53 2.51 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -86.03 54.54 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.232 2.621 . . . . 0.0 112.882 -152.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.54 -34.86 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.46 -46.2 94.31 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.605 0.639 . . . . 0.0 112.947 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.86 -36.9 75.9 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.259 -1.142 . . . . 0.0 112.645 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.88 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.785 -0.572 . . . . 0.0 109.98 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.44 91.68 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.356 -0.84 . . . . 0.0 112.576 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -55.78 -41.99 74.88 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.468 -0.77 . . . . 0.0 112.287 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.71 -45.24 81.98 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.888 0.767 . . . . 0.0 112.134 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.26 -40.59 86.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.308 0.643 . . . . 0.0 112.251 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.55 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.083 0.553 . . . . 0.0 110.261 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.13 -37.33 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.72 1.208 . . . . 0.0 112.322 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.82 98.32 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.047 0.84 . . . . 0.0 111.275 171.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.05 91.66 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.847 0.737 . . . . 0.0 113.242 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.4 -42.47 87.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.954 0.877 . . . . 0.0 111.032 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.48 -50.21 70.48 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.811 0.844 . . . . 0.0 112.45 173.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.79 -43.42 76.81 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 118.853 0.751 . . . . 0.0 111.956 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.43 -47.68 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.406 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.67 -32.89 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.992 1.269 . . . . 0.0 112.907 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -60.43 -45.36 93.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.899 0.88 . . . . 0.0 111.5 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.3 ttp -74.51 -38.24 62.88 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.597 1.559 . . . . 0.0 113.336 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.3 t80 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 128.483 2.713 . . . . 0.0 114.671 -172.571 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 N--CA 1.479 0.666 0 N-CA-C 112.965 0.333 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.22 134.86 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.46 1.104 . . . . 0.0 108.451 163.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.91 154.92 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.136 1.374 . . . . 0.0 109.665 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.67 116.72 32.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.48 0.712 . . . . 0.0 109.171 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.43 177.97 6.95 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.514 0.673 . . . . 0.0 112.511 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.87 -26.49 68.8 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.56 -2.24 57.94 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.825 1.25 . . . . 0.0 113.024 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.07 2.94 85.6 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.467 1.032 . . . . 0.0 114.142 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.74 128.29 35.73 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.815 1.308 . . . . 0.0 109.7 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.69 29.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.01 123.4 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.066 1.347 . . . . 0.0 108.648 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.68 139.68 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.572 0.701 . . . . 0.0 111.21 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.64 141.17 48.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.488 1.915 . . . . 0.0 107.922 169.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.17 152.31 20.77 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.977 0.808 . . . . 0.0 111.237 170.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.62 136.83 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.651 -0.656 . . . . 0.0 111.571 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.59 129.98 93.32 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.167 0.587 . . . . 0.0 111.157 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.07 -34.57 68.66 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.86 2.373 . . . . 0.0 113.543 167.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.39 -38.13 86.81 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.475 -0.765 . . . . 0.0 112.55 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.88 -44.4 97.12 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.728 0.695 . . . . 0.0 111.383 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.45 -44.42 94.55 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.251 0.478 . . . . 0.0 112.211 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.12 -47.25 85.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.087 0.555 . . . . 0.0 111.441 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.1 -45.19 95.73 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.633 0.773 . . . . 0.0 111.892 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -59.98 -47.53 85.43 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.806 0.842 . . . . 0.0 112.729 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.7 t -56.85 -54.13 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.408 0.549 . . . . 0.0 110.493 174.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.72 -37.36 78.68 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.344 1.058 . . . . 0.0 113.214 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.414 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -58.24 -52.11 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.917 1.287 . . . . 0.0 111.345 170.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.19 -35.98 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 122.948 0.499 . . . . 0.0 111.336 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.66 -23.45 59.25 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.98 -25.72 11.04 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -135.87 16.03 3.31 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.46 -37.83 2.57 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -117.86 14.56 14.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.374 1.07 . . . . 0.0 113.141 -172.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.5 p -113.64 152.95 45.89 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.008 0.923 . . . . 0.0 111.513 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.85 -30.81 59.43 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.216 2.61 . . . . 0.0 115.249 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.06 -20.93 64.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.54 -32.19 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.424 1.011 . . . . 0.0 112.482 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.7 mt -70.36 -57.2 5.97 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.76 1.224 . . . . 0.0 112.561 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.81 -29.57 58.95 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.859 1.699 . . . . 0.0 112.793 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.414 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.25 -40.07 78.08 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.838 1.199 . . . . 0.0 112.733 172.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -57.15 -47.08 82.05 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.877 0.762 . . . . 0.0 111.507 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m -60.79 -44.24 97.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.65 71.05 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.233 1.013 . . . . 0.0 113.264 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.8 4.59 52.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.389 1.476 . . . . 0.0 113.514 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.7 p -133.1 22.79 4.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.54 120.23 5.87 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.49 -1.381 . . . . 0.0 111.491 168.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.64 11.59 60.3 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 115.367 0.907 . . . . 0.0 115.367 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.49 131.04 47.83 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.567 1.683 . . . . 0.0 112.487 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.7 p -73.47 159.81 83.85 Favored Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 123.667 0.787 . . . . 0.0 110.722 167.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.63 -35.35 37.62 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.161 1.908 . . . . 0.0 115.429 168.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.1 -40.24 86.89 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -60.26 -45.35 93.59 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.66 -0.65 . . . . 0.0 111.089 172.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.62 -44.27 94.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.328 1.051 . . . . 0.0 112.146 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -59.18 -41.43 88.44 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.672 -0.642 . . . . 0.0 112.03 171.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.6 m -60.25 -45.25 93.91 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.561 0.619 . . . . 0.0 111.059 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.47 -48.86 78.08 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.196 0.907 . . . . 0.0 112.16 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.18 -38.13 89.97 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.11 -32.82 70.18 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.3 p -74.14 -12.29 60.55 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.11 8.28 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.81 -3.78 11.77 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 117.446 1.739 . . . . 0.0 117.446 -175.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.32 -32.79 64.32 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 119.556 1.678 . . . . 0.0 115.279 -177.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -89.75 77.36 7.08 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 123.06 1.409 . . . . 0.0 110.481 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.33 -35.08 26.12 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.859 1.664 . . . . 0.0 115.416 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.9 -40.9 75.36 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 120.159 1.345 . . . . 0.0 112.312 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.64 -43.45 84.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.158 0.583 . . . . 0.0 111.366 173.227 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.14 -40.13 96.68 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.494 -0.754 . . . . 0.0 112.246 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.83 74.6 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.257 1.023 . . . . 0.0 111.541 173.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.04 -45.5 79.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.092 0.957 . . . . 0.0 112.189 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.3 tp -61.85 -48.77 79.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.332 0.653 . . . . 0.0 112.08 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.79 -38.18 90.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.861 0.865 . . . . 0.0 112.483 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.01 -45.52 92.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.664 0.665 . . . . 0.0 112.034 170.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.54 -42.47 99.55 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.792 0.724 . . . . 0.0 112.105 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.81 -46.14 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.491 -0.755 . . . . 0.0 111.077 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.1 -39.45 94.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.819 0.736 . . . . 0.0 112.717 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -60.83 -47.36 86.69 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.77 0.828 . . . . 0.0 111.98 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.17 -34.3 72.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.56 91.79 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.451 -0.781 . . . . 0.0 112.371 172.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.04 98.56 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.202 0.601 . . . . 0.0 111.832 172.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.09 -42.27 99.57 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.905 -0.497 . . . . 0.0 112.221 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.8 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.615 0.643 . . . . 0.0 111.649 173.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.03 -30.31 71.5 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.14 -39.1 79.05 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.324 1.05 . . . . 0.0 112.52 173.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.17 -27.66 42.67 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.785 1.234 . . . . 0.0 113.307 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -132.78 61.03 54.11 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.646 1.978 . . . . 0.0 111.276 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.92 120.16 7.44 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.48 2.12 . . . . 0.0 110.277 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.23 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.363 1.465 . . . . 0.0 112.151 -169.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.98 160.37 25.94 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.13 0.572 . . . . 0.0 110.861 168.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.15 -20.03 65.02 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 174.77 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.048 1.309 . . . . 0.0 112.656 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.55 169.17 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.66 2.907 . . . . 0.0 112.93 177.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.62 -39.2 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.867 1.267 . . . . 0.0 111.841 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.62 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.884 1.674 . . . . 0.0 110.631 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.91 133.41 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.456 2.77 . . . . 0.0 113.116 168.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.99 -15.04 60.37 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.562 1.077 . . . . 0.0 115.013 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -78.09 143.41 37.39 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.928 1.364 . . . . 0.0 110.218 173.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.51 54.2 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.726 -0.608 . . . . 0.0 110.826 168.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -68.55 152.89 44.74 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.694 0.798 . . . . 0.0 111.669 171.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -72.3 131.69 84.77 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.917 -0.563 . . . . 0.0 109.858 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.33 140.41 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -75.19 171.67 13.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.72 1.608 . . . . 0.0 111.862 163.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.51 -43.93 93.93 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.968 -0.458 . . . . 0.0 113.006 168.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.83 -25.77 64.83 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.67 -41.65 65.13 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.064 -1.022 . . . . 0.0 111.765 171.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.65 -42.72 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.712 0.805 . . . . 0.0 110.801 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.3 14.11 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.13 74.17 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.626 1.107 . . . . 0.0 115.458 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.6 p -96.22 -19.43 19.33 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.09 1.445 . . . . 0.0 113.255 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.2 p -126.16 -1.5 7.05 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.4 p -103.64 149.8 24.6 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.034 0.934 . . . . 0.0 111.778 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.1 p -81.68 162.34 23.06 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.341 0.591 . . . . 0.0 110.775 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.72 -39.44 73.91 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.448 -0.783 . . . . 0.0 111.429 169.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.51 -39.01 93.32 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.531 -0.731 . . . . 0.0 112.636 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -64.6 -42.65 95.42 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.72 -46.42 90.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.652 0.781 . . . . 0.0 112.119 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.42 -46.35 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.12 0.968 . . . . 0.0 110.301 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.07 54.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.806 0.717 . . . . 0.0 112.889 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.24 -50.09 73.12 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.831 0.816 . . . . 0.0 112.48 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.2 mtp -68.62 -18.52 64.32 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.92 8.41 20.33 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.665 1.186 . . . . 0.0 113.072 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.42 162.3 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.971 1.309 . . . . 0.0 111.461 165.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.32 48.97 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.15 163.8 89.21 Favored 'Cis proline' 0 CA--C 1.544 1.021 0 CA-C-N 119.466 0.845 . . . . 0.0 111.735 -6.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -49.93 141.34 29.28 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.184 2.59 . . . . 0.0 114.207 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.21 96.44 2.51 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 163.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.97 54.67 3.51 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.65 -34.84 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.24 94.25 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 118.656 0.662 . . . . 0.0 112.991 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -69.73 -36.98 76.32 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.281 -1.129 . . . . 0.0 112.609 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.93 -44.6 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.762 -0.586 . . . . 0.0 109.949 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.85 -40.37 91.64 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.352 -0.842 . . . . 0.0 112.543 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.04 75.12 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.455 -0.778 . . . . 0.0 112.243 173.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -56.7 -45.17 81.99 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.933 0.788 . . . . 0.0 112.098 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.33 -40.55 85.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.29 0.636 . . . . 0.0 112.251 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.69 -46.94 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.062 0.545 . . . . 0.0 110.321 174.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.34 -37.31 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.688 1.195 . . . . 0.0 112.314 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.81 98.3 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.019 0.827 . . . . 0.0 111.223 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.11 91.4 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.796 0.712 . . . . 0.0 113.265 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.49 -42.24 87.15 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.01 0.905 . . . . 0.0 111.092 173.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.39 -50.25 70.22 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.766 0.826 . . . . 0.0 112.461 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.93 -43.1 77.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.823 0.738 . . . . 0.0 112.011 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.44 -48.13 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.721 -0.656 . . . . 0.0 111.372 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -69.38 -32.83 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 119.973 1.261 . . . . 0.0 112.89 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.95 -42.79 94.8 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.931 0.892 . . . . 0.0 111.552 171.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.0 ttp -79.02 -35.65 42.4 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.718 1.607 . . . . 0.0 113.704 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 t80 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 128.383 2.673 . . . . 0.0 114.513 -172.013 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.656 0 N-CA-C 112.952 0.328 . . . . 0.0 112.952 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.89 135.17 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.48 1.112 . . . . 0.0 108.438 163.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.12 154.89 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.113 1.365 . . . . 0.0 109.698 170.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.62 116.71 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.522 0.729 . . . . 0.0 109.128 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -76.57 177.73 7.23 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.604 0.716 . . . . 0.0 112.408 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.53 -26.53 68.61 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -173.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -85.64 -2.22 57.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.76 1.224 . . . . 0.0 113.037 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.99 3.13 85.65 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.53 1.062 . . . . 0.0 114.049 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.71 128.19 35.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.877 1.338 . . . . 0.0 109.726 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.6 29.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.99 123.42 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.045 1.338 . . . . 0.0 108.674 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.56 139.65 38.59 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.52 0.676 . . . . 0.0 111.222 170.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.61 141.06 48.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.476 1.91 . . . . 0.0 107.909 169.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.18 152.34 20.76 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.974 0.806 . . . . 0.0 111.244 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.54 136.86 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.492 0.663 . . . . 0.0 111.575 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.68 129.96 93.23 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.112 0.565 . . . . 0.0 111.18 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -52.91 -34.69 67.57 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.865 2.377 . . . . 0.0 113.589 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -66.33 -38.14 86.99 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.419 -0.801 . . . . 0.0 112.572 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.91 -44.39 97.24 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.749 0.704 . . . . 0.0 111.359 171.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.43 -44.48 94.46 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.29 0.495 . . . . 0.0 112.275 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.05 -47.25 85.91 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.113 0.565 . . . . 0.0 111.42 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.99 96.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.614 0.766 . . . . 0.0 111.914 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -60.14 -47.47 85.77 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.828 0.851 . . . . 0.0 112.754 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.4 t -56.74 -54.15 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 118.392 0.542 . . . . 0.0 110.418 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.79 -37.38 78.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.3 1.04 . . . . 0.0 113.227 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.409 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.85 -52.09 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.035 1.334 . . . . 0.0 111.278 170.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.6 -35.96 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 122.99 0.516 . . . . 0.0 111.362 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -58.61 -23.43 58.85 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -108.06 -25.48 11.11 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -136.07 15.67 3.28 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -166.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.41 -37.53 2.37 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -117.73 14.45 14.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.436 1.095 . . . . 0.0 113.093 -172.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 p -113.92 152.96 46.14 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.078 0.951 . . . . 0.0 111.659 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.84 -31.17 60.96 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.287 2.658 . . . . 0.0 115.292 -172.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -61.69 -21.01 64.09 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.33 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.387 0.994 . . . . 0.0 112.472 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.33 -57.12 6.07 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.717 1.207 . . . . 0.0 112.633 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.78 -29.61 59.2 Favored 'Trans proline' 0 C--N 1.351 0.709 0 CA-C-N 121.901 1.715 . . . . 0.0 112.783 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.409 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.4 mtm -69.18 -40.21 78.25 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.809 1.186 . . . . 0.0 112.683 172.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -57.04 -46.85 82.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.836 0.744 . . . . 0.0 111.544 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -61.03 -44.43 97.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.368 0.667 . . . . 0.0 112.784 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.57 -31.64 70.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.242 1.017 . . . . 0.0 113.26 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.87 4.88 52.44 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.384 1.474 . . . . 0.0 113.523 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.8 p -133.46 22.8 4.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -53.41 120.36 5.97 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.468 -1.395 . . . . 0.0 111.48 168.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.4 11.6 59.71 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.46 130.84 47.01 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.517 1.659 . . . . 0.0 112.449 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.5 p -73.45 159.55 84.48 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 123.701 0.801 . . . . 0.0 110.65 167.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.58 -35.52 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.198 1.932 . . . . 0.0 115.388 168.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.84 -40.43 87.94 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -60.21 -45.31 93.62 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.64 -0.663 . . . . 0.0 111.049 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.58 -44.29 94.48 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.288 1.035 . . . . 0.0 112.164 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -59.19 -41.4 88.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.578 0.626 . . . . 0.0 112.05 171.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.3 m -60.24 -45.19 94.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.55 0.614 . . . . 0.0 111.161 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.41 -48.88 77.92 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.196 0.907 . . . . 0.0 112.185 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.6 mt -63.12 -38.46 91.28 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.78 -33.03 69.85 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.4 p -73.87 -12.47 60.68 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.34 7.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.02 -3.7 9.3 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 117.506 1.762 . . . . 0.0 117.506 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.98 -34.08 65.07 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 119.501 1.651 . . . . 0.0 115.226 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -88.27 77.45 8.22 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.062 1.411 . . . . 0.0 110.485 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -50.36 -35.3 27.36 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.826 1.65 . . . . 0.0 115.341 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.24 74.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.118 1.327 . . . . 0.0 112.249 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.39 -43.53 85.62 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.128 0.571 . . . . 0.0 111.35 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.07 -40.16 96.86 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.592 -0.692 . . . . 0.0 112.271 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.93 -50.12 73.54 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.262 1.025 . . . . 0.0 111.539 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -55.77 -45.4 78.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.067 0.947 . . . . 0.0 112.241 174.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.3 tp -61.98 -48.71 79.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.363 0.665 . . . . 0.0 112.064 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.73 -38.23 90.32 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.857 0.863 . . . . 0.0 112.514 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.12 -45.52 92.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.623 0.647 . . . . 0.0 112.058 170.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.62 -42.34 99.53 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.768 0.713 . . . . 0.0 112.186 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.83 -46.0 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.462 -0.774 . . . . 0.0 111.051 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.17 -39.55 94.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.776 0.716 . . . . 0.0 112.738 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -60.55 -47.66 85.21 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.739 0.816 . . . . 0.0 111.968 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -70.0 -34.33 73.19 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.75 -41.53 92.02 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.44 -0.787 . . . . 0.0 112.391 172.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.85 98.25 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.123 0.569 . . . . 0.0 111.781 172.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -63.58 -42.11 98.31 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.856 -0.528 . . . . 0.0 112.182 175.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.67 -48.51 79.3 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.564 0.62 . . . . 0.0 111.744 172.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.28 -30.07 71.28 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -69.28 -39.1 78.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.363 1.065 . . . . 0.0 112.432 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.2 -27.77 42.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.796 1.239 . . . . 0.0 113.337 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.62 61.03 54.4 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.635 1.974 . . . . 0.0 111.216 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.91 120.14 7.42 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.424 2.083 . . . . 0.0 110.315 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.44 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.292 1.437 . . . . 0.0 112.158 -169.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -80.1 160.39 25.78 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.174 0.59 . . . . 0.0 110.894 168.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.17 -19.88 64.9 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.11 174.7 41.71 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.048 1.309 . . . . 0.0 112.606 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.55 169.17 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.631 2.887 . . . . 0.0 112.906 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.69 -39.0 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.874 1.269 . . . . 0.0 111.785 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.71 161.83 28.75 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.888 1.675 . . . . 0.0 110.592 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.93 133.46 22.94 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.479 2.786 . . . . 0.0 113.098 168.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.89 -14.97 60.41 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.566 1.079 . . . . 0.0 115.062 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.2 143.45 37.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.95 1.375 . . . . 0.0 110.164 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.3 145.63 54.04 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.742 -0.599 . . . . 0.0 110.869 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -68.49 152.5 45.3 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.76 0.824 . . . . 0.0 111.615 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -72.25 131.64 84.91 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-O 118.898 -0.572 . . . . 0.0 109.814 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.49 140.23 43.17 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.062 1.841 . . . . 0.0 112.401 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -74.8 171.28 14.26 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.773 1.629 . . . . 0.0 111.891 163.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.46 -43.81 93.88 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 123.33 0.491 . . . . 0.0 113.035 168.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.3 p -68.71 -25.73 64.91 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -72.97 -41.44 64.38 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.034 -1.041 . . . . 0.0 111.78 172.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.69 -42.84 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.839 0.856 . . . . 0.0 110.761 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.82 -1.52 14.41 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 173.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.11 18.15 74.49 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.922 -1.111 . . . . 0.0 115.406 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.9 p -96.02 -19.31 19.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.067 1.433 . . . . 0.0 113.287 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.9 p -126.62 -1.69 6.75 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -103.25 150.38 23.78 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.164 0.986 . . . . 0.0 111.554 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.2 p -82.48 162.61 22.0 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.342 0.591 . . . . 0.0 110.781 169.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.6 tp -56.57 -39.54 73.66 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.501 -0.749 . . . . 0.0 111.541 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.45 -38.95 93.12 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.454 -0.779 . . . . 0.0 112.666 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -64.71 -42.69 95.09 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.612 -0.68 . . . . 0.0 111.988 171.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.58 -46.35 90.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.678 0.791 . . . . 0.0 112.097 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.64 -46.16 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.167 0.987 . . . . 0.0 110.312 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.62 -50.98 55.39 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.852 0.739 . . . . 0.0 112.876 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.35 -50.04 73.16 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 117.74 0.77 . . . . 0.0 112.532 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.6 64.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.1 p -111.83 8.32 20.44 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.677 1.191 . . . . 0.0 113.033 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.3 162.31 1.53 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.045 1.338 . . . . 0.0 111.451 165.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.64 103.32 48.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.046 0.938 . . . . 0.0 110.778 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.1 163.81 89.21 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.466 0.845 . . . . 0.0 111.713 -6.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -49.93 141.38 29.26 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.199 2.6 . . . . 0.0 114.186 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.25 96.42 2.51 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 163.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.02 54.59 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.255 2.637 . . . . 0.0 112.852 -152.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.52 -35.11 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -61.91 -46.57 93.85 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.595 0.634 . . . . 0.0 113.031 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -69.88 -36.69 75.66 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.281 -1.129 . . . . 0.0 112.636 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.3 mt -62.94 -44.66 99.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.757 -0.589 . . . . 0.0 109.902 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -65.81 -40.37 91.78 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.265 -0.897 . . . . 0.0 112.497 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -55.89 -42.04 75.37 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.472 -0.767 . . . . 0.0 112.232 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.7 -45.22 81.93 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.892 0.769 . . . . 0.0 112.134 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.25 -40.66 86.3 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.242 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.55 -47.05 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.041 0.536 . . . . 0.0 110.283 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.33 -37.27 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.672 1.189 . . . . 0.0 112.261 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.86 -42.76 98.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.027 0.83 . . . . 0.0 111.235 171.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.49 -45.26 90.84 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.863 0.744 . . . . 0.0 113.176 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.41 -42.34 86.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.039 0.919 . . . . 0.0 111.112 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -55.34 -50.2 70.26 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.815 0.846 . . . . 0.0 112.473 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -55.95 -43.16 77.19 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.865 0.757 . . . . 0.0 111.971 175.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.44 -48.06 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.338 0.655 . . . . 0.0 111.448 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.52 -32.69 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.916 1.235 . . . . 0.0 112.952 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.3 -43.91 95.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.901 0.88 . . . . 0.0 111.498 171.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.7 ttp -76.99 -37.1 55.8 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.66 1.584 . . . . 0.0 113.48 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 C--O 1.252 1.192 0 C-N-CA 128.377 2.671 . . . . 0.0 114.48 -172.057 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.82 135.0 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.467 1.107 . . . . 0.0 108.402 163.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.92 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.686 170.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.62 116.68 32.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.57 0.748 . . . . 0.0 109.18 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.47 178.07 6.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.58 0.705 . . . . 0.0 112.451 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.95 -26.45 68.83 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.59 -2.19 57.9 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.776 1.231 . . . . 0.0 113.0 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.02 85.69 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.76 128.28 35.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.823 1.311 . . . . 0.0 109.745 174.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.89 125.62 29.62 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.99 123.4 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.07 1.348 . . . . 0.0 108.629 -174.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.7 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.71 141.15 48.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.5 1.92 . . . . 0.0 107.929 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 21.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.998 0.817 . . . . 0.0 111.191 170.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.53 136.84 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.607 -0.683 . . . . 0.0 111.544 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.64 130.03 93.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.059 0.544 . . . . 0.0 111.169 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.09 -34.5 68.53 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.86 2.373 . . . . 0.0 113.575 167.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.53 -38.04 86.32 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.508 -0.745 . . . . 0.0 112.562 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.91 -44.31 97.34 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.767 0.712 . . . . 0.0 111.377 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.53 -44.33 94.55 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.328 0.513 . . . . 0.0 112.321 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.17 -47.33 85.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.136 0.574 . . . . 0.0 111.359 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.35 95.19 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.644 0.778 . . . . 0.0 111.883 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.7 t-105 -60.02 -47.42 85.93 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.855 0.862 . . . . 0.0 112.763 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.68 -55.0 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.465 0.575 . . . . 0.0 110.273 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.04 -37.82 77.89 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.396 1.079 . . . . 0.0 113.243 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.41 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.33 -51.9 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.031 1.332 . . . . 0.0 111.329 170.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.65 -35.88 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.435 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -58.98 -23.1 61.44 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.707 1.139 . . . . 0.0 114.038 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.73 -25.94 11.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -135.86 16.3 3.31 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -166.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.53 -37.68 2.57 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -118.25 14.73 13.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.392 1.077 . . . . 0.0 113.149 -172.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -113.93 152.94 46.13 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 111.566 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.85 -30.75 59.21 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.257 2.638 . . . . 0.0 115.276 -172.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.05 -20.67 64.2 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.82 -31.97 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.376 0.989 . . . . 0.0 112.528 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.1 mt -71.34 -55.08 6.35 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.943 1.297 . . . . 0.0 112.961 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.83 -30.12 49.72 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.688 1.639 . . . . 0.0 112.661 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.41 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.6 mtm -69.06 -40.22 78.64 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.86 1.209 . . . . 0.0 112.623 172.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.23 -46.53 82.87 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.816 0.735 . . . . 0.0 111.581 169.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.7 m -61.01 -44.52 97.3 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 175.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.82 -32.09 71.47 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.255 1.022 . . . . 0.0 113.207 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.29 4.44 53.47 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.39 1.476 . . . . 0.0 113.522 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.4 p -132.98 22.83 4.18 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.62 120.3 6.0 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.47 -1.394 . . . . 0.0 111.491 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.54 60.16 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.42 130.84 47.06 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.565 1.682 . . . . 0.0 112.499 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.39 159.69 84.21 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.714 0.806 . . . . 0.0 110.661 167.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.28 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -60.4 -45.29 94.11 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.663 -0.648 . . . . 0.0 111.025 172.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.51 -44.34 94.57 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 112.103 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -59.11 -41.58 88.5 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.635 0.652 . . . . 0.0 111.994 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.13 -45.31 93.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.594 0.633 . . . . 0.0 111.084 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.43 -48.81 78.15 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.209 0.913 . . . . 0.0 112.188 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.18 -38.27 90.53 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.98 -33.63 70.9 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -73.29 -12.76 60.96 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.15 9.21 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.23 -5.51 8.22 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 117.328 1.691 . . . . 0.0 117.328 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.36 -31.3 59.55 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 119.336 1.568 . . . . 0.0 115.563 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -93.61 78.12 4.32 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.003 1.402 . . . . 0.0 110.652 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.79 -35.78 33.68 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -173.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.05 -41.02 74.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.123 1.328 . . . . 0.0 112.246 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.5 -43.5 85.14 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.164 0.585 . . . . 0.0 111.371 173.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.7 tpp -63.06 -40.14 96.82 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.521 -0.737 . . . . 0.0 112.263 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.99 -49.93 74.24 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.235 1.014 . . . . 0.0 111.521 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.02 -45.47 79.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.091 0.956 . . . . 0.0 112.188 174.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -61.91 -48.72 79.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.277 0.631 . . . . 0.0 112.088 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.7 -38.28 90.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 0.0 112.479 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.99 -45.49 92.54 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 112.02 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.6 m -62.61 -42.38 99.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.848 0.749 . . . . 0.0 112.149 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.9 -46.04 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 121.472 -0.768 . . . . 0.0 111.097 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.49 94.13 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.876 0.762 . . . . 0.0 112.684 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -60.78 -47.39 86.53 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.741 0.816 . . . . 0.0 111.94 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.13 -34.35 72.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.53 91.62 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.484 -0.76 . . . . 0.0 112.322 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.11 98.61 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.224 0.61 . . . . 0.0 111.781 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.17 -42.11 99.33 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.84 -0.538 . . . . 0.0 112.207 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -57.88 -48.55 79.52 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.673 0.67 . . . . 0.0 111.694 173.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.01 -30.35 71.53 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.11 -39.06 79.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.354 1.062 . . . . 0.0 112.482 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.79 60.98 53.75 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.85 120.1 7.36 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.451 2.101 . . . . 0.0 110.341 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.29 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.351 1.461 . . . . 0.0 112.142 -169.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.0 160.47 25.88 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.053 0.541 . . . . 0.0 110.903 168.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.91 65.0 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.74 41.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.096 1.332 . . . . 0.0 112.631 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.56 169.2 14.73 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.601 2.867 . . . . 0.0 112.917 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.66 -39.2 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.904 1.282 . . . . 0.0 111.753 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.61 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 110.585 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -47.94 133.42 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.479 2.786 . . . . 0.0 113.106 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.93 -14.96 60.48 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.567 1.08 . . . . 0.0 115.037 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.13 143.32 37.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.95 1.375 . . . . 0.0 110.214 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.11 145.48 54.35 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.654 -0.654 . . . . 0.0 110.843 168.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.47 152.82 44.86 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.27 131.69 84.83 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.916 -0.564 . . . . 0.0 109.872 170.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.35 140.36 44.03 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.107 1.871 . . . . 0.0 112.435 -177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -75.14 171.65 13.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.705 1.602 . . . . 0.0 111.805 163.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.6 -43.78 94.15 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.916 -0.49 . . . . 0.0 113.035 168.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.89 -25.78 64.78 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.65 65.03 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.989 -1.069 . . . . 0.0 111.749 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.65 -42.7 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.686 0.794 . . . . 0.0 110.812 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.06 -1.26 14.09 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 173.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.23 74.26 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 120.865 -1.147 . . . . 0.0 115.444 174.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.5 19.21 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.079 1.439 . . . . 0.0 113.263 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 p -126.13 -1.28 7.08 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.76 149.84 24.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.08 0.952 . . . . 0.0 111.789 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.5 p -81.81 162.32 22.91 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.288 0.566 . . . . 0.0 110.73 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.81 -39.37 74.04 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.529 -0.732 . . . . 0.0 111.438 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.5 -38.99 93.24 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.576 -0.702 . . . . 0.0 112.675 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.6 95.45 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.573 -0.705 . . . . 0.0 112.085 171.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.77 -46.47 90.36 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.626 0.77 . . . . 0.0 112.092 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.33 -46.35 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.126 0.971 . . . . 0.0 110.35 172.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.03 54.41 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.753 0.692 . . . . 0.0 112.945 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.79 0.795 . . . . 0.0 112.485 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.9 8.36 20.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.66 1.184 . . . . 0.0 113.033 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.46 162.31 1.62 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.029 1.332 . . . . 0.0 111.361 165.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.34 48.99 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.035 0.934 . . . . 0.0 110.811 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.14 163.78 89.25 Favored 'Cis proline' 0 CA--C 1.543 0.951 0 CA-C-N 119.466 0.845 . . . . 0.0 111.735 -6.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -49.9 141.39 29.0 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.205 2.604 . . . . 0.0 114.171 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.19 96.38 2.46 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 163.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.96 54.56 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.27 2.647 . . . . 0.0 112.86 -152.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.57 -34.83 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.39 -46.26 94.22 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.638 0.654 . . . . 0.0 112.967 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.83 -36.86 75.94 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.91 -44.56 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.732 -0.605 . . . . 0.0 110.004 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.37 91.6 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.307 -0.871 . . . . 0.0 112.557 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.83 -41.97 75.03 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.489 -0.757 . . . . 0.0 112.287 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -56.71 -45.27 81.94 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.889 0.768 . . . . 0.0 112.08 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.32 -40.46 85.98 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.236 0.614 . . . . 0.0 112.315 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.7 -46.98 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.044 0.538 . . . . 0.0 110.34 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.23 -37.39 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.686 1.195 . . . . 0.0 112.3 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.81 98.3 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.011 0.823 . . . . 0.0 111.223 171.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.49 -45.19 91.19 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.796 0.712 . . . . 0.0 113.26 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.42 -42.26 86.87 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.003 0.901 . . . . 0.0 111.113 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.45 -50.22 70.41 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.772 0.829 . . . . 0.0 112.453 173.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.18 76.94 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.856 0.753 . . . . 0.0 111.973 175.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.48 -48.01 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.377 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.47 -32.84 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.988 1.267 . . . . 0.0 112.945 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.96 -43.23 95.18 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.877 0.871 . . . . 0.0 111.562 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.8 ttp -78.41 -36.71 45.37 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.72 1.608 . . . . 0.0 113.619 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.3 t80 . . . . . 0 C--O 1.252 1.219 0 C-N-CA 128.423 2.689 . . . . 0.0 114.629 -171.91 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.93 135.02 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.453 1.101 . . . . 0.0 108.425 163.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.92 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.62 116.7 32.52 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.521 0.729 . . . . 0.0 109.201 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.41 178.04 6.88 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.598 0.713 . . . . 0.0 112.441 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.94 -26.5 68.85 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.13 57.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.97 2.99 85.8 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.458 1.028 . . . . 0.0 114.12 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.73 128.3 35.75 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.801 1.301 . . . . 0.0 109.683 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.6 29.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 168.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -126.0 123.39 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.046 1.338 . . . . 0.0 108.659 -174.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.65 141.14 48.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.491 1.916 . . . . 0.0 107.914 169.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 21.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.015 0.825 . . . . 0.0 111.191 170.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.47 136.83 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.601 -0.687 . . . . 0.0 111.58 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.7 130.06 93.18 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.11 0.564 . . . . 0.0 111.088 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.09 -34.54 68.73 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.86 2.373 . . . . 0.0 113.575 167.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.43 -38.03 86.5 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.526 -0.734 . . . . 0.0 112.622 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.94 -44.32 97.43 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.691 0.678 . . . . 0.0 111.373 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.55 -44.36 94.39 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.251 0.478 . . . . 0.0 112.266 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.19 -47.21 86.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.105 0.562 . . . . 0.0 111.432 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.14 95.91 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.683 0.793 . . . . 0.0 111.879 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.19 -47.23 86.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.861 0.864 . . . . 0.0 112.766 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.8 -54.44 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.397 0.544 . . . . 0.0 110.369 174.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.71 -37.34 78.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.347 1.059 . . . . 0.0 113.2 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.54 -52.15 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.058 1.343 . . . . 0.0 111.288 170.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.75 -35.9 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.406 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -58.7 -23.86 60.34 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.37 -25.65 11.35 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.93 16.12 3.3 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -166.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.19 -38.22 2.41 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -117.56 13.97 14.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.415 1.086 . . . . 0.0 113.105 -172.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.5 p -113.2 152.97 45.54 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.027 0.931 . . . . 0.0 111.582 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.9 -30.76 59.7 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.277 2.651 . . . . 0.0 115.229 -172.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.02 -20.69 64.19 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.85 -31.89 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.431 1.014 . . . . 0.0 112.548 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.38 -55.07 6.31 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.957 1.303 . . . . 0.0 113.011 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.88 -30.08 49.31 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.653 1.626 . . . . 0.0 112.641 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.403 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.06 -40.16 78.67 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.901 1.228 . . . . 0.0 112.673 172.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -57.27 -46.51 83.01 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.758 0.708 . . . . 0.0 111.583 169.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -61.05 -44.48 97.33 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.86 -31.98 71.42 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.284 1.034 . . . . 0.0 113.292 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.34 4.44 53.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.344 1.458 . . . . 0.0 113.508 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.6 p -132.91 22.75 4.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.54 120.31 5.98 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.474 -1.391 . . . . 0.0 111.47 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.66 60.1 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.362 0.905 . . . . 0.0 115.362 -177.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.51 130.82 46.87 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.554 1.677 . . . . 0.0 112.53 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.33 159.66 84.35 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.718 167.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.61 -35.31 37.27 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.15 1.9 . . . . 0.0 115.454 168.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.16 -40.19 86.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.34 -45.3 93.95 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.6 -0.687 . . . . 0.0 111.1 172.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.52 -44.37 94.44 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.364 1.066 . . . . 0.0 112.134 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.13 -41.51 88.42 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.658 -0.651 . . . . 0.0 112.031 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.18 -45.35 93.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.622 0.646 . . . . 0.0 111.084 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.36 -48.87 77.9 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.179 0.9 . . . . 0.0 112.19 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -63.15 -38.44 91.17 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.95 -33.36 70.53 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.0 p -73.67 -12.5 60.75 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.25 7.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.87 -4.49 5.86 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.82 -33.19 55.8 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 119.249 1.524 . . . . 0.0 115.425 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -91.23 78.63 5.78 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.84 1.32 . . . . 0.0 110.613 171.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.16 -35.86 38.06 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.39 -41.1 73.48 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 120.107 1.322 . . . . 0.0 112.299 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.28 -43.61 85.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.202 0.601 . . . . 0.0 111.335 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.05 -40.1 96.71 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.514 -0.741 . . . . 0.0 112.255 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -50.02 73.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.251 1.02 . . . . 0.0 111.539 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -56.0 -45.39 79.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.97 -48.72 79.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.338 0.655 . . . . 0.0 112.055 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.75 -38.27 90.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.411 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.95 -45.48 92.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.735 0.698 . . . . 0.0 112.046 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.64 -42.37 99.55 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.149 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.84 -46.07 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.507 -0.745 . . . . 0.0 111.093 174.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.19 -39.33 93.76 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.816 0.734 . . . . 0.0 112.738 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.89 -47.4 86.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.745 0.818 . . . . 0.0 111.964 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.16 -34.33 72.87 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.48 91.66 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.481 -0.762 . . . . 0.0 112.355 173.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.16 98.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.2 0.6 . . . . 0.0 111.787 172.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.03 -42.28 99.74 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.888 -0.508 . . . . 0.0 112.166 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.676 0.671 . . . . 0.0 111.71 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.07 -30.2 71.41 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.22 -39.1 78.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.397 1.079 . . . . 0.0 112.45 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.0 53.92 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.88 120.08 7.34 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.479 2.119 . . . . 0.0 110.312 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.26 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.35 1.46 . . . . 0.0 112.179 -169.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.98 160.47 25.9 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.079 0.552 . . . . 0.0 110.903 168.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.98 65.01 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.77 41.6 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.053 1.311 . . . . 0.0 112.647 174.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.62 169.16 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.944 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.61 -39.2 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.91 1.284 . . . . 0.0 111.799 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.47 161.94 28.51 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.884 1.674 . . . . 0.0 110.587 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.94 133.42 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.479 2.786 . . . . 0.0 113.106 168.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.98 -15.08 60.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.567 1.08 . . . . 0.0 115.01 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.6 54.12 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.694 -0.629 . . . . 0.0 110.824 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.48 152.7 45.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.765 0.826 . . . . 0.0 111.626 171.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -72.25 131.7 84.85 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.912 -0.565 . . . . 0.0 109.835 170.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.38 140.43 44.06 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.074 1.849 . . . . 0.0 112.442 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -75.1 171.61 13.83 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.763 1.625 . . . . 0.0 111.871 163.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.87 94.1 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.895 -0.503 . . . . 0.0 113.035 168.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.0 p -68.81 -25.68 64.8 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.82 -41.6 64.72 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.03 -1.044 . . . . 0.0 111.733 171.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.67 -42.71 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.742 0.817 . . . . 0.0 110.787 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.23 13.99 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.98 18.11 74.21 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.626 1.107 . . . . 0.0 115.413 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.21 -19.36 19.39 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.141 1.471 . . . . 0.0 113.312 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.25 -1.52 6.99 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.56 150.01 24.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.063 0.945 . . . . 0.0 111.773 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.9 p -82.01 162.3 22.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.311 0.577 . . . . 0.0 110.806 169.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.66 -39.45 73.76 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.431 -0.793 . . . . 0.0 111.427 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.49 -38.93 93.03 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.533 -0.729 . . . . 0.0 112.701 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -64.67 -42.75 95.15 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 111.997 171.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.6 -46.41 90.36 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.575 0.75 . . . . 0.0 112.152 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.47 -46.29 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.106 0.962 . . . . 0.0 110.338 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.1 54.01 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 0.0 112.869 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.07 73.19 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.512 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.95 8.42 20.29 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.6 1.16 . . . . 0.0 113.046 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.39 162.28 1.6 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.991 1.316 . . . . 0.0 111.403 165.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.54 103.37 48.97 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.035 0.934 . . . . 0.0 110.792 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.14 163.87 89.05 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.509 0.86 . . . . 0.0 111.676 -6.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -50.04 141.36 30.06 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 0.0 114.205 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.11 96.41 2.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.97 54.6 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.54 -34.89 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.24 94.26 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.633 0.652 . . . . 0.0 112.999 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.8 -36.87 76.02 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.348 -1.09 . . . . 0.0 112.723 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.92 -44.56 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.732 -0.605 . . . . 0.0 109.987 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.89 -40.39 91.53 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.307 -0.871 . . . . 0.0 112.521 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.83 -41.98 75.06 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.431 -0.793 . . . . 0.0 112.259 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.74 -45.23 82.12 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.956 0.798 . . . . 0.0 112.044 174.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.3 -40.57 86.06 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.257 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.53 -47.22 93.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.065 0.546 . . . . 0.0 110.295 174.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.09 -37.39 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.68 1.192 . . . . 0.0 112.3 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.78 98.35 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.011 0.823 . . . . 0.0 111.224 171.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.07 91.47 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.844 0.735 . . . . 0.0 113.252 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.35 -42.42 86.86 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.988 0.894 . . . . 0.0 111.076 173.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.18 70.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.9 -43.23 77.07 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.83 0.741 . . . . 0.0 111.975 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.51 -47.79 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.43 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.56 -32.91 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.963 1.256 . . . . 0.0 112.911 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.23 -44.79 94.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.933 0.893 . . . . 0.0 111.487 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.2 ttp -75.42 -36.34 60.81 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.631 1.573 . . . . 0.0 113.442 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.252 1.196 0 C-N-CA 128.394 2.678 . . . . 0.0 114.54 -172.815 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.009 0.35 . . . . 0.0 113.009 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.76 135.02 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.472 1.109 . . . . 0.0 108.436 163.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.96 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.72 116.74 32.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.501 0.72 . . . . 0.0 109.195 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.452 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.89 -26.46 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -173.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.19 57.93 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.809 1.244 . . . . 0.0 112.988 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.04 2.94 85.67 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.504 1.05 . . . . 0.0 114.103 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.64 128.29 35.68 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.866 1.333 . . . . 0.0 109.745 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.61 29.61 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 168.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.0 t -125.97 123.34 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.045 1.338 . . . . 0.0 108.723 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.5 139.73 38.64 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.512 0.672 . . . . 0.0 111.206 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.76 141.17 48.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.477 1.911 . . . . 0.0 107.897 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.38 20.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.804 . . . . 0.0 111.238 170.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.5 136.79 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.611 -0.681 . . . . 0.0 111.591 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.64 130.01 93.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 123.114 0.566 . . . . 0.0 111.151 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.887 2.391 . . . . 0.0 113.575 167.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.4 -38.09 86.69 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 112.579 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.0 -44.28 97.65 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.687 0.676 . . . . 0.0 111.347 171.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.55 -44.23 94.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.328 0.513 . . . . 0.0 112.309 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.28 -47.28 85.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.124 0.569 . . . . 0.0 111.392 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.2 95.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.658 0.783 . . . . 0.0 111.9 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.17 -47.23 86.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.809 0.844 . . . . 0.0 112.77 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.76 -54.52 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.455 0.57 . . . . 0.0 110.397 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.59 -37.44 78.54 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.354 1.062 . . . . 0.0 113.191 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.405 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.59 -52.1 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.026 1.33 . . . . 0.0 111.295 170.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.64 -35.92 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.915 0.486 . . . . 0.0 111.399 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -58.72 -23.95 60.63 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.21 -25.73 11.39 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.88 16.13 3.31 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.16 -38.38 2.44 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -117.48 14.1 14.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.404 1.081 . . . . 0.0 113.115 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.9 p -113.18 153.02 45.54 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 123.952 0.901 . . . . 0.0 111.565 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.89 -30.66 59.12 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.289 2.659 . . . . 0.0 115.27 -172.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.12 -20.74 64.37 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.73 -32.01 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.387 0.994 . . . . 0.0 112.539 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.33 -55.05 6.39 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.943 1.297 . . . . 0.0 113.011 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.89 -30.08 49.23 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.685 1.637 . . . . 0.0 112.655 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.405 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.08 -40.21 78.58 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.876 1.216 . . . . 0.0 112.598 172.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -57.28 -46.52 83.03 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.776 0.716 . . . . 0.0 111.522 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.2 m -61.11 -44.4 97.4 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.9 -32.02 71.5 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.268 1.027 . . . . 0.0 113.27 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.23 4.43 53.55 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.4 1.48 . . . . 0.0 113.536 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -133.03 22.8 4.16 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.62 120.34 6.06 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.491 168.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.69 60.06 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.9 47.19 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.565 1.683 . . . . 0.0 112.481 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.37 159.66 84.33 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 123.748 0.819 . . . . 0.0 110.705 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -49.54 -35.48 37.11 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.3 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.36 -45.26 94.12 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.049 172.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.54 -44.37 94.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.386 1.074 . . . . 0.0 112.134 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -59.13 -41.51 88.42 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.658 -0.651 . . . . 0.0 112.031 171.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.5 m -60.23 -45.28 93.78 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.622 0.646 . . . . 0.0 111.073 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.44 -48.85 78.06 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.254 0.934 . . . . 0.0 112.191 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.13 -38.45 91.24 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.87 -33.43 70.48 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.1 p -73.66 -12.52 60.76 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.4 m -122.2 7.84 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.93 -4.54 6.0 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 117.193 1.637 . . . . 0.0 117.193 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.83 -33.22 55.93 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.257 1.528 . . . . 0.0 115.404 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -91.18 78.49 5.83 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.875 1.338 . . . . 0.0 110.605 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.06 -35.86 36.88 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.35 -41.09 73.61 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.094 1.315 . . . . 0.0 112.242 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.54 85.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.174 0.59 . . . . 0.0 111.311 173.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.05 -40.13 96.77 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.514 -0.741 . . . . 0.0 112.265 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -49.92 74.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.198 0.999 . . . . 0.0 111.58 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.99 -45.52 78.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.091 0.956 . . . . 0.0 112.199 174.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.2 tp -61.87 -48.81 78.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.326 0.65 . . . . 0.0 112.055 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.63 -38.28 90.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.842 0.857 . . . . 0.0 112.49 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.99 -45.55 92.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 111.985 170.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.3 m -62.51 -42.45 99.51 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.87 0.759 . . . . 0.0 112.155 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.86 -46.08 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.478 -0.764 . . . . 0.0 111.059 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.18 -39.37 93.85 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.858 0.754 . . . . 0.0 112.752 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.81 -47.48 86.13 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.925 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.09 -34.32 73.0 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.582 -0.699 . . . . 0.0 112.85 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.69 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.408 -0.808 . . . . 0.0 112.361 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.09 98.7 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.215 0.606 . . . . 0.0 111.751 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.25 99.58 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 0.0 112.218 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.77 -48.57 79.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.737 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.05 -30.23 71.43 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.24 -39.11 78.71 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.337 1.055 . . . . 0.0 112.482 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.24 -27.58 42.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.76 1.224 . . . . 0.0 113.327 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.76 61.03 54.17 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.646 1.978 . . . . 0.0 111.247 -174.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.92 120.14 7.41 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.509 2.139 . . . . 0.0 110.261 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.42 136.3 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.298 1.439 . . . . 0.0 112.108 -169.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.97 160.37 25.95 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.116 0.567 . . . . 0.0 110.922 168.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.97 65.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 174.77 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.048 1.309 . . . . 0.0 112.656 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 169.16 14.85 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.66 2.907 . . . . 0.0 112.896 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.64 -39.18 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.926 1.29 . . . . 0.0 111.762 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.55 161.87 28.65 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.858 1.663 . . . . 0.0 110.561 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.93 133.44 22.94 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.403 2.735 . . . . 0.0 113.141 168.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.08 60.29 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.562 1.077 . . . . 0.0 114.978 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.22 145.5 54.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.694 -0.629 . . . . 0.0 110.815 168.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -68.54 152.83 44.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.658 0.783 . . . . 0.0 111.668 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.18 131.64 85.03 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.83 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.37 140.44 44.13 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.076 1.851 . . . . 0.0 112.426 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -75.12 171.58 13.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.74 1.616 . . . . 0.0 111.906 163.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.51 -43.87 93.96 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.971 -0.455 . . . . 0.0 113.049 168.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.85 -25.7 64.78 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.68 64.88 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.068 -1.02 . . . . 0.0 111.727 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.63 -42.69 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 110.817 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.29 14.23 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.16 74.31 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.605 1.098 . . . . 0.0 115.447 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.31 -19.46 19.24 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.074 1.437 . . . . 0.0 113.263 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 p -126.14 -1.34 7.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.86 149.81 24.73 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.095 0.958 . . . . 0.0 111.752 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.6 p -81.73 162.27 23.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.303 0.573 . . . . 0.0 110.799 170.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.72 -39.38 73.81 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.466 -0.771 . . . . 0.0 111.445 169.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.58 -38.91 92.91 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.554 -0.716 . . . . 0.0 112.706 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.57 -42.79 95.41 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.542 -0.724 . . . . 0.0 112.011 171.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.62 -46.43 90.3 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.68 0.792 . . . . 0.0 112.144 176.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.46 -46.35 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.106 0.962 . . . . 0.0 110.301 172.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.39 -51.11 53.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.872 0.748 . . . . 0.0 112.882 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 0.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.62 -18.56 64.33 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.86 8.42 20.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.624 1.17 . . . . 0.0 113.064 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.41 162.3 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.952 1.301 . . . . 0.0 111.461 165.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.39 48.92 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.035 0.934 . . . . 0.0 110.811 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.07 163.84 89.16 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.429 0.832 . . . . 0.0 111.701 -6.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -50.04 141.35 30.07 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 0.0 114.205 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.13 96.48 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.05 54.58 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.274 2.649 . . . . 0.0 112.827 -152.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.59 -34.77 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.48 -46.2 94.31 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.637 0.653 . . . . 0.0 112.996 173.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.8 -36.92 76.07 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.293 -1.122 . . . . 0.0 112.665 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.0 mt -62.93 -44.57 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.808 -0.557 . . . . 0.0 109.921 174.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.42 91.66 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.303 -0.873 . . . . 0.0 112.489 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.84 -41.99 75.1 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.294 173.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -56.7 -45.24 81.95 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.926 0.784 . . . . 0.0 112.071 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -67.34 -40.48 85.9 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.266 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.62 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.044 0.538 . . . . 0.0 110.291 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.03 -37.35 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.683 1.193 . . . . 0.0 112.355 177.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.77 98.4 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.03 0.832 . . . . 0.0 111.224 171.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.09 91.41 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.796 0.712 . . . . 0.0 113.242 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.38 -42.35 86.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 117.986 0.893 . . . . 0.0 111.097 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.55 -50.17 70.73 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.798 0.839 . . . . 0.0 112.445 173.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.26 77.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.86 0.755 . . . . 0.0 111.991 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.4 -47.9 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.335 0.654 . . . . 0.0 111.44 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.92 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.924 1.238 . . . . 0.0 112.9 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.17 -44.54 94.94 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.884 0.874 . . . . 0.0 111.473 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.78 -35.86 59.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.655 1.582 . . . . 0.0 113.468 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 128.39 2.676 . . . . 0.0 114.59 -172.737 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.998 0.345 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.9 135.09 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.457 1.103 . . . . 0.0 108.402 163.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.13 154.83 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.063 1.345 . . . . 0.0 109.627 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.7 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.9 -26.45 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.61 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.825 1.25 . . . . 0.0 113.03 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.02 85.77 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.5 1.048 . . . . 0.0 114.144 -175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.7 128.22 35.43 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.801 1.301 . . . . 0.0 109.745 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.63 29.63 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 168.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -125.95 123.36 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.107 1.363 . . . . 0.0 108.669 -174.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.56 139.71 38.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.543 0.687 . . . . 0.0 111.191 170.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.72 141.11 48.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.465 1.906 . . . . 0.0 107.929 169.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.36 21.02 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.254 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.5 136.89 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.492 0.663 . . . . 0.0 111.572 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.69 129.96 93.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.068 0.547 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.01 -34.56 68.05 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.868 2.378 . . . . 0.0 113.56 167.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.41 -38.07 86.64 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.451 -0.78 . . . . 0.0 112.587 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.97 -44.3 97.55 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.779 0.718 . . . . 0.0 111.377 171.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.54 -44.37 94.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.29 0.496 . . . . 0.0 112.244 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.22 -47.25 86.04 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.115 0.566 . . . . 0.0 111.37 176.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.24 95.61 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.651 0.78 . . . . 0.0 111.897 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.24 -47.01 87.79 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.771 0.829 . . . . 0.0 112.812 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.78 -54.55 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.439 0.563 . . . . 0.0 110.344 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.66 -37.36 78.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.343 1.057 . . . . 0.0 113.219 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.4 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.38 -52.22 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.138 1.375 . . . . 0.0 111.253 170.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.82 -36.02 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.996 0.518 . . . . 0.0 111.407 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.66 -23.89 60.13 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.3 -25.62 11.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.98 16.08 3.29 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -165.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.37 -38.13 2.59 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -117.44 13.8 14.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.345 1.058 . . . . 0.0 113.127 -172.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -112.99 153.0 45.38 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.96 0.904 . . . . 0.0 111.566 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.88 -30.74 59.39 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.311 2.674 . . . . 0.0 115.218 -172.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.02 -20.74 64.25 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.88 -31.88 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.414 1.006 . . . . 0.0 112.488 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.41 -55.01 6.32 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.957 1.303 . . . . 0.0 112.989 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.93 -30.08 48.9 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 121.678 1.635 . . . . 0.0 112.641 174.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.4 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.06 -40.21 78.65 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.901 1.228 . . . . 0.0 112.673 172.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.27 -46.47 83.05 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.765 0.711 . . . . 0.0 111.569 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -61.09 -44.44 97.36 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -32.0 71.51 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.268 1.027 . . . . 0.0 113.257 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.3 4.48 53.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.325 1.45 . . . . 0.0 113.511 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -133.03 22.8 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.54 120.31 5.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.478 -1.389 . . . . 0.0 111.468 168.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.63 60.04 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.46 130.88 47.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.573 1.687 . . . . 0.0 112.482 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.35 159.66 84.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.753 0.821 . . . . 0.0 110.666 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.22 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.41 -45.22 94.38 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.66 -0.65 . . . . 0.0 111.108 172.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.57 -44.26 94.62 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 112.163 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.3 -41.35 88.78 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.696 -0.628 . . . . 0.0 111.989 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.26 -45.33 93.68 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.629 0.65 . . . . 0.0 111.091 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.33 -48.91 77.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.205 0.911 . . . . 0.0 112.179 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.11 -38.49 91.38 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.91 -33.56 70.69 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 p -73.57 -12.46 60.77 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.34 7.73 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.57 -4.8 5.73 Favored Glycine 0 CA--C 1.541 1.702 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.71 -33.32 55.25 Favored Glycine 0 CA--C 1.537 1.433 0 CA-C-N 119.183 1.491 . . . . 0.0 115.462 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -90.81 78.77 6.06 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.836 1.318 . . . . 0.0 110.634 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.32 -35.94 40.43 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.49 -41.2 73.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.094 1.315 . . . . 0.0 112.293 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.57 86.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.155 0.582 . . . . 0.0 111.337 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.13 -40.04 96.44 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.555 -0.716 . . . . 0.0 112.224 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.99 -50.0 74.03 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.056 -1.028 . . . . 0.0 111.521 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.0 -45.42 79.05 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 tp -61.88 -48.75 79.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.277 0.631 . . . . 0.0 112.105 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.77 -38.21 90.26 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.836 0.854 . . . . 0.0 112.463 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.97 -45.48 92.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.699 0.681 . . . . 0.0 112.075 170.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.65 -42.37 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.118 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.85 -46.14 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.477 -0.765 . . . . 0.0 111.03 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.09 -39.43 94.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.842 0.746 . . . . 0.0 112.757 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.75 -47.46 86.2 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.703 0.801 . . . . 0.0 111.975 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.09 -34.38 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.87 -41.42 91.63 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.467 -0.771 . . . . 0.0 112.341 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.08 98.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.184 0.594 . . . . 0.0 111.772 172.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.14 -42.21 99.44 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.924 -0.485 . . . . 0.0 112.135 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.84 -48.58 79.38 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.682 0.674 . . . . 0.0 111.699 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.04 -30.19 71.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.16 -39.18 78.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.361 1.065 . . . . 0.0 112.499 173.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.61 42.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 113.29 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.76 61.03 54.13 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.696 1.998 . . . . 0.0 111.225 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.9 120.16 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.481 2.12 . . . . 0.0 110.277 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.46 136.23 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.318 1.447 . . . . 0.0 112.121 -169.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.92 160.49 25.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.05 0.54 . . . . 0.0 110.903 168.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.9 64.99 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.98 174.71 41.62 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.099 1.333 . . . . 0.0 112.653 174.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.63 169.14 14.96 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.658 2.905 . . . . 0.0 112.915 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.6 -39.23 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.94 1.296 . . . . 0.0 111.762 -175.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.44 161.93 28.53 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.817 1.647 . . . . 0.0 110.573 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.95 133.47 23.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.441 2.761 . . . . 0.0 113.132 168.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.99 60.33 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.613 1.101 . . . . 0.0 115.056 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.36 37.46 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.946 1.373 . . . . 0.0 110.198 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.11 145.54 54.29 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.693 -0.63 . . . . 0.0 110.858 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.51 152.7 45.02 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.728 0.811 . . . . 0.0 111.653 171.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.21 131.66 84.96 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.34 140.38 44.09 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.134 1.889 . . . . 0.0 112.416 -177.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -75.11 171.66 13.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.709 1.604 . . . . 0.0 111.89 163.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.91 94.07 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.895 -0.503 . . . . 0.0 112.991 168.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.6 p -68.78 -25.77 64.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.76 -41.59 64.92 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.027 -1.046 . . . . 0.0 111.778 171.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.65 -42.69 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.718 0.807 . . . . 0.0 110.793 173.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.26 13.93 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 173.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.91 18.16 74.12 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.922 -1.111 . . . . 0.0 115.477 175.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.3 -19.35 19.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.131 1.466 . . . . 0.0 113.305 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.0 p -126.27 -1.51 6.98 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.6 149.97 24.41 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.103 0.961 . . . . 0.0 111.824 173.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.6 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.318 0.58 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.81 -39.44 74.16 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.418 -0.801 . . . . 0.0 111.372 169.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.5 -38.93 93.03 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.576 -0.702 . . . . 0.0 112.685 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.8 95.31 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.602 -0.686 . . . . 0.0 112.008 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.61 -46.39 90.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.648 0.779 . . . . 0.0 112.097 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.35 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.301 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.05 54.33 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.85 0.738 . . . . 0.0 112.866 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.14 72.91 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.828 0.814 . . . . 0.0 112.517 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.62 -18.48 64.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.4 p -111.88 8.36 20.39 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.688 1.195 . . . . 0.0 113.051 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.43 162.31 1.6 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.989 1.316 . . . . 0.0 111.434 165.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.34 48.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.035 0.934 . . . . 0.0 110.837 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.85 89.11 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.447 0.838 . . . . 0.0 111.701 -6.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -50.06 141.37 30.24 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.21 2.607 . . . . 0.0 114.135 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.14 96.49 2.5 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 163.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.0 54.59 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.251 2.634 . . . . 0.0 112.86 -152.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.63 -34.81 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.26 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.999 173.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.83 -36.87 75.95 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.91 -44.6 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.709 -0.62 . . . . 0.0 109.942 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.82 -40.46 91.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.307 -0.871 . . . . 0.0 112.54 176.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -42.03 74.99 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.455 -0.778 . . . . 0.0 112.287 173.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.68 -45.21 81.9 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.865 0.757 . . . . 0.0 112.147 174.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.35 -40.47 85.83 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.272 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.64 -47.27 93.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.085 0.554 . . . . 0.0 110.206 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.05 -37.36 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.634 1.174 . . . . 0.0 112.322 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.74 -42.87 98.24 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.095 0.861 . . . . 0.0 111.233 171.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.55 -45.07 91.56 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.821 0.724 . . . . 0.0 113.252 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.28 -42.49 86.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.988 0.894 . . . . 0.0 111.102 173.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.5 -50.16 70.67 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.772 0.829 . . . . 0.0 112.503 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.86 -43.27 76.95 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.864 0.756 . . . . 0.0 112.027 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.46 -47.74 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.337 0.655 . . . . 0.0 111.467 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.64 -32.89 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.923 1.238 . . . . 0.0 112.874 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.34 -45.11 94.6 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.958 0.903 . . . . 0.0 111.463 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.3 ttp -74.74 -36.7 62.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.666 1.586 . . . . 0.0 113.362 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 128.417 2.687 . . . . 0.0 114.655 -173.026 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.81 135.01 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.458 1.103 . . . . 0.0 108.437 163.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.02 154.94 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.1 1.36 . . . . 0.0 109.648 170.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.66 116.69 32.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.516 0.726 . . . . 0.0 109.17 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.604 0.716 . . . . 0.0 112.452 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.89 -26.45 68.79 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.63 -2.19 57.92 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.767 1.227 . . . . 0.0 112.988 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.03 85.67 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.78 128.27 35.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.861 1.331 . . . . 0.0 109.664 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.61 29.61 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 168.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.97 123.35 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.046 1.338 . . . . 0.0 108.678 -174.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.52 139.65 38.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.236 170.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.13 48.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.468 1.907 . . . . 0.0 107.94 169.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.24 152.37 20.91 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.221 170.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.54 136.9 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.65 -0.656 . . . . 0.0 111.509 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.71 130.01 93.19 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 123.098 0.559 . . . . 0.0 111.151 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.99 -34.6 67.96 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.907 2.405 . . . . 0.0 113.604 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.43 -38.06 86.57 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 112.594 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.94 -44.32 97.43 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.691 0.678 . . . . 0.0 111.373 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.57 -44.29 94.53 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.251 0.478 . . . . 0.0 112.254 175.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.23 -47.27 85.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.079 0.551 . . . . 0.0 111.399 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.23 95.63 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.663 0.785 . . . . 0.0 111.882 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.11 -47.27 86.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.801 0.84 . . . . 0.0 112.801 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.8 -54.4 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.431 0.559 . . . . 0.0 110.397 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.7 -37.36 78.63 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.301 1.04 . . . . 0.0 113.218 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.55 -52.19 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.027 1.331 . . . . 0.0 111.318 170.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.61 -35.96 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.417 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -58.66 -23.96 60.27 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.2 -25.73 11.39 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.83 15.91 3.33 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -166.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.05 -38.22 2.24 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -117.61 14.05 14.4 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.402 1.081 . . . . 0.0 113.141 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 p -113.14 152.97 45.49 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.982 0.913 . . . . 0.0 111.523 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.74 -30.96 58.98 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.258 2.639 . . . . 0.0 115.203 -172.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.01 -21.01 64.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.16 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.41 1.005 . . . . 0.0 112.485 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.36 -57.18 5.98 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.76 1.224 . . . . 0.0 112.561 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.84 -29.52 58.68 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.891 1.711 . . . . 0.0 112.814 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.403 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.25 -40.16 78.03 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.781 1.173 . . . . 0.0 112.705 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.09 -47.02 82.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.847 0.748 . . . . 0.0 111.53 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -60.92 -44.2 97.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.68 71.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.227 1.011 . . . . 0.0 113.225 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.76 4.53 52.85 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.373 1.469 . . . . 0.0 113.47 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.5 p -133.08 22.79 4.14 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -53.56 120.33 6.01 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.508 -1.37 . . . . 0.0 111.454 168.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.62 60.02 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.447 0.939 . . . . 0.0 115.447 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.89 47.15 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.489 1.644 . . . . 0.0 112.515 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.32 159.68 84.33 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.771 0.828 . . . . 0.0 110.665 167.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.57 -35.48 37.46 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.227 1.951 . . . . 0.0 115.381 168.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.3 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.33 -45.3 93.9 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.062 172.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.57 -44.29 94.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.354 1.062 . . . . 0.0 112.134 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -59.21 -41.49 88.74 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.682 -0.636 . . . . 0.0 111.973 171.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.25 -45.24 93.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.654 0.661 . . . . 0.0 111.08 175.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.38 -48.87 77.92 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.254 0.934 . . . . 0.0 112.202 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.0 mt -63.13 -38.47 91.32 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.91 -33.41 70.51 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.4 p -73.66 -12.52 60.76 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.2 m -122.14 7.79 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -174.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.77 -4.64 5.87 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.85 -32.94 55.83 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 119.236 1.518 . . . . 0.0 115.411 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -91.57 78.62 5.56 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.875 1.337 . . . . 0.0 110.585 171.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.18 -35.92 38.59 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.33 -41.06 73.73 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.12 1.327 . . . . 0.0 112.315 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.6 86.01 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.16 0.584 . . . . 0.0 111.361 173.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.04 -40.18 96.95 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.476 -0.765 . . . . 0.0 112.255 175.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.9 -50.0 73.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.237 1.015 . . . . 0.0 111.548 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.99 -45.42 79.02 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.095 0.958 . . . . 0.0 112.21 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.97 -48.72 79.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.338 0.655 . . . . 0.0 112.055 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -63.75 -38.24 90.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.448 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.98 -45.53 92.42 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.684 0.675 . . . . 0.0 112.046 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.54 -42.42 99.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.848 0.749 . . . . 0.0 112.164 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.84 -46.1 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.507 -0.745 . . . . 0.0 111.093 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.13 -39.4 93.94 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.847 0.749 . . . . 0.0 112.759 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.8 -47.46 86.23 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.948 174.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.11 -34.32 72.96 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.46 91.76 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.408 -0.808 . . . . 0.0 112.376 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.12 98.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.208 0.603 . . . . 0.0 111.772 172.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.0 -42.32 99.81 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.869 -0.519 . . . . 0.0 112.165 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.77 -48.63 79.11 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.645 0.657 . . . . 0.0 111.676 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.02 -30.25 71.45 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -39.1 78.79 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.326 1.05 . . . . 0.0 112.451 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.22 -27.61 42.5 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 113.339 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.76 61.01 54.03 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.646 1.978 . . . . 0.0 111.247 -174.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.89 120.16 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.51 2.14 . . . . 0.0 110.261 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.45 136.24 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.383 1.473 . . . . 0.0 112.086 -169.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -79.94 160.43 25.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.082 0.553 . . . . 0.0 110.909 168.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.98 65.02 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.016 1.293 . . . . 0.0 112.617 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 169.2 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.917 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.65 -39.17 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.897 1.279 . . . . 0.0 111.799 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.51 161.9 28.59 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.911 1.684 . . . . 0.0 110.599 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.427 2.751 . . . . 0.0 113.132 168.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.07 60.28 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 115.005 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.021 1.41 . . . . 0.0 110.198 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.5 54.27 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.726 -0.608 . . . . 0.0 110.848 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.53 152.77 44.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.666 0.787 . . . . 0.0 111.664 171.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.24 131.73 84.85 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.883 -0.58 . . . . 0.0 109.821 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.42 140.44 43.95 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.037 1.825 . . . . 0.0 112.426 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -75.1 171.62 13.8 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.74 1.616 . . . . 0.0 111.898 163.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.55 -43.94 94.0 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 121.895 -0.503 . . . . 0.0 112.986 168.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.5 p -68.77 -25.73 64.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.8 -41.61 64.76 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.068 -1.02 . . . . 0.0 111.721 171.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.75 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.784 0.834 . . . . 0.0 110.782 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.05 -1.25 14.05 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.97 18.13 74.21 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.879 -1.138 . . . . 0.0 115.485 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.34 -19.3 19.33 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.092 1.446 . . . . 0.0 113.313 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.26 -1.5 6.99 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.63 149.95 24.45 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.055 0.942 . . . . 0.0 111.799 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.1 p -81.79 162.42 22.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.309 0.576 . . . . 0.0 110.773 169.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.81 -39.41 74.13 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.454 -0.778 . . . . 0.0 111.431 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.52 -38.91 92.93 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.518 -0.739 . . . . 0.0 112.674 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.62 -42.75 95.3 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.628 -0.67 . . . . 0.0 112.033 171.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.35 90.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.62 0.768 . . . . 0.0 112.11 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.51 -46.33 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.151 0.981 . . . . 0.0 110.255 172.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.09 54.06 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.823 0.725 . . . . 0.0 112.884 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.22 -50.1 73.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.517 174.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.61 -18.58 64.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.9 8.41 20.37 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.581 1.153 . . . . 0.0 113.046 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.41 162.3 1.59 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.935 1.294 . . . . 0.0 111.461 165.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.87 89.08 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.451 0.84 . . . . 0.0 111.713 -6.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -50.08 141.4 30.3 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.189 2.593 . . . . 0.0 114.135 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.16 96.43 2.48 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.97 54.63 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.66 -34.78 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.44 -46.2 94.33 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.666 0.666 . . . . 0.0 112.996 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.84 -36.89 75.93 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.259 -1.142 . . . . 0.0 112.679 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.89 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.802 -0.561 . . . . 0.0 109.98 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.9 -40.4 91.47 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.313 -0.867 . . . . 0.0 112.521 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -42.04 75.07 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.69 -45.28 81.88 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.924 0.784 . . . . 0.0 112.058 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.3 -40.54 86.04 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.305 0.642 . . . . 0.0 112.227 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.64 -47.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.279 174.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.25 -37.29 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.685 1.194 . . . . 0.0 112.282 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.8 -42.78 98.31 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.112 0.869 . . . . 0.0 111.245 171.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.06 91.55 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.796 0.712 . . . . 0.0 113.242 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.41 -42.4 87.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.019 0.91 . . . . 0.0 111.078 173.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.19 70.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.26 77.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.86 0.755 . . . . 0.0 111.991 175.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.43 -47.94 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.402 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.48 -32.88 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.951 1.251 . . . . 0.0 112.911 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.24 -44.55 95.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.902 0.881 . . . . 0.0 111.474 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.77 -36.2 59.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.69 1.596 . . . . 0.0 113.437 -177.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.5 t80 . . . . . 0 C--O 1.251 1.16 0 C-N-CA 128.415 2.686 . . . . 0.0 114.504 -172.665 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.85 135.0 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.504 1.121 . . . . 0.0 108.402 163.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.7 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.88 -26.5 68.81 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.0 3.05 85.7 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.475 1.036 . . . . 0.0 114.092 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.19 35.32 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.87 1.335 . . . . 0.0 109.741 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.85 125.52 29.47 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 168.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.9 t -125.9 123.36 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.063 1.345 . . . . 0.0 108.659 -174.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.54 139.67 38.61 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.177 170.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.16 48.41 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 20.99 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.803 . . . . 0.0 111.191 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.53 136.91 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.472 0.653 . . . . 0.0 111.578 176.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.71 130.0 93.19 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.108 0.563 . . . . 0.0 111.137 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.873 2.382 . . . . 0.0 113.575 167.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.44 -38.09 86.61 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.464 -0.773 . . . . 0.0 112.56 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.92 -44.32 97.35 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 0.0 111.373 171.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.53 -44.31 94.6 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.24 -47.26 86.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.079 0.551 . . . . 0.0 111.366 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.18 95.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.626 0.77 . . . . 0.0 111.91 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.11 -47.14 87.12 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.833 0.853 . . . . 0.0 112.786 176.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.0 t -56.89 -54.26 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.381 0.537 . . . . 0.0 110.474 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.83 -37.26 78.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.358 1.063 . . . . 0.0 113.19 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.45 -52.3 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.096 1.358 . . . . 0.0 111.257 170.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.83 -35.85 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 119.053 -0.499 . . . . 0.0 111.466 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.73 -23.71 60.31 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.49 -25.62 11.3 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.92 16.11 3.3 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -166.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.39 -37.5 2.34 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -118.23 13.84 13.79 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.475 1.11 . . . . 0.0 113.148 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.9 p -113.05 153.06 45.42 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.971 0.908 . . . . 0.0 111.568 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.89 -30.88 60.16 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.256 2.638 . . . . 0.0 115.182 -172.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.95 64.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.17 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.41 1.005 . . . . 0.0 112.462 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.6 mt -70.35 -57.18 6.0 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.743 1.217 . . . . 0.0 112.561 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.88 -29.45 58.36 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.891 1.711 . . . . 0.0 112.816 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.24 -40.17 78.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.831 1.196 . . . . 0.0 112.709 172.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.12 -47.01 82.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.83 0.741 . . . . 0.0 111.562 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -60.91 -44.2 97.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.73 -31.68 70.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.228 1.011 . . . . 0.0 113.251 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.87 4.62 52.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.419 1.488 . . . . 0.0 113.458 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.1 p -133.11 22.86 4.14 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.61 120.3 6.0 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.453 -1.404 . . . . 0.0 111.465 168.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.71 60.16 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.59 130.91 47.18 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.478 1.639 . . . . 0.0 112.453 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.35 159.65 84.37 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.771 0.828 . . . . 0.0 110.653 167.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.58 -35.44 37.43 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.171 1.914 . . . . 0.0 115.372 168.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.07 -40.24 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -60.32 -45.32 93.81 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.662 -0.649 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.57 -44.27 94.59 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 112.163 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -59.21 -41.43 88.58 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.682 -0.636 . . . . 0.0 111.996 171.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.6 m -60.25 -45.42 93.33 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.583 0.629 . . . . 0.0 111.028 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.28 -48.85 77.85 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.228 0.922 . . . . 0.0 112.179 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.8 mt -63.18 -38.29 90.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 178.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.07 -34.2 71.69 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -72.81 -12.93 61.18 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.4 13.11 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.267 1.027 . . . . 0.0 113.505 -175.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.48 -5.91 4.1 Favored Glycine 0 CA--C 1.543 1.835 0 N-CA-C 117.067 1.587 . . . . 0.0 117.067 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.67 -0.13 6.21 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 125.84 1.686 . . . . 0.0 116.919 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -124.78 79.79 1.81 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.339 1.57 . . . . 0.0 110.347 166.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.81 -36.08 46.59 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -172.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.17 -41.01 74.33 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.118 1.326 . . . . 0.0 112.19 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.47 -43.68 84.82 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.19 0.596 . . . . 0.0 111.317 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.2 tpp -62.86 -40.3 97.04 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.508 -0.745 . . . . 0.0 112.2 175.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.97 74.18 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.296 1.038 . . . . 0.0 111.536 173.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -56.02 -45.43 79.1 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.101 0.961 . . . . 0.0 112.206 174.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.8 tp -61.88 -48.81 78.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.289 0.636 . . . . 0.0 112.055 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.63 -38.31 90.65 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.455 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.02 -45.45 92.75 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.668 0.667 . . . . 0.0 112.013 170.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.61 -42.45 99.58 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.848 0.749 . . . . 0.0 112.094 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.8 -46.11 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.535 -0.728 . . . . 0.0 111.053 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.16 -39.4 93.94 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.865 0.757 . . . . 0.0 112.717 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -60.84 -47.44 86.35 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.964 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.1 -34.3 72.96 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.55 91.78 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.451 -0.781 . . . . 0.0 112.369 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.01 98.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.201 0.6 . . . . 0.0 111.784 172.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.1 -42.28 99.54 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.864 -0.523 . . . . 0.0 112.19 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.88 -48.45 79.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.646 0.657 . . . . 0.0 111.687 173.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.09 -30.3 71.49 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.08 -39.12 79.26 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.361 1.064 . . . . 0.0 112.499 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.29 -27.6 42.21 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.776 1.23 . . . . 0.0 113.302 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.83 61.03 54.02 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.672 1.989 . . . . 0.0 111.241 -174.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.93 120.16 7.44 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.421 2.08 . . . . 0.0 110.258 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.4 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.34 1.456 . . . . 0.0 112.152 -169.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.05 160.47 25.81 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.043 0.537 . . . . 0.0 110.909 168.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.26 -19.97 65.03 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.71 41.58 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.048 1.309 . . . . 0.0 112.61 174.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.45 169.17 14.61 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.668 2.912 . . . . 0.0 112.954 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.74 -39.17 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.909 1.284 . . . . 0.0 111.742 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.94 28.52 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -47.91 133.42 22.84 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.479 2.786 . . . . 0.0 113.089 168.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.06 60.35 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.562 1.077 . . . . 0.0 114.978 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.35 37.47 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.96 1.38 . . . . 0.0 110.198 173.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.17 145.57 54.21 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.717 -0.614 . . . . 0.0 110.826 168.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.56 152.73 44.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.709 0.804 . . . . 0.0 111.614 171.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.25 131.73 84.82 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.916 -0.564 . . . . 0.0 109.835 170.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.42 140.39 43.83 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.099 1.866 . . . . 0.0 112.442 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.7 mtp85 -75.02 171.63 13.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.737 1.615 . . . . 0.0 111.852 163.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.68 -43.82 94.27 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.942 -0.474 . . . . 0.0 112.954 168.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.77 -25.86 64.92 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.56 65.11 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.041 -1.037 . . . . 0.0 111.756 171.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.66 -42.69 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.731 0.812 . . . . 0.0 110.827 173.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.29 14.03 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 173.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.11 74.16 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.934 -1.104 . . . . 0.0 115.477 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.39 19.35 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.11 1.455 . . . . 0.0 113.292 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.6 p -126.21 -1.54 7.02 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.57 149.99 24.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.067 0.947 . . . . 0.0 111.773 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.9 p -81.85 162.37 22.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.307 0.575 . . . . 0.0 110.794 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.81 -39.45 74.19 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.484 -0.76 . . . . 0.0 111.4 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.59 -38.83 92.62 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.556 -0.715 . . . . 0.0 112.683 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.63 -42.76 95.25 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.628 -0.67 . . . . 0.0 112.047 171.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.63 -46.42 90.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.61 0.764 . . . . 0.0 112.11 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.39 -46.33 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.142 0.977 . . . . 0.0 110.354 172.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.12 53.81 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.81 0.719 . . . . 0.0 112.902 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.21 -50.07 73.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.778 0.789 . . . . 0.0 112.512 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.1 p -111.95 8.42 20.29 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.6 1.16 . . . . 0.0 113.009 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.44 162.31 1.61 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.952 1.301 . . . . 0.0 111.441 165.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.85 89.12 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.451 0.84 . . . . 0.0 111.762 -6.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -49.97 141.31 29.73 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.238 2.625 . . . . 0.0 114.174 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.12 96.48 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.81 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.17 94.4 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.638 0.654 . . . . 0.0 113.011 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.89 -36.86 75.76 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.296 -1.12 . . . . 0.0 112.634 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.92 -44.58 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.785 -0.572 . . . . 0.0 109.954 173.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.89 -40.38 91.52 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.303 -0.873 . . . . 0.0 112.521 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.05 75.1 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.275 173.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.65 -45.21 81.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.901 0.773 . . . . 0.0 112.147 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.28 -40.53 86.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.69 -47.04 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.05 0.54 . . . . 0.0 110.286 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.29 -37.3 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.636 1.174 . . . . 0.0 112.282 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.82 -42.77 98.35 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.051 0.842 . . . . 0.0 111.215 171.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.17 90.96 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.836 0.731 . . . . 0.0 113.184 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.43 -42.29 86.97 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.045 0.922 . . . . 0.0 111.073 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.26 70.4 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.424 173.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.77 -43.26 76.57 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.874 0.761 . . . . 0.0 111.961 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.2 mt -64.6 -47.76 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.431 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.56 -32.89 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.965 1.257 . . . . 0.0 112.9 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.25 -44.84 94.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.939 0.895 . . . . 0.0 111.468 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.39 -36.87 60.82 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.683 1.593 . . . . 0.0 113.428 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 128.425 2.69 . . . . 0.0 114.577 -172.73 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.89 135.06 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.482 1.113 . . . . 0.0 108.402 163.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -126.07 154.84 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.092 1.357 . . . . 0.0 109.688 170.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.56 116.7 32.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.519 0.728 . . . . 0.0 109.139 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.46 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.514 0.673 . . . . 0.0 112.474 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.85 -26.53 68.8 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -173.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.87 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.81 1.244 . . . . 0.0 113.019 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.94 3.09 85.81 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.458 1.028 . . . . 0.0 114.08 -175.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.21 35.39 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.823 1.312 . . . . 0.0 109.683 174.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.53 29.49 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 168.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.9 123.31 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.086 1.354 . . . . 0.0 108.698 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.58 139.66 38.57 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.555 0.693 . . . . 0.0 111.23 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.09 48.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.491 1.916 . . . . 0.0 107.921 169.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.4 20.9 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.248 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.56 136.85 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.605 -0.685 . . . . 0.0 111.555 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.65 129.98 93.26 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.136 0.575 . . . . 0.0 111.149 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.02 -34.58 68.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.907 2.405 . . . . 0.0 113.586 167.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.44 -38.08 86.6 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.513 -0.742 . . . . 0.0 112.588 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.87 -44.34 97.19 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.767 0.712 . . . . 0.0 111.386 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.52 -44.33 94.57 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.296 0.498 . . . . 0.0 112.267 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.23 -47.22 86.14 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.139 0.576 . . . . 0.0 111.4 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.24 95.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.664 0.786 . . . . 0.0 111.899 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.14 -47.12 87.25 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.795 0.838 . . . . 0.0 112.772 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.1 t -56.91 -54.3 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.392 0.542 . . . . 0.0 110.41 174.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.81 -37.18 78.42 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.324 1.05 . . . . 0.0 113.247 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.57 -52.19 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.044 1.338 . . . . 0.0 111.286 170.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.91 -35.86 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.972 0.509 . . . . 0.0 111.412 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -58.66 -23.79 59.96 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.52 -25.58 11.31 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -135.94 16.12 3.29 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.42 -37.4 2.33 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -175.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -118.31 13.91 13.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.473 1.109 . . . . 0.0 113.148 -172.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.1 p -113.15 153.02 45.52 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.962 0.905 . . . . 0.0 111.515 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.82 -30.91 59.64 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.287 2.658 . . . . 0.0 115.218 -172.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.91 64.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.61 -32.24 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.406 1.003 . . . . 0.0 112.422 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.6 mt -70.33 -57.15 6.05 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.684 1.194 . . . . 0.0 112.572 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.86 -29.45 58.49 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.896 1.713 . . . . 0.0 112.816 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.29 -40.08 77.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.818 1.19 . . . . 0.0 112.694 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -57.17 -47.05 82.18 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.878 0.763 . . . . 0.0 111.537 169.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -60.88 -44.21 97.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.79 -31.61 70.97 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.193 0.997 . . . . 0.0 113.297 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.88 4.74 52.54 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.368 1.467 . . . . 0.0 113.55 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.0 p -133.15 22.73 4.12 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.57 120.29 5.96 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.474 -1.391 . . . . 0.0 111.456 168.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.53 60.15 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.47 130.82 46.91 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.528 1.664 . . . . 0.0 112.53 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.28 159.66 84.43 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.718 0.807 . . . . 0.0 110.692 167.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.61 -35.37 37.49 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.144 1.896 . . . . 0.0 115.4 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.03 -40.3 87.18 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.3 93.89 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.066 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.55 -44.28 94.62 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.329 1.051 . . . . 0.0 112.175 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -59.24 -41.37 88.58 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.612 -0.68 . . . . 0.0 112.047 171.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.2 -45.41 93.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.597 0.635 . . . . 0.0 111.115 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.28 -48.85 77.84 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.187 0.903 . . . . 0.0 112.176 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.0 mt -63.18 -38.33 90.73 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.06 -34.16 71.62 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -72.78 -12.98 61.21 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.36 13.15 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.315 1.046 . . . . 0.0 113.557 -175.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.48 -5.92 4.11 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 117.055 1.582 . . . . 0.0 117.055 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.71 -0.2 6.38 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 125.909 1.719 . . . . 0.0 116.845 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -124.71 79.76 1.8 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.347 1.574 . . . . 0.0 110.385 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.87 -36.03 47.07 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.718 1.607 . . . . 0.0 115.304 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.2 -40.98 74.29 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.154 1.343 . . . . 0.0 112.191 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.44 -43.75 84.73 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.254 0.622 . . . . 0.0 111.315 173.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.2 tpp -62.77 -40.3 96.87 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.491 -0.756 . . . . 0.0 112.257 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.05 -49.95 74.26 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.292 1.037 . . . . 0.0 111.544 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -56.0 -45.42 79.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.101 0.961 . . . . 0.0 112.234 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.88 -48.84 78.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.308 0.643 . . . . 0.0 112.054 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.69 -38.3 90.58 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.873 0.869 . . . . 0.0 112.424 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.95 -45.49 92.49 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.705 0.684 . . . . 0.0 112.034 170.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.7 m -62.65 -42.36 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.793 0.724 . . . . 0.0 112.118 175.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.87 -46.08 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.507 -0.745 . . . . 0.0 111.045 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.4 93.96 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.838 0.745 . . . . 0.0 112.717 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -60.84 -47.41 86.48 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.743 0.817 . . . . 0.0 111.958 174.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.12 -34.34 72.96 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.593 -0.692 . . . . 0.0 112.859 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.56 91.81 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.484 -0.76 . . . . 0.0 112.371 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.09 98.58 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.246 0.619 . . . . 0.0 111.766 172.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.17 -42.22 99.37 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.864 -0.523 . . . . 0.0 112.191 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.71 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.06 -30.22 71.43 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.19 -39.06 78.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.342 1.057 . . . . 0.0 112.488 173.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.57 42.28 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.796 1.239 . . . . 0.0 113.354 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.0 53.92 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.94 120.15 7.43 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.452 2.101 . . . . 0.0 110.285 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.44 136.36 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.372 1.469 . . . . 0.0 112.077 -169.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -80.0 160.47 25.87 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.048 0.539 . . . . 0.0 110.909 168.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.24 -19.98 65.03 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.91 174.81 41.58 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.075 1.322 . . . . 0.0 112.625 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.64 169.18 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.635 2.89 . . . . 0.0 112.889 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.68 -39.19 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.903 1.281 . . . . 0.0 111.749 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.46 161.89 28.6 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.842 1.657 . . . . 0.0 110.551 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.427 2.751 . . . . 0.0 113.132 168.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.98 -15.08 60.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.567 1.08 . . . . 0.0 115.01 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.23 145.48 54.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.691 -0.631 . . . . 0.0 110.859 168.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.47 152.82 44.86 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.2 131.69 84.94 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.83 170.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.44 140.36 43.69 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.097 1.864 . . . . 0.0 112.426 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -75.04 171.62 13.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.649 1.58 . . . . 0.0 111.89 163.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.55 -43.85 94.02 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.949 -0.469 . . . . 0.0 113.035 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.76 -25.85 64.94 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.63 -41.63 65.32 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.061 -1.025 . . . . 0.0 111.795 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.75 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.784 0.834 . . . . 0.0 110.782 173.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.26 14.02 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 173.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.93 18.16 74.16 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.908 -1.12 . . . . 0.0 115.491 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.26 -19.46 19.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.053 1.426 . . . . 0.0 113.263 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.0 p -126.1 -1.49 7.09 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.67 149.89 24.53 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.052 0.941 . . . . 0.0 111.814 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.0 p -81.76 162.31 22.97 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.318 0.58 . . . . 0.0 110.827 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.75 -39.43 73.97 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.446 -0.784 . . . . 0.0 111.43 169.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.56 -38.9 92.89 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.516 -0.74 . . . . 0.0 112.706 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.76 95.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 112.008 171.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.68 -46.36 90.66 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.156 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.47 -46.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.091 0.956 . . . . 0.0 110.288 172.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.1 54.01 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 0.0 112.869 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.07 73.19 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.512 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.61 -18.53 64.33 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.91 8.36 20.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.645 1.178 . . . . 0.0 112.996 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.44 162.33 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.995 1.318 . . . . 0.0 111.447 165.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.6 103.34 48.91 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.065 0.946 . . . . 0.0 110.778 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.451 0.84 . . . . 0.0 111.762 -6.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -50.0 141.36 29.81 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.155 2.57 . . . . 0.0 114.205 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.11 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.56 -34.84 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -173.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.21 94.29 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.605 0.639 . . . . 0.0 112.996 173.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.84 -36.9 75.95 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.289 -1.124 . . . . 0.0 112.645 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.9 -44.57 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.745 -0.597 . . . . 0.0 109.914 173.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.91 -40.35 91.4 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.282 -0.886 . . . . 0.0 112.521 176.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.87 -42.07 75.34 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.439 -0.788 . . . . 0.0 112.204 173.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.63 -45.25 81.66 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.899 0.772 . . . . 0.0 112.093 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.28 -40.53 86.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.66 -47.08 94.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.085 0.554 . . . . 0.0 110.285 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.26 -37.32 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.645 1.178 . . . . 0.0 112.298 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.82 98.41 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.028 0.831 . . . . 0.0 111.185 171.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.48 -45.21 91.12 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.878 0.751 . . . . 0.0 113.228 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.38 -42.3 86.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.003 0.901 . . . . 0.0 111.14 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.26 70.4 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.424 173.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.83 -43.19 76.74 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.874 0.761 . . . . 0.0 111.975 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.6 -47.79 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.344 0.658 . . . . 0.0 111.431 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.89 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.961 1.255 . . . . 0.0 112.9 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -60.26 -44.87 94.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.939 0.895 . . . . 0.0 111.461 171.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.33 -36.95 60.99 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.672 1.589 . . . . 0.0 113.45 -177.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 128.454 2.702 . . . . 0.0 114.562 -172.701 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.85 135.0 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.488 1.115 . . . . 0.0 108.482 163.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.65 32.46 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.43 178.06 6.88 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 121.529 0.68 . . . . 0.0 112.46 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.88 -26.56 68.84 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.03 3.02 85.65 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.475 1.036 . . . . 0.0 114.07 -175.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.71 128.2 35.35 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.893 1.347 . . . . 0.0 109.712 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.55 29.51 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 168.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.94 123.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.074 1.349 . . . . 0.0 108.629 -174.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.65 141.14 48.49 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.488 1.915 . . . . 0.0 107.89 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.29 21.03 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.023 0.829 . . . . 0.0 111.254 170.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.48 136.85 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.523 0.678 . . . . 0.0 111.55 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.69 130.0 93.21 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.068 0.547 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.02 -34.58 68.22 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.894 2.396 . . . . 0.0 113.583 167.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.44 -38.06 86.55 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.437 -0.789 . . . . 0.0 112.588 174.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.95 -44.31 97.47 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 0.0 111.349 171.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.57 -44.35 94.36 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.29 0.496 . . . . 0.0 112.309 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.12 -47.31 85.73 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.142 0.577 . . . . 0.0 111.388 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.32 95.29 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.604 0.761 . . . . 0.0 111.896 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -60.07 -47.29 86.47 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.849 0.859 . . . . 0.0 112.791 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.6 t -56.74 -54.94 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 118.417 0.553 . . . . 0.0 110.254 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.15 -37.71 77.98 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.371 1.068 . . . . 0.0 113.237 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.404 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.21 -51.96 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.064 1.346 . . . . 0.0 111.28 170.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.81 -35.87 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.993 0.517 . . . . 0.0 111.485 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -58.94 -23.29 61.29 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.709 1.141 . . . . 0.0 113.972 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.55 -25.91 11.15 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -135.9 16.26 3.3 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -165.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.65 -37.47 2.6 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -118.3 14.58 13.86 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.39 1.076 . . . . 0.0 113.1 -172.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -113.77 153.02 46.05 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.004 0.922 . . . . 0.0 111.526 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.9 -30.79 59.87 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.274 2.649 . . . . 0.0 115.224 -172.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.09 -20.64 64.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.78 -31.96 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.397 0.998 . . . . 0.0 112.539 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.38 -55.08 6.3 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.974 1.31 . . . . 0.0 112.944 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.85 -30.07 49.59 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.658 1.628 . . . . 0.0 112.669 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.404 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.04 -40.3 78.68 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.921 1.237 . . . . 0.0 112.606 172.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.25 -46.46 82.99 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.735 0.698 . . . . 0.0 111.576 169.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -61.1 -44.47 97.31 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.84 -31.95 71.37 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.317 1.047 . . . . 0.0 113.25 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.47 4.58 53.13 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.333 1.453 . . . . 0.0 113.526 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.1 p -133.09 22.8 4.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.58 120.34 6.04 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.47 168.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.69 60.07 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.371 0.909 . . . . 0.0 115.371 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.54 130.89 47.14 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.565 1.683 . . . . 0.0 112.515 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.33 159.69 84.29 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 123.748 0.819 . . . . 0.0 110.718 167.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.61 -35.44 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.204 1.936 . . . . 0.0 115.372 168.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.24 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.35 93.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -59.2 -41.49 88.66 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.696 -0.628 . . . . 0.0 112.024 171.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.22 -45.33 93.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.569 0.622 . . . . 0.0 111.091 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.33 -48.86 77.88 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.205 0.911 . . . . 0.0 112.164 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.19 -38.33 90.76 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.06 -33.7 71.09 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.4 p -73.07 -12.92 61.09 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.17 8.9 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -174.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.86 -5.55 7.55 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 117.267 1.667 . . . . 0.0 117.267 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.23 -31.24 59.12 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.318 1.559 . . . . 0.0 115.648 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -93.42 78.44 4.41 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.962 1.381 . . . . 0.0 110.536 172.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.07 -35.8 36.64 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.03 73.96 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.154 1.343 . . . . 0.0 112.243 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.58 85.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.199 0.599 . . . . 0.0 111.35 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.06 -40.08 96.64 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.53 -0.732 . . . . 0.0 112.238 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.96 74.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.247 1.019 . . . . 0.0 111.529 173.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -55.9 -45.5 78.63 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.1 0.96 . . . . 0.0 112.228 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.92 -48.77 78.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.265 0.626 . . . . 0.0 112.035 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.69 -38.31 90.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.873 0.869 . . . . 0.0 112.49 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.96 -45.49 92.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.689 0.677 . . . . 0.0 112.02 170.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.6 -42.43 99.57 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.848 0.749 . . . . 0.0 112.13 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.83 -46.08 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.535 -0.728 . . . . 0.0 111.059 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.21 -39.35 93.79 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.858 0.754 . . . . 0.0 112.731 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.84 -47.39 86.59 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.964 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.19 -34.27 72.74 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.6 91.91 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.451 -0.781 . . . . 0.0 112.333 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -42.04 98.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.224 0.61 . . . . 0.0 111.783 172.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.19 -42.26 99.33 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.855 -0.528 . . . . 0.0 112.191 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.74 -48.55 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.625 0.648 . . . . 0.0 111.71 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -63.04 -30.3 71.49 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -38.99 78.83 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.33 1.052 . . . . 0.0 112.458 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.36 -27.5 41.95 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.776 1.23 . . . . 0.0 113.313 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.84 61.02 53.98 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.622 1.969 . . . . 0.0 111.241 -174.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -63.91 120.12 7.38 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.479 2.119 . . . . 0.0 110.293 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.39 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.32 1.448 . . . . 0.0 112.135 -169.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.03 160.49 25.83 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.083 0.553 . . . . 0.0 110.897 168.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -19.93 65.01 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.94 174.77 41.59 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.032 1.301 . . . . 0.0 112.656 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.57 169.17 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.66 2.907 . . . . 0.0 112.906 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.69 -39.14 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.843 1.257 . . . . 0.0 111.824 -175.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.91 28.57 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.83 133.41 22.44 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.519 2.812 . . . . 0.0 113.132 168.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.9 -15.0 60.33 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.607 1.099 . . . . 0.0 114.992 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.992 1.396 . . . . 0.0 110.198 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.52 54.19 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.694 -0.629 . . . . 0.0 110.787 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.47 152.84 44.83 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.3 131.73 84.73 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 118.945 -0.55 . . . . 0.0 109.824 170.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.38 140.38 43.93 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.074 1.849 . . . . 0.0 112.442 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -74.98 171.61 13.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.761 1.625 . . . . 0.0 111.872 163.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.64 -43.82 94.19 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.912 -0.493 . . . . 0.0 112.974 168.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.5 p -68.74 -25.85 64.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.72 -41.64 65.0 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.082 -1.011 . . . . 0.0 111.725 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.63 -42.69 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.718 0.807 . . . . 0.0 110.827 173.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.96 -1.34 14.13 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.21 74.24 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 120.877 -1.139 . . . . 0.0 115.463 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.31 -19.46 19.24 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.099 1.449 . . . . 0.0 113.263 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.12 -1.42 7.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.7 149.87 24.57 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.073 0.949 . . . . 0.0 111.788 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.1 p -81.76 162.33 22.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.318 0.58 . . . . 0.0 110.827 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.78 -39.47 74.14 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.418 -0.801 . . . . 0.0 111.347 169.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.52 -38.9 92.89 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.554 -0.716 . . . . 0.0 112.722 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.62 -42.76 95.3 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.584 -0.698 . . . . 0.0 112.033 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.65 -46.39 90.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.687 0.795 . . . . 0.0 112.097 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.29 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.338 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.51 -51.02 54.73 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.81 0.719 . . . . 0.0 112.927 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.27 -50.04 73.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.819 0.81 . . . . 0.0 112.542 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.69 -18.49 64.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.0 p -111.93 8.46 20.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.643 1.177 . . . . 0.0 113.062 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.45 162.31 1.62 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.989 1.316 . . . . 0.0 111.441 165.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.37 48.93 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.029 0.932 . . . . 0.0 110.758 176.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.06 163.81 89.24 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.494 0.855 . . . . 0.0 111.713 -6.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -49.93 141.36 29.3 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.199 2.6 . . . . 0.0 114.149 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.16 96.45 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 163.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -86.0 54.56 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.251 2.634 . . . . 0.0 112.86 -152.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.56 -34.86 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.22 94.31 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.638 0.654 . . . . 0.0 112.999 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -69.9 -36.83 75.72 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.327 -1.102 . . . . 0.0 112.688 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.87 -44.64 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.795 -0.566 . . . . 0.0 109.912 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.88 -40.34 91.52 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.303 -0.873 . . . . 0.0 112.564 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.88 -41.98 75.26 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.412 -0.805 . . . . 0.0 112.253 173.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.69 -45.16 81.95 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.924 0.784 . . . . 0.0 112.147 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.33 -40.53 85.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.29 0.636 . . . . 0.0 112.251 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.67 -47.09 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.085 0.554 . . . . 0.0 110.249 174.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.19 -37.39 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.674 1.19 . . . . 0.0 112.3 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.8 -42.79 98.31 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.011 0.823 . . . . 0.0 111.253 171.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.11 91.4 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.796 0.712 . . . . 0.0 113.265 175.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.46 -42.3 87.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.01 0.905 . . . . 0.0 111.092 173.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.19 70.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.23 77.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.86 0.755 . . . . 0.0 111.986 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.41 -47.91 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.415 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -69.64 -32.8 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.0 1.273 . . . . 0.0 112.86 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.11 -44.02 95.18 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.863 0.865 . . . . 0.0 111.505 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.3 ttp -77.04 -37.36 54.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.652 1.581 . . . . 0.0 113.558 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.251 1.177 0 C-N-CA 128.427 2.691 . . . . 0.0 114.649 -172.059 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.48 0.686 0 N-CA-C 112.997 0.345 . . . . 20.0 112.997 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.99 135.01 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.473 1.109 . . . . 20.0 108.448 163.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.81 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 20.0 109.686 170.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.47 116.7 32.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.531 0.733 . . . . 20.0 109.17 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.503 0.668 . . . . 20.0 112.495 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.82 -26.57 68.81 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.432 1.271 . . . . 20.0 114.432 -173.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 20.0 113.03 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.0 3.07 85.68 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.475 1.036 . . . . 20.0 114.058 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.22 35.46 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.847 1.323 . . . . 20.0 109.731 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.52 29.47 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.453 -0.573 . . . . 20.0 109.453 168.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.9 123.39 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.014 1.326 . . . . 20.0 108.648 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 20.0 111.213 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.67 141.12 48.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.511 1.924 . . . . 20.0 107.935 169.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.37 20.84 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.949 0.795 . . . . 20.0 111.191 170.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.53 136.81 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.625 -0.672 . . . . 20.0 111.61 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.62 129.96 93.29 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.084 0.553 . . . . 20.0 111.137 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.05 -34.48 67.98 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.868 2.378 . . . . 20.0 113.542 167.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.51 -38.09 86.46 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.453 -0.779 . . . . 20.0 112.56 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.99 -44.21 97.74 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 20.0 111.354 171.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.58 -44.45 94.02 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.341 0.519 . . . . 20.0 112.256 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.08 -47.19 86.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.076 0.55 . . . . 20.0 111.402 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.2 95.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.64 0.776 . . . . 20.0 111.881 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -60.29 -46.89 88.26 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.81 0.844 . . . . 20.0 112.781 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.9 t -57.0 -54.24 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.412 0.551 . . . . 20.0 110.355 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.8 -37.25 78.59 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.374 1.07 . . . . 20.0 113.229 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.22 -52.31 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.206 1.403 . . . . 20.0 111.233 170.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.08 -36.14 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.022 0.529 . . . . 20.0 111.405 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -58.55 -23.85 59.37 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.978 1.103 . . . . 20.0 113.978 175.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.47 -25.47 11.38 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.04 1.126 . . . . 20.0 114.04 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -136.19 16.09 3.24 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.367 1.247 . . . . 20.0 114.367 -165.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.08 -36.78 2.71 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.478 2.029 . . . . 20.0 116.478 -175.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.48 15.34 13.78 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.492 1.117 . . . . 20.0 113.098 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -114.87 153.01 47.0 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.961 0.904 . . . . 20.0 111.456 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.96 -30.6 59.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.218 2.612 . . . . 20.0 115.238 -172.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.17 -20.74 64.45 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.173 1.175 . . . . 20.0 114.173 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.88 -31.82 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.468 1.031 . . . . 20.0 112.548 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.7 mt -71.47 -54.98 6.26 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.927 1.291 . . . . 20.0 113.01 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.89 -30.16 49.16 Favored 'Trans proline' 0 C--N 1.351 0.686 0 CA-C-N 121.673 1.633 . . . . 20.0 112.633 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -68.96 -40.26 79.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.867 1.212 . . . . 20.0 112.674 172.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.3 -46.44 83.17 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.476 0.711 . . . . 20.0 111.576 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.0 m -61.12 -44.53 97.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.608 0.596 . . . . 20.0 112.608 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.8 -31.88 71.26 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.28 1.032 . . . . 20.0 113.315 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.52 4.57 53.07 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.364 1.466 . . . . 20.0 113.499 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.5 p -133.1 22.88 4.14 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.437 1.273 . . . . 20.0 114.437 -176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.63 120.27 5.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.485 -1.384 . . . . 20.0 111.47 168.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.6 11.59 60.19 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 115.365 0.906 . . . . 20.0 115.365 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.45 130.82 46.9 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.542 1.671 . . . . 20.0 112.48 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.33 159.66 84.37 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.706 0.802 . . . . 20.0 110.68 167.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.57 -35.47 37.43 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.144 1.896 . . . . 20.0 115.406 168.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.04 -40.17 87.11 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.098 0.777 . . . . 20.0 113.098 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.42 -45.26 94.26 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.629 -0.669 . . . . 20.0 111.047 172.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.56 -44.28 94.58 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.32 1.048 . . . . 20.0 112.115 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -59.25 -41.39 88.66 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.618 0.644 . . . . 20.0 112.008 171.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.9 m -60.3 -45.28 93.93 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.597 0.635 . . . . 20.0 111.066 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.38 -48.98 77.64 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.218 0.917 . . . . 20.0 112.114 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.04 -38.34 90.8 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.827 0.677 . . . . 20.0 112.827 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.04 -33.66 71.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.89 0.7 . . . . 20.0 112.89 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.8 p -73.1 -12.81 61.04 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.662 1.356 . . . . 20.0 114.662 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.03 7.78 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.357 1.063 . . . . 20.0 113.868 -174.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.09 -5.43 10.05 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 117.46 1.744 . . . . 20.0 117.46 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.05 -35.42 69.21 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 119.32 1.56 . . . . 20.0 115.282 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -85.28 77.84 9.91 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 123.053 1.406 . . . . 20.0 110.56 171.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.98 -35.61 34.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.624 1.57 . . . . 20.0 115.225 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.58 -41.42 72.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.226 1.375 . . . . 20.0 112.306 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.32 -43.59 85.75 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.777 -0.577 . . . . 20.0 111.37 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -63.13 -39.98 96.26 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.475 -0.766 . . . . 20.0 112.239 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -57.05 -49.94 74.27 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.05 -1.031 . . . . 20.0 111.548 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.95 -45.46 78.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 20.0 112.239 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.96 -48.73 79.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.27 0.628 . . . . 20.0 112.034 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.73 -38.37 90.85 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 20.0 112.403 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.78 -45.59 91.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.807 0.73 . . . . 20.0 112.048 170.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.5 m -62.67 -42.41 99.6 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.724 0.693 . . . . 20.0 112.118 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.78 -46.1 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.431 -0.793 . . . . 20.0 111.093 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.12 -39.48 94.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.788 0.722 . . . . 20.0 112.715 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -60.77 -47.45 86.28 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.716 0.806 . . . . 20.0 111.958 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.09 -34.3 72.97 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.901 0.704 . . . . 20.0 112.901 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.59 91.73 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.434 -0.791 . . . . 20.0 112.369 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.11 98.57 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.264 0.625 . . . . 20.0 111.781 172.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.12 -42.27 99.5 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 20.0 112.163 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.81 -48.49 79.57 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.661 0.664 . . . . 20.0 111.669 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.06 -30.33 71.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.906 0.706 . . . . 20.0 112.906 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.17 -38.99 79.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.331 1.052 . . . . 20.0 112.457 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.4 -27.58 41.81 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.807 1.243 . . . . 20.0 113.306 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.1 54.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.587 1.955 . . . . 20.0 111.217 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.0 120.13 7.4 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.483 2.122 . . . . 20.0 110.242 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.41 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.366 1.466 . . . . 20.0 112.158 -169.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.09 160.47 25.76 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.103 0.561 . . . . 20.0 110.903 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -19.97 65.05 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.367 1.247 . . . . 20.0 114.367 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.88 174.81 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.064 1.316 . . . . 20.0 112.68 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.57 169.17 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.66 2.907 . . . . 20.0 112.906 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.73 -39.05 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.843 1.257 . . . . 20.0 111.82 -175.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.55 161.85 28.7 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.877 1.671 . . . . 20.0 110.603 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.92 133.45 22.9 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.473 2.782 . . . . 20.0 113.132 168.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.94 -15.02 60.35 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.567 1.08 . . . . 20.0 115.001 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -78.14 143.36 37.35 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.978 1.389 . . . . 20.0 110.187 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.14 145.58 54.24 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.719 -0.613 . . . . 20.0 110.826 168.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.51 152.69 45.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.717 0.807 . . . . 20.0 111.616 171.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.21 131.73 84.9 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.917 -0.563 . . . . 20.0 109.834 170.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.42 140.27 43.55 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.096 1.864 . . . . 20.0 112.451 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -74.92 171.62 13.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.743 1.617 . . . . 20.0 111.872 163.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.87 94.09 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.935 -0.478 . . . . 20.0 112.998 168.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.75 -25.83 64.93 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.059 1.133 . . . . 20.0 114.059 175.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.6 64.98 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.062 -1.024 . . . . 20.0 111.742 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.65 -42.72 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.731 0.812 . . . . 20.0 110.812 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.29 14.06 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.87 1.063 . . . . 20.0 113.87 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.26 74.28 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 120.865 -1.147 . . . . 20.0 115.393 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.41 19.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.11 1.455 . . . . 20.0 113.263 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.6 p -126.22 -1.46 7.02 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.273 1.212 . . . . 20.0 114.273 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.67 149.96 24.46 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.032 0.933 . . . . 20.0 111.824 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.8 p -82.02 162.43 22.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.347 0.594 . . . . 20.0 110.797 170.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.71 -39.5 73.97 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.404 -0.81 . . . . 20.0 111.454 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.5 -38.95 93.08 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.512 -0.742 . . . . 20.0 112.648 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.55 -42.78 95.47 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.637 -0.665 . . . . 20.0 112.084 171.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.63 -46.36 90.59 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.603 0.761 . . . . 20.0 112.156 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.47 -46.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.091 0.956 . . . . 20.0 110.288 172.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.07 54.18 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 20.0 112.869 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 20.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 20.0 114.434 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.91 8.36 20.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.645 1.178 . . . . 20.0 113.033 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.38 162.3 1.58 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.027 1.331 . . . . 20.0 111.396 165.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.59 103.32 48.95 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.071 0.949 . . . . 20.0 110.837 176.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.13 163.84 89.13 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.462 0.844 . . . . 20.0 111.701 -6.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -50.03 141.37 30.02 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 20.0 114.168 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.3 mt -96.11 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 20.0 104.858 163.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.98 54.57 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 20.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.89 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.029 1.122 . . . . 20.0 114.029 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.27 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.688 0.676 . . . . 20.0 112.958 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.86 -36.86 75.85 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.289 -1.124 . . . . 20.0 112.693 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.89 -44.62 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.808 -0.557 . . . . 20.0 109.952 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.41 91.65 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.303 -0.873 . . . . 20.0 112.533 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -41.97 74.91 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.395 -0.816 . . . . 20.0 112.287 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.74 -45.19 82.13 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.889 0.768 . . . . 20.0 112.12 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.37 -40.54 85.74 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.287 0.635 . . . . 20.0 112.227 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.58 -47.23 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.039 0.536 . . . . 20.0 110.235 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.05 -37.39 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.749 1.22 . . . . 20.0 112.308 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.87 98.53 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.01 0.823 . . . . 20.0 111.194 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.53 -45.02 91.88 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.832 0.729 . . . . 20.0 113.26 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.42 -42.49 87.37 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.002 0.901 . . . . 20.0 111.056 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.5 -50.12 70.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.795 0.838 . . . . 20.0 112.449 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.79 -43.35 76.74 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.915 0.78 . . . . 20.0 111.996 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.6 mt -64.28 -48.32 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.26 0.624 . . . . 20.0 111.366 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.54 -31.48 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.791 1.178 . . . . 20.0 112.981 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -61.43 -42.14 98.29 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.102 0.864 . . . . 20.0 111.642 171.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.3 ttp -80.6 -36.29 32.96 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.726 1.61 . . . . 20.0 113.884 -174.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 1.103 ' OXT' ' C ' ' A' ' 145' ' ' TYR . 70.5 m-85 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 127.784 2.434 . . . . 20.0 114.432 -168.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 N--CA 1.479 0.661 0 N-CA-C 113.01 0.35 . . . . 0.0 113.01 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.58 135.04 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.47 1.108 . . . . 0.0 108.413 163.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -126.07 155.0 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.633 170.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -104.84 116.81 32.64 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.465 0.706 . . . . 0.0 109.143 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.48 178.03 6.93 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.587 0.708 . . . . 0.0 112.441 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.94 -26.43 68.81 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.11 57.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.794 1.237 . . . . 0.0 113.011 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.91 85.85 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.514 1.054 . . . . 0.0 114.128 -175.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.63 128.29 35.68 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.816 1.308 . . . . 0.0 109.695 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.73 29.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 168.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -126.09 123.32 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.075 1.35 . . . . 0.0 108.68 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.57 139.69 38.58 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.18 48.48 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.513 1.925 . . . . 0.0 107.979 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.24 152.35 20.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.202 170.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.86 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.453 0.644 . . . . 0.0 111.555 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 129.96 93.26 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.164 0.585 . . . . 0.0 111.095 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.97 -34.67 68.08 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.907 2.405 . . . . 0.0 113.572 167.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.39 -38.02 86.58 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.508 -0.745 . . . . 0.0 112.594 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.0 -44.31 97.61 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.716 0.689 . . . . 0.0 111.356 171.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.5 -44.33 94.64 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.296 0.498 . . . . 0.0 112.256 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.23 -47.32 85.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.079 0.551 . . . . 0.0 111.417 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.14 96.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.599 0.76 . . . . 0.0 111.896 176.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -60.07 -47.5 85.63 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.844 0.858 . . . . 0.0 112.711 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.2 t -56.7 -54.55 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.4 0.545 . . . . 0.0 110.404 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.5 -37.6 78.69 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.348 1.059 . . . . 0.0 113.221 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.411 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.61 -51.99 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.945 1.298 . . . . 0.0 111.329 170.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.52 -35.94 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.416 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.64 -23.98 60.21 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.2 -25.85 11.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.8 16.25 3.32 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -166.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.05 -38.49 2.34 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -118.06 15.79 14.16 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.36 1.064 . . . . 0.0 113.055 -171.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 p -114.93 152.7 46.76 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.98 0.912 . . . . 0.0 111.464 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.77 -30.68 57.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.282 2.655 . . . . 0.0 115.205 -172.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.69 64.26 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.643 1.177 . . . . 0.0 114.173 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.93 -31.81 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.424 1.011 . . . . 0.0 112.515 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.1 mt -71.45 -55.05 6.23 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.987 1.315 . . . . 0.0 112.972 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.85 -30.14 49.5 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.685 1.637 . . . . 0.0 112.652 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.411 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.6 mtm -69.06 -40.24 78.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.894 1.225 . . . . 0.0 112.65 172.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.22 -46.55 82.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.768 0.713 . . . . 0.0 111.522 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -60.94 -44.69 96.9 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -32.27 71.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.279 1.031 . . . . 0.0 113.246 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.1 4.48 53.65 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.406 1.482 . . . . 0.0 113.539 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.7 p -133.0 22.78 4.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.52 120.35 6.02 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.473 -1.392 . . . . 0.0 111.483 168.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.44 11.63 59.86 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.447 0.939 . . . . 0.0 115.447 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.57 130.88 47.06 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.525 1.663 . . . . 0.0 112.528 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.3 p -73.28 159.66 84.42 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.722 0.809 . . . . 0.0 110.711 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.58 -35.38 37.25 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.134 1.89 . . . . 0.0 115.47 168.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -67.19 -40.2 86.48 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.28 -45.25 93.97 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.626 -0.671 . . . . 0.0 111.098 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.5 mt -63.71 -44.32 93.97 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.351 1.06 . . . . 0.0 112.127 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -59.15 -41.48 88.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.642 0.656 . . . . 0.0 111.984 171.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 m -60.18 -45.28 93.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.599 0.636 . . . . 0.0 111.11 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.42 -48.86 78.01 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.246 0.93 . . . . 0.0 112.153 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.16 -38.44 91.19 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.84 -33.23 70.19 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 p -73.88 -12.44 60.67 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.5 m -122.19 8.14 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.28 -4.5 6.51 Favored Glycine 0 CA--C 1.542 1.753 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.8 -33.51 56.01 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 119.256 1.528 . . . . 0.0 115.389 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -91.18 78.29 5.86 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.802 1.301 . . . . 0.0 110.55 171.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.77 -35.92 34.21 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.95 74.73 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 120.023 1.283 . . . . 0.0 112.303 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.44 -43.54 85.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.194 0.597 . . . . 0.0 111.353 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -62.99 -40.17 96.93 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.545 -0.722 . . . . 0.0 112.263 175.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.95 -49.99 73.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.314 1.045 . . . . 0.0 111.565 173.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.1 tpp -56.04 -45.43 79.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.096 0.958 . . . . 0.0 112.205 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.85 -48.77 79.05 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.289 0.636 . . . . 0.0 112.087 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.72 -38.37 90.84 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.45 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.86 -45.56 92.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.698 0.681 . . . . 0.0 112.014 170.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.9 m -62.56 -42.41 99.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.777 0.717 . . . . 0.0 112.128 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.81 -46.2 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.514 -0.741 . . . . 0.0 111.041 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.07 -39.45 94.09 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.829 0.741 . . . . 0.0 112.759 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.78 -47.46 86.24 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.78 0.832 . . . . 0.0 111.964 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -70.07 -34.41 73.16 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.24 91.71 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.437 -0.789 . . . . 0.0 112.403 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.14 98.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.232 0.613 . . . . 0.0 111.781 172.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.19 99.59 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.834 -0.541 . . . . 0.0 112.183 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.85 -48.69 79.06 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.648 0.658 . . . . 0.0 111.665 173.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.95 -30.13 71.33 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.21 -39.22 78.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.399 1.08 . . . . 0.0 112.443 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.49 42.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.739 1.216 . . . . 0.0 113.32 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.81 60.92 53.35 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 126.675 1.99 . . . . 0.0 111.249 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.94 119.99 7.21 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.509 2.139 . . . . 0.0 110.306 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.24 136.16 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.342 1.457 . . . . 0.0 112.144 -169.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -79.92 160.43 26.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.101 0.561 . . . . 0.0 110.861 168.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.31 -19.8 64.93 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.03 174.68 41.65 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.083 1.325 . . . . 0.0 112.653 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.49 169.11 14.8 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.644 2.896 . . . . 0.0 112.954 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.7 mt -57.65 -39.11 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.894 1.278 . . . . 0.0 111.739 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.54 161.92 28.55 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.841 1.656 . . . . 0.0 110.584 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.96 133.47 23.1 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.479 2.786 . . . . 0.0 113.116 168.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.05 60.32 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.605 1.098 . . . . 0.0 115.019 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.15 143.31 37.37 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.946 1.373 . . . . 0.0 110.234 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.12 145.44 54.38 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.729 -0.607 . . . . 0.0 110.805 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -68.65 153.07 44.46 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.641 0.776 . . . . 0.0 111.673 171.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -72.16 131.7 85.01 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.858 170.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.37 140.53 44.38 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.137 1.891 . . . . 0.0 112.383 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 67.8 mtp85 -75.31 171.59 13.93 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.727 1.611 . . . . 0.0 111.859 163.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.37 -43.72 93.75 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 123.274 0.464 . . . . 0.0 113.04 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.5 p -69.15 -25.64 64.47 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -72.72 -41.66 64.98 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.02 -1.05 . . . . 0.0 111.71 171.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.73 -42.74 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.648 0.779 . . . . 0.0 110.824 173.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.11 -1.16 13.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.0 18.03 74.16 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.953 -1.092 . . . . 0.0 115.453 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.62 19.18 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.147 1.473 . . . . 0.0 113.259 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.2 p -125.9 -0.86 7.26 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.9 p -104.59 149.06 25.84 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.045 0.938 . . . . 0.0 111.798 173.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.4 p -80.95 162.18 23.99 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.348 0.595 . . . . 0.0 110.747 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.2 tp -56.85 -39.32 74.05 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.423 -0.798 . . . . 0.0 111.397 169.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.62 -39.06 93.41 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.558 -0.714 . . . . 0.0 112.644 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -64.37 -42.83 95.97 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.666 -0.646 . . . . 0.0 112.028 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -60.68 -46.35 90.7 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.677 0.791 . . . . 0.0 112.192 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.34 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 110.305 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.43 -51.17 53.36 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.83 0.729 . . . . 0.0 112.913 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.19 -50.08 73.23 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.788 0.794 . . . . 0.0 112.526 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.69 -18.5 64.27 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.1 p -111.81 8.33 20.5 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.675 1.19 . . . . 0.0 113.018 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.36 162.31 1.56 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.009 1.324 . . . . 0.0 111.433 165.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.52 103.38 49.02 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.089 0.956 . . . . 0.0 110.787 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.03 163.83 89.2 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.477 0.849 . . . . 0.0 111.746 -6.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -50.01 141.42 29.71 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.208 2.606 . . . . 0.0 114.173 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.19 96.36 2.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.97 54.6 3.5 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.326 2.684 . . . . 0.0 112.89 -152.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.61 -34.89 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.44 -46.16 94.4 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 118.641 0.655 . . . . 0.0 113.004 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.74 -36.96 76.29 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.313 -1.11 . . . . 0.0 112.667 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.88 -44.63 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.802 -0.561 . . . . 0.0 109.94 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.85 -40.42 91.7 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.327 -0.858 . . . . 0.0 112.547 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -42.02 74.98 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.395 -0.816 . . . . 0.0 112.259 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.72 -45.24 82.0 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.945 0.793 . . . . 0.0 112.093 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.26 -40.53 86.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.308 0.643 . . . . 0.0 112.251 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.68 -47.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.032 0.533 . . . . 0.0 110.279 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.19 -37.37 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.698 1.199 . . . . 0.0 112.263 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.75 98.36 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.039 0.836 . . . . 0.0 111.245 171.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.5 -45.2 91.08 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.879 0.752 . . . . 0.0 113.235 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.4 -42.28 86.81 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.019 0.91 . . . . 0.0 111.114 173.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.52 -50.2 70.6 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.788 0.835 . . . . 0.0 112.43 173.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -55.84 -43.0 76.62 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.872 0.76 . . . . 0.0 112.062 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.401 HG21 H13A ' A' ' 146' ' ' JPR . 70.0 mt -64.47 -48.64 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.332 0.653 . . . . 0.0 111.361 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.28 -31.61 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.8 1.182 . . . . 0.0 112.978 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.98 -39.64 90.38 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.057 0.844 . . . . 0.0 111.877 171.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.4 ttp -84.45 -33.36 23.66 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.758 1.623 . . . . 0.0 113.976 -173.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 . . . . . 0 C--O 1.255 1.351 0 C-N-CA 127.599 2.36 . . . . 0.0 114.287 -169.744 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 146' ' ' JPR . . . . . 0.401 H13A HG21 ' A' ' 141' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.697 0 N-CA-C 112.967 0.333 . . . . 0.0 112.967 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -92.01 135.02 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.51 1.124 . . . . 0.0 108.448 163.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.04 154.69 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.067 1.347 . . . . 0.0 109.709 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.29 116.62 32.47 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.555 0.742 . . . . 0.0 109.166 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.44 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.573 0.702 . . . . 0.0 112.476 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.87 -26.5 68.8 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -85.68 -2.13 57.88 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.792 1.237 . . . . 0.0 112.998 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.21 85.8 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.426 1.012 . . . . 0.0 114.094 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.14 35.13 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.883 1.342 . . . . 0.0 109.695 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.88 125.53 29.48 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 168.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.86 123.39 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.077 1.351 . . . . 0.0 108.648 -174.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.7 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.1 48.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.36 20.98 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.988 0.813 . . . . 0.0 111.217 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.46 136.84 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.605 -0.684 . . . . 0.0 111.537 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.03 93.23 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.1 -34.54 68.75 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.86 2.373 . . . . 0.0 113.572 167.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.48 -38.06 86.47 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.464 -0.773 . . . . 0.0 112.521 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.98 -44.2 97.72 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.805 0.729 . . . . 0.0 111.382 171.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.65 -44.28 94.3 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.341 0.519 . . . . 0.0 112.292 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.26 -47.16 86.39 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.149 0.58 . . . . 0.0 111.338 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.26 95.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.621 0.768 . . . . 0.0 111.856 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -60.31 -46.73 88.83 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.835 0.854 . . . . 0.0 112.818 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.87 -54.53 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.443 0.565 . . . . 0.0 110.31 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.76 -37.23 78.44 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.332 1.053 . . . . 0.0 113.256 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.82 -52.33 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.227 1.411 . . . . 0.0 111.202 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -65.42 -36.08 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.016 0.526 . . . . 0.0 111.484 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.54 -24.05 59.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.2 -25.47 11.5 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.17 16.07 3.24 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -165.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.97 -37.22 2.82 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -175.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.14 15.37 14.09 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.539 1.136 . . . . 0.0 113.087 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -114.9 152.88 46.9 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.937 0.895 . . . . 0.0 111.458 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.75 -30.83 58.42 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.253 2.636 . . . . 0.0 115.222 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -61.93 -20.88 64.27 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.89 -31.84 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.448 1.022 . . . . 0.0 112.512 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.44 -55.07 6.24 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.97 1.308 . . . . 0.0 112.961 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.87 -30.08 49.42 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.72 1.65 . . . . 0.0 112.685 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -68.99 -40.24 78.87 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.849 1.204 . . . . 0.0 112.63 172.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.33 -46.48 83.21 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.771 0.714 . . . . 0.0 111.585 169.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.1 m -61.09 -44.44 97.36 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.76 71.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.281 1.033 . . . . 0.0 113.261 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.61 4.54 53.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.372 1.469 . . . . 0.0 113.508 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.9 p -133.09 22.83 4.14 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -176.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.57 120.31 5.99 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.422 -1.424 . . . . 0.0 111.45 168.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.67 60.04 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.5 130.79 46.75 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.498 1.649 . . . . 0.0 112.53 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.0 p -73.28 159.63 84.51 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.741 0.816 . . . . 0.0 110.666 167.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.46 -35.58 36.67 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.183 1.922 . . . . 0.0 115.422 168.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.96 -40.27 87.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.32 -45.38 93.6 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.662 -0.649 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.53 -44.22 94.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.342 1.057 . . . . 0.0 112.162 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -59.3 -41.35 88.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.587 0.63 . . . . 0.0 112.008 171.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.32 -45.33 93.8 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.65 0.659 . . . . 0.0 111.098 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.29 -48.96 77.57 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.175 0.898 . . . . 0.0 112.143 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.04 -38.6 91.83 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.84 -33.96 71.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.6 p -73.1 -12.64 60.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 m -122.25 7.53 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.68 -5.35 5.08 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 117.094 1.598 . . . . 0.0 117.094 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.56 56.15 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 119.1 1.45 . . . . 0.0 115.519 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -91.22 79.59 5.68 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.977 1.388 . . . . 0.0 110.594 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.82 -36.18 47.1 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.04 -41.21 71.11 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.131 1.332 . . . . 0.0 112.328 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.6 86.3 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.772 -0.58 . . . . 0.0 111.296 172.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.06 -40.07 96.6 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.538 -0.726 . . . . 0.0 112.239 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.91 -50.1 73.6 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.087 -1.008 . . . . 0.0 111.538 173.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.3 tpp -55.99 -45.41 79.01 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.051 0.941 . . . . 0.0 112.231 174.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.93 -48.73 79.14 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.307 0.643 . . . . 0.0 112.109 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.63 -38.31 90.65 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.455 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.03 -45.43 92.85 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 112.019 170.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.6 m -62.67 -42.4 99.6 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.842 0.746 . . . . 0.0 112.113 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.92 -46.04 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.472 -0.768 . . . . 0.0 111.063 174.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.11 -39.44 94.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.876 0.762 . . . . 0.0 112.757 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -60.87 -47.4 86.53 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.714 0.806 . . . . 0.0 111.95 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.12 -34.3 72.92 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.71 -41.79 91.89 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.447 -0.783 . . . . 0.0 112.33 172.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.02 98.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.248 0.619 . . . . 0.0 111.799 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.19 -42.23 99.3 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.812 -0.555 . . . . 0.0 112.211 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.82 -48.38 79.9 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.696 0.68 . . . . 0.0 111.675 173.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -63.16 -30.33 71.5 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.13 -38.96 79.13 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.306 1.042 . . . . 0.0 112.489 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.31 -27.64 42.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.833 1.253 . . . . 0.0 113.346 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.79 61.04 54.13 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.583 1.953 . . . . 0.0 111.22 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.95 120.12 7.39 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.452 2.102 . . . . 0.0 110.266 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.42 136.56 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.283 1.433 . . . . 0.0 112.119 -169.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.07 160.49 25.78 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.098 0.559 . . . . 0.0 110.905 168.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.26 -19.92 64.99 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 174.8 41.62 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.018 1.294 . . . . 0.0 112.602 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.62 169.16 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.944 177.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.61 -39.21 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.88 1.272 . . . . 0.0 111.801 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.49 161.93 28.54 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.817 1.647 . . . . 0.0 110.549 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.441 2.761 . . . . 0.0 113.132 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -15.03 60.34 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.577 1.084 . . . . 0.0 115.065 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.35 37.47 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.928 1.364 . . . . 0.0 110.198 173.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.2 145.62 54.14 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.753 -0.592 . . . . 0.0 110.835 168.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.51 152.72 44.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.717 0.807 . . . . 0.0 111.653 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.27 131.75 84.78 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.886 -0.578 . . . . 0.0 109.797 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.46 140.25 43.31 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.122 1.881 . . . . 0.0 112.414 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.3 mtp85 -74.86 171.58 13.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.716 1.607 . . . . 0.0 111.849 163.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.52 -43.87 93.97 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.934 -0.479 . . . . 0.0 113.029 168.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.73 -25.83 64.95 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 175.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.75 -41.6 64.93 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.986 -1.071 . . . . 0.0 111.739 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.68 -42.69 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.716 0.806 . . . . 0.0 110.756 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.91 -1.32 13.94 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 173.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.91 18.17 74.14 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.603 1.096 . . . . 0.0 115.488 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.3 -19.38 19.31 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.073 1.436 . . . . 0.0 113.284 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.0 p -126.23 -1.48 7.01 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.71 149.99 24.46 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.024 0.93 . . . . 0.0 111.737 173.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 p -81.89 162.32 22.81 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.293 0.568 . . . . 0.0 110.811 170.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.74 -39.49 74.06 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.424 -0.798 . . . . 0.0 111.425 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.59 -38.82 92.59 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.518 -0.739 . . . . 0.0 112.657 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -64.67 -42.75 95.15 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.622 -0.673 . . . . 0.0 111.997 171.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.3 90.87 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.58 0.752 . . . . 0.0 112.146 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.5 -46.4 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.151 0.981 . . . . 0.0 110.256 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.45 -51.04 54.34 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.793 0.711 . . . . 0.0 112.881 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.828 0.814 . . . . 0.0 112.485 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.68 -18.39 64.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.96 8.35 20.24 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.664 1.186 . . . . 0.0 113.033 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.43 162.31 1.6 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.978 1.311 . . . . 0.0 111.412 165.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.36 48.93 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.005 0.922 . . . . 0.0 110.836 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.14 163.81 89.19 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-N 119.462 0.844 . . . . 0.0 111.715 -6.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -49.95 141.29 29.56 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.205 2.604 . . . . 0.0 114.169 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.13 96.49 2.49 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 163.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.92 54.52 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.257 2.638 . . . . 0.0 112.909 -152.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.83 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.26 94.22 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.985 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.91 -36.78 75.65 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.358 -1.084 . . . . 0.0 112.648 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.03 -44.46 99.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.745 -0.597 . . . . 0.0 109.951 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.93 -40.42 91.4 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.313 -0.867 . . . . 0.0 112.489 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -41.96 74.96 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.8 -45.29 82.31 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.912 0.778 . . . . 0.0 112.093 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.25 -40.51 86.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.233 0.613 . . . . 0.0 112.279 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.57 -47.37 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.23 174.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -61.91 -37.29 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.707 1.203 . . . . 0.0 112.355 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.88 -42.83 98.73 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.057 0.844 . . . . 0.0 111.187 171.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.58 -44.99 91.83 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.87 0.748 . . . . 0.0 113.257 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.24 -42.69 86.88 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.876 0.87 . . . . 0.0 110.997 173.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.17 70.6 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.791 0.836 . . . . 0.0 112.454 173.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.74 -43.41 76.58 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 118.87 0.759 . . . . 0.0 111.992 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.1 mt -64.47 -48.19 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.342 0.657 . . . . 0.0 111.361 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.44 -31.66 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.73 1.15 . . . . 0.0 112.983 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -61.67 -43.58 98.58 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.168 0.895 . . . . 0.0 111.649 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.9 ttp -77.11 -35.75 56.12 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.726 1.61 . . . . 0.0 113.696 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 127.641 2.376 . . . . 0.0 114.205 -168.979 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 N--CA 1.48 0.686 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.81 135.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.03 154.89 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.665 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.61 116.71 32.53 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.521 0.729 . . . . 0.0 109.19 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.46 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.507 0.67 . . . . 0.0 112.474 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.54 68.79 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.58 -2.18 57.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.851 1.26 . . . . 0.0 113.043 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.94 3.1 85.8 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.458 1.028 . . . . 0.0 114.08 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.2 35.34 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.883 1.342 . . . . 0.0 109.727 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.85 125.55 29.51 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.94 123.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.074 1.349 . . . . 0.0 108.629 -174.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.58 139.66 38.57 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.487 0.66 . . . . 0.0 111.239 170.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.07 48.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.491 1.916 . . . . 0.0 107.921 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.2 152.37 20.77 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.019 0.827 . . . . 0.0 111.259 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.87 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.462 0.649 . . . . 0.0 111.579 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.01 93.24 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.99 -34.56 67.76 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.907 2.405 . . . . 0.0 113.604 167.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.48 -38.06 86.47 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.457 -0.777 . . . . 0.0 112.594 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 m -60.93 -44.31 97.41 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.691 0.678 . . . . 0.0 111.401 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.52 -44.39 94.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.251 0.478 . . . . 0.0 112.256 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.18 -47.3 85.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.115 0.566 . . . . 0.0 111.366 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.23 95.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.672 0.789 . . . . 0.0 111.908 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -60.16 -47.16 87.08 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.806 0.842 . . . . 0.0 112.783 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.75 -54.57 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.443 0.565 . . . . 0.0 110.375 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.62 -37.36 78.4 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.296 1.039 . . . . 0.0 113.234 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.401 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.43 -52.16 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.094 1.358 . . . . 0.0 111.296 170.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -64.8 -35.86 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 122.909 0.484 . . . . 0.0 111.471 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.74 -23.82 60.56 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.38 -25.64 11.35 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.06 16.16 3.26 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -166.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.42 -37.95 2.57 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -118.17 15.66 14.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.438 1.095 . . . . 0.0 113.057 -172.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.0 p -115.0 152.86 46.97 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.966 0.907 . . . . 0.0 111.463 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.88 -30.61 58.75 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.262 2.641 . . . . 0.0 115.208 -172.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.19 -20.67 64.41 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.87 -31.84 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.41 1.005 . . . . 0.0 112.548 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.6 mt -71.47 -55.05 6.21 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.966 1.307 . . . . 0.0 112.971 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.88 -30.05 49.34 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.653 1.626 . . . . 0.0 112.641 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.401 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.16 -40.16 78.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.867 1.212 . . . . 0.0 112.602 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.25 -46.46 83.01 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.808 0.731 . . . . 0.0 111.576 169.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.6 m -61.12 -44.42 97.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.0 71.51 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.333 1.053 . . . . 0.0 113.208 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.41 4.5 53.27 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.367 1.467 . . . . 0.0 113.488 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.5 p -133.01 22.8 4.16 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.68 120.31 6.05 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 120.477 -1.389 . . . . 0.0 111.477 168.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.63 11.57 60.24 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.377 0.911 . . . . 0.0 115.377 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.52 130.88 47.14 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.575 1.687 . . . . 0.0 112.464 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.39 159.64 84.35 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.758 0.823 . . . . 0.0 110.685 167.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.61 -35.4 37.6 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.144 1.896 . . . . 0.0 115.4 168.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -66.99 -40.29 87.36 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 174.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.35 93.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.039 172.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.56 -44.26 94.64 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 112.133 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -59.17 -41.49 88.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.618 0.645 . . . . 0.0 112.031 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.8 m -60.29 -45.22 94.1 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.582 0.628 . . . . 0.0 111.074 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.37 -48.91 77.8 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.254 0.934 . . . . 0.0 112.179 174.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.13 -38.45 91.24 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.89 -33.45 70.54 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.4 p -73.65 -12.5 60.76 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 m -122.19 7.88 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.72 -4.62 5.77 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 117.159 1.624 . . . . 0.0 117.159 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.88 -33.13 56.19 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 119.224 1.512 . . . . 0.0 115.423 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -91.32 78.7 5.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.892 1.346 . . . . 0.0 110.605 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.26 -35.82 39.1 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -173.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.41 -41.1 73.38 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.086 1.312 . . . . 0.0 112.315 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.28 -43.56 86.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.167 0.587 . . . . 0.0 111.337 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.3 tpp -63.1 -40.1 96.65 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.565 -0.709 . . . . 0.0 112.229 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.93 -50.02 73.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.218 1.007 . . . . 0.0 111.539 173.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.95 -45.5 78.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.044 0.938 . . . . 0.0 112.233 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -61.88 -48.77 79.01 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.276 0.63 . . . . 0.0 112.055 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.64 -38.28 90.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.845 0.858 . . . . 0.0 112.479 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.98 -45.45 92.67 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.668 0.667 . . . . 0.0 112.048 170.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.7 -42.39 99.61 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.815 0.734 . . . . 0.0 112.082 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.85 -46.1 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.441 -0.787 . . . . 0.0 111.059 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.08 -39.46 94.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.831 0.741 . . . . 0.0 112.736 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.84 -47.37 86.69 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.667 0.787 . . . . 0.0 111.971 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -70.13 -34.3 72.89 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.68 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.43 -0.794 . . . . 0.0 112.361 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.11 98.68 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.231 0.613 . . . . 0.0 111.781 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.21 99.57 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 0.0 112.218 174.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.85 -48.55 79.47 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.667 0.667 . . . . 0.0 111.726 173.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.04 -30.25 71.46 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.12 -39.18 79.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.343 1.057 . . . . 0.0 112.499 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.64 42.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 113.29 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.72 61.01 54.1 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.67 1.988 . . . . 0.0 111.247 -174.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.9 120.17 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.452 2.101 . . . . 0.0 110.315 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.36 136.31 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.377 1.471 . . . . 0.0 112.136 -169.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.97 160.45 25.92 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.124 0.57 . . . . 0.0 110.855 168.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.91 65.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.99 174.77 41.63 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.059 1.314 . . . . 0.0 112.64 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.58 169.15 14.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.682 2.921 . . . . 0.0 112.878 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.68 -39.15 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.873 1.269 . . . . 0.0 111.787 -175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.51 161.9 28.6 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.856 1.662 . . . . 0.0 110.561 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.83 133.42 22.44 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.519 2.812 . . . . 0.0 113.132 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.89 -15.0 60.33 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.551 1.072 . . . . 0.0 115.001 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.11 143.39 37.38 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.996 1.398 . . . . 0.0 110.214 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.24 145.52 54.19 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.664 -0.647 . . . . 0.0 110.793 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.52 152.78 44.91 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.674 0.79 . . . . 0.0 111.617 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.23 131.68 84.9 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.883 -0.58 . . . . 0.0 109.821 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.37 140.4 44.03 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.076 1.851 . . . . 0.0 112.426 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -75.08 171.66 13.72 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.679 1.592 . . . . 0.0 111.89 163.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.78 94.19 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.912 -0.493 . . . . 0.0 113.04 168.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.1 p -68.81 -25.78 64.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.7 64.98 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.989 -1.069 . . . . 0.0 111.727 171.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.6 -42.74 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.704 0.801 . . . . 0.0 110.771 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.2 13.79 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.92 18.11 74.09 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.897 -1.127 . . . . 0.0 115.496 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.47 19.29 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.073 1.436 . . . . 0.0 113.29 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -126.18 -1.38 7.04 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.67 149.91 24.51 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.14 0.976 . . . . 0.0 111.763 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.0 p -81.86 162.27 22.87 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.319 0.581 . . . . 0.0 110.778 170.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.74 -39.4 73.89 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.415 -0.803 . . . . 0.0 111.404 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.55 -38.97 93.16 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.481 -0.762 . . . . 0.0 112.659 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.77 95.55 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.39 90.54 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.119 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.4 -46.39 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.203 1.001 . . . . 0.0 110.285 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.01 54.55 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.753 0.692 . . . . 0.0 112.945 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.32 -50.01 73.34 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.751 0.776 . . . . 0.0 112.537 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.69 -18.49 64.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.93 8.42 20.32 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.651 1.18 . . . . 0.0 113.035 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.45 162.31 1.62 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.989 1.316 . . . . 0.0 111.414 165.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.451 0.84 . . . . 0.0 111.701 -6.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.99 141.33 29.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.258 2.639 . . . . 0.0 114.136 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.3 mt -96.15 96.49 2.5 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 163.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -86.02 54.59 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.289 2.659 . . . . 0.0 112.86 -152.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.84 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.36 -46.34 94.07 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 118.605 0.639 . . . . 0.0 112.958 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.82 -36.8 75.93 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.313 -1.11 . . . . 0.0 112.678 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.97 -44.56 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.732 -0.605 . . . . 0.0 109.942 174.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.46 91.67 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.292 -0.88 . . . . 0.0 112.504 176.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.04 75.08 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.275 173.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.67 -45.23 81.82 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.901 0.773 . . . . 0.0 112.12 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.31 -40.5 86.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.296 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.62 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.044 0.538 . . . . 0.0 110.291 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.03 -37.35 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.683 1.193 . . . . 0.0 112.355 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.75 98.19 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.03 0.832 . . . . 0.0 111.275 171.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.67 -45.0 91.52 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.828 0.727 . . . . 0.0 113.23 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.4 -42.42 87.11 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.075 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.21 70.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.811 0.844 . . . . 0.0 112.425 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.79 -43.28 76.68 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.892 0.769 . . . . 0.0 111.968 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.37 -48.36 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.337 0.655 . . . . 0.0 111.415 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.34 -31.74 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 119.725 1.148 . . . . 0.0 113.012 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -61.14 -41.76 97.31 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.074 0.852 . . . . 0.0 111.722 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.7 ttp -80.96 -34.43 33.16 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.738 1.615 . . . . 0.0 113.935 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 127.614 2.366 . . . . 0.0 114.236 -169.036 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.81 135.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.08 154.81 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.685 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.55 116.74 32.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.488 0.715 . . . . 0.0 109.191 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.84 -26.49 68.78 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -173.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.58 -2.21 57.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.852 1.261 . . . . 0.0 112.991 175.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.02 85.77 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.5 1.048 . . . . 0.0 114.144 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.7 128.23 35.47 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.801 1.301 . . . . 0.0 109.678 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.89 125.57 29.55 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.88 123.39 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.11 1.364 . . . . 0.0 108.7 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.71 38.55 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.72 141.11 48.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.465 1.906 . . . . 0.0 107.929 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.27 152.4 20.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.217 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.9 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.607 -0.683 . . . . 0.0 111.579 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.66 130.01 93.24 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.068 0.547 . . . . 0.0 111.125 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.887 2.391 . . . . 0.0 113.575 167.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.41 -38.05 86.6 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.451 -0.78 . . . . 0.0 112.587 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.8 m -60.96 -44.32 97.48 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.747 0.703 . . . . 0.0 111.386 171.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.54 -44.37 94.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.258 0.481 . . . . 0.0 112.244 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.22 -47.27 85.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.115 0.566 . . . . 0.0 111.37 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.96 -45.26 95.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.67 0.788 . . . . 0.0 111.914 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.22 -47.09 87.42 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.868 0.867 . . . . 0.0 112.774 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.8 t -56.82 -54.55 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.489 0.586 . . . . 0.0 110.31 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.61 -37.4 78.47 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.35 1.06 . . . . 0.0 113.247 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.36 -52.17 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.092 1.357 . . . . 0.0 111.302 170.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.82 -35.99 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.996 0.518 . . . . 0.0 111.407 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.69 -23.86 60.3 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.34 -25.62 11.38 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -136.03 16.15 3.27 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -166.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.47 -37.91 2.61 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -118.08 15.62 14.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.478 1.111 . . . . 0.0 113.107 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.7 p -114.91 152.87 46.9 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.959 0.903 . . . . 0.0 111.49 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.86 -30.63 58.77 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.238 2.625 . . . . 0.0 115.276 -172.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.11 -20.73 64.36 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.81 -31.96 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 119.466 1.03 . . . . 0.0 112.479 176.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.36 -55.07 6.34 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.957 1.303 . . . . 0.0 112.995 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.88 -30.08 49.28 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.681 1.636 . . . . 0.0 112.671 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.05 -40.2 78.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.914 1.234 . . . . 0.0 112.665 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.3 -46.48 83.12 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.421 0.689 . . . . 0.0 111.576 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -61.07 -44.45 97.36 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.85 -32.03 71.45 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.284 1.034 . . . . 0.0 113.278 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.36 4.47 53.36 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.355 1.462 . . . . 0.0 113.484 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -133.03 22.84 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.58 120.3 5.99 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.456 -1.402 . . . . 0.0 111.432 168.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.67 60.04 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 130.88 47.14 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.498 1.649 . . . . 0.0 112.482 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.35 159.66 84.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.753 0.821 . . . . 0.0 110.666 167.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.22 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.34 -45.33 93.83 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.66 -0.65 . . . . 0.0 111.1 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -59.28 -41.34 88.68 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.692 -0.63 . . . . 0.0 112.02 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.27 -45.32 93.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.596 0.634 . . . . 0.0 111.097 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.32 -48.91 77.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.233 0.924 . . . . 0.0 112.179 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.11 -38.46 91.27 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.91 -33.56 70.69 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.9 p -73.5 -12.54 60.82 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.24 7.85 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.54 -4.69 5.55 Favored Glycine 0 CA--C 1.541 1.684 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.96 -32.99 56.57 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.186 1.493 . . . . 0.0 115.435 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -91.28 78.76 5.74 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.918 1.359 . . . . 0.0 110.619 171.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.36 -35.92 40.74 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.43 -41.15 73.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.137 1.335 . . . . 0.0 112.293 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.51 86.07 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.139 0.576 . . . . 0.0 111.329 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.09 -40.12 96.71 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.514 -0.741 . . . . 0.0 112.198 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.98 -49.97 74.1 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.202 1.001 . . . . 0.0 111.518 173.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.97 -45.46 78.92 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.094 0.958 . . . . 0.0 112.245 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.91 -48.77 78.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.331 0.652 . . . . 0.0 112.055 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.66 -38.27 90.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.453 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.01 -45.48 92.62 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.664 0.665 . . . . 0.0 112.048 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.65 -42.37 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.118 175.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.85 -46.14 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.441 -0.787 . . . . 0.0 111.03 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.06 -39.46 94.13 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.842 0.746 . . . . 0.0 112.736 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -60.78 -47.49 86.1 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.943 174.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.06 -34.33 73.07 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.69 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.408 -0.808 . . . . 0.0 112.361 172.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.09 98.7 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.215 0.606 . . . . 0.0 111.751 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.12 -42.25 99.49 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.86 -0.525 . . . . 0.0 112.138 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.81 -48.52 79.5 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.666 0.666 . . . . 0.0 111.722 173.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.11 -30.19 71.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.22 -39.06 78.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.354 1.062 . . . . 0.0 112.482 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.3 -27.6 42.18 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.791 1.236 . . . . 0.0 113.29 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.78 60.99 53.88 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.639 1.976 . . . . 0.0 111.22 -174.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.92 120.21 7.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.481 2.12 . . . . 0.0 110.24 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.46 136.37 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.287 1.435 . . . . 0.0 112.13 -169.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.04 160.47 25.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.075 0.55 . . . . 0.0 110.915 168.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.92 65.01 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.11 1.338 . . . . 0.0 112.655 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.59 169.15 14.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.687 2.925 . . . . 0.0 112.878 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.68 -39.19 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.903 1.281 . . . . 0.0 111.749 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.44 161.97 28.44 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.817 1.647 . . . . 0.0 110.573 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.97 133.45 23.18 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.477 2.785 . . . . 0.0 113.149 168.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.99 60.34 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.613 1.101 . . . . 0.0 115.051 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.38 37.45 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.952 1.376 . . . . 0.0 110.198 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.51 54.26 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.66 -0.65 . . . . 0.0 110.842 168.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.48 152.73 44.98 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.684 0.794 . . . . 0.0 111.653 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.23 131.65 84.93 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.33 140.35 44.06 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -75.02 171.61 13.79 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.733 1.613 . . . . 0.0 111.867 163.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.57 -43.9 94.05 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.876 -0.515 . . . . 0.0 113.021 168.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.79 -25.78 64.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.69 -41.69 65.03 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.064 -1.022 . . . . 0.0 111.757 171.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.54 -42.84 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.73 0.812 . . . . 0.0 110.798 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.95 -1.26 13.83 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.98 18.15 74.24 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.626 1.107 . . . . 0.0 115.445 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.38 19.3 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.131 1.466 . . . . 0.0 113.301 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -126.2 -1.48 7.03 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.66 149.96 24.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.052 0.941 . . . . 0.0 111.788 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.5 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.293 0.568 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.83 -39.4 74.15 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.441 -0.787 . . . . 0.0 111.374 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.52 -38.93 93.02 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.531 -0.73 . . . . 0.0 112.685 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.64 -42.73 95.27 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 112.031 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.66 -46.37 90.58 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.651 0.78 . . . . 0.0 112.143 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.32 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.301 172.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.45 -51.06 54.19 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.782 0.706 . . . . 0.0 112.884 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 0.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.64 -18.49 64.3 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.87 8.36 20.4 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.703 1.201 . . . . 0.0 113.051 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.44 162.31 1.61 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.995 1.318 . . . . 0.0 111.447 165.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.34 48.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.035 0.934 . . . . 0.0 110.837 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.447 0.838 . . . . 0.0 111.701 -6.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.99 141.33 29.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.258 2.639 . . . . 0.0 114.136 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.17 96.48 2.51 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 163.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -86.0 54.56 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.257 2.638 . . . . 0.0 112.86 -152.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.56 -34.83 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.26 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.999 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.83 -36.87 75.95 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.91 -44.6 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.709 -0.62 . . . . 0.0 109.942 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.78 -40.5 92.02 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.307 -0.871 . . . . 0.0 112.559 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.78 -41.97 74.85 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.468 -0.77 . . . . 0.0 112.287 173.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.76 -45.22 82.2 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.889 0.768 . . . . 0.0 112.093 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.31 -40.5 86.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.296 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.62 -47.19 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.067 0.547 . . . . 0.0 110.272 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.15 -37.35 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.682 1.193 . . . . 0.0 112.292 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.82 -42.76 98.3 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.011 0.823 . . . . 0.0 111.244 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.59 -45.03 91.61 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.87 0.748 . . . . 0.0 113.252 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.4 -42.42 87.11 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.075 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.49 -50.16 70.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.811 0.844 . . . . 0.0 112.453 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.81 -43.27 76.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.875 0.762 . . . . 0.0 112.005 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.37 -48.36 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.337 0.655 . . . . 0.0 111.415 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.34 -31.81 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 119.725 1.148 . . . . 0.0 113.012 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -61.03 -42.07 97.76 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.058 0.845 . . . . 0.0 111.721 171.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.1 ttp -80.47 -34.64 35.73 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.761 1.624 . . . . 0.0 113.901 -174.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 127.621 2.368 . . . . 0.0 114.251 -168.981 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.998 0.345 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.9 mm -92.07 135.01 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.484 1.114 . . . . 0.0 108.489 163.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.03 154.6 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.076 1.35 . . . . 0.0 109.662 170.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.22 116.74 32.71 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.554 0.742 . . . . 0.0 109.201 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.53 177.98 7.01 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.557 0.694 . . . . 0.0 112.436 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.84 -26.54 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.63 -2.2 57.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.81 1.244 . . . . 0.0 113.047 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.97 3.17 85.66 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.418 1.009 . . . . 0.0 114.096 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.14 35.11 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.857 1.328 . . . . 0.0 109.726 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.84 125.55 29.52 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 168.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.84 123.38 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.077 1.351 . . . . 0.0 108.679 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.53 139.63 38.62 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.236 170.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.71 141.16 48.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.431 1.892 . . . . 0.0 107.897 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.28 152.44 20.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.803 . . . . 0.0 111.221 170.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.51 136.86 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.65 -0.656 . . . . 0.0 111.563 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.65 129.96 93.27 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.07 0.548 . . . . 0.0 111.155 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.05 -34.46 67.9 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.864 2.376 . . . . 0.0 113.597 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.55 -38.06 86.32 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.453 -0.779 . . . . 0.0 112.521 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.02 -44.13 97.86 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.805 0.729 . . . . 0.0 111.372 171.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.66 -44.37 93.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.354 0.525 . . . . 0.0 112.311 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.18 -47.11 86.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.424 0.556 . . . . 0.0 111.38 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.05 -45.34 95.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.612 0.765 . . . . 0.0 111.866 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -60.41 -46.39 90.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.808 0.843 . . . . 0.0 112.846 177.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.04 -54.51 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 118.458 0.572 . . . . 0.0 110.302 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.77 -37.11 78.14 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.404 1.082 . . . . 0.0 113.289 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.61 -52.41 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.398 1.479 . . . . 0.0 111.223 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.64 -36.2 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.069 0.548 . . . . 0.0 111.479 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.51 -24.24 60.03 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 175.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -106.93 -25.38 11.67 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -136.32 15.7 3.21 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -165.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.62 -37.36 2.53 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -117.23 12.5 14.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.478 1.111 . . . . 0.0 113.198 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.9 p -111.63 153.21 44.37 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.876 0.87 . . . . 0.0 111.497 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.83 -30.87 59.54 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.284 2.656 . . . . 0.0 115.173 -172.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.09 -20.98 64.59 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.61 -32.13 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.437 1.017 . . . . 0.0 112.458 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.41 -57.17 5.92 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.718 1.207 . . . . 0.0 112.538 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.89 -29.5 58.21 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 121.885 1.709 . . . . 0.0 112.786 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.13 -40.13 78.46 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.779 1.172 . . . . 0.0 112.698 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.25 -47.08 82.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.848 0.749 . . . . 0.0 111.546 169.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m -60.88 -44.11 97.53 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 175.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.54 70.96 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.249 1.019 . . . . 0.0 113.252 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -96.0 4.69 52.44 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.382 1.473 . . . . 0.0 113.491 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.8 p -133.17 22.78 4.11 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -53.57 120.25 5.92 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.437 -1.414 . . . . 0.0 111.42 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.6 11.68 60.35 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 115.391 0.916 . . . . 0.0 115.391 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.84 46.9 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.516 1.658 . . . . 0.0 112.481 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.27 159.68 84.4 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.718 0.807 . . . . 0.0 110.7 167.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.53 -35.5 37.15 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.144 1.896 . . . . 0.0 115.412 168.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.98 -40.32 87.4 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 174.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.29 -45.33 93.72 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.062 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.5 mt -63.53 -44.24 94.79 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.31 1.044 . . . . 0.0 112.151 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -59.26 -41.36 88.61 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.663 -0.648 . . . . 0.0 112.024 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.6 m -60.33 -45.43 93.45 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.626 0.648 . . . . 0.0 111.078 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.17 -49.01 77.29 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.218 0.917 . . . . 0.0 112.17 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.7 mt -63.04 -38.62 91.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.95 -34.2 71.49 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.3 p -72.88 -12.52 61.0 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.44 7.49 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.44 -5.75 5.23 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 117.102 1.601 . . . . 0.0 117.102 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.96 56.42 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 119.053 1.427 . . . . 0.0 115.526 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -90.23 79.8 6.33 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.029 1.414 . . . . 0.0 110.607 171.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -52.1 -36.28 50.44 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.23 -41.32 70.32 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.203 1.365 . . . . 0.0 112.348 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.17 -43.52 86.66 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.784 -0.573 . . . . 0.0 111.335 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -63.15 -40.03 96.38 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.566 -0.708 . . . . 0.0 112.204 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.88 -50.07 73.6 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.072 -1.017 . . . . 0.0 111.538 172.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.03 -45.38 79.19 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.056 0.942 . . . . 0.0 112.22 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.8 tp -61.96 -48.78 78.82 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.295 0.638 . . . . 0.0 112.045 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.71 -38.12 89.9 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.832 0.853 . . . . 0.0 112.45 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.06 -45.53 92.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.653 0.661 . . . . 0.0 112.001 170.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.61 -42.42 99.57 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.806 0.73 . . . . 0.0 112.114 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.9 -46.04 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.506 -0.747 . . . . 0.0 111.037 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -64.16 -39.44 94.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.887 0.767 . . . . 0.0 112.684 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -60.84 -47.44 86.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.934 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -70.05 -34.38 73.14 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.63 -41.98 92.02 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.49 -0.756 . . . . 0.0 112.299 172.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.57 -42.04 98.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.231 0.613 . . . . 0.0 111.784 172.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.15 -42.35 99.44 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.825 -0.547 . . . . 0.0 112.189 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -57.72 -48.48 79.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.677 0.671 . . . . 0.0 111.653 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.06 -30.4 71.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.09 -38.95 79.26 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.359 1.064 . . . . 0.0 112.488 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.44 -27.61 41.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.803 1.241 . . . . 0.0 113.318 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 60.98 53.81 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.583 1.953 . . . . 0.0 111.22 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.89 120.17 7.46 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.456 2.104 . . . . 0.0 110.296 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.52 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.335 1.454 . . . . 0.0 112.154 -169.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.12 160.46 25.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.1 0.56 . . . . 0.0 110.845 168.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.19 -19.96 64.98 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 174.7 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.069 1.319 . . . . 0.0 112.647 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.55 169.2 14.71 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.624 2.883 . . . . 0.0 112.944 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.65 -39.26 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.897 1.279 . . . . 0.0 111.762 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.45 161.91 28.56 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.862 1.665 . . . . 0.0 110.597 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.92 133.42 22.9 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.473 2.782 . . . . 0.0 113.132 168.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -15.05 60.3 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.531 1.063 . . . . 0.0 115.037 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.03 143.35 37.56 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.942 1.371 . . . . 0.0 110.197 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.14 145.64 54.17 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.663 -0.648 . . . . 0.0 110.793 168.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -68.59 152.67 45.05 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.677 0.791 . . . . 0.0 111.69 171.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -72.22 131.78 84.83 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.848 170.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.38 140.26 43.63 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.15 1.9 . . . . 0.0 112.465 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -74.87 171.65 13.65 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.707 1.603 . . . . 0.0 111.879 163.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.54 -44.0 93.95 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.921 -0.487 . . . . 0.0 112.955 168.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.66 -25.9 65.05 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.67 -41.61 65.19 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.057 -1.027 . . . . 0.0 111.777 171.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.66 -42.65 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.737 0.815 . . . . 0.0 110.819 173.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.98 -1.28 13.99 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.93 18.28 74.27 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.899 -1.126 . . . . 0.0 115.437 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.38 -19.39 19.24 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.115 1.458 . . . . 0.0 113.301 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 p -126.21 -1.55 7.02 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.3 p -103.43 150.05 24.22 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.099 0.96 . . . . 0.0 111.783 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.2 p -81.96 162.45 22.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.268 0.556 . . . . 0.0 110.848 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.87 -39.4 74.27 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.444 -0.785 . . . . 0.0 111.445 169.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.52 -38.87 92.8 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.513 -0.742 . . . . 0.0 112.688 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -64.59 -42.8 95.35 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.584 -0.698 . . . . 0.0 112.069 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.68 -46.3 90.87 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.574 0.75 . . . . 0.0 112.155 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.5 -46.36 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.122 0.969 . . . . 0.0 110.288 172.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.42 -51.01 54.42 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.806 0.717 . . . . 0.0 112.945 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.3 -50.09 73.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.751 0.776 . . . . 0.0 112.48 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.66 -18.35 64.26 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -112.01 8.39 20.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.628 1.171 . . . . 0.0 113.035 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.46 162.33 1.62 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.921 1.288 . . . . 0.0 111.461 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.93 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.065 0.946 . . . . 0.0 110.758 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.84 89.15 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.461 0.843 . . . . 0.0 111.713 -6.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -50.0 141.28 29.98 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.216 2.611 . . . . 0.0 114.206 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 74.9 mt -96.1 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 163.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.91 54.48 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.295 2.663 . . . . 0.0 112.884 -152.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.54 -34.85 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.26 94.22 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.985 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.91 -36.84 75.68 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.358 -1.083 . . . . 0.0 112.645 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.92 -44.61 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.753 -0.592 . . . . 0.0 109.987 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.79 -40.39 91.9 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.352 -0.842 . . . . 0.0 112.572 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -55.84 -41.99 75.11 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.476 -0.765 . . . . 0.0 112.287 173.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.76 -45.24 82.16 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.888 0.767 . . . . 0.0 112.125 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.27 -40.56 86.17 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.273 0.629 . . . . 0.0 112.246 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.48 -47.53 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 122.987 0.515 . . . . 0.0 110.216 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.97 -37.12 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.708 1.203 . . . . 0.0 112.326 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.85 98.55 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.107 0.867 . . . . 0.0 111.264 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.85 91.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.838 0.733 . . . . 0.0 113.199 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -58.1 -42.93 86.74 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.02 0.91 . . . . 0.0 110.987 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.24 70.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.842 0.857 . . . . 0.0 112.458 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -55.72 -43.44 76.55 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.894 0.77 . . . . 0.0 111.987 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.9 mt -64.57 -47.48 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 118.707 -0.663 . . . . 0.0 111.452 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.61 -32.99 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 119.918 1.235 . . . . 0.0 112.881 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -60.87 -46.46 90.51 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.949 0.9 . . . . 0.0 111.468 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.4 ttp -72.23 -38.38 68.95 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.588 1.555 . . . . 0.0 113.082 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.7 t80 . . . . . 0 C--O 1.251 1.156 0 C-N-CA 128.345 2.658 . . . . 0.0 114.73 -174.362 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.017 0.353 . . . . 0.0 113.017 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -92.0 135.05 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.51 1.124 . . . . 0.0 108.471 163.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.08 154.66 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.685 170.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.36 116.63 32.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.519 0.728 . . . . 0.0 109.181 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.4 177.97 6.92 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.55 0.69 . . . . 0.0 112.474 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.61 68.82 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.59 -2.12 57.83 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.746 1.219 . . . . 0.0 113.046 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.25 85.75 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.5 1.048 . . . . 0.0 114.066 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.82 128.16 35.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.848 1.324 . . . . 0.0 109.715 174.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.81 125.46 29.38 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 168.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.89 123.39 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.053 1.341 . . . . 0.0 108.659 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.66 141.1 48.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.513 1.925 . . . . 0.0 107.959 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.3 152.38 21.16 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.98 0.809 . . . . 0.0 111.274 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.49 136.85 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.645 -0.659 . . . . 0.0 111.61 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.0 93.24 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.02 -34.56 68.04 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.918 2.412 . . . . 0.0 113.569 167.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.46 -38.08 86.55 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.457 -0.777 . . . . 0.0 112.545 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.98 -44.21 97.7 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.718 0.69 . . . . 0.0 111.425 171.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.58 -44.42 94.11 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.291 0.496 . . . . 0.0 112.256 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.15 -47.17 86.26 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.441 0.564 . . . . 0.0 111.398 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.14 95.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.606 0.763 . . . . 0.0 111.879 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.7 t-105 -60.38 -46.83 88.57 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.734 0.813 . . . . 0.0 112.85 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.98 -54.16 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.436 0.562 . . . . 0.0 110.343 174.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.89 -37.14 78.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.391 1.076 . . . . 0.0 113.249 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.26 -52.46 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.236 1.414 . . . . 0.0 111.236 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.8 t -64.98 -36.09 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.023 0.529 . . . . 0.0 111.441 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.39 -24.04 58.86 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.51 -25.29 11.45 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -136.36 15.98 3.2 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -165.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.05 -36.98 2.77 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 -175.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -117.89 13.61 14.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.415 1.086 . . . . 0.0 113.114 -172.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.4 p -113.03 153.09 45.4 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.944 0.898 . . . . 0.0 111.55 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.88 -30.77 59.6 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.303 2.669 . . . . 0.0 115.181 -172.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -62.05 -20.82 64.36 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.81 -31.83 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.404 1.002 . . . . 0.0 112.525 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.49 -55.02 6.2 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 124.904 1.282 . . . . 0.0 112.968 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.84 -30.15 49.58 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.718 1.649 . . . . 0.0 112.633 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.0 -40.25 78.83 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.911 1.232 . . . . 0.0 112.669 172.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -57.23 -46.53 82.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.716 0.689 . . . . 0.0 111.592 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.2 m -61.04 -44.45 97.39 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.83 71.34 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.317 1.047 . . . . 0.0 113.229 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.54 4.5 53.13 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.455 1.502 . . . . 0.0 113.522 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -133.03 22.76 4.16 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.55 120.26 5.92 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.44 -1.413 . . . . 0.0 111.517 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.52 11.72 60.23 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.57 130.84 46.89 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.546 1.673 . . . . 0.0 112.437 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.31 159.68 84.36 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.7 167.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.53 -35.53 37.25 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.144 1.896 . . . . 0.0 115.412 168.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.96 -40.26 87.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.37 -45.31 93.95 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.695 -0.628 . . . . 0.0 111.038 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -59.18 -41.49 88.61 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.696 -0.628 . . . . 0.0 112.031 171.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.2 m -60.23 -45.28 93.77 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.582 0.628 . . . . 0.0 111.11 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.34 -48.99 77.56 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.246 0.93 . . . . 0.0 112.165 174.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -62.98 -38.38 90.9 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.01 -33.42 70.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.9 p -73.49 -12.72 60.88 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.6 m -122.53 6.98 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.22 -4.1 7.78 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 117.414 1.726 . . . . 0.0 117.414 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.59 -35.58 67.49 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 119.353 1.576 . . . . 0.0 115.173 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -85.35 77.89 9.86 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.944 1.354 . . . . 0.0 110.5 170.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.86 -35.51 32.96 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.597 1.559 . . . . 0.0 115.165 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.6 -41.33 72.45 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.142 1.337 . . . . 0.0 112.345 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.61 86.14 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.767 -0.583 . . . . 0.0 111.362 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -63.11 -40.02 96.4 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.576 -0.702 . . . . 0.0 112.228 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.02 -49.94 74.26 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.018 -1.051 . . . . 0.0 111.523 173.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.97 -45.41 78.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.066 0.946 . . . . 0.0 112.251 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.6 tp -61.94 -48.77 78.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.307 0.643 . . . . 0.0 112.071 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.72 -38.28 90.51 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 0.0 112.44 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.98 -45.49 92.55 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.715 0.689 . . . . 0.0 112.034 170.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.62 -42.43 99.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.793 0.724 . . . . 0.0 112.109 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.82 -46.11 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.426 -0.796 . . . . 0.0 111.03 174.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.12 -39.43 94.03 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.869 0.759 . . . . 0.0 112.724 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -60.82 -47.4 86.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.721 0.808 . . . . 0.0 111.961 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -70.15 -34.3 72.85 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.81 91.08 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.44 -0.788 . . . . 0.0 112.468 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.18 99.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.211 0.604 . . . . 0.0 111.737 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -62.91 -42.12 99.68 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.907 -0.496 . . . . 0.0 112.13 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -58.17 -48.81 79.14 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.641 -0.662 . . . . 0.0 111.751 173.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -62.76 -29.7 70.88 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.73 -39.48 76.78 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.398 1.079 . . . . 0.0 112.52 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.06 -27.59 43.1 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.731 1.212 . . . . 0.0 113.337 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.76 61.1 54.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.675 1.99 . . . . 0.0 111.229 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.77 120.22 7.53 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.484 2.123 . . . . 0.0 110.313 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.38 135.97 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.325 1.45 . . . . 0.0 112.079 -169.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -79.74 160.48 26.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.062 0.545 . . . . 0.0 110.908 168.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.99 65.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 174.78 41.62 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.115 1.34 . . . . 0.0 112.677 174.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.62 169.14 14.95 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.642 2.895 . . . . 0.0 112.906 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.6 -39.22 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.887 1.275 . . . . 0.0 111.787 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.91 28.56 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.845 1.658 . . . . 0.0 110.597 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.89 133.45 22.75 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.473 2.782 . . . . 0.0 113.114 168.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.91 -15.0 60.36 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.577 1.084 . . . . 0.0 115.056 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.32 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.906 1.353 . . . . 0.0 110.198 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.15 145.58 54.22 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.719 -0.613 . . . . 0.0 110.868 168.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -68.39 152.58 45.21 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.682 0.793 . . . . 0.0 111.616 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.07 131.58 85.27 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.805 170.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.26 140.47 44.63 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.051 1.834 . . . . 0.0 112.362 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -75.23 171.83 13.49 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.654 1.582 . . . . 0.0 111.99 162.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.78 -43.98 94.39 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 123.36 0.505 . . . . 0.0 113.012 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.71 -25.89 65.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -72.65 -41.67 65.2 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.977 -1.077 . . . . 0.0 111.764 171.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -62.52 -42.81 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.788 0.835 . . . . 0.0 110.76 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.99 -1.32 14.12 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.92 18.27 74.25 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.827 -1.17 . . . . 0.0 115.423 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.6 p -96.19 -19.53 19.27 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.13 1.465 . . . . 0.0 113.394 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 61.8 p -126.23 -1.55 7.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.613 1.165 . . . . 0.0 114.072 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -103.27 150.21 23.96 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.758 0.823 . . . . 0.0 112.25 173.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.8 p -82.53 162.4 22.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.361 0.601 . . . . 0.0 110.793 170.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.9 tp -56.57 -39.61 73.77 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.52 -0.737 . . . . 0.0 111.368 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.28 -39.0 93.34 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.547 -0.721 . . . . 0.0 112.63 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -64.68 -42.6 95.22 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.478 -0.764 . . . . 0.0 112.152 171.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -60.66 -46.34 90.69 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.618 0.767 . . . . 0.0 112.133 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.38 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.122 0.969 . . . . 0.0 110.288 172.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.43 -51.05 54.14 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.819 0.723 . . . . 0.0 112.9 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.22 -50.14 72.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.866 0.833 . . . . 0.0 112.517 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.63 -18.39 64.29 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.94 8.35 20.26 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.671 1.189 . . . . 0.0 113.051 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.43 162.33 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.978 1.311 . . . . 0.0 111.447 165.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.29 49.02 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.065 0.946 . . . . 0.0 110.821 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.1 163.84 89.14 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.497 0.856 . . . . 0.0 111.713 -6.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -50.01 141.26 30.1 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.231 2.621 . . . . 0.0 114.148 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.04 96.46 2.44 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.84 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.36 -46.24 94.28 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.638 0.654 . . . . 0.0 112.985 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.88 -36.89 75.83 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.362 -1.081 . . . . 0.0 112.645 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.88 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.722 -0.611 . . . . 0.0 109.947 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.92 -40.38 91.38 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.282 -0.886 . . . . 0.0 112.521 176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -42.02 75.05 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.71 -45.19 82.0 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.924 0.784 . . . . 0.0 112.12 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -67.41 -40.49 85.59 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.248 0.619 . . . . 0.0 112.292 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.57 -47.23 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 122.997 0.519 . . . . 0.0 110.235 174.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.05 -37.37 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.749 1.22 . . . . 0.0 112.308 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.85 -42.84 98.63 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.038 0.836 . . . . 0.0 111.216 171.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.55 -45.03 91.75 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.821 0.724 . . . . 0.0 113.252 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.37 -42.48 87.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.055 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.46 -50.17 70.57 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.811 0.844 . . . . 0.0 112.5 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.88 -43.33 77.09 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.855 0.752 . . . . 0.0 111.984 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.2 mt -64.43 -47.62 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.443 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.75 -32.91 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.952 1.251 . . . . 0.0 112.889 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -60.45 -45.86 92.16 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.901 0.88 . . . . 0.0 111.448 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.9 ttp -73.57 -38.43 65.17 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.564 1.546 . . . . 0.0 113.313 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.9 t80 . . . . . 0 C--O 1.255 1.39 0 C-N-CA 128.43 2.692 . . . . 0.0 114.714 -172.964 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.81 135.01 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.92 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.686 170.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.62 116.69 32.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.57 0.748 . . . . 0.0 109.17 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.46 178.06 6.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.46 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.95 -26.44 68.82 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.62 -2.16 57.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.818 1.247 . . . . 0.0 113.03 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.0 85.7 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.67 128.26 35.58 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.858 1.329 . . . . 0.0 109.726 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.92 125.62 29.62 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.99 123.4 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.07 1.348 . . . . 0.0 108.629 -174.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.73 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.75 141.14 48.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.477 1.911 . . . . 0.0 107.948 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.28 152.45 20.89 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.196 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.58 136.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.6 -0.687 . . . . 0.0 111.544 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.69 130.01 93.2 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.068 0.547 . . . . 0.0 111.106 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.05 -34.52 68.15 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.794 2.329 . . . . 0.0 113.607 167.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.46 -38.08 86.54 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.448 -0.783 . . . . 0.0 112.56 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.98 -44.29 97.58 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.753 0.706 . . . . 0.0 111.362 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.45 -44.42 94.56 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.277 0.49 . . . . 0.0 112.275 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.17 -47.28 85.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.162 0.585 . . . . 0.0 111.386 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.17 95.87 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.611 0.764 . . . . 0.0 111.856 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -60.14 -47.46 85.82 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.809 0.843 . . . . 0.0 112.748 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.8 -54.16 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.426 0.557 . . . . 0.0 110.384 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.8 -37.47 79.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.297 1.039 . . . . 0.0 113.207 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.409 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.87 -52.08 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.962 1.305 . . . . 0.0 111.281 170.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.58 -35.81 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.414 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.84 -23.51 60.72 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.72 -25.6 11.21 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -135.78 16.36 3.32 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -166.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.12 -38.35 2.38 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -175.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -118.01 14.08 14.04 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.49 1.116 . . . . 0.0 113.024 -171.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 p -113.13 152.91 45.43 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.997 0.919 . . . . 0.0 111.523 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.83 -30.95 59.87 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.296 2.664 . . . . 0.0 115.214 -172.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.08 -20.94 64.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.59 -32.17 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.413 1.006 . . . . 0.0 112.485 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.37 -57.16 5.98 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.715 1.206 . . . . 0.0 112.555 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.87 -29.43 58.45 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 121.833 1.69 . . . . 0.0 112.809 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.409 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.3 -40.1 77.91 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.841 1.2 . . . . 0.0 112.703 172.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.12 -47.05 82.06 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.885 0.766 . . . . 0.0 111.537 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -60.88 -44.17 97.46 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.84 -31.66 71.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.178 0.991 . . . . 0.0 113.261 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.76 4.59 52.79 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.362 1.465 . . . . 0.0 113.514 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.5 p -133.12 22.86 4.13 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.59 120.34 6.04 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.47 -1.394 . . . . 0.0 111.472 168.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.49 11.69 60.08 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.371 0.909 . . . . 0.0 115.371 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.87 47.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.565 1.683 . . . . 0.0 112.481 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.0 p -73.32 159.67 84.36 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.732 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.57 -35.43 37.32 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.144 1.896 . . . . 0.0 115.406 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.0 -40.34 87.33 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.28 -45.3 93.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.627 -0.671 . . . . 0.0 111.1 172.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.62 -44.23 94.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.343 1.057 . . . . 0.0 112.085 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.3 -41.31 88.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.649 0.659 . . . . 0.0 112.02 171.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.27 -45.41 93.42 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.611 0.642 . . . . 0.0 111.071 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.37 -48.66 78.44 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.192 0.906 . . . . 0.0 112.151 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.1 mt -63.23 -38.36 90.85 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.03 -34.36 71.82 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.627 -0.671 . . . . 0.0 112.776 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.2 p -72.4 -13.39 61.45 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 m -118.19 11.16 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.367 1.067 . . . . 0.0 113.391 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.75 -10.59 4.74 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 117.141 1.616 . . . . 0.0 117.141 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.85 9.5 2.78 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 125.811 1.672 . . . . 0.0 117.009 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -127.85 79.11 1.87 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.232 1.516 . . . . 0.0 110.0 162.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -52.17 -36.0 50.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -171.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.87 -40.9 75.44 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.127 1.331 . . . . 0.0 112.147 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.58 83.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.298 0.639 . . . . 0.0 111.351 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.0 tpp -62.88 -40.3 97.09 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.531 -0.73 . . . . 0.0 112.281 175.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.02 -50.0 74.06 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.267 1.027 . . . . 0.0 111.544 173.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.8 tpp -56.04 -45.45 79.19 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.098 0.959 . . . . 0.0 112.184 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.87 -48.82 78.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.337 0.655 . . . . 0.0 112.017 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.67 -38.31 90.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.905 0.882 . . . . 0.0 112.49 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -60.0 -45.44 92.74 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.689 0.677 . . . . 0.0 112.048 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.64 -42.36 99.56 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.827 0.739 . . . . 0.0 112.118 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.86 -46.11 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.472 -0.768 . . . . 0.0 111.03 174.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.11 -39.43 94.02 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.869 0.759 . . . . 0.0 112.738 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.85 -47.42 86.43 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.758 0.823 . . . . 0.0 111.892 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.09 -34.38 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.47 91.54 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.484 -0.76 . . . . 0.0 112.327 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.11 98.64 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.256 0.622 . . . . 0.0 111.781 172.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.12 -42.22 99.49 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.872 -0.517 . . . . 0.0 112.191 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.71 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.05 -30.24 71.44 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -39.1 78.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.397 1.079 . . . . 0.0 112.45 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.79 60.98 53.75 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.91 120.14 7.42 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.424 2.083 . . . . 0.0 110.315 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.35 136.29 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.332 1.453 . . . . 0.0 112.129 -169.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -80.01 160.47 25.86 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.054 0.541 . . . . 0.0 110.915 168.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.92 65.01 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.11 1.338 . . . . 0.0 112.686 174.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.6 169.19 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.658 2.905 . . . . 0.0 112.889 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.66 -39.2 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.904 1.282 . . . . 0.0 111.753 -175.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.61 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 110.585 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.89 133.38 22.73 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.487 2.791 . . . . 0.0 113.15 168.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.94 -15.04 60.29 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.567 1.08 . . . . 0.0 115.001 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.992 1.396 . . . . 0.0 110.198 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.22 145.58 54.16 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.691 -0.631 . . . . 0.0 110.793 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.54 152.82 44.85 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.655 0.782 . . . . 0.0 111.67 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.27 131.65 84.85 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.29 140.41 44.36 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.11 1.873 . . . . 0.0 112.442 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -75.18 171.62 13.84 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.697 1.599 . . . . 0.0 111.893 163.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.83 94.0 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.971 -0.455 . . . . 0.0 113.03 168.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.85 -25.75 64.8 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.66 64.9 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.03 -1.044 . . . . 0.0 111.779 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.59 -42.76 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 110.82 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.26 14.03 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.16 74.31 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.927 -1.108 . . . . 0.0 115.447 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.34 -19.39 19.27 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.074 1.437 . . . . 0.0 113.284 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.2 p -126.18 -1.44 7.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.71 149.96 24.49 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.036 0.935 . . . . 0.0 111.788 173.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.2 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.282 0.563 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.86 -39.37 74.17 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.451 -0.781 . . . . 0.0 111.394 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.49 -38.98 93.21 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.554 -0.716 . . . . 0.0 112.701 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.82 95.52 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.58 -46.44 90.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.636 0.774 . . . . 0.0 112.142 176.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.43 -46.36 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.158 0.983 . . . . 0.0 110.304 172.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.04 54.4 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.81 0.719 . . . . 0.0 112.93 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.79 0.795 . . . . 0.0 112.485 174.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.9 8.32 20.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.66 1.184 . . . . 0.0 113.033 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.39 162.29 1.59 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.041 1.336 . . . . 0.0 111.39 165.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.36 48.92 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.042 0.937 . . . . 0.0 110.758 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.09 163.83 89.17 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.509 0.86 . . . . 0.0 111.746 -6.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -49.98 141.36 29.67 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.253 2.635 . . . . 0.0 114.117 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.2 96.42 2.49 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -85.96 54.56 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.27 2.647 . . . . 0.0 112.86 -152.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.78 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.19 94.34 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.61 0.641 . . . . 0.0 113.011 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.87 -36.87 75.83 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.326 -1.102 . . . . 0.0 112.634 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.94 -44.56 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.808 -0.557 . . . . 0.0 109.949 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.36 91.58 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.303 -0.873 . . . . 0.0 112.557 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.85 -42.07 75.26 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.472 -0.767 . . . . 0.0 112.217 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -56.59 -45.26 81.49 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 112.087 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.39 -40.41 85.66 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.248 0.619 . . . . 0.0 112.286 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.73 -46.97 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.093 0.557 . . . . 0.0 110.286 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.38 -37.27 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.648 1.179 . . . . 0.0 112.32 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.85 -42.8 98.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.036 0.835 . . . . 0.0 111.176 171.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.24 91.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.878 0.751 . . . . 0.0 113.181 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.48 -42.21 87.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.035 0.918 . . . . 0.0 111.113 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.24 70.44 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.774 0.83 . . . . 0.0 112.399 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.83 -43.06 76.62 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.884 0.765 . . . . 0.0 112.027 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.64 -47.96 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.371 0.668 . . . . 0.0 111.451 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.46 -32.83 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 119.894 1.225 . . . . 0.0 112.895 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.11 -43.85 95.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.867 0.867 . . . . 0.0 111.512 171.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.6 ttp -76.99 -36.27 56.54 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.644 1.577 . . . . 0.0 113.606 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.255 1.375 0 C-N-CA 128.35 2.66 . . . . 0.0 114.599 -172.764 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.75 134.99 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.501 1.121 . . . . 0.0 108.436 163.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.98 154.96 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.114 1.366 . . . . 0.0 109.665 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.7 116.69 32.48 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.555 0.742 . . . . 0.0 109.222 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.46 178.07 6.89 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.604 0.716 . . . . 0.0 112.46 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.87 -26.57 68.84 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.08 57.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.746 1.219 . . . . 0.0 113.002 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.0 85.78 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.487 1.042 . . . . 0.0 114.091 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.75 128.29 35.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.858 1.329 . . . . 0.0 109.714 174.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.86 125.64 29.65 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 168.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.9 t -126.04 123.28 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.103 1.361 . . . . 0.0 108.712 -174.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.53 139.71 38.62 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.15 48.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.465 1.906 . . . . 0.0 107.922 169.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.34 20.89 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.015 0.825 . . . . 0.0 111.233 170.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.57 136.88 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.607 -0.683 . . . . 0.0 111.579 176.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.63 130.02 93.27 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.112 0.565 . . . . 0.0 111.139 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.04 -34.54 68.22 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.864 2.376 . . . . 0.0 113.607 167.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.44 -38.03 86.47 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.463 -0.773 . . . . 0.0 112.588 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 m -60.93 -44.33 97.38 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.722 0.692 . . . . 0.0 111.401 171.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.53 -44.17 95.02 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.3 -47.29 85.96 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.167 0.587 . . . . 0.0 111.416 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.13 95.91 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.626 0.77 . . . . 0.0 111.897 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -60.21 -47.26 86.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.86 0.864 . . . . 0.0 112.73 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.51 -54.95 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 118.471 0.578 . . . . 0.0 110.345 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.48 -37.3 77.87 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.272 1.029 . . . . 0.0 113.178 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.47 -52.16 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.028 1.331 . . . . 0.0 111.29 170.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.68 -36.02 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 119.016 -0.516 . . . . 0.0 111.452 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -58.53 -24.17 59.96 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.04 -25.81 11.43 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.91 15.97 3.31 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -165.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.08 -38.92 2.54 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -116.62 13.73 15.3 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.379 1.072 . . . . 0.0 113.154 -172.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.1 p -112.87 152.95 45.27 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 123.941 0.897 . . . . 0.0 111.544 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.82 -30.77 58.93 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.299 2.666 . . . . 0.0 115.233 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.02 -20.74 64.24 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.8 -31.86 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.435 1.016 . . . . 0.0 112.548 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.45 -55.05 6.24 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.907 1.283 . . . . 0.0 112.956 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.83 -30.12 49.72 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.688 1.639 . . . . 0.0 112.661 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.403 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.07 -40.22 78.61 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.86 1.209 . . . . 0.0 112.64 172.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -57.27 -46.49 83.04 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.719 0.69 . . . . 0.0 111.579 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -61.04 -44.48 97.33 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.07 71.51 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.341 1.056 . . . . 0.0 113.225 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.23 4.44 53.53 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.4 1.48 . . . . 0.0 113.522 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.9 p -133.03 22.82 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.61 120.27 5.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.44 -1.413 . . . . 0.0 111.484 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.59 11.6 60.19 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.422 0.929 . . . . 0.0 115.422 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.51 130.87 47.09 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.525 1.663 . . . . 0.0 112.498 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.35 159.68 84.3 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.758 0.823 . . . . 0.0 110.697 167.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.65 -35.41 37.95 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.204 1.936 . . . . 0.0 115.366 168.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.0 -40.27 87.29 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.33 -45.31 93.88 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.596 -0.69 . . . . 0.0 111.044 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.6 -44.21 94.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.318 1.047 . . . . 0.0 112.175 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -59.24 -41.48 88.82 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.649 -0.657 . . . . 0.0 111.973 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.2 m -60.23 -45.28 93.77 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.614 0.643 . . . . 0.0 111.11 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -57.33 -49.01 77.48 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.246 0.93 . . . . 0.0 112.193 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.02 -38.54 91.59 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.87 -33.22 70.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.9 p -73.68 -13.37 60.97 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.6 m -122.45 6.2 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.5 -4.36 6.65 Favored Glycine 0 CA--C 1.541 1.67 0 N-CA-C 117.243 1.657 . . . . 0.0 117.243 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.75 -35.28 57.61 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 119.179 1.489 . . . . 0.0 115.177 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -86.18 77.95 9.47 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.838 1.304 . . . . 0.0 110.551 170.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.95 -35.91 35.96 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.36 -41.18 73.47 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.047 1.294 . . . . 0.0 112.301 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.36 -43.55 85.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.137 0.575 . . . . 0.0 111.33 173.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 59.8 tpp -63.25 -39.96 96.08 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.47 -0.769 . . . . 0.0 112.223 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -50.0 73.98 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.079 -1.013 . . . . 0.0 111.521 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -56.0 -45.43 79.04 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.88 -48.81 78.85 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.314 0.646 . . . . 0.0 112.055 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.7 -38.21 90.26 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.835 0.854 . . . . 0.0 112.448 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.99 -45.53 92.42 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.664 0.665 . . . . 0.0 112.027 170.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -62.64 -42.37 99.55 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.149 175.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.86 -46.1 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.47 -0.769 . . . . 0.0 111.059 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.08 -39.46 94.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.831 0.741 . . . . 0.0 112.736 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.82 -47.4 86.51 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.958 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.1 -34.32 72.97 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.584 -0.697 . . . . 0.0 112.835 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.92 -41.47 91.35 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.441 -0.787 . . . . 0.0 112.307 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.12 98.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.238 0.615 . . . . 0.0 111.772 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.09 -42.28 99.58 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.915 -0.491 . . . . 0.0 112.138 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -57.8 -48.58 79.32 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.661 0.664 . . . . 0.0 111.71 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.06 -30.24 71.44 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.2 -39.13 78.84 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.391 1.076 . . . . 0.0 112.48 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.26 -27.6 42.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.812 1.245 . . . . 0.0 113.302 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.8 61.02 54.01 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.668 1.987 . . . . 0.0 111.228 -174.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.9 120.13 7.4 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.507 2.138 . . . . 0.0 110.285 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.45 136.23 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.298 1.439 . . . . 0.0 112.121 -169.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -79.85 160.43 26.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.087 0.555 . . . . 0.0 110.915 168.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.27 -19.97 65.05 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.74 41.58 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.048 1.309 . . . . 0.0 112.64 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.58 169.23 14.72 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.611 2.874 . . . . 0.0 112.882 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.66 -39.22 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.925 1.29 . . . . 0.0 111.806 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.62 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.884 1.674 . . . . 0.0 110.631 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.91 133.41 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.456 2.77 . . . . 0.0 113.116 168.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.05 60.34 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 115.005 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.1 143.42 37.36 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.006 1.403 . . . . 0.0 110.185 173.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.2 145.56 54.2 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.721 -0.612 . . . . 0.0 110.842 168.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.49 152.73 44.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.748 0.819 . . . . 0.0 111.666 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -72.26 131.72 84.81 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.808 170.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.33 140.41 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -75.2 171.66 13.77 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.697 1.599 . . . . 0.0 111.889 163.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.5 -43.94 93.9 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.934 -0.479 . . . . 0.0 113.03 168.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.81 -25.73 64.83 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.78 -41.63 64.8 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.05 -1.032 . . . . 0.0 111.728 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.77 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.77 0.828 . . . . 0.0 110.771 173.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.26 13.94 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.2 74.23 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.596 1.093 . . . . 0.0 115.449 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.43 19.26 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.157 1.478 . . . . 0.0 113.283 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.19 -1.42 7.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.74 149.84 24.62 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.082 0.953 . . . . 0.0 111.799 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.5 p -81.78 162.32 22.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.291 0.567 . . . . 0.0 110.779 170.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.74 -39.38 73.85 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.448 -0.783 . . . . 0.0 111.445 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.54 -38.98 93.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.554 -0.716 . . . . 0.0 112.685 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.77 95.55 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.68 -46.35 90.69 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.119 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.33 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 110.268 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.04 54.46 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.795 0.712 . . . . 0.0 112.92 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.29 -50.05 73.22 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.812 0.806 . . . . 0.0 112.537 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.48 64.29 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.87 8.36 20.4 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.703 1.201 . . . . 0.0 113.051 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.5 162.33 1.64 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.991 1.316 . . . . 0.0 111.399 165.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.35 48.98 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.066 0.946 . . . . 0.0 110.813 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.82 89.2 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-N 119.429 0.832 . . . . 0.0 111.69 -6.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.94 141.39 29.27 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.187 2.591 . . . . 0.0 114.171 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.23 96.49 2.54 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 163.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.05 54.62 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.214 2.61 . . . . 0.0 112.83 -152.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.81 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.17 94.4 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.638 0.654 . . . . 0.0 113.011 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.89 -36.84 75.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.296 -1.12 . . . . 0.0 112.634 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.8 mt -62.95 -44.62 99.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.799 -0.563 . . . . 0.0 109.914 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.87 -40.35 91.57 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.327 -0.858 . . . . 0.0 112.521 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -55.86 -42.04 75.25 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.439 -0.788 . . . . 0.0 112.246 173.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.72 -45.23 82.04 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.924 0.784 . . . . 0.0 112.125 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.26 -40.57 86.22 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.294 0.638 . . . . 0.0 112.244 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.57 -47.33 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.23 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.98 -37.36 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.695 1.198 . . . . 0.0 112.301 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.84 -42.77 98.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.039 0.836 . . . . 0.0 111.217 171.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.62 -44.98 91.71 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 123.855 0.74 . . . . 0.0 113.214 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.35 -42.57 87.17 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.007 0.903 . . . . 0.0 110.992 173.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.24 70.37 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.807 0.843 . . . . 0.0 112.483 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.82 -43.28 76.81 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.88 0.764 . . . . 0.0 111.961 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.426 HG21 H13A ' A' ' 146' ' ' JPR . 69.2 mt -64.52 -47.8 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.334 0.654 . . . . 0.0 111.418 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.93 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 119.911 1.232 . . . . 0.0 112.893 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -60.36 -44.86 95.18 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.949 0.9 . . . . 0.0 111.428 171.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.4 ttp -74.89 -35.72 62.25 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.683 1.593 . . . . 0.0 113.422 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.0 t80 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 128.341 2.656 . . . . 0.0 114.546 -173.291 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 146' ' ' JPR . . . . . 0.426 H13A HG21 ' A' ' 141' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.042 0.362 . . . . 0.0 113.042 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.97 135.05 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.468 1.107 . . . . 0.0 108.466 163.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.06 154.71 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.662 170.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.4 116.65 32.5 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.534 0.734 . . . . 0.0 109.17 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.41 177.97 6.93 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.557 0.694 . . . . 0.0 112.474 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.55 68.79 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.67 -2.1 57.85 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.798 1.239 . . . . 0.0 113.001 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.12 85.87 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.454 1.026 . . . . 0.0 114.133 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.75 128.17 35.24 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.826 1.313 . . . . 0.0 109.695 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.85 125.5 29.43 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.89 123.39 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.077 1.351 . . . . 0.0 108.674 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.56 139.71 38.58 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.1 48.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.4 20.87 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.988 0.813 . . . . 0.0 111.217 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.53 136.86 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.644 -0.66 . . . . 0.0 111.544 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.68 130.0 93.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.11 0.564 . . . . 0.0 111.137 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.99 -34.6 67.98 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.894 2.396 . . . . 0.0 113.602 167.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -66.44 -38.03 86.49 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.425 -0.797 . . . . 0.0 112.56 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -61.04 -44.26 97.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.747 0.703 . . . . 0.0 111.337 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.54 -44.42 94.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.302 0.501 . . . . 0.0 112.256 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.12 -47.18 86.21 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.121 0.569 . . . . 0.0 111.396 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.19 95.75 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.667 0.787 . . . . 0.0 111.874 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.28 -46.95 88.04 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.779 0.831 . . . . 0.0 112.811 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.8 t -56.9 -54.26 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.4 0.546 . . . . 0.0 110.368 174.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.77 -37.17 78.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.412 1.085 . . . . 0.0 113.287 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.41 -52.35 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.206 1.402 . . . . 0.0 111.209 170.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.96 -36.06 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.958 0.503 . . . . 0.0 111.405 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.48 -24.0 59.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.48 -25.33 11.44 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.23 15.83 3.23 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -165.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.9 -37.07 2.67 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -117.88 13.84 14.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.385 1.074 . . . . 0.0 113.151 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.0 p -113.11 153.11 45.46 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.968 0.907 . . . . 0.0 111.474 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.86 -30.87 59.77 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.25 2.633 . . . . 0.0 115.185 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.11 -20.99 64.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.52 -32.24 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.396 0.998 . . . . 0.0 112.452 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.36 -57.16 6.0 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.726 1.21 . . . . 0.0 112.578 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.88 -29.46 58.31 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.928 1.724 . . . . 0.0 112.764 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.29 -40.09 77.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.866 1.212 . . . . 0.0 112.661 172.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -57.2 -46.98 82.39 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.873 0.76 . . . . 0.0 111.555 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.2 m -60.86 -44.26 97.26 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.65 70.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.248 1.019 . . . . 0.0 113.251 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.85 4.59 52.7 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.436 1.494 . . . . 0.0 113.528 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.9 p -133.13 22.85 4.13 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -176.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.56 120.28 5.96 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.501 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.54 60.17 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.377 0.911 . . . . 0.0 115.377 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 130.82 46.9 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.565 1.682 . . . . 0.0 112.53 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.28 159.71 84.31 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.699 167.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.6 -35.46 37.64 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.209 1.94 . . . . 0.0 115.39 168.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.98 -40.25 87.39 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.45 -45.22 94.48 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.569 -0.707 . . . . 0.0 111.055 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.62 -44.21 94.61 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.307 1.043 . . . . 0.0 112.115 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -59.25 -41.47 88.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.649 0.659 . . . . 0.0 111.965 171.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.9 m -60.25 -45.22 94.03 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.601 0.637 . . . . 0.0 111.066 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.46 -48.88 77.99 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.196 0.907 . . . . 0.0 112.174 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -63.07 -38.34 90.8 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.99 -33.33 70.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.3 p -73.58 -12.72 60.85 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -122.43 7.21 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -174.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.42 -4.06 8.36 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 117.413 1.725 . . . . 0.0 117.413 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.71 -35.2 66.46 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.394 1.597 . . . . 0.0 115.17 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -85.94 77.81 9.61 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.006 1.384 . . . . 0.0 110.537 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.71 -35.55 31.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.663 1.585 . . . . 0.0 115.223 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.48 -41.32 72.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.129 1.331 . . . . 0.0 112.332 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.63 85.94 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.776 -0.577 . . . . 0.0 111.348 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.15 -39.97 96.22 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.548 -0.72 . . . . 0.0 112.22 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.98 -49.97 74.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.223 1.009 . . . . 0.0 111.569 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.96 -45.44 78.87 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 0.0 112.212 174.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.6 tp -61.92 -48.77 78.98 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.344 0.657 . . . . 0.0 112.071 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.71 -38.27 90.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.873 0.869 . . . . 0.0 112.488 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.96 -45.58 92.19 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.684 0.675 . . . . 0.0 111.966 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.2 m -62.54 -42.46 99.54 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.828 0.74 . . . . 0.0 112.155 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.6 mt -58.8 -46.1 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.453 -0.78 . . . . 0.0 111.093 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.36 93.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.847 0.749 . . . . 0.0 112.759 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.93 -47.42 86.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.756 0.822 . . . . 0.0 111.908 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.12 -34.3 72.92 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.72 -41.73 91.91 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.447 -0.783 . . . . 0.0 112.328 172.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -41.98 98.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.139 0.576 . . . . 0.0 111.817 172.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.17 -42.26 99.37 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.918 -0.489 . . . . 0.0 112.163 174.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.8 -48.47 79.62 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.68 0.673 . . . . 0.0 111.694 173.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -63.13 -30.34 71.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.06 -39.09 79.31 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.342 1.057 . . . . 0.0 112.482 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.32 -27.57 42.13 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.796 1.239 . . . . 0.0 113.325 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.74 60.97 53.77 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.653 1.981 . . . . 0.0 111.274 -174.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.86 120.13 7.41 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.483 2.122 . . . . 0.0 110.323 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.294 1.438 . . . . 0.0 112.115 -169.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -80.2 160.52 25.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.07 0.548 . . . . 0.0 110.857 168.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.19 -20.02 65.03 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.7 41.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.096 1.332 . . . . 0.0 112.631 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.52 169.2 14.66 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.624 2.883 . . . . 0.0 112.917 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.66 -39.19 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.874 1.27 . . . . 0.0 111.791 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.94 28.52 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.93 133.38 22.92 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.441 2.761 . . . . 0.0 113.163 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -14.95 60.55 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.648 1.118 . . . . 0.0 115.042 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.38 37.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.952 1.376 . . . . 0.0 110.198 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.64 54.14 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.726 -0.608 . . . . 0.0 110.793 168.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -68.64 152.77 44.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.648 0.779 . . . . 0.0 111.618 171.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.26 131.72 84.81 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-O 118.888 -0.577 . . . . 0.0 109.831 170.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.4 140.32 43.71 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.063 1.842 . . . . 0.0 112.442 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -74.94 171.61 13.76 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.8 1.64 . . . . 0.0 111.817 163.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.61 -43.86 94.12 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.913 -0.492 . . . . 0.0 112.979 168.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.75 -25.88 64.96 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.71 -41.53 65.13 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.076 -1.015 . . . . 0.0 111.778 171.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.73 -42.63 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.719 0.807 . . . . 0.0 110.812 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.02 -1.29 14.12 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.03 18.13 74.33 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.929 -1.107 . . . . 0.0 115.445 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.25 -19.42 19.31 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.073 1.436 . . . . 0.0 113.289 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.2 -1.58 7.02 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.57 150.04 24.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.067 0.947 . . . . 0.0 111.773 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.4 p -81.95 162.44 22.7 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.321 0.582 . . . . 0.0 110.797 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.88 -39.36 74.23 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.414 -0.804 . . . . 0.0 111.445 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.62 -38.84 92.65 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.557 -0.715 . . . . 0.0 112.635 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -64.62 -42.8 95.27 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.628 -0.67 . . . . 0.0 112.033 171.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.61 -46.46 90.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.648 0.779 . . . . 0.0 112.097 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.38 -46.39 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.142 0.977 . . . . 0.0 110.317 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.42 -51.01 54.42 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.806 0.717 . . . . 0.0 112.945 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.3 -50.09 73.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.751 0.776 . . . . 0.0 112.48 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.0 p -111.93 8.43 20.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.637 1.175 . . . . 0.0 113.027 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.46 162.34 1.61 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.939 1.295 . . . . 0.0 111.434 165.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.63 103.35 48.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.054 0.942 . . . . 0.0 110.758 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.79 89.26 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.451 0.84 . . . . 0.0 111.701 -6.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -49.98 141.37 29.62 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.176 2.584 . . . . 0.0 114.168 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.12 96.53 2.51 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -86.03 54.54 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.232 2.621 . . . . 0.0 112.882 -152.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.54 -34.86 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.46 -46.2 94.31 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.605 0.639 . . . . 0.0 112.947 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.86 -36.9 75.9 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.259 -1.142 . . . . 0.0 112.645 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.88 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.785 -0.572 . . . . 0.0 109.98 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.44 91.68 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.356 -0.84 . . . . 0.0 112.576 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -55.78 -41.99 74.88 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.468 -0.77 . . . . 0.0 112.287 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.71 -45.24 81.98 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.888 0.767 . . . . 0.0 112.134 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.26 -40.59 86.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.308 0.643 . . . . 0.0 112.251 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.55 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.083 0.553 . . . . 0.0 110.261 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.13 -37.33 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.72 1.208 . . . . 0.0 112.322 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.82 98.32 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.047 0.84 . . . . 0.0 111.275 171.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.05 91.66 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.847 0.737 . . . . 0.0 113.242 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.4 -42.47 87.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.954 0.877 . . . . 0.0 111.032 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.48 -50.21 70.48 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.811 0.844 . . . . 0.0 112.45 173.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.79 -43.42 76.81 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 118.853 0.751 . . . . 0.0 111.956 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.43 -47.68 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.406 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.67 -32.89 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.992 1.269 . . . . 0.0 112.907 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -60.43 -45.36 93.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.899 0.88 . . . . 0.0 111.5 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.3 ttp -74.51 -38.24 62.88 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.597 1.559 . . . . 0.0 113.336 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.3 t80 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 128.483 2.713 . . . . 0.0 114.671 -172.571 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 N--CA 1.479 0.666 0 N-CA-C 112.965 0.333 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.22 134.86 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.46 1.104 . . . . 0.0 108.451 163.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.91 154.92 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.136 1.374 . . . . 0.0 109.665 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.67 116.72 32.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.48 0.712 . . . . 0.0 109.171 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.43 177.97 6.95 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.514 0.673 . . . . 0.0 112.511 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.87 -26.49 68.8 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.56 -2.24 57.94 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.825 1.25 . . . . 0.0 113.024 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.07 2.94 85.6 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.467 1.032 . . . . 0.0 114.142 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.74 128.29 35.73 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.815 1.308 . . . . 0.0 109.7 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.69 29.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.01 123.4 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.066 1.347 . . . . 0.0 108.648 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.68 139.68 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.572 0.701 . . . . 0.0 111.21 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.64 141.17 48.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.488 1.915 . . . . 0.0 107.922 169.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.17 152.31 20.77 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.977 0.808 . . . . 0.0 111.237 170.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.62 136.83 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.651 -0.656 . . . . 0.0 111.571 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.59 129.98 93.32 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.167 0.587 . . . . 0.0 111.157 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.07 -34.57 68.66 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.86 2.373 . . . . 0.0 113.543 167.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.39 -38.13 86.81 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.475 -0.765 . . . . 0.0 112.55 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.88 -44.4 97.12 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.728 0.695 . . . . 0.0 111.383 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.45 -44.42 94.55 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.251 0.478 . . . . 0.0 112.211 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.12 -47.25 85.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.087 0.555 . . . . 0.0 111.441 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.1 -45.19 95.73 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.633 0.773 . . . . 0.0 111.892 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -59.98 -47.53 85.43 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.806 0.842 . . . . 0.0 112.729 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.7 t -56.85 -54.13 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.408 0.549 . . . . 0.0 110.493 174.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.72 -37.36 78.68 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.344 1.058 . . . . 0.0 113.214 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.414 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -58.24 -52.11 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.917 1.287 . . . . 0.0 111.345 170.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.19 -35.98 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 122.948 0.499 . . . . 0.0 111.336 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.66 -23.45 59.25 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.98 -25.72 11.04 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -135.87 16.03 3.31 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.46 -37.83 2.57 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -117.86 14.56 14.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.374 1.07 . . . . 0.0 113.141 -172.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.5 p -113.64 152.95 45.89 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.008 0.923 . . . . 0.0 111.513 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.85 -30.81 59.43 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.216 2.61 . . . . 0.0 115.249 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.06 -20.93 64.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.54 -32.19 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.424 1.011 . . . . 0.0 112.482 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.7 mt -70.36 -57.2 5.97 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.76 1.224 . . . . 0.0 112.561 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.81 -29.57 58.95 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.859 1.699 . . . . 0.0 112.793 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.414 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.25 -40.07 78.08 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.838 1.199 . . . . 0.0 112.733 172.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -57.15 -47.08 82.05 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.877 0.762 . . . . 0.0 111.507 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m -60.79 -44.24 97.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.65 71.05 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.233 1.013 . . . . 0.0 113.264 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.8 4.59 52.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.389 1.476 . . . . 0.0 113.514 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.7 p -133.1 22.79 4.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.54 120.23 5.87 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.49 -1.381 . . . . 0.0 111.491 168.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.64 11.59 60.3 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 115.367 0.907 . . . . 0.0 115.367 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.49 131.04 47.83 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.567 1.683 . . . . 0.0 112.487 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.7 p -73.47 159.81 83.85 Favored Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 123.667 0.787 . . . . 0.0 110.722 167.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.63 -35.35 37.62 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.161 1.908 . . . . 0.0 115.429 168.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.1 -40.24 86.89 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -60.26 -45.35 93.59 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.66 -0.65 . . . . 0.0 111.089 172.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.62 -44.27 94.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.328 1.051 . . . . 0.0 112.146 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -59.18 -41.43 88.44 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.672 -0.642 . . . . 0.0 112.03 171.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.6 m -60.25 -45.25 93.91 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.561 0.619 . . . . 0.0 111.059 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.47 -48.86 78.08 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.196 0.907 . . . . 0.0 112.16 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.18 -38.13 89.97 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.11 -32.82 70.18 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.3 p -74.14 -12.29 60.55 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.11 8.28 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.81 -3.78 11.77 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 117.446 1.739 . . . . 0.0 117.446 -175.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.32 -32.79 64.32 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 119.556 1.678 . . . . 0.0 115.279 -177.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -89.75 77.36 7.08 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 123.06 1.409 . . . . 0.0 110.481 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.33 -35.08 26.12 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.859 1.664 . . . . 0.0 115.416 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.9 -40.9 75.36 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 120.159 1.345 . . . . 0.0 112.312 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.64 -43.45 84.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.158 0.583 . . . . 0.0 111.366 173.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.14 -40.13 96.68 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.494 -0.754 . . . . 0.0 112.246 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.83 74.6 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.257 1.023 . . . . 0.0 111.541 173.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.04 -45.5 79.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.092 0.957 . . . . 0.0 112.189 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.3 tp -61.85 -48.77 79.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.332 0.653 . . . . 0.0 112.08 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.79 -38.18 90.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.861 0.865 . . . . 0.0 112.483 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.01 -45.52 92.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.664 0.665 . . . . 0.0 112.034 170.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.54 -42.47 99.55 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.792 0.724 . . . . 0.0 112.105 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.81 -46.14 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.491 -0.755 . . . . 0.0 111.077 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.1 -39.45 94.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.819 0.736 . . . . 0.0 112.717 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -60.83 -47.36 86.69 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.77 0.828 . . . . 0.0 111.98 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.17 -34.3 72.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.56 91.79 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.451 -0.781 . . . . 0.0 112.371 172.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.04 98.56 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.202 0.601 . . . . 0.0 111.832 172.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.09 -42.27 99.57 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.905 -0.497 . . . . 0.0 112.221 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.8 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.615 0.643 . . . . 0.0 111.649 173.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.03 -30.31 71.5 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.14 -39.1 79.05 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.324 1.05 . . . . 0.0 112.52 173.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.17 -27.66 42.67 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.785 1.234 . . . . 0.0 113.307 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -132.78 61.03 54.11 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.646 1.978 . . . . 0.0 111.276 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.92 120.16 7.44 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.48 2.12 . . . . 0.0 110.277 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.23 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.363 1.465 . . . . 0.0 112.151 -169.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.98 160.37 25.94 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.13 0.572 . . . . 0.0 110.861 168.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.15 -20.03 65.02 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 174.77 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.048 1.309 . . . . 0.0 112.656 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.55 169.17 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.66 2.907 . . . . 0.0 112.93 177.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.62 -39.2 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.867 1.267 . . . . 0.0 111.841 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.62 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.884 1.674 . . . . 0.0 110.631 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.91 133.41 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.456 2.77 . . . . 0.0 113.116 168.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.99 -15.04 60.37 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.562 1.077 . . . . 0.0 115.013 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -78.09 143.41 37.39 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.928 1.364 . . . . 0.0 110.218 173.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.51 54.2 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.726 -0.608 . . . . 0.0 110.826 168.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -68.55 152.89 44.74 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.694 0.798 . . . . 0.0 111.669 171.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -72.3 131.69 84.77 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.917 -0.563 . . . . 0.0 109.858 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.33 140.41 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -75.19 171.67 13.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.72 1.608 . . . . 0.0 111.862 163.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.51 -43.93 93.93 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.968 -0.458 . . . . 0.0 113.006 168.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.83 -25.77 64.83 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.67 -41.65 65.13 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.064 -1.022 . . . . 0.0 111.765 171.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.65 -42.72 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.712 0.805 . . . . 0.0 110.801 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.3 14.11 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.13 74.17 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.626 1.107 . . . . 0.0 115.458 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.6 p -96.22 -19.43 19.33 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.09 1.445 . . . . 0.0 113.255 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.2 p -126.16 -1.5 7.05 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.4 p -103.64 149.8 24.6 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.034 0.934 . . . . 0.0 111.778 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.1 p -81.68 162.34 23.06 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.341 0.591 . . . . 0.0 110.775 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.72 -39.44 73.91 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.448 -0.783 . . . . 0.0 111.429 169.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.51 -39.01 93.32 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.531 -0.731 . . . . 0.0 112.636 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -64.6 -42.65 95.42 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.72 -46.42 90.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.652 0.781 . . . . 0.0 112.119 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.42 -46.35 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.12 0.968 . . . . 0.0 110.301 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.07 54.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.806 0.717 . . . . 0.0 112.889 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.24 -50.09 73.12 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.831 0.816 . . . . 0.0 112.48 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.2 mtp -68.62 -18.52 64.32 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.92 8.41 20.33 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.665 1.186 . . . . 0.0 113.072 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.42 162.3 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.971 1.309 . . . . 0.0 111.461 165.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.32 48.97 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.15 163.8 89.21 Favored 'Cis proline' 0 CA--C 1.544 1.021 0 CA-C-N 119.466 0.845 . . . . 0.0 111.735 -6.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -49.93 141.34 29.28 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.184 2.59 . . . . 0.0 114.207 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.21 96.44 2.51 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 163.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.97 54.67 3.51 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.65 -34.84 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.24 94.25 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 118.656 0.662 . . . . 0.0 112.991 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -69.73 -36.98 76.32 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.281 -1.129 . . . . 0.0 112.609 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.93 -44.6 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.762 -0.586 . . . . 0.0 109.949 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.85 -40.37 91.64 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.352 -0.842 . . . . 0.0 112.543 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.04 75.12 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.455 -0.778 . . . . 0.0 112.243 173.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -56.7 -45.17 81.99 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.933 0.788 . . . . 0.0 112.098 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.33 -40.55 85.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.29 0.636 . . . . 0.0 112.251 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.69 -46.94 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.062 0.545 . . . . 0.0 110.321 174.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.34 -37.31 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.688 1.195 . . . . 0.0 112.314 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.81 98.3 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.019 0.827 . . . . 0.0 111.223 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.11 91.4 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.796 0.712 . . . . 0.0 113.265 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.49 -42.24 87.15 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.01 0.905 . . . . 0.0 111.092 173.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.39 -50.25 70.22 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.766 0.826 . . . . 0.0 112.461 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.93 -43.1 77.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.823 0.738 . . . . 0.0 112.011 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.44 -48.13 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.721 -0.656 . . . . 0.0 111.372 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -69.38 -32.83 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 119.973 1.261 . . . . 0.0 112.89 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.95 -42.79 94.8 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.931 0.892 . . . . 0.0 111.552 171.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.0 ttp -79.02 -35.65 42.4 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.718 1.607 . . . . 0.0 113.704 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 t80 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 128.383 2.673 . . . . 0.0 114.513 -172.013 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.656 0 N-CA-C 112.952 0.328 . . . . 0.0 112.952 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.89 135.17 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.48 1.112 . . . . 0.0 108.438 163.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.12 154.89 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.113 1.365 . . . . 0.0 109.698 170.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.62 116.71 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.522 0.729 . . . . 0.0 109.128 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -76.57 177.73 7.23 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.604 0.716 . . . . 0.0 112.408 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.53 -26.53 68.61 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -173.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -85.64 -2.22 57.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.76 1.224 . . . . 0.0 113.037 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.99 3.13 85.65 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.53 1.062 . . . . 0.0 114.049 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.71 128.19 35.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.877 1.338 . . . . 0.0 109.726 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.6 29.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.99 123.42 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.045 1.338 . . . . 0.0 108.674 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.56 139.65 38.59 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.52 0.676 . . . . 0.0 111.222 170.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.61 141.06 48.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.476 1.91 . . . . 0.0 107.909 169.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.18 152.34 20.76 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.974 0.806 . . . . 0.0 111.244 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.54 136.86 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.492 0.663 . . . . 0.0 111.575 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.68 129.96 93.23 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.112 0.565 . . . . 0.0 111.18 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -52.91 -34.69 67.57 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.865 2.377 . . . . 0.0 113.589 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -66.33 -38.14 86.99 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.419 -0.801 . . . . 0.0 112.572 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.91 -44.39 97.24 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.749 0.704 . . . . 0.0 111.359 171.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.43 -44.48 94.46 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.29 0.495 . . . . 0.0 112.275 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.05 -47.25 85.91 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.113 0.565 . . . . 0.0 111.42 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.99 96.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.614 0.766 . . . . 0.0 111.914 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -60.14 -47.47 85.77 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.828 0.851 . . . . 0.0 112.754 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.4 t -56.74 -54.15 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 118.392 0.542 . . . . 0.0 110.418 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.79 -37.38 78.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.3 1.04 . . . . 0.0 113.227 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.409 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.85 -52.09 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.035 1.334 . . . . 0.0 111.278 170.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.6 -35.96 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 122.99 0.516 . . . . 0.0 111.362 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -58.61 -23.43 58.85 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -108.06 -25.48 11.11 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -136.07 15.67 3.28 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -166.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.41 -37.53 2.37 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -117.73 14.45 14.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.436 1.095 . . . . 0.0 113.093 -172.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 p -113.92 152.96 46.14 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.078 0.951 . . . . 0.0 111.659 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.84 -31.17 60.96 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.287 2.658 . . . . 0.0 115.292 -172.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -61.69 -21.01 64.09 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.33 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.387 0.994 . . . . 0.0 112.472 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.33 -57.12 6.07 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.717 1.207 . . . . 0.0 112.633 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.78 -29.61 59.2 Favored 'Trans proline' 0 C--N 1.351 0.709 0 CA-C-N 121.901 1.715 . . . . 0.0 112.783 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.409 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.4 mtm -69.18 -40.21 78.25 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.809 1.186 . . . . 0.0 112.683 172.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -57.04 -46.85 82.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.836 0.744 . . . . 0.0 111.544 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -61.03 -44.43 97.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.368 0.667 . . . . 0.0 112.784 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.57 -31.64 70.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.242 1.017 . . . . 0.0 113.26 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.87 4.88 52.44 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.384 1.474 . . . . 0.0 113.523 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.8 p -133.46 22.8 4.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -53.41 120.36 5.97 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.468 -1.395 . . . . 0.0 111.48 168.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.4 11.6 59.71 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.46 130.84 47.01 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.517 1.659 . . . . 0.0 112.449 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.5 p -73.45 159.55 84.48 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 123.701 0.801 . . . . 0.0 110.65 167.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.58 -35.52 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.198 1.932 . . . . 0.0 115.388 168.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.84 -40.43 87.94 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -60.21 -45.31 93.62 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.64 -0.663 . . . . 0.0 111.049 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.58 -44.29 94.48 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.288 1.035 . . . . 0.0 112.164 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -59.19 -41.4 88.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.578 0.626 . . . . 0.0 112.05 171.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.3 m -60.24 -45.19 94.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.55 0.614 . . . . 0.0 111.161 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.41 -48.88 77.92 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.196 0.907 . . . . 0.0 112.185 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.6 mt -63.12 -38.46 91.28 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.78 -33.03 69.85 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.4 p -73.87 -12.47 60.68 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.34 7.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.02 -3.7 9.3 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 117.506 1.762 . . . . 0.0 117.506 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.98 -34.08 65.07 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 119.501 1.651 . . . . 0.0 115.226 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -88.27 77.45 8.22 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.062 1.411 . . . . 0.0 110.485 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -50.36 -35.3 27.36 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.826 1.65 . . . . 0.0 115.341 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.24 74.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.118 1.327 . . . . 0.0 112.249 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.39 -43.53 85.62 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.128 0.571 . . . . 0.0 111.35 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.07 -40.16 96.86 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.592 -0.692 . . . . 0.0 112.271 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.93 -50.12 73.54 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.262 1.025 . . . . 0.0 111.539 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -55.77 -45.4 78.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.067 0.947 . . . . 0.0 112.241 174.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.3 tp -61.98 -48.71 79.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.363 0.665 . . . . 0.0 112.064 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.73 -38.23 90.32 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.857 0.863 . . . . 0.0 112.514 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.12 -45.52 92.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.623 0.647 . . . . 0.0 112.058 170.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.62 -42.34 99.53 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.768 0.713 . . . . 0.0 112.186 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.83 -46.0 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.462 -0.774 . . . . 0.0 111.051 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.17 -39.55 94.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.776 0.716 . . . . 0.0 112.738 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -60.55 -47.66 85.21 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.739 0.816 . . . . 0.0 111.968 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -70.0 -34.33 73.19 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.75 -41.53 92.02 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.44 -0.787 . . . . 0.0 112.391 172.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.85 98.25 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.123 0.569 . . . . 0.0 111.781 172.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -63.58 -42.11 98.31 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.856 -0.528 . . . . 0.0 112.182 175.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.67 -48.51 79.3 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.564 0.62 . . . . 0.0 111.744 172.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.28 -30.07 71.28 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -69.28 -39.1 78.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.363 1.065 . . . . 0.0 112.432 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.2 -27.77 42.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.796 1.239 . . . . 0.0 113.337 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.62 61.03 54.4 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.635 1.974 . . . . 0.0 111.216 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.91 120.14 7.42 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.424 2.083 . . . . 0.0 110.315 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.44 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.292 1.437 . . . . 0.0 112.158 -169.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -80.1 160.39 25.78 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.174 0.59 . . . . 0.0 110.894 168.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.17 -19.88 64.9 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.11 174.7 41.71 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.048 1.309 . . . . 0.0 112.606 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.55 169.17 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.631 2.887 . . . . 0.0 112.906 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.69 -39.0 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.874 1.269 . . . . 0.0 111.785 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.71 161.83 28.75 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.888 1.675 . . . . 0.0 110.592 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.93 133.46 22.94 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.479 2.786 . . . . 0.0 113.098 168.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.89 -14.97 60.41 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.566 1.079 . . . . 0.0 115.062 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.2 143.45 37.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.95 1.375 . . . . 0.0 110.164 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.3 145.63 54.04 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.742 -0.599 . . . . 0.0 110.869 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -68.49 152.5 45.3 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.76 0.824 . . . . 0.0 111.615 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -72.25 131.64 84.91 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-O 118.898 -0.572 . . . . 0.0 109.814 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.49 140.23 43.17 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.062 1.841 . . . . 0.0 112.401 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -74.8 171.28 14.26 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.773 1.629 . . . . 0.0 111.891 163.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.46 -43.81 93.88 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 123.33 0.491 . . . . 0.0 113.035 168.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.3 p -68.71 -25.73 64.91 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -72.97 -41.44 64.38 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.034 -1.041 . . . . 0.0 111.78 172.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.69 -42.84 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.839 0.856 . . . . 0.0 110.761 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.82 -1.52 14.41 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 173.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.11 18.15 74.49 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.922 -1.111 . . . . 0.0 115.406 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.9 p -96.02 -19.31 19.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.067 1.433 . . . . 0.0 113.287 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.9 p -126.62 -1.69 6.75 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -103.25 150.38 23.78 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.164 0.986 . . . . 0.0 111.554 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.2 p -82.48 162.61 22.0 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.342 0.591 . . . . 0.0 110.781 169.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.6 tp -56.57 -39.54 73.66 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.501 -0.749 . . . . 0.0 111.541 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.45 -38.95 93.12 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.454 -0.779 . . . . 0.0 112.666 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -64.71 -42.69 95.09 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.612 -0.68 . . . . 0.0 111.988 171.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.58 -46.35 90.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.678 0.791 . . . . 0.0 112.097 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.64 -46.16 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.167 0.987 . . . . 0.0 110.312 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.62 -50.98 55.39 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.852 0.739 . . . . 0.0 112.876 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.35 -50.04 73.16 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 117.74 0.77 . . . . 0.0 112.532 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.6 64.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.1 p -111.83 8.32 20.44 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.677 1.191 . . . . 0.0 113.033 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.3 162.31 1.53 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.045 1.338 . . . . 0.0 111.451 165.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.64 103.32 48.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.046 0.938 . . . . 0.0 110.778 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.1 163.81 89.21 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.466 0.845 . . . . 0.0 111.713 -6.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -49.93 141.38 29.26 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.199 2.6 . . . . 0.0 114.186 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.25 96.42 2.51 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 163.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.02 54.59 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.255 2.637 . . . . 0.0 112.852 -152.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.52 -35.11 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -61.91 -46.57 93.85 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.595 0.634 . . . . 0.0 113.031 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -69.88 -36.69 75.66 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.281 -1.129 . . . . 0.0 112.636 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.3 mt -62.94 -44.66 99.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.757 -0.589 . . . . 0.0 109.902 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -65.81 -40.37 91.78 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.265 -0.897 . . . . 0.0 112.497 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -55.89 -42.04 75.37 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.472 -0.767 . . . . 0.0 112.232 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.7 -45.22 81.93 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.892 0.769 . . . . 0.0 112.134 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.25 -40.66 86.3 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.242 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.55 -47.05 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.041 0.536 . . . . 0.0 110.283 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.33 -37.27 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.672 1.189 . . . . 0.0 112.261 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.86 -42.76 98.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.027 0.83 . . . . 0.0 111.235 171.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.49 -45.26 90.84 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.863 0.744 . . . . 0.0 113.176 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.41 -42.34 86.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.039 0.919 . . . . 0.0 111.112 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -55.34 -50.2 70.26 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.815 0.846 . . . . 0.0 112.473 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -55.95 -43.16 77.19 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.865 0.757 . . . . 0.0 111.971 175.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.44 -48.06 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.338 0.655 . . . . 0.0 111.448 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.52 -32.69 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.916 1.235 . . . . 0.0 112.952 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.3 -43.91 95.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.901 0.88 . . . . 0.0 111.498 171.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.7 ttp -76.99 -37.1 55.8 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.66 1.584 . . . . 0.0 113.48 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 C--O 1.252 1.192 0 C-N-CA 128.377 2.671 . . . . 0.0 114.48 -172.057 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.82 135.0 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.467 1.107 . . . . 0.0 108.402 163.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.92 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.686 170.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.62 116.68 32.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.57 0.748 . . . . 0.0 109.18 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.47 178.07 6.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.58 0.705 . . . . 0.0 112.451 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.95 -26.45 68.83 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.59 -2.19 57.9 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.776 1.231 . . . . 0.0 113.0 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.02 85.69 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.76 128.28 35.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.823 1.311 . . . . 0.0 109.745 174.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.89 125.62 29.62 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.99 123.4 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.07 1.348 . . . . 0.0 108.629 -174.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.7 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.71 141.15 48.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.5 1.92 . . . . 0.0 107.929 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 21.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.998 0.817 . . . . 0.0 111.191 170.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.53 136.84 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.607 -0.683 . . . . 0.0 111.544 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.64 130.03 93.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.059 0.544 . . . . 0.0 111.169 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.09 -34.5 68.53 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.86 2.373 . . . . 0.0 113.575 167.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.53 -38.04 86.32 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.508 -0.745 . . . . 0.0 112.562 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.91 -44.31 97.34 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.767 0.712 . . . . 0.0 111.377 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.53 -44.33 94.55 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.328 0.513 . . . . 0.0 112.321 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.17 -47.33 85.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.136 0.574 . . . . 0.0 111.359 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.35 95.19 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.644 0.778 . . . . 0.0 111.883 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.7 t-105 -60.02 -47.42 85.93 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.855 0.862 . . . . 0.0 112.763 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.68 -55.0 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.465 0.575 . . . . 0.0 110.273 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.04 -37.82 77.89 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.396 1.079 . . . . 0.0 113.243 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.41 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.33 -51.9 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.031 1.332 . . . . 0.0 111.329 170.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.65 -35.88 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.435 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -58.98 -23.1 61.44 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.707 1.139 . . . . 0.0 114.038 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.73 -25.94 11.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -135.86 16.3 3.31 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -166.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.53 -37.68 2.57 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -118.25 14.73 13.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.392 1.077 . . . . 0.0 113.149 -172.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -113.93 152.94 46.13 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 111.566 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.85 -30.75 59.21 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.257 2.638 . . . . 0.0 115.276 -172.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.05 -20.67 64.2 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.82 -31.97 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.376 0.989 . . . . 0.0 112.528 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.1 mt -71.34 -55.08 6.35 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.943 1.297 . . . . 0.0 112.961 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.83 -30.12 49.72 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.688 1.639 . . . . 0.0 112.661 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.41 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.6 mtm -69.06 -40.22 78.64 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.86 1.209 . . . . 0.0 112.623 172.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.23 -46.53 82.87 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.816 0.735 . . . . 0.0 111.581 169.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.7 m -61.01 -44.52 97.3 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 175.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.82 -32.09 71.47 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.255 1.022 . . . . 0.0 113.207 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.29 4.44 53.47 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.39 1.476 . . . . 0.0 113.522 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.4 p -132.98 22.83 4.18 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.62 120.3 6.0 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.47 -1.394 . . . . 0.0 111.491 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.54 60.16 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.42 130.84 47.06 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.565 1.682 . . . . 0.0 112.499 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.39 159.69 84.21 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.714 0.806 . . . . 0.0 110.661 167.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.28 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -60.4 -45.29 94.11 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.663 -0.648 . . . . 0.0 111.025 172.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.51 -44.34 94.57 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 112.103 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -59.11 -41.58 88.5 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.635 0.652 . . . . 0.0 111.994 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.13 -45.31 93.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.594 0.633 . . . . 0.0 111.084 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.43 -48.81 78.15 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.209 0.913 . . . . 0.0 112.188 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.18 -38.27 90.53 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.98 -33.63 70.9 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -73.29 -12.76 60.96 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.15 9.21 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.23 -5.51 8.22 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 117.328 1.691 . . . . 0.0 117.328 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.36 -31.3 59.55 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 119.336 1.568 . . . . 0.0 115.563 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -93.61 78.12 4.32 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.003 1.402 . . . . 0.0 110.652 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.79 -35.78 33.68 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -173.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.05 -41.02 74.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.123 1.328 . . . . 0.0 112.246 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.5 -43.5 85.14 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.164 0.585 . . . . 0.0 111.371 173.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.7 tpp -63.06 -40.14 96.82 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.521 -0.737 . . . . 0.0 112.263 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.99 -49.93 74.24 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.235 1.014 . . . . 0.0 111.521 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.02 -45.47 79.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.091 0.956 . . . . 0.0 112.188 174.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -61.91 -48.72 79.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.277 0.631 . . . . 0.0 112.088 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.7 -38.28 90.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 0.0 112.479 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.99 -45.49 92.54 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 112.02 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.6 m -62.61 -42.38 99.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.848 0.749 . . . . 0.0 112.149 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.9 -46.04 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 121.472 -0.768 . . . . 0.0 111.097 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.49 94.13 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.876 0.762 . . . . 0.0 112.684 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -60.78 -47.39 86.53 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.741 0.816 . . . . 0.0 111.94 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.13 -34.35 72.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.53 91.62 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.484 -0.76 . . . . 0.0 112.322 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.11 98.61 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.224 0.61 . . . . 0.0 111.781 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.17 -42.11 99.33 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.84 -0.538 . . . . 0.0 112.207 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -57.88 -48.55 79.52 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.673 0.67 . . . . 0.0 111.694 173.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.01 -30.35 71.53 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.11 -39.06 79.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.354 1.062 . . . . 0.0 112.482 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.79 60.98 53.75 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.85 120.1 7.36 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.451 2.101 . . . . 0.0 110.341 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.29 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.351 1.461 . . . . 0.0 112.142 -169.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.0 160.47 25.88 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.053 0.541 . . . . 0.0 110.903 168.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.91 65.0 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.74 41.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.096 1.332 . . . . 0.0 112.631 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.56 169.2 14.73 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.601 2.867 . . . . 0.0 112.917 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.66 -39.2 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.904 1.282 . . . . 0.0 111.753 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.61 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 110.585 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -47.94 133.42 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.479 2.786 . . . . 0.0 113.106 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.93 -14.96 60.48 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.567 1.08 . . . . 0.0 115.037 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.13 143.32 37.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.95 1.375 . . . . 0.0 110.214 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.11 145.48 54.35 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.654 -0.654 . . . . 0.0 110.843 168.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.47 152.82 44.86 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.27 131.69 84.83 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.916 -0.564 . . . . 0.0 109.872 170.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.35 140.36 44.03 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.107 1.871 . . . . 0.0 112.435 -177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -75.14 171.65 13.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.705 1.602 . . . . 0.0 111.805 163.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.6 -43.78 94.15 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.916 -0.49 . . . . 0.0 113.035 168.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.89 -25.78 64.78 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.65 65.03 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.989 -1.069 . . . . 0.0 111.749 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.65 -42.7 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.686 0.794 . . . . 0.0 110.812 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.06 -1.26 14.09 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 173.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.23 74.26 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 120.865 -1.147 . . . . 0.0 115.444 174.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.5 19.21 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.079 1.439 . . . . 0.0 113.263 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 p -126.13 -1.28 7.08 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.76 149.84 24.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.08 0.952 . . . . 0.0 111.789 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.5 p -81.81 162.32 22.91 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.288 0.566 . . . . 0.0 110.73 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.81 -39.37 74.04 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.529 -0.732 . . . . 0.0 111.438 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.5 -38.99 93.24 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.576 -0.702 . . . . 0.0 112.675 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.6 95.45 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.573 -0.705 . . . . 0.0 112.085 171.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.77 -46.47 90.36 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.626 0.77 . . . . 0.0 112.092 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.33 -46.35 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.126 0.971 . . . . 0.0 110.35 172.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.03 54.41 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.753 0.692 . . . . 0.0 112.945 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.79 0.795 . . . . 0.0 112.485 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.9 8.36 20.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.66 1.184 . . . . 0.0 113.033 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.46 162.31 1.62 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.029 1.332 . . . . 0.0 111.361 165.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.34 48.99 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.035 0.934 . . . . 0.0 110.811 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.14 163.78 89.25 Favored 'Cis proline' 0 CA--C 1.543 0.951 0 CA-C-N 119.466 0.845 . . . . 0.0 111.735 -6.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -49.9 141.39 29.0 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.205 2.604 . . . . 0.0 114.171 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.19 96.38 2.46 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 163.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.96 54.56 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.27 2.647 . . . . 0.0 112.86 -152.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.57 -34.83 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.39 -46.26 94.22 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.638 0.654 . . . . 0.0 112.967 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.83 -36.86 75.94 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.91 -44.56 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.732 -0.605 . . . . 0.0 110.004 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.37 91.6 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.307 -0.871 . . . . 0.0 112.557 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.83 -41.97 75.03 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.489 -0.757 . . . . 0.0 112.287 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -56.71 -45.27 81.94 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.889 0.768 . . . . 0.0 112.08 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.32 -40.46 85.98 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.236 0.614 . . . . 0.0 112.315 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.7 -46.98 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.044 0.538 . . . . 0.0 110.34 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.23 -37.39 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.686 1.195 . . . . 0.0 112.3 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.81 98.3 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.011 0.823 . . . . 0.0 111.223 171.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.49 -45.19 91.19 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.796 0.712 . . . . 0.0 113.26 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.42 -42.26 86.87 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.003 0.901 . . . . 0.0 111.113 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.45 -50.22 70.41 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.772 0.829 . . . . 0.0 112.453 173.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.18 76.94 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.856 0.753 . . . . 0.0 111.973 175.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.48 -48.01 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.377 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.47 -32.84 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.988 1.267 . . . . 0.0 112.945 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.96 -43.23 95.18 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.877 0.871 . . . . 0.0 111.562 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.8 ttp -78.41 -36.71 45.37 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.72 1.608 . . . . 0.0 113.619 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.3 t80 . . . . . 0 C--O 1.252 1.219 0 C-N-CA 128.423 2.689 . . . . 0.0 114.629 -171.91 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.93 135.02 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.453 1.101 . . . . 0.0 108.425 163.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.92 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.62 116.7 32.52 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.521 0.729 . . . . 0.0 109.201 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.41 178.04 6.88 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.598 0.713 . . . . 0.0 112.441 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.94 -26.5 68.85 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.13 57.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.97 2.99 85.8 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.458 1.028 . . . . 0.0 114.12 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.73 128.3 35.75 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.801 1.301 . . . . 0.0 109.683 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.6 29.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 168.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -126.0 123.39 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.046 1.338 . . . . 0.0 108.659 -174.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.65 141.14 48.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.491 1.916 . . . . 0.0 107.914 169.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 21.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.015 0.825 . . . . 0.0 111.191 170.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.47 136.83 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.601 -0.687 . . . . 0.0 111.58 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.7 130.06 93.18 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.11 0.564 . . . . 0.0 111.088 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.09 -34.54 68.73 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.86 2.373 . . . . 0.0 113.575 167.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.43 -38.03 86.5 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.526 -0.734 . . . . 0.0 112.622 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.94 -44.32 97.43 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.691 0.678 . . . . 0.0 111.373 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.55 -44.36 94.39 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.251 0.478 . . . . 0.0 112.266 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.19 -47.21 86.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.105 0.562 . . . . 0.0 111.432 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.14 95.91 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.683 0.793 . . . . 0.0 111.879 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.19 -47.23 86.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.861 0.864 . . . . 0.0 112.766 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.8 -54.44 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.397 0.544 . . . . 0.0 110.369 174.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.71 -37.34 78.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.347 1.059 . . . . 0.0 113.2 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.54 -52.15 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.058 1.343 . . . . 0.0 111.288 170.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.75 -35.9 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.406 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -58.7 -23.86 60.34 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.37 -25.65 11.35 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.93 16.12 3.3 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -166.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.19 -38.22 2.41 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -117.56 13.97 14.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.415 1.086 . . . . 0.0 113.105 -172.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.5 p -113.2 152.97 45.54 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.027 0.931 . . . . 0.0 111.582 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.9 -30.76 59.7 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.277 2.651 . . . . 0.0 115.229 -172.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.02 -20.69 64.19 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.85 -31.89 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.431 1.014 . . . . 0.0 112.548 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.38 -55.07 6.31 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.957 1.303 . . . . 0.0 113.011 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.88 -30.08 49.31 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.653 1.626 . . . . 0.0 112.641 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.403 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.06 -40.16 78.67 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.901 1.228 . . . . 0.0 112.673 172.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -57.27 -46.51 83.01 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.758 0.708 . . . . 0.0 111.583 169.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -61.05 -44.48 97.33 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.86 -31.98 71.42 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.284 1.034 . . . . 0.0 113.292 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.34 4.44 53.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.344 1.458 . . . . 0.0 113.508 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.6 p -132.91 22.75 4.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.54 120.31 5.98 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.474 -1.391 . . . . 0.0 111.47 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.66 60.1 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.362 0.905 . . . . 0.0 115.362 -177.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.51 130.82 46.87 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.554 1.677 . . . . 0.0 112.53 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.33 159.66 84.35 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.718 167.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.61 -35.31 37.27 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.15 1.9 . . . . 0.0 115.454 168.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.16 -40.19 86.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.34 -45.3 93.95 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.6 -0.687 . . . . 0.0 111.1 172.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.52 -44.37 94.44 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.364 1.066 . . . . 0.0 112.134 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.13 -41.51 88.42 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.658 -0.651 . . . . 0.0 112.031 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.18 -45.35 93.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.622 0.646 . . . . 0.0 111.084 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.36 -48.87 77.9 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.179 0.9 . . . . 0.0 112.19 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -63.15 -38.44 91.17 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.95 -33.36 70.53 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.0 p -73.67 -12.5 60.75 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.25 7.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.87 -4.49 5.86 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.82 -33.19 55.8 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 119.249 1.524 . . . . 0.0 115.425 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -91.23 78.63 5.78 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.84 1.32 . . . . 0.0 110.613 171.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.16 -35.86 38.06 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.39 -41.1 73.48 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 120.107 1.322 . . . . 0.0 112.299 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.28 -43.61 85.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.202 0.601 . . . . 0.0 111.335 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.05 -40.1 96.71 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.514 -0.741 . . . . 0.0 112.255 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -50.02 73.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.251 1.02 . . . . 0.0 111.539 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -56.0 -45.39 79.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.97 -48.72 79.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.338 0.655 . . . . 0.0 112.055 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.75 -38.27 90.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.411 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.95 -45.48 92.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.735 0.698 . . . . 0.0 112.046 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.64 -42.37 99.55 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.149 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.84 -46.07 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.507 -0.745 . . . . 0.0 111.093 174.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.19 -39.33 93.76 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.816 0.734 . . . . 0.0 112.738 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.89 -47.4 86.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.745 0.818 . . . . 0.0 111.964 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.16 -34.33 72.87 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.48 91.66 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.481 -0.762 . . . . 0.0 112.355 173.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.16 98.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.2 0.6 . . . . 0.0 111.787 172.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.03 -42.28 99.74 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.888 -0.508 . . . . 0.0 112.166 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.676 0.671 . . . . 0.0 111.71 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.07 -30.2 71.41 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.22 -39.1 78.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.397 1.079 . . . . 0.0 112.45 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.0 53.92 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.88 120.08 7.34 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.479 2.119 . . . . 0.0 110.312 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.26 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.35 1.46 . . . . 0.0 112.179 -169.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.98 160.47 25.9 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.079 0.552 . . . . 0.0 110.903 168.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.98 65.01 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.77 41.6 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.053 1.311 . . . . 0.0 112.647 174.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.62 169.16 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.944 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.61 -39.2 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.91 1.284 . . . . 0.0 111.799 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.47 161.94 28.51 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.884 1.674 . . . . 0.0 110.587 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.94 133.42 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.479 2.786 . . . . 0.0 113.106 168.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.98 -15.08 60.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.567 1.08 . . . . 0.0 115.01 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.6 54.12 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.694 -0.629 . . . . 0.0 110.824 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.48 152.7 45.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.765 0.826 . . . . 0.0 111.626 171.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -72.25 131.7 84.85 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.912 -0.565 . . . . 0.0 109.835 170.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.38 140.43 44.06 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.074 1.849 . . . . 0.0 112.442 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -75.1 171.61 13.83 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.763 1.625 . . . . 0.0 111.871 163.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.87 94.1 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.895 -0.503 . . . . 0.0 113.035 168.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.0 p -68.81 -25.68 64.8 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.82 -41.6 64.72 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.03 -1.044 . . . . 0.0 111.733 171.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.67 -42.71 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.742 0.817 . . . . 0.0 110.787 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.23 13.99 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.98 18.11 74.21 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.626 1.107 . . . . 0.0 115.413 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.21 -19.36 19.39 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.141 1.471 . . . . 0.0 113.312 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.25 -1.52 6.99 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.56 150.01 24.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.063 0.945 . . . . 0.0 111.773 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.9 p -82.01 162.3 22.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.311 0.577 . . . . 0.0 110.806 169.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.66 -39.45 73.76 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.431 -0.793 . . . . 0.0 111.427 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.49 -38.93 93.03 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.533 -0.729 . . . . 0.0 112.701 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -64.67 -42.75 95.15 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 111.997 171.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.6 -46.41 90.36 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.575 0.75 . . . . 0.0 112.152 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.47 -46.29 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.106 0.962 . . . . 0.0 110.338 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.1 54.01 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 0.0 112.869 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.07 73.19 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.512 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.95 8.42 20.29 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.6 1.16 . . . . 0.0 113.046 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.39 162.28 1.6 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.991 1.316 . . . . 0.0 111.403 165.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.54 103.37 48.97 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.035 0.934 . . . . 0.0 110.792 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.14 163.87 89.05 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.509 0.86 . . . . 0.0 111.676 -6.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -50.04 141.36 30.06 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 0.0 114.205 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.11 96.41 2.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.97 54.6 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.54 -34.89 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.24 94.26 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.633 0.652 . . . . 0.0 112.999 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.8 -36.87 76.02 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.348 -1.09 . . . . 0.0 112.723 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.92 -44.56 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.732 -0.605 . . . . 0.0 109.987 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.89 -40.39 91.53 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.307 -0.871 . . . . 0.0 112.521 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.83 -41.98 75.06 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.431 -0.793 . . . . 0.0 112.259 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.74 -45.23 82.12 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.956 0.798 . . . . 0.0 112.044 174.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.3 -40.57 86.06 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.257 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.53 -47.22 93.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.065 0.546 . . . . 0.0 110.295 174.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.09 -37.39 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.68 1.192 . . . . 0.0 112.3 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.78 98.35 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.011 0.823 . . . . 0.0 111.224 171.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.07 91.47 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.844 0.735 . . . . 0.0 113.252 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.35 -42.42 86.86 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.988 0.894 . . . . 0.0 111.076 173.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.18 70.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.9 -43.23 77.07 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.83 0.741 . . . . 0.0 111.975 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.51 -47.79 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.43 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.56 -32.91 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.963 1.256 . . . . 0.0 112.911 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.23 -44.79 94.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.933 0.893 . . . . 0.0 111.487 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.2 ttp -75.42 -36.34 60.81 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.631 1.573 . . . . 0.0 113.442 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.252 1.196 0 C-N-CA 128.394 2.678 . . . . 0.0 114.54 -172.815 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.009 0.35 . . . . 0.0 113.009 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.76 135.02 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.472 1.109 . . . . 0.0 108.436 163.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.96 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.72 116.74 32.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.501 0.72 . . . . 0.0 109.195 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.452 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.89 -26.46 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -173.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.19 57.93 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.809 1.244 . . . . 0.0 112.988 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.04 2.94 85.67 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.504 1.05 . . . . 0.0 114.103 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.64 128.29 35.68 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.866 1.333 . . . . 0.0 109.745 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.61 29.61 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 168.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.0 t -125.97 123.34 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.045 1.338 . . . . 0.0 108.723 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.5 139.73 38.64 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.512 0.672 . . . . 0.0 111.206 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.76 141.17 48.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.477 1.911 . . . . 0.0 107.897 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.38 20.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.804 . . . . 0.0 111.238 170.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.5 136.79 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.611 -0.681 . . . . 0.0 111.591 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.64 130.01 93.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 123.114 0.566 . . . . 0.0 111.151 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.887 2.391 . . . . 0.0 113.575 167.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.4 -38.09 86.69 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 112.579 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.0 -44.28 97.65 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.687 0.676 . . . . 0.0 111.347 171.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.55 -44.23 94.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.328 0.513 . . . . 0.0 112.309 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.28 -47.28 85.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.124 0.569 . . . . 0.0 111.392 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.2 95.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.658 0.783 . . . . 0.0 111.9 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.17 -47.23 86.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.809 0.844 . . . . 0.0 112.77 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.76 -54.52 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.455 0.57 . . . . 0.0 110.397 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.59 -37.44 78.54 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.354 1.062 . . . . 0.0 113.191 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.405 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.59 -52.1 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.026 1.33 . . . . 0.0 111.295 170.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.64 -35.92 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.915 0.486 . . . . 0.0 111.399 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -58.72 -23.95 60.63 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.21 -25.73 11.39 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.88 16.13 3.31 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.16 -38.38 2.44 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -117.48 14.1 14.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.404 1.081 . . . . 0.0 113.115 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.9 p -113.18 153.02 45.54 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 123.952 0.901 . . . . 0.0 111.565 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.89 -30.66 59.12 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.289 2.659 . . . . 0.0 115.27 -172.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.12 -20.74 64.37 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.73 -32.01 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.387 0.994 . . . . 0.0 112.539 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.33 -55.05 6.39 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.943 1.297 . . . . 0.0 113.011 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.89 -30.08 49.23 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.685 1.637 . . . . 0.0 112.655 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.405 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.08 -40.21 78.58 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.876 1.216 . . . . 0.0 112.598 172.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -57.28 -46.52 83.03 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.776 0.716 . . . . 0.0 111.522 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.2 m -61.11 -44.4 97.4 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.9 -32.02 71.5 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.268 1.027 . . . . 0.0 113.27 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.23 4.43 53.55 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.4 1.48 . . . . 0.0 113.536 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -133.03 22.8 4.16 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.62 120.34 6.06 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.491 168.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.69 60.06 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.9 47.19 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.565 1.683 . . . . 0.0 112.481 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.37 159.66 84.33 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 123.748 0.819 . . . . 0.0 110.705 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -49.54 -35.48 37.11 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.3 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.36 -45.26 94.12 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.049 172.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.54 -44.37 94.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.386 1.074 . . . . 0.0 112.134 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -59.13 -41.51 88.42 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.658 -0.651 . . . . 0.0 112.031 171.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.5 m -60.23 -45.28 93.78 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.622 0.646 . . . . 0.0 111.073 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.44 -48.85 78.06 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.254 0.934 . . . . 0.0 112.191 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.13 -38.45 91.24 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.87 -33.43 70.48 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.1 p -73.66 -12.52 60.76 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.4 m -122.2 7.84 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.93 -4.54 6.0 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 117.193 1.637 . . . . 0.0 117.193 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.83 -33.22 55.93 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.257 1.528 . . . . 0.0 115.404 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -91.18 78.49 5.83 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.875 1.338 . . . . 0.0 110.605 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.06 -35.86 36.88 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.35 -41.09 73.61 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.094 1.315 . . . . 0.0 112.242 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.54 85.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.174 0.59 . . . . 0.0 111.311 173.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.05 -40.13 96.77 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.514 -0.741 . . . . 0.0 112.265 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -49.92 74.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.198 0.999 . . . . 0.0 111.58 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.99 -45.52 78.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.091 0.956 . . . . 0.0 112.199 174.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.2 tp -61.87 -48.81 78.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.326 0.65 . . . . 0.0 112.055 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.63 -38.28 90.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.842 0.857 . . . . 0.0 112.49 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.99 -45.55 92.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 111.985 170.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.3 m -62.51 -42.45 99.51 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.87 0.759 . . . . 0.0 112.155 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.86 -46.08 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.478 -0.764 . . . . 0.0 111.059 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.18 -39.37 93.85 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.858 0.754 . . . . 0.0 112.752 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.81 -47.48 86.13 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.925 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.09 -34.32 73.0 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.582 -0.699 . . . . 0.0 112.85 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.69 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.408 -0.808 . . . . 0.0 112.361 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.09 98.7 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.215 0.606 . . . . 0.0 111.751 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.25 99.58 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 0.0 112.218 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.77 -48.57 79.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.737 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.05 -30.23 71.43 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.24 -39.11 78.71 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.337 1.055 . . . . 0.0 112.482 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.24 -27.58 42.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.76 1.224 . . . . 0.0 113.327 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.76 61.03 54.17 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.646 1.978 . . . . 0.0 111.247 -174.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.92 120.14 7.41 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.509 2.139 . . . . 0.0 110.261 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.42 136.3 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.298 1.439 . . . . 0.0 112.108 -169.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.97 160.37 25.95 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.116 0.567 . . . . 0.0 110.922 168.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.97 65.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 174.77 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.048 1.309 . . . . 0.0 112.656 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 169.16 14.85 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.66 2.907 . . . . 0.0 112.896 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.64 -39.18 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.926 1.29 . . . . 0.0 111.762 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.55 161.87 28.65 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.858 1.663 . . . . 0.0 110.561 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.93 133.44 22.94 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.403 2.735 . . . . 0.0 113.141 168.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.08 60.29 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.562 1.077 . . . . 0.0 114.978 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.22 145.5 54.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.694 -0.629 . . . . 0.0 110.815 168.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -68.54 152.83 44.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.658 0.783 . . . . 0.0 111.668 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.18 131.64 85.03 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.83 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.37 140.44 44.13 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.076 1.851 . . . . 0.0 112.426 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -75.12 171.58 13.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.74 1.616 . . . . 0.0 111.906 163.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.51 -43.87 93.96 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.971 -0.455 . . . . 0.0 113.049 168.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.85 -25.7 64.78 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.68 64.88 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.068 -1.02 . . . . 0.0 111.727 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.63 -42.69 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 110.817 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.29 14.23 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.16 74.31 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.605 1.098 . . . . 0.0 115.447 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.31 -19.46 19.24 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.074 1.437 . . . . 0.0 113.263 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 p -126.14 -1.34 7.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.86 149.81 24.73 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.095 0.958 . . . . 0.0 111.752 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.6 p -81.73 162.27 23.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.303 0.573 . . . . 0.0 110.799 170.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.72 -39.38 73.81 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.466 -0.771 . . . . 0.0 111.445 169.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.58 -38.91 92.91 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.554 -0.716 . . . . 0.0 112.706 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.57 -42.79 95.41 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.542 -0.724 . . . . 0.0 112.011 171.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.62 -46.43 90.3 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.68 0.792 . . . . 0.0 112.144 176.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.46 -46.35 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.106 0.962 . . . . 0.0 110.301 172.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.39 -51.11 53.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.872 0.748 . . . . 0.0 112.882 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 0.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.62 -18.56 64.33 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.86 8.42 20.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.624 1.17 . . . . 0.0 113.064 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.41 162.3 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.952 1.301 . . . . 0.0 111.461 165.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.39 48.92 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.035 0.934 . . . . 0.0 110.811 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.07 163.84 89.16 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.429 0.832 . . . . 0.0 111.701 -6.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -50.04 141.35 30.07 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 0.0 114.205 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.13 96.48 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.05 54.58 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.274 2.649 . . . . 0.0 112.827 -152.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.59 -34.77 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.48 -46.2 94.31 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.637 0.653 . . . . 0.0 112.996 173.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.8 -36.92 76.07 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.293 -1.122 . . . . 0.0 112.665 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.0 mt -62.93 -44.57 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.808 -0.557 . . . . 0.0 109.921 174.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.42 91.66 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.303 -0.873 . . . . 0.0 112.489 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.84 -41.99 75.1 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.294 173.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -56.7 -45.24 81.95 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.926 0.784 . . . . 0.0 112.071 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -67.34 -40.48 85.9 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.266 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.62 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.044 0.538 . . . . 0.0 110.291 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.03 -37.35 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.683 1.193 . . . . 0.0 112.355 177.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.77 98.4 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.03 0.832 . . . . 0.0 111.224 171.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.09 91.41 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.796 0.712 . . . . 0.0 113.242 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.38 -42.35 86.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 117.986 0.893 . . . . 0.0 111.097 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.55 -50.17 70.73 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.798 0.839 . . . . 0.0 112.445 173.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.26 77.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.86 0.755 . . . . 0.0 111.991 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.4 -47.9 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.335 0.654 . . . . 0.0 111.44 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.92 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.924 1.238 . . . . 0.0 112.9 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.17 -44.54 94.94 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.884 0.874 . . . . 0.0 111.473 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.78 -35.86 59.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.655 1.582 . . . . 0.0 113.468 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 128.39 2.676 . . . . 0.0 114.59 -172.737 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.998 0.345 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.9 135.09 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.457 1.103 . . . . 0.0 108.402 163.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.13 154.83 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.063 1.345 . . . . 0.0 109.627 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.7 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.9 -26.45 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.61 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.825 1.25 . . . . 0.0 113.03 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.02 85.77 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.5 1.048 . . . . 0.0 114.144 -175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.7 128.22 35.43 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.801 1.301 . . . . 0.0 109.745 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.63 29.63 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 168.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -125.95 123.36 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.107 1.363 . . . . 0.0 108.669 -174.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.56 139.71 38.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.543 0.687 . . . . 0.0 111.191 170.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.72 141.11 48.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.465 1.906 . . . . 0.0 107.929 169.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.36 21.02 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.254 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.5 136.89 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.492 0.663 . . . . 0.0 111.572 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.69 129.96 93.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.068 0.547 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.01 -34.56 68.05 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.868 2.378 . . . . 0.0 113.56 167.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.41 -38.07 86.64 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.451 -0.78 . . . . 0.0 112.587 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.97 -44.3 97.55 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.779 0.718 . . . . 0.0 111.377 171.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.54 -44.37 94.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.29 0.496 . . . . 0.0 112.244 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.22 -47.25 86.04 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.115 0.566 . . . . 0.0 111.37 176.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.24 95.61 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.651 0.78 . . . . 0.0 111.897 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.24 -47.01 87.79 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.771 0.829 . . . . 0.0 112.812 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.78 -54.55 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.439 0.563 . . . . 0.0 110.344 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.66 -37.36 78.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.343 1.057 . . . . 0.0 113.219 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.4 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.38 -52.22 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.138 1.375 . . . . 0.0 111.253 170.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.82 -36.02 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.996 0.518 . . . . 0.0 111.407 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.66 -23.89 60.13 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.3 -25.62 11.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.98 16.08 3.29 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -165.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.37 -38.13 2.59 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -117.44 13.8 14.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.345 1.058 . . . . 0.0 113.127 -172.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -112.99 153.0 45.38 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.96 0.904 . . . . 0.0 111.566 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.88 -30.74 59.39 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.311 2.674 . . . . 0.0 115.218 -172.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.02 -20.74 64.25 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.88 -31.88 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.414 1.006 . . . . 0.0 112.488 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.41 -55.01 6.32 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.957 1.303 . . . . 0.0 112.989 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.93 -30.08 48.9 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 121.678 1.635 . . . . 0.0 112.641 174.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.4 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.06 -40.21 78.65 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.901 1.228 . . . . 0.0 112.673 172.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.27 -46.47 83.05 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.765 0.711 . . . . 0.0 111.569 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -61.09 -44.44 97.36 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -32.0 71.51 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.268 1.027 . . . . 0.0 113.257 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.3 4.48 53.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.325 1.45 . . . . 0.0 113.511 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -133.03 22.8 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.54 120.31 5.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.478 -1.389 . . . . 0.0 111.468 168.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.63 60.04 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.46 130.88 47.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.573 1.687 . . . . 0.0 112.482 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.35 159.66 84.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.753 0.821 . . . . 0.0 110.666 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.22 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.41 -45.22 94.38 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.66 -0.65 . . . . 0.0 111.108 172.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.57 -44.26 94.62 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 112.163 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.3 -41.35 88.78 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.696 -0.628 . . . . 0.0 111.989 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.26 -45.33 93.68 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.629 0.65 . . . . 0.0 111.091 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.33 -48.91 77.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.205 0.911 . . . . 0.0 112.179 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.11 -38.49 91.38 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.91 -33.56 70.69 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 p -73.57 -12.46 60.77 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.34 7.73 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.57 -4.8 5.73 Favored Glycine 0 CA--C 1.541 1.702 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.71 -33.32 55.25 Favored Glycine 0 CA--C 1.537 1.433 0 CA-C-N 119.183 1.491 . . . . 0.0 115.462 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -90.81 78.77 6.06 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.836 1.318 . . . . 0.0 110.634 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.32 -35.94 40.43 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.49 -41.2 73.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.094 1.315 . . . . 0.0 112.293 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.57 86.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.155 0.582 . . . . 0.0 111.337 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.13 -40.04 96.44 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.555 -0.716 . . . . 0.0 112.224 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.99 -50.0 74.03 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.056 -1.028 . . . . 0.0 111.521 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.0 -45.42 79.05 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 tp -61.88 -48.75 79.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.277 0.631 . . . . 0.0 112.105 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.77 -38.21 90.26 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.836 0.854 . . . . 0.0 112.463 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.97 -45.48 92.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.699 0.681 . . . . 0.0 112.075 170.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.65 -42.37 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.118 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.85 -46.14 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.477 -0.765 . . . . 0.0 111.03 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.09 -39.43 94.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.842 0.746 . . . . 0.0 112.757 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.75 -47.46 86.2 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.703 0.801 . . . . 0.0 111.975 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.09 -34.38 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.87 -41.42 91.63 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.467 -0.771 . . . . 0.0 112.341 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.08 98.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.184 0.594 . . . . 0.0 111.772 172.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.14 -42.21 99.44 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.924 -0.485 . . . . 0.0 112.135 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.84 -48.58 79.38 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.682 0.674 . . . . 0.0 111.699 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.04 -30.19 71.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.16 -39.18 78.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.361 1.065 . . . . 0.0 112.499 173.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.61 42.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 113.29 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.76 61.03 54.13 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.696 1.998 . . . . 0.0 111.225 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.9 120.16 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.481 2.12 . . . . 0.0 110.277 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.46 136.23 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.318 1.447 . . . . 0.0 112.121 -169.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.92 160.49 25.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.05 0.54 . . . . 0.0 110.903 168.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.9 64.99 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.98 174.71 41.62 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.099 1.333 . . . . 0.0 112.653 174.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.63 169.14 14.96 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.658 2.905 . . . . 0.0 112.915 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.6 -39.23 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.94 1.296 . . . . 0.0 111.762 -175.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.44 161.93 28.53 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.817 1.647 . . . . 0.0 110.573 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.95 133.47 23.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.441 2.761 . . . . 0.0 113.132 168.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.99 60.33 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.613 1.101 . . . . 0.0 115.056 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.36 37.46 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.946 1.373 . . . . 0.0 110.198 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.11 145.54 54.29 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.693 -0.63 . . . . 0.0 110.858 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.51 152.7 45.02 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.728 0.811 . . . . 0.0 111.653 171.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.21 131.66 84.96 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.34 140.38 44.09 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.134 1.889 . . . . 0.0 112.416 -177.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -75.11 171.66 13.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.709 1.604 . . . . 0.0 111.89 163.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.91 94.07 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.895 -0.503 . . . . 0.0 112.991 168.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.6 p -68.78 -25.77 64.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.76 -41.59 64.92 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.027 -1.046 . . . . 0.0 111.778 171.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.65 -42.69 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.718 0.807 . . . . 0.0 110.793 173.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.26 13.93 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 173.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.91 18.16 74.12 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.922 -1.111 . . . . 0.0 115.477 175.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.3 -19.35 19.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.131 1.466 . . . . 0.0 113.305 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.0 p -126.27 -1.51 6.98 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.6 149.97 24.41 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.103 0.961 . . . . 0.0 111.824 173.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.6 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.318 0.58 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.81 -39.44 74.16 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.418 -0.801 . . . . 0.0 111.372 169.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.5 -38.93 93.03 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.576 -0.702 . . . . 0.0 112.685 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.8 95.31 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.602 -0.686 . . . . 0.0 112.008 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.61 -46.39 90.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.648 0.779 . . . . 0.0 112.097 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.35 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.301 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.05 54.33 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.85 0.738 . . . . 0.0 112.866 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.14 72.91 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.828 0.814 . . . . 0.0 112.517 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.62 -18.48 64.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.4 p -111.88 8.36 20.39 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.688 1.195 . . . . 0.0 113.051 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.43 162.31 1.6 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.989 1.316 . . . . 0.0 111.434 165.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.34 48.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.035 0.934 . . . . 0.0 110.837 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.85 89.11 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.447 0.838 . . . . 0.0 111.701 -6.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -50.06 141.37 30.24 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.21 2.607 . . . . 0.0 114.135 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.14 96.49 2.5 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 163.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.0 54.59 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.251 2.634 . . . . 0.0 112.86 -152.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.63 -34.81 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.26 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.999 173.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.83 -36.87 75.95 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.91 -44.6 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.709 -0.62 . . . . 0.0 109.942 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.82 -40.46 91.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.307 -0.871 . . . . 0.0 112.54 176.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -42.03 74.99 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.455 -0.778 . . . . 0.0 112.287 173.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.68 -45.21 81.9 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.865 0.757 . . . . 0.0 112.147 174.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.35 -40.47 85.83 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.272 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.64 -47.27 93.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.085 0.554 . . . . 0.0 110.206 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.05 -37.36 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.634 1.174 . . . . 0.0 112.322 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.74 -42.87 98.24 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.095 0.861 . . . . 0.0 111.233 171.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.55 -45.07 91.56 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.821 0.724 . . . . 0.0 113.252 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.28 -42.49 86.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.988 0.894 . . . . 0.0 111.102 173.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.5 -50.16 70.67 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.772 0.829 . . . . 0.0 112.503 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.86 -43.27 76.95 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.864 0.756 . . . . 0.0 112.027 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.46 -47.74 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.337 0.655 . . . . 0.0 111.467 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.64 -32.89 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.923 1.238 . . . . 0.0 112.874 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.34 -45.11 94.6 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.958 0.903 . . . . 0.0 111.463 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.3 ttp -74.74 -36.7 62.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.666 1.586 . . . . 0.0 113.362 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 128.417 2.687 . . . . 0.0 114.655 -173.026 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.81 135.01 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.458 1.103 . . . . 0.0 108.437 163.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.02 154.94 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.1 1.36 . . . . 0.0 109.648 170.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.66 116.69 32.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.516 0.726 . . . . 0.0 109.17 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.604 0.716 . . . . 0.0 112.452 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.89 -26.45 68.79 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.63 -2.19 57.92 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.767 1.227 . . . . 0.0 112.988 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.03 85.67 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.78 128.27 35.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.861 1.331 . . . . 0.0 109.664 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.61 29.61 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 168.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.97 123.35 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.046 1.338 . . . . 0.0 108.678 -174.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.52 139.65 38.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.236 170.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.13 48.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.468 1.907 . . . . 0.0 107.94 169.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.24 152.37 20.91 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.221 170.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.54 136.9 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.65 -0.656 . . . . 0.0 111.509 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.71 130.01 93.19 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 123.098 0.559 . . . . 0.0 111.151 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.99 -34.6 67.96 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.907 2.405 . . . . 0.0 113.604 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.43 -38.06 86.57 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 112.594 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.94 -44.32 97.43 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.691 0.678 . . . . 0.0 111.373 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.57 -44.29 94.53 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.251 0.478 . . . . 0.0 112.254 175.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.23 -47.27 85.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.079 0.551 . . . . 0.0 111.399 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.23 95.63 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.663 0.785 . . . . 0.0 111.882 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.11 -47.27 86.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.801 0.84 . . . . 0.0 112.801 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.8 -54.4 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.431 0.559 . . . . 0.0 110.397 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.7 -37.36 78.63 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.301 1.04 . . . . 0.0 113.218 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.55 -52.19 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.027 1.331 . . . . 0.0 111.318 170.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.61 -35.96 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.417 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -58.66 -23.96 60.27 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.2 -25.73 11.39 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.83 15.91 3.33 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -166.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.05 -38.22 2.24 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -117.61 14.05 14.4 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.402 1.081 . . . . 0.0 113.141 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 p -113.14 152.97 45.49 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.982 0.913 . . . . 0.0 111.523 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.74 -30.96 58.98 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.258 2.639 . . . . 0.0 115.203 -172.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.01 -21.01 64.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.16 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.41 1.005 . . . . 0.0 112.485 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.36 -57.18 5.98 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.76 1.224 . . . . 0.0 112.561 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.84 -29.52 58.68 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.891 1.711 . . . . 0.0 112.814 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.403 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.25 -40.16 78.03 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.781 1.173 . . . . 0.0 112.705 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.09 -47.02 82.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.847 0.748 . . . . 0.0 111.53 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -60.92 -44.2 97.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.68 71.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.227 1.011 . . . . 0.0 113.225 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.76 4.53 52.85 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.373 1.469 . . . . 0.0 113.47 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.5 p -133.08 22.79 4.14 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -53.56 120.33 6.01 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.508 -1.37 . . . . 0.0 111.454 168.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.62 60.02 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.447 0.939 . . . . 0.0 115.447 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.89 47.15 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.489 1.644 . . . . 0.0 112.515 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.32 159.68 84.33 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.771 0.828 . . . . 0.0 110.665 167.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.57 -35.48 37.46 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.227 1.951 . . . . 0.0 115.381 168.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.3 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.33 -45.3 93.9 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.062 172.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.57 -44.29 94.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.354 1.062 . . . . 0.0 112.134 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -59.21 -41.49 88.74 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.682 -0.636 . . . . 0.0 111.973 171.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.25 -45.24 93.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.654 0.661 . . . . 0.0 111.08 175.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.38 -48.87 77.92 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.254 0.934 . . . . 0.0 112.202 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.0 mt -63.13 -38.47 91.32 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.91 -33.41 70.51 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.4 p -73.66 -12.52 60.76 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.2 m -122.14 7.79 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -174.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.77 -4.64 5.87 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.85 -32.94 55.83 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 119.236 1.518 . . . . 0.0 115.411 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -91.57 78.62 5.56 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.875 1.337 . . . . 0.0 110.585 171.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.18 -35.92 38.59 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.33 -41.06 73.73 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.12 1.327 . . . . 0.0 112.315 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.6 86.01 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.16 0.584 . . . . 0.0 111.361 173.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.04 -40.18 96.95 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.476 -0.765 . . . . 0.0 112.255 175.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.9 -50.0 73.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.237 1.015 . . . . 0.0 111.548 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.99 -45.42 79.02 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.095 0.958 . . . . 0.0 112.21 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.97 -48.72 79.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.338 0.655 . . . . 0.0 112.055 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -63.75 -38.24 90.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.448 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.98 -45.53 92.42 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.684 0.675 . . . . 0.0 112.046 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.54 -42.42 99.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.848 0.749 . . . . 0.0 112.164 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.84 -46.1 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.507 -0.745 . . . . 0.0 111.093 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.13 -39.4 93.94 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.847 0.749 . . . . 0.0 112.759 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.8 -47.46 86.23 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.948 174.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.11 -34.32 72.96 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.46 91.76 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.408 -0.808 . . . . 0.0 112.376 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.12 98.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.208 0.603 . . . . 0.0 111.772 172.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.0 -42.32 99.81 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.869 -0.519 . . . . 0.0 112.165 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.77 -48.63 79.11 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.645 0.657 . . . . 0.0 111.676 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.02 -30.25 71.45 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -39.1 78.79 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.326 1.05 . . . . 0.0 112.451 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.22 -27.61 42.5 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 113.339 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.76 61.01 54.03 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.646 1.978 . . . . 0.0 111.247 -174.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.89 120.16 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.51 2.14 . . . . 0.0 110.261 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.45 136.24 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.383 1.473 . . . . 0.0 112.086 -169.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -79.94 160.43 25.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.082 0.553 . . . . 0.0 110.909 168.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.98 65.02 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.016 1.293 . . . . 0.0 112.617 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 169.2 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.917 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.65 -39.17 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.897 1.279 . . . . 0.0 111.799 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.51 161.9 28.59 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.911 1.684 . . . . 0.0 110.599 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.427 2.751 . . . . 0.0 113.132 168.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.07 60.28 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 115.005 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.021 1.41 . . . . 0.0 110.198 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.5 54.27 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.726 -0.608 . . . . 0.0 110.848 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.53 152.77 44.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.666 0.787 . . . . 0.0 111.664 171.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.24 131.73 84.85 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.883 -0.58 . . . . 0.0 109.821 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.42 140.44 43.95 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.037 1.825 . . . . 0.0 112.426 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -75.1 171.62 13.8 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.74 1.616 . . . . 0.0 111.898 163.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.55 -43.94 94.0 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 121.895 -0.503 . . . . 0.0 112.986 168.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.5 p -68.77 -25.73 64.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.8 -41.61 64.76 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.068 -1.02 . . . . 0.0 111.721 171.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.75 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.784 0.834 . . . . 0.0 110.782 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.05 -1.25 14.05 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.97 18.13 74.21 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.879 -1.138 . . . . 0.0 115.485 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.34 -19.3 19.33 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.092 1.446 . . . . 0.0 113.313 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.26 -1.5 6.99 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.63 149.95 24.45 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.055 0.942 . . . . 0.0 111.799 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.1 p -81.79 162.42 22.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.309 0.576 . . . . 0.0 110.773 169.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.81 -39.41 74.13 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.454 -0.778 . . . . 0.0 111.431 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.52 -38.91 92.93 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.518 -0.739 . . . . 0.0 112.674 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.62 -42.75 95.3 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.628 -0.67 . . . . 0.0 112.033 171.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.35 90.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.62 0.768 . . . . 0.0 112.11 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.51 -46.33 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.151 0.981 . . . . 0.0 110.255 172.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.09 54.06 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.823 0.725 . . . . 0.0 112.884 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.22 -50.1 73.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.517 174.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.61 -18.58 64.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.9 8.41 20.37 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.581 1.153 . . . . 0.0 113.046 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.41 162.3 1.59 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.935 1.294 . . . . 0.0 111.461 165.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.87 89.08 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.451 0.84 . . . . 0.0 111.713 -6.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -50.08 141.4 30.3 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.189 2.593 . . . . 0.0 114.135 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.16 96.43 2.48 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.97 54.63 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.66 -34.78 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.44 -46.2 94.33 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.666 0.666 . . . . 0.0 112.996 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.84 -36.89 75.93 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.259 -1.142 . . . . 0.0 112.679 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.89 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.802 -0.561 . . . . 0.0 109.98 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.9 -40.4 91.47 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.313 -0.867 . . . . 0.0 112.521 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -42.04 75.07 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.69 -45.28 81.88 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.924 0.784 . . . . 0.0 112.058 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.3 -40.54 86.04 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.305 0.642 . . . . 0.0 112.227 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.64 -47.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.279 174.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.25 -37.29 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.685 1.194 . . . . 0.0 112.282 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.8 -42.78 98.31 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.112 0.869 . . . . 0.0 111.245 171.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.06 91.55 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.796 0.712 . . . . 0.0 113.242 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.41 -42.4 87.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.019 0.91 . . . . 0.0 111.078 173.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.19 70.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.26 77.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.86 0.755 . . . . 0.0 111.991 175.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.43 -47.94 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.402 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.48 -32.88 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.951 1.251 . . . . 0.0 112.911 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.24 -44.55 95.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.902 0.881 . . . . 0.0 111.474 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.77 -36.2 59.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.69 1.596 . . . . 0.0 113.437 -177.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.5 t80 . . . . . 0 C--O 1.251 1.16 0 C-N-CA 128.415 2.686 . . . . 0.0 114.504 -172.665 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.85 135.0 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.504 1.121 . . . . 0.0 108.402 163.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.7 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.88 -26.5 68.81 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.0 3.05 85.7 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.475 1.036 . . . . 0.0 114.092 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.19 35.32 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.87 1.335 . . . . 0.0 109.741 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.85 125.52 29.47 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 168.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.9 t -125.9 123.36 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.063 1.345 . . . . 0.0 108.659 -174.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.54 139.67 38.61 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.177 170.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.16 48.41 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 20.99 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.803 . . . . 0.0 111.191 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.53 136.91 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.472 0.653 . . . . 0.0 111.578 176.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.71 130.0 93.19 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.108 0.563 . . . . 0.0 111.137 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.873 2.382 . . . . 0.0 113.575 167.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.44 -38.09 86.61 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.464 -0.773 . . . . 0.0 112.56 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.92 -44.32 97.35 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 0.0 111.373 171.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.53 -44.31 94.6 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.24 -47.26 86.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.079 0.551 . . . . 0.0 111.366 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.18 95.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.626 0.77 . . . . 0.0 111.91 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.11 -47.14 87.12 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.833 0.853 . . . . 0.0 112.786 176.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.0 t -56.89 -54.26 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.381 0.537 . . . . 0.0 110.474 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.83 -37.26 78.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.358 1.063 . . . . 0.0 113.19 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.45 -52.3 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.096 1.358 . . . . 0.0 111.257 170.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.83 -35.85 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 119.053 -0.499 . . . . 0.0 111.466 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.73 -23.71 60.31 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.49 -25.62 11.3 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.92 16.11 3.3 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -166.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.39 -37.5 2.34 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -118.23 13.84 13.79 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.475 1.11 . . . . 0.0 113.148 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.9 p -113.05 153.06 45.42 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.971 0.908 . . . . 0.0 111.568 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.89 -30.88 60.16 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.256 2.638 . . . . 0.0 115.182 -172.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.95 64.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.17 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.41 1.005 . . . . 0.0 112.462 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.6 mt -70.35 -57.18 6.0 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.743 1.217 . . . . 0.0 112.561 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.88 -29.45 58.36 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.891 1.711 . . . . 0.0 112.816 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.24 -40.17 78.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.831 1.196 . . . . 0.0 112.709 172.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.12 -47.01 82.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.83 0.741 . . . . 0.0 111.562 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -60.91 -44.2 97.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.73 -31.68 70.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.228 1.011 . . . . 0.0 113.251 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.87 4.62 52.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.419 1.488 . . . . 0.0 113.458 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.1 p -133.11 22.86 4.14 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.61 120.3 6.0 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.453 -1.404 . . . . 0.0 111.465 168.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.71 60.16 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.59 130.91 47.18 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.478 1.639 . . . . 0.0 112.453 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.35 159.65 84.37 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.771 0.828 . . . . 0.0 110.653 167.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.58 -35.44 37.43 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.171 1.914 . . . . 0.0 115.372 168.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.07 -40.24 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -60.32 -45.32 93.81 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.662 -0.649 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.57 -44.27 94.59 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 112.163 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -59.21 -41.43 88.58 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.682 -0.636 . . . . 0.0 111.996 171.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.6 m -60.25 -45.42 93.33 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.583 0.629 . . . . 0.0 111.028 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.28 -48.85 77.85 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.228 0.922 . . . . 0.0 112.179 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.8 mt -63.18 -38.29 90.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 178.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.07 -34.2 71.69 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -72.81 -12.93 61.18 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.4 13.11 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.267 1.027 . . . . 0.0 113.505 -175.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.48 -5.91 4.1 Favored Glycine 0 CA--C 1.543 1.835 0 N-CA-C 117.067 1.587 . . . . 0.0 117.067 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.67 -0.13 6.21 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 125.84 1.686 . . . . 0.0 116.919 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -124.78 79.79 1.81 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.339 1.57 . . . . 0.0 110.347 166.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.81 -36.08 46.59 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -172.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.17 -41.01 74.33 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.118 1.326 . . . . 0.0 112.19 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.47 -43.68 84.82 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.19 0.596 . . . . 0.0 111.317 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.2 tpp -62.86 -40.3 97.04 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.508 -0.745 . . . . 0.0 112.2 175.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.97 74.18 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.296 1.038 . . . . 0.0 111.536 173.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -56.02 -45.43 79.1 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.101 0.961 . . . . 0.0 112.206 174.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.8 tp -61.88 -48.81 78.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.289 0.636 . . . . 0.0 112.055 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.63 -38.31 90.65 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.455 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.02 -45.45 92.75 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.668 0.667 . . . . 0.0 112.013 170.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.61 -42.45 99.58 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.848 0.749 . . . . 0.0 112.094 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.8 -46.11 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.535 -0.728 . . . . 0.0 111.053 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.16 -39.4 93.94 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.865 0.757 . . . . 0.0 112.717 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -60.84 -47.44 86.35 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.964 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.1 -34.3 72.96 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.55 91.78 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.451 -0.781 . . . . 0.0 112.369 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.01 98.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.201 0.6 . . . . 0.0 111.784 172.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.1 -42.28 99.54 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.864 -0.523 . . . . 0.0 112.19 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.88 -48.45 79.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.646 0.657 . . . . 0.0 111.687 173.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.09 -30.3 71.49 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.08 -39.12 79.26 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.361 1.064 . . . . 0.0 112.499 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.29 -27.6 42.21 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.776 1.23 . . . . 0.0 113.302 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.83 61.03 54.02 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.672 1.989 . . . . 0.0 111.241 -174.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.93 120.16 7.44 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.421 2.08 . . . . 0.0 110.258 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.4 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.34 1.456 . . . . 0.0 112.152 -169.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.05 160.47 25.81 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.043 0.537 . . . . 0.0 110.909 168.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.26 -19.97 65.03 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.71 41.58 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.048 1.309 . . . . 0.0 112.61 174.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.45 169.17 14.61 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.668 2.912 . . . . 0.0 112.954 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.74 -39.17 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.909 1.284 . . . . 0.0 111.742 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.94 28.52 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -47.91 133.42 22.84 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.479 2.786 . . . . 0.0 113.089 168.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.06 60.35 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.562 1.077 . . . . 0.0 114.978 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.35 37.47 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.96 1.38 . . . . 0.0 110.198 173.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.17 145.57 54.21 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.717 -0.614 . . . . 0.0 110.826 168.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.56 152.73 44.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.709 0.804 . . . . 0.0 111.614 171.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.25 131.73 84.82 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.916 -0.564 . . . . 0.0 109.835 170.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.42 140.39 43.83 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.099 1.866 . . . . 0.0 112.442 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.7 mtp85 -75.02 171.63 13.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.737 1.615 . . . . 0.0 111.852 163.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.68 -43.82 94.27 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.942 -0.474 . . . . 0.0 112.954 168.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.77 -25.86 64.92 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.56 65.11 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.041 -1.037 . . . . 0.0 111.756 171.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.66 -42.69 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.731 0.812 . . . . 0.0 110.827 173.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.29 14.03 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 173.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.11 74.16 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.934 -1.104 . . . . 0.0 115.477 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.39 19.35 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.11 1.455 . . . . 0.0 113.292 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.6 p -126.21 -1.54 7.02 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.57 149.99 24.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.067 0.947 . . . . 0.0 111.773 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.9 p -81.85 162.37 22.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.307 0.575 . . . . 0.0 110.794 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.81 -39.45 74.19 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.484 -0.76 . . . . 0.0 111.4 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.59 -38.83 92.62 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.556 -0.715 . . . . 0.0 112.683 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.63 -42.76 95.25 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.628 -0.67 . . . . 0.0 112.047 171.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.63 -46.42 90.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.61 0.764 . . . . 0.0 112.11 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.39 -46.33 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.142 0.977 . . . . 0.0 110.354 172.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.12 53.81 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.81 0.719 . . . . 0.0 112.902 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.21 -50.07 73.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.778 0.789 . . . . 0.0 112.512 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.1 p -111.95 8.42 20.29 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.6 1.16 . . . . 0.0 113.009 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.44 162.31 1.61 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.952 1.301 . . . . 0.0 111.441 165.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.85 89.12 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.451 0.84 . . . . 0.0 111.762 -6.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -49.97 141.31 29.73 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.238 2.625 . . . . 0.0 114.174 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.12 96.48 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.81 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.17 94.4 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.638 0.654 . . . . 0.0 113.011 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.89 -36.86 75.76 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.296 -1.12 . . . . 0.0 112.634 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.92 -44.58 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.785 -0.572 . . . . 0.0 109.954 173.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.89 -40.38 91.52 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.303 -0.873 . . . . 0.0 112.521 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.05 75.1 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.275 173.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.65 -45.21 81.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.901 0.773 . . . . 0.0 112.147 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.28 -40.53 86.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.69 -47.04 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.05 0.54 . . . . 0.0 110.286 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.29 -37.3 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.636 1.174 . . . . 0.0 112.282 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.82 -42.77 98.35 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.051 0.842 . . . . 0.0 111.215 171.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.17 90.96 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.836 0.731 . . . . 0.0 113.184 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.43 -42.29 86.97 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.045 0.922 . . . . 0.0 111.073 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.26 70.4 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.424 173.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.77 -43.26 76.57 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.874 0.761 . . . . 0.0 111.961 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.2 mt -64.6 -47.76 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.431 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.56 -32.89 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.965 1.257 . . . . 0.0 112.9 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.25 -44.84 94.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.939 0.895 . . . . 0.0 111.468 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.39 -36.87 60.82 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.683 1.593 . . . . 0.0 113.428 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 128.425 2.69 . . . . 0.0 114.577 -172.73 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.89 135.06 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.482 1.113 . . . . 0.0 108.402 163.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -126.07 154.84 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.092 1.357 . . . . 0.0 109.688 170.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.56 116.7 32.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.519 0.728 . . . . 0.0 109.139 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.46 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.514 0.673 . . . . 0.0 112.474 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.85 -26.53 68.8 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -173.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.87 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.81 1.244 . . . . 0.0 113.019 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.94 3.09 85.81 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.458 1.028 . . . . 0.0 114.08 -175.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.21 35.39 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.823 1.312 . . . . 0.0 109.683 174.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.53 29.49 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 168.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.9 123.31 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.086 1.354 . . . . 0.0 108.698 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.58 139.66 38.57 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.555 0.693 . . . . 0.0 111.23 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.09 48.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.491 1.916 . . . . 0.0 107.921 169.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.4 20.9 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.248 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.56 136.85 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.605 -0.685 . . . . 0.0 111.555 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.65 129.98 93.26 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.136 0.575 . . . . 0.0 111.149 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.02 -34.58 68.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.907 2.405 . . . . 0.0 113.586 167.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.44 -38.08 86.6 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.513 -0.742 . . . . 0.0 112.588 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.87 -44.34 97.19 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.767 0.712 . . . . 0.0 111.386 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.52 -44.33 94.57 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.296 0.498 . . . . 0.0 112.267 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.23 -47.22 86.14 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.139 0.576 . . . . 0.0 111.4 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.24 95.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.664 0.786 . . . . 0.0 111.899 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.14 -47.12 87.25 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.795 0.838 . . . . 0.0 112.772 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.1 t -56.91 -54.3 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.392 0.542 . . . . 0.0 110.41 174.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.81 -37.18 78.42 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.324 1.05 . . . . 0.0 113.247 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.57 -52.19 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.044 1.338 . . . . 0.0 111.286 170.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.91 -35.86 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.972 0.509 . . . . 0.0 111.412 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -58.66 -23.79 59.96 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.52 -25.58 11.31 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -135.94 16.12 3.29 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.42 -37.4 2.33 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -175.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -118.31 13.91 13.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.473 1.109 . . . . 0.0 113.148 -172.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.1 p -113.15 153.02 45.52 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.962 0.905 . . . . 0.0 111.515 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.82 -30.91 59.64 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.287 2.658 . . . . 0.0 115.218 -172.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.91 64.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.61 -32.24 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.406 1.003 . . . . 0.0 112.422 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.6 mt -70.33 -57.15 6.05 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.684 1.194 . . . . 0.0 112.572 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.86 -29.45 58.49 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.896 1.713 . . . . 0.0 112.816 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.29 -40.08 77.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.818 1.19 . . . . 0.0 112.694 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -57.17 -47.05 82.18 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.878 0.763 . . . . 0.0 111.537 169.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -60.88 -44.21 97.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.79 -31.61 70.97 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.193 0.997 . . . . 0.0 113.297 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.88 4.74 52.54 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.368 1.467 . . . . 0.0 113.55 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.0 p -133.15 22.73 4.12 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.57 120.29 5.96 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.474 -1.391 . . . . 0.0 111.456 168.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.53 60.15 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.47 130.82 46.91 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.528 1.664 . . . . 0.0 112.53 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.28 159.66 84.43 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.718 0.807 . . . . 0.0 110.692 167.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.61 -35.37 37.49 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.144 1.896 . . . . 0.0 115.4 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.03 -40.3 87.18 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.3 93.89 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.066 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.55 -44.28 94.62 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.329 1.051 . . . . 0.0 112.175 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -59.24 -41.37 88.58 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.612 -0.68 . . . . 0.0 112.047 171.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.2 -45.41 93.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.597 0.635 . . . . 0.0 111.115 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.28 -48.85 77.84 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.187 0.903 . . . . 0.0 112.176 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.0 mt -63.18 -38.33 90.73 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.06 -34.16 71.62 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -72.78 -12.98 61.21 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.36 13.15 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.315 1.046 . . . . 0.0 113.557 -175.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.48 -5.92 4.11 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 117.055 1.582 . . . . 0.0 117.055 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.71 -0.2 6.38 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 125.909 1.719 . . . . 0.0 116.845 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -124.71 79.76 1.8 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.347 1.574 . . . . 0.0 110.385 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.87 -36.03 47.07 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.718 1.607 . . . . 0.0 115.304 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.2 -40.98 74.29 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.154 1.343 . . . . 0.0 112.191 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.44 -43.75 84.73 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.254 0.622 . . . . 0.0 111.315 173.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.2 tpp -62.77 -40.3 96.87 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.491 -0.756 . . . . 0.0 112.257 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.05 -49.95 74.26 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.292 1.037 . . . . 0.0 111.544 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -56.0 -45.42 79.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.101 0.961 . . . . 0.0 112.234 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.88 -48.84 78.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.308 0.643 . . . . 0.0 112.054 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.69 -38.3 90.58 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.873 0.869 . . . . 0.0 112.424 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.95 -45.49 92.49 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.705 0.684 . . . . 0.0 112.034 170.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.7 m -62.65 -42.36 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.793 0.724 . . . . 0.0 112.118 175.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.87 -46.08 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.507 -0.745 . . . . 0.0 111.045 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.4 93.96 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.838 0.745 . . . . 0.0 112.717 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -60.84 -47.41 86.48 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.743 0.817 . . . . 0.0 111.958 174.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.12 -34.34 72.96 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.593 -0.692 . . . . 0.0 112.859 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.56 91.81 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.484 -0.76 . . . . 0.0 112.371 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.09 98.58 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.246 0.619 . . . . 0.0 111.766 172.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.17 -42.22 99.37 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.864 -0.523 . . . . 0.0 112.191 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.71 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.06 -30.22 71.43 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.19 -39.06 78.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.342 1.057 . . . . 0.0 112.488 173.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.57 42.28 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.796 1.239 . . . . 0.0 113.354 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.0 53.92 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.94 120.15 7.43 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.452 2.101 . . . . 0.0 110.285 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.44 136.36 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.372 1.469 . . . . 0.0 112.077 -169.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -80.0 160.47 25.87 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.048 0.539 . . . . 0.0 110.909 168.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.24 -19.98 65.03 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.91 174.81 41.58 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.075 1.322 . . . . 0.0 112.625 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.64 169.18 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.635 2.89 . . . . 0.0 112.889 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.68 -39.19 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.903 1.281 . . . . 0.0 111.749 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.46 161.89 28.6 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.842 1.657 . . . . 0.0 110.551 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.427 2.751 . . . . 0.0 113.132 168.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.98 -15.08 60.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.567 1.08 . . . . 0.0 115.01 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.23 145.48 54.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.691 -0.631 . . . . 0.0 110.859 168.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.47 152.82 44.86 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.2 131.69 84.94 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.83 170.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.44 140.36 43.69 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.097 1.864 . . . . 0.0 112.426 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -75.04 171.62 13.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.649 1.58 . . . . 0.0 111.89 163.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.55 -43.85 94.02 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.949 -0.469 . . . . 0.0 113.035 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.76 -25.85 64.94 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.63 -41.63 65.32 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.061 -1.025 . . . . 0.0 111.795 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.75 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.784 0.834 . . . . 0.0 110.782 173.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.26 14.02 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 173.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.93 18.16 74.16 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.908 -1.12 . . . . 0.0 115.491 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.26 -19.46 19.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.053 1.426 . . . . 0.0 113.263 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.0 p -126.1 -1.49 7.09 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.67 149.89 24.53 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.052 0.941 . . . . 0.0 111.814 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.0 p -81.76 162.31 22.97 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.318 0.58 . . . . 0.0 110.827 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.75 -39.43 73.97 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.446 -0.784 . . . . 0.0 111.43 169.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.56 -38.9 92.89 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.516 -0.74 . . . . 0.0 112.706 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.76 95.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 112.008 171.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.68 -46.36 90.66 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.156 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.47 -46.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.091 0.956 . . . . 0.0 110.288 172.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.1 54.01 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 0.0 112.869 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.07 73.19 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.512 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.61 -18.53 64.33 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.91 8.36 20.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.645 1.178 . . . . 0.0 112.996 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.44 162.33 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.995 1.318 . . . . 0.0 111.447 165.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.6 103.34 48.91 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.065 0.946 . . . . 0.0 110.778 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.451 0.84 . . . . 0.0 111.762 -6.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -50.0 141.36 29.81 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.155 2.57 . . . . 0.0 114.205 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.11 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.56 -34.84 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -173.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.21 94.29 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.605 0.639 . . . . 0.0 112.996 173.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.84 -36.9 75.95 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.289 -1.124 . . . . 0.0 112.645 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.9 -44.57 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.745 -0.597 . . . . 0.0 109.914 173.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.91 -40.35 91.4 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.282 -0.886 . . . . 0.0 112.521 176.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.87 -42.07 75.34 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.439 -0.788 . . . . 0.0 112.204 173.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.63 -45.25 81.66 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.899 0.772 . . . . 0.0 112.093 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.28 -40.53 86.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.66 -47.08 94.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.085 0.554 . . . . 0.0 110.285 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.26 -37.32 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.645 1.178 . . . . 0.0 112.298 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.82 98.41 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.028 0.831 . . . . 0.0 111.185 171.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.48 -45.21 91.12 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.878 0.751 . . . . 0.0 113.228 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.38 -42.3 86.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.003 0.901 . . . . 0.0 111.14 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.26 70.4 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.424 173.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.83 -43.19 76.74 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.874 0.761 . . . . 0.0 111.975 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.6 -47.79 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.344 0.658 . . . . 0.0 111.431 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.89 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.961 1.255 . . . . 0.0 112.9 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -60.26 -44.87 94.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.939 0.895 . . . . 0.0 111.461 171.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.33 -36.95 60.99 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.672 1.589 . . . . 0.0 113.45 -177.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 128.454 2.702 . . . . 0.0 114.562 -172.701 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.85 135.0 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.488 1.115 . . . . 0.0 108.482 163.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.65 32.46 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.43 178.06 6.88 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 121.529 0.68 . . . . 0.0 112.46 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.88 -26.56 68.84 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.03 3.02 85.65 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.475 1.036 . . . . 0.0 114.07 -175.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.71 128.2 35.35 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.893 1.347 . . . . 0.0 109.712 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.55 29.51 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 168.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.94 123.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.074 1.349 . . . . 0.0 108.629 -174.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.65 141.14 48.49 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.488 1.915 . . . . 0.0 107.89 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.29 21.03 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.023 0.829 . . . . 0.0 111.254 170.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.48 136.85 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.523 0.678 . . . . 0.0 111.55 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.69 130.0 93.21 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.068 0.547 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.02 -34.58 68.22 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.894 2.396 . . . . 0.0 113.583 167.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.44 -38.06 86.55 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.437 -0.789 . . . . 0.0 112.588 174.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.95 -44.31 97.47 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 0.0 111.349 171.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.57 -44.35 94.36 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.29 0.496 . . . . 0.0 112.309 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.12 -47.31 85.73 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.142 0.577 . . . . 0.0 111.388 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.32 95.29 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.604 0.761 . . . . 0.0 111.896 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -60.07 -47.29 86.47 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.849 0.859 . . . . 0.0 112.791 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.6 t -56.74 -54.94 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 118.417 0.553 . . . . 0.0 110.254 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.15 -37.71 77.98 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.371 1.068 . . . . 0.0 113.237 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.404 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.21 -51.96 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.064 1.346 . . . . 0.0 111.28 170.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.81 -35.87 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.993 0.517 . . . . 0.0 111.485 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -58.94 -23.29 61.29 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.709 1.141 . . . . 0.0 113.972 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.55 -25.91 11.15 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -135.9 16.26 3.3 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -165.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.65 -37.47 2.6 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -118.3 14.58 13.86 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.39 1.076 . . . . 0.0 113.1 -172.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -113.77 153.02 46.05 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.004 0.922 . . . . 0.0 111.526 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.9 -30.79 59.87 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.274 2.649 . . . . 0.0 115.224 -172.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.09 -20.64 64.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.78 -31.96 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.397 0.998 . . . . 0.0 112.539 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.38 -55.08 6.3 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.974 1.31 . . . . 0.0 112.944 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.85 -30.07 49.59 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.658 1.628 . . . . 0.0 112.669 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.404 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.04 -40.3 78.68 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.921 1.237 . . . . 0.0 112.606 172.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.25 -46.46 82.99 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.735 0.698 . . . . 0.0 111.576 169.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -61.1 -44.47 97.31 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.84 -31.95 71.37 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.317 1.047 . . . . 0.0 113.25 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.47 4.58 53.13 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.333 1.453 . . . . 0.0 113.526 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.1 p -133.09 22.8 4.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.58 120.34 6.04 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.47 168.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.69 60.07 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.371 0.909 . . . . 0.0 115.371 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.54 130.89 47.14 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.565 1.683 . . . . 0.0 112.515 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.33 159.69 84.29 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 123.748 0.819 . . . . 0.0 110.718 167.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.61 -35.44 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.204 1.936 . . . . 0.0 115.372 168.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.24 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.35 93.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -59.2 -41.49 88.66 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.696 -0.628 . . . . 0.0 112.024 171.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.22 -45.33 93.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.569 0.622 . . . . 0.0 111.091 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.33 -48.86 77.88 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.205 0.911 . . . . 0.0 112.164 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.19 -38.33 90.76 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.06 -33.7 71.09 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.4 p -73.07 -12.92 61.09 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.17 8.9 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -174.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.86 -5.55 7.55 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 117.267 1.667 . . . . 0.0 117.267 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.23 -31.24 59.12 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.318 1.559 . . . . 0.0 115.648 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -93.42 78.44 4.41 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.962 1.381 . . . . 0.0 110.536 172.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.07 -35.8 36.64 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.03 73.96 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.154 1.343 . . . . 0.0 112.243 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.58 85.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.199 0.599 . . . . 0.0 111.35 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.06 -40.08 96.64 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.53 -0.732 . . . . 0.0 112.238 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.96 74.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.247 1.019 . . . . 0.0 111.529 173.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -55.9 -45.5 78.63 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.1 0.96 . . . . 0.0 112.228 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.92 -48.77 78.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.265 0.626 . . . . 0.0 112.035 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.69 -38.31 90.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.873 0.869 . . . . 0.0 112.49 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.96 -45.49 92.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.689 0.677 . . . . 0.0 112.02 170.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.6 -42.43 99.57 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.848 0.749 . . . . 0.0 112.13 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.83 -46.08 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.535 -0.728 . . . . 0.0 111.059 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.21 -39.35 93.79 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.858 0.754 . . . . 0.0 112.731 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.84 -47.39 86.59 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.964 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.19 -34.27 72.74 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.6 91.91 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.451 -0.781 . . . . 0.0 112.333 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -42.04 98.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.224 0.61 . . . . 0.0 111.783 172.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.19 -42.26 99.33 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.855 -0.528 . . . . 0.0 112.191 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.74 -48.55 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.625 0.648 . . . . 0.0 111.71 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -63.04 -30.3 71.49 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -38.99 78.83 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.33 1.052 . . . . 0.0 112.458 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.36 -27.5 41.95 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.776 1.23 . . . . 0.0 113.313 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.84 61.02 53.98 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.622 1.969 . . . . 0.0 111.241 -174.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -63.91 120.12 7.38 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.479 2.119 . . . . 0.0 110.293 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.39 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.32 1.448 . . . . 0.0 112.135 -169.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.03 160.49 25.83 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.083 0.553 . . . . 0.0 110.897 168.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -19.93 65.01 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.94 174.77 41.59 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.032 1.301 . . . . 0.0 112.656 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.57 169.17 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.66 2.907 . . . . 0.0 112.906 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.69 -39.14 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.843 1.257 . . . . 0.0 111.824 -175.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.91 28.57 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.83 133.41 22.44 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.519 2.812 . . . . 0.0 113.132 168.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.9 -15.0 60.33 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.607 1.099 . . . . 0.0 114.992 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.992 1.396 . . . . 0.0 110.198 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.52 54.19 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.694 -0.629 . . . . 0.0 110.787 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.47 152.84 44.83 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.3 131.73 84.73 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 118.945 -0.55 . . . . 0.0 109.824 170.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.38 140.38 43.93 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.074 1.849 . . . . 0.0 112.442 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -74.98 171.61 13.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.761 1.625 . . . . 0.0 111.872 163.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.64 -43.82 94.19 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.912 -0.493 . . . . 0.0 112.974 168.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.5 p -68.74 -25.85 64.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.72 -41.64 65.0 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.082 -1.011 . . . . 0.0 111.725 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.63 -42.69 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.718 0.807 . . . . 0.0 110.827 173.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.96 -1.34 14.13 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.21 74.24 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 120.877 -1.139 . . . . 0.0 115.463 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.31 -19.46 19.24 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.099 1.449 . . . . 0.0 113.263 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.12 -1.42 7.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.7 149.87 24.57 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.073 0.949 . . . . 0.0 111.788 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.1 p -81.76 162.33 22.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.318 0.58 . . . . 0.0 110.827 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.78 -39.47 74.14 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.418 -0.801 . . . . 0.0 111.347 169.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.52 -38.9 92.89 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.554 -0.716 . . . . 0.0 112.722 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.62 -42.76 95.3 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.584 -0.698 . . . . 0.0 112.033 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.65 -46.39 90.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.687 0.795 . . . . 0.0 112.097 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.29 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.338 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.51 -51.02 54.73 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.81 0.719 . . . . 0.0 112.927 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.27 -50.04 73.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.819 0.81 . . . . 0.0 112.542 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.69 -18.49 64.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.0 p -111.93 8.46 20.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.643 1.177 . . . . 0.0 113.062 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.45 162.31 1.62 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.989 1.316 . . . . 0.0 111.441 165.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.37 48.93 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.029 0.932 . . . . 0.0 110.758 176.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.06 163.81 89.24 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.494 0.855 . . . . 0.0 111.713 -6.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -49.93 141.36 29.3 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.199 2.6 . . . . 0.0 114.149 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.16 96.45 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 163.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -86.0 54.56 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.251 2.634 . . . . 0.0 112.86 -152.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.56 -34.86 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.22 94.31 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.638 0.654 . . . . 0.0 112.999 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -69.9 -36.83 75.72 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.327 -1.102 . . . . 0.0 112.688 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.87 -44.64 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.795 -0.566 . . . . 0.0 109.912 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.88 -40.34 91.52 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.303 -0.873 . . . . 0.0 112.564 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.88 -41.98 75.26 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.412 -0.805 . . . . 0.0 112.253 173.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.69 -45.16 81.95 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.924 0.784 . . . . 0.0 112.147 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.33 -40.53 85.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.29 0.636 . . . . 0.0 112.251 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.67 -47.09 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.085 0.554 . . . . 0.0 110.249 174.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.19 -37.39 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.674 1.19 . . . . 0.0 112.3 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.8 -42.79 98.31 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.011 0.823 . . . . 0.0 111.253 171.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.11 91.4 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.796 0.712 . . . . 0.0 113.265 175.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.46 -42.3 87.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.01 0.905 . . . . 0.0 111.092 173.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.19 70.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.23 77.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.86 0.755 . . . . 0.0 111.986 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.41 -47.91 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.415 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -69.64 -32.8 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.0 1.273 . . . . 0.0 112.86 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.11 -44.02 95.18 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.863 0.865 . . . . 0.0 111.505 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.3 ttp -77.04 -37.36 54.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.652 1.581 . . . . 0.0 113.558 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.251 1.177 0 C-N-CA 128.427 2.691 . . . . 0.0 114.649 -172.059 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.48 0.686 0 N-CA-C 112.997 0.345 . . . . 20.0 112.997 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.99 135.01 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.473 1.109 . . . . 20.0 108.448 163.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.81 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 20.0 109.686 170.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.47 116.7 32.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.531 0.733 . . . . 20.0 109.17 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.503 0.668 . . . . 20.0 112.495 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.82 -26.57 68.81 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.432 1.271 . . . . 20.0 114.432 -173.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 20.0 113.03 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.0 3.07 85.68 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.475 1.036 . . . . 20.0 114.058 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.22 35.46 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.847 1.323 . . . . 20.0 109.731 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.52 29.47 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.453 -0.573 . . . . 20.0 109.453 168.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.9 123.39 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.014 1.326 . . . . 20.0 108.648 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 20.0 111.213 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.67 141.12 48.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.511 1.924 . . . . 20.0 107.935 169.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.37 20.84 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.949 0.795 . . . . 20.0 111.191 170.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.53 136.81 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.625 -0.672 . . . . 20.0 111.61 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.62 129.96 93.29 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.084 0.553 . . . . 20.0 111.137 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.05 -34.48 67.98 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.868 2.378 . . . . 20.0 113.542 167.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.51 -38.09 86.46 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.453 -0.779 . . . . 20.0 112.56 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.99 -44.21 97.74 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 20.0 111.354 171.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.58 -44.45 94.02 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.341 0.519 . . . . 20.0 112.256 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.08 -47.19 86.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.076 0.55 . . . . 20.0 111.402 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.2 95.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.64 0.776 . . . . 20.0 111.881 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -60.29 -46.89 88.26 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.81 0.844 . . . . 20.0 112.781 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.9 t -57.0 -54.24 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.412 0.551 . . . . 20.0 110.355 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.8 -37.25 78.59 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.374 1.07 . . . . 20.0 113.229 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.22 -52.31 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.206 1.403 . . . . 20.0 111.233 170.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.08 -36.14 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.022 0.529 . . . . 20.0 111.405 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -58.55 -23.85 59.37 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.978 1.103 . . . . 20.0 113.978 175.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.47 -25.47 11.38 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.04 1.126 . . . . 20.0 114.04 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -136.19 16.09 3.24 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.367 1.247 . . . . 20.0 114.367 -165.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.08 -36.78 2.71 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.478 2.029 . . . . 20.0 116.478 -175.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.48 15.34 13.78 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.492 1.117 . . . . 20.0 113.098 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -114.87 153.01 47.0 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.961 0.904 . . . . 20.0 111.456 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.96 -30.6 59.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.218 2.612 . . . . 20.0 115.238 -172.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.17 -20.74 64.45 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.173 1.175 . . . . 20.0 114.173 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.88 -31.82 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.468 1.031 . . . . 20.0 112.548 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.7 mt -71.47 -54.98 6.26 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.927 1.291 . . . . 20.0 113.01 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.89 -30.16 49.16 Favored 'Trans proline' 0 C--N 1.351 0.686 0 CA-C-N 121.673 1.633 . . . . 20.0 112.633 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -68.96 -40.26 79.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.867 1.212 . . . . 20.0 112.674 172.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.3 -46.44 83.17 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.476 0.711 . . . . 20.0 111.576 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.0 m -61.12 -44.53 97.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.608 0.596 . . . . 20.0 112.608 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.8 -31.88 71.26 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.28 1.032 . . . . 20.0 113.315 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.52 4.57 53.07 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.364 1.466 . . . . 20.0 113.499 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.5 p -133.1 22.88 4.14 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.437 1.273 . . . . 20.0 114.437 -176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.63 120.27 5.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.485 -1.384 . . . . 20.0 111.47 168.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.6 11.59 60.19 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 115.365 0.906 . . . . 20.0 115.365 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.45 130.82 46.9 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.542 1.671 . . . . 20.0 112.48 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.33 159.66 84.37 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.706 0.802 . . . . 20.0 110.68 167.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.57 -35.47 37.43 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.144 1.896 . . . . 20.0 115.406 168.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.04 -40.17 87.11 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.098 0.777 . . . . 20.0 113.098 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.42 -45.26 94.26 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.629 -0.669 . . . . 20.0 111.047 172.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.56 -44.28 94.58 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.32 1.048 . . . . 20.0 112.115 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -59.25 -41.39 88.66 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.618 0.644 . . . . 20.0 112.008 171.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.9 m -60.3 -45.28 93.93 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.597 0.635 . . . . 20.0 111.066 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.38 -48.98 77.64 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.218 0.917 . . . . 20.0 112.114 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.04 -38.34 90.8 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.827 0.677 . . . . 20.0 112.827 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.04 -33.66 71.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.89 0.7 . . . . 20.0 112.89 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.8 p -73.1 -12.81 61.04 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.662 1.356 . . . . 20.0 114.662 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.03 7.78 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.357 1.063 . . . . 20.0 113.868 -174.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.09 -5.43 10.05 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 117.46 1.744 . . . . 20.0 117.46 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.05 -35.42 69.21 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 119.32 1.56 . . . . 20.0 115.282 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -85.28 77.84 9.91 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 123.053 1.406 . . . . 20.0 110.56 171.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.98 -35.61 34.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.624 1.57 . . . . 20.0 115.225 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.58 -41.42 72.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.226 1.375 . . . . 20.0 112.306 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.32 -43.59 85.75 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.777 -0.577 . . . . 20.0 111.37 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -63.13 -39.98 96.26 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.475 -0.766 . . . . 20.0 112.239 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -57.05 -49.94 74.27 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.05 -1.031 . . . . 20.0 111.548 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.95 -45.46 78.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 20.0 112.239 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.96 -48.73 79.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.27 0.628 . . . . 20.0 112.034 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.73 -38.37 90.85 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 20.0 112.403 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.78 -45.59 91.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.807 0.73 . . . . 20.0 112.048 170.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.5 m -62.67 -42.41 99.6 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.724 0.693 . . . . 20.0 112.118 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.78 -46.1 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.431 -0.793 . . . . 20.0 111.093 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.12 -39.48 94.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.788 0.722 . . . . 20.0 112.715 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -60.77 -47.45 86.28 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.716 0.806 . . . . 20.0 111.958 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.09 -34.3 72.97 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.901 0.704 . . . . 20.0 112.901 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.59 91.73 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.434 -0.791 . . . . 20.0 112.369 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.11 98.57 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.264 0.625 . . . . 20.0 111.781 172.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.12 -42.27 99.5 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 20.0 112.163 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.81 -48.49 79.57 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.661 0.664 . . . . 20.0 111.669 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.06 -30.33 71.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.906 0.706 . . . . 20.0 112.906 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.17 -38.99 79.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.331 1.052 . . . . 20.0 112.457 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.4 -27.58 41.81 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.807 1.243 . . . . 20.0 113.306 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.1 54.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.587 1.955 . . . . 20.0 111.217 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.0 120.13 7.4 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.483 2.122 . . . . 20.0 110.242 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.41 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.366 1.466 . . . . 20.0 112.158 -169.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.09 160.47 25.76 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.103 0.561 . . . . 20.0 110.903 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -19.97 65.05 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.367 1.247 . . . . 20.0 114.367 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.88 174.81 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.064 1.316 . . . . 20.0 112.68 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.57 169.17 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.66 2.907 . . . . 20.0 112.906 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.73 -39.05 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.843 1.257 . . . . 20.0 111.82 -175.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.55 161.85 28.7 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.877 1.671 . . . . 20.0 110.603 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.92 133.45 22.9 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.473 2.782 . . . . 20.0 113.132 168.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.94 -15.02 60.35 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.567 1.08 . . . . 20.0 115.001 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -78.14 143.36 37.35 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.978 1.389 . . . . 20.0 110.187 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.14 145.58 54.24 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.719 -0.613 . . . . 20.0 110.826 168.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.51 152.69 45.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.717 0.807 . . . . 20.0 111.616 171.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.21 131.73 84.9 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.917 -0.563 . . . . 20.0 109.834 170.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.42 140.27 43.55 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.096 1.864 . . . . 20.0 112.451 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -74.92 171.62 13.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.743 1.617 . . . . 20.0 111.872 163.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.87 94.09 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.935 -0.478 . . . . 20.0 112.998 168.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.75 -25.83 64.93 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.059 1.133 . . . . 20.0 114.059 175.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.6 64.98 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.062 -1.024 . . . . 20.0 111.742 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.65 -42.72 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.731 0.812 . . . . 20.0 110.812 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.29 14.06 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.87 1.063 . . . . 20.0 113.87 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.26 74.28 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 120.865 -1.147 . . . . 20.0 115.393 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.41 19.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.11 1.455 . . . . 20.0 113.263 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.6 p -126.22 -1.46 7.02 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.273 1.212 . . . . 20.0 114.273 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.67 149.96 24.46 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.032 0.933 . . . . 20.0 111.824 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.8 p -82.02 162.43 22.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.347 0.594 . . . . 20.0 110.797 170.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.71 -39.5 73.97 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.404 -0.81 . . . . 20.0 111.454 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.5 -38.95 93.08 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.512 -0.742 . . . . 20.0 112.648 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.55 -42.78 95.47 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.637 -0.665 . . . . 20.0 112.084 171.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.63 -46.36 90.59 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.603 0.761 . . . . 20.0 112.156 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.47 -46.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.091 0.956 . . . . 20.0 110.288 172.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.07 54.18 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 20.0 112.869 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 20.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 20.0 114.434 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.91 8.36 20.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.645 1.178 . . . . 20.0 113.033 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.38 162.3 1.58 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.027 1.331 . . . . 20.0 111.396 165.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.59 103.32 48.95 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.071 0.949 . . . . 20.0 110.837 176.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.13 163.84 89.13 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.462 0.844 . . . . 20.0 111.701 -6.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -50.03 141.37 30.02 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 20.0 114.168 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.3 mt -96.11 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 20.0 104.858 163.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.98 54.57 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 20.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.89 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.029 1.122 . . . . 20.0 114.029 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.27 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.688 0.676 . . . . 20.0 112.958 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.86 -36.86 75.85 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.289 -1.124 . . . . 20.0 112.693 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.89 -44.62 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.808 -0.557 . . . . 20.0 109.952 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.41 91.65 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.303 -0.873 . . . . 20.0 112.533 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -41.97 74.91 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.395 -0.816 . . . . 20.0 112.287 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.74 -45.19 82.13 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.889 0.768 . . . . 20.0 112.12 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.37 -40.54 85.74 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.287 0.635 . . . . 20.0 112.227 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.58 -47.23 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.039 0.536 . . . . 20.0 110.235 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.05 -37.39 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.749 1.22 . . . . 20.0 112.308 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.87 98.53 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.01 0.823 . . . . 20.0 111.194 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.53 -45.02 91.88 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.832 0.729 . . . . 20.0 113.26 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.42 -42.49 87.37 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.002 0.901 . . . . 20.0 111.056 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.5 -50.12 70.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.795 0.838 . . . . 20.0 112.449 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.79 -43.35 76.74 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.915 0.78 . . . . 20.0 111.996 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.6 mt -64.28 -48.32 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.26 0.624 . . . . 20.0 111.366 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.54 -31.48 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.791 1.178 . . . . 20.0 112.981 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -61.43 -42.14 98.29 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.102 0.864 . . . . 20.0 111.642 171.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.3 ttp -80.6 -36.29 32.96 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.726 1.61 . . . . 20.0 113.884 -174.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 1.103 ' OXT' ' C ' ' A' ' 145' ' ' TYR . 70.5 m-85 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 127.784 2.434 . . . . 20.0 114.432 -168.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 N--CA 1.479 0.661 0 N-CA-C 113.01 0.35 . . . . 0.0 113.01 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.58 135.04 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.47 1.108 . . . . 0.0 108.413 163.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -126.07 155.0 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.633 170.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -104.84 116.81 32.64 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.465 0.706 . . . . 0.0 109.143 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.48 178.03 6.93 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.587 0.708 . . . . 0.0 112.441 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.94 -26.43 68.81 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.11 57.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.794 1.237 . . . . 0.0 113.011 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.91 85.85 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.514 1.054 . . . . 0.0 114.128 -175.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.63 128.29 35.68 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.816 1.308 . . . . 0.0 109.695 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.73 29.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 168.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -126.09 123.32 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.075 1.35 . . . . 0.0 108.68 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.57 139.69 38.58 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.18 48.48 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.513 1.925 . . . . 0.0 107.979 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.24 152.35 20.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.202 170.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.86 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.453 0.644 . . . . 0.0 111.555 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 129.96 93.26 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.164 0.585 . . . . 0.0 111.095 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.97 -34.67 68.08 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.907 2.405 . . . . 0.0 113.572 167.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.39 -38.02 86.58 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.508 -0.745 . . . . 0.0 112.594 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.0 -44.31 97.61 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.716 0.689 . . . . 0.0 111.356 171.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.5 -44.33 94.64 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.296 0.498 . . . . 0.0 112.256 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.23 -47.32 85.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.079 0.551 . . . . 0.0 111.417 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.14 96.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.599 0.76 . . . . 0.0 111.896 176.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -60.07 -47.5 85.63 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.844 0.858 . . . . 0.0 112.711 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.2 t -56.7 -54.55 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.4 0.545 . . . . 0.0 110.404 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.5 -37.6 78.69 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.348 1.059 . . . . 0.0 113.221 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.411 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.61 -51.99 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.945 1.298 . . . . 0.0 111.329 170.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.52 -35.94 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.416 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.64 -23.98 60.21 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.2 -25.85 11.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.8 16.25 3.32 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -166.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.05 -38.49 2.34 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -118.06 15.79 14.16 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.36 1.064 . . . . 0.0 113.055 -171.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 p -114.93 152.7 46.76 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.98 0.912 . . . . 0.0 111.464 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.77 -30.68 57.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.282 2.655 . . . . 0.0 115.205 -172.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.69 64.26 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.643 1.177 . . . . 0.0 114.173 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.93 -31.81 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.424 1.011 . . . . 0.0 112.515 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.1 mt -71.45 -55.05 6.23 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.987 1.315 . . . . 0.0 112.972 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.85 -30.14 49.5 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.685 1.637 . . . . 0.0 112.652 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.411 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.6 mtm -69.06 -40.24 78.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.894 1.225 . . . . 0.0 112.65 172.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.22 -46.55 82.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.768 0.713 . . . . 0.0 111.522 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -60.94 -44.69 96.9 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -32.27 71.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.279 1.031 . . . . 0.0 113.246 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.1 4.48 53.65 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.406 1.482 . . . . 0.0 113.539 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.7 p -133.0 22.78 4.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.52 120.35 6.02 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.473 -1.392 . . . . 0.0 111.483 168.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.44 11.63 59.86 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.447 0.939 . . . . 0.0 115.447 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.57 130.88 47.06 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.525 1.663 . . . . 0.0 112.528 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.3 p -73.28 159.66 84.42 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.722 0.809 . . . . 0.0 110.711 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.58 -35.38 37.25 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.134 1.89 . . . . 0.0 115.47 168.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -67.19 -40.2 86.48 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.28 -45.25 93.97 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.626 -0.671 . . . . 0.0 111.098 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.5 mt -63.71 -44.32 93.97 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.351 1.06 . . . . 0.0 112.127 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -59.15 -41.48 88.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.642 0.656 . . . . 0.0 111.984 171.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 m -60.18 -45.28 93.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.599 0.636 . . . . 0.0 111.11 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.42 -48.86 78.01 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.246 0.93 . . . . 0.0 112.153 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.16 -38.44 91.19 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.84 -33.23 70.19 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 p -73.88 -12.44 60.67 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.5 m -122.19 8.14 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.28 -4.5 6.51 Favored Glycine 0 CA--C 1.542 1.753 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.8 -33.51 56.01 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 119.256 1.528 . . . . 0.0 115.389 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -91.18 78.29 5.86 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.802 1.301 . . . . 0.0 110.55 171.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.77 -35.92 34.21 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.95 74.73 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 120.023 1.283 . . . . 0.0 112.303 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.44 -43.54 85.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.194 0.597 . . . . 0.0 111.353 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -62.99 -40.17 96.93 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.545 -0.722 . . . . 0.0 112.263 175.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.95 -49.99 73.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.314 1.045 . . . . 0.0 111.565 173.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.1 tpp -56.04 -45.43 79.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.096 0.958 . . . . 0.0 112.205 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.85 -48.77 79.05 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.289 0.636 . . . . 0.0 112.087 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.72 -38.37 90.84 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.45 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.86 -45.56 92.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.698 0.681 . . . . 0.0 112.014 170.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.9 m -62.56 -42.41 99.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.777 0.717 . . . . 0.0 112.128 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.81 -46.2 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.514 -0.741 . . . . 0.0 111.041 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.07 -39.45 94.09 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.829 0.741 . . . . 0.0 112.759 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.78 -47.46 86.24 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.78 0.832 . . . . 0.0 111.964 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -70.07 -34.41 73.16 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.24 91.71 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.437 -0.789 . . . . 0.0 112.403 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.14 98.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.232 0.613 . . . . 0.0 111.781 172.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.19 99.59 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.834 -0.541 . . . . 0.0 112.183 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.85 -48.69 79.06 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.648 0.658 . . . . 0.0 111.665 173.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.95 -30.13 71.33 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.21 -39.22 78.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.399 1.08 . . . . 0.0 112.443 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.49 42.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.739 1.216 . . . . 0.0 113.32 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.81 60.92 53.35 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 126.675 1.99 . . . . 0.0 111.249 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.94 119.99 7.21 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.509 2.139 . . . . 0.0 110.306 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.24 136.16 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.342 1.457 . . . . 0.0 112.144 -169.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -79.92 160.43 26.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.101 0.561 . . . . 0.0 110.861 168.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.31 -19.8 64.93 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.03 174.68 41.65 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.083 1.325 . . . . 0.0 112.653 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.49 169.11 14.8 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.644 2.896 . . . . 0.0 112.954 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.7 mt -57.65 -39.11 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.894 1.278 . . . . 0.0 111.739 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.54 161.92 28.55 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.841 1.656 . . . . 0.0 110.584 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.96 133.47 23.1 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.479 2.786 . . . . 0.0 113.116 168.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.05 60.32 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.605 1.098 . . . . 0.0 115.019 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.15 143.31 37.37 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.946 1.373 . . . . 0.0 110.234 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.12 145.44 54.38 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.729 -0.607 . . . . 0.0 110.805 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -68.65 153.07 44.46 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.641 0.776 . . . . 0.0 111.673 171.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -72.16 131.7 85.01 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.858 170.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.37 140.53 44.38 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.137 1.891 . . . . 0.0 112.383 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 67.8 mtp85 -75.31 171.59 13.93 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.727 1.611 . . . . 0.0 111.859 163.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.37 -43.72 93.75 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 123.274 0.464 . . . . 0.0 113.04 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.5 p -69.15 -25.64 64.47 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -72.72 -41.66 64.98 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.02 -1.05 . . . . 0.0 111.71 171.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.73 -42.74 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.648 0.779 . . . . 0.0 110.824 173.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.11 -1.16 13.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.0 18.03 74.16 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.953 -1.092 . . . . 0.0 115.453 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.62 19.18 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.147 1.473 . . . . 0.0 113.259 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.2 p -125.9 -0.86 7.26 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.9 p -104.59 149.06 25.84 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.045 0.938 . . . . 0.0 111.798 173.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.4 p -80.95 162.18 23.99 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.348 0.595 . . . . 0.0 110.747 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.2 tp -56.85 -39.32 74.05 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.423 -0.798 . . . . 0.0 111.397 169.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.62 -39.06 93.41 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.558 -0.714 . . . . 0.0 112.644 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -64.37 -42.83 95.97 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.666 -0.646 . . . . 0.0 112.028 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -60.68 -46.35 90.7 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.677 0.791 . . . . 0.0 112.192 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.34 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 110.305 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.43 -51.17 53.36 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.83 0.729 . . . . 0.0 112.913 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.19 -50.08 73.23 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.788 0.794 . . . . 0.0 112.526 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.69 -18.5 64.27 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.1 p -111.81 8.33 20.5 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.675 1.19 . . . . 0.0 113.018 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.36 162.31 1.56 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.009 1.324 . . . . 0.0 111.433 165.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.52 103.38 49.02 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.089 0.956 . . . . 0.0 110.787 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.03 163.83 89.2 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.477 0.849 . . . . 0.0 111.746 -6.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -50.01 141.42 29.71 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.208 2.606 . . . . 0.0 114.173 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.19 96.36 2.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.97 54.6 3.5 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.326 2.684 . . . . 0.0 112.89 -152.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.61 -34.89 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.44 -46.16 94.4 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 118.641 0.655 . . . . 0.0 113.004 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.74 -36.96 76.29 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.313 -1.11 . . . . 0.0 112.667 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.88 -44.63 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.802 -0.561 . . . . 0.0 109.94 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.85 -40.42 91.7 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.327 -0.858 . . . . 0.0 112.547 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -42.02 74.98 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.395 -0.816 . . . . 0.0 112.259 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.72 -45.24 82.0 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.945 0.793 . . . . 0.0 112.093 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.26 -40.53 86.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.308 0.643 . . . . 0.0 112.251 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.68 -47.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.032 0.533 . . . . 0.0 110.279 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.19 -37.37 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.698 1.199 . . . . 0.0 112.263 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.75 98.36 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.039 0.836 . . . . 0.0 111.245 171.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.5 -45.2 91.08 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.879 0.752 . . . . 0.0 113.235 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.4 -42.28 86.81 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.019 0.91 . . . . 0.0 111.114 173.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.52 -50.2 70.6 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.788 0.835 . . . . 0.0 112.43 173.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -55.84 -43.0 76.62 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.872 0.76 . . . . 0.0 112.062 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.0 mt -64.47 -48.64 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.332 0.653 . . . . 0.0 111.361 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.28 -31.61 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.8 1.182 . . . . 0.0 112.978 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.98 -39.64 90.38 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.057 0.844 . . . . 0.0 111.877 171.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.4 ttp -84.45 -33.36 23.66 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.758 1.623 . . . . 0.0 113.976 -173.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 . . . . . 0 C--O 1.255 1.351 0 C-N-CA 127.599 2.36 . . . . 0.0 114.287 -169.744 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.697 0 N-CA-C 112.967 0.333 . . . . 0.0 112.967 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -92.01 135.02 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.51 1.124 . . . . 0.0 108.448 163.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.04 154.69 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.067 1.347 . . . . 0.0 109.709 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.29 116.62 32.47 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.555 0.742 . . . . 0.0 109.166 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.44 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.573 0.702 . . . . 0.0 112.476 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.87 -26.5 68.8 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -85.68 -2.13 57.88 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.792 1.237 . . . . 0.0 112.998 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.21 85.8 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.426 1.012 . . . . 0.0 114.094 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.14 35.13 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.883 1.342 . . . . 0.0 109.695 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.88 125.53 29.48 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 168.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.86 123.39 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.077 1.351 . . . . 0.0 108.648 -174.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.7 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.1 48.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.36 20.98 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.988 0.813 . . . . 0.0 111.217 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.46 136.84 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.605 -0.684 . . . . 0.0 111.537 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.03 93.23 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.1 -34.54 68.75 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.86 2.373 . . . . 0.0 113.572 167.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.48 -38.06 86.47 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.464 -0.773 . . . . 0.0 112.521 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.98 -44.2 97.72 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.805 0.729 . . . . 0.0 111.382 171.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.65 -44.28 94.3 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.341 0.519 . . . . 0.0 112.292 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.26 -47.16 86.39 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.149 0.58 . . . . 0.0 111.338 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.26 95.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.621 0.768 . . . . 0.0 111.856 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -60.31 -46.73 88.83 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.835 0.854 . . . . 0.0 112.818 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.87 -54.53 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.443 0.565 . . . . 0.0 110.31 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.76 -37.23 78.44 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.332 1.053 . . . . 0.0 113.256 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.82 -52.33 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.227 1.411 . . . . 0.0 111.202 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -65.42 -36.08 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.016 0.526 . . . . 0.0 111.484 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.54 -24.05 59.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.2 -25.47 11.5 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.17 16.07 3.24 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -165.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.97 -37.22 2.82 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -175.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.14 15.37 14.09 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.539 1.136 . . . . 0.0 113.087 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -114.9 152.88 46.9 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.937 0.895 . . . . 0.0 111.458 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.75 -30.83 58.42 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.253 2.636 . . . . 0.0 115.222 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -61.93 -20.88 64.27 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.89 -31.84 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.448 1.022 . . . . 0.0 112.512 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.44 -55.07 6.24 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.97 1.308 . . . . 0.0 112.961 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.87 -30.08 49.42 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.72 1.65 . . . . 0.0 112.685 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -68.99 -40.24 78.87 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.849 1.204 . . . . 0.0 112.63 172.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.33 -46.48 83.21 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.771 0.714 . . . . 0.0 111.585 169.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.1 m -61.09 -44.44 97.36 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.76 71.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.281 1.033 . . . . 0.0 113.261 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.61 4.54 53.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.372 1.469 . . . . 0.0 113.508 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.9 p -133.09 22.83 4.14 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -176.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.57 120.31 5.99 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.422 -1.424 . . . . 0.0 111.45 168.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.67 60.04 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.5 130.79 46.75 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.498 1.649 . . . . 0.0 112.53 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.0 p -73.28 159.63 84.51 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.741 0.816 . . . . 0.0 110.666 167.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.46 -35.58 36.67 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.183 1.922 . . . . 0.0 115.422 168.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.96 -40.27 87.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.32 -45.38 93.6 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.662 -0.649 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.53 -44.22 94.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.342 1.057 . . . . 0.0 112.162 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -59.3 -41.35 88.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.587 0.63 . . . . 0.0 112.008 171.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.32 -45.33 93.8 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.65 0.659 . . . . 0.0 111.098 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.29 -48.96 77.57 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.175 0.898 . . . . 0.0 112.143 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.04 -38.6 91.83 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.84 -33.96 71.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.6 p -73.1 -12.64 60.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 m -122.25 7.53 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.68 -5.35 5.08 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 117.094 1.598 . . . . 0.0 117.094 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.56 56.15 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 119.1 1.45 . . . . 0.0 115.519 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -91.22 79.59 5.68 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.977 1.388 . . . . 0.0 110.594 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.82 -36.18 47.1 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.04 -41.21 71.11 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.131 1.332 . . . . 0.0 112.328 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.6 86.3 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.772 -0.58 . . . . 0.0 111.296 172.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.06 -40.07 96.6 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.538 -0.726 . . . . 0.0 112.239 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.91 -50.1 73.6 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.087 -1.008 . . . . 0.0 111.538 173.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.3 tpp -55.99 -45.41 79.01 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.051 0.941 . . . . 0.0 112.231 174.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.93 -48.73 79.14 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.307 0.643 . . . . 0.0 112.109 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.63 -38.31 90.65 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.455 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.03 -45.43 92.85 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 112.019 170.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.6 m -62.67 -42.4 99.6 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.842 0.746 . . . . 0.0 112.113 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.92 -46.04 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.472 -0.768 . . . . 0.0 111.063 174.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.11 -39.44 94.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.876 0.762 . . . . 0.0 112.757 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -60.87 -47.4 86.53 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.714 0.806 . . . . 0.0 111.95 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.12 -34.3 72.92 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.71 -41.79 91.89 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.447 -0.783 . . . . 0.0 112.33 172.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.02 98.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.248 0.619 . . . . 0.0 111.799 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.19 -42.23 99.3 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.812 -0.555 . . . . 0.0 112.211 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.82 -48.38 79.9 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.696 0.68 . . . . 0.0 111.675 173.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -63.16 -30.33 71.5 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.13 -38.96 79.13 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.306 1.042 . . . . 0.0 112.489 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.31 -27.64 42.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.833 1.253 . . . . 0.0 113.346 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.79 61.04 54.13 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.583 1.953 . . . . 0.0 111.22 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.95 120.12 7.39 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.452 2.102 . . . . 0.0 110.266 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.42 136.56 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.283 1.433 . . . . 0.0 112.119 -169.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.07 160.49 25.78 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.098 0.559 . . . . 0.0 110.905 168.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.26 -19.92 64.99 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 174.8 41.62 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.018 1.294 . . . . 0.0 112.602 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.62 169.16 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.944 177.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.61 -39.21 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.88 1.272 . . . . 0.0 111.801 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.49 161.93 28.54 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.817 1.647 . . . . 0.0 110.549 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.441 2.761 . . . . 0.0 113.132 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -15.03 60.34 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.577 1.084 . . . . 0.0 115.065 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.35 37.47 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.928 1.364 . . . . 0.0 110.198 173.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.2 145.62 54.14 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.753 -0.592 . . . . 0.0 110.835 168.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.51 152.72 44.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.717 0.807 . . . . 0.0 111.653 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.27 131.75 84.78 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.886 -0.578 . . . . 0.0 109.797 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.46 140.25 43.31 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.122 1.881 . . . . 0.0 112.414 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.3 mtp85 -74.86 171.58 13.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.716 1.607 . . . . 0.0 111.849 163.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.52 -43.87 93.97 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.934 -0.479 . . . . 0.0 113.029 168.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.73 -25.83 64.95 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 175.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.75 -41.6 64.93 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.986 -1.071 . . . . 0.0 111.739 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.68 -42.69 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.716 0.806 . . . . 0.0 110.756 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.91 -1.32 13.94 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 173.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.91 18.17 74.14 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.603 1.096 . . . . 0.0 115.488 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.3 -19.38 19.31 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.073 1.436 . . . . 0.0 113.284 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.0 p -126.23 -1.48 7.01 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.71 149.99 24.46 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.024 0.93 . . . . 0.0 111.737 173.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 p -81.89 162.32 22.81 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.293 0.568 . . . . 0.0 110.811 170.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.74 -39.49 74.06 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.424 -0.798 . . . . 0.0 111.425 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.59 -38.82 92.59 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.518 -0.739 . . . . 0.0 112.657 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -64.67 -42.75 95.15 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.622 -0.673 . . . . 0.0 111.997 171.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.3 90.87 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.58 0.752 . . . . 0.0 112.146 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.5 -46.4 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.151 0.981 . . . . 0.0 110.256 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.45 -51.04 54.34 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.793 0.711 . . . . 0.0 112.881 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.828 0.814 . . . . 0.0 112.485 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.68 -18.39 64.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.96 8.35 20.24 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.664 1.186 . . . . 0.0 113.033 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.43 162.31 1.6 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.978 1.311 . . . . 0.0 111.412 165.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.36 48.93 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.005 0.922 . . . . 0.0 110.836 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.14 163.81 89.19 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-N 119.462 0.844 . . . . 0.0 111.715 -6.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -49.95 141.29 29.56 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.205 2.604 . . . . 0.0 114.169 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.13 96.49 2.49 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 163.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.92 54.52 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.257 2.638 . . . . 0.0 112.909 -152.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.83 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.26 94.22 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.985 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.91 -36.78 75.65 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.358 -1.084 . . . . 0.0 112.648 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.03 -44.46 99.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.745 -0.597 . . . . 0.0 109.951 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.93 -40.42 91.4 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.313 -0.867 . . . . 0.0 112.489 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -41.96 74.96 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.8 -45.29 82.31 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.912 0.778 . . . . 0.0 112.093 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.25 -40.51 86.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.233 0.613 . . . . 0.0 112.279 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.57 -47.37 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.23 174.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -61.91 -37.29 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.707 1.203 . . . . 0.0 112.355 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.88 -42.83 98.73 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.057 0.844 . . . . 0.0 111.187 171.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.58 -44.99 91.83 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.87 0.748 . . . . 0.0 113.257 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.24 -42.69 86.88 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.876 0.87 . . . . 0.0 110.997 173.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.17 70.6 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.791 0.836 . . . . 0.0 112.454 173.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.74 -43.41 76.58 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 118.87 0.759 . . . . 0.0 111.992 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.1 mt -64.47 -48.19 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.342 0.657 . . . . 0.0 111.361 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.44 -31.66 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.73 1.15 . . . . 0.0 112.983 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -61.67 -43.58 98.58 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.168 0.895 . . . . 0.0 111.649 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.9 ttp -77.11 -35.75 56.12 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.726 1.61 . . . . 0.0 113.696 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 127.641 2.376 . . . . 0.0 114.205 -168.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 N--CA 1.48 0.686 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.81 135.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.03 154.89 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.665 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.61 116.71 32.53 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.521 0.729 . . . . 0.0 109.19 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.46 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.507 0.67 . . . . 0.0 112.474 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.54 68.79 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.58 -2.18 57.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.851 1.26 . . . . 0.0 113.043 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.94 3.1 85.8 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.458 1.028 . . . . 0.0 114.08 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.2 35.34 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.883 1.342 . . . . 0.0 109.727 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.85 125.55 29.51 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.94 123.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.074 1.349 . . . . 0.0 108.629 -174.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.58 139.66 38.57 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.487 0.66 . . . . 0.0 111.239 170.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.07 48.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.491 1.916 . . . . 0.0 107.921 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.2 152.37 20.77 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.019 0.827 . . . . 0.0 111.259 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.87 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.462 0.649 . . . . 0.0 111.579 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.01 93.24 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.99 -34.56 67.76 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.907 2.405 . . . . 0.0 113.604 167.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.48 -38.06 86.47 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.457 -0.777 . . . . 0.0 112.594 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 m -60.93 -44.31 97.41 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.691 0.678 . . . . 0.0 111.401 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.52 -44.39 94.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.251 0.478 . . . . 0.0 112.256 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.18 -47.3 85.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.115 0.566 . . . . 0.0 111.366 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.23 95.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.672 0.789 . . . . 0.0 111.908 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -60.16 -47.16 87.08 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.806 0.842 . . . . 0.0 112.783 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.75 -54.57 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.443 0.565 . . . . 0.0 110.375 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.62 -37.36 78.4 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.296 1.039 . . . . 0.0 113.234 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.401 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.43 -52.16 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.094 1.358 . . . . 0.0 111.296 170.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -64.8 -35.86 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 122.909 0.484 . . . . 0.0 111.471 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.74 -23.82 60.56 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.38 -25.64 11.35 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.06 16.16 3.26 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -166.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.42 -37.95 2.57 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -118.17 15.66 14.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.438 1.095 . . . . 0.0 113.057 -172.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.0 p -115.0 152.86 46.97 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.966 0.907 . . . . 0.0 111.463 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.88 -30.61 58.75 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.262 2.641 . . . . 0.0 115.208 -172.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.19 -20.67 64.41 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.87 -31.84 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.41 1.005 . . . . 0.0 112.548 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.6 mt -71.47 -55.05 6.21 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.966 1.307 . . . . 0.0 112.971 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.88 -30.05 49.34 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.653 1.626 . . . . 0.0 112.641 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.401 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.16 -40.16 78.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.867 1.212 . . . . 0.0 112.602 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.25 -46.46 83.01 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.808 0.731 . . . . 0.0 111.576 169.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.6 m -61.12 -44.42 97.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.0 71.51 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.333 1.053 . . . . 0.0 113.208 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.41 4.5 53.27 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.367 1.467 . . . . 0.0 113.488 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.5 p -133.01 22.8 4.16 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.68 120.31 6.05 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 120.477 -1.389 . . . . 0.0 111.477 168.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.63 11.57 60.24 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.377 0.911 . . . . 0.0 115.377 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.52 130.88 47.14 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.575 1.687 . . . . 0.0 112.464 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.39 159.64 84.35 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.758 0.823 . . . . 0.0 110.685 167.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.61 -35.4 37.6 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.144 1.896 . . . . 0.0 115.4 168.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -66.99 -40.29 87.36 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 174.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.35 93.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.039 172.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.56 -44.26 94.64 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 112.133 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -59.17 -41.49 88.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.618 0.645 . . . . 0.0 112.031 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.8 m -60.29 -45.22 94.1 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.582 0.628 . . . . 0.0 111.074 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.37 -48.91 77.8 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.254 0.934 . . . . 0.0 112.179 174.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.13 -38.45 91.24 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.89 -33.45 70.54 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.4 p -73.65 -12.5 60.76 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 m -122.19 7.88 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.72 -4.62 5.77 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 117.159 1.624 . . . . 0.0 117.159 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.88 -33.13 56.19 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 119.224 1.512 . . . . 0.0 115.423 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -91.32 78.7 5.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.892 1.346 . . . . 0.0 110.605 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.26 -35.82 39.1 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -173.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.41 -41.1 73.38 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.086 1.312 . . . . 0.0 112.315 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.28 -43.56 86.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.167 0.587 . . . . 0.0 111.337 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.3 tpp -63.1 -40.1 96.65 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.565 -0.709 . . . . 0.0 112.229 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.93 -50.02 73.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.218 1.007 . . . . 0.0 111.539 173.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.95 -45.5 78.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.044 0.938 . . . . 0.0 112.233 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -61.88 -48.77 79.01 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.276 0.63 . . . . 0.0 112.055 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.64 -38.28 90.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.845 0.858 . . . . 0.0 112.479 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.98 -45.45 92.67 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.668 0.667 . . . . 0.0 112.048 170.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.7 -42.39 99.61 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.815 0.734 . . . . 0.0 112.082 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.85 -46.1 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.441 -0.787 . . . . 0.0 111.059 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.08 -39.46 94.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.831 0.741 . . . . 0.0 112.736 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.84 -47.37 86.69 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.667 0.787 . . . . 0.0 111.971 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -70.13 -34.3 72.89 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.68 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.43 -0.794 . . . . 0.0 112.361 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.11 98.68 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.231 0.613 . . . . 0.0 111.781 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.21 99.57 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 0.0 112.218 174.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.85 -48.55 79.47 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.667 0.667 . . . . 0.0 111.726 173.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.04 -30.25 71.46 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.12 -39.18 79.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.343 1.057 . . . . 0.0 112.499 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.64 42.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 113.29 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.72 61.01 54.1 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.67 1.988 . . . . 0.0 111.247 -174.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.9 120.17 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.452 2.101 . . . . 0.0 110.315 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.36 136.31 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.377 1.471 . . . . 0.0 112.136 -169.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.97 160.45 25.92 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.124 0.57 . . . . 0.0 110.855 168.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.91 65.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.99 174.77 41.63 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.059 1.314 . . . . 0.0 112.64 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.58 169.15 14.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.682 2.921 . . . . 0.0 112.878 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.68 -39.15 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.873 1.269 . . . . 0.0 111.787 -175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.51 161.9 28.6 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.856 1.662 . . . . 0.0 110.561 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.83 133.42 22.44 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.519 2.812 . . . . 0.0 113.132 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.89 -15.0 60.33 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.551 1.072 . . . . 0.0 115.001 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.11 143.39 37.38 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.996 1.398 . . . . 0.0 110.214 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.24 145.52 54.19 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.664 -0.647 . . . . 0.0 110.793 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.52 152.78 44.91 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.674 0.79 . . . . 0.0 111.617 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.23 131.68 84.9 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.883 -0.58 . . . . 0.0 109.821 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.37 140.4 44.03 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.076 1.851 . . . . 0.0 112.426 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -75.08 171.66 13.72 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.679 1.592 . . . . 0.0 111.89 163.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.78 94.19 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.912 -0.493 . . . . 0.0 113.04 168.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.1 p -68.81 -25.78 64.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.7 64.98 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.989 -1.069 . . . . 0.0 111.727 171.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.6 -42.74 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.704 0.801 . . . . 0.0 110.771 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.2 13.79 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.92 18.11 74.09 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.897 -1.127 . . . . 0.0 115.496 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.47 19.29 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.073 1.436 . . . . 0.0 113.29 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -126.18 -1.38 7.04 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.67 149.91 24.51 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.14 0.976 . . . . 0.0 111.763 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.0 p -81.86 162.27 22.87 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.319 0.581 . . . . 0.0 110.778 170.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.74 -39.4 73.89 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.415 -0.803 . . . . 0.0 111.404 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.55 -38.97 93.16 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.481 -0.762 . . . . 0.0 112.659 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.77 95.55 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.39 90.54 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.119 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.4 -46.39 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.203 1.001 . . . . 0.0 110.285 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.01 54.55 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.753 0.692 . . . . 0.0 112.945 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.32 -50.01 73.34 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.751 0.776 . . . . 0.0 112.537 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.69 -18.49 64.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.93 8.42 20.32 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.651 1.18 . . . . 0.0 113.035 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.45 162.31 1.62 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.989 1.316 . . . . 0.0 111.414 165.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.451 0.84 . . . . 0.0 111.701 -6.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.99 141.33 29.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.258 2.639 . . . . 0.0 114.136 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.3 mt -96.15 96.49 2.5 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 163.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -86.02 54.59 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.289 2.659 . . . . 0.0 112.86 -152.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.84 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.36 -46.34 94.07 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 118.605 0.639 . . . . 0.0 112.958 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.82 -36.8 75.93 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.313 -1.11 . . . . 0.0 112.678 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.97 -44.56 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.732 -0.605 . . . . 0.0 109.942 174.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.46 91.67 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.292 -0.88 . . . . 0.0 112.504 176.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.04 75.08 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.275 173.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.67 -45.23 81.82 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.901 0.773 . . . . 0.0 112.12 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.31 -40.5 86.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.296 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.62 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.044 0.538 . . . . 0.0 110.291 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.03 -37.35 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.683 1.193 . . . . 0.0 112.355 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.75 98.19 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.03 0.832 . . . . 0.0 111.275 171.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.67 -45.0 91.52 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.828 0.727 . . . . 0.0 113.23 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.4 -42.42 87.11 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.075 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.21 70.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.811 0.844 . . . . 0.0 112.425 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.79 -43.28 76.68 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.892 0.769 . . . . 0.0 111.968 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.37 -48.36 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.337 0.655 . . . . 0.0 111.415 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.34 -31.74 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 119.725 1.148 . . . . 0.0 113.012 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -61.14 -41.76 97.31 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.074 0.852 . . . . 0.0 111.722 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.7 ttp -80.96 -34.43 33.16 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.738 1.615 . . . . 0.0 113.935 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 127.614 2.366 . . . . 0.0 114.236 -169.036 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.81 135.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.08 154.81 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.685 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.55 116.74 32.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.488 0.715 . . . . 0.0 109.191 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.84 -26.49 68.78 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -173.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.58 -2.21 57.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.852 1.261 . . . . 0.0 112.991 175.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.02 85.77 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.5 1.048 . . . . 0.0 114.144 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.7 128.23 35.47 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.801 1.301 . . . . 0.0 109.678 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.89 125.57 29.55 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.88 123.39 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.11 1.364 . . . . 0.0 108.7 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.71 38.55 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.72 141.11 48.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.465 1.906 . . . . 0.0 107.929 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.27 152.4 20.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.217 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.9 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.607 -0.683 . . . . 0.0 111.579 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.66 130.01 93.24 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.068 0.547 . . . . 0.0 111.125 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.887 2.391 . . . . 0.0 113.575 167.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.41 -38.05 86.6 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.451 -0.78 . . . . 0.0 112.587 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.8 m -60.96 -44.32 97.48 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.747 0.703 . . . . 0.0 111.386 171.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.54 -44.37 94.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.258 0.481 . . . . 0.0 112.244 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.22 -47.27 85.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.115 0.566 . . . . 0.0 111.37 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.96 -45.26 95.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.67 0.788 . . . . 0.0 111.914 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.22 -47.09 87.42 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.868 0.867 . . . . 0.0 112.774 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.8 t -56.82 -54.55 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.489 0.586 . . . . 0.0 110.31 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.61 -37.4 78.47 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.35 1.06 . . . . 0.0 113.247 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.36 -52.17 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.092 1.357 . . . . 0.0 111.302 170.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.82 -35.99 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.996 0.518 . . . . 0.0 111.407 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.69 -23.86 60.3 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.34 -25.62 11.38 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -136.03 16.15 3.27 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -166.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.47 -37.91 2.61 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -118.08 15.62 14.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.478 1.111 . . . . 0.0 113.107 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.7 p -114.91 152.87 46.9 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.959 0.903 . . . . 0.0 111.49 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.86 -30.63 58.77 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.238 2.625 . . . . 0.0 115.276 -172.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.11 -20.73 64.36 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.81 -31.96 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 119.466 1.03 . . . . 0.0 112.479 176.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.36 -55.07 6.34 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.957 1.303 . . . . 0.0 112.995 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.88 -30.08 49.28 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.681 1.636 . . . . 0.0 112.671 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.05 -40.2 78.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.914 1.234 . . . . 0.0 112.665 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.3 -46.48 83.12 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.421 0.689 . . . . 0.0 111.576 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -61.07 -44.45 97.36 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.85 -32.03 71.45 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.284 1.034 . . . . 0.0 113.278 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.36 4.47 53.36 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.355 1.462 . . . . 0.0 113.484 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -133.03 22.84 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.58 120.3 5.99 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.456 -1.402 . . . . 0.0 111.432 168.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.67 60.04 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 130.88 47.14 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.498 1.649 . . . . 0.0 112.482 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.35 159.66 84.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.753 0.821 . . . . 0.0 110.666 167.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.22 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.34 -45.33 93.83 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.66 -0.65 . . . . 0.0 111.1 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -59.28 -41.34 88.68 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.692 -0.63 . . . . 0.0 112.02 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.27 -45.32 93.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.596 0.634 . . . . 0.0 111.097 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.32 -48.91 77.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.233 0.924 . . . . 0.0 112.179 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.11 -38.46 91.27 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.91 -33.56 70.69 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.9 p -73.5 -12.54 60.82 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.24 7.85 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.54 -4.69 5.55 Favored Glycine 0 CA--C 1.541 1.684 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.96 -32.99 56.57 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.186 1.493 . . . . 0.0 115.435 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -91.28 78.76 5.74 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.918 1.359 . . . . 0.0 110.619 171.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.36 -35.92 40.74 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.43 -41.15 73.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.137 1.335 . . . . 0.0 112.293 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.51 86.07 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.139 0.576 . . . . 0.0 111.329 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.09 -40.12 96.71 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.514 -0.741 . . . . 0.0 112.198 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.98 -49.97 74.1 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.202 1.001 . . . . 0.0 111.518 173.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.97 -45.46 78.92 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.094 0.958 . . . . 0.0 112.245 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.91 -48.77 78.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.331 0.652 . . . . 0.0 112.055 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.66 -38.27 90.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.453 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.01 -45.48 92.62 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.664 0.665 . . . . 0.0 112.048 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.65 -42.37 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.118 175.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.85 -46.14 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.441 -0.787 . . . . 0.0 111.03 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.06 -39.46 94.13 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.842 0.746 . . . . 0.0 112.736 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -60.78 -47.49 86.1 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.943 174.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.06 -34.33 73.07 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.69 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.408 -0.808 . . . . 0.0 112.361 172.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.09 98.7 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.215 0.606 . . . . 0.0 111.751 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.12 -42.25 99.49 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.86 -0.525 . . . . 0.0 112.138 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.81 -48.52 79.5 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.666 0.666 . . . . 0.0 111.722 173.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.11 -30.19 71.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.22 -39.06 78.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.354 1.062 . . . . 0.0 112.482 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.3 -27.6 42.18 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.791 1.236 . . . . 0.0 113.29 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.78 60.99 53.88 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.639 1.976 . . . . 0.0 111.22 -174.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.92 120.21 7.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.481 2.12 . . . . 0.0 110.24 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.46 136.37 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.287 1.435 . . . . 0.0 112.13 -169.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.04 160.47 25.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.075 0.55 . . . . 0.0 110.915 168.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.92 65.01 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.11 1.338 . . . . 0.0 112.655 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.59 169.15 14.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.687 2.925 . . . . 0.0 112.878 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.68 -39.19 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.903 1.281 . . . . 0.0 111.749 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.44 161.97 28.44 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.817 1.647 . . . . 0.0 110.573 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.97 133.45 23.18 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.477 2.785 . . . . 0.0 113.149 168.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.99 60.34 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.613 1.101 . . . . 0.0 115.051 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.38 37.45 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.952 1.376 . . . . 0.0 110.198 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.51 54.26 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.66 -0.65 . . . . 0.0 110.842 168.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.48 152.73 44.98 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.684 0.794 . . . . 0.0 111.653 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.23 131.65 84.93 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.33 140.35 44.06 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -75.02 171.61 13.79 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.733 1.613 . . . . 0.0 111.867 163.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.57 -43.9 94.05 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.876 -0.515 . . . . 0.0 113.021 168.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.79 -25.78 64.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.69 -41.69 65.03 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.064 -1.022 . . . . 0.0 111.757 171.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.54 -42.84 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.73 0.812 . . . . 0.0 110.798 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.95 -1.26 13.83 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.98 18.15 74.24 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.626 1.107 . . . . 0.0 115.445 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.38 19.3 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.131 1.466 . . . . 0.0 113.301 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -126.2 -1.48 7.03 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.66 149.96 24.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.052 0.941 . . . . 0.0 111.788 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.5 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.293 0.568 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.83 -39.4 74.15 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.441 -0.787 . . . . 0.0 111.374 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.52 -38.93 93.02 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.531 -0.73 . . . . 0.0 112.685 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.64 -42.73 95.27 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 112.031 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.66 -46.37 90.58 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.651 0.78 . . . . 0.0 112.143 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.32 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.301 172.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.45 -51.06 54.19 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.782 0.706 . . . . 0.0 112.884 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 0.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.64 -18.49 64.3 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.87 8.36 20.4 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.703 1.201 . . . . 0.0 113.051 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.44 162.31 1.61 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.995 1.318 . . . . 0.0 111.447 165.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.34 48.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.035 0.934 . . . . 0.0 110.837 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.447 0.838 . . . . 0.0 111.701 -6.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.99 141.33 29.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.258 2.639 . . . . 0.0 114.136 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.17 96.48 2.51 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 163.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -86.0 54.56 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.257 2.638 . . . . 0.0 112.86 -152.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.56 -34.83 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.26 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.999 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.83 -36.87 75.95 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.91 -44.6 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.709 -0.62 . . . . 0.0 109.942 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.78 -40.5 92.02 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.307 -0.871 . . . . 0.0 112.559 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.78 -41.97 74.85 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.468 -0.77 . . . . 0.0 112.287 173.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.76 -45.22 82.2 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.889 0.768 . . . . 0.0 112.093 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.31 -40.5 86.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.296 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.62 -47.19 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.067 0.547 . . . . 0.0 110.272 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.15 -37.35 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.682 1.193 . . . . 0.0 112.292 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.82 -42.76 98.3 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.011 0.823 . . . . 0.0 111.244 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.59 -45.03 91.61 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.87 0.748 . . . . 0.0 113.252 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.4 -42.42 87.11 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.075 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.49 -50.16 70.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.811 0.844 . . . . 0.0 112.453 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.81 -43.27 76.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.875 0.762 . . . . 0.0 112.005 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.37 -48.36 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.337 0.655 . . . . 0.0 111.415 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.34 -31.81 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 119.725 1.148 . . . . 0.0 113.012 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -61.03 -42.07 97.76 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.058 0.845 . . . . 0.0 111.721 171.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.1 ttp -80.47 -34.64 35.73 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.761 1.624 . . . . 0.0 113.901 -174.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 127.621 2.368 . . . . 0.0 114.251 -168.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.998 0.345 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.9 mm -92.07 135.01 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.484 1.114 . . . . 0.0 108.489 163.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.03 154.6 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.076 1.35 . . . . 0.0 109.662 170.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.22 116.74 32.71 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.554 0.742 . . . . 0.0 109.201 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.53 177.98 7.01 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.557 0.694 . . . . 0.0 112.436 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.84 -26.54 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.63 -2.2 57.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.81 1.244 . . . . 0.0 113.047 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.97 3.17 85.66 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.418 1.009 . . . . 0.0 114.096 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.14 35.11 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.857 1.328 . . . . 0.0 109.726 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.84 125.55 29.52 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 168.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.84 123.38 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.077 1.351 . . . . 0.0 108.679 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.53 139.63 38.62 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.236 170.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.71 141.16 48.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.431 1.892 . . . . 0.0 107.897 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.28 152.44 20.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.803 . . . . 0.0 111.221 170.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.51 136.86 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.65 -0.656 . . . . 0.0 111.563 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.65 129.96 93.27 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.07 0.548 . . . . 0.0 111.155 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.05 -34.46 67.9 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.864 2.376 . . . . 0.0 113.597 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.55 -38.06 86.32 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.453 -0.779 . . . . 0.0 112.521 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.02 -44.13 97.86 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.805 0.729 . . . . 0.0 111.372 171.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.66 -44.37 93.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.354 0.525 . . . . 0.0 112.311 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.18 -47.11 86.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.424 0.556 . . . . 0.0 111.38 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.05 -45.34 95.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.612 0.765 . . . . 0.0 111.866 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -60.41 -46.39 90.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.808 0.843 . . . . 0.0 112.846 177.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.04 -54.51 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 118.458 0.572 . . . . 0.0 110.302 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.77 -37.11 78.14 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.404 1.082 . . . . 0.0 113.289 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.61 -52.41 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.398 1.479 . . . . 0.0 111.223 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.64 -36.2 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.069 0.548 . . . . 0.0 111.479 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.51 -24.24 60.03 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 175.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -106.93 -25.38 11.67 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -136.32 15.7 3.21 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -165.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.62 -37.36 2.53 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -117.23 12.5 14.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.478 1.111 . . . . 0.0 113.198 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.9 p -111.63 153.21 44.37 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.876 0.87 . . . . 0.0 111.497 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.83 -30.87 59.54 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.284 2.656 . . . . 0.0 115.173 -172.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.09 -20.98 64.59 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.61 -32.13 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.437 1.017 . . . . 0.0 112.458 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.41 -57.17 5.92 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.718 1.207 . . . . 0.0 112.538 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.89 -29.5 58.21 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 121.885 1.709 . . . . 0.0 112.786 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.13 -40.13 78.46 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.779 1.172 . . . . 0.0 112.698 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.25 -47.08 82.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.848 0.749 . . . . 0.0 111.546 169.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m -60.88 -44.11 97.53 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 175.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.54 70.96 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.249 1.019 . . . . 0.0 113.252 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -96.0 4.69 52.44 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.382 1.473 . . . . 0.0 113.491 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.8 p -133.17 22.78 4.11 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -53.57 120.25 5.92 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.437 -1.414 . . . . 0.0 111.42 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.6 11.68 60.35 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 115.391 0.916 . . . . 0.0 115.391 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.84 46.9 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.516 1.658 . . . . 0.0 112.481 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.27 159.68 84.4 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.718 0.807 . . . . 0.0 110.7 167.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.53 -35.5 37.15 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.144 1.896 . . . . 0.0 115.412 168.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.98 -40.32 87.4 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 174.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.29 -45.33 93.72 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.062 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.5 mt -63.53 -44.24 94.79 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.31 1.044 . . . . 0.0 112.151 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -59.26 -41.36 88.61 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.663 -0.648 . . . . 0.0 112.024 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.6 m -60.33 -45.43 93.45 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.626 0.648 . . . . 0.0 111.078 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.17 -49.01 77.29 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.218 0.917 . . . . 0.0 112.17 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.7 mt -63.04 -38.62 91.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.95 -34.2 71.49 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.3 p -72.88 -12.52 61.0 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.44 7.49 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.44 -5.75 5.23 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 117.102 1.601 . . . . 0.0 117.102 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.96 56.42 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 119.053 1.427 . . . . 0.0 115.526 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -90.23 79.8 6.33 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.029 1.414 . . . . 0.0 110.607 171.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -52.1 -36.28 50.44 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.23 -41.32 70.32 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.203 1.365 . . . . 0.0 112.348 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.17 -43.52 86.66 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.784 -0.573 . . . . 0.0 111.335 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -63.15 -40.03 96.38 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.566 -0.708 . . . . 0.0 112.204 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.88 -50.07 73.6 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.072 -1.017 . . . . 0.0 111.538 172.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.03 -45.38 79.19 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.056 0.942 . . . . 0.0 112.22 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.8 tp -61.96 -48.78 78.82 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.295 0.638 . . . . 0.0 112.045 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.71 -38.12 89.9 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.832 0.853 . . . . 0.0 112.45 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.06 -45.53 92.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.653 0.661 . . . . 0.0 112.001 170.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.61 -42.42 99.57 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.806 0.73 . . . . 0.0 112.114 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.9 -46.04 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.506 -0.747 . . . . 0.0 111.037 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -64.16 -39.44 94.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.887 0.767 . . . . 0.0 112.684 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -60.84 -47.44 86.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.934 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -70.05 -34.38 73.14 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.63 -41.98 92.02 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.49 -0.756 . . . . 0.0 112.299 172.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.57 -42.04 98.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.231 0.613 . . . . 0.0 111.784 172.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.15 -42.35 99.44 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.825 -0.547 . . . . 0.0 112.189 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -57.72 -48.48 79.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.677 0.671 . . . . 0.0 111.653 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.06 -30.4 71.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.09 -38.95 79.26 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.359 1.064 . . . . 0.0 112.488 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.44 -27.61 41.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.803 1.241 . . . . 0.0 113.318 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 60.98 53.81 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.583 1.953 . . . . 0.0 111.22 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.89 120.17 7.46 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.456 2.104 . . . . 0.0 110.296 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.52 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.335 1.454 . . . . 0.0 112.154 -169.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.12 160.46 25.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.1 0.56 . . . . 0.0 110.845 168.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.19 -19.96 64.98 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 174.7 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.069 1.319 . . . . 0.0 112.647 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.55 169.2 14.71 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.624 2.883 . . . . 0.0 112.944 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.65 -39.26 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.897 1.279 . . . . 0.0 111.762 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.45 161.91 28.56 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.862 1.665 . . . . 0.0 110.597 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.92 133.42 22.9 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.473 2.782 . . . . 0.0 113.132 168.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -15.05 60.3 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.531 1.063 . . . . 0.0 115.037 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.03 143.35 37.56 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.942 1.371 . . . . 0.0 110.197 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.14 145.64 54.17 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.663 -0.648 . . . . 0.0 110.793 168.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -68.59 152.67 45.05 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.677 0.791 . . . . 0.0 111.69 171.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -72.22 131.78 84.83 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.848 170.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.38 140.26 43.63 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.15 1.9 . . . . 0.0 112.465 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -74.87 171.65 13.65 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.707 1.603 . . . . 0.0 111.879 163.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.54 -44.0 93.95 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.921 -0.487 . . . . 0.0 112.955 168.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.66 -25.9 65.05 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.67 -41.61 65.19 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.057 -1.027 . . . . 0.0 111.777 171.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.66 -42.65 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.737 0.815 . . . . 0.0 110.819 173.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.98 -1.28 13.99 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.93 18.28 74.27 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.899 -1.126 . . . . 0.0 115.437 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.38 -19.39 19.24 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.115 1.458 . . . . 0.0 113.301 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 p -126.21 -1.55 7.02 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.3 p -103.43 150.05 24.22 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.099 0.96 . . . . 0.0 111.783 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.2 p -81.96 162.45 22.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.268 0.556 . . . . 0.0 110.848 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.87 -39.4 74.27 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.444 -0.785 . . . . 0.0 111.445 169.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.52 -38.87 92.8 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.513 -0.742 . . . . 0.0 112.688 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -64.59 -42.8 95.35 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.584 -0.698 . . . . 0.0 112.069 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.68 -46.3 90.87 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.574 0.75 . . . . 0.0 112.155 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.5 -46.36 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.122 0.969 . . . . 0.0 110.288 172.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.42 -51.01 54.42 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.806 0.717 . . . . 0.0 112.945 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.3 -50.09 73.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.751 0.776 . . . . 0.0 112.48 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.66 -18.35 64.26 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -112.01 8.39 20.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.628 1.171 . . . . 0.0 113.035 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.46 162.33 1.62 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.921 1.288 . . . . 0.0 111.461 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.93 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.065 0.946 . . . . 0.0 110.758 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.84 89.15 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.461 0.843 . . . . 0.0 111.713 -6.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -50.0 141.28 29.98 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.216 2.611 . . . . 0.0 114.206 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 74.9 mt -96.1 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 163.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.91 54.48 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.295 2.663 . . . . 0.0 112.884 -152.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.54 -34.85 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.26 94.22 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.985 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.91 -36.84 75.68 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.358 -1.083 . . . . 0.0 112.645 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.92 -44.61 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.753 -0.592 . . . . 0.0 109.987 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.79 -40.39 91.9 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.352 -0.842 . . . . 0.0 112.572 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -55.84 -41.99 75.11 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.476 -0.765 . . . . 0.0 112.287 173.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.76 -45.24 82.16 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.888 0.767 . . . . 0.0 112.125 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.27 -40.56 86.17 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.273 0.629 . . . . 0.0 112.246 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.48 -47.53 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 122.987 0.515 . . . . 0.0 110.216 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.97 -37.12 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.708 1.203 . . . . 0.0 112.326 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.85 98.55 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.107 0.867 . . . . 0.0 111.264 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.85 91.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.838 0.733 . . . . 0.0 113.199 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -58.1 -42.93 86.74 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.02 0.91 . . . . 0.0 110.987 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.24 70.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.842 0.857 . . . . 0.0 112.458 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -55.72 -43.44 76.55 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.894 0.77 . . . . 0.0 111.987 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.9 mt -64.57 -47.48 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 118.707 -0.663 . . . . 0.0 111.452 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.61 -32.99 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 119.918 1.235 . . . . 0.0 112.881 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -60.87 -46.46 90.51 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.949 0.9 . . . . 0.0 111.468 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.4 ttp -72.23 -38.38 68.95 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.588 1.555 . . . . 0.0 113.082 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.7 t80 . . . . . 0 C--O 1.251 1.156 0 C-N-CA 128.345 2.658 . . . . 0.0 114.73 -174.362 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.017 0.353 . . . . 0.0 113.017 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -92.0 135.05 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.51 1.124 . . . . 0.0 108.471 163.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.08 154.66 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.685 170.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.36 116.63 32.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.519 0.728 . . . . 0.0 109.181 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.4 177.97 6.92 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.55 0.69 . . . . 0.0 112.474 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.61 68.82 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.59 -2.12 57.83 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.746 1.219 . . . . 0.0 113.046 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.25 85.75 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.5 1.048 . . . . 0.0 114.066 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.82 128.16 35.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.848 1.324 . . . . 0.0 109.715 174.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.81 125.46 29.38 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 168.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.89 123.39 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.053 1.341 . . . . 0.0 108.659 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.66 141.1 48.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.513 1.925 . . . . 0.0 107.959 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.3 152.38 21.16 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.98 0.809 . . . . 0.0 111.274 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.49 136.85 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.645 -0.659 . . . . 0.0 111.61 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.0 93.24 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.02 -34.56 68.04 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.918 2.412 . . . . 0.0 113.569 167.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.46 -38.08 86.55 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.457 -0.777 . . . . 0.0 112.545 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.98 -44.21 97.7 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.718 0.69 . . . . 0.0 111.425 171.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.58 -44.42 94.11 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.291 0.496 . . . . 0.0 112.256 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.15 -47.17 86.26 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.441 0.564 . . . . 0.0 111.398 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.14 95.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.606 0.763 . . . . 0.0 111.879 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.7 t-105 -60.38 -46.83 88.57 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.734 0.813 . . . . 0.0 112.85 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.98 -54.16 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.436 0.562 . . . . 0.0 110.343 174.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.89 -37.14 78.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.391 1.076 . . . . 0.0 113.249 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.26 -52.46 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.236 1.414 . . . . 0.0 111.236 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.8 t -64.98 -36.09 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.023 0.529 . . . . 0.0 111.441 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.39 -24.04 58.86 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.51 -25.29 11.45 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -136.36 15.98 3.2 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -165.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.05 -36.98 2.77 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 -175.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -117.89 13.61 14.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.415 1.086 . . . . 0.0 113.114 -172.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.4 p -113.03 153.09 45.4 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.944 0.898 . . . . 0.0 111.55 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.88 -30.77 59.6 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.303 2.669 . . . . 0.0 115.181 -172.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -62.05 -20.82 64.36 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.81 -31.83 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.404 1.002 . . . . 0.0 112.525 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.49 -55.02 6.2 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 124.904 1.282 . . . . 0.0 112.968 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.84 -30.15 49.58 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.718 1.649 . . . . 0.0 112.633 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.0 -40.25 78.83 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.911 1.232 . . . . 0.0 112.669 172.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -57.23 -46.53 82.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.716 0.689 . . . . 0.0 111.592 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.2 m -61.04 -44.45 97.39 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.83 71.34 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.317 1.047 . . . . 0.0 113.229 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.54 4.5 53.13 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.455 1.502 . . . . 0.0 113.522 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -133.03 22.76 4.16 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.55 120.26 5.92 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.44 -1.413 . . . . 0.0 111.517 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.52 11.72 60.23 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.57 130.84 46.89 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.546 1.673 . . . . 0.0 112.437 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.31 159.68 84.36 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.7 167.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.53 -35.53 37.25 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.144 1.896 . . . . 0.0 115.412 168.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.96 -40.26 87.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.37 -45.31 93.95 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.695 -0.628 . . . . 0.0 111.038 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -59.18 -41.49 88.61 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.696 -0.628 . . . . 0.0 112.031 171.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.2 m -60.23 -45.28 93.77 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.582 0.628 . . . . 0.0 111.11 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.34 -48.99 77.56 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.246 0.93 . . . . 0.0 112.165 174.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -62.98 -38.38 90.9 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.01 -33.42 70.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.9 p -73.49 -12.72 60.88 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.6 m -122.53 6.98 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.22 -4.1 7.78 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 117.414 1.726 . . . . 0.0 117.414 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.59 -35.58 67.49 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 119.353 1.576 . . . . 0.0 115.173 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -85.35 77.89 9.86 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.944 1.354 . . . . 0.0 110.5 170.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.86 -35.51 32.96 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.597 1.559 . . . . 0.0 115.165 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.6 -41.33 72.45 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.142 1.337 . . . . 0.0 112.345 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.61 86.14 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.767 -0.583 . . . . 0.0 111.362 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -63.11 -40.02 96.4 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.576 -0.702 . . . . 0.0 112.228 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.02 -49.94 74.26 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.018 -1.051 . . . . 0.0 111.523 173.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.97 -45.41 78.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.066 0.946 . . . . 0.0 112.251 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.6 tp -61.94 -48.77 78.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.307 0.643 . . . . 0.0 112.071 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.72 -38.28 90.51 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 0.0 112.44 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.98 -45.49 92.55 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.715 0.689 . . . . 0.0 112.034 170.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.62 -42.43 99.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.793 0.724 . . . . 0.0 112.109 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.82 -46.11 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.426 -0.796 . . . . 0.0 111.03 174.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.12 -39.43 94.03 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.869 0.759 . . . . 0.0 112.724 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -60.82 -47.4 86.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.721 0.808 . . . . 0.0 111.961 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -70.15 -34.3 72.85 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.81 91.08 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.44 -0.788 . . . . 0.0 112.468 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.18 99.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.211 0.604 . . . . 0.0 111.737 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -62.91 -42.12 99.68 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.907 -0.496 . . . . 0.0 112.13 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -58.17 -48.81 79.14 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.641 -0.662 . . . . 0.0 111.751 173.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -62.76 -29.7 70.88 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.73 -39.48 76.78 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.398 1.079 . . . . 0.0 112.52 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.06 -27.59 43.1 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.731 1.212 . . . . 0.0 113.337 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.76 61.1 54.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.675 1.99 . . . . 0.0 111.229 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.77 120.22 7.53 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.484 2.123 . . . . 0.0 110.313 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.38 135.97 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.325 1.45 . . . . 0.0 112.079 -169.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -79.74 160.48 26.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.062 0.545 . . . . 0.0 110.908 168.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.99 65.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 174.78 41.62 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.115 1.34 . . . . 0.0 112.677 174.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.62 169.14 14.95 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.642 2.895 . . . . 0.0 112.906 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.6 -39.22 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.887 1.275 . . . . 0.0 111.787 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.91 28.56 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.845 1.658 . . . . 0.0 110.597 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.89 133.45 22.75 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.473 2.782 . . . . 0.0 113.114 168.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.91 -15.0 60.36 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.577 1.084 . . . . 0.0 115.056 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.32 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.906 1.353 . . . . 0.0 110.198 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.15 145.58 54.22 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.719 -0.613 . . . . 0.0 110.868 168.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -68.39 152.58 45.21 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.682 0.793 . . . . 0.0 111.616 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.07 131.58 85.27 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.805 170.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.26 140.47 44.63 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.051 1.834 . . . . 0.0 112.362 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -75.23 171.83 13.49 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.654 1.582 . . . . 0.0 111.99 162.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.78 -43.98 94.39 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 123.36 0.505 . . . . 0.0 113.012 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.71 -25.89 65.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -72.65 -41.67 65.2 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.977 -1.077 . . . . 0.0 111.764 171.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -62.52 -42.81 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.788 0.835 . . . . 0.0 110.76 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.99 -1.32 14.12 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.92 18.27 74.25 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.827 -1.17 . . . . 0.0 115.423 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.6 p -96.19 -19.53 19.27 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.13 1.465 . . . . 0.0 113.394 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 61.8 p -126.23 -1.55 7.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.613 1.165 . . . . 0.0 114.072 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -103.27 150.21 23.96 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.758 0.823 . . . . 0.0 112.25 173.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.8 p -82.53 162.4 22.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.361 0.601 . . . . 0.0 110.793 170.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.9 tp -56.57 -39.61 73.77 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.52 -0.737 . . . . 0.0 111.368 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.28 -39.0 93.34 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.547 -0.721 . . . . 0.0 112.63 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -64.68 -42.6 95.22 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.478 -0.764 . . . . 0.0 112.152 171.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -60.66 -46.34 90.69 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.618 0.767 . . . . 0.0 112.133 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.38 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.122 0.969 . . . . 0.0 110.288 172.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.43 -51.05 54.14 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.819 0.723 . . . . 0.0 112.9 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.22 -50.14 72.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.866 0.833 . . . . 0.0 112.517 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.63 -18.39 64.29 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.94 8.35 20.26 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.671 1.189 . . . . 0.0 113.051 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.43 162.33 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.978 1.311 . . . . 0.0 111.447 165.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.29 49.02 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.065 0.946 . . . . 0.0 110.821 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.1 163.84 89.14 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.497 0.856 . . . . 0.0 111.713 -6.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -50.01 141.26 30.1 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.231 2.621 . . . . 0.0 114.148 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.04 96.46 2.44 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.84 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.36 -46.24 94.28 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.638 0.654 . . . . 0.0 112.985 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.88 -36.89 75.83 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.362 -1.081 . . . . 0.0 112.645 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.88 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.722 -0.611 . . . . 0.0 109.947 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.92 -40.38 91.38 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.282 -0.886 . . . . 0.0 112.521 176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -42.02 75.05 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.71 -45.19 82.0 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.924 0.784 . . . . 0.0 112.12 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -67.41 -40.49 85.59 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.248 0.619 . . . . 0.0 112.292 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.57 -47.23 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 122.997 0.519 . . . . 0.0 110.235 174.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.05 -37.37 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.749 1.22 . . . . 0.0 112.308 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.85 -42.84 98.63 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.038 0.836 . . . . 0.0 111.216 171.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.55 -45.03 91.75 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.821 0.724 . . . . 0.0 113.252 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.37 -42.48 87.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.055 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.46 -50.17 70.57 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.811 0.844 . . . . 0.0 112.5 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.88 -43.33 77.09 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.855 0.752 . . . . 0.0 111.984 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.2 mt -64.43 -47.62 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.443 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.75 -32.91 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.952 1.251 . . . . 0.0 112.889 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -60.45 -45.86 92.16 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.901 0.88 . . . . 0.0 111.448 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.9 ttp -73.57 -38.43 65.17 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.564 1.546 . . . . 0.0 113.313 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.9 t80 . . . . . 0 C--O 1.255 1.39 0 C-N-CA 128.43 2.692 . . . . 0.0 114.714 -172.964 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.81 135.01 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.92 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.686 170.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.62 116.69 32.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.57 0.748 . . . . 0.0 109.17 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.46 178.06 6.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.46 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.95 -26.44 68.82 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.62 -2.16 57.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.818 1.247 . . . . 0.0 113.03 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.0 85.7 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.67 128.26 35.58 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.858 1.329 . . . . 0.0 109.726 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.92 125.62 29.62 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.99 123.4 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.07 1.348 . . . . 0.0 108.629 -174.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.73 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.75 141.14 48.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.477 1.911 . . . . 0.0 107.948 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.28 152.45 20.89 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.196 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.58 136.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.6 -0.687 . . . . 0.0 111.544 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.69 130.01 93.2 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.068 0.547 . . . . 0.0 111.106 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.05 -34.52 68.15 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.794 2.329 . . . . 0.0 113.607 167.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.46 -38.08 86.54 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.448 -0.783 . . . . 0.0 112.56 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.98 -44.29 97.58 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.753 0.706 . . . . 0.0 111.362 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.45 -44.42 94.56 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.277 0.49 . . . . 0.0 112.275 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.17 -47.28 85.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.162 0.585 . . . . 0.0 111.386 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.17 95.87 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.611 0.764 . . . . 0.0 111.856 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -60.14 -47.46 85.82 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.809 0.843 . . . . 0.0 112.748 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.8 -54.16 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.426 0.557 . . . . 0.0 110.384 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.8 -37.47 79.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.297 1.039 . . . . 0.0 113.207 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.409 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.87 -52.08 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.962 1.305 . . . . 0.0 111.281 170.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.58 -35.81 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.414 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.84 -23.51 60.72 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.72 -25.6 11.21 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -135.78 16.36 3.32 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -166.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.12 -38.35 2.38 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -175.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -118.01 14.08 14.04 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.49 1.116 . . . . 0.0 113.024 -171.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 p -113.13 152.91 45.43 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.997 0.919 . . . . 0.0 111.523 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.83 -30.95 59.87 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.296 2.664 . . . . 0.0 115.214 -172.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.08 -20.94 64.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.59 -32.17 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.413 1.006 . . . . 0.0 112.485 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.37 -57.16 5.98 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.715 1.206 . . . . 0.0 112.555 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.87 -29.43 58.45 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 121.833 1.69 . . . . 0.0 112.809 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.409 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.3 -40.1 77.91 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.841 1.2 . . . . 0.0 112.703 172.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.12 -47.05 82.06 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.885 0.766 . . . . 0.0 111.537 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -60.88 -44.17 97.46 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.84 -31.66 71.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.178 0.991 . . . . 0.0 113.261 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.76 4.59 52.79 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.362 1.465 . . . . 0.0 113.514 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.5 p -133.12 22.86 4.13 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.59 120.34 6.04 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.47 -1.394 . . . . 0.0 111.472 168.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.49 11.69 60.08 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.371 0.909 . . . . 0.0 115.371 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.87 47.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.565 1.683 . . . . 0.0 112.481 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.0 p -73.32 159.67 84.36 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.732 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.57 -35.43 37.32 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.144 1.896 . . . . 0.0 115.406 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.0 -40.34 87.33 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.28 -45.3 93.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.627 -0.671 . . . . 0.0 111.1 172.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.62 -44.23 94.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.343 1.057 . . . . 0.0 112.085 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.3 -41.31 88.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.649 0.659 . . . . 0.0 112.02 171.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.27 -45.41 93.42 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.611 0.642 . . . . 0.0 111.071 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.37 -48.66 78.44 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.192 0.906 . . . . 0.0 112.151 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.1 mt -63.23 -38.36 90.85 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.03 -34.36 71.82 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.627 -0.671 . . . . 0.0 112.776 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.2 p -72.4 -13.39 61.45 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 m -118.19 11.16 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.367 1.067 . . . . 0.0 113.391 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.75 -10.59 4.74 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 117.141 1.616 . . . . 0.0 117.141 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.85 9.5 2.78 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 125.811 1.672 . . . . 0.0 117.009 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -127.85 79.11 1.87 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.232 1.516 . . . . 0.0 110.0 162.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -52.17 -36.0 50.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -171.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.87 -40.9 75.44 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.127 1.331 . . . . 0.0 112.147 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.58 83.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.298 0.639 . . . . 0.0 111.351 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.0 tpp -62.88 -40.3 97.09 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.531 -0.73 . . . . 0.0 112.281 175.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.02 -50.0 74.06 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.267 1.027 . . . . 0.0 111.544 173.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.8 tpp -56.04 -45.45 79.19 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.098 0.959 . . . . 0.0 112.184 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.87 -48.82 78.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.337 0.655 . . . . 0.0 112.017 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.67 -38.31 90.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.905 0.882 . . . . 0.0 112.49 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -60.0 -45.44 92.74 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.689 0.677 . . . . 0.0 112.048 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.64 -42.36 99.56 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.827 0.739 . . . . 0.0 112.118 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.86 -46.11 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.472 -0.768 . . . . 0.0 111.03 174.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.11 -39.43 94.02 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.869 0.759 . . . . 0.0 112.738 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.85 -47.42 86.43 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.758 0.823 . . . . 0.0 111.892 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.09 -34.38 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.47 91.54 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.484 -0.76 . . . . 0.0 112.327 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.11 98.64 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.256 0.622 . . . . 0.0 111.781 172.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.12 -42.22 99.49 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.872 -0.517 . . . . 0.0 112.191 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.71 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.05 -30.24 71.44 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -39.1 78.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.397 1.079 . . . . 0.0 112.45 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.79 60.98 53.75 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.91 120.14 7.42 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.424 2.083 . . . . 0.0 110.315 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.35 136.29 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.332 1.453 . . . . 0.0 112.129 -169.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -80.01 160.47 25.86 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.054 0.541 . . . . 0.0 110.915 168.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.92 65.01 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.11 1.338 . . . . 0.0 112.686 174.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.6 169.19 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.658 2.905 . . . . 0.0 112.889 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.66 -39.2 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.904 1.282 . . . . 0.0 111.753 -175.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.61 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 110.585 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.89 133.38 22.73 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.487 2.791 . . . . 0.0 113.15 168.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.94 -15.04 60.29 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.567 1.08 . . . . 0.0 115.001 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.992 1.396 . . . . 0.0 110.198 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.22 145.58 54.16 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.691 -0.631 . . . . 0.0 110.793 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.54 152.82 44.85 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.655 0.782 . . . . 0.0 111.67 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.27 131.65 84.85 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.29 140.41 44.36 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.11 1.873 . . . . 0.0 112.442 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -75.18 171.62 13.84 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.697 1.599 . . . . 0.0 111.893 163.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.83 94.0 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.971 -0.455 . . . . 0.0 113.03 168.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.85 -25.75 64.8 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.66 64.9 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.03 -1.044 . . . . 0.0 111.779 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.59 -42.76 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 110.82 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.26 14.03 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.16 74.31 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.927 -1.108 . . . . 0.0 115.447 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.34 -19.39 19.27 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.074 1.437 . . . . 0.0 113.284 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.2 p -126.18 -1.44 7.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.71 149.96 24.49 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.036 0.935 . . . . 0.0 111.788 173.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.2 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.282 0.563 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.86 -39.37 74.17 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.451 -0.781 . . . . 0.0 111.394 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.49 -38.98 93.21 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.554 -0.716 . . . . 0.0 112.701 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.82 95.52 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.58 -46.44 90.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.636 0.774 . . . . 0.0 112.142 176.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.43 -46.36 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.158 0.983 . . . . 0.0 110.304 172.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.04 54.4 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.81 0.719 . . . . 0.0 112.93 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.79 0.795 . . . . 0.0 112.485 174.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.9 8.32 20.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.66 1.184 . . . . 0.0 113.033 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.39 162.29 1.59 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.041 1.336 . . . . 0.0 111.39 165.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.36 48.92 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.042 0.937 . . . . 0.0 110.758 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.09 163.83 89.17 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.509 0.86 . . . . 0.0 111.746 -6.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -49.98 141.36 29.67 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.253 2.635 . . . . 0.0 114.117 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.2 96.42 2.49 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -85.96 54.56 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.27 2.647 . . . . 0.0 112.86 -152.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.78 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.19 94.34 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.61 0.641 . . . . 0.0 113.011 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.87 -36.87 75.83 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.326 -1.102 . . . . 0.0 112.634 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.94 -44.56 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.808 -0.557 . . . . 0.0 109.949 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.36 91.58 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.303 -0.873 . . . . 0.0 112.557 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.85 -42.07 75.26 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.472 -0.767 . . . . 0.0 112.217 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -56.59 -45.26 81.49 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 112.087 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.39 -40.41 85.66 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.248 0.619 . . . . 0.0 112.286 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.73 -46.97 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.093 0.557 . . . . 0.0 110.286 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.38 -37.27 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.648 1.179 . . . . 0.0 112.32 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.85 -42.8 98.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.036 0.835 . . . . 0.0 111.176 171.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.24 91.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.878 0.751 . . . . 0.0 113.181 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.48 -42.21 87.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.035 0.918 . . . . 0.0 111.113 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.24 70.44 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.774 0.83 . . . . 0.0 112.399 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.83 -43.06 76.62 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.884 0.765 . . . . 0.0 112.027 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.64 -47.96 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.371 0.668 . . . . 0.0 111.451 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.46 -32.83 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 119.894 1.225 . . . . 0.0 112.895 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.11 -43.85 95.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.867 0.867 . . . . 0.0 111.512 171.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.6 ttp -76.99 -36.27 56.54 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.644 1.577 . . . . 0.0 113.606 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.255 1.375 0 C-N-CA 128.35 2.66 . . . . 0.0 114.599 -172.764 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.75 134.99 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.501 1.121 . . . . 0.0 108.436 163.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.98 154.96 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.114 1.366 . . . . 0.0 109.665 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.7 116.69 32.48 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.555 0.742 . . . . 0.0 109.222 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.46 178.07 6.89 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.604 0.716 . . . . 0.0 112.46 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.87 -26.57 68.84 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.08 57.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.746 1.219 . . . . 0.0 113.002 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.0 85.78 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.487 1.042 . . . . 0.0 114.091 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.75 128.29 35.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.858 1.329 . . . . 0.0 109.714 174.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.86 125.64 29.65 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 168.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.9 t -126.04 123.28 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.103 1.361 . . . . 0.0 108.712 -174.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.53 139.71 38.62 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.15 48.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.465 1.906 . . . . 0.0 107.922 169.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.34 20.89 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.015 0.825 . . . . 0.0 111.233 170.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.57 136.88 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.607 -0.683 . . . . 0.0 111.579 176.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.63 130.02 93.27 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.112 0.565 . . . . 0.0 111.139 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.04 -34.54 68.22 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.864 2.376 . . . . 0.0 113.607 167.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.44 -38.03 86.47 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.463 -0.773 . . . . 0.0 112.588 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 m -60.93 -44.33 97.38 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.722 0.692 . . . . 0.0 111.401 171.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.53 -44.17 95.02 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.3 -47.29 85.96 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.167 0.587 . . . . 0.0 111.416 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.13 95.91 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.626 0.77 . . . . 0.0 111.897 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -60.21 -47.26 86.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.86 0.864 . . . . 0.0 112.73 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.51 -54.95 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 118.471 0.578 . . . . 0.0 110.345 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.48 -37.3 77.87 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.272 1.029 . . . . 0.0 113.178 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.47 -52.16 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.028 1.331 . . . . 0.0 111.29 170.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.68 -36.02 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 119.016 -0.516 . . . . 0.0 111.452 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -58.53 -24.17 59.96 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.04 -25.81 11.43 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.91 15.97 3.31 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -165.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.08 -38.92 2.54 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -116.62 13.73 15.3 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.379 1.072 . . . . 0.0 113.154 -172.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.1 p -112.87 152.95 45.27 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 123.941 0.897 . . . . 0.0 111.544 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.82 -30.77 58.93 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.299 2.666 . . . . 0.0 115.233 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.02 -20.74 64.24 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.8 -31.86 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.435 1.016 . . . . 0.0 112.548 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.45 -55.05 6.24 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.907 1.283 . . . . 0.0 112.956 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.83 -30.12 49.72 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.688 1.639 . . . . 0.0 112.661 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.403 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.07 -40.22 78.61 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.86 1.209 . . . . 0.0 112.64 172.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -57.27 -46.49 83.04 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.719 0.69 . . . . 0.0 111.579 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -61.04 -44.48 97.33 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.07 71.51 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.341 1.056 . . . . 0.0 113.225 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.23 4.44 53.53 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.4 1.48 . . . . 0.0 113.522 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.9 p -133.03 22.82 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.61 120.27 5.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.44 -1.413 . . . . 0.0 111.484 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.59 11.6 60.19 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.422 0.929 . . . . 0.0 115.422 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.51 130.87 47.09 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.525 1.663 . . . . 0.0 112.498 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.35 159.68 84.3 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.758 0.823 . . . . 0.0 110.697 167.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.65 -35.41 37.95 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.204 1.936 . . . . 0.0 115.366 168.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.0 -40.27 87.29 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.33 -45.31 93.88 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.596 -0.69 . . . . 0.0 111.044 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.6 -44.21 94.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.318 1.047 . . . . 0.0 112.175 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -59.24 -41.48 88.82 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.649 -0.657 . . . . 0.0 111.973 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.2 m -60.23 -45.28 93.77 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.614 0.643 . . . . 0.0 111.11 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -57.33 -49.01 77.48 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.246 0.93 . . . . 0.0 112.193 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.02 -38.54 91.59 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.87 -33.22 70.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.9 p -73.68 -13.37 60.97 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.6 m -122.45 6.2 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.5 -4.36 6.65 Favored Glycine 0 CA--C 1.541 1.67 0 N-CA-C 117.243 1.657 . . . . 0.0 117.243 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.75 -35.28 57.61 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 119.179 1.489 . . . . 0.0 115.177 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -86.18 77.95 9.47 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.838 1.304 . . . . 0.0 110.551 170.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.95 -35.91 35.96 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.36 -41.18 73.47 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.047 1.294 . . . . 0.0 112.301 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.36 -43.55 85.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.137 0.575 . . . . 0.0 111.33 173.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 59.8 tpp -63.25 -39.96 96.08 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.47 -0.769 . . . . 0.0 112.223 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -50.0 73.98 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.079 -1.013 . . . . 0.0 111.521 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -56.0 -45.43 79.04 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.88 -48.81 78.85 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.314 0.646 . . . . 0.0 112.055 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.7 -38.21 90.26 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.835 0.854 . . . . 0.0 112.448 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.99 -45.53 92.42 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.664 0.665 . . . . 0.0 112.027 170.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -62.64 -42.37 99.55 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.149 175.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.86 -46.1 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.47 -0.769 . . . . 0.0 111.059 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.08 -39.46 94.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.831 0.741 . . . . 0.0 112.736 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.82 -47.4 86.51 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.958 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.1 -34.32 72.97 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.584 -0.697 . . . . 0.0 112.835 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.92 -41.47 91.35 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.441 -0.787 . . . . 0.0 112.307 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.12 98.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.238 0.615 . . . . 0.0 111.772 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.09 -42.28 99.58 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.915 -0.491 . . . . 0.0 112.138 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -57.8 -48.58 79.32 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.661 0.664 . . . . 0.0 111.71 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.06 -30.24 71.44 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.2 -39.13 78.84 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.391 1.076 . . . . 0.0 112.48 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.26 -27.6 42.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.812 1.245 . . . . 0.0 113.302 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.8 61.02 54.01 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.668 1.987 . . . . 0.0 111.228 -174.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.9 120.13 7.4 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.507 2.138 . . . . 0.0 110.285 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.45 136.23 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.298 1.439 . . . . 0.0 112.121 -169.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -79.85 160.43 26.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.087 0.555 . . . . 0.0 110.915 168.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.27 -19.97 65.05 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.74 41.58 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.048 1.309 . . . . 0.0 112.64 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.58 169.23 14.72 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.611 2.874 . . . . 0.0 112.882 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.66 -39.22 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.925 1.29 . . . . 0.0 111.806 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.62 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.884 1.674 . . . . 0.0 110.631 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.91 133.41 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.456 2.77 . . . . 0.0 113.116 168.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.05 60.34 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 115.005 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.1 143.42 37.36 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.006 1.403 . . . . 0.0 110.185 173.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.2 145.56 54.2 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.721 -0.612 . . . . 0.0 110.842 168.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.49 152.73 44.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.748 0.819 . . . . 0.0 111.666 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -72.26 131.72 84.81 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.808 170.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.33 140.41 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -75.2 171.66 13.77 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.697 1.599 . . . . 0.0 111.889 163.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.5 -43.94 93.9 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.934 -0.479 . . . . 0.0 113.03 168.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.81 -25.73 64.83 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.78 -41.63 64.8 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.05 -1.032 . . . . 0.0 111.728 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.77 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.77 0.828 . . . . 0.0 110.771 173.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.26 13.94 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.2 74.23 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.596 1.093 . . . . 0.0 115.449 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.43 19.26 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.157 1.478 . . . . 0.0 113.283 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.19 -1.42 7.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.74 149.84 24.62 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.082 0.953 . . . . 0.0 111.799 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.5 p -81.78 162.32 22.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.291 0.567 . . . . 0.0 110.779 170.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.74 -39.38 73.85 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.448 -0.783 . . . . 0.0 111.445 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.54 -38.98 93.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.554 -0.716 . . . . 0.0 112.685 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.77 95.55 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.68 -46.35 90.69 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.119 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.33 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 110.268 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.04 54.46 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.795 0.712 . . . . 0.0 112.92 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.29 -50.05 73.22 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.812 0.806 . . . . 0.0 112.537 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.48 64.29 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.87 8.36 20.4 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.703 1.201 . . . . 0.0 113.051 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.5 162.33 1.64 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.991 1.316 . . . . 0.0 111.399 165.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.35 48.98 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.066 0.946 . . . . 0.0 110.813 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.82 89.2 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-N 119.429 0.832 . . . . 0.0 111.69 -6.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.94 141.39 29.27 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.187 2.591 . . . . 0.0 114.171 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.23 96.49 2.54 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 163.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.05 54.62 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.214 2.61 . . . . 0.0 112.83 -152.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.81 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.17 94.4 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.638 0.654 . . . . 0.0 113.011 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.89 -36.84 75.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.296 -1.12 . . . . 0.0 112.634 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.8 mt -62.95 -44.62 99.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.799 -0.563 . . . . 0.0 109.914 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.87 -40.35 91.57 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.327 -0.858 . . . . 0.0 112.521 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -55.86 -42.04 75.25 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.439 -0.788 . . . . 0.0 112.246 173.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.72 -45.23 82.04 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.924 0.784 . . . . 0.0 112.125 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.26 -40.57 86.22 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.294 0.638 . . . . 0.0 112.244 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.57 -47.33 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.23 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.98 -37.36 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.695 1.198 . . . . 0.0 112.301 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.84 -42.77 98.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.039 0.836 . . . . 0.0 111.217 171.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.62 -44.98 91.71 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 123.855 0.74 . . . . 0.0 113.214 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.35 -42.57 87.17 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.007 0.903 . . . . 0.0 110.992 173.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.24 70.37 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.807 0.843 . . . . 0.0 112.483 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.82 -43.28 76.81 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.88 0.764 . . . . 0.0 111.961 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.2 mt -64.52 -47.8 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.334 0.654 . . . . 0.0 111.418 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.93 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 119.911 1.232 . . . . 0.0 112.893 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -60.36 -44.86 95.18 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.949 0.9 . . . . 0.0 111.428 171.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.4 ttp -74.89 -35.72 62.25 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.683 1.593 . . . . 0.0 113.422 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.0 t80 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 128.341 2.656 . . . . 0.0 114.546 -173.291 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.042 0.362 . . . . 0.0 113.042 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.97 135.05 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.468 1.107 . . . . 0.0 108.466 163.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.06 154.71 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.662 170.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.4 116.65 32.5 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.534 0.734 . . . . 0.0 109.17 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.41 177.97 6.93 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.557 0.694 . . . . 0.0 112.474 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.55 68.79 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.67 -2.1 57.85 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.798 1.239 . . . . 0.0 113.001 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.12 85.87 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.454 1.026 . . . . 0.0 114.133 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.75 128.17 35.24 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.826 1.313 . . . . 0.0 109.695 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.85 125.5 29.43 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.89 123.39 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.077 1.351 . . . . 0.0 108.674 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.56 139.71 38.58 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.1 48.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.4 20.87 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.988 0.813 . . . . 0.0 111.217 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.53 136.86 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.644 -0.66 . . . . 0.0 111.544 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.68 130.0 93.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.11 0.564 . . . . 0.0 111.137 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.99 -34.6 67.98 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.894 2.396 . . . . 0.0 113.602 167.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -66.44 -38.03 86.49 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.425 -0.797 . . . . 0.0 112.56 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -61.04 -44.26 97.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.747 0.703 . . . . 0.0 111.337 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.54 -44.42 94.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.302 0.501 . . . . 0.0 112.256 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.12 -47.18 86.21 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.121 0.569 . . . . 0.0 111.396 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.19 95.75 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.667 0.787 . . . . 0.0 111.874 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.28 -46.95 88.04 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.779 0.831 . . . . 0.0 112.811 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.8 t -56.9 -54.26 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.4 0.546 . . . . 0.0 110.368 174.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.77 -37.17 78.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.412 1.085 . . . . 0.0 113.287 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.41 -52.35 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.206 1.402 . . . . 0.0 111.209 170.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.96 -36.06 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.958 0.503 . . . . 0.0 111.405 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.48 -24.0 59.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.48 -25.33 11.44 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.23 15.83 3.23 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -165.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.9 -37.07 2.67 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -117.88 13.84 14.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.385 1.074 . . . . 0.0 113.151 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.0 p -113.11 153.11 45.46 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.968 0.907 . . . . 0.0 111.474 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.86 -30.87 59.77 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.25 2.633 . . . . 0.0 115.185 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.11 -20.99 64.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.52 -32.24 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.396 0.998 . . . . 0.0 112.452 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.36 -57.16 6.0 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.726 1.21 . . . . 0.0 112.578 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.88 -29.46 58.31 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.928 1.724 . . . . 0.0 112.764 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.29 -40.09 77.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.866 1.212 . . . . 0.0 112.661 172.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -57.2 -46.98 82.39 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.873 0.76 . . . . 0.0 111.555 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.2 m -60.86 -44.26 97.26 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.65 70.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.248 1.019 . . . . 0.0 113.251 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.85 4.59 52.7 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.436 1.494 . . . . 0.0 113.528 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.9 p -133.13 22.85 4.13 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -176.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.56 120.28 5.96 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.501 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.54 60.17 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.377 0.911 . . . . 0.0 115.377 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 130.82 46.9 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.565 1.682 . . . . 0.0 112.53 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.28 159.71 84.31 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.699 167.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.6 -35.46 37.64 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.209 1.94 . . . . 0.0 115.39 168.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.98 -40.25 87.39 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.45 -45.22 94.48 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.569 -0.707 . . . . 0.0 111.055 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.62 -44.21 94.61 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.307 1.043 . . . . 0.0 112.115 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -59.25 -41.47 88.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.649 0.659 . . . . 0.0 111.965 171.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.9 m -60.25 -45.22 94.03 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.601 0.637 . . . . 0.0 111.066 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.46 -48.88 77.99 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.196 0.907 . . . . 0.0 112.174 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -63.07 -38.34 90.8 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.99 -33.33 70.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.3 p -73.58 -12.72 60.85 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -122.43 7.21 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -174.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.42 -4.06 8.36 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 117.413 1.725 . . . . 0.0 117.413 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.71 -35.2 66.46 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.394 1.597 . . . . 0.0 115.17 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -85.94 77.81 9.61 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.006 1.384 . . . . 0.0 110.537 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.71 -35.55 31.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.663 1.585 . . . . 0.0 115.223 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.48 -41.32 72.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.129 1.331 . . . . 0.0 112.332 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.63 85.94 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.776 -0.577 . . . . 0.0 111.348 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.15 -39.97 96.22 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.548 -0.72 . . . . 0.0 112.22 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.98 -49.97 74.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.223 1.009 . . . . 0.0 111.569 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.96 -45.44 78.87 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 0.0 112.212 174.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.6 tp -61.92 -48.77 78.98 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.344 0.657 . . . . 0.0 112.071 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.71 -38.27 90.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.873 0.869 . . . . 0.0 112.488 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.96 -45.58 92.19 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.684 0.675 . . . . 0.0 111.966 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.2 m -62.54 -42.46 99.54 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.828 0.74 . . . . 0.0 112.155 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.6 mt -58.8 -46.1 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.453 -0.78 . . . . 0.0 111.093 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.36 93.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.847 0.749 . . . . 0.0 112.759 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.93 -47.42 86.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.756 0.822 . . . . 0.0 111.908 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.12 -34.3 72.92 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.72 -41.73 91.91 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.447 -0.783 . . . . 0.0 112.328 172.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -41.98 98.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.139 0.576 . . . . 0.0 111.817 172.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.17 -42.26 99.37 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.918 -0.489 . . . . 0.0 112.163 174.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.8 -48.47 79.62 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.68 0.673 . . . . 0.0 111.694 173.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -63.13 -30.34 71.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.06 -39.09 79.31 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.342 1.057 . . . . 0.0 112.482 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.32 -27.57 42.13 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.796 1.239 . . . . 0.0 113.325 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.74 60.97 53.77 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.653 1.981 . . . . 0.0 111.274 -174.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.86 120.13 7.41 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.483 2.122 . . . . 0.0 110.323 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.294 1.438 . . . . 0.0 112.115 -169.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -80.2 160.52 25.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.07 0.548 . . . . 0.0 110.857 168.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.19 -20.02 65.03 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.7 41.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.096 1.332 . . . . 0.0 112.631 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.52 169.2 14.66 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.624 2.883 . . . . 0.0 112.917 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.66 -39.19 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.874 1.27 . . . . 0.0 111.791 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.94 28.52 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.93 133.38 22.92 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.441 2.761 . . . . 0.0 113.163 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -14.95 60.55 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.648 1.118 . . . . 0.0 115.042 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.38 37.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.952 1.376 . . . . 0.0 110.198 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.64 54.14 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.726 -0.608 . . . . 0.0 110.793 168.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -68.64 152.77 44.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.648 0.779 . . . . 0.0 111.618 171.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.26 131.72 84.81 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-O 118.888 -0.577 . . . . 0.0 109.831 170.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.4 140.32 43.71 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.063 1.842 . . . . 0.0 112.442 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -74.94 171.61 13.76 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.8 1.64 . . . . 0.0 111.817 163.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.61 -43.86 94.12 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.913 -0.492 . . . . 0.0 112.979 168.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.75 -25.88 64.96 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.71 -41.53 65.13 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.076 -1.015 . . . . 0.0 111.778 171.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.73 -42.63 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.719 0.807 . . . . 0.0 110.812 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.02 -1.29 14.12 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.03 18.13 74.33 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.929 -1.107 . . . . 0.0 115.445 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.25 -19.42 19.31 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.073 1.436 . . . . 0.0 113.289 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.2 -1.58 7.02 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.57 150.04 24.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.067 0.947 . . . . 0.0 111.773 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.4 p -81.95 162.44 22.7 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.321 0.582 . . . . 0.0 110.797 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.88 -39.36 74.23 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.414 -0.804 . . . . 0.0 111.445 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.62 -38.84 92.65 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.557 -0.715 . . . . 0.0 112.635 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -64.62 -42.8 95.27 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.628 -0.67 . . . . 0.0 112.033 171.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.61 -46.46 90.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.648 0.779 . . . . 0.0 112.097 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.38 -46.39 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.142 0.977 . . . . 0.0 110.317 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.42 -51.01 54.42 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.806 0.717 . . . . 0.0 112.945 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.3 -50.09 73.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.751 0.776 . . . . 0.0 112.48 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.0 p -111.93 8.43 20.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.637 1.175 . . . . 0.0 113.027 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.46 162.34 1.61 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.939 1.295 . . . . 0.0 111.434 165.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.63 103.35 48.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.054 0.942 . . . . 0.0 110.758 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.79 89.26 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.451 0.84 . . . . 0.0 111.701 -6.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -49.98 141.37 29.62 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.176 2.584 . . . . 0.0 114.168 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.12 96.53 2.51 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -86.03 54.54 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.232 2.621 . . . . 0.0 112.882 -152.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.54 -34.86 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.46 -46.2 94.31 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.605 0.639 . . . . 0.0 112.947 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.86 -36.9 75.9 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.259 -1.142 . . . . 0.0 112.645 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.88 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.785 -0.572 . . . . 0.0 109.98 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.44 91.68 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.356 -0.84 . . . . 0.0 112.576 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -55.78 -41.99 74.88 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.468 -0.77 . . . . 0.0 112.287 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.71 -45.24 81.98 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.888 0.767 . . . . 0.0 112.134 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.26 -40.59 86.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.308 0.643 . . . . 0.0 112.251 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.55 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.083 0.553 . . . . 0.0 110.261 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.13 -37.33 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.72 1.208 . . . . 0.0 112.322 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.82 98.32 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.047 0.84 . . . . 0.0 111.275 171.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.05 91.66 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.847 0.737 . . . . 0.0 113.242 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.4 -42.47 87.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.954 0.877 . . . . 0.0 111.032 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.48 -50.21 70.48 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.811 0.844 . . . . 0.0 112.45 173.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.79 -43.42 76.81 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 118.853 0.751 . . . . 0.0 111.956 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.43 -47.68 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.406 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.67 -32.89 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.992 1.269 . . . . 0.0 112.907 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -60.43 -45.36 93.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.899 0.88 . . . . 0.0 111.5 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.3 ttp -74.51 -38.24 62.88 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.597 1.559 . . . . 0.0 113.336 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.3 t80 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 128.483 2.713 . . . . 0.0 114.671 -172.571 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 N--CA 1.479 0.666 0 N-CA-C 112.965 0.333 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.22 134.86 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.46 1.104 . . . . 0.0 108.451 163.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.91 154.92 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.136 1.374 . . . . 0.0 109.665 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.67 116.72 32.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.48 0.712 . . . . 0.0 109.171 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.43 177.97 6.95 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.514 0.673 . . . . 0.0 112.511 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.87 -26.49 68.8 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.56 -2.24 57.94 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.825 1.25 . . . . 0.0 113.024 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.07 2.94 85.6 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.467 1.032 . . . . 0.0 114.142 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.74 128.29 35.73 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.815 1.308 . . . . 0.0 109.7 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.69 29.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.01 123.4 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.066 1.347 . . . . 0.0 108.648 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.68 139.68 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.572 0.701 . . . . 0.0 111.21 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.64 141.17 48.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.488 1.915 . . . . 0.0 107.922 169.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.17 152.31 20.77 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.977 0.808 . . . . 0.0 111.237 170.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.62 136.83 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.651 -0.656 . . . . 0.0 111.571 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.59 129.98 93.32 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.167 0.587 . . . . 0.0 111.157 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.07 -34.57 68.66 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.86 2.373 . . . . 0.0 113.543 167.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.39 -38.13 86.81 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.475 -0.765 . . . . 0.0 112.55 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.88 -44.4 97.12 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.728 0.695 . . . . 0.0 111.383 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.45 -44.42 94.55 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.251 0.478 . . . . 0.0 112.211 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.12 -47.25 85.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.087 0.555 . . . . 0.0 111.441 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.1 -45.19 95.73 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.633 0.773 . . . . 0.0 111.892 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -59.98 -47.53 85.43 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.806 0.842 . . . . 0.0 112.729 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.7 t -56.85 -54.13 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.408 0.549 . . . . 0.0 110.493 174.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.72 -37.36 78.68 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.344 1.058 . . . . 0.0 113.214 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.414 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -58.24 -52.11 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.917 1.287 . . . . 0.0 111.345 170.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.19 -35.98 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 122.948 0.499 . . . . 0.0 111.336 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.66 -23.45 59.25 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.98 -25.72 11.04 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -135.87 16.03 3.31 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.46 -37.83 2.57 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -117.86 14.56 14.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.374 1.07 . . . . 0.0 113.141 -172.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.5 p -113.64 152.95 45.89 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.008 0.923 . . . . 0.0 111.513 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.85 -30.81 59.43 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.216 2.61 . . . . 0.0 115.249 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.06 -20.93 64.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.54 -32.19 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.424 1.011 . . . . 0.0 112.482 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.7 mt -70.36 -57.2 5.97 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.76 1.224 . . . . 0.0 112.561 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.81 -29.57 58.95 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.859 1.699 . . . . 0.0 112.793 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.414 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.25 -40.07 78.08 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.838 1.199 . . . . 0.0 112.733 172.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -57.15 -47.08 82.05 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.877 0.762 . . . . 0.0 111.507 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m -60.79 -44.24 97.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.65 71.05 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.233 1.013 . . . . 0.0 113.264 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.8 4.59 52.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.389 1.476 . . . . 0.0 113.514 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.7 p -133.1 22.79 4.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.54 120.23 5.87 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.49 -1.381 . . . . 0.0 111.491 168.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.64 11.59 60.3 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 115.367 0.907 . . . . 0.0 115.367 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.49 131.04 47.83 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.567 1.683 . . . . 0.0 112.487 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.7 p -73.47 159.81 83.85 Favored Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 123.667 0.787 . . . . 0.0 110.722 167.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.63 -35.35 37.62 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.161 1.908 . . . . 0.0 115.429 168.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.1 -40.24 86.89 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -60.26 -45.35 93.59 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.66 -0.65 . . . . 0.0 111.089 172.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.62 -44.27 94.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.328 1.051 . . . . 0.0 112.146 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -59.18 -41.43 88.44 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.672 -0.642 . . . . 0.0 112.03 171.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.6 m -60.25 -45.25 93.91 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.561 0.619 . . . . 0.0 111.059 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.47 -48.86 78.08 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.196 0.907 . . . . 0.0 112.16 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.18 -38.13 89.97 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.11 -32.82 70.18 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.3 p -74.14 -12.29 60.55 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.11 8.28 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.81 -3.78 11.77 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 117.446 1.739 . . . . 0.0 117.446 -175.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.32 -32.79 64.32 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 119.556 1.678 . . . . 0.0 115.279 -177.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -89.75 77.36 7.08 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 123.06 1.409 . . . . 0.0 110.481 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.33 -35.08 26.12 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.859 1.664 . . . . 0.0 115.416 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.9 -40.9 75.36 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 120.159 1.345 . . . . 0.0 112.312 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.64 -43.45 84.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.158 0.583 . . . . 0.0 111.366 173.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.14 -40.13 96.68 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.494 -0.754 . . . . 0.0 112.246 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.83 74.6 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.257 1.023 . . . . 0.0 111.541 173.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.04 -45.5 79.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.092 0.957 . . . . 0.0 112.189 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.3 tp -61.85 -48.77 79.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.332 0.653 . . . . 0.0 112.08 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.79 -38.18 90.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.861 0.865 . . . . 0.0 112.483 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.01 -45.52 92.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.664 0.665 . . . . 0.0 112.034 170.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.54 -42.47 99.55 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.792 0.724 . . . . 0.0 112.105 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.81 -46.14 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.491 -0.755 . . . . 0.0 111.077 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.1 -39.45 94.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.819 0.736 . . . . 0.0 112.717 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -60.83 -47.36 86.69 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.77 0.828 . . . . 0.0 111.98 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.17 -34.3 72.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.56 91.79 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.451 -0.781 . . . . 0.0 112.371 172.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.04 98.56 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.202 0.601 . . . . 0.0 111.832 172.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.09 -42.27 99.57 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.905 -0.497 . . . . 0.0 112.221 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.8 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.615 0.643 . . . . 0.0 111.649 173.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.03 -30.31 71.5 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.14 -39.1 79.05 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.324 1.05 . . . . 0.0 112.52 173.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.17 -27.66 42.67 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.785 1.234 . . . . 0.0 113.307 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -132.78 61.03 54.11 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.646 1.978 . . . . 0.0 111.276 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.92 120.16 7.44 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.48 2.12 . . . . 0.0 110.277 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.23 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.363 1.465 . . . . 0.0 112.151 -169.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.98 160.37 25.94 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.13 0.572 . . . . 0.0 110.861 168.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.15 -20.03 65.02 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 174.77 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.048 1.309 . . . . 0.0 112.656 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.55 169.17 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.66 2.907 . . . . 0.0 112.93 177.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.62 -39.2 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.867 1.267 . . . . 0.0 111.841 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.62 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.884 1.674 . . . . 0.0 110.631 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.91 133.41 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.456 2.77 . . . . 0.0 113.116 168.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.99 -15.04 60.37 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.562 1.077 . . . . 0.0 115.013 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -78.09 143.41 37.39 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.928 1.364 . . . . 0.0 110.218 173.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.51 54.2 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.726 -0.608 . . . . 0.0 110.826 168.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -68.55 152.89 44.74 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.694 0.798 . . . . 0.0 111.669 171.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -72.3 131.69 84.77 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.917 -0.563 . . . . 0.0 109.858 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.33 140.41 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -75.19 171.67 13.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.72 1.608 . . . . 0.0 111.862 163.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.51 -43.93 93.93 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.968 -0.458 . . . . 0.0 113.006 168.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.83 -25.77 64.83 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.67 -41.65 65.13 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.064 -1.022 . . . . 0.0 111.765 171.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.65 -42.72 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.712 0.805 . . . . 0.0 110.801 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.3 14.11 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.13 74.17 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.626 1.107 . . . . 0.0 115.458 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.6 p -96.22 -19.43 19.33 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.09 1.445 . . . . 0.0 113.255 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.2 p -126.16 -1.5 7.05 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.4 p -103.64 149.8 24.6 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.034 0.934 . . . . 0.0 111.778 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.1 p -81.68 162.34 23.06 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.341 0.591 . . . . 0.0 110.775 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.72 -39.44 73.91 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.448 -0.783 . . . . 0.0 111.429 169.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.51 -39.01 93.32 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.531 -0.731 . . . . 0.0 112.636 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -64.6 -42.65 95.42 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.72 -46.42 90.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.652 0.781 . . . . 0.0 112.119 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.42 -46.35 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.12 0.968 . . . . 0.0 110.301 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.07 54.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.806 0.717 . . . . 0.0 112.889 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.24 -50.09 73.12 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.831 0.816 . . . . 0.0 112.48 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.2 mtp -68.62 -18.52 64.32 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.92 8.41 20.33 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.665 1.186 . . . . 0.0 113.072 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.42 162.3 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.971 1.309 . . . . 0.0 111.461 165.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.32 48.97 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.15 163.8 89.21 Favored 'Cis proline' 0 CA--C 1.544 1.021 0 CA-C-N 119.466 0.845 . . . . 0.0 111.735 -6.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -49.93 141.34 29.28 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.184 2.59 . . . . 0.0 114.207 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.21 96.44 2.51 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 163.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.97 54.67 3.51 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.65 -34.84 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.24 94.25 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 118.656 0.662 . . . . 0.0 112.991 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -69.73 -36.98 76.32 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.281 -1.129 . . . . 0.0 112.609 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.93 -44.6 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.762 -0.586 . . . . 0.0 109.949 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.85 -40.37 91.64 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.352 -0.842 . . . . 0.0 112.543 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.04 75.12 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.455 -0.778 . . . . 0.0 112.243 173.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -56.7 -45.17 81.99 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.933 0.788 . . . . 0.0 112.098 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.33 -40.55 85.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.29 0.636 . . . . 0.0 112.251 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.69 -46.94 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.062 0.545 . . . . 0.0 110.321 174.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.34 -37.31 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.688 1.195 . . . . 0.0 112.314 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.81 98.3 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.019 0.827 . . . . 0.0 111.223 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.11 91.4 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.796 0.712 . . . . 0.0 113.265 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.49 -42.24 87.15 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.01 0.905 . . . . 0.0 111.092 173.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.39 -50.25 70.22 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.766 0.826 . . . . 0.0 112.461 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.93 -43.1 77.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.823 0.738 . . . . 0.0 112.011 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.44 -48.13 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.721 -0.656 . . . . 0.0 111.372 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -69.38 -32.83 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 119.973 1.261 . . . . 0.0 112.89 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.95 -42.79 94.8 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.931 0.892 . . . . 0.0 111.552 171.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.0 ttp -79.02 -35.65 42.4 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.718 1.607 . . . . 0.0 113.704 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 t80 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 128.383 2.673 . . . . 0.0 114.513 -172.013 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.656 0 N-CA-C 112.952 0.328 . . . . 0.0 112.952 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.89 135.17 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.48 1.112 . . . . 0.0 108.438 163.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.12 154.89 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.113 1.365 . . . . 0.0 109.698 170.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.62 116.71 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.522 0.729 . . . . 0.0 109.128 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -76.57 177.73 7.23 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.604 0.716 . . . . 0.0 112.408 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.53 -26.53 68.61 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -173.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -85.64 -2.22 57.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.76 1.224 . . . . 0.0 113.037 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.99 3.13 85.65 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.53 1.062 . . . . 0.0 114.049 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.71 128.19 35.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.877 1.338 . . . . 0.0 109.726 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.6 29.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.99 123.42 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.045 1.338 . . . . 0.0 108.674 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.56 139.65 38.59 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.52 0.676 . . . . 0.0 111.222 170.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.61 141.06 48.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.476 1.91 . . . . 0.0 107.909 169.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.18 152.34 20.76 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.974 0.806 . . . . 0.0 111.244 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.54 136.86 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.492 0.663 . . . . 0.0 111.575 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.68 129.96 93.23 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.112 0.565 . . . . 0.0 111.18 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -52.91 -34.69 67.57 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.865 2.377 . . . . 0.0 113.589 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -66.33 -38.14 86.99 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.419 -0.801 . . . . 0.0 112.572 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.91 -44.39 97.24 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.749 0.704 . . . . 0.0 111.359 171.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.43 -44.48 94.46 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.29 0.495 . . . . 0.0 112.275 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.05 -47.25 85.91 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.113 0.565 . . . . 0.0 111.42 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.99 96.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.614 0.766 . . . . 0.0 111.914 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -60.14 -47.47 85.77 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.828 0.851 . . . . 0.0 112.754 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.4 t -56.74 -54.15 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 118.392 0.542 . . . . 0.0 110.418 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.79 -37.38 78.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.3 1.04 . . . . 0.0 113.227 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.409 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.85 -52.09 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.035 1.334 . . . . 0.0 111.278 170.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.6 -35.96 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 122.99 0.516 . . . . 0.0 111.362 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -58.61 -23.43 58.85 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -108.06 -25.48 11.11 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -136.07 15.67 3.28 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -166.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.41 -37.53 2.37 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -117.73 14.45 14.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.436 1.095 . . . . 0.0 113.093 -172.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 p -113.92 152.96 46.14 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.078 0.951 . . . . 0.0 111.659 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.84 -31.17 60.96 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.287 2.658 . . . . 0.0 115.292 -172.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -61.69 -21.01 64.09 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.33 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.387 0.994 . . . . 0.0 112.472 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.33 -57.12 6.07 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.717 1.207 . . . . 0.0 112.633 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.78 -29.61 59.2 Favored 'Trans proline' 0 C--N 1.351 0.709 0 CA-C-N 121.901 1.715 . . . . 0.0 112.783 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.409 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.4 mtm -69.18 -40.21 78.25 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.809 1.186 . . . . 0.0 112.683 172.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -57.04 -46.85 82.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.836 0.744 . . . . 0.0 111.544 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -61.03 -44.43 97.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.368 0.667 . . . . 0.0 112.784 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.57 -31.64 70.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.242 1.017 . . . . 0.0 113.26 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.87 4.88 52.44 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.384 1.474 . . . . 0.0 113.523 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.8 p -133.46 22.8 4.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -53.41 120.36 5.97 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.468 -1.395 . . . . 0.0 111.48 168.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.4 11.6 59.71 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.46 130.84 47.01 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.517 1.659 . . . . 0.0 112.449 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.5 p -73.45 159.55 84.48 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 123.701 0.801 . . . . 0.0 110.65 167.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.58 -35.52 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.198 1.932 . . . . 0.0 115.388 168.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.84 -40.43 87.94 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -60.21 -45.31 93.62 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.64 -0.663 . . . . 0.0 111.049 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.58 -44.29 94.48 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.288 1.035 . . . . 0.0 112.164 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -59.19 -41.4 88.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.578 0.626 . . . . 0.0 112.05 171.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.3 m -60.24 -45.19 94.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.55 0.614 . . . . 0.0 111.161 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.41 -48.88 77.92 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.196 0.907 . . . . 0.0 112.185 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.6 mt -63.12 -38.46 91.28 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.78 -33.03 69.85 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.4 p -73.87 -12.47 60.68 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.34 7.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.02 -3.7 9.3 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 117.506 1.762 . . . . 0.0 117.506 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.98 -34.08 65.07 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 119.501 1.651 . . . . 0.0 115.226 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -88.27 77.45 8.22 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.062 1.411 . . . . 0.0 110.485 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -50.36 -35.3 27.36 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.826 1.65 . . . . 0.0 115.341 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.24 74.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.118 1.327 . . . . 0.0 112.249 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.39 -43.53 85.62 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.128 0.571 . . . . 0.0 111.35 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.07 -40.16 96.86 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.592 -0.692 . . . . 0.0 112.271 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.93 -50.12 73.54 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.262 1.025 . . . . 0.0 111.539 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -55.77 -45.4 78.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.067 0.947 . . . . 0.0 112.241 174.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.3 tp -61.98 -48.71 79.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.363 0.665 . . . . 0.0 112.064 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.73 -38.23 90.32 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.857 0.863 . . . . 0.0 112.514 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.12 -45.52 92.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.623 0.647 . . . . 0.0 112.058 170.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.62 -42.34 99.53 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.768 0.713 . . . . 0.0 112.186 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.83 -46.0 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.462 -0.774 . . . . 0.0 111.051 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.17 -39.55 94.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.776 0.716 . . . . 0.0 112.738 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -60.55 -47.66 85.21 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.739 0.816 . . . . 0.0 111.968 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -70.0 -34.33 73.19 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.75 -41.53 92.02 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.44 -0.787 . . . . 0.0 112.391 172.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.85 98.25 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.123 0.569 . . . . 0.0 111.781 172.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -63.58 -42.11 98.31 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.856 -0.528 . . . . 0.0 112.182 175.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.67 -48.51 79.3 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.564 0.62 . . . . 0.0 111.744 172.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.28 -30.07 71.28 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -69.28 -39.1 78.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.363 1.065 . . . . 0.0 112.432 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.2 -27.77 42.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.796 1.239 . . . . 0.0 113.337 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.62 61.03 54.4 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.635 1.974 . . . . 0.0 111.216 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.91 120.14 7.42 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.424 2.083 . . . . 0.0 110.315 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.44 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.292 1.437 . . . . 0.0 112.158 -169.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -80.1 160.39 25.78 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.174 0.59 . . . . 0.0 110.894 168.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.17 -19.88 64.9 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.11 174.7 41.71 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.048 1.309 . . . . 0.0 112.606 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.55 169.17 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.631 2.887 . . . . 0.0 112.906 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.69 -39.0 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.874 1.269 . . . . 0.0 111.785 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.71 161.83 28.75 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.888 1.675 . . . . 0.0 110.592 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.93 133.46 22.94 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.479 2.786 . . . . 0.0 113.098 168.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.89 -14.97 60.41 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.566 1.079 . . . . 0.0 115.062 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.2 143.45 37.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.95 1.375 . . . . 0.0 110.164 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.3 145.63 54.04 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.742 -0.599 . . . . 0.0 110.869 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -68.49 152.5 45.3 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.76 0.824 . . . . 0.0 111.615 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -72.25 131.64 84.91 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-O 118.898 -0.572 . . . . 0.0 109.814 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.49 140.23 43.17 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.062 1.841 . . . . 0.0 112.401 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -74.8 171.28 14.26 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.773 1.629 . . . . 0.0 111.891 163.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.46 -43.81 93.88 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 123.33 0.491 . . . . 0.0 113.035 168.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.3 p -68.71 -25.73 64.91 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -72.97 -41.44 64.38 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.034 -1.041 . . . . 0.0 111.78 172.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.69 -42.84 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.839 0.856 . . . . 0.0 110.761 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.82 -1.52 14.41 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 173.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.11 18.15 74.49 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.922 -1.111 . . . . 0.0 115.406 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.9 p -96.02 -19.31 19.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.067 1.433 . . . . 0.0 113.287 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.9 p -126.62 -1.69 6.75 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -103.25 150.38 23.78 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.164 0.986 . . . . 0.0 111.554 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.2 p -82.48 162.61 22.0 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.342 0.591 . . . . 0.0 110.781 169.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.6 tp -56.57 -39.54 73.66 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.501 -0.749 . . . . 0.0 111.541 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.45 -38.95 93.12 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.454 -0.779 . . . . 0.0 112.666 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -64.71 -42.69 95.09 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.612 -0.68 . . . . 0.0 111.988 171.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.58 -46.35 90.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.678 0.791 . . . . 0.0 112.097 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.64 -46.16 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.167 0.987 . . . . 0.0 110.312 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.62 -50.98 55.39 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.852 0.739 . . . . 0.0 112.876 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.35 -50.04 73.16 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 117.74 0.77 . . . . 0.0 112.532 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.6 64.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.1 p -111.83 8.32 20.44 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.677 1.191 . . . . 0.0 113.033 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.3 162.31 1.53 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.045 1.338 . . . . 0.0 111.451 165.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.64 103.32 48.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.046 0.938 . . . . 0.0 110.778 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.1 163.81 89.21 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.466 0.845 . . . . 0.0 111.713 -6.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -49.93 141.38 29.26 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.199 2.6 . . . . 0.0 114.186 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.25 96.42 2.51 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 163.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.02 54.59 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.255 2.637 . . . . 0.0 112.852 -152.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.52 -35.11 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -61.91 -46.57 93.85 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.595 0.634 . . . . 0.0 113.031 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -69.88 -36.69 75.66 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.281 -1.129 . . . . 0.0 112.636 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.3 mt -62.94 -44.66 99.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.757 -0.589 . . . . 0.0 109.902 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -65.81 -40.37 91.78 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.265 -0.897 . . . . 0.0 112.497 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -55.89 -42.04 75.37 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.472 -0.767 . . . . 0.0 112.232 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.7 -45.22 81.93 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.892 0.769 . . . . 0.0 112.134 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.25 -40.66 86.3 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.242 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.55 -47.05 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.041 0.536 . . . . 0.0 110.283 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.33 -37.27 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.672 1.189 . . . . 0.0 112.261 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.86 -42.76 98.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.027 0.83 . . . . 0.0 111.235 171.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.49 -45.26 90.84 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.863 0.744 . . . . 0.0 113.176 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.41 -42.34 86.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.039 0.919 . . . . 0.0 111.112 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -55.34 -50.2 70.26 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.815 0.846 . . . . 0.0 112.473 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -55.95 -43.16 77.19 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.865 0.757 . . . . 0.0 111.971 175.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.44 -48.06 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.338 0.655 . . . . 0.0 111.448 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.52 -32.69 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.916 1.235 . . . . 0.0 112.952 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.3 -43.91 95.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.901 0.88 . . . . 0.0 111.498 171.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.7 ttp -76.99 -37.1 55.8 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.66 1.584 . . . . 0.0 113.48 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 C--O 1.252 1.192 0 C-N-CA 128.377 2.671 . . . . 0.0 114.48 -172.057 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.82 135.0 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.467 1.107 . . . . 0.0 108.402 163.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.92 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.686 170.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.62 116.68 32.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.57 0.748 . . . . 0.0 109.18 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.47 178.07 6.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.58 0.705 . . . . 0.0 112.451 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.95 -26.45 68.83 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.59 -2.19 57.9 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.776 1.231 . . . . 0.0 113.0 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.02 85.69 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.76 128.28 35.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.823 1.311 . . . . 0.0 109.745 174.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.89 125.62 29.62 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.99 123.4 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.07 1.348 . . . . 0.0 108.629 -174.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.7 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.71 141.15 48.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.5 1.92 . . . . 0.0 107.929 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 21.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.998 0.817 . . . . 0.0 111.191 170.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.53 136.84 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.607 -0.683 . . . . 0.0 111.544 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.64 130.03 93.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.059 0.544 . . . . 0.0 111.169 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.09 -34.5 68.53 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.86 2.373 . . . . 0.0 113.575 167.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.53 -38.04 86.32 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.508 -0.745 . . . . 0.0 112.562 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.91 -44.31 97.34 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.767 0.712 . . . . 0.0 111.377 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.53 -44.33 94.55 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.328 0.513 . . . . 0.0 112.321 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.17 -47.33 85.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.136 0.574 . . . . 0.0 111.359 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.35 95.19 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.644 0.778 . . . . 0.0 111.883 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.7 t-105 -60.02 -47.42 85.93 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.855 0.862 . . . . 0.0 112.763 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.68 -55.0 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.465 0.575 . . . . 0.0 110.273 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.04 -37.82 77.89 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.396 1.079 . . . . 0.0 113.243 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.41 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.33 -51.9 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.031 1.332 . . . . 0.0 111.329 170.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.65 -35.88 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.435 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -58.98 -23.1 61.44 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.707 1.139 . . . . 0.0 114.038 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.73 -25.94 11.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -135.86 16.3 3.31 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -166.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.53 -37.68 2.57 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -118.25 14.73 13.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.392 1.077 . . . . 0.0 113.149 -172.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -113.93 152.94 46.13 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 111.566 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.85 -30.75 59.21 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.257 2.638 . . . . 0.0 115.276 -172.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.05 -20.67 64.2 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.82 -31.97 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.376 0.989 . . . . 0.0 112.528 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.1 mt -71.34 -55.08 6.35 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.943 1.297 . . . . 0.0 112.961 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.83 -30.12 49.72 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.688 1.639 . . . . 0.0 112.661 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.41 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.6 mtm -69.06 -40.22 78.64 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.86 1.209 . . . . 0.0 112.623 172.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.23 -46.53 82.87 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.816 0.735 . . . . 0.0 111.581 169.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.7 m -61.01 -44.52 97.3 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 175.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.82 -32.09 71.47 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.255 1.022 . . . . 0.0 113.207 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.29 4.44 53.47 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.39 1.476 . . . . 0.0 113.522 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.4 p -132.98 22.83 4.18 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.62 120.3 6.0 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.47 -1.394 . . . . 0.0 111.491 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.54 60.16 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.42 130.84 47.06 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.565 1.682 . . . . 0.0 112.499 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.39 159.69 84.21 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.714 0.806 . . . . 0.0 110.661 167.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.28 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -60.4 -45.29 94.11 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.663 -0.648 . . . . 0.0 111.025 172.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.51 -44.34 94.57 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 112.103 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -59.11 -41.58 88.5 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.635 0.652 . . . . 0.0 111.994 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.13 -45.31 93.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.594 0.633 . . . . 0.0 111.084 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.43 -48.81 78.15 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.209 0.913 . . . . 0.0 112.188 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.18 -38.27 90.53 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.98 -33.63 70.9 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -73.29 -12.76 60.96 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.15 9.21 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.23 -5.51 8.22 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 117.328 1.691 . . . . 0.0 117.328 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.36 -31.3 59.55 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 119.336 1.568 . . . . 0.0 115.563 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -93.61 78.12 4.32 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.003 1.402 . . . . 0.0 110.652 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.79 -35.78 33.68 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -173.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.05 -41.02 74.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.123 1.328 . . . . 0.0 112.246 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.5 -43.5 85.14 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.164 0.585 . . . . 0.0 111.371 173.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.7 tpp -63.06 -40.14 96.82 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.521 -0.737 . . . . 0.0 112.263 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.99 -49.93 74.24 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.235 1.014 . . . . 0.0 111.521 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.02 -45.47 79.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.091 0.956 . . . . 0.0 112.188 174.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -61.91 -48.72 79.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.277 0.631 . . . . 0.0 112.088 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.7 -38.28 90.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 0.0 112.479 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.99 -45.49 92.54 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 112.02 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.6 m -62.61 -42.38 99.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.848 0.749 . . . . 0.0 112.149 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.9 -46.04 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 121.472 -0.768 . . . . 0.0 111.097 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.49 94.13 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.876 0.762 . . . . 0.0 112.684 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -60.78 -47.39 86.53 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.741 0.816 . . . . 0.0 111.94 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.13 -34.35 72.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.53 91.62 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.484 -0.76 . . . . 0.0 112.322 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.11 98.61 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.224 0.61 . . . . 0.0 111.781 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.17 -42.11 99.33 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.84 -0.538 . . . . 0.0 112.207 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -57.88 -48.55 79.52 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.673 0.67 . . . . 0.0 111.694 173.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.01 -30.35 71.53 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.11 -39.06 79.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.354 1.062 . . . . 0.0 112.482 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.79 60.98 53.75 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.85 120.1 7.36 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.451 2.101 . . . . 0.0 110.341 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.29 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.351 1.461 . . . . 0.0 112.142 -169.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.0 160.47 25.88 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.053 0.541 . . . . 0.0 110.903 168.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.91 65.0 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.74 41.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.096 1.332 . . . . 0.0 112.631 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.56 169.2 14.73 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.601 2.867 . . . . 0.0 112.917 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.66 -39.2 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.904 1.282 . . . . 0.0 111.753 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.61 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 110.585 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -47.94 133.42 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.479 2.786 . . . . 0.0 113.106 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.93 -14.96 60.48 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.567 1.08 . . . . 0.0 115.037 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.13 143.32 37.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.95 1.375 . . . . 0.0 110.214 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.11 145.48 54.35 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.654 -0.654 . . . . 0.0 110.843 168.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.47 152.82 44.86 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.27 131.69 84.83 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.916 -0.564 . . . . 0.0 109.872 170.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.35 140.36 44.03 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.107 1.871 . . . . 0.0 112.435 -177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -75.14 171.65 13.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.705 1.602 . . . . 0.0 111.805 163.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.6 -43.78 94.15 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.916 -0.49 . . . . 0.0 113.035 168.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.89 -25.78 64.78 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.65 65.03 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.989 -1.069 . . . . 0.0 111.749 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.65 -42.7 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.686 0.794 . . . . 0.0 110.812 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.06 -1.26 14.09 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 173.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.23 74.26 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 120.865 -1.147 . . . . 0.0 115.444 174.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.5 19.21 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.079 1.439 . . . . 0.0 113.263 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 p -126.13 -1.28 7.08 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.76 149.84 24.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.08 0.952 . . . . 0.0 111.789 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.5 p -81.81 162.32 22.91 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.288 0.566 . . . . 0.0 110.73 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.81 -39.37 74.04 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.529 -0.732 . . . . 0.0 111.438 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.5 -38.99 93.24 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.576 -0.702 . . . . 0.0 112.675 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.6 95.45 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.573 -0.705 . . . . 0.0 112.085 171.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.77 -46.47 90.36 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.626 0.77 . . . . 0.0 112.092 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.33 -46.35 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.126 0.971 . . . . 0.0 110.35 172.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.03 54.41 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.753 0.692 . . . . 0.0 112.945 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.79 0.795 . . . . 0.0 112.485 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.9 8.36 20.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.66 1.184 . . . . 0.0 113.033 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.46 162.31 1.62 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.029 1.332 . . . . 0.0 111.361 165.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.34 48.99 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.035 0.934 . . . . 0.0 110.811 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.14 163.78 89.25 Favored 'Cis proline' 0 CA--C 1.543 0.951 0 CA-C-N 119.466 0.845 . . . . 0.0 111.735 -6.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -49.9 141.39 29.0 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.205 2.604 . . . . 0.0 114.171 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.19 96.38 2.46 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 163.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.96 54.56 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.27 2.647 . . . . 0.0 112.86 -152.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.57 -34.83 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.39 -46.26 94.22 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.638 0.654 . . . . 0.0 112.967 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.83 -36.86 75.94 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.91 -44.56 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.732 -0.605 . . . . 0.0 110.004 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.37 91.6 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.307 -0.871 . . . . 0.0 112.557 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.83 -41.97 75.03 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.489 -0.757 . . . . 0.0 112.287 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -56.71 -45.27 81.94 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.889 0.768 . . . . 0.0 112.08 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.32 -40.46 85.98 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.236 0.614 . . . . 0.0 112.315 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.7 -46.98 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.044 0.538 . . . . 0.0 110.34 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.23 -37.39 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.686 1.195 . . . . 0.0 112.3 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.81 98.3 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.011 0.823 . . . . 0.0 111.223 171.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.49 -45.19 91.19 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.796 0.712 . . . . 0.0 113.26 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.42 -42.26 86.87 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.003 0.901 . . . . 0.0 111.113 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.45 -50.22 70.41 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.772 0.829 . . . . 0.0 112.453 173.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.18 76.94 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.856 0.753 . . . . 0.0 111.973 175.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.48 -48.01 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.377 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.47 -32.84 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.988 1.267 . . . . 0.0 112.945 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.96 -43.23 95.18 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.877 0.871 . . . . 0.0 111.562 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.8 ttp -78.41 -36.71 45.37 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.72 1.608 . . . . 0.0 113.619 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.3 t80 . . . . . 0 C--O 1.252 1.219 0 C-N-CA 128.423 2.689 . . . . 0.0 114.629 -171.91 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.93 135.02 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.453 1.101 . . . . 0.0 108.425 163.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.92 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.62 116.7 32.52 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.521 0.729 . . . . 0.0 109.201 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.41 178.04 6.88 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.598 0.713 . . . . 0.0 112.441 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.94 -26.5 68.85 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.13 57.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.97 2.99 85.8 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.458 1.028 . . . . 0.0 114.12 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.73 128.3 35.75 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.801 1.301 . . . . 0.0 109.683 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.6 29.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 168.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -126.0 123.39 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.046 1.338 . . . . 0.0 108.659 -174.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.65 141.14 48.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.491 1.916 . . . . 0.0 107.914 169.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 21.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.015 0.825 . . . . 0.0 111.191 170.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.47 136.83 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.601 -0.687 . . . . 0.0 111.58 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.7 130.06 93.18 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.11 0.564 . . . . 0.0 111.088 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.09 -34.54 68.73 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.86 2.373 . . . . 0.0 113.575 167.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.43 -38.03 86.5 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.526 -0.734 . . . . 0.0 112.622 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.94 -44.32 97.43 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.691 0.678 . . . . 0.0 111.373 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.55 -44.36 94.39 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.251 0.478 . . . . 0.0 112.266 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.19 -47.21 86.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.105 0.562 . . . . 0.0 111.432 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.14 95.91 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.683 0.793 . . . . 0.0 111.879 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.19 -47.23 86.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.861 0.864 . . . . 0.0 112.766 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.8 -54.44 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.397 0.544 . . . . 0.0 110.369 174.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.71 -37.34 78.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.347 1.059 . . . . 0.0 113.2 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.54 -52.15 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.058 1.343 . . . . 0.0 111.288 170.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.75 -35.9 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.406 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -58.7 -23.86 60.34 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.37 -25.65 11.35 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.93 16.12 3.3 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -166.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.19 -38.22 2.41 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -117.56 13.97 14.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.415 1.086 . . . . 0.0 113.105 -172.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.5 p -113.2 152.97 45.54 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.027 0.931 . . . . 0.0 111.582 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.9 -30.76 59.7 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.277 2.651 . . . . 0.0 115.229 -172.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.02 -20.69 64.19 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.85 -31.89 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.431 1.014 . . . . 0.0 112.548 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.38 -55.07 6.31 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.957 1.303 . . . . 0.0 113.011 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.88 -30.08 49.31 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.653 1.626 . . . . 0.0 112.641 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.403 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.06 -40.16 78.67 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.901 1.228 . . . . 0.0 112.673 172.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -57.27 -46.51 83.01 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.758 0.708 . . . . 0.0 111.583 169.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -61.05 -44.48 97.33 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.86 -31.98 71.42 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.284 1.034 . . . . 0.0 113.292 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.34 4.44 53.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.344 1.458 . . . . 0.0 113.508 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.6 p -132.91 22.75 4.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.54 120.31 5.98 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.474 -1.391 . . . . 0.0 111.47 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.66 60.1 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.362 0.905 . . . . 0.0 115.362 -177.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.51 130.82 46.87 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.554 1.677 . . . . 0.0 112.53 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.33 159.66 84.35 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.718 167.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.61 -35.31 37.27 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.15 1.9 . . . . 0.0 115.454 168.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.16 -40.19 86.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.34 -45.3 93.95 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.6 -0.687 . . . . 0.0 111.1 172.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.52 -44.37 94.44 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.364 1.066 . . . . 0.0 112.134 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.13 -41.51 88.42 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.658 -0.651 . . . . 0.0 112.031 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.18 -45.35 93.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.622 0.646 . . . . 0.0 111.084 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.36 -48.87 77.9 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.179 0.9 . . . . 0.0 112.19 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -63.15 -38.44 91.17 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.95 -33.36 70.53 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.0 p -73.67 -12.5 60.75 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.25 7.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.87 -4.49 5.86 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.82 -33.19 55.8 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 119.249 1.524 . . . . 0.0 115.425 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -91.23 78.63 5.78 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.84 1.32 . . . . 0.0 110.613 171.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.16 -35.86 38.06 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.39 -41.1 73.48 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 120.107 1.322 . . . . 0.0 112.299 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.28 -43.61 85.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.202 0.601 . . . . 0.0 111.335 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.05 -40.1 96.71 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.514 -0.741 . . . . 0.0 112.255 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -50.02 73.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.251 1.02 . . . . 0.0 111.539 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -56.0 -45.39 79.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.97 -48.72 79.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.338 0.655 . . . . 0.0 112.055 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.75 -38.27 90.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.411 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.95 -45.48 92.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.735 0.698 . . . . 0.0 112.046 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.64 -42.37 99.55 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.149 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.84 -46.07 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.507 -0.745 . . . . 0.0 111.093 174.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.19 -39.33 93.76 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.816 0.734 . . . . 0.0 112.738 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.89 -47.4 86.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.745 0.818 . . . . 0.0 111.964 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.16 -34.33 72.87 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.48 91.66 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.481 -0.762 . . . . 0.0 112.355 173.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.16 98.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.2 0.6 . . . . 0.0 111.787 172.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.03 -42.28 99.74 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.888 -0.508 . . . . 0.0 112.166 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.676 0.671 . . . . 0.0 111.71 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.07 -30.2 71.41 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.22 -39.1 78.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.397 1.079 . . . . 0.0 112.45 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.0 53.92 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.88 120.08 7.34 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.479 2.119 . . . . 0.0 110.312 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.26 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.35 1.46 . . . . 0.0 112.179 -169.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.98 160.47 25.9 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.079 0.552 . . . . 0.0 110.903 168.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.98 65.01 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.77 41.6 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.053 1.311 . . . . 0.0 112.647 174.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.62 169.16 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.944 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.61 -39.2 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.91 1.284 . . . . 0.0 111.799 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.47 161.94 28.51 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.884 1.674 . . . . 0.0 110.587 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.94 133.42 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.479 2.786 . . . . 0.0 113.106 168.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.98 -15.08 60.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.567 1.08 . . . . 0.0 115.01 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.6 54.12 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.694 -0.629 . . . . 0.0 110.824 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.48 152.7 45.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.765 0.826 . . . . 0.0 111.626 171.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -72.25 131.7 84.85 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.912 -0.565 . . . . 0.0 109.835 170.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.38 140.43 44.06 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.074 1.849 . . . . 0.0 112.442 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -75.1 171.61 13.83 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.763 1.625 . . . . 0.0 111.871 163.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.87 94.1 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.895 -0.503 . . . . 0.0 113.035 168.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.0 p -68.81 -25.68 64.8 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.82 -41.6 64.72 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.03 -1.044 . . . . 0.0 111.733 171.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.67 -42.71 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.742 0.817 . . . . 0.0 110.787 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.23 13.99 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.98 18.11 74.21 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.626 1.107 . . . . 0.0 115.413 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.21 -19.36 19.39 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.141 1.471 . . . . 0.0 113.312 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.25 -1.52 6.99 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.56 150.01 24.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.063 0.945 . . . . 0.0 111.773 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.9 p -82.01 162.3 22.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.311 0.577 . . . . 0.0 110.806 169.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.66 -39.45 73.76 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.431 -0.793 . . . . 0.0 111.427 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.49 -38.93 93.03 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.533 -0.729 . . . . 0.0 112.701 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -64.67 -42.75 95.15 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 111.997 171.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.6 -46.41 90.36 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.575 0.75 . . . . 0.0 112.152 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.47 -46.29 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.106 0.962 . . . . 0.0 110.338 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.1 54.01 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 0.0 112.869 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.07 73.19 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.512 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.95 8.42 20.29 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.6 1.16 . . . . 0.0 113.046 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.39 162.28 1.6 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.991 1.316 . . . . 0.0 111.403 165.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.54 103.37 48.97 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.035 0.934 . . . . 0.0 110.792 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.14 163.87 89.05 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.509 0.86 . . . . 0.0 111.676 -6.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -50.04 141.36 30.06 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 0.0 114.205 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.11 96.41 2.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.97 54.6 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.54 -34.89 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.24 94.26 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.633 0.652 . . . . 0.0 112.999 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.8 -36.87 76.02 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.348 -1.09 . . . . 0.0 112.723 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.92 -44.56 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.732 -0.605 . . . . 0.0 109.987 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.89 -40.39 91.53 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.307 -0.871 . . . . 0.0 112.521 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.83 -41.98 75.06 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.431 -0.793 . . . . 0.0 112.259 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.74 -45.23 82.12 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.956 0.798 . . . . 0.0 112.044 174.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.3 -40.57 86.06 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.257 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.53 -47.22 93.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.065 0.546 . . . . 0.0 110.295 174.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.09 -37.39 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.68 1.192 . . . . 0.0 112.3 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.78 98.35 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.011 0.823 . . . . 0.0 111.224 171.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.07 91.47 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.844 0.735 . . . . 0.0 113.252 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.35 -42.42 86.86 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.988 0.894 . . . . 0.0 111.076 173.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.18 70.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.9 -43.23 77.07 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.83 0.741 . . . . 0.0 111.975 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.51 -47.79 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.43 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.56 -32.91 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.963 1.256 . . . . 0.0 112.911 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.23 -44.79 94.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.933 0.893 . . . . 0.0 111.487 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.2 ttp -75.42 -36.34 60.81 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.631 1.573 . . . . 0.0 113.442 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.252 1.196 0 C-N-CA 128.394 2.678 . . . . 0.0 114.54 -172.815 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.009 0.35 . . . . 0.0 113.009 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.76 135.02 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.472 1.109 . . . . 0.0 108.436 163.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.96 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.72 116.74 32.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.501 0.72 . . . . 0.0 109.195 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.452 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.89 -26.46 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -173.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.19 57.93 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.809 1.244 . . . . 0.0 112.988 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.04 2.94 85.67 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.504 1.05 . . . . 0.0 114.103 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.64 128.29 35.68 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.866 1.333 . . . . 0.0 109.745 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.61 29.61 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 168.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.0 t -125.97 123.34 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.045 1.338 . . . . 0.0 108.723 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.5 139.73 38.64 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.512 0.672 . . . . 0.0 111.206 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.76 141.17 48.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.477 1.911 . . . . 0.0 107.897 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.38 20.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.804 . . . . 0.0 111.238 170.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.5 136.79 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.611 -0.681 . . . . 0.0 111.591 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.64 130.01 93.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 123.114 0.566 . . . . 0.0 111.151 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.887 2.391 . . . . 0.0 113.575 167.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.4 -38.09 86.69 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 112.579 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.0 -44.28 97.65 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.687 0.676 . . . . 0.0 111.347 171.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.55 -44.23 94.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.328 0.513 . . . . 0.0 112.309 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.28 -47.28 85.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.124 0.569 . . . . 0.0 111.392 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.2 95.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.658 0.783 . . . . 0.0 111.9 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.17 -47.23 86.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.809 0.844 . . . . 0.0 112.77 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.76 -54.52 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.455 0.57 . . . . 0.0 110.397 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.59 -37.44 78.54 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.354 1.062 . . . . 0.0 113.191 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.405 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.59 -52.1 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.026 1.33 . . . . 0.0 111.295 170.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.64 -35.92 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.915 0.486 . . . . 0.0 111.399 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -58.72 -23.95 60.63 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.21 -25.73 11.39 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.88 16.13 3.31 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.16 -38.38 2.44 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -117.48 14.1 14.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.404 1.081 . . . . 0.0 113.115 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.9 p -113.18 153.02 45.54 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 123.952 0.901 . . . . 0.0 111.565 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.89 -30.66 59.12 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.289 2.659 . . . . 0.0 115.27 -172.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.12 -20.74 64.37 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.73 -32.01 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.387 0.994 . . . . 0.0 112.539 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.33 -55.05 6.39 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.943 1.297 . . . . 0.0 113.011 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.89 -30.08 49.23 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.685 1.637 . . . . 0.0 112.655 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.405 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.08 -40.21 78.58 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.876 1.216 . . . . 0.0 112.598 172.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -57.28 -46.52 83.03 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.776 0.716 . . . . 0.0 111.522 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.2 m -61.11 -44.4 97.4 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.9 -32.02 71.5 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.268 1.027 . . . . 0.0 113.27 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.23 4.43 53.55 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.4 1.48 . . . . 0.0 113.536 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -133.03 22.8 4.16 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.62 120.34 6.06 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.491 168.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.69 60.06 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.9 47.19 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.565 1.683 . . . . 0.0 112.481 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.37 159.66 84.33 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 123.748 0.819 . . . . 0.0 110.705 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -49.54 -35.48 37.11 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.3 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.36 -45.26 94.12 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.049 172.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.54 -44.37 94.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.386 1.074 . . . . 0.0 112.134 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -59.13 -41.51 88.42 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.658 -0.651 . . . . 0.0 112.031 171.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.5 m -60.23 -45.28 93.78 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.622 0.646 . . . . 0.0 111.073 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.44 -48.85 78.06 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.254 0.934 . . . . 0.0 112.191 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.13 -38.45 91.24 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.87 -33.43 70.48 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.1 p -73.66 -12.52 60.76 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.4 m -122.2 7.84 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.93 -4.54 6.0 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 117.193 1.637 . . . . 0.0 117.193 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.83 -33.22 55.93 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.257 1.528 . . . . 0.0 115.404 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -91.18 78.49 5.83 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.875 1.338 . . . . 0.0 110.605 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.06 -35.86 36.88 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.35 -41.09 73.61 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.094 1.315 . . . . 0.0 112.242 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.54 85.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.174 0.59 . . . . 0.0 111.311 173.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.05 -40.13 96.77 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.514 -0.741 . . . . 0.0 112.265 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -49.92 74.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.198 0.999 . . . . 0.0 111.58 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.99 -45.52 78.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.091 0.956 . . . . 0.0 112.199 174.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.2 tp -61.87 -48.81 78.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.326 0.65 . . . . 0.0 112.055 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.63 -38.28 90.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.842 0.857 . . . . 0.0 112.49 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.99 -45.55 92.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 111.985 170.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.3 m -62.51 -42.45 99.51 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.87 0.759 . . . . 0.0 112.155 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.86 -46.08 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.478 -0.764 . . . . 0.0 111.059 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.18 -39.37 93.85 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.858 0.754 . . . . 0.0 112.752 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.81 -47.48 86.13 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.925 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.09 -34.32 73.0 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.582 -0.699 . . . . 0.0 112.85 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.69 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.408 -0.808 . . . . 0.0 112.361 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.09 98.7 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.215 0.606 . . . . 0.0 111.751 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.25 99.58 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 0.0 112.218 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.77 -48.57 79.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.737 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.05 -30.23 71.43 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.24 -39.11 78.71 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.337 1.055 . . . . 0.0 112.482 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.24 -27.58 42.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.76 1.224 . . . . 0.0 113.327 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.76 61.03 54.17 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.646 1.978 . . . . 0.0 111.247 -174.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.92 120.14 7.41 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.509 2.139 . . . . 0.0 110.261 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.42 136.3 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.298 1.439 . . . . 0.0 112.108 -169.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.97 160.37 25.95 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.116 0.567 . . . . 0.0 110.922 168.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.97 65.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 174.77 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.048 1.309 . . . . 0.0 112.656 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 169.16 14.85 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.66 2.907 . . . . 0.0 112.896 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.64 -39.18 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.926 1.29 . . . . 0.0 111.762 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.55 161.87 28.65 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.858 1.663 . . . . 0.0 110.561 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.93 133.44 22.94 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.403 2.735 . . . . 0.0 113.141 168.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.08 60.29 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.562 1.077 . . . . 0.0 114.978 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.22 145.5 54.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.694 -0.629 . . . . 0.0 110.815 168.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -68.54 152.83 44.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.658 0.783 . . . . 0.0 111.668 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.18 131.64 85.03 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.83 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.37 140.44 44.13 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.076 1.851 . . . . 0.0 112.426 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -75.12 171.58 13.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.74 1.616 . . . . 0.0 111.906 163.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.51 -43.87 93.96 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.971 -0.455 . . . . 0.0 113.049 168.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.85 -25.7 64.78 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.68 64.88 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.068 -1.02 . . . . 0.0 111.727 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.63 -42.69 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 110.817 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.29 14.23 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.16 74.31 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.605 1.098 . . . . 0.0 115.447 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.31 -19.46 19.24 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.074 1.437 . . . . 0.0 113.263 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 p -126.14 -1.34 7.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.86 149.81 24.73 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.095 0.958 . . . . 0.0 111.752 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.6 p -81.73 162.27 23.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.303 0.573 . . . . 0.0 110.799 170.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.72 -39.38 73.81 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.466 -0.771 . . . . 0.0 111.445 169.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.58 -38.91 92.91 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.554 -0.716 . . . . 0.0 112.706 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.57 -42.79 95.41 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.542 -0.724 . . . . 0.0 112.011 171.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.62 -46.43 90.3 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.68 0.792 . . . . 0.0 112.144 176.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.46 -46.35 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.106 0.962 . . . . 0.0 110.301 172.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.39 -51.11 53.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.872 0.748 . . . . 0.0 112.882 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 0.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.62 -18.56 64.33 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.86 8.42 20.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.624 1.17 . . . . 0.0 113.064 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.41 162.3 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.952 1.301 . . . . 0.0 111.461 165.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.39 48.92 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.035 0.934 . . . . 0.0 110.811 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.07 163.84 89.16 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.429 0.832 . . . . 0.0 111.701 -6.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -50.04 141.35 30.07 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 0.0 114.205 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.13 96.48 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.05 54.58 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.274 2.649 . . . . 0.0 112.827 -152.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.59 -34.77 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.48 -46.2 94.31 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.637 0.653 . . . . 0.0 112.996 173.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.8 -36.92 76.07 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.293 -1.122 . . . . 0.0 112.665 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.0 mt -62.93 -44.57 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.808 -0.557 . . . . 0.0 109.921 174.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.42 91.66 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.303 -0.873 . . . . 0.0 112.489 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.84 -41.99 75.1 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.294 173.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -56.7 -45.24 81.95 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.926 0.784 . . . . 0.0 112.071 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -67.34 -40.48 85.9 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.266 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.62 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.044 0.538 . . . . 0.0 110.291 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.03 -37.35 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.683 1.193 . . . . 0.0 112.355 177.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.77 98.4 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.03 0.832 . . . . 0.0 111.224 171.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.09 91.41 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.796 0.712 . . . . 0.0 113.242 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.38 -42.35 86.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 117.986 0.893 . . . . 0.0 111.097 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.55 -50.17 70.73 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.798 0.839 . . . . 0.0 112.445 173.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.26 77.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.86 0.755 . . . . 0.0 111.991 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.4 -47.9 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.335 0.654 . . . . 0.0 111.44 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.92 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.924 1.238 . . . . 0.0 112.9 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.17 -44.54 94.94 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.884 0.874 . . . . 0.0 111.473 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.78 -35.86 59.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.655 1.582 . . . . 0.0 113.468 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 128.39 2.676 . . . . 0.0 114.59 -172.737 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.998 0.345 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.9 135.09 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.457 1.103 . . . . 0.0 108.402 163.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.13 154.83 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.063 1.345 . . . . 0.0 109.627 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.7 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.9 -26.45 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.61 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.825 1.25 . . . . 0.0 113.03 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.02 85.77 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.5 1.048 . . . . 0.0 114.144 -175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.7 128.22 35.43 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.801 1.301 . . . . 0.0 109.745 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.63 29.63 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 168.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -125.95 123.36 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.107 1.363 . . . . 0.0 108.669 -174.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.56 139.71 38.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.543 0.687 . . . . 0.0 111.191 170.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.72 141.11 48.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.465 1.906 . . . . 0.0 107.929 169.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.36 21.02 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.254 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.5 136.89 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.492 0.663 . . . . 0.0 111.572 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.69 129.96 93.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.068 0.547 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.01 -34.56 68.05 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.868 2.378 . . . . 0.0 113.56 167.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.41 -38.07 86.64 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.451 -0.78 . . . . 0.0 112.587 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.97 -44.3 97.55 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.779 0.718 . . . . 0.0 111.377 171.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.54 -44.37 94.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.29 0.496 . . . . 0.0 112.244 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.22 -47.25 86.04 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.115 0.566 . . . . 0.0 111.37 176.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.24 95.61 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.651 0.78 . . . . 0.0 111.897 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.24 -47.01 87.79 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.771 0.829 . . . . 0.0 112.812 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.78 -54.55 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.439 0.563 . . . . 0.0 110.344 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.66 -37.36 78.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.343 1.057 . . . . 0.0 113.219 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.4 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.38 -52.22 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.138 1.375 . . . . 0.0 111.253 170.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.82 -36.02 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.996 0.518 . . . . 0.0 111.407 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.66 -23.89 60.13 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.3 -25.62 11.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.98 16.08 3.29 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -165.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.37 -38.13 2.59 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -117.44 13.8 14.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.345 1.058 . . . . 0.0 113.127 -172.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -112.99 153.0 45.38 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.96 0.904 . . . . 0.0 111.566 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.88 -30.74 59.39 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.311 2.674 . . . . 0.0 115.218 -172.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.02 -20.74 64.25 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.88 -31.88 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.414 1.006 . . . . 0.0 112.488 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.41 -55.01 6.32 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.957 1.303 . . . . 0.0 112.989 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.93 -30.08 48.9 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 121.678 1.635 . . . . 0.0 112.641 174.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.4 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.06 -40.21 78.65 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.901 1.228 . . . . 0.0 112.673 172.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.27 -46.47 83.05 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.765 0.711 . . . . 0.0 111.569 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -61.09 -44.44 97.36 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -32.0 71.51 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.268 1.027 . . . . 0.0 113.257 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.3 4.48 53.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.325 1.45 . . . . 0.0 113.511 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -133.03 22.8 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.54 120.31 5.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.478 -1.389 . . . . 0.0 111.468 168.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.63 60.04 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.46 130.88 47.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.573 1.687 . . . . 0.0 112.482 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.35 159.66 84.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.753 0.821 . . . . 0.0 110.666 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.22 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.41 -45.22 94.38 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.66 -0.65 . . . . 0.0 111.108 172.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.57 -44.26 94.62 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 112.163 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.3 -41.35 88.78 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.696 -0.628 . . . . 0.0 111.989 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.26 -45.33 93.68 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.629 0.65 . . . . 0.0 111.091 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.33 -48.91 77.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.205 0.911 . . . . 0.0 112.179 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.11 -38.49 91.38 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.91 -33.56 70.69 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 p -73.57 -12.46 60.77 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.34 7.73 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.57 -4.8 5.73 Favored Glycine 0 CA--C 1.541 1.702 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.71 -33.32 55.25 Favored Glycine 0 CA--C 1.537 1.433 0 CA-C-N 119.183 1.491 . . . . 0.0 115.462 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -90.81 78.77 6.06 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.836 1.318 . . . . 0.0 110.634 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.32 -35.94 40.43 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.49 -41.2 73.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.094 1.315 . . . . 0.0 112.293 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.57 86.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.155 0.582 . . . . 0.0 111.337 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.13 -40.04 96.44 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.555 -0.716 . . . . 0.0 112.224 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.99 -50.0 74.03 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.056 -1.028 . . . . 0.0 111.521 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.0 -45.42 79.05 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 tp -61.88 -48.75 79.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.277 0.631 . . . . 0.0 112.105 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.77 -38.21 90.26 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.836 0.854 . . . . 0.0 112.463 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.97 -45.48 92.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.699 0.681 . . . . 0.0 112.075 170.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.65 -42.37 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.118 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.85 -46.14 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.477 -0.765 . . . . 0.0 111.03 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.09 -39.43 94.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.842 0.746 . . . . 0.0 112.757 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.75 -47.46 86.2 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.703 0.801 . . . . 0.0 111.975 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.09 -34.38 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.87 -41.42 91.63 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.467 -0.771 . . . . 0.0 112.341 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.08 98.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.184 0.594 . . . . 0.0 111.772 172.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.14 -42.21 99.44 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.924 -0.485 . . . . 0.0 112.135 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.84 -48.58 79.38 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.682 0.674 . . . . 0.0 111.699 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.04 -30.19 71.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.16 -39.18 78.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.361 1.065 . . . . 0.0 112.499 173.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.61 42.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 113.29 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.76 61.03 54.13 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.696 1.998 . . . . 0.0 111.225 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.9 120.16 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.481 2.12 . . . . 0.0 110.277 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.46 136.23 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.318 1.447 . . . . 0.0 112.121 -169.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.92 160.49 25.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.05 0.54 . . . . 0.0 110.903 168.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.9 64.99 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.98 174.71 41.62 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.099 1.333 . . . . 0.0 112.653 174.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.63 169.14 14.96 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.658 2.905 . . . . 0.0 112.915 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.6 -39.23 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.94 1.296 . . . . 0.0 111.762 -175.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.44 161.93 28.53 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.817 1.647 . . . . 0.0 110.573 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.95 133.47 23.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.441 2.761 . . . . 0.0 113.132 168.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.99 60.33 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.613 1.101 . . . . 0.0 115.056 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.36 37.46 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.946 1.373 . . . . 0.0 110.198 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.11 145.54 54.29 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.693 -0.63 . . . . 0.0 110.858 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.51 152.7 45.02 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.728 0.811 . . . . 0.0 111.653 171.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.21 131.66 84.96 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.34 140.38 44.09 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.134 1.889 . . . . 0.0 112.416 -177.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -75.11 171.66 13.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.709 1.604 . . . . 0.0 111.89 163.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.91 94.07 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.895 -0.503 . . . . 0.0 112.991 168.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.6 p -68.78 -25.77 64.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.76 -41.59 64.92 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.027 -1.046 . . . . 0.0 111.778 171.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.65 -42.69 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.718 0.807 . . . . 0.0 110.793 173.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.26 13.93 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 173.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.91 18.16 74.12 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.922 -1.111 . . . . 0.0 115.477 175.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.3 -19.35 19.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.131 1.466 . . . . 0.0 113.305 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.0 p -126.27 -1.51 6.98 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.6 149.97 24.41 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.103 0.961 . . . . 0.0 111.824 173.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.6 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.318 0.58 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.81 -39.44 74.16 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.418 -0.801 . . . . 0.0 111.372 169.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.5 -38.93 93.03 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.576 -0.702 . . . . 0.0 112.685 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.8 95.31 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.602 -0.686 . . . . 0.0 112.008 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.61 -46.39 90.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.648 0.779 . . . . 0.0 112.097 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.35 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.301 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.05 54.33 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.85 0.738 . . . . 0.0 112.866 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.14 72.91 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.828 0.814 . . . . 0.0 112.517 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.62 -18.48 64.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.4 p -111.88 8.36 20.39 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.688 1.195 . . . . 0.0 113.051 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.43 162.31 1.6 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.989 1.316 . . . . 0.0 111.434 165.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.34 48.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.035 0.934 . . . . 0.0 110.837 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.85 89.11 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.447 0.838 . . . . 0.0 111.701 -6.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -50.06 141.37 30.24 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.21 2.607 . . . . 0.0 114.135 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.14 96.49 2.5 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 163.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.0 54.59 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.251 2.634 . . . . 0.0 112.86 -152.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.63 -34.81 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.26 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.999 173.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.83 -36.87 75.95 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.91 -44.6 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.709 -0.62 . . . . 0.0 109.942 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.82 -40.46 91.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.307 -0.871 . . . . 0.0 112.54 176.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -42.03 74.99 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.455 -0.778 . . . . 0.0 112.287 173.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.68 -45.21 81.9 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.865 0.757 . . . . 0.0 112.147 174.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.35 -40.47 85.83 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.272 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.64 -47.27 93.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.085 0.554 . . . . 0.0 110.206 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.05 -37.36 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.634 1.174 . . . . 0.0 112.322 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.74 -42.87 98.24 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.095 0.861 . . . . 0.0 111.233 171.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.55 -45.07 91.56 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.821 0.724 . . . . 0.0 113.252 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.28 -42.49 86.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.988 0.894 . . . . 0.0 111.102 173.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.5 -50.16 70.67 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.772 0.829 . . . . 0.0 112.503 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.86 -43.27 76.95 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.864 0.756 . . . . 0.0 112.027 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.46 -47.74 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.337 0.655 . . . . 0.0 111.467 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.64 -32.89 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.923 1.238 . . . . 0.0 112.874 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.34 -45.11 94.6 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.958 0.903 . . . . 0.0 111.463 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.3 ttp -74.74 -36.7 62.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.666 1.586 . . . . 0.0 113.362 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 128.417 2.687 . . . . 0.0 114.655 -173.026 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.81 135.01 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.458 1.103 . . . . 0.0 108.437 163.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.02 154.94 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.1 1.36 . . . . 0.0 109.648 170.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.66 116.69 32.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.516 0.726 . . . . 0.0 109.17 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.604 0.716 . . . . 0.0 112.452 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.89 -26.45 68.79 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.63 -2.19 57.92 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.767 1.227 . . . . 0.0 112.988 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.03 85.67 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.78 128.27 35.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.861 1.331 . . . . 0.0 109.664 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.61 29.61 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 168.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.97 123.35 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.046 1.338 . . . . 0.0 108.678 -174.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.52 139.65 38.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.236 170.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.13 48.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.468 1.907 . . . . 0.0 107.94 169.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.24 152.37 20.91 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.221 170.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.54 136.9 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.65 -0.656 . . . . 0.0 111.509 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.71 130.01 93.19 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 123.098 0.559 . . . . 0.0 111.151 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.99 -34.6 67.96 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.907 2.405 . . . . 0.0 113.604 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.43 -38.06 86.57 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 112.594 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.94 -44.32 97.43 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.691 0.678 . . . . 0.0 111.373 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.57 -44.29 94.53 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.251 0.478 . . . . 0.0 112.254 175.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.23 -47.27 85.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.079 0.551 . . . . 0.0 111.399 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.23 95.63 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.663 0.785 . . . . 0.0 111.882 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.11 -47.27 86.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.801 0.84 . . . . 0.0 112.801 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.8 -54.4 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.431 0.559 . . . . 0.0 110.397 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.7 -37.36 78.63 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.301 1.04 . . . . 0.0 113.218 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.55 -52.19 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.027 1.331 . . . . 0.0 111.318 170.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.61 -35.96 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.417 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -58.66 -23.96 60.27 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.2 -25.73 11.39 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.83 15.91 3.33 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -166.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.05 -38.22 2.24 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -117.61 14.05 14.4 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.402 1.081 . . . . 0.0 113.141 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 p -113.14 152.97 45.49 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.982 0.913 . . . . 0.0 111.523 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.74 -30.96 58.98 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.258 2.639 . . . . 0.0 115.203 -172.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.01 -21.01 64.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.16 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.41 1.005 . . . . 0.0 112.485 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.36 -57.18 5.98 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.76 1.224 . . . . 0.0 112.561 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.84 -29.52 58.68 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.891 1.711 . . . . 0.0 112.814 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.403 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.25 -40.16 78.03 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.781 1.173 . . . . 0.0 112.705 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.09 -47.02 82.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.847 0.748 . . . . 0.0 111.53 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -60.92 -44.2 97.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.68 71.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.227 1.011 . . . . 0.0 113.225 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.76 4.53 52.85 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.373 1.469 . . . . 0.0 113.47 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.5 p -133.08 22.79 4.14 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -53.56 120.33 6.01 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.508 -1.37 . . . . 0.0 111.454 168.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.62 60.02 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.447 0.939 . . . . 0.0 115.447 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.89 47.15 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.489 1.644 . . . . 0.0 112.515 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.32 159.68 84.33 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.771 0.828 . . . . 0.0 110.665 167.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.57 -35.48 37.46 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.227 1.951 . . . . 0.0 115.381 168.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.3 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.33 -45.3 93.9 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.062 172.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.57 -44.29 94.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.354 1.062 . . . . 0.0 112.134 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -59.21 -41.49 88.74 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.682 -0.636 . . . . 0.0 111.973 171.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.25 -45.24 93.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.654 0.661 . . . . 0.0 111.08 175.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.38 -48.87 77.92 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.254 0.934 . . . . 0.0 112.202 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.0 mt -63.13 -38.47 91.32 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.91 -33.41 70.51 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.4 p -73.66 -12.52 60.76 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.2 m -122.14 7.79 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -174.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.77 -4.64 5.87 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.85 -32.94 55.83 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 119.236 1.518 . . . . 0.0 115.411 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -91.57 78.62 5.56 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.875 1.337 . . . . 0.0 110.585 171.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.18 -35.92 38.59 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.33 -41.06 73.73 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.12 1.327 . . . . 0.0 112.315 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.6 86.01 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.16 0.584 . . . . 0.0 111.361 173.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.04 -40.18 96.95 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.476 -0.765 . . . . 0.0 112.255 175.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.9 -50.0 73.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.237 1.015 . . . . 0.0 111.548 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.99 -45.42 79.02 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.095 0.958 . . . . 0.0 112.21 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.97 -48.72 79.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.338 0.655 . . . . 0.0 112.055 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -63.75 -38.24 90.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.448 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.98 -45.53 92.42 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.684 0.675 . . . . 0.0 112.046 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.54 -42.42 99.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.848 0.749 . . . . 0.0 112.164 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.84 -46.1 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.507 -0.745 . . . . 0.0 111.093 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.13 -39.4 93.94 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.847 0.749 . . . . 0.0 112.759 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.8 -47.46 86.23 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.948 174.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.11 -34.32 72.96 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.46 91.76 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.408 -0.808 . . . . 0.0 112.376 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.12 98.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.208 0.603 . . . . 0.0 111.772 172.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.0 -42.32 99.81 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.869 -0.519 . . . . 0.0 112.165 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.77 -48.63 79.11 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.645 0.657 . . . . 0.0 111.676 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.02 -30.25 71.45 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -39.1 78.79 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.326 1.05 . . . . 0.0 112.451 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.22 -27.61 42.5 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 113.339 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.76 61.01 54.03 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.646 1.978 . . . . 0.0 111.247 -174.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.89 120.16 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.51 2.14 . . . . 0.0 110.261 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.45 136.24 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.383 1.473 . . . . 0.0 112.086 -169.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -79.94 160.43 25.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.082 0.553 . . . . 0.0 110.909 168.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.98 65.02 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.016 1.293 . . . . 0.0 112.617 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 169.2 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.917 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.65 -39.17 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.897 1.279 . . . . 0.0 111.799 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.51 161.9 28.59 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.911 1.684 . . . . 0.0 110.599 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.427 2.751 . . . . 0.0 113.132 168.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.07 60.28 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 115.005 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.021 1.41 . . . . 0.0 110.198 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.5 54.27 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.726 -0.608 . . . . 0.0 110.848 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.53 152.77 44.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.666 0.787 . . . . 0.0 111.664 171.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.24 131.73 84.85 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.883 -0.58 . . . . 0.0 109.821 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.42 140.44 43.95 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.037 1.825 . . . . 0.0 112.426 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -75.1 171.62 13.8 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.74 1.616 . . . . 0.0 111.898 163.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.55 -43.94 94.0 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 121.895 -0.503 . . . . 0.0 112.986 168.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.5 p -68.77 -25.73 64.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.8 -41.61 64.76 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.068 -1.02 . . . . 0.0 111.721 171.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.75 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.784 0.834 . . . . 0.0 110.782 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.05 -1.25 14.05 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.97 18.13 74.21 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.879 -1.138 . . . . 0.0 115.485 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.34 -19.3 19.33 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.092 1.446 . . . . 0.0 113.313 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.26 -1.5 6.99 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.63 149.95 24.45 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.055 0.942 . . . . 0.0 111.799 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.1 p -81.79 162.42 22.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.309 0.576 . . . . 0.0 110.773 169.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.81 -39.41 74.13 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.454 -0.778 . . . . 0.0 111.431 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.52 -38.91 92.93 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.518 -0.739 . . . . 0.0 112.674 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.62 -42.75 95.3 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.628 -0.67 . . . . 0.0 112.033 171.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.35 90.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.62 0.768 . . . . 0.0 112.11 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.51 -46.33 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.151 0.981 . . . . 0.0 110.255 172.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.09 54.06 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.823 0.725 . . . . 0.0 112.884 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.22 -50.1 73.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.517 174.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.61 -18.58 64.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.9 8.41 20.37 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.581 1.153 . . . . 0.0 113.046 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.41 162.3 1.59 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.935 1.294 . . . . 0.0 111.461 165.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.87 89.08 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.451 0.84 . . . . 0.0 111.713 -6.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -50.08 141.4 30.3 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.189 2.593 . . . . 0.0 114.135 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.16 96.43 2.48 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.97 54.63 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.66 -34.78 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.44 -46.2 94.33 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.666 0.666 . . . . 0.0 112.996 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.84 -36.89 75.93 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.259 -1.142 . . . . 0.0 112.679 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.89 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.802 -0.561 . . . . 0.0 109.98 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.9 -40.4 91.47 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.313 -0.867 . . . . 0.0 112.521 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -42.04 75.07 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.69 -45.28 81.88 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.924 0.784 . . . . 0.0 112.058 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.3 -40.54 86.04 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.305 0.642 . . . . 0.0 112.227 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.64 -47.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.279 174.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.25 -37.29 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.685 1.194 . . . . 0.0 112.282 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.8 -42.78 98.31 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.112 0.869 . . . . 0.0 111.245 171.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.06 91.55 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.796 0.712 . . . . 0.0 113.242 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.41 -42.4 87.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.019 0.91 . . . . 0.0 111.078 173.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.19 70.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.26 77.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.86 0.755 . . . . 0.0 111.991 175.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.43 -47.94 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.402 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.48 -32.88 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.951 1.251 . . . . 0.0 112.911 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.24 -44.55 95.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.902 0.881 . . . . 0.0 111.474 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.77 -36.2 59.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.69 1.596 . . . . 0.0 113.437 -177.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.5 t80 . . . . . 0 C--O 1.251 1.16 0 C-N-CA 128.415 2.686 . . . . 0.0 114.504 -172.665 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.85 135.0 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.504 1.121 . . . . 0.0 108.402 163.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.7 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.88 -26.5 68.81 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.0 3.05 85.7 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.475 1.036 . . . . 0.0 114.092 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.19 35.32 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.87 1.335 . . . . 0.0 109.741 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.85 125.52 29.47 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 168.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.9 t -125.9 123.36 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.063 1.345 . . . . 0.0 108.659 -174.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.54 139.67 38.61 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.177 170.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.16 48.41 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 20.99 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.803 . . . . 0.0 111.191 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.53 136.91 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.472 0.653 . . . . 0.0 111.578 176.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.71 130.0 93.19 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.108 0.563 . . . . 0.0 111.137 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.873 2.382 . . . . 0.0 113.575 167.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.44 -38.09 86.61 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.464 -0.773 . . . . 0.0 112.56 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.92 -44.32 97.35 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 0.0 111.373 171.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.53 -44.31 94.6 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.24 -47.26 86.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.079 0.551 . . . . 0.0 111.366 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.18 95.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.626 0.77 . . . . 0.0 111.91 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.11 -47.14 87.12 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.833 0.853 . . . . 0.0 112.786 176.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.0 t -56.89 -54.26 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.381 0.537 . . . . 0.0 110.474 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.83 -37.26 78.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.358 1.063 . . . . 0.0 113.19 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.45 -52.3 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.096 1.358 . . . . 0.0 111.257 170.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.83 -35.85 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 119.053 -0.499 . . . . 0.0 111.466 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.73 -23.71 60.31 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.49 -25.62 11.3 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.92 16.11 3.3 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -166.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.39 -37.5 2.34 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -118.23 13.84 13.79 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.475 1.11 . . . . 0.0 113.148 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.9 p -113.05 153.06 45.42 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.971 0.908 . . . . 0.0 111.568 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.89 -30.88 60.16 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.256 2.638 . . . . 0.0 115.182 -172.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.95 64.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.17 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.41 1.005 . . . . 0.0 112.462 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.6 mt -70.35 -57.18 6.0 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.743 1.217 . . . . 0.0 112.561 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.88 -29.45 58.36 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.891 1.711 . . . . 0.0 112.816 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.24 -40.17 78.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.831 1.196 . . . . 0.0 112.709 172.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.12 -47.01 82.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.83 0.741 . . . . 0.0 111.562 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -60.91 -44.2 97.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.73 -31.68 70.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.228 1.011 . . . . 0.0 113.251 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.87 4.62 52.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.419 1.488 . . . . 0.0 113.458 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.1 p -133.11 22.86 4.14 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.61 120.3 6.0 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.453 -1.404 . . . . 0.0 111.465 168.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.71 60.16 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.59 130.91 47.18 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.478 1.639 . . . . 0.0 112.453 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.35 159.65 84.37 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.771 0.828 . . . . 0.0 110.653 167.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.58 -35.44 37.43 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.171 1.914 . . . . 0.0 115.372 168.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.07 -40.24 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -60.32 -45.32 93.81 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.662 -0.649 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.57 -44.27 94.59 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 112.163 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -59.21 -41.43 88.58 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.682 -0.636 . . . . 0.0 111.996 171.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.6 m -60.25 -45.42 93.33 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.583 0.629 . . . . 0.0 111.028 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.28 -48.85 77.85 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.228 0.922 . . . . 0.0 112.179 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.8 mt -63.18 -38.29 90.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 178.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.07 -34.2 71.69 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -72.81 -12.93 61.18 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.4 13.11 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.267 1.027 . . . . 0.0 113.505 -175.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.48 -5.91 4.1 Favored Glycine 0 CA--C 1.543 1.835 0 N-CA-C 117.067 1.587 . . . . 0.0 117.067 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.67 -0.13 6.21 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 125.84 1.686 . . . . 0.0 116.919 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -124.78 79.79 1.81 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.339 1.57 . . . . 0.0 110.347 166.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.81 -36.08 46.59 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -172.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.17 -41.01 74.33 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.118 1.326 . . . . 0.0 112.19 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.47 -43.68 84.82 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.19 0.596 . . . . 0.0 111.317 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.2 tpp -62.86 -40.3 97.04 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.508 -0.745 . . . . 0.0 112.2 175.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.97 74.18 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.296 1.038 . . . . 0.0 111.536 173.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -56.02 -45.43 79.1 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.101 0.961 . . . . 0.0 112.206 174.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.8 tp -61.88 -48.81 78.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.289 0.636 . . . . 0.0 112.055 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.63 -38.31 90.65 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.455 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.02 -45.45 92.75 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.668 0.667 . . . . 0.0 112.013 170.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.61 -42.45 99.58 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.848 0.749 . . . . 0.0 112.094 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.8 -46.11 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.535 -0.728 . . . . 0.0 111.053 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.16 -39.4 93.94 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.865 0.757 . . . . 0.0 112.717 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -60.84 -47.44 86.35 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.964 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.1 -34.3 72.96 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.55 91.78 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.451 -0.781 . . . . 0.0 112.369 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.01 98.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.201 0.6 . . . . 0.0 111.784 172.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.1 -42.28 99.54 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.864 -0.523 . . . . 0.0 112.19 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.88 -48.45 79.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.646 0.657 . . . . 0.0 111.687 173.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.09 -30.3 71.49 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.08 -39.12 79.26 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.361 1.064 . . . . 0.0 112.499 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.29 -27.6 42.21 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.776 1.23 . . . . 0.0 113.302 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.83 61.03 54.02 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.672 1.989 . . . . 0.0 111.241 -174.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.93 120.16 7.44 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.421 2.08 . . . . 0.0 110.258 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.4 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.34 1.456 . . . . 0.0 112.152 -169.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.05 160.47 25.81 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.043 0.537 . . . . 0.0 110.909 168.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.26 -19.97 65.03 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.71 41.58 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.048 1.309 . . . . 0.0 112.61 174.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.45 169.17 14.61 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.668 2.912 . . . . 0.0 112.954 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.74 -39.17 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.909 1.284 . . . . 0.0 111.742 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.94 28.52 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -47.91 133.42 22.84 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.479 2.786 . . . . 0.0 113.089 168.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.06 60.35 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.562 1.077 . . . . 0.0 114.978 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.35 37.47 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.96 1.38 . . . . 0.0 110.198 173.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.17 145.57 54.21 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.717 -0.614 . . . . 0.0 110.826 168.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.56 152.73 44.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.709 0.804 . . . . 0.0 111.614 171.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.25 131.73 84.82 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.916 -0.564 . . . . 0.0 109.835 170.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.42 140.39 43.83 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.099 1.866 . . . . 0.0 112.442 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.7 mtp85 -75.02 171.63 13.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.737 1.615 . . . . 0.0 111.852 163.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.68 -43.82 94.27 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.942 -0.474 . . . . 0.0 112.954 168.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.77 -25.86 64.92 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.56 65.11 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.041 -1.037 . . . . 0.0 111.756 171.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.66 -42.69 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.731 0.812 . . . . 0.0 110.827 173.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.29 14.03 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 173.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.11 74.16 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.934 -1.104 . . . . 0.0 115.477 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.39 19.35 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.11 1.455 . . . . 0.0 113.292 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.6 p -126.21 -1.54 7.02 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.57 149.99 24.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.067 0.947 . . . . 0.0 111.773 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.9 p -81.85 162.37 22.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.307 0.575 . . . . 0.0 110.794 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.81 -39.45 74.19 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.484 -0.76 . . . . 0.0 111.4 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.59 -38.83 92.62 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.556 -0.715 . . . . 0.0 112.683 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.63 -42.76 95.25 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.628 -0.67 . . . . 0.0 112.047 171.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.63 -46.42 90.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.61 0.764 . . . . 0.0 112.11 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.39 -46.33 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.142 0.977 . . . . 0.0 110.354 172.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.12 53.81 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.81 0.719 . . . . 0.0 112.902 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.21 -50.07 73.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.778 0.789 . . . . 0.0 112.512 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.1 p -111.95 8.42 20.29 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.6 1.16 . . . . 0.0 113.009 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.44 162.31 1.61 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.952 1.301 . . . . 0.0 111.441 165.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.85 89.12 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.451 0.84 . . . . 0.0 111.762 -6.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -49.97 141.31 29.73 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.238 2.625 . . . . 0.0 114.174 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.12 96.48 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.81 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.17 94.4 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.638 0.654 . . . . 0.0 113.011 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.89 -36.86 75.76 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.296 -1.12 . . . . 0.0 112.634 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.92 -44.58 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.785 -0.572 . . . . 0.0 109.954 173.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.89 -40.38 91.52 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.303 -0.873 . . . . 0.0 112.521 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.05 75.1 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.275 173.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.65 -45.21 81.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.901 0.773 . . . . 0.0 112.147 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.28 -40.53 86.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.69 -47.04 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.05 0.54 . . . . 0.0 110.286 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.29 -37.3 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.636 1.174 . . . . 0.0 112.282 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.82 -42.77 98.35 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.051 0.842 . . . . 0.0 111.215 171.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.17 90.96 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.836 0.731 . . . . 0.0 113.184 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.43 -42.29 86.97 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.045 0.922 . . . . 0.0 111.073 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.26 70.4 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.424 173.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.77 -43.26 76.57 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.874 0.761 . . . . 0.0 111.961 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.2 mt -64.6 -47.76 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.431 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.56 -32.89 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.965 1.257 . . . . 0.0 112.9 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.25 -44.84 94.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.939 0.895 . . . . 0.0 111.468 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.39 -36.87 60.82 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.683 1.593 . . . . 0.0 113.428 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 128.425 2.69 . . . . 0.0 114.577 -172.73 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.89 135.06 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.482 1.113 . . . . 0.0 108.402 163.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -126.07 154.84 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.092 1.357 . . . . 0.0 109.688 170.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.56 116.7 32.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.519 0.728 . . . . 0.0 109.139 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.46 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.514 0.673 . . . . 0.0 112.474 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.85 -26.53 68.8 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -173.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.87 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.81 1.244 . . . . 0.0 113.019 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.94 3.09 85.81 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.458 1.028 . . . . 0.0 114.08 -175.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.21 35.39 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.823 1.312 . . . . 0.0 109.683 174.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.53 29.49 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 168.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.9 123.31 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.086 1.354 . . . . 0.0 108.698 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.58 139.66 38.57 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.555 0.693 . . . . 0.0 111.23 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.09 48.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.491 1.916 . . . . 0.0 107.921 169.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.4 20.9 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.248 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.56 136.85 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.605 -0.685 . . . . 0.0 111.555 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.65 129.98 93.26 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.136 0.575 . . . . 0.0 111.149 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.02 -34.58 68.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.907 2.405 . . . . 0.0 113.586 167.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.44 -38.08 86.6 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.513 -0.742 . . . . 0.0 112.588 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.87 -44.34 97.19 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.767 0.712 . . . . 0.0 111.386 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.52 -44.33 94.57 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.296 0.498 . . . . 0.0 112.267 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.23 -47.22 86.14 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.139 0.576 . . . . 0.0 111.4 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.24 95.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.664 0.786 . . . . 0.0 111.899 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.14 -47.12 87.25 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.795 0.838 . . . . 0.0 112.772 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.1 t -56.91 -54.3 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.392 0.542 . . . . 0.0 110.41 174.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.81 -37.18 78.42 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.324 1.05 . . . . 0.0 113.247 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.57 -52.19 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.044 1.338 . . . . 0.0 111.286 170.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.91 -35.86 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.972 0.509 . . . . 0.0 111.412 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -58.66 -23.79 59.96 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.52 -25.58 11.31 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -135.94 16.12 3.29 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.42 -37.4 2.33 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -175.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -118.31 13.91 13.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.473 1.109 . . . . 0.0 113.148 -172.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.1 p -113.15 153.02 45.52 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.962 0.905 . . . . 0.0 111.515 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.82 -30.91 59.64 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.287 2.658 . . . . 0.0 115.218 -172.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.91 64.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.61 -32.24 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.406 1.003 . . . . 0.0 112.422 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.6 mt -70.33 -57.15 6.05 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.684 1.194 . . . . 0.0 112.572 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.86 -29.45 58.49 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.896 1.713 . . . . 0.0 112.816 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.29 -40.08 77.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.818 1.19 . . . . 0.0 112.694 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -57.17 -47.05 82.18 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.878 0.763 . . . . 0.0 111.537 169.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -60.88 -44.21 97.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.79 -31.61 70.97 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.193 0.997 . . . . 0.0 113.297 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.88 4.74 52.54 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.368 1.467 . . . . 0.0 113.55 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.0 p -133.15 22.73 4.12 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.57 120.29 5.96 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.474 -1.391 . . . . 0.0 111.456 168.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.53 60.15 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.47 130.82 46.91 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.528 1.664 . . . . 0.0 112.53 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.28 159.66 84.43 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.718 0.807 . . . . 0.0 110.692 167.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.61 -35.37 37.49 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.144 1.896 . . . . 0.0 115.4 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.03 -40.3 87.18 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.3 93.89 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.066 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.55 -44.28 94.62 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.329 1.051 . . . . 0.0 112.175 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -59.24 -41.37 88.58 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.612 -0.68 . . . . 0.0 112.047 171.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.2 -45.41 93.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.597 0.635 . . . . 0.0 111.115 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.28 -48.85 77.84 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.187 0.903 . . . . 0.0 112.176 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.0 mt -63.18 -38.33 90.73 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.06 -34.16 71.62 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -72.78 -12.98 61.21 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.36 13.15 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.315 1.046 . . . . 0.0 113.557 -175.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.48 -5.92 4.11 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 117.055 1.582 . . . . 0.0 117.055 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.71 -0.2 6.38 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 125.909 1.719 . . . . 0.0 116.845 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -124.71 79.76 1.8 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.347 1.574 . . . . 0.0 110.385 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.87 -36.03 47.07 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.718 1.607 . . . . 0.0 115.304 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.2 -40.98 74.29 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.154 1.343 . . . . 0.0 112.191 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.44 -43.75 84.73 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.254 0.622 . . . . 0.0 111.315 173.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.2 tpp -62.77 -40.3 96.87 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.491 -0.756 . . . . 0.0 112.257 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.05 -49.95 74.26 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.292 1.037 . . . . 0.0 111.544 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -56.0 -45.42 79.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.101 0.961 . . . . 0.0 112.234 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.88 -48.84 78.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.308 0.643 . . . . 0.0 112.054 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.69 -38.3 90.58 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.873 0.869 . . . . 0.0 112.424 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.95 -45.49 92.49 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.705 0.684 . . . . 0.0 112.034 170.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.7 m -62.65 -42.36 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.793 0.724 . . . . 0.0 112.118 175.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.87 -46.08 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.507 -0.745 . . . . 0.0 111.045 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.4 93.96 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.838 0.745 . . . . 0.0 112.717 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -60.84 -47.41 86.48 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.743 0.817 . . . . 0.0 111.958 174.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.12 -34.34 72.96 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.593 -0.692 . . . . 0.0 112.859 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.56 91.81 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.484 -0.76 . . . . 0.0 112.371 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.09 98.58 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.246 0.619 . . . . 0.0 111.766 172.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.17 -42.22 99.37 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.864 -0.523 . . . . 0.0 112.191 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.71 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.06 -30.22 71.43 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.19 -39.06 78.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.342 1.057 . . . . 0.0 112.488 173.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.57 42.28 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.796 1.239 . . . . 0.0 113.354 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.0 53.92 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.94 120.15 7.43 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.452 2.101 . . . . 0.0 110.285 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.44 136.36 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.372 1.469 . . . . 0.0 112.077 -169.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -80.0 160.47 25.87 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.048 0.539 . . . . 0.0 110.909 168.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.24 -19.98 65.03 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.91 174.81 41.58 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.075 1.322 . . . . 0.0 112.625 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.64 169.18 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.635 2.89 . . . . 0.0 112.889 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.68 -39.19 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.903 1.281 . . . . 0.0 111.749 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.46 161.89 28.6 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.842 1.657 . . . . 0.0 110.551 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.427 2.751 . . . . 0.0 113.132 168.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.98 -15.08 60.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.567 1.08 . . . . 0.0 115.01 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.23 145.48 54.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.691 -0.631 . . . . 0.0 110.859 168.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.47 152.82 44.86 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.2 131.69 84.94 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.83 170.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.44 140.36 43.69 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.097 1.864 . . . . 0.0 112.426 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -75.04 171.62 13.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.649 1.58 . . . . 0.0 111.89 163.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.55 -43.85 94.02 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.949 -0.469 . . . . 0.0 113.035 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.76 -25.85 64.94 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.63 -41.63 65.32 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.061 -1.025 . . . . 0.0 111.795 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.75 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.784 0.834 . . . . 0.0 110.782 173.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.26 14.02 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 173.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.93 18.16 74.16 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.908 -1.12 . . . . 0.0 115.491 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.26 -19.46 19.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.053 1.426 . . . . 0.0 113.263 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.0 p -126.1 -1.49 7.09 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.67 149.89 24.53 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.052 0.941 . . . . 0.0 111.814 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.0 p -81.76 162.31 22.97 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.318 0.58 . . . . 0.0 110.827 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.75 -39.43 73.97 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.446 -0.784 . . . . 0.0 111.43 169.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.56 -38.9 92.89 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.516 -0.74 . . . . 0.0 112.706 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.76 95.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 112.008 171.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.68 -46.36 90.66 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.156 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.47 -46.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.091 0.956 . . . . 0.0 110.288 172.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.1 54.01 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 0.0 112.869 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.07 73.19 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.512 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.61 -18.53 64.33 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.91 8.36 20.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.645 1.178 . . . . 0.0 112.996 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.44 162.33 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.995 1.318 . . . . 0.0 111.447 165.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.6 103.34 48.91 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.065 0.946 . . . . 0.0 110.778 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.451 0.84 . . . . 0.0 111.762 -6.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -50.0 141.36 29.81 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.155 2.57 . . . . 0.0 114.205 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.11 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.56 -34.84 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -173.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.21 94.29 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.605 0.639 . . . . 0.0 112.996 173.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.84 -36.9 75.95 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.289 -1.124 . . . . 0.0 112.645 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.9 -44.57 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.745 -0.597 . . . . 0.0 109.914 173.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.91 -40.35 91.4 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.282 -0.886 . . . . 0.0 112.521 176.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.87 -42.07 75.34 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.439 -0.788 . . . . 0.0 112.204 173.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.63 -45.25 81.66 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.899 0.772 . . . . 0.0 112.093 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.28 -40.53 86.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.66 -47.08 94.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.085 0.554 . . . . 0.0 110.285 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.26 -37.32 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.645 1.178 . . . . 0.0 112.298 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.82 98.41 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.028 0.831 . . . . 0.0 111.185 171.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.48 -45.21 91.12 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.878 0.751 . . . . 0.0 113.228 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.38 -42.3 86.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.003 0.901 . . . . 0.0 111.14 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.26 70.4 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.424 173.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.83 -43.19 76.74 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.874 0.761 . . . . 0.0 111.975 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.6 -47.79 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.344 0.658 . . . . 0.0 111.431 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.89 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.961 1.255 . . . . 0.0 112.9 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -60.26 -44.87 94.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.939 0.895 . . . . 0.0 111.461 171.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.33 -36.95 60.99 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.672 1.589 . . . . 0.0 113.45 -177.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 128.454 2.702 . . . . 0.0 114.562 -172.701 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.85 135.0 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.488 1.115 . . . . 0.0 108.482 163.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.65 32.46 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.43 178.06 6.88 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 121.529 0.68 . . . . 0.0 112.46 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.88 -26.56 68.84 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.03 3.02 85.65 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.475 1.036 . . . . 0.0 114.07 -175.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.71 128.2 35.35 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.893 1.347 . . . . 0.0 109.712 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.55 29.51 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 168.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.94 123.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.074 1.349 . . . . 0.0 108.629 -174.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.65 141.14 48.49 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.488 1.915 . . . . 0.0 107.89 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.29 21.03 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.023 0.829 . . . . 0.0 111.254 170.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.48 136.85 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.523 0.678 . . . . 0.0 111.55 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.69 130.0 93.21 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.068 0.547 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.02 -34.58 68.22 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.894 2.396 . . . . 0.0 113.583 167.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.44 -38.06 86.55 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.437 -0.789 . . . . 0.0 112.588 174.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.95 -44.31 97.47 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 0.0 111.349 171.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.57 -44.35 94.36 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.29 0.496 . . . . 0.0 112.309 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.12 -47.31 85.73 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.142 0.577 . . . . 0.0 111.388 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.32 95.29 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.604 0.761 . . . . 0.0 111.896 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -60.07 -47.29 86.47 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.849 0.859 . . . . 0.0 112.791 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.6 t -56.74 -54.94 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 118.417 0.553 . . . . 0.0 110.254 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.15 -37.71 77.98 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.371 1.068 . . . . 0.0 113.237 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.404 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.21 -51.96 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.064 1.346 . . . . 0.0 111.28 170.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.81 -35.87 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.993 0.517 . . . . 0.0 111.485 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -58.94 -23.29 61.29 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.709 1.141 . . . . 0.0 113.972 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.55 -25.91 11.15 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -135.9 16.26 3.3 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -165.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.65 -37.47 2.6 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -118.3 14.58 13.86 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.39 1.076 . . . . 0.0 113.1 -172.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -113.77 153.02 46.05 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.004 0.922 . . . . 0.0 111.526 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.9 -30.79 59.87 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.274 2.649 . . . . 0.0 115.224 -172.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.09 -20.64 64.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.78 -31.96 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.397 0.998 . . . . 0.0 112.539 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.38 -55.08 6.3 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.974 1.31 . . . . 0.0 112.944 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.85 -30.07 49.59 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.658 1.628 . . . . 0.0 112.669 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.404 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.04 -40.3 78.68 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.921 1.237 . . . . 0.0 112.606 172.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.25 -46.46 82.99 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.735 0.698 . . . . 0.0 111.576 169.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -61.1 -44.47 97.31 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.84 -31.95 71.37 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.317 1.047 . . . . 0.0 113.25 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.47 4.58 53.13 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.333 1.453 . . . . 0.0 113.526 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.1 p -133.09 22.8 4.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.58 120.34 6.04 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.47 168.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.69 60.07 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.371 0.909 . . . . 0.0 115.371 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.54 130.89 47.14 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.565 1.683 . . . . 0.0 112.515 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.33 159.69 84.29 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 123.748 0.819 . . . . 0.0 110.718 167.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.61 -35.44 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.204 1.936 . . . . 0.0 115.372 168.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.24 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.35 93.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -59.2 -41.49 88.66 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.696 -0.628 . . . . 0.0 112.024 171.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.22 -45.33 93.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.569 0.622 . . . . 0.0 111.091 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.33 -48.86 77.88 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.205 0.911 . . . . 0.0 112.164 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.19 -38.33 90.76 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.06 -33.7 71.09 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.4 p -73.07 -12.92 61.09 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.17 8.9 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -174.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.86 -5.55 7.55 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 117.267 1.667 . . . . 0.0 117.267 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.23 -31.24 59.12 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.318 1.559 . . . . 0.0 115.648 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -93.42 78.44 4.41 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.962 1.381 . . . . 0.0 110.536 172.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.07 -35.8 36.64 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.03 73.96 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.154 1.343 . . . . 0.0 112.243 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.58 85.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.199 0.599 . . . . 0.0 111.35 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.06 -40.08 96.64 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.53 -0.732 . . . . 0.0 112.238 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.96 74.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.247 1.019 . . . . 0.0 111.529 173.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -55.9 -45.5 78.63 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.1 0.96 . . . . 0.0 112.228 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.92 -48.77 78.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.265 0.626 . . . . 0.0 112.035 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.69 -38.31 90.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.873 0.869 . . . . 0.0 112.49 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.96 -45.49 92.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.689 0.677 . . . . 0.0 112.02 170.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.6 -42.43 99.57 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.848 0.749 . . . . 0.0 112.13 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.83 -46.08 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.535 -0.728 . . . . 0.0 111.059 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.21 -39.35 93.79 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.858 0.754 . . . . 0.0 112.731 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.84 -47.39 86.59 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.964 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.19 -34.27 72.74 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.6 91.91 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.451 -0.781 . . . . 0.0 112.333 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -42.04 98.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.224 0.61 . . . . 0.0 111.783 172.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.19 -42.26 99.33 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.855 -0.528 . . . . 0.0 112.191 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.74 -48.55 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.625 0.648 . . . . 0.0 111.71 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -63.04 -30.3 71.49 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -38.99 78.83 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.33 1.052 . . . . 0.0 112.458 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.36 -27.5 41.95 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.776 1.23 . . . . 0.0 113.313 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.84 61.02 53.98 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.622 1.969 . . . . 0.0 111.241 -174.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -63.91 120.12 7.38 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.479 2.119 . . . . 0.0 110.293 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.39 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.32 1.448 . . . . 0.0 112.135 -169.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.03 160.49 25.83 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.083 0.553 . . . . 0.0 110.897 168.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -19.93 65.01 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.94 174.77 41.59 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.032 1.301 . . . . 0.0 112.656 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.57 169.17 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.66 2.907 . . . . 0.0 112.906 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.69 -39.14 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.843 1.257 . . . . 0.0 111.824 -175.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.91 28.57 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.83 133.41 22.44 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.519 2.812 . . . . 0.0 113.132 168.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.9 -15.0 60.33 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.607 1.099 . . . . 0.0 114.992 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.992 1.396 . . . . 0.0 110.198 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.52 54.19 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.694 -0.629 . . . . 0.0 110.787 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.47 152.84 44.83 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.3 131.73 84.73 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 118.945 -0.55 . . . . 0.0 109.824 170.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.38 140.38 43.93 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.074 1.849 . . . . 0.0 112.442 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -74.98 171.61 13.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.761 1.625 . . . . 0.0 111.872 163.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.64 -43.82 94.19 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.912 -0.493 . . . . 0.0 112.974 168.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.5 p -68.74 -25.85 64.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.72 -41.64 65.0 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.082 -1.011 . . . . 0.0 111.725 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.63 -42.69 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.718 0.807 . . . . 0.0 110.827 173.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.96 -1.34 14.13 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.21 74.24 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 120.877 -1.139 . . . . 0.0 115.463 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.31 -19.46 19.24 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.099 1.449 . . . . 0.0 113.263 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.12 -1.42 7.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.7 149.87 24.57 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.073 0.949 . . . . 0.0 111.788 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.1 p -81.76 162.33 22.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.318 0.58 . . . . 0.0 110.827 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.78 -39.47 74.14 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.418 -0.801 . . . . 0.0 111.347 169.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.52 -38.9 92.89 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.554 -0.716 . . . . 0.0 112.722 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.62 -42.76 95.3 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.584 -0.698 . . . . 0.0 112.033 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.65 -46.39 90.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.687 0.795 . . . . 0.0 112.097 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.29 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.338 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.51 -51.02 54.73 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.81 0.719 . . . . 0.0 112.927 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.27 -50.04 73.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.819 0.81 . . . . 0.0 112.542 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.69 -18.49 64.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.0 p -111.93 8.46 20.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.643 1.177 . . . . 0.0 113.062 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.45 162.31 1.62 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.989 1.316 . . . . 0.0 111.441 165.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.37 48.93 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.029 0.932 . . . . 0.0 110.758 176.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.06 163.81 89.24 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.494 0.855 . . . . 0.0 111.713 -6.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -49.93 141.36 29.3 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.199 2.6 . . . . 0.0 114.149 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.16 96.45 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 163.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -86.0 54.56 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.251 2.634 . . . . 0.0 112.86 -152.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.56 -34.86 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.22 94.31 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.638 0.654 . . . . 0.0 112.999 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -69.9 -36.83 75.72 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.327 -1.102 . . . . 0.0 112.688 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.87 -44.64 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.795 -0.566 . . . . 0.0 109.912 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.88 -40.34 91.52 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.303 -0.873 . . . . 0.0 112.564 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.88 -41.98 75.26 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.412 -0.805 . . . . 0.0 112.253 173.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.69 -45.16 81.95 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.924 0.784 . . . . 0.0 112.147 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.33 -40.53 85.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.29 0.636 . . . . 0.0 112.251 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.67 -47.09 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.085 0.554 . . . . 0.0 110.249 174.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.19 -37.39 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.674 1.19 . . . . 0.0 112.3 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.8 -42.79 98.31 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.011 0.823 . . . . 0.0 111.253 171.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.11 91.4 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.796 0.712 . . . . 0.0 113.265 175.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.46 -42.3 87.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.01 0.905 . . . . 0.0 111.092 173.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.19 70.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.23 77.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.86 0.755 . . . . 0.0 111.986 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.41 -47.91 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.415 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -69.64 -32.8 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.0 1.273 . . . . 0.0 112.86 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.11 -44.02 95.18 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.863 0.865 . . . . 0.0 111.505 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.3 ttp -77.04 -37.36 54.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.652 1.581 . . . . 0.0 113.558 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.251 1.177 0 C-N-CA 128.427 2.691 . . . . 0.0 114.649 -172.059 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.48 0.686 0 N-CA-C 112.997 0.345 . . . . 20.0 112.997 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.99 135.01 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.473 1.109 . . . . 20.0 108.448 163.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.81 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 20.0 109.686 170.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.47 116.7 32.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.531 0.733 . . . . 20.0 109.17 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.503 0.668 . . . . 20.0 112.495 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.82 -26.57 68.81 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.432 1.271 . . . . 20.0 114.432 -173.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 20.0 113.03 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.0 3.07 85.68 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.475 1.036 . . . . 20.0 114.058 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.22 35.46 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.847 1.323 . . . . 20.0 109.731 174.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.52 29.47 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.453 -0.573 . . . . 20.0 109.453 168.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.9 123.39 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.014 1.326 . . . . 20.0 108.648 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 20.0 111.213 170.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.67 141.12 48.46 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.511 1.924 . . . . 20.0 107.935 169.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.37 20.84 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.949 0.795 . . . . 20.0 111.191 170.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.53 136.81 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.625 -0.672 . . . . 20.0 111.61 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.62 129.96 93.29 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.084 0.553 . . . . 20.0 111.137 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.05 -34.48 67.98 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 122.868 2.378 . . . . 20.0 113.542 167.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.51 -38.09 86.46 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.453 -0.779 . . . . 20.0 112.56 174.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.99 -44.21 97.74 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 20.0 111.354 171.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.58 -44.45 94.02 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.341 0.519 . . . . 20.0 112.256 175.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.08 -47.19 86.14 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.076 0.55 . . . . 20.0 111.402 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.2 95.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.64 0.776 . . . . 20.0 111.881 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 52.0 t-105 -60.29 -46.89 88.26 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.81 0.844 . . . . 20.0 112.781 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 63.9 t -57.0 -54.24 32.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 CA-C-N 118.412 0.551 . . . . 20.0 110.355 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.8 -37.25 78.59 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.374 1.07 . . . . 20.0 113.229 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.22 -52.31 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.206 1.403 . . . . 20.0 111.233 170.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.9 t -65.08 -36.14 77.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.022 0.529 . . . . 20.0 111.405 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -58.55 -23.85 59.37 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.978 1.103 . . . . 20.0 113.978 175.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.47 -25.47 11.38 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.04 1.126 . . . . 20.0 114.04 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -136.19 16.09 3.24 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.367 1.247 . . . . 20.0 114.367 -165.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.08 -36.78 2.71 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 116.478 2.029 . . . . 20.0 116.478 -175.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.48 15.34 13.78 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.492 1.117 . . . . 20.0 113.098 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -114.87 153.01 47.0 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 123.961 0.904 . . . . 20.0 111.456 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.96 -30.6 59.64 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.218 2.612 . . . . 20.0 115.238 -172.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.17 -20.74 64.45 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.173 1.175 . . . . 20.0 114.173 -177.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.88 -31.82 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.468 1.031 . . . . 20.0 112.548 176.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.7 mt -71.47 -54.98 6.26 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.927 1.291 . . . . 20.0 113.01 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.89 -30.16 49.16 Favored 'Trans proline' 0 C--N 1.351 0.686 0 CA-C-N 121.673 1.633 . . . . 20.0 112.633 174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -68.96 -40.26 79.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 119.867 1.212 . . . . 20.0 112.674 172.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.3 -46.44 83.17 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.476 0.711 . . . . 20.0 111.576 169.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.0 m -61.12 -44.53 97.2 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.608 0.596 . . . . 20.0 112.608 175.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.8 -31.88 71.26 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.28 1.032 . . . . 20.0 113.315 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.52 4.57 53.07 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.364 1.466 . . . . 20.0 113.499 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.5 p -133.1 22.88 4.14 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.437 1.273 . . . . 20.0 114.437 -176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.63 120.27 5.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.485 -1.384 . . . . 20.0 111.47 168.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.6 11.59 60.19 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 115.365 0.906 . . . . 20.0 115.365 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.45 130.82 46.9 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.542 1.671 . . . . 20.0 112.48 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.33 159.66 84.37 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.706 0.802 . . . . 20.0 110.68 167.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.57 -35.47 37.43 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.144 1.896 . . . . 20.0 115.406 168.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.04 -40.17 87.11 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.098 0.777 . . . . 20.0 113.098 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.42 -45.26 94.26 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.629 -0.669 . . . . 20.0 111.047 172.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.56 -44.28 94.58 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.32 1.048 . . . . 20.0 112.115 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -59.25 -41.39 88.66 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.618 0.644 . . . . 20.0 112.008 171.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.9 m -60.3 -45.28 93.93 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.597 0.635 . . . . 20.0 111.066 175.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.38 -48.98 77.64 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.218 0.917 . . . . 20.0 112.114 174.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.04 -38.34 90.8 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.827 0.677 . . . . 20.0 112.827 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.04 -33.66 71.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 112.89 0.7 . . . . 20.0 112.89 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.8 p -73.1 -12.81 61.04 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.662 1.356 . . . . 20.0 114.662 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.03 7.78 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.357 1.063 . . . . 20.0 113.868 -174.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.09 -5.43 10.05 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 117.46 1.744 . . . . 20.0 117.46 -176.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.05 -35.42 69.21 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-N 119.32 1.56 . . . . 20.0 115.282 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -85.28 77.84 9.91 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 123.053 1.406 . . . . 20.0 110.56 171.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.98 -35.61 34.66 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.624 1.57 . . . . 20.0 115.225 -174.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.58 -41.42 72.41 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 120.226 1.375 . . . . 20.0 112.306 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.32 -43.59 85.75 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.777 -0.577 . . . . 20.0 111.37 173.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -63.13 -39.98 96.26 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.475 -0.766 . . . . 20.0 112.239 175.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -57.05 -49.94 74.27 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 121.05 -1.031 . . . . 20.0 111.548 173.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.95 -45.46 78.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 20.0 112.239 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.96 -48.73 79.07 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.27 0.628 . . . . 20.0 112.034 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.73 -38.37 90.85 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 20.0 112.403 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -59.78 -45.59 91.82 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.807 0.73 . . . . 20.0 112.048 170.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.5 m -62.67 -42.41 99.6 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.724 0.693 . . . . 20.0 112.118 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.78 -46.1 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.431 -0.793 . . . . 20.0 111.093 174.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.12 -39.48 94.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.788 0.722 . . . . 20.0 112.715 177.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -60.77 -47.45 86.28 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.716 0.806 . . . . 20.0 111.958 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.09 -34.3 72.97 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.901 0.704 . . . . 20.0 112.901 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.59 91.73 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.434 -0.791 . . . . 20.0 112.369 172.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.77 -42.11 98.57 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.264 0.625 . . . . 20.0 111.781 172.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.12 -42.27 99.5 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 20.0 112.163 175.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.81 -48.49 79.57 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.661 0.664 . . . . 20.0 111.669 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.06 -30.33 71.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.906 0.706 . . . . 20.0 112.906 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.17 -38.99 79.01 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.331 1.052 . . . . 20.0 112.457 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.4 -27.58 41.81 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.807 1.243 . . . . 20.0 113.306 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.1 54.5 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 126.587 1.955 . . . . 20.0 111.217 -174.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.0 120.13 7.4 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.483 2.122 . . . . 20.0 110.242 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.41 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.366 1.466 . . . . 20.0 112.158 -169.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.09 160.47 25.76 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.103 0.561 . . . . 20.0 110.903 168.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -19.97 65.05 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.367 1.247 . . . . 20.0 114.367 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.88 174.81 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.064 1.316 . . . . 20.0 112.68 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.57 169.17 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.66 2.907 . . . . 20.0 112.906 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.73 -39.05 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.843 1.257 . . . . 20.0 111.82 -175.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.55 161.85 28.7 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.877 1.671 . . . . 20.0 110.603 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.92 133.45 22.9 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.473 2.782 . . . . 20.0 113.132 168.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.94 -15.02 60.35 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.567 1.08 . . . . 20.0 115.001 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -78.14 143.36 37.35 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.978 1.389 . . . . 20.0 110.187 173.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.14 145.58 54.24 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.719 -0.613 . . . . 20.0 110.826 168.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.51 152.69 45.03 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.717 0.807 . . . . 20.0 111.616 171.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.21 131.73 84.9 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.917 -0.563 . . . . 20.0 109.834 170.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.42 140.27 43.55 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.096 1.864 . . . . 20.0 112.451 -177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 70.1 mtp85 -74.92 171.62 13.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.743 1.617 . . . . 20.0 111.872 163.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.87 94.09 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.935 -0.478 . . . . 20.0 112.998 168.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.75 -25.83 64.93 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.059 1.133 . . . . 20.0 114.059 175.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.6 64.98 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.062 -1.024 . . . . 20.0 111.742 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.65 -42.72 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.731 0.812 . . . . 20.0 110.812 173.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.29 14.06 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.87 1.063 . . . . 20.0 113.87 173.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.26 74.28 Favored Glycine 0 CA--C 1.535 1.32 0 O-C-N 120.865 -1.147 . . . . 20.0 115.393 175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.41 19.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.11 1.455 . . . . 20.0 113.263 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.6 p -126.22 -1.46 7.02 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.273 1.212 . . . . 20.0 114.273 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.67 149.96 24.46 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.032 0.933 . . . . 20.0 111.824 173.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 38.8 p -82.02 162.43 22.62 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.347 0.594 . . . . 20.0 110.797 170.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.71 -39.5 73.97 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.404 -0.81 . . . . 20.0 111.454 169.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.5 -38.95 93.08 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.512 -0.742 . . . . 20.0 112.648 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.55 -42.78 95.47 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 121.637 -0.665 . . . . 20.0 112.084 171.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.63 -46.36 90.59 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.603 0.761 . . . . 20.0 112.156 176.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.47 -46.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.091 0.956 . . . . 20.0 110.288 172.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.07 54.18 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 20.0 112.869 177.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 20.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 20.0 114.434 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.91 8.36 20.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.645 1.178 . . . . 20.0 113.033 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.38 162.3 1.58 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.027 1.331 . . . . 20.0 111.396 165.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.59 103.32 48.95 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.071 0.949 . . . . 20.0 110.837 176.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.13 163.84 89.13 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.462 0.844 . . . . 20.0 111.701 -6.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -50.03 141.37 30.02 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 20.0 114.168 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.3 mt -96.11 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 20.0 104.858 163.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.98 54.57 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 20.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.89 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.029 1.122 . . . . 20.0 114.029 -173.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.37 -46.27 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.688 0.676 . . . . 20.0 112.958 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.86 -36.86 75.85 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.289 -1.124 . . . . 20.0 112.693 178.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.89 -44.62 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.808 -0.557 . . . . 20.0 109.952 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.41 91.65 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.303 -0.873 . . . . 20.0 112.533 176.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -41.97 74.91 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.395 -0.816 . . . . 20.0 112.287 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.74 -45.19 82.13 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.889 0.768 . . . . 20.0 112.12 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.37 -40.54 85.74 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.287 0.635 . . . . 20.0 112.227 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.58 -47.23 93.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.039 0.536 . . . . 20.0 110.235 174.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.05 -37.39 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.749 1.22 . . . . 20.0 112.308 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.87 98.53 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.01 0.823 . . . . 20.0 111.194 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.53 -45.02 91.88 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.832 0.729 . . . . 20.0 113.26 175.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.42 -42.49 87.37 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.002 0.901 . . . . 20.0 111.056 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.5 -50.12 70.77 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.795 0.838 . . . . 20.0 112.449 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.79 -43.35 76.74 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.915 0.78 . . . . 20.0 111.996 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.6 mt -64.28 -48.32 85.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.26 0.624 . . . . 20.0 111.366 -179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.54 -31.48 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.791 1.178 . . . . 20.0 112.981 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -61.43 -42.14 98.29 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.102 0.864 . . . . 20.0 111.642 171.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.3 ttp -80.6 -36.29 32.96 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.726 1.61 . . . . 20.0 113.884 -174.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 1.103 ' OXT' ' C ' ' A' ' 145' ' ' TYR . 70.5 m-85 . . . . . 0 C--O 1.254 1.306 0 C-N-CA 127.784 2.434 . . . . 20.0 114.432 -168.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo . . . . . 0 N--CA 1.479 0.661 0 N-CA-C 113.01 0.35 . . . . 0.0 113.01 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.58 135.04 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.47 1.108 . . . . 0.0 108.413 163.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -126.07 155.0 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.633 170.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -104.84 116.81 32.64 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.465 0.706 . . . . 0.0 109.143 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.48 178.03 6.93 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.587 0.708 . . . . 0.0 112.441 177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.94 -26.43 68.81 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -173.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.11 57.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.794 1.237 . . . . 0.0 113.011 175.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 2.91 85.85 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 124.514 1.054 . . . . 0.0 114.128 -175.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.63 128.29 35.68 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.816 1.308 . . . . 0.0 109.695 174.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.73 29.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 168.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -126.09 123.32 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.075 1.35 . . . . 0.0 108.68 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.57 139.69 38.58 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.18 48.48 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.513 1.925 . . . . 0.0 107.979 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.24 152.35 20.96 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.202 170.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.86 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 CA-C-O 121.453 0.644 . . . . 0.0 111.555 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 129.96 93.26 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.164 0.585 . . . . 0.0 111.095 177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.97 -34.67 68.08 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.907 2.405 . . . . 0.0 113.572 167.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.39 -38.02 86.58 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.508 -0.745 . . . . 0.0 112.594 174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.0 -44.31 97.61 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.716 0.689 . . . . 0.0 111.356 171.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.5 -44.33 94.64 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.296 0.498 . . . . 0.0 112.256 175.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.23 -47.32 85.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.079 0.551 . . . . 0.0 111.417 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.14 96.0 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.599 0.76 . . . . 0.0 111.896 176.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.2 t-105 -60.07 -47.5 85.63 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.844 0.858 . . . . 0.0 112.711 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.2 t -56.7 -54.55 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.4 0.545 . . . . 0.0 110.404 174.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.5 -37.6 78.69 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.348 1.059 . . . . 0.0 113.221 -179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.411 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.61 -51.99 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 124.945 1.298 . . . . 0.0 111.329 170.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.52 -35.94 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 119.075 -0.488 . . . . 0.0 111.416 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.64 -23.98 60.21 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.2 -25.85 11.34 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.8 16.25 3.32 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -166.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.05 -38.49 2.34 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.368 1.988 . . . . 0.0 116.368 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -118.06 15.79 14.16 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.36 1.064 . . . . 0.0 113.055 -171.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 p -114.93 152.7 46.76 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 123.98 0.912 . . . . 0.0 111.464 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.77 -30.68 57.99 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.282 2.655 . . . . 0.0 115.205 -172.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.69 64.26 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.643 1.177 . . . . 0.0 114.173 -177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.93 -31.81 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.424 1.011 . . . . 0.0 112.515 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.1 mt -71.45 -55.05 6.23 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.987 1.315 . . . . 0.0 112.972 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.85 -30.14 49.5 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.685 1.637 . . . . 0.0 112.652 174.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.411 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.6 mtm -69.06 -40.24 78.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.894 1.225 . . . . 0.0 112.65 172.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.22 -46.55 82.85 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.768 0.713 . . . . 0.0 111.522 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -60.94 -44.69 96.9 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 175.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.63 -32.27 71.43 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.279 1.031 . . . . 0.0 113.246 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.1 4.48 53.65 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.406 1.482 . . . . 0.0 113.539 -178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.7 p -133.0 22.78 4.17 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.52 120.35 6.02 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.473 -1.392 . . . . 0.0 111.483 168.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.44 11.63 59.86 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.447 0.939 . . . . 0.0 115.447 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.57 130.88 47.06 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.525 1.663 . . . . 0.0 112.528 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.3 p -73.28 159.66 84.42 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 123.722 0.809 . . . . 0.0 110.711 167.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -49.58 -35.38 37.25 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 122.134 1.89 . . . . 0.0 115.47 168.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -67.19 -40.2 86.48 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 174.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.28 -45.25 93.97 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.626 -0.671 . . . . 0.0 111.098 172.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.5 mt -63.71 -44.32 93.97 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.351 1.06 . . . . 0.0 112.127 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 52.6 m-20 -59.15 -41.48 88.45 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.642 0.656 . . . . 0.0 111.984 171.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.5 m -60.18 -45.28 93.67 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.599 0.636 . . . . 0.0 111.11 175.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.42 -48.86 78.01 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.246 0.93 . . . . 0.0 112.153 174.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.16 -38.44 91.19 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.84 -33.23 70.19 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 177.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 p -73.88 -12.44 60.67 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.5 m -122.19 8.14 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -174.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.28 -4.5 6.51 Favored Glycine 0 CA--C 1.542 1.753 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.8 -33.51 56.01 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 119.256 1.528 . . . . 0.0 115.389 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -91.18 78.29 5.86 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 118.802 1.301 . . . . 0.0 110.55 171.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.77 -35.92 34.21 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 -173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.95 74.73 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 120.023 1.283 . . . . 0.0 112.303 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.44 -43.54 85.32 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.194 0.597 . . . . 0.0 111.353 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -62.99 -40.17 96.93 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.545 -0.722 . . . . 0.0 112.263 175.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.95 -49.99 73.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.314 1.045 . . . . 0.0 111.565 173.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.1 tpp -56.04 -45.43 79.2 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.096 0.958 . . . . 0.0 112.205 174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.1 tp -61.85 -48.77 79.05 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.289 0.636 . . . . 0.0 112.087 176.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.72 -38.37 90.84 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.45 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -59.86 -45.56 92.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.698 0.681 . . . . 0.0 112.014 170.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.9 m -62.56 -42.41 99.53 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 118.777 0.717 . . . . 0.0 112.128 175.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.81 -46.2 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.514 -0.741 . . . . 0.0 111.041 174.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.07 -39.45 94.09 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.829 0.741 . . . . 0.0 112.759 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.78 -47.46 86.24 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.78 0.832 . . . . 0.0 111.964 174.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -70.07 -34.41 73.16 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.91 -41.24 91.71 Favored 'General case' 0 CA--C 1.543 0.681 0 O-C-N 121.437 -0.789 . . . . 0.0 112.403 173.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.99 -42.14 98.82 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.232 0.613 . . . . 0.0 111.781 172.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.19 99.59 Favored 'General case' 0 CA--C 1.535 0.395 0 O-C-N 121.834 -0.541 . . . . 0.0 112.183 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.85 -48.69 79.06 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.648 0.658 . . . . 0.0 111.665 173.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.95 -30.13 71.33 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.21 -39.22 78.73 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.399 1.08 . . . . 0.0 112.443 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.49 42.34 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.739 1.216 . . . . 0.0 113.32 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.81 60.92 53.35 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 126.675 1.99 . . . . 0.0 111.249 -174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.94 119.99 7.21 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.509 2.139 . . . . 0.0 110.306 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.24 136.16 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.342 1.457 . . . . 0.0 112.144 -169.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -79.92 160.43 26.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.101 0.561 . . . . 0.0 110.861 168.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.31 -19.8 64.93 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.03 174.68 41.65 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.083 1.325 . . . . 0.0 112.653 174.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.49 169.11 14.8 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.644 2.896 . . . . 0.0 112.954 176.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.7 mt -57.65 -39.11 68.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.894 1.278 . . . . 0.0 111.739 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.54 161.92 28.55 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.841 1.656 . . . . 0.0 110.584 176.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.96 133.47 23.1 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.479 2.786 . . . . 0.0 113.116 168.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.05 60.32 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.605 1.098 . . . . 0.0 115.019 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.15 143.31 37.37 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.946 1.373 . . . . 0.0 110.234 173.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.12 145.44 54.38 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.729 -0.607 . . . . 0.0 110.805 168.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 38.4 ptt85 -68.65 153.07 44.46 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.641 0.776 . . . . 0.0 111.673 171.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -72.16 131.7 85.01 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-O 118.928 -0.558 . . . . 0.0 109.858 170.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.37 140.53 44.38 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.137 1.891 . . . . 0.0 112.383 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 67.8 mtp85 -75.31 171.59 13.93 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.727 1.611 . . . . 0.0 111.859 163.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.37 -43.72 93.75 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 123.274 0.464 . . . . 0.0 113.04 168.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.5 p -69.15 -25.64 64.47 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 175.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -72.72 -41.66 64.98 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.02 -1.05 . . . . 0.0 111.71 171.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.73 -42.74 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.648 0.779 . . . . 0.0 110.824 173.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.11 -1.16 13.85 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 173.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.0 18.03 74.16 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.953 -1.092 . . . . 0.0 115.453 174.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.62 19.18 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.147 1.473 . . . . 0.0 113.259 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 67.2 p -125.9 -0.86 7.26 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.252 1.205 . . . . 0.0 114.252 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.9 p -104.59 149.06 25.84 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.045 0.938 . . . . 0.0 111.798 173.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.4 p -80.95 162.18 23.99 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.348 0.595 . . . . 0.0 110.747 170.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.2 tp -56.85 -39.32 74.05 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.423 -0.798 . . . . 0.0 111.397 169.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.62 -39.06 93.41 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.558 -0.714 . . . . 0.0 112.644 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -64.37 -42.83 95.97 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.666 -0.646 . . . . 0.0 112.028 171.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -60.68 -46.35 90.7 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 123.677 0.791 . . . . 0.0 112.192 176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.34 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 110.305 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.43 -51.17 53.36 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.83 0.729 . . . . 0.0 112.913 177.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.19 -50.08 73.23 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.788 0.794 . . . . 0.0 112.526 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.69 -18.5 64.27 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 114.457 1.28 . . . . 0.0 114.457 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.1 p -111.81 8.33 20.5 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.675 1.19 . . . . 0.0 113.018 178.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.36 162.31 1.56 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.009 1.324 . . . . 0.0 111.433 165.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.52 103.38 49.02 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 124.089 0.956 . . . . 0.0 110.787 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.03 163.83 89.2 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.477 0.849 . . . . 0.0 111.746 -6.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -50.01 141.42 29.71 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.208 2.606 . . . . 0.0 114.173 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.19 96.36 2.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.97 54.6 3.5 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.326 2.684 . . . . 0.0 112.89 -152.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.61 -34.89 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -173.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.44 -46.16 94.4 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 118.641 0.655 . . . . 0.0 113.004 173.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.74 -36.96 76.29 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.313 -1.11 . . . . 0.0 112.667 178.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.88 -44.63 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.802 -0.561 . . . . 0.0 109.94 174.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.85 -40.42 91.7 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.327 -0.858 . . . . 0.0 112.547 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -42.02 74.98 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.395 -0.816 . . . . 0.0 112.259 173.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.72 -45.24 82.0 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.945 0.793 . . . . 0.0 112.093 174.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.26 -40.53 86.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.308 0.643 . . . . 0.0 112.251 178.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.68 -47.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.032 0.533 . . . . 0.0 110.279 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.9 mt -62.19 -37.37 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.698 1.199 . . . . 0.0 112.263 177.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.75 98.36 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.039 0.836 . . . . 0.0 111.245 171.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.5 -45.2 91.08 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.879 0.752 . . . . 0.0 113.235 175.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.4 -42.28 86.81 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.019 0.91 . . . . 0.0 111.114 173.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.52 -50.2 70.6 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.788 0.835 . . . . 0.0 112.43 173.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -55.84 -43.0 76.62 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.872 0.76 . . . . 0.0 112.062 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.401 HG21 H13A ' A' ' 146' ' ' JPR . 70.0 mt -64.47 -48.64 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.332 0.653 . . . . 0.0 111.361 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.28 -31.61 50.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.8 1.182 . . . . 0.0 112.978 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.98 -39.64 90.38 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 119.057 0.844 . . . . 0.0 111.877 171.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.4 ttp -84.45 -33.36 23.66 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.758 1.623 . . . . 0.0 113.976 -173.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 . . . . . 0 C--O 1.255 1.351 0 C-N-CA 127.599 2.36 . . . . 0.0 114.287 -169.744 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . 0.401 H13A HG21 ' A' ' 141' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.697 0 N-CA-C 112.967 0.333 . . . . 0.0 112.967 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -92.01 135.02 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.51 1.124 . . . . 0.0 108.448 163.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.04 154.69 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.067 1.347 . . . . 0.0 109.709 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.29 116.62 32.47 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.555 0.742 . . . . 0.0 109.166 178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.44 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-O 121.573 0.702 . . . . 0.0 112.476 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.87 -26.5 68.8 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -173.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -85.68 -2.13 57.88 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.792 1.237 . . . . 0.0 112.998 175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.21 85.8 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.426 1.012 . . . . 0.0 114.094 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.14 35.13 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.883 1.342 . . . . 0.0 109.695 174.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.88 125.53 29.48 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 168.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.86 123.39 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.077 1.351 . . . . 0.0 108.648 -174.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.7 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.1 48.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.36 20.98 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.988 0.813 . . . . 0.0 111.217 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.46 136.84 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 O-C-N 121.605 -0.684 . . . . 0.0 111.537 176.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.03 93.23 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -53.1 -34.54 68.75 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.86 2.373 . . . . 0.0 113.572 167.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.48 -38.06 86.47 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.464 -0.773 . . . . 0.0 112.521 174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.98 -44.2 97.72 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.805 0.729 . . . . 0.0 111.382 171.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.65 -44.28 94.3 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.341 0.519 . . . . 0.0 112.292 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.26 -47.16 86.39 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.149 0.58 . . . . 0.0 111.338 176.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.26 95.43 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.621 0.768 . . . . 0.0 111.856 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -60.31 -46.73 88.83 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.835 0.854 . . . . 0.0 112.818 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.87 -54.53 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.443 0.565 . . . . 0.0 110.31 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.76 -37.23 78.44 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.332 1.053 . . . . 0.0 113.256 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.82 -52.33 56.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.227 1.411 . . . . 0.0 111.202 170.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -65.42 -36.08 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 123.016 0.526 . . . . 0.0 111.484 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.54 -24.05 59.77 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 175.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.2 -25.47 11.5 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.17 16.07 3.24 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.349 1.24 . . . . 0.0 114.349 -165.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.97 -37.22 2.82 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 -175.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -118.14 15.37 14.09 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.539 1.136 . . . . 0.0 113.087 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.2 p -114.9 152.88 46.9 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.937 0.895 . . . . 0.0 111.458 -178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.75 -30.83 58.42 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.253 2.636 . . . . 0.0 115.222 -172.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -61.93 -20.88 64.27 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.89 -31.84 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.448 1.022 . . . . 0.0 112.512 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.44 -55.07 6.24 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.97 1.308 . . . . 0.0 112.961 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.87 -30.08 49.42 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.72 1.65 . . . . 0.0 112.685 174.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -68.99 -40.24 78.87 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.849 1.204 . . . . 0.0 112.63 172.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.33 -46.48 83.21 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.771 0.714 . . . . 0.0 111.585 169.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.1 m -61.09 -44.44 97.36 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.76 71.27 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.281 1.033 . . . . 0.0 113.261 178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.61 4.54 53.01 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.372 1.469 . . . . 0.0 113.508 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.9 p -133.09 22.83 4.14 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -176.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.57 120.31 5.99 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.422 -1.424 . . . . 0.0 111.45 168.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.67 60.04 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.5 130.79 46.75 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.498 1.649 . . . . 0.0 112.53 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.0 p -73.28 159.63 84.51 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.741 0.816 . . . . 0.0 110.666 167.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -49.46 -35.58 36.67 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.183 1.922 . . . . 0.0 115.422 168.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.96 -40.27 87.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.32 -45.38 93.6 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.662 -0.649 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.53 -44.22 94.88 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.342 1.057 . . . . 0.0 112.162 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.8 m-20 -59.3 -41.35 88.8 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.587 0.63 . . . . 0.0 112.008 171.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.32 -45.33 93.8 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 118.65 0.659 . . . . 0.0 111.098 175.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.29 -48.96 77.57 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.175 0.898 . . . . 0.0 112.143 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.04 -38.6 91.83 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.84 -33.96 71.02 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 177.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.6 p -73.1 -12.64 60.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.5 m -122.25 7.53 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.68 -5.35 5.08 Favored Glycine 0 CA--C 1.541 1.708 0 N-CA-C 117.094 1.598 . . . . 0.0 117.094 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.56 56.15 Favored Glycine 0 CA--C 1.536 1.406 0 CA-C-N 119.1 1.45 . . . . 0.0 115.519 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -91.22 79.59 5.68 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 118.977 1.388 . . . . 0.0 110.594 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.82 -36.18 47.1 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.04 -41.21 71.11 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 120.131 1.332 . . . . 0.0 112.328 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.2 -43.6 86.3 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.772 -0.58 . . . . 0.0 111.296 172.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.06 -40.07 96.6 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.538 -0.726 . . . . 0.0 112.239 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.91 -50.1 73.6 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.087 -1.008 . . . . 0.0 111.538 173.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.3 tpp -55.99 -45.41 79.01 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.051 0.941 . . . . 0.0 112.231 174.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.93 -48.73 79.14 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.307 0.643 . . . . 0.0 112.109 176.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.63 -38.31 90.65 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.455 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -60.03 -45.43 92.85 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 112.019 170.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.6 m -62.67 -42.4 99.6 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.842 0.746 . . . . 0.0 112.113 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.92 -46.04 91.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.472 -0.768 . . . . 0.0 111.063 174.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.11 -39.44 94.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.876 0.762 . . . . 0.0 112.757 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -60.87 -47.4 86.53 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.714 0.806 . . . . 0.0 111.95 174.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.12 -34.3 72.92 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.71 -41.79 91.89 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.447 -0.783 . . . . 0.0 112.33 172.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.68 -42.02 98.36 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.248 0.619 . . . . 0.0 111.799 172.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.19 -42.23 99.3 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.812 -0.555 . . . . 0.0 112.211 174.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.82 -48.38 79.9 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.696 0.68 . . . . 0.0 111.675 173.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -63.16 -30.33 71.5 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.13 -38.96 79.13 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.306 1.042 . . . . 0.0 112.489 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.31 -27.64 42.14 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.833 1.253 . . . . 0.0 113.346 176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.79 61.04 54.13 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.583 1.953 . . . . 0.0 111.22 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.95 120.12 7.39 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.452 2.102 . . . . 0.0 110.266 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.42 136.56 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.283 1.433 . . . . 0.0 112.119 -169.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.07 160.49 25.78 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.098 0.559 . . . . 0.0 110.905 168.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.26 -19.92 64.99 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 174.8 41.62 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.018 1.294 . . . . 0.0 112.602 174.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.62 169.16 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.944 177.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.61 -39.21 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.88 1.272 . . . . 0.0 111.801 -175.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.49 161.93 28.54 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 125.817 1.647 . . . . 0.0 110.549 176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.441 2.761 . . . . 0.0 113.132 168.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -15.03 60.34 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.577 1.084 . . . . 0.0 115.065 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.35 37.47 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.928 1.364 . . . . 0.0 110.198 173.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.2 145.62 54.14 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.753 -0.592 . . . . 0.0 110.835 168.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.51 152.72 44.99 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.717 0.807 . . . . 0.0 111.653 171.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.27 131.75 84.78 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.886 -0.578 . . . . 0.0 109.797 170.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.46 140.25 43.31 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.122 1.881 . . . . 0.0 112.414 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.3 mtp85 -74.86 171.58 13.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.716 1.607 . . . . 0.0 111.849 163.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.52 -43.87 93.97 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.934 -0.479 . . . . 0.0 113.029 168.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.73 -25.83 64.95 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.09 1.145 . . . . 0.0 114.09 175.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.75 -41.6 64.93 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.986 -1.071 . . . . 0.0 111.739 171.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.68 -42.69 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.716 0.806 . . . . 0.0 110.756 173.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.91 -1.32 13.94 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 173.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.91 18.17 74.14 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.603 1.096 . . . . 0.0 115.488 175.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.3 -19.38 19.31 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.073 1.436 . . . . 0.0 113.284 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.0 p -126.23 -1.48 7.01 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.71 149.99 24.46 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.024 0.93 . . . . 0.0 111.737 173.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.3 p -81.89 162.32 22.81 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.293 0.568 . . . . 0.0 110.811 170.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.74 -39.49 74.06 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.424 -0.798 . . . . 0.0 111.425 169.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.59 -38.82 92.59 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.518 -0.739 . . . . 0.0 112.657 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -64.67 -42.75 95.15 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.622 -0.673 . . . . 0.0 111.997 171.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.3 90.87 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.58 0.752 . . . . 0.0 112.146 176.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.5 -46.4 92.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.151 0.981 . . . . 0.0 110.256 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.45 -51.04 54.34 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.793 0.711 . . . . 0.0 112.881 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.828 0.814 . . . . 0.0 112.485 174.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.68 -18.39 64.26 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -176.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.96 8.35 20.24 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.664 1.186 . . . . 0.0 113.033 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.43 162.31 1.6 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.978 1.311 . . . . 0.0 111.412 165.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.36 48.93 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.005 0.922 . . . . 0.0 110.836 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.14 163.81 89.19 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-N 119.462 0.844 . . . . 0.0 111.715 -6.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -49.95 141.29 29.56 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.205 2.604 . . . . 0.0 114.169 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.13 96.49 2.49 Favored Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 163.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.92 54.52 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.257 2.638 . . . . 0.0 112.909 -152.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.83 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.26 94.22 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.985 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.91 -36.78 75.65 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.358 -1.084 . . . . 0.0 112.648 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.8 mt -63.03 -44.46 99.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.745 -0.597 . . . . 0.0 109.951 173.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.93 -40.42 91.4 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.313 -0.867 . . . . 0.0 112.489 176.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -41.96 74.96 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.8 -45.29 82.31 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.912 0.778 . . . . 0.0 112.093 174.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.25 -40.51 86.26 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.233 0.613 . . . . 0.0 112.279 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.57 -47.37 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.23 174.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -61.91 -37.29 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.707 1.203 . . . . 0.0 112.355 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.88 -42.83 98.73 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.057 0.844 . . . . 0.0 111.187 171.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.58 -44.99 91.83 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 123.87 0.748 . . . . 0.0 113.257 175.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.24 -42.69 86.88 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.876 0.87 . . . . 0.0 110.997 173.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.17 70.6 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.791 0.836 . . . . 0.0 112.454 173.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.74 -43.41 76.58 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 118.87 0.759 . . . . 0.0 111.992 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.1 mt -64.47 -48.19 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.342 0.657 . . . . 0.0 111.361 -179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.1 m -69.44 -31.66 50.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.73 1.15 . . . . 0.0 112.983 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.4 mtp180 -61.67 -43.58 98.58 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 119.168 0.895 . . . . 0.0 111.649 171.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.9 ttp -77.11 -35.75 56.12 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.726 1.61 . . . . 0.0 113.696 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 C--O 1.25 1.109 0 C-N-CA 127.641 2.376 . . . . 0.0 114.205 -168.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 N--CA 1.48 0.686 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.81 135.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.03 154.89 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.665 170.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.61 116.71 32.53 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.521 0.729 . . . . 0.0 109.19 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.46 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.507 0.67 . . . . 0.0 112.474 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.54 68.79 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.58 -2.18 57.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.851 1.26 . . . . 0.0 113.043 175.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.94 3.1 85.8 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.458 1.028 . . . . 0.0 114.08 -175.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.2 35.34 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-N 118.883 1.342 . . . . 0.0 109.727 174.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.85 125.55 29.51 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.94 123.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.074 1.349 . . . . 0.0 108.629 -174.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.58 139.66 38.57 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.487 0.66 . . . . 0.0 111.239 170.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.07 48.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.491 1.916 . . . . 0.0 107.921 169.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.2 152.37 20.77 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.019 0.827 . . . . 0.0 111.259 170.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.87 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-O 121.462 0.649 . . . . 0.0 111.579 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.01 93.24 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.99 -34.56 67.76 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.907 2.405 . . . . 0.0 113.604 167.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.48 -38.06 86.47 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.457 -0.777 . . . . 0.0 112.594 174.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 m -60.93 -44.31 97.41 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.691 0.678 . . . . 0.0 111.401 171.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.52 -44.39 94.42 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.251 0.478 . . . . 0.0 112.256 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.18 -47.3 85.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.115 0.566 . . . . 0.0 111.366 176.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.23 95.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.672 0.789 . . . . 0.0 111.908 176.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -60.16 -47.16 87.08 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.806 0.842 . . . . 0.0 112.783 177.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.7 t -56.75 -54.57 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.443 0.565 . . . . 0.0 110.375 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.62 -37.36 78.4 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.296 1.039 . . . . 0.0 113.234 -179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.401 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.43 -52.16 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 125.094 1.358 . . . . 0.0 111.296 170.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.1 t -64.8 -35.86 76.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 122.909 0.484 . . . . 0.0 111.471 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.74 -23.82 60.56 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.38 -25.64 11.35 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.06 16.16 3.26 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.317 1.229 . . . . 0.0 114.317 -166.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.42 -37.95 2.57 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -118.17 15.66 14.06 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.438 1.095 . . . . 0.0 113.057 -172.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.0 p -115.0 152.86 46.97 Favored Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 123.966 0.907 . . . . 0.0 111.463 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.88 -30.61 58.75 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.262 2.641 . . . . 0.0 115.208 -172.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.19 -20.67 64.41 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.87 -31.84 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.41 1.005 . . . . 0.0 112.548 176.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.6 mt -71.47 -55.05 6.21 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.966 1.307 . . . . 0.0 112.971 -178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.88 -30.05 49.34 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.653 1.626 . . . . 0.0 112.641 174.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.401 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.16 -40.16 78.33 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.867 1.212 . . . . 0.0 112.602 172.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.25 -46.46 83.01 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.808 0.731 . . . . 0.0 111.576 169.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.6 m -61.12 -44.42 97.37 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 175.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.0 71.51 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.333 1.053 . . . . 0.0 113.208 178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.41 4.5 53.27 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.367 1.467 . . . . 0.0 113.488 -178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.5 p -133.01 22.8 4.16 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.68 120.31 6.05 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 120.477 -1.389 . . . . 0.0 111.477 168.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.63 11.57 60.24 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.377 0.911 . . . . 0.0 115.377 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.52 130.88 47.14 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.575 1.687 . . . . 0.0 112.464 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.39 159.64 84.35 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.758 0.823 . . . . 0.0 110.685 167.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.61 -35.4 37.6 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.144 1.896 . . . . 0.0 115.4 168.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -66.99 -40.29 87.36 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 174.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.35 93.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.039 172.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.56 -44.26 94.64 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 112.133 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 -59.17 -41.49 88.56 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 118.618 0.645 . . . . 0.0 112.031 171.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.8 m -60.29 -45.22 94.1 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 118.582 0.628 . . . . 0.0 111.074 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.37 -48.91 77.8 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.254 0.934 . . . . 0.0 112.179 174.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.13 -38.45 91.24 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.89 -33.45 70.54 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 177.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.4 p -73.65 -12.5 60.76 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.7 m -122.19 7.88 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -174.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.72 -4.62 5.77 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 117.159 1.624 . . . . 0.0 117.159 -178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.88 -33.13 56.19 Favored Glycine 0 CA--C 1.537 1.413 0 CA-C-N 119.224 1.512 . . . . 0.0 115.423 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -91.32 78.7 5.72 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 118.892 1.346 . . . . 0.0 110.605 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.26 -35.82 39.1 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 -173.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.41 -41.1 73.38 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.086 1.312 . . . . 0.0 112.315 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.28 -43.56 86.02 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.167 0.587 . . . . 0.0 111.337 173.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.3 tpp -63.1 -40.1 96.65 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.565 -0.709 . . . . 0.0 112.229 175.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.93 -50.02 73.87 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.218 1.007 . . . . 0.0 111.539 173.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.95 -45.5 78.82 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.044 0.938 . . . . 0.0 112.233 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.7 tp -61.88 -48.77 79.01 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.276 0.63 . . . . 0.0 112.055 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.64 -38.28 90.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.845 0.858 . . . . 0.0 112.479 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.98 -45.45 92.67 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.668 0.667 . . . . 0.0 112.048 170.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.7 -42.39 99.61 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 118.815 0.734 . . . . 0.0 112.082 175.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.85 -46.1 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.441 -0.787 . . . . 0.0 111.059 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.08 -39.46 94.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.831 0.741 . . . . 0.0 112.736 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.84 -47.37 86.69 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.667 0.787 . . . . 0.0 111.971 174.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -70.13 -34.3 72.89 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.68 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.43 -0.794 . . . . 0.0 112.361 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.11 98.68 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.231 0.613 . . . . 0.0 111.781 172.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.21 99.57 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 0.0 112.218 174.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.85 -48.55 79.47 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.667 0.667 . . . . 0.0 111.726 173.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.04 -30.25 71.46 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.12 -39.18 79.09 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.343 1.057 . . . . 0.0 112.499 173.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.64 42.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 113.29 176.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.72 61.01 54.1 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.67 1.988 . . . . 0.0 111.247 -174.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.9 120.17 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.452 2.101 . . . . 0.0 110.315 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.36 136.31 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.377 1.471 . . . . 0.0 112.136 -169.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.97 160.45 25.92 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.124 0.57 . . . . 0.0 110.855 168.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.91 65.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.99 174.77 41.63 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.059 1.314 . . . . 0.0 112.64 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.58 169.15 14.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.682 2.921 . . . . 0.0 112.878 177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.68 -39.15 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.873 1.269 . . . . 0.0 111.787 -175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.51 161.9 28.6 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.856 1.662 . . . . 0.0 110.561 176.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.83 133.42 22.44 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.519 2.812 . . . . 0.0 113.132 168.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.89 -15.0 60.33 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.551 1.072 . . . . 0.0 115.001 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.11 143.39 37.38 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.996 1.398 . . . . 0.0 110.214 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.24 145.52 54.19 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.664 -0.647 . . . . 0.0 110.793 168.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.52 152.78 44.91 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.674 0.79 . . . . 0.0 111.617 171.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.23 131.68 84.9 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.883 -0.58 . . . . 0.0 109.821 170.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.37 140.4 44.03 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.076 1.851 . . . . 0.0 112.426 -177.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.1 mtp85 -75.08 171.66 13.72 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.679 1.592 . . . . 0.0 111.89 163.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.63 -43.78 94.19 Favored Glycine 0 CA--C 1.534 1.247 0 O-C-N 121.912 -0.493 . . . . 0.0 113.04 168.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.1 p -68.81 -25.78 64.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.099 1.148 . . . . 0.0 114.099 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.7 64.98 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.989 -1.069 . . . . 0.0 111.727 171.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.6 -42.74 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.704 0.801 . . . . 0.0 110.771 173.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.2 13.79 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 173.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.92 18.11 74.09 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.897 -1.127 . . . . 0.0 115.496 175.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.47 19.29 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 119.073 1.436 . . . . 0.0 113.29 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -126.18 -1.38 7.04 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.67 149.91 24.51 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.14 0.976 . . . . 0.0 111.763 173.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.0 p -81.86 162.27 22.87 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.319 0.581 . . . . 0.0 110.778 170.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.74 -39.4 73.89 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.415 -0.803 . . . . 0.0 111.404 169.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.55 -38.97 93.16 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.481 -0.762 . . . . 0.0 112.659 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.77 95.55 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.39 90.54 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.119 176.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.4 -46.39 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.203 1.001 . . . . 0.0 110.285 172.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.01 54.55 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.753 0.692 . . . . 0.0 112.945 177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.32 -50.01 73.34 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.751 0.776 . . . . 0.0 112.537 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.69 -18.49 64.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.93 8.42 20.32 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.651 1.18 . . . . 0.0 113.035 178.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.45 162.31 1.62 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.989 1.316 . . . . 0.0 111.414 165.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.451 0.84 . . . . 0.0 111.701 -6.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.99 141.33 29.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.258 2.639 . . . . 0.0 114.136 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.3 mt -96.15 96.49 2.5 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 163.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -86.02 54.59 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.289 2.659 . . . . 0.0 112.86 -152.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.84 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -173.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.36 -46.34 94.07 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 118.605 0.639 . . . . 0.0 112.958 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.82 -36.8 75.93 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.313 -1.11 . . . . 0.0 112.678 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.97 -44.56 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.732 -0.605 . . . . 0.0 109.942 174.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.46 91.67 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.292 -0.88 . . . . 0.0 112.504 176.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.04 75.08 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.275 173.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.67 -45.23 81.82 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.901 0.773 . . . . 0.0 112.12 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.31 -40.5 86.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.296 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.62 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.044 0.538 . . . . 0.0 110.291 174.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.03 -37.35 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.683 1.193 . . . . 0.0 112.355 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.75 98.19 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.03 0.832 . . . . 0.0 111.275 171.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.67 -45.0 91.52 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.828 0.727 . . . . 0.0 113.23 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.4 -42.42 87.11 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.075 173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.21 70.43 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.811 0.844 . . . . 0.0 112.425 173.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.79 -43.28 76.68 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.892 0.769 . . . . 0.0 111.968 176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.37 -48.36 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.337 0.655 . . . . 0.0 111.415 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.34 -31.74 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 119.725 1.148 . . . . 0.0 113.012 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -61.14 -41.76 97.31 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 119.074 0.852 . . . . 0.0 111.722 171.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.7 ttp -80.96 -34.43 33.16 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.738 1.615 . . . . 0.0 113.935 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 127.614 2.366 . . . . 0.0 114.236 -169.036 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.81 135.06 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.08 154.81 35.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.685 170.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.55 116.74 32.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.488 0.715 . . . . 0.0 109.191 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.84 -26.49 68.78 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -173.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.58 -2.21 57.93 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.852 1.261 . . . . 0.0 112.991 175.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.02 85.77 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.5 1.048 . . . . 0.0 114.144 -175.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.7 128.23 35.47 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 118.801 1.301 . . . . 0.0 109.678 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.89 125.57 29.55 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.88 123.39 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 125.11 1.364 . . . . 0.0 108.7 -174.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.71 38.55 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.72 141.11 48.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.465 1.906 . . . . 0.0 107.929 169.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.27 152.4 20.99 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.217 170.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.57 136.9 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.607 -0.683 . . . . 0.0 111.579 176.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.66 130.01 93.24 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 123.068 0.547 . . . . 0.0 111.125 177.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.887 2.391 . . . . 0.0 113.575 167.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.41 -38.05 86.6 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.451 -0.78 . . . . 0.0 112.587 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.8 m -60.96 -44.32 97.48 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.747 0.703 . . . . 0.0 111.386 171.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.54 -44.37 94.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.258 0.481 . . . . 0.0 112.244 175.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.22 -47.27 85.95 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.115 0.566 . . . . 0.0 111.37 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.96 -45.26 95.47 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.67 0.788 . . . . 0.0 111.914 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.22 -47.09 87.42 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.868 0.867 . . . . 0.0 112.774 177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.8 t -56.82 -54.55 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.489 0.586 . . . . 0.0 110.31 174.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.61 -37.4 78.47 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.35 1.06 . . . . 0.0 113.247 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.36 -52.17 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 125.092 1.357 . . . . 0.0 111.302 170.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.82 -35.99 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.996 0.518 . . . . 0.0 111.407 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.69 -23.86 60.3 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.34 -25.62 11.38 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -177.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -136.03 16.15 3.27 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -166.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.47 -37.91 2.61 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 116.377 1.991 . . . . 0.0 116.377 -175.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -118.08 15.62 14.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.478 1.111 . . . . 0.0 113.107 -172.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.7 p -114.91 152.87 46.9 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 123.959 0.903 . . . . 0.0 111.49 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.86 -30.63 58.77 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.238 2.625 . . . . 0.0 115.276 -172.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.11 -20.73 64.36 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.81 -31.96 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 CA-C-N 119.466 1.03 . . . . 0.0 112.479 176.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.36 -55.07 6.34 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.957 1.303 . . . . 0.0 112.995 -178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -65.88 -30.08 49.28 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.681 1.636 . . . . 0.0 112.671 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.05 -40.2 78.71 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.914 1.234 . . . . 0.0 112.665 172.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.3 -46.48 83.12 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.421 0.689 . . . . 0.0 111.576 169.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -61.07 -44.45 97.36 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 175.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.85 -32.03 71.45 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.284 1.034 . . . . 0.0 113.278 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.36 4.47 53.36 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.355 1.462 . . . . 0.0 113.484 -178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -133.03 22.84 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -176.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.58 120.3 5.99 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 120.456 -1.402 . . . . 0.0 111.432 168.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.67 60.04 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 130.88 47.14 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.498 1.649 . . . . 0.0 112.482 -178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.35 159.66 84.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.753 0.821 . . . . 0.0 110.666 167.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.22 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.34 -45.33 93.83 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.66 -0.65 . . . . 0.0 111.1 172.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -59.28 -41.34 88.68 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.692 -0.63 . . . . 0.0 112.02 171.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.27 -45.32 93.71 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.596 0.634 . . . . 0.0 111.097 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.32 -48.91 77.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.233 0.924 . . . . 0.0 112.179 174.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.11 -38.46 91.27 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.91 -33.56 70.69 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.9 p -73.5 -12.54 60.82 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.24 7.85 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 -174.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.54 -4.69 5.55 Favored Glycine 0 CA--C 1.541 1.684 0 N-CA-C 117.229 1.652 . . . . 0.0 117.229 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.96 -32.99 56.57 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.186 1.493 . . . . 0.0 115.435 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -91.28 78.76 5.74 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.918 1.359 . . . . 0.0 110.619 171.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.36 -35.92 40.74 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 -173.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.43 -41.15 73.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.137 1.335 . . . . 0.0 112.293 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.3 -43.51 86.07 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.139 0.576 . . . . 0.0 111.329 173.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.09 -40.12 96.71 Favored 'General case' 0 CA--C 1.54 0.594 0 O-C-N 121.514 -0.741 . . . . 0.0 112.198 175.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.98 -49.97 74.1 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.202 1.001 . . . . 0.0 111.518 173.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.4 tpp -55.97 -45.46 78.92 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.094 0.958 . . . . 0.0 112.245 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.91 -48.77 78.97 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.331 0.652 . . . . 0.0 112.055 176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.66 -38.27 90.49 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.453 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.01 -45.48 92.62 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 118.664 0.665 . . . . 0.0 112.048 170.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.65 -42.37 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.118 175.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.85 -46.14 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.441 -0.787 . . . . 0.0 111.03 174.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.06 -39.46 94.13 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.842 0.746 . . . . 0.0 112.736 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -60.78 -47.49 86.1 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.943 174.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.06 -34.33 73.07 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.69 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.408 -0.808 . . . . 0.0 112.361 172.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.09 98.7 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.215 0.606 . . . . 0.0 111.751 172.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.12 -42.25 99.49 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 121.86 -0.525 . . . . 0.0 112.138 175.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.81 -48.52 79.5 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.666 0.666 . . . . 0.0 111.722 173.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -63.11 -30.19 71.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.22 -39.06 78.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.354 1.062 . . . . 0.0 112.482 173.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.3 -27.6 42.18 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.791 1.236 . . . . 0.0 113.29 176.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.78 60.99 53.88 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.639 1.976 . . . . 0.0 111.22 -174.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.92 120.21 7.5 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.481 2.12 . . . . 0.0 110.24 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.46 136.37 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.287 1.435 . . . . 0.0 112.13 -169.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.04 160.47 25.83 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.075 0.55 . . . . 0.0 110.915 168.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.92 65.01 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.11 1.338 . . . . 0.0 112.655 174.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.59 169.15 14.87 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.687 2.925 . . . . 0.0 112.878 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.68 -39.19 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.903 1.281 . . . . 0.0 111.749 -175.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.44 161.97 28.44 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.817 1.647 . . . . 0.0 110.573 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.97 133.45 23.18 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.477 2.785 . . . . 0.0 113.149 168.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.99 60.34 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.613 1.101 . . . . 0.0 115.051 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.38 37.45 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.952 1.376 . . . . 0.0 110.198 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.51 54.26 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.66 -0.65 . . . . 0.0 110.842 168.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.48 152.73 44.98 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.684 0.794 . . . . 0.0 111.653 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.23 131.65 84.93 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.33 140.35 44.06 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.4 mtp85 -75.02 171.61 13.79 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.733 1.613 . . . . 0.0 111.867 163.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.57 -43.9 94.05 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.876 -0.515 . . . . 0.0 113.021 168.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.79 -25.78 64.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.69 -41.69 65.03 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.064 -1.022 . . . . 0.0 111.757 171.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.54 -42.84 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.73 0.812 . . . . 0.0 110.798 173.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.95 -1.26 13.83 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.98 18.15 74.24 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 124.626 1.107 . . . . 0.0 115.445 174.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.38 19.3 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.131 1.466 . . . . 0.0 113.301 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.9 p -126.2 -1.48 7.03 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.66 149.96 24.46 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.052 0.941 . . . . 0.0 111.788 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.5 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.293 0.568 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.83 -39.4 74.15 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.441 -0.787 . . . . 0.0 111.374 169.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.52 -38.93 93.02 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.531 -0.73 . . . . 0.0 112.685 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.64 -42.73 95.27 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 112.031 171.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.66 -46.37 90.58 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.651 0.78 . . . . 0.0 112.143 176.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.32 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.301 172.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.45 -51.06 54.19 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.782 0.706 . . . . 0.0 112.884 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 0.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.64 -18.49 64.3 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.87 8.36 20.4 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.703 1.201 . . . . 0.0 113.051 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.44 162.31 1.61 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.995 1.318 . . . . 0.0 111.447 165.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.34 48.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.035 0.934 . . . . 0.0 110.837 176.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.447 0.838 . . . . 0.0 111.701 -6.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.99 141.33 29.84 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.258 2.639 . . . . 0.0 114.136 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.17 96.48 2.51 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 163.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -86.0 54.56 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.257 2.638 . . . . 0.0 112.86 -152.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.56 -34.83 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.26 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.999 173.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.83 -36.87 75.95 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.91 -44.6 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.709 -0.62 . . . . 0.0 109.942 174.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.78 -40.5 92.02 Favored 'General case' 0 CA--C 1.538 0.498 0 O-C-N 121.307 -0.871 . . . . 0.0 112.559 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.78 -41.97 74.85 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.468 -0.77 . . . . 0.0 112.287 173.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.76 -45.22 82.2 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.889 0.768 . . . . 0.0 112.093 174.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.31 -40.5 86.03 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.296 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.62 -47.19 94.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.067 0.547 . . . . 0.0 110.272 174.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.15 -37.35 78.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.682 1.193 . . . . 0.0 112.292 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.82 -42.76 98.3 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 119.011 0.823 . . . . 0.0 111.244 171.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.59 -45.03 91.61 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.87 0.748 . . . . 0.0 113.252 175.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.4 -42.42 87.11 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.075 173.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.49 -50.16 70.66 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 123.811 0.844 . . . . 0.0 112.453 173.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.81 -43.27 76.73 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 118.875 0.762 . . . . 0.0 112.005 176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.7 mt -64.37 -48.36 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.337 0.655 . . . . 0.0 111.415 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.34 -31.81 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 119.725 1.148 . . . . 0.0 113.012 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -61.03 -42.07 97.76 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 119.058 0.845 . . . . 0.0 111.721 171.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.1 ttp -80.47 -34.64 35.73 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 125.761 1.624 . . . . 0.0 113.901 -174.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 . . . . . 0 N--CA 1.482 1.151 0 C-N-CA 127.621 2.368 . . . . 0.0 114.251 -168.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.998 0.345 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 18.9 mm -92.07 135.01 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.484 1.114 . . . . 0.0 108.489 163.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.03 154.6 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.076 1.35 . . . . 0.0 109.662 170.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.22 116.74 32.71 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.554 0.742 . . . . 0.0 109.201 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.53 177.98 7.01 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.557 0.694 . . . . 0.0 112.436 177.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.84 -26.54 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 -173.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.63 -2.2 57.92 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.81 1.244 . . . . 0.0 113.047 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.97 3.17 85.66 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.418 1.009 . . . . 0.0 114.096 -175.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.14 35.11 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 118.857 1.328 . . . . 0.0 109.726 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.84 125.55 29.52 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 168.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.84 123.38 64.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.077 1.351 . . . . 0.0 108.679 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.53 139.63 38.62 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.236 170.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.71 141.16 48.43 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.431 1.892 . . . . 0.0 107.897 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.28 152.44 20.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.803 . . . . 0.0 111.221 170.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.51 136.86 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.65 -0.656 . . . . 0.0 111.563 176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.65 129.96 93.27 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.07 0.548 . . . . 0.0 111.155 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -53.05 -34.46 67.9 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.864 2.376 . . . . 0.0 113.597 167.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.55 -38.06 86.32 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.453 -0.779 . . . . 0.0 112.521 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.02 -44.13 97.86 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.805 0.729 . . . . 0.0 111.372 171.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.66 -44.37 93.97 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.354 0.525 . . . . 0.0 112.311 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.18 -47.11 86.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.424 0.556 . . . . 0.0 111.38 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.05 -45.34 95.17 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.612 0.765 . . . . 0.0 111.866 176.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -60.41 -46.39 90.17 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.808 0.843 . . . . 0.0 112.846 177.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.7 t -57.04 -54.51 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-N 118.458 0.572 . . . . 0.0 110.302 174.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.77 -37.11 78.14 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.404 1.082 . . . . 0.0 113.289 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -56.61 -52.41 53.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.398 1.479 . . . . 0.0 111.223 170.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.64 -36.2 77.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 123.069 0.548 . . . . 0.0 111.479 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -58.51 -24.24 60.03 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 175.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -106.93 -25.38 11.67 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -136.32 15.7 3.21 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 -165.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.62 -37.36 2.53 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 -175.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -117.23 12.5 14.41 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.478 1.111 . . . . 0.0 113.198 -172.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.9 p -111.63 153.21 44.37 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.876 0.87 . . . . 0.0 111.497 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.83 -30.87 59.54 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.284 2.656 . . . . 0.0 115.173 -172.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.09 -20.98 64.59 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 114.163 1.171 . . . . 0.0 114.163 -177.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.61 -32.13 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.437 1.017 . . . . 0.0 112.458 176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.41 -57.17 5.92 Favored Pre-proline 0 CA--C 1.543 0.696 0 C-N-CA 124.718 1.207 . . . . 0.0 112.538 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.89 -29.5 58.21 Favored 'Trans proline' 0 C--N 1.35 0.655 0 CA-C-N 121.885 1.709 . . . . 0.0 112.786 175.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.13 -40.13 78.46 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.779 1.172 . . . . 0.0 112.698 172.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.25 -47.08 82.29 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.848 0.749 . . . . 0.0 111.546 169.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m -60.88 -44.11 97.53 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 175.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.54 70.96 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.249 1.019 . . . . 0.0 113.252 178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -96.0 4.69 52.44 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.382 1.473 . . . . 0.0 113.491 -178.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.8 p -133.17 22.78 4.11 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -53.57 120.25 5.92 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 120.437 -1.414 . . . . 0.0 111.42 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.6 11.68 60.35 Favored Glycine 0 CA--C 1.537 1.415 0 N-CA-C 115.391 0.916 . . . . 0.0 115.391 -178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.84 46.9 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.516 1.658 . . . . 0.0 112.481 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.27 159.68 84.4 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.718 0.807 . . . . 0.0 110.7 167.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.53 -35.5 37.15 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.144 1.896 . . . . 0.0 115.412 168.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.98 -40.32 87.4 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 174.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -60.29 -45.33 93.72 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.062 172.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.5 mt -63.53 -44.24 94.79 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.31 1.044 . . . . 0.0 112.151 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -59.26 -41.36 88.61 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.663 -0.648 . . . . 0.0 112.024 171.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.6 m -60.33 -45.43 93.45 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 118.626 0.648 . . . . 0.0 111.078 175.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.17 -49.01 77.29 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 119.218 0.917 . . . . 0.0 112.17 174.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.7 mt -63.04 -38.62 91.91 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.95 -34.2 71.49 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.3 p -72.88 -12.52 61.0 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 114.559 1.318 . . . . 0.0 114.559 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.5 m -122.44 7.49 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 -175.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.44 -5.75 5.23 Favored Glycine 0 CA--C 1.54 1.651 0 N-CA-C 117.102 1.601 . . . . 0.0 117.102 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.94 -32.96 56.42 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 119.053 1.427 . . . . 0.0 115.526 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -90.23 79.8 6.33 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 119.029 1.414 . . . . 0.0 110.607 171.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -52.1 -36.28 50.44 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -173.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -71.23 -41.32 70.32 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 120.203 1.365 . . . . 0.0 112.348 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.17 -43.52 86.66 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.784 -0.573 . . . . 0.0 111.335 172.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 tpp -63.15 -40.03 96.38 Favored 'General case' 0 CA--C 1.541 0.596 0 O-C-N 121.566 -0.708 . . . . 0.0 112.204 175.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -56.88 -50.07 73.6 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.072 -1.017 . . . . 0.0 111.538 172.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.03 -45.38 79.19 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.056 0.942 . . . . 0.0 112.22 174.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.8 tp -61.96 -48.78 78.82 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.295 0.638 . . . . 0.0 112.045 176.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.71 -38.12 89.9 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.832 0.853 . . . . 0.0 112.45 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.06 -45.53 92.56 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.653 0.661 . . . . 0.0 112.001 170.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.61 -42.42 99.57 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.806 0.73 . . . . 0.0 112.114 175.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.9 -46.04 91.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 O-C-N 121.506 -0.747 . . . . 0.0 111.037 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -64.16 -39.44 94.01 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.887 0.767 . . . . 0.0 112.684 177.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -60.84 -47.44 86.37 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.934 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -70.05 -34.38 73.14 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.63 -41.98 92.02 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.49 -0.756 . . . . 0.0 112.299 172.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.57 -42.04 98.27 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.231 0.613 . . . . 0.0 111.784 172.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.15 -42.35 99.44 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.825 -0.547 . . . . 0.0 112.189 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -57.72 -48.48 79.46 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.677 0.671 . . . . 0.0 111.653 173.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -63.06 -30.4 71.56 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.09 -38.95 79.26 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.359 1.064 . . . . 0.0 112.488 173.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.44 -27.61 41.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.803 1.241 . . . . 0.0 113.318 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 60.98 53.81 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.583 1.953 . . . . 0.0 111.22 -174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.89 120.17 7.46 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.456 2.104 . . . . 0.0 110.296 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.52 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 125.335 1.454 . . . . 0.0 112.154 -169.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.12 160.46 25.72 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.1 0.56 . . . . 0.0 110.845 168.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.19 -19.96 64.98 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.9 174.7 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.069 1.319 . . . . 0.0 112.647 174.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.55 169.2 14.71 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.624 2.883 . . . . 0.0 112.944 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.0 mt -57.65 -39.26 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.897 1.279 . . . . 0.0 111.762 -175.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.45 161.91 28.56 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.862 1.665 . . . . 0.0 110.597 176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.92 133.42 22.9 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.473 2.782 . . . . 0.0 113.132 168.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -15.05 60.3 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.531 1.063 . . . . 0.0 115.037 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.03 143.35 37.56 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.942 1.371 . . . . 0.0 110.197 173.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.14 145.64 54.17 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.663 -0.648 . . . . 0.0 110.793 168.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -68.59 152.67 45.05 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.677 0.791 . . . . 0.0 111.69 171.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -72.22 131.78 84.83 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.949 -0.548 . . . . 0.0 109.848 170.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.38 140.26 43.63 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.15 1.9 . . . . 0.0 112.465 -177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.7 mtp85 -74.87 171.65 13.65 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.707 1.603 . . . . 0.0 111.879 163.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.54 -44.0 93.95 Favored Glycine 0 CA--C 1.535 1.325 0 O-C-N 121.921 -0.487 . . . . 0.0 112.955 168.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.66 -25.9 65.05 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.67 -41.61 65.19 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.057 -1.027 . . . . 0.0 111.777 171.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.66 -42.65 96.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.737 0.815 . . . . 0.0 110.819 173.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.98 -1.28 13.99 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 173.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.93 18.28 74.27 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.899 -1.126 . . . . 0.0 115.437 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.38 -19.39 19.24 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.115 1.458 . . . . 0.0 113.301 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 p -126.21 -1.55 7.02 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.3 p -103.43 150.05 24.22 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.099 0.96 . . . . 0.0 111.783 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.2 p -81.96 162.45 22.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.268 0.556 . . . . 0.0 110.848 169.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.87 -39.4 74.27 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.444 -0.785 . . . . 0.0 111.445 169.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.52 -38.87 92.8 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.513 -0.742 . . . . 0.0 112.688 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -64.59 -42.8 95.35 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 121.584 -0.698 . . . . 0.0 112.069 171.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.68 -46.3 90.87 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.574 0.75 . . . . 0.0 112.155 176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.5 -46.36 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.122 0.969 . . . . 0.0 110.288 172.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.42 -51.01 54.42 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.806 0.717 . . . . 0.0 112.945 177.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.3 -50.09 73.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.751 0.776 . . . . 0.0 112.48 174.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.66 -18.35 64.26 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.505 1.298 . . . . 0.0 114.505 -176.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -112.01 8.39 20.16 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.628 1.171 . . . . 0.0 113.035 178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.46 162.33 1.62 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.921 1.288 . . . . 0.0 111.461 165.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.93 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.065 0.946 . . . . 0.0 110.758 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.84 89.15 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.461 0.843 . . . . 0.0 111.713 -6.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -50.0 141.28 29.98 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.216 2.611 . . . . 0.0 114.206 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 74.9 mt -96.1 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 163.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.91 54.48 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.295 2.663 . . . . 0.0 112.884 -152.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.54 -34.85 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -173.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.26 94.22 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.985 173.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.91 -36.84 75.68 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.358 -1.083 . . . . 0.0 112.645 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.92 -44.61 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.753 -0.592 . . . . 0.0 109.987 173.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.79 -40.39 91.9 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.352 -0.842 . . . . 0.0 112.572 176.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -55.84 -41.99 75.11 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.476 -0.765 . . . . 0.0 112.287 173.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.76 -45.24 82.16 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.888 0.767 . . . . 0.0 112.125 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.27 -40.56 86.17 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.273 0.629 . . . . 0.0 112.246 178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.48 -47.53 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 122.987 0.515 . . . . 0.0 110.216 174.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -61.97 -37.12 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.708 1.203 . . . . 0.0 112.326 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.85 98.55 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.107 0.867 . . . . 0.0 111.264 170.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.85 91.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 123.838 0.733 . . . . 0.0 113.199 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.5 mt -58.1 -42.93 86.74 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.02 0.91 . . . . 0.0 110.987 173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.24 70.37 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.842 0.857 . . . . 0.0 112.458 173.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.7 mttt -55.72 -43.44 76.55 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.894 0.77 . . . . 0.0 111.987 175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.9 mt -64.57 -47.48 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 118.707 -0.663 . . . . 0.0 111.452 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.2 m -69.61 -32.99 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 119.918 1.235 . . . . 0.0 112.881 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.5 mtp180 -60.87 -46.46 90.51 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.949 0.9 . . . . 0.0 111.468 172.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.4 ttp -72.23 -38.38 68.95 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.588 1.555 . . . . 0.0 113.082 -177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.7 t80 . . . . . 0 C--O 1.251 1.156 0 C-N-CA 128.345 2.658 . . . . 0.0 114.73 -174.362 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.017 0.353 . . . . 0.0 113.017 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -92.0 135.05 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 124.51 1.124 . . . . 0.0 108.471 163.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.08 154.66 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.685 170.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -104.36 116.63 32.48 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.519 0.728 . . . . 0.0 109.181 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.4 177.97 6.92 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.55 0.69 . . . . 0.0 112.474 177.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.61 68.82 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.59 -2.12 57.83 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.746 1.219 . . . . 0.0 113.046 175.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.25 85.75 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 124.5 1.048 . . . . 0.0 114.066 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.82 128.16 35.24 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.848 1.324 . . . . 0.0 109.715 174.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.81 125.46 29.38 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 168.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.89 123.39 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.053 1.341 . . . . 0.0 108.659 -174.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.66 141.1 48.46 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.513 1.925 . . . . 0.0 107.959 169.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.3 152.38 21.16 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.98 0.809 . . . . 0.0 111.274 170.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.49 136.85 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 O-C-N 121.645 -0.659 . . . . 0.0 111.61 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.66 130.0 93.24 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.07 0.548 . . . . 0.0 111.137 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -53.02 -34.56 68.04 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.918 2.412 . . . . 0.0 113.569 167.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.46 -38.08 86.55 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.457 -0.777 . . . . 0.0 112.545 174.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.98 -44.21 97.7 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.718 0.69 . . . . 0.0 111.425 171.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.58 -44.42 94.11 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.291 0.496 . . . . 0.0 112.256 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.15 -47.17 86.26 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 118.441 0.564 . . . . 0.0 111.398 176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.14 95.95 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.606 0.763 . . . . 0.0 111.879 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.7 t-105 -60.38 -46.83 88.57 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.734 0.813 . . . . 0.0 112.85 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.0 t -56.98 -54.16 33.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.436 0.562 . . . . 0.0 110.343 174.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.89 -37.14 78.54 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.391 1.076 . . . . 0.0 113.249 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.26 -52.46 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.236 1.414 . . . . 0.0 111.236 170.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.8 t -64.98 -36.09 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 123.023 0.529 . . . . 0.0 111.441 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.39 -24.04 58.86 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.997 1.11 . . . . 0.0 113.997 175.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.51 -25.29 11.45 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -136.36 15.98 3.2 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -165.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -44.05 -36.98 2.77 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 -175.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -117.89 13.61 14.06 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.415 1.086 . . . . 0.0 113.114 -172.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.4 p -113.03 153.09 45.4 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.944 0.898 . . . . 0.0 111.55 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.88 -30.77 59.6 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.303 2.669 . . . . 0.0 115.181 -172.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -62.05 -20.82 64.36 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.81 -31.83 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.404 1.002 . . . . 0.0 112.525 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.49 -55.02 6.2 Favored Pre-proline 0 CA--C 1.542 0.673 0 C-N-CA 124.904 1.282 . . . . 0.0 112.968 -178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.84 -30.15 49.58 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.718 1.649 . . . . 0.0 112.633 174.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.0 -40.25 78.83 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.911 1.232 . . . . 0.0 112.669 172.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -57.23 -46.53 82.87 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.716 0.689 . . . . 0.0 111.592 169.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.2 m -61.04 -44.45 97.39 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -31.83 71.34 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.317 1.047 . . . . 0.0 113.229 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.54 4.5 53.13 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.455 1.502 . . . . 0.0 113.522 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -133.03 22.76 4.16 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -176.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -53.55 120.26 5.92 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 120.44 -1.413 . . . . 0.0 111.517 168.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.52 11.72 60.23 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.57 130.84 46.89 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.546 1.673 . . . . 0.0 112.437 -178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.31 159.68 84.36 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.7 167.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.53 -35.53 37.25 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.144 1.896 . . . . 0.0 115.412 168.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.96 -40.26 87.44 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.056 0.762 . . . . 0.0 113.056 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.37 -45.31 93.95 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.695 -0.628 . . . . 0.0 111.038 172.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.9 m-20 -59.18 -41.49 88.61 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.696 -0.628 . . . . 0.0 112.031 171.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.2 m -60.23 -45.28 93.77 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.582 0.628 . . . . 0.0 111.11 175.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.34 -48.99 77.56 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.246 0.93 . . . . 0.0 112.165 174.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -62.98 -38.38 90.9 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 178.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.01 -33.42 70.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.9 p -73.49 -12.72 60.88 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.6 m -122.53 6.98 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.22 -4.1 7.78 Favored Glycine 0 CA--C 1.54 1.643 0 N-CA-C 117.414 1.726 . . . . 0.0 117.414 -176.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.59 -35.58 67.49 Favored Glycine 0 CA--C 1.535 1.339 0 CA-C-N 119.353 1.576 . . . . 0.0 115.173 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -85.35 77.89 9.86 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 122.944 1.354 . . . . 0.0 110.5 170.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.86 -35.51 32.96 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.597 1.559 . . . . 0.0 115.165 -174.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.6 -41.33 72.45 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 120.142 1.337 . . . . 0.0 112.345 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.61 86.14 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.767 -0.583 . . . . 0.0 111.362 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.1 tpp -63.11 -40.02 96.4 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.576 -0.702 . . . . 0.0 112.228 175.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.02 -49.94 74.26 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.018 -1.051 . . . . 0.0 111.523 173.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.97 -45.41 78.93 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.066 0.946 . . . . 0.0 112.251 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.6 tp -61.94 -48.77 78.95 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.307 0.643 . . . . 0.0 112.071 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.72 -38.28 90.51 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 0.0 112.44 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -59.98 -45.49 92.55 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.715 0.689 . . . . 0.0 112.034 170.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.62 -42.43 99.58 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.793 0.724 . . . . 0.0 112.109 175.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.1 mt -58.82 -46.11 91.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.426 -0.796 . . . . 0.0 111.03 174.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.12 -39.43 94.03 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.869 0.759 . . . . 0.0 112.724 177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -60.82 -47.4 86.53 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.721 0.808 . . . . 0.0 111.961 174.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -70.15 -34.3 72.85 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.09 -40.81 91.08 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.44 -0.788 . . . . 0.0 112.468 173.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.31 -42.18 99.15 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.211 0.604 . . . . 0.0 111.737 172.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -62.91 -42.12 99.68 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.907 -0.496 . . . . 0.0 112.13 174.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -58.17 -48.81 79.14 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.641 -0.662 . . . . 0.0 111.751 173.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -62.76 -29.7 70.88 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.73 -39.48 76.78 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.398 1.079 . . . . 0.0 112.52 173.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.06 -27.59 43.1 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.731 1.212 . . . . 0.0 113.337 176.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.76 61.1 54.57 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.675 1.99 . . . . 0.0 111.229 -174.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.77 120.22 7.53 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.484 2.123 . . . . 0.0 110.313 179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.38 135.97 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.325 1.45 . . . . 0.0 112.079 -169.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.9 m170 -79.74 160.48 26.2 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.062 0.545 . . . . 0.0 110.908 168.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.99 65.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 174.78 41.62 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.115 1.34 . . . . 0.0 112.677 174.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.62 169.14 14.95 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.642 2.895 . . . . 0.0 112.906 177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.6 -39.22 68.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.887 1.275 . . . . 0.0 111.787 -175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.91 28.56 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.845 1.658 . . . . 0.0 110.597 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.89 133.45 22.75 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.473 2.782 . . . . 0.0 113.114 168.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.91 -15.0 60.36 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.577 1.084 . . . . 0.0 115.056 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.32 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.906 1.353 . . . . 0.0 110.198 173.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.15 145.58 54.22 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.719 -0.613 . . . . 0.0 110.868 168.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.9 ptt85 -68.39 152.58 45.21 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.682 0.793 . . . . 0.0 111.616 171.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.07 131.58 85.27 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.805 170.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.26 140.47 44.63 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.051 1.834 . . . . 0.0 112.362 -177.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 65.5 mtp85 -75.23 171.83 13.49 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.654 1.582 . . . . 0.0 111.99 162.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.78 -43.98 94.39 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 123.36 0.505 . . . . 0.0 113.012 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.71 -25.89 65.0 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 175.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -72.65 -41.67 65.2 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 120.977 -1.077 . . . . 0.0 111.764 171.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 67.9 mt -62.52 -42.81 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.788 0.835 . . . . 0.0 110.76 173.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.99 -1.32 14.12 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 173.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.92 18.27 74.25 Favored Glycine 0 CA--C 1.534 1.276 0 O-C-N 120.827 -1.17 . . . . 0.0 115.423 175.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.6 p -96.19 -19.53 19.27 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.13 1.465 . . . . 0.0 113.394 -178.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 61.8 p -126.23 -1.55 7.01 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.613 1.165 . . . . 0.0 114.072 177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -103.27 150.21 23.96 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.758 0.823 . . . . 0.0 112.25 173.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.8 p -82.53 162.4 22.01 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.361 0.601 . . . . 0.0 110.793 170.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 66.9 tp -56.57 -39.61 73.77 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 121.52 -0.737 . . . . 0.0 111.368 169.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.28 -39.0 93.34 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.547 -0.721 . . . . 0.0 112.63 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -64.68 -42.6 95.22 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 121.478 -0.764 . . . . 0.0 112.152 171.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -60.66 -46.34 90.69 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.618 0.767 . . . . 0.0 112.133 176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.38 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.122 0.969 . . . . 0.0 110.288 172.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.43 -51.05 54.14 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.819 0.723 . . . . 0.0 112.9 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.22 -50.14 72.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.866 0.833 . . . . 0.0 112.517 174.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.63 -18.39 64.29 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.94 8.35 20.26 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.671 1.189 . . . . 0.0 113.051 178.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.43 162.33 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.978 1.311 . . . . 0.0 111.447 165.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.29 49.02 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.065 0.946 . . . . 0.0 110.821 176.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.1 163.84 89.14 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.497 0.856 . . . . 0.0 111.713 -6.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -50.01 141.26 30.1 Favored 'Trans proline' 0 CA--C 1.534 0.492 0 C-N-CA 123.231 2.621 . . . . 0.0 114.148 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.04 96.46 2.44 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.84 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.36 -46.24 94.28 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.638 0.654 . . . . 0.0 112.985 173.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.88 -36.89 75.83 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.362 -1.081 . . . . 0.0 112.645 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.88 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.722 -0.611 . . . . 0.0 109.947 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.92 -40.38 91.38 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.282 -0.886 . . . . 0.0 112.521 176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -42.02 75.05 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.71 -45.19 82.0 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.924 0.784 . . . . 0.0 112.12 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -67.41 -40.49 85.59 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.248 0.619 . . . . 0.0 112.292 178.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.57 -47.23 93.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 122.997 0.519 . . . . 0.0 110.235 174.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.05 -37.37 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 124.749 1.22 . . . . 0.0 112.308 177.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.85 -42.84 98.63 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.038 0.836 . . . . 0.0 111.216 171.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.55 -45.03 91.75 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.821 0.724 . . . . 0.0 113.252 175.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.37 -42.48 87.1 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.962 0.881 . . . . 0.0 111.055 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.46 -50.17 70.57 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.811 0.844 . . . . 0.0 112.5 173.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.88 -43.33 77.09 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 118.855 0.752 . . . . 0.0 111.984 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.2 mt -64.43 -47.62 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.443 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.75 -32.91 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 CA-C-N 119.952 1.251 . . . . 0.0 112.889 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -60.45 -45.86 92.16 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.901 0.88 . . . . 0.0 111.448 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.9 ttp -73.57 -38.43 65.17 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.564 1.546 . . . . 0.0 113.313 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.9 t80 . . . . . 0 C--O 1.255 1.39 0 C-N-CA 128.43 2.692 . . . . 0.0 114.714 -172.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.81 135.01 28.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.492 1.117 . . . . 0.0 108.459 163.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.92 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.686 170.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.62 116.69 32.49 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.57 0.748 . . . . 0.0 109.17 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.46 178.06 6.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.46 177.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.95 -26.44 68.82 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.62 -2.16 57.89 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.818 1.247 . . . . 0.0 113.03 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.0 85.7 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.67 128.26 35.58 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.858 1.329 . . . . 0.0 109.726 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.92 125.62 29.62 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.99 123.4 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.07 1.348 . . . . 0.0 108.629 -174.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.73 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.75 141.14 48.38 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 126.477 1.911 . . . . 0.0 107.948 169.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.28 152.45 20.89 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.196 170.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.58 136.87 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.6 -0.687 . . . . 0.0 111.544 176.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.69 130.01 93.2 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.068 0.547 . . . . 0.0 111.106 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.05 -34.52 68.15 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.794 2.329 . . . . 0.0 113.607 167.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.46 -38.08 86.54 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.448 -0.783 . . . . 0.0 112.56 174.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.98 -44.29 97.58 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.753 0.706 . . . . 0.0 111.362 171.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.2 mt -63.45 -44.42 94.56 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.277 0.49 . . . . 0.0 112.275 175.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.17 -47.28 85.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.162 0.585 . . . . 0.0 111.386 176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.17 95.87 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.611 0.764 . . . . 0.0 111.856 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.4 t-105 -60.14 -47.46 85.82 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.809 0.843 . . . . 0.0 112.748 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.7 t -56.8 -54.16 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 CA-C-N 118.426 0.557 . . . . 0.0 110.384 174.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.8 -37.47 79.22 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.297 1.039 . . . . 0.0 113.207 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.409 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.87 -52.08 62.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.962 1.305 . . . . 0.0 111.281 170.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.58 -35.81 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 119.043 -0.503 . . . . 0.0 111.414 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.84 -23.51 60.72 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 174.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.72 -25.6 11.21 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -135.78 16.36 3.32 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -166.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.12 -38.35 2.38 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -175.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -118.01 14.08 14.04 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.49 1.116 . . . . 0.0 113.024 -171.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.2 p -113.13 152.91 45.43 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.997 0.919 . . . . 0.0 111.523 -178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.83 -30.95 59.87 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.296 2.664 . . . . 0.0 115.214 -172.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.08 -20.94 64.54 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 -177.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.59 -32.17 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.413 1.006 . . . . 0.0 112.485 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.37 -57.16 5.98 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.715 1.206 . . . . 0.0 112.555 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.87 -29.43 58.45 Favored 'Trans proline' 0 C--N 1.351 0.71 0 CA-C-N 121.833 1.69 . . . . 0.0 112.809 175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.409 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.3 -40.1 77.91 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.841 1.2 . . . . 0.0 112.703 172.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.12 -47.05 82.06 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.885 0.766 . . . . 0.0 111.537 169.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -60.88 -44.17 97.46 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 175.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.84 -31.66 71.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.178 0.991 . . . . 0.0 113.261 178.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.76 4.59 52.79 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.362 1.465 . . . . 0.0 113.514 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.5 p -133.12 22.86 4.13 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.59 120.34 6.04 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.47 -1.394 . . . . 0.0 111.472 168.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.49 11.69 60.08 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.371 0.909 . . . . 0.0 115.371 -177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.87 47.03 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.565 1.683 . . . . 0.0 112.481 -178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.0 p -73.32 159.67 84.36 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.732 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.57 -35.43 37.32 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.144 1.896 . . . . 0.0 115.406 168.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.0 -40.34 87.33 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.28 -45.3 93.81 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.627 -0.671 . . . . 0.0 111.1 172.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.7 mt -63.62 -44.23 94.53 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.343 1.057 . . . . 0.0 112.085 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.3 -41.31 88.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 118.649 0.659 . . . . 0.0 112.02 171.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.27 -45.41 93.42 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.611 0.642 . . . . 0.0 111.071 175.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.37 -48.66 78.44 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 119.192 0.906 . . . . 0.0 112.151 174.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.1 mt -63.23 -38.36 90.85 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.03 -34.36 71.82 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.627 -0.671 . . . . 0.0 112.776 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.2 p -72.4 -13.39 61.45 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 -179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 m -118.19 11.16 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.367 1.067 . . . . 0.0 113.391 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.75 -10.59 4.74 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 117.141 1.616 . . . . 0.0 117.141 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -69.85 9.5 2.78 Favored Glycine 0 CA--C 1.542 1.735 0 C-N-CA 125.811 1.672 . . . . 0.0 117.009 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -127.85 79.11 1.87 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.232 1.516 . . . . 0.0 110.0 162.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -52.17 -36.0 50.39 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 -171.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.87 -40.9 75.44 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 120.127 1.331 . . . . 0.0 112.147 -178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.8 -43.58 83.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.298 0.639 . . . . 0.0 111.351 173.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.0 tpp -62.88 -40.3 97.09 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 121.531 -0.73 . . . . 0.0 112.281 175.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.02 -50.0 74.06 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.267 1.027 . . . . 0.0 111.544 173.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.8 tpp -56.04 -45.45 79.19 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.098 0.959 . . . . 0.0 112.184 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.5 tp -61.87 -48.82 78.8 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.337 0.655 . . . . 0.0 112.017 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.67 -38.31 90.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.905 0.882 . . . . 0.0 112.49 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -60.0 -45.44 92.74 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.689 0.677 . . . . 0.0 112.048 170.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.64 -42.36 99.56 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.827 0.739 . . . . 0.0 112.118 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.86 -46.11 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.472 -0.768 . . . . 0.0 111.03 174.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.11 -39.43 94.02 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.869 0.759 . . . . 0.0 112.738 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.85 -47.42 86.43 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.758 0.823 . . . . 0.0 111.892 174.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.09 -34.38 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.47 91.54 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.484 -0.76 . . . . 0.0 112.327 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.11 98.64 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.256 0.622 . . . . 0.0 111.781 172.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.12 -42.22 99.49 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.872 -0.517 . . . . 0.0 112.191 174.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.7 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.71 173.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.05 -30.24 71.44 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -39.1 78.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.397 1.079 . . . . 0.0 112.45 173.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.79 60.98 53.75 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.91 120.14 7.42 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.424 2.083 . . . . 0.0 110.315 179.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.35 136.29 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.332 1.453 . . . . 0.0 112.129 -169.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -80.01 160.47 25.86 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.054 0.541 . . . . 0.0 110.915 168.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.92 65.01 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.11 1.338 . . . . 0.0 112.686 174.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.6 169.19 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.658 2.905 . . . . 0.0 112.889 177.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.66 -39.2 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.904 1.282 . . . . 0.0 111.753 -175.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.61 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 110.585 176.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.89 133.38 22.73 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.487 2.791 . . . . 0.0 113.15 168.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.94 -15.04 60.29 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.567 1.08 . . . . 0.0 115.001 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.992 1.396 . . . . 0.0 110.198 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.22 145.58 54.16 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.691 -0.631 . . . . 0.0 110.793 168.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.54 152.82 44.85 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.655 0.782 . . . . 0.0 111.67 171.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.27 131.65 84.85 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.29 140.41 44.36 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.11 1.873 . . . . 0.0 112.442 -177.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -75.18 171.62 13.84 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.697 1.599 . . . . 0.0 111.893 163.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.83 94.0 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.971 -0.455 . . . . 0.0 113.03 168.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.85 -25.75 64.8 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.66 64.9 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.03 -1.044 . . . . 0.0 111.779 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.59 -42.76 97.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 110.82 173.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.26 14.03 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 173.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.16 74.31 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.927 -1.108 . . . . 0.0 115.447 174.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.34 -19.39 19.27 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.074 1.437 . . . . 0.0 113.284 -178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.2 p -126.18 -1.44 7.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.71 149.96 24.49 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.036 0.935 . . . . 0.0 111.788 173.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.2 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.282 0.563 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.86 -39.37 74.17 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 121.451 -0.781 . . . . 0.0 111.394 169.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.49 -38.98 93.21 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.554 -0.716 . . . . 0.0 112.701 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.82 95.52 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.58 -46.44 90.23 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.636 0.774 . . . . 0.0 112.142 176.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.43 -46.36 92.79 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.158 0.983 . . . . 0.0 110.304 172.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.04 54.4 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.81 0.719 . . . . 0.0 112.93 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.79 0.795 . . . . 0.0 112.485 174.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.9 8.32 20.32 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.66 1.184 . . . . 0.0 113.033 178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.39 162.29 1.59 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.041 1.336 . . . . 0.0 111.39 165.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.36 48.92 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.042 0.937 . . . . 0.0 110.758 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.09 163.83 89.17 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.509 0.86 . . . . 0.0 111.746 -6.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 99.5 Cg_exo -49.98 141.36 29.67 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.253 2.635 . . . . 0.0 114.117 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.2 96.42 2.49 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -85.96 54.56 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.27 2.647 . . . . 0.0 112.86 -152.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.78 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.19 94.34 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.61 0.641 . . . . 0.0 113.011 173.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.87 -36.87 75.83 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.326 -1.102 . . . . 0.0 112.634 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.94 -44.56 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.808 -0.557 . . . . 0.0 109.949 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.36 91.58 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.303 -0.873 . . . . 0.0 112.557 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.85 -42.07 75.26 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.472 -0.767 . . . . 0.0 112.217 173.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -56.59 -45.26 81.49 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.642 0.777 . . . . 0.0 112.087 174.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.39 -40.41 85.66 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.248 0.619 . . . . 0.0 112.286 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.73 -46.97 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.093 0.557 . . . . 0.0 110.286 174.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.38 -37.27 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.648 1.179 . . . . 0.0 112.32 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.85 -42.8 98.52 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.036 0.835 . . . . 0.0 111.176 171.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.42 -45.24 91.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.878 0.751 . . . . 0.0 113.181 175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.48 -42.21 87.01 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.035 0.918 . . . . 0.0 111.113 173.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.24 70.44 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.774 0.83 . . . . 0.0 112.399 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.83 -43.06 76.62 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.884 0.765 . . . . 0.0 112.027 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.2 mt -64.64 -47.96 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 123.371 0.668 . . . . 0.0 111.451 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.46 -32.83 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 119.894 1.225 . . . . 0.0 112.895 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.11 -43.85 95.31 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.867 0.867 . . . . 0.0 111.512 171.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.6 ttp -76.99 -36.27 56.54 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.644 1.577 . . . . 0.0 113.606 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.255 1.375 0 C-N-CA 128.35 2.66 . . . . 0.0 114.599 -172.764 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.75 134.99 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 C-N-CA 124.501 1.121 . . . . 0.0 108.436 163.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.98 154.96 35.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.114 1.366 . . . . 0.0 109.665 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.7 116.69 32.48 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.555 0.742 . . . . 0.0 109.222 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.46 178.07 6.89 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.604 0.716 . . . . 0.0 112.46 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.87 -26.57 68.84 Favored 'General case' 0 CA--C 1.545 0.75 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.08 57.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.746 1.219 . . . . 0.0 113.002 175.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.0 85.78 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.487 1.042 . . . . 0.0 114.091 -175.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.75 128.29 35.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.858 1.329 . . . . 0.0 109.714 174.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.86 125.64 29.65 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 168.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.9 t -126.04 123.28 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.103 1.361 . . . . 0.0 108.712 -174.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.53 139.71 38.62 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.15 48.46 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.465 1.906 . . . . 0.0 107.922 169.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.34 20.89 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.015 0.825 . . . . 0.0 111.233 170.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.57 136.88 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.607 -0.683 . . . . 0.0 111.579 176.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.63 130.02 93.27 Favored Pre-proline 0 CA--C 1.538 0.481 0 C-N-CA 123.112 0.565 . . . . 0.0 111.139 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -53.04 -34.54 68.22 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.864 2.376 . . . . 0.0 113.607 167.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.44 -38.03 86.47 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 121.463 -0.773 . . . . 0.0 112.588 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.0 m -60.93 -44.33 97.38 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.722 0.692 . . . . 0.0 111.401 171.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.53 -44.17 95.02 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 175.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.3 -47.29 85.96 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.167 0.587 . . . . 0.0 111.416 176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.13 95.91 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.626 0.77 . . . . 0.0 111.897 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -60.21 -47.26 86.7 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.86 0.864 . . . . 0.0 112.73 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.3 t -56.51 -54.95 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 CA-C-N 118.471 0.578 . . . . 0.0 110.345 174.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.48 -37.3 77.87 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.272 1.029 . . . . 0.0 113.178 -178.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.47 -52.16 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.028 1.331 . . . . 0.0 111.29 170.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.68 -36.02 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 CA-C-O 119.016 -0.516 . . . . 0.0 111.452 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -58.53 -24.17 59.96 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 174.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.04 -25.81 11.43 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.91 15.97 3.31 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 -165.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.08 -38.92 2.54 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -175.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -116.62 13.73 15.3 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.379 1.072 . . . . 0.0 113.154 -172.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.1 p -112.87 152.95 45.27 Favored Pre-proline 0 CA--C 1.541 0.611 0 C-N-CA 123.941 0.897 . . . . 0.0 111.544 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.82 -30.77 58.93 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.299 2.666 . . . . 0.0 115.233 -172.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.02 -20.74 64.24 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.8 -31.86 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.435 1.016 . . . . 0.0 112.548 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.45 -55.05 6.24 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.907 1.283 . . . . 0.0 112.956 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.83 -30.12 49.72 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.688 1.639 . . . . 0.0 112.661 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.403 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.07 -40.22 78.61 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.86 1.209 . . . . 0.0 112.64 172.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -57.27 -46.49 83.04 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.719 0.69 . . . . 0.0 111.579 169.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -61.04 -44.48 97.33 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 175.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.87 -32.07 71.51 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.341 1.056 . . . . 0.0 113.225 178.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.23 4.44 53.53 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.4 1.48 . . . . 0.0 113.522 -178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.9 p -133.03 22.82 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.437 1.273 . . . . 0.0 114.437 -176.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.61 120.27 5.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.44 -1.413 . . . . 0.0 111.484 168.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.59 11.6 60.19 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.422 0.929 . . . . 0.0 115.422 -177.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.51 130.87 47.09 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.525 1.663 . . . . 0.0 112.498 -178.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.35 159.68 84.3 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.758 0.823 . . . . 0.0 110.697 167.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.65 -35.41 37.95 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.204 1.936 . . . . 0.0 115.366 168.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.0 -40.27 87.29 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 174.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.33 -45.31 93.88 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.596 -0.69 . . . . 0.0 111.044 172.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.6 -44.21 94.67 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.318 1.047 . . . . 0.0 112.175 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -59.24 -41.48 88.82 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.649 -0.657 . . . . 0.0 111.973 171.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.2 m -60.23 -45.28 93.77 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.614 0.643 . . . . 0.0 111.11 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.0 mtp -57.33 -49.01 77.48 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 119.246 0.93 . . . . 0.0 112.193 174.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.02 -38.54 91.59 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.87 -33.22 70.23 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.9 p -73.68 -13.37 60.97 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.6 m -122.45 6.2 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.5 -4.36 6.65 Favored Glycine 0 CA--C 1.541 1.67 0 N-CA-C 117.243 1.657 . . . . 0.0 117.243 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.75 -35.28 57.61 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-N 119.179 1.489 . . . . 0.0 115.177 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -86.18 77.95 9.47 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 122.838 1.304 . . . . 0.0 110.551 170.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.95 -35.91 35.96 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.254 1.575 . . . . 0.0 115.254 -173.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.36 -41.18 73.47 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.047 1.294 . . . . 0.0 112.301 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.36 -43.55 85.72 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.137 0.575 . . . . 0.0 111.33 173.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 59.8 tpp -63.25 -39.96 96.08 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.47 -0.769 . . . . 0.0 112.223 176.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -50.0 73.98 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.079 -1.013 . . . . 0.0 111.521 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -56.0 -45.43 79.04 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.88 -48.81 78.85 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.314 0.646 . . . . 0.0 112.055 176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.7 -38.21 90.26 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.835 0.854 . . . . 0.0 112.448 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.99 -45.53 92.42 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.664 0.665 . . . . 0.0 112.027 170.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.1 m -62.64 -42.37 99.55 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.149 175.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.86 -46.1 91.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.47 -0.769 . . . . 0.0 111.059 174.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.08 -39.46 94.12 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.831 0.741 . . . . 0.0 112.736 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.82 -47.4 86.51 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.704 0.801 . . . . 0.0 111.958 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.1 -34.32 72.97 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.584 -0.697 . . . . 0.0 112.835 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.92 -41.47 91.35 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.441 -0.787 . . . . 0.0 112.307 173.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.88 -42.12 98.68 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.238 0.615 . . . . 0.0 111.772 172.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.09 -42.28 99.58 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.915 -0.491 . . . . 0.0 112.138 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.4 t-105 -57.8 -48.58 79.32 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.661 0.664 . . . . 0.0 111.71 173.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.06 -30.24 71.44 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.2 -39.13 78.84 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.391 1.076 . . . . 0.0 112.48 173.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.26 -27.6 42.36 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.812 1.245 . . . . 0.0 113.302 176.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.8 61.02 54.01 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.668 1.987 . . . . 0.0 111.228 -174.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.9 120.13 7.4 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.507 2.138 . . . . 0.0 110.285 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.45 136.23 24.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.298 1.439 . . . . 0.0 112.121 -169.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -79.85 160.43 26.08 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.087 0.555 . . . . 0.0 110.915 168.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.27 -19.97 65.05 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.74 41.58 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.048 1.309 . . . . 0.0 112.64 174.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.58 169.23 14.72 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.611 2.874 . . . . 0.0 112.882 177.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.66 -39.22 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.925 1.29 . . . . 0.0 111.806 -175.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.62 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.884 1.674 . . . . 0.0 110.631 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.91 133.41 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.456 2.77 . . . . 0.0 113.116 168.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.05 60.34 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 115.005 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.1 143.42 37.36 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.006 1.403 . . . . 0.0 110.185 173.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.6 mtm -68.2 145.56 54.2 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.721 -0.612 . . . . 0.0 110.842 168.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.49 152.73 44.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.748 0.819 . . . . 0.0 111.666 171.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -72.26 131.72 84.81 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.884 -0.579 . . . . 0.0 109.808 170.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.33 140.41 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -75.2 171.66 13.77 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.697 1.599 . . . . 0.0 111.889 163.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.5 -43.94 93.9 Favored Glycine 0 CA--C 1.535 1.293 0 O-C-N 121.934 -0.479 . . . . 0.0 113.03 168.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.81 -25.73 64.83 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.78 -41.63 64.8 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.05 -1.032 . . . . 0.0 111.728 171.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.77 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.77 0.828 . . . . 0.0 110.771 173.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.26 13.94 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.2 74.23 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.596 1.093 . . . . 0.0 115.449 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.43 19.26 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.157 1.478 . . . . 0.0 113.283 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.19 -1.42 7.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.74 149.84 24.62 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 124.082 0.953 . . . . 0.0 111.799 173.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.5 p -81.78 162.32 22.94 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.291 0.567 . . . . 0.0 110.779 170.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.74 -39.38 73.85 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.448 -0.783 . . . . 0.0 111.445 169.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.54 -38.98 93.2 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.554 -0.716 . . . . 0.0 112.685 179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -64.53 -42.77 95.55 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.68 -46.35 90.69 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.119 176.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.5 -46.33 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 124.167 0.987 . . . . 0.0 110.268 172.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.04 54.46 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.795 0.712 . . . . 0.0 112.92 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.29 -50.05 73.22 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.812 0.806 . . . . 0.0 112.537 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.48 64.29 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.7 p -111.87 8.36 20.4 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.703 1.201 . . . . 0.0 113.051 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.5 162.33 1.64 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.991 1.316 . . . . 0.0 111.399 165.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.35 48.98 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.066 0.946 . . . . 0.0 110.813 176.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.82 89.2 Favored 'Cis proline' 0 CA--C 1.544 0.984 0 CA-C-N 119.429 0.832 . . . . 0.0 111.69 -6.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -49.94 141.39 29.27 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.187 2.591 . . . . 0.0 114.171 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.23 96.49 2.54 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 104.817 -2.29 . . . . 0.0 104.817 163.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.05 54.62 3.46 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.214 2.61 . . . . 0.0 112.83 -152.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.81 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.17 94.4 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.638 0.654 . . . . 0.0 113.011 173.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.89 -36.84 75.75 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.296 -1.12 . . . . 0.0 112.634 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.8 mt -62.95 -44.62 99.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.799 -0.563 . . . . 0.0 109.914 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.87 -40.35 91.57 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.327 -0.858 . . . . 0.0 112.521 176.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -55.86 -42.04 75.25 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.439 -0.788 . . . . 0.0 112.246 173.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.72 -45.23 82.04 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.924 0.784 . . . . 0.0 112.125 174.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.26 -40.57 86.22 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.294 0.638 . . . . 0.0 112.244 178.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.3 mt -62.57 -47.33 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.23 174.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -61.98 -37.36 78.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.695 1.198 . . . . 0.0 112.301 177.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.84 -42.77 98.44 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.039 0.836 . . . . 0.0 111.217 171.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.62 -44.98 91.71 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 123.855 0.74 . . . . 0.0 113.214 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.35 -42.57 87.17 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.007 0.903 . . . . 0.0 110.992 173.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.45 -50.24 70.37 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 123.807 0.843 . . . . 0.0 112.483 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.82 -43.28 76.81 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.88 0.764 . . . . 0.0 111.961 175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.426 HG21 H13A ' A' ' 146' ' ' JPR . 69.2 mt -64.52 -47.8 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 123.334 0.654 . . . . 0.0 111.418 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.93 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 119.911 1.232 . . . . 0.0 112.893 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -60.36 -44.86 95.18 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.949 0.9 . . . . 0.0 111.428 171.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.4 ttp -74.89 -35.72 62.25 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.683 1.593 . . . . 0.0 113.422 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.0 t80 . . . . . 0 C--O 1.251 1.152 0 C-N-CA 128.341 2.656 . . . . 0.0 114.546 -173.291 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . 0.426 H13A HG21 ' A' ' 141' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.042 0.362 . . . . 0.0 113.042 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.97 135.05 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 C-N-CA 124.468 1.107 . . . . 0.0 108.466 163.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.06 154.71 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.13 1.372 . . . . 0.0 109.662 170.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.4 116.65 32.5 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.534 0.734 . . . . 0.0 109.17 178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.41 177.97 6.93 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.557 0.694 . . . . 0.0 112.474 177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.81 -26.55 68.79 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -173.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.67 -2.1 57.85 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.798 1.239 . . . . 0.0 113.001 175.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.9 3.12 85.87 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.454 1.026 . . . . 0.0 114.133 -175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.75 128.17 35.24 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.826 1.313 . . . . 0.0 109.695 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.6 mmt -77.85 125.5 29.43 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.7 t -125.89 123.39 64.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.077 1.351 . . . . 0.0 108.674 -174.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.56 139.71 38.58 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.18 170.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.1 48.38 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.4 20.87 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.988 0.813 . . . . 0.0 111.217 170.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.53 136.86 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.644 -0.66 . . . . 0.0 111.544 176.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.68 130.0 93.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.11 0.564 . . . . 0.0 111.137 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -52.99 -34.6 67.98 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.894 2.396 . . . . 0.0 113.602 167.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -66.44 -38.03 86.49 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.425 -0.797 . . . . 0.0 112.56 174.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -61.04 -44.26 97.66 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 118.747 0.703 . . . . 0.0 111.337 171.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.54 -44.42 94.24 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.302 0.501 . . . . 0.0 112.256 175.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.12 -47.18 86.21 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.121 0.569 . . . . 0.0 111.396 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.19 95.75 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.667 0.787 . . . . 0.0 111.874 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.28 -46.95 88.04 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.779 0.831 . . . . 0.0 112.811 177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.8 t -56.9 -54.26 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 118.4 0.546 . . . . 0.0 110.368 174.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -59.77 -37.17 78.29 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.412 1.085 . . . . 0.0 113.287 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.41 -52.35 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.206 1.402 . . . . 0.0 111.209 170.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.96 -36.06 76.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 122.958 0.503 . . . . 0.0 111.405 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -58.48 -24.0 59.3 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.48 -25.33 11.44 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 69.0 mmtt -136.23 15.83 3.23 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.352 1.242 . . . . 0.0 114.352 -165.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.9 -37.07 2.67 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -175.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -117.88 13.84 14.11 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.385 1.074 . . . . 0.0 113.151 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.0 p -113.11 153.11 45.46 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.968 0.907 . . . . 0.0 111.474 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.86 -30.87 59.77 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.25 2.633 . . . . 0.0 115.185 -172.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.11 -20.99 64.63 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.52 -32.24 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.396 0.998 . . . . 0.0 112.452 176.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.36 -57.16 6.0 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.726 1.21 . . . . 0.0 112.578 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.88 -29.46 58.31 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.928 1.724 . . . . 0.0 112.764 175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.4 mtm -69.29 -40.09 77.92 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 119.866 1.212 . . . . 0.0 112.661 172.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -57.2 -46.98 82.39 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.873 0.76 . . . . 0.0 111.555 169.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.2 m -60.86 -44.26 97.26 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 175.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.75 -31.65 70.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.248 1.019 . . . . 0.0 113.251 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.85 4.59 52.7 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.436 1.494 . . . . 0.0 113.528 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.9 p -133.13 22.85 4.13 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -176.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.56 120.28 5.96 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.501 168.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.54 60.17 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.377 0.911 . . . . 0.0 115.377 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.48 130.82 46.9 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.565 1.682 . . . . 0.0 112.53 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.28 159.71 84.31 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.699 167.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.6 -35.46 37.64 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.209 1.94 . . . . 0.0 115.39 168.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.98 -40.25 87.39 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.45 -45.22 94.48 Favored 'General case' 0 N--CA 1.471 0.585 0 O-C-N 121.569 -0.707 . . . . 0.0 111.055 172.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.62 -44.21 94.61 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.307 1.043 . . . . 0.0 112.115 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -59.25 -41.47 88.87 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 118.649 0.659 . . . . 0.0 111.965 171.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.9 m -60.25 -45.22 94.03 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.601 0.637 . . . . 0.0 111.066 175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.46 -48.88 77.99 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.196 0.907 . . . . 0.0 112.174 174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.2 mt -63.07 -38.34 90.8 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.99 -33.33 70.57 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.3 p -73.58 -12.72 60.85 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -122.43 7.21 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -174.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.42 -4.06 8.36 Favored Glycine 0 CA--C 1.54 1.635 0 N-CA-C 117.413 1.725 . . . . 0.0 117.413 -176.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.71 -35.2 66.46 Favored Glycine 0 CA--C 1.536 1.344 0 CA-C-N 119.394 1.597 . . . . 0.0 115.17 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -85.94 77.81 9.61 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.006 1.384 . . . . 0.0 110.537 170.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.71 -35.55 31.76 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.663 1.585 . . . . 0.0 115.223 -174.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.48 -41.32 72.88 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 120.129 1.331 . . . . 0.0 112.332 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.63 85.94 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.776 -0.577 . . . . 0.0 111.348 173.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.15 -39.97 96.22 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.548 -0.72 . . . . 0.0 112.22 175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.98 -49.97 74.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.223 1.009 . . . . 0.0 111.569 173.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.96 -45.44 78.87 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.051 0.94 . . . . 0.0 112.212 174.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.6 tp -61.92 -48.77 78.98 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.344 0.657 . . . . 0.0 112.071 176.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.71 -38.27 90.48 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.873 0.869 . . . . 0.0 112.488 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -59.96 -45.58 92.19 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 118.684 0.675 . . . . 0.0 111.966 170.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.2 m -62.54 -42.46 99.54 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.828 0.74 . . . . 0.0 112.155 175.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.6 mt -58.8 -46.1 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.453 -0.78 . . . . 0.0 111.093 174.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.36 93.86 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.847 0.749 . . . . 0.0 112.759 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.93 -47.42 86.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.756 0.822 . . . . 0.0 111.908 174.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.12 -34.3 72.92 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.72 -41.73 91.91 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.447 -0.783 . . . . 0.0 112.328 172.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.78 -41.98 98.41 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.139 0.576 . . . . 0.0 111.817 172.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.17 -42.26 99.37 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.918 -0.489 . . . . 0.0 112.163 174.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.8 -48.47 79.62 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.68 0.673 . . . . 0.0 111.694 173.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -63.13 -30.34 71.51 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.06 -39.09 79.31 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.342 1.057 . . . . 0.0 112.482 173.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.32 -27.57 42.13 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.796 1.239 . . . . 0.0 113.325 176.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.74 60.97 53.77 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.653 1.981 . . . . 0.0 111.274 -174.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.86 120.13 7.41 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.483 2.122 . . . . 0.0 110.323 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.294 1.438 . . . . 0.0 112.115 -169.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -80.2 160.52 25.6 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.07 0.548 . . . . 0.0 110.857 168.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.19 -20.02 65.03 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.7 41.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.096 1.332 . . . . 0.0 112.631 174.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.52 169.2 14.66 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.624 2.883 . . . . 0.0 112.917 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.66 -39.19 68.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.874 1.27 . . . . 0.0 111.791 -175.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.94 28.52 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -47.93 133.38 22.92 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.441 2.761 . . . . 0.0 113.163 168.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.95 -14.95 60.55 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 124.648 1.118 . . . . 0.0 115.042 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.38 37.44 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.952 1.376 . . . . 0.0 110.198 173.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.64 54.14 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.726 -0.608 . . . . 0.0 110.793 168.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -68.64 152.77 44.91 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.648 0.779 . . . . 0.0 111.618 171.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.26 131.72 84.81 Favored Pre-proline 0 CA--C 1.547 0.852 0 CA-C-O 118.888 -0.577 . . . . 0.0 109.831 170.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.4 140.32 43.71 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.063 1.842 . . . . 0.0 112.442 -177.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 70.7 mtp85 -74.94 171.61 13.76 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.8 1.64 . . . . 0.0 111.817 163.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.61 -43.86 94.12 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 121.913 -0.492 . . . . 0.0 112.979 168.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.75 -25.88 64.96 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.71 -41.53 65.13 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.076 -1.015 . . . . 0.0 111.778 171.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.73 -42.63 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.719 0.807 . . . . 0.0 110.812 173.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.02 -1.29 14.12 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 173.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.03 18.13 74.33 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.929 -1.107 . . . . 0.0 115.445 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.25 -19.42 19.31 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 119.073 1.436 . . . . 0.0 113.289 -178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.2 -1.58 7.02 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 177.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.57 150.04 24.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.067 0.947 . . . . 0.0 111.773 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.4 p -81.95 162.44 22.7 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.321 0.582 . . . . 0.0 110.797 170.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.88 -39.36 74.23 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.414 -0.804 . . . . 0.0 111.445 169.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.62 -38.84 92.65 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.557 -0.715 . . . . 0.0 112.635 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.6 mt-10 -64.62 -42.8 95.27 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.628 -0.67 . . . . 0.0 112.033 171.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.61 -46.46 90.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.648 0.779 . . . . 0.0 112.097 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.38 -46.39 92.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.142 0.977 . . . . 0.0 110.317 172.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.42 -51.01 54.42 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.806 0.717 . . . . 0.0 112.945 177.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.3 -50.09 73.04 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.751 0.776 . . . . 0.0 112.48 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.0 p -111.93 8.43 20.32 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.637 1.175 . . . . 0.0 113.027 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.46 162.34 1.61 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.939 1.295 . . . . 0.0 111.434 165.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.63 103.35 48.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.054 0.942 . . . . 0.0 110.758 176.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.79 89.26 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.451 0.84 . . . . 0.0 111.701 -6.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -49.98 141.37 29.62 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.176 2.584 . . . . 0.0 114.168 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.12 96.53 2.51 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -86.03 54.54 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.232 2.621 . . . . 0.0 112.882 -152.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.54 -34.86 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.46 -46.2 94.31 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.605 0.639 . . . . 0.0 112.947 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.86 -36.9 75.9 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.259 -1.142 . . . . 0.0 112.645 178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.88 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.785 -0.572 . . . . 0.0 109.98 173.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.44 91.68 Favored 'General case' 0 CA--C 1.538 0.511 0 O-C-N 121.356 -0.84 . . . . 0.0 112.576 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -55.78 -41.99 74.88 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.468 -0.77 . . . . 0.0 112.287 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.71 -45.24 81.98 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.888 0.767 . . . . 0.0 112.134 174.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.26 -40.59 86.24 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.308 0.643 . . . . 0.0 112.251 178.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.55 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.083 0.553 . . . . 0.0 110.261 174.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.13 -37.33 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.72 1.208 . . . . 0.0 112.322 177.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.82 98.32 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.047 0.84 . . . . 0.0 111.275 171.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.05 91.66 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.847 0.737 . . . . 0.0 113.242 175.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.4 -42.47 87.2 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.954 0.877 . . . . 0.0 111.032 173.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.48 -50.21 70.48 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.811 0.844 . . . . 0.0 112.45 173.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -55.79 -43.42 76.81 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 118.853 0.751 . . . . 0.0 111.956 175.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.43 -47.68 88.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.406 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.67 -32.89 54.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 CA-C-N 119.992 1.269 . . . . 0.0 112.907 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 54.9 mtp180 -60.43 -45.36 93.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.899 0.88 . . . . 0.0 111.5 171.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.3 ttp -74.51 -38.24 62.88 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.597 1.559 . . . . 0.0 113.336 -177.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 8.3 t80 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 128.483 2.713 . . . . 0.0 114.671 -172.571 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 N--CA 1.479 0.666 0 N-CA-C 112.965 0.333 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.22 134.86 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.46 1.104 . . . . 0.0 108.451 163.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.91 154.92 35.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.136 1.374 . . . . 0.0 109.665 170.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.67 116.72 32.53 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.48 0.712 . . . . 0.0 109.171 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.43 177.97 6.95 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.514 0.673 . . . . 0.0 112.511 177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.87 -26.49 68.8 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.56 -2.24 57.94 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.825 1.25 . . . . 0.0 113.024 175.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.07 2.94 85.6 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 124.467 1.032 . . . . 0.0 114.142 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.74 128.29 35.73 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.815 1.308 . . . . 0.0 109.7 174.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.69 29.73 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 168.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -126.01 123.4 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.066 1.347 . . . . 0.0 108.648 -174.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.68 139.68 38.46 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.572 0.701 . . . . 0.0 111.21 170.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.64 141.17 48.52 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.488 1.915 . . . . 0.0 107.922 169.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.17 152.31 20.77 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.977 0.808 . . . . 0.0 111.237 170.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.62 136.83 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 121.651 -0.656 . . . . 0.0 111.571 176.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.59 129.98 93.32 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.167 0.587 . . . . 0.0 111.157 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.07 -34.57 68.66 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 122.86 2.373 . . . . 0.0 113.543 167.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.39 -38.13 86.81 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.475 -0.765 . . . . 0.0 112.55 174.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.88 -44.4 97.12 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.728 0.695 . . . . 0.0 111.383 171.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.45 -44.42 94.55 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.251 0.478 . . . . 0.0 112.211 175.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.12 -47.25 85.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.087 0.555 . . . . 0.0 111.441 176.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.1 -45.19 95.73 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.633 0.773 . . . . 0.0 111.892 176.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -59.98 -47.53 85.43 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.806 0.842 . . . . 0.0 112.729 176.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.7 t -56.85 -54.13 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 CA-C-N 118.408 0.549 . . . . 0.0 110.493 174.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.72 -37.36 78.68 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.344 1.058 . . . . 0.0 113.214 -179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.414 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -58.24 -52.11 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.917 1.287 . . . . 0.0 111.345 170.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.3 t -64.19 -35.98 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 122.948 0.499 . . . . 0.0 111.336 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.66 -23.45 59.25 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.98 -25.72 11.04 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -135.87 16.03 3.31 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.46 -37.83 2.57 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 116.431 2.011 . . . . 0.0 116.431 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -117.86 14.56 14.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.374 1.07 . . . . 0.0 113.141 -172.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.5 p -113.64 152.95 45.89 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.008 0.923 . . . . 0.0 111.513 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.85 -30.81 59.43 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.216 2.61 . . . . 0.0 115.249 -172.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -62.06 -20.93 64.5 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.54 -32.19 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.424 1.011 . . . . 0.0 112.482 176.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.7 mt -70.36 -57.2 5.97 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.76 1.224 . . . . 0.0 112.561 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.81 -29.57 58.95 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.859 1.699 . . . . 0.0 112.793 175.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.414 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.25 -40.07 78.08 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.838 1.199 . . . . 0.0 112.733 172.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -57.15 -47.08 82.05 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.877 0.762 . . . . 0.0 111.507 169.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.3 m -60.79 -44.24 97.07 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 175.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.81 -31.65 71.05 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.233 1.013 . . . . 0.0 113.264 178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.8 4.59 52.75 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.389 1.476 . . . . 0.0 113.514 -178.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.7 p -133.1 22.79 4.13 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.54 120.23 5.87 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.49 -1.381 . . . . 0.0 111.491 168.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.64 11.59 60.3 Favored Glycine 0 CA--C 1.536 1.383 0 N-CA-C 115.367 0.907 . . . . 0.0 115.367 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.49 131.04 47.83 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.567 1.683 . . . . 0.0 112.487 -178.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 42.7 p -73.47 159.81 83.85 Favored Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 123.667 0.787 . . . . 0.0 110.722 167.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.63 -35.35 37.62 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.161 1.908 . . . . 0.0 115.429 168.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.1 -40.24 86.89 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 174.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -60.26 -45.35 93.59 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 121.66 -0.65 . . . . 0.0 111.089 172.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.62 -44.27 94.43 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.328 1.051 . . . . 0.0 112.146 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.3 m-20 -59.18 -41.43 88.44 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.672 -0.642 . . . . 0.0 112.03 171.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.6 m -60.25 -45.25 93.91 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 118.561 0.619 . . . . 0.0 111.059 175.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.47 -48.86 78.08 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.196 0.907 . . . . 0.0 112.16 174.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.18 -38.13 89.97 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.11 -32.82 70.18 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.3 p -74.14 -12.29 60.55 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.0 m -122.11 8.28 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 114.112 1.152 . . . . 0.0 114.112 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.81 -3.78 11.77 Favored Glycine 0 CA--C 1.542 1.743 0 N-CA-C 117.446 1.739 . . . . 0.0 117.446 -175.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -57.32 -32.79 64.32 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 119.556 1.678 . . . . 0.0 115.279 -177.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -89.75 77.36 7.08 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-O 123.06 1.409 . . . . 0.0 110.481 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.33 -35.08 26.12 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.859 1.664 . . . . 0.0 115.416 -174.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.9 -40.9 75.36 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 120.159 1.345 . . . . 0.0 112.312 -179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.64 -43.45 84.64 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.158 0.583 . . . . 0.0 111.366 173.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.14 -40.13 96.68 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.494 -0.754 . . . . 0.0 112.246 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.83 74.6 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.257 1.023 . . . . 0.0 111.541 173.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.04 -45.5 79.19 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.092 0.957 . . . . 0.0 112.189 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.3 tp -61.85 -48.77 79.05 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 123.332 0.653 . . . . 0.0 112.08 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.79 -38.18 90.15 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.861 0.865 . . . . 0.0 112.483 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -60.01 -45.52 92.5 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.664 0.665 . . . . 0.0 112.034 170.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.2 m -62.54 -42.47 99.55 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 118.792 0.724 . . . . 0.0 112.105 175.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.81 -46.14 91.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.491 -0.755 . . . . 0.0 111.077 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.1 -39.45 94.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.819 0.736 . . . . 0.0 112.717 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.7 mt-10 -60.83 -47.36 86.69 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.77 0.828 . . . . 0.0 111.98 174.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.17 -34.3 72.83 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.56 91.79 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.451 -0.781 . . . . 0.0 112.371 172.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.85 -42.04 98.56 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.202 0.601 . . . . 0.0 111.832 172.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.09 -42.27 99.57 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 121.905 -0.497 . . . . 0.0 112.221 174.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.8 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.615 0.643 . . . . 0.0 111.649 173.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.03 -30.31 71.5 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.14 -39.1 79.05 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.324 1.05 . . . . 0.0 112.52 173.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.17 -27.66 42.67 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.785 1.234 . . . . 0.0 113.307 176.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -132.78 61.03 54.11 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.646 1.978 . . . . 0.0 111.276 -174.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.92 120.16 7.44 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.48 2.12 . . . . 0.0 110.277 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.23 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 C-N-CA 125.363 1.465 . . . . 0.0 112.151 -169.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.98 160.37 25.94 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.13 0.572 . . . . 0.0 110.861 168.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.15 -20.03 65.02 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 174.77 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.048 1.309 . . . . 0.0 112.656 174.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.55 169.17 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.66 2.907 . . . . 0.0 112.93 177.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.62 -39.2 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 124.867 1.267 . . . . 0.0 111.841 -175.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.62 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.884 1.674 . . . . 0.0 110.631 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -47.91 133.41 22.87 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.456 2.77 . . . . 0.0 113.116 168.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.99 -15.04 60.37 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 124.562 1.077 . . . . 0.0 115.013 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -78.09 143.41 37.39 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.928 1.364 . . . . 0.0 110.218 173.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.51 54.2 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 121.726 -0.608 . . . . 0.0 110.826 168.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.7 ptt85 -68.55 152.89 44.74 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 123.694 0.798 . . . . 0.0 111.669 171.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -72.3 131.69 84.77 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.917 -0.563 . . . . 0.0 109.858 170.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.33 140.41 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.11 1.873 . . . . 0.0 112.451 -177.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.2 mtp85 -75.19 171.67 13.76 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.72 1.608 . . . . 0.0 111.862 163.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.51 -43.93 93.93 Favored Glycine 0 CA--C 1.535 1.313 0 O-C-N 121.968 -0.458 . . . . 0.0 113.006 168.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.4 p -68.83 -25.77 64.83 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.67 -41.65 65.13 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.064 -1.022 . . . . 0.0 111.765 171.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.0 mt -62.65 -42.72 97.15 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.712 0.805 . . . . 0.0 110.801 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.3 14.11 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.13 74.17 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.626 1.107 . . . . 0.0 115.458 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.6 p -96.22 -19.43 19.33 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 119.09 1.445 . . . . 0.0 113.255 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.2 p -126.16 -1.5 7.05 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.4 p -103.64 149.8 24.6 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.034 0.934 . . . . 0.0 111.778 173.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 44.1 p -81.68 162.34 23.06 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.341 0.591 . . . . 0.0 110.775 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.72 -39.44 73.91 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.448 -0.783 . . . . 0.0 111.429 169.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.51 -39.01 93.32 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 121.531 -0.731 . . . . 0.0 112.636 179.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -64.6 -42.65 95.42 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 121.637 -0.665 . . . . 0.0 112.045 171.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.72 -46.42 90.48 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.652 0.781 . . . . 0.0 112.119 176.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.42 -46.35 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.12 0.968 . . . . 0.0 110.301 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.07 54.18 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 123.806 0.717 . . . . 0.0 112.889 177.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.24 -50.09 73.12 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.831 0.816 . . . . 0.0 112.48 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.2 mtp -68.62 -18.52 64.32 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -176.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.92 8.41 20.33 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.665 1.186 . . . . 0.0 113.072 178.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.42 162.3 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.971 1.309 . . . . 0.0 111.461 165.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.32 48.97 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -76.15 163.8 89.21 Favored 'Cis proline' 0 CA--C 1.544 1.021 0 CA-C-N 119.466 0.845 . . . . 0.0 111.735 -6.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_exo -49.93 141.34 29.28 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.184 2.59 . . . . 0.0 114.207 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.21 96.44 2.51 Favored Pre-proline 0 CA--C 1.542 0.664 0 N-CA-C 104.815 -2.291 . . . . 0.0 104.815 163.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.97 54.67 3.51 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.65 -34.84 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.101 1.149 . . . . 0.0 114.101 -173.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.4 -46.24 94.25 Favored Glycine 0 CA--C 1.533 1.161 0 CA-C-N 118.656 0.662 . . . . 0.0 112.991 173.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -69.73 -36.98 76.32 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.281 -1.129 . . . . 0.0 112.609 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.93 -44.6 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.762 -0.586 . . . . 0.0 109.949 174.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.85 -40.37 91.64 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.352 -0.842 . . . . 0.0 112.543 176.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.04 75.12 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 121.455 -0.778 . . . . 0.0 112.243 173.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -56.7 -45.17 81.99 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.933 0.788 . . . . 0.0 112.098 174.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.33 -40.55 85.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.29 0.636 . . . . 0.0 112.251 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.69 -46.94 95.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.062 0.545 . . . . 0.0 110.321 174.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.34 -37.31 78.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.688 1.195 . . . . 0.0 112.314 177.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.81 98.3 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.019 0.827 . . . . 0.0 111.223 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.11 91.4 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.796 0.712 . . . . 0.0 113.265 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.49 -42.24 87.15 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.01 0.905 . . . . 0.0 111.092 173.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.39 -50.25 70.22 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.766 0.826 . . . . 0.0 112.461 173.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.93 -43.1 77.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.823 0.738 . . . . 0.0 112.011 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.44 -48.13 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-O 118.721 -0.656 . . . . 0.0 111.372 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -69.38 -32.83 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 CA-C-N 119.973 1.261 . . . . 0.0 112.89 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.95 -42.79 94.8 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.931 0.892 . . . . 0.0 111.552 171.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.0 ttp -79.02 -35.65 42.4 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.718 1.607 . . . . 0.0 113.704 -176.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 6.8 t80 . . . . . 0 N--CA 1.483 1.177 0 C-N-CA 128.383 2.673 . . . . 0.0 114.513 -172.013 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo . . . . . 0 N--CA 1.479 0.656 0 N-CA-C 112.952 0.328 . . . . 0.0 112.952 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.89 135.17 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 124.48 1.112 . . . . 0.0 108.438 163.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.12 154.89 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.113 1.365 . . . . 0.0 109.698 170.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.62 116.71 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.522 0.729 . . . . 0.0 109.128 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -76.57 177.73 7.23 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.604 0.716 . . . . 0.0 112.408 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.53 -26.53 68.61 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -173.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 mp0 -85.64 -2.22 57.96 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.76 1.224 . . . . 0.0 113.037 175.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.99 3.13 85.65 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.53 1.062 . . . . 0.0 114.049 -175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.71 128.19 35.33 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.877 1.338 . . . . 0.0 109.726 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.6 29.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 168.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.3 t -125.99 123.42 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.045 1.338 . . . . 0.0 108.674 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -78.56 139.65 38.59 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.52 0.676 . . . . 0.0 111.222 170.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -132.61 141.06 48.49 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.476 1.91 . . . . 0.0 107.909 169.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.18 152.34 20.76 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.974 0.806 . . . . 0.0 111.244 170.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.54 136.86 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 CA-C-O 121.492 0.663 . . . . 0.0 111.575 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.68 129.96 93.23 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 123.112 0.565 . . . . 0.0 111.18 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -52.91 -34.69 67.57 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 122.865 2.377 . . . . 0.0 113.589 167.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -66.33 -38.14 86.99 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.419 -0.801 . . . . 0.0 112.572 174.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.91 -44.39 97.24 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.749 0.704 . . . . 0.0 111.359 171.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.43 -44.48 94.46 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.29 0.495 . . . . 0.0 112.275 175.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.05 -47.25 85.91 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.113 0.565 . . . . 0.0 111.42 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.19 -44.99 96.41 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.614 0.766 . . . . 0.0 111.914 176.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.1 t-105 -60.14 -47.47 85.77 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.828 0.851 . . . . 0.0 112.754 176.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.4 t -56.74 -54.15 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-N 118.392 0.542 . . . . 0.0 110.418 174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.79 -37.38 78.94 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.3 1.04 . . . . 0.0 113.227 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.409 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.85 -52.09 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 125.035 1.334 . . . . 0.0 111.278 170.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.6 -35.96 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 122.99 0.516 . . . . 0.0 111.362 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -58.61 -23.43 58.85 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 175.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -108.06 -25.48 11.11 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -136.07 15.67 3.28 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -166.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.41 -37.53 2.37 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -175.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -117.73 14.45 14.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.436 1.095 . . . . 0.0 113.093 -172.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.8 p -113.92 152.96 46.14 Favored Pre-proline 0 CA--C 1.54 0.587 0 C-N-CA 124.078 0.951 . . . . 0.0 111.659 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.84 -31.17 60.96 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.287 2.658 . . . . 0.0 115.292 -172.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -61.69 -21.01 64.09 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 114.268 1.211 . . . . 0.0 114.268 -177.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.33 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 119.387 0.994 . . . . 0.0 112.472 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.33 -57.12 6.07 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.717 1.207 . . . . 0.0 112.633 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -64.78 -29.61 59.2 Favored 'Trans proline' 0 C--N 1.351 0.709 0 CA-C-N 121.901 1.715 . . . . 0.0 112.783 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.409 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.4 mtm -69.18 -40.21 78.25 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.809 1.186 . . . . 0.0 112.683 172.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -57.04 -46.85 82.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 118.836 0.744 . . . . 0.0 111.544 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -61.03 -44.43 97.41 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.368 0.667 . . . . 0.0 112.784 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.57 -31.64 70.76 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.242 1.017 . . . . 0.0 113.26 178.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.87 4.88 52.44 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.384 1.474 . . . . 0.0 113.523 -178.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 92.8 p -133.46 22.8 4.02 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -176.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.3 mm-40 -53.41 120.36 5.97 Favored 'General case' 0 N--CA 1.473 0.698 0 O-C-N 120.468 -1.395 . . . . 0.0 111.48 168.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.4 11.6 59.71 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.46 130.84 47.01 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.517 1.659 . . . . 0.0 112.449 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.5 p -73.45 159.55 84.48 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 123.701 0.801 . . . . 0.0 110.65 167.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -49.58 -35.52 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.198 1.932 . . . . 0.0 115.388 168.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -66.84 -40.43 87.94 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 174.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 -60.21 -45.31 93.62 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.64 -0.663 . . . . 0.0 111.049 172.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.0 mt -63.58 -44.29 94.48 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.288 1.035 . . . . 0.0 112.164 179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.9 m-20 -59.19 -41.4 88.4 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.578 0.626 . . . . 0.0 112.05 171.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.3 m -60.24 -45.19 94.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.55 0.614 . . . . 0.0 111.161 175.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.2 mtp -57.41 -48.88 77.92 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 119.196 0.907 . . . . 0.0 112.185 174.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.6 mt -63.12 -38.46 91.28 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -58.78 -33.03 69.85 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 177.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.4 p -73.87 -12.47 60.68 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.34 7.8 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -173.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.02 -3.7 9.3 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 117.506 1.762 . . . . 0.0 117.506 -176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.98 -34.08 65.07 Favored Glycine 0 CA--C 1.536 1.356 0 CA-C-N 119.501 1.651 . . . . 0.0 115.226 -178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -88.27 77.45 8.22 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.062 1.411 . . . . 0.0 110.485 171.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -50.36 -35.3 27.36 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.826 1.65 . . . . 0.0 115.341 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -69.94 -41.24 74.82 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 120.118 1.327 . . . . 0.0 112.249 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.39 -43.53 85.62 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 123.128 0.571 . . . . 0.0 111.35 173.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.07 -40.16 96.86 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.592 -0.692 . . . . 0.0 112.271 175.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.93 -50.12 73.54 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.262 1.025 . . . . 0.0 111.539 173.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -55.77 -45.4 78.13 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.067 0.947 . . . . 0.0 112.241 174.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.3 tp -61.98 -48.71 79.13 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.363 0.665 . . . . 0.0 112.064 176.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.73 -38.23 90.32 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.857 0.863 . . . . 0.0 112.514 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -60.12 -45.52 92.71 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 118.623 0.647 . . . . 0.0 112.058 170.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.62 -42.34 99.53 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 118.768 0.713 . . . . 0.0 112.186 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.9 mt -58.83 -46.0 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 O-C-N 121.462 -0.774 . . . . 0.0 111.051 174.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -64.17 -39.55 94.23 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 118.776 0.716 . . . . 0.0 112.738 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -60.55 -47.66 85.21 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.739 0.816 . . . . 0.0 111.968 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -70.0 -34.33 73.19 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.855 0.687 . . . . 0.0 112.855 179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.75 -41.53 92.02 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.44 -0.787 . . . . 0.0 112.391 172.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.85 98.25 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.123 0.569 . . . . 0.0 111.781 172.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -63.58 -42.11 98.31 Favored 'General case' 0 CA--C 1.536 0.405 0 O-C-N 121.856 -0.528 . . . . 0.0 112.182 175.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.67 -48.51 79.3 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.564 0.62 . . . . 0.0 111.744 172.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -63.28 -30.07 71.28 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.6 ttp85 -69.28 -39.1 78.56 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.363 1.065 . . . . 0.0 112.432 173.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.2 -27.77 42.59 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.796 1.239 . . . . 0.0 113.337 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -132.62 61.03 54.4 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.635 1.974 . . . . 0.0 111.216 -174.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.91 120.14 7.42 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.424 2.083 . . . . 0.0 110.315 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.44 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.292 1.437 . . . . 0.0 112.158 -169.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -80.1 160.39 25.78 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.174 0.59 . . . . 0.0 110.894 168.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.17 -19.88 64.9 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -166.11 174.7 41.71 Favored Glycine 0 CA--C 1.537 1.424 0 C-N-CA 125.048 1.309 . . . . 0.0 112.606 174.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -66.55 169.17 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.631 2.887 . . . . 0.0 112.906 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.69 -39.0 67.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.874 1.269 . . . . 0.0 111.785 -175.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.71 161.83 28.75 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.888 1.675 . . . . 0.0 110.592 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -47.93 133.46 22.94 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.479 2.786 . . . . 0.0 113.098 168.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.89 -14.97 60.41 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.566 1.079 . . . . 0.0 115.062 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.2 143.45 37.16 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.95 1.375 . . . . 0.0 110.164 173.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.3 145.63 54.04 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.742 -0.599 . . . . 0.0 110.869 168.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 36.8 ptt85 -68.49 152.5 45.3 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.76 0.824 . . . . 0.0 111.615 171.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -72.25 131.64 84.91 Favored Pre-proline 0 CA--C 1.546 0.827 0 CA-C-O 118.898 -0.572 . . . . 0.0 109.814 170.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.49 140.23 43.17 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 122.062 1.841 . . . . 0.0 112.401 -176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -74.8 171.28 14.26 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.773 1.629 . . . . 0.0 111.891 163.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.46 -43.81 93.88 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 123.33 0.491 . . . . 0.0 113.035 168.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 25.3 p -68.71 -25.73 64.91 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 175.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -72.97 -41.44 64.38 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.034 -1.041 . . . . 0.0 111.78 172.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.4 mt -62.69 -42.84 97.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.839 0.856 . . . . 0.0 110.761 172.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.82 -1.52 14.41 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 173.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.11 18.15 74.49 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.922 -1.111 . . . . 0.0 115.406 175.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.9 p -96.02 -19.31 19.56 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 119.067 1.433 . . . . 0.0 113.287 -178.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 62.9 p -126.62 -1.69 6.75 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.1 p -103.25 150.38 23.78 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.164 0.986 . . . . 0.0 111.554 173.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 34.2 p -82.48 162.61 22.0 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.342 0.591 . . . . 0.0 110.781 169.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.6 tp -56.57 -39.54 73.66 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.501 -0.749 . . . . 0.0 111.541 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.45 -38.95 93.12 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.454 -0.779 . . . . 0.0 112.666 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -64.71 -42.69 95.09 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.612 -0.68 . . . . 0.0 111.988 171.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -60.58 -46.35 90.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.678 0.791 . . . . 0.0 112.097 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.64 -46.16 93.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.167 0.987 . . . . 0.0 110.312 172.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.62 -50.98 55.39 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 123.852 0.739 . . . . 0.0 112.876 177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.35 -50.04 73.16 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 117.74 0.77 . . . . 0.0 112.532 174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.6 64.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 39.1 p -111.83 8.32 20.44 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.677 1.191 . . . . 0.0 113.033 178.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.3 162.31 1.53 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.045 1.338 . . . . 0.0 111.451 165.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.64 103.32 48.83 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.046 0.938 . . . . 0.0 110.778 176.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -76.1 163.81 89.21 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.466 0.845 . . . . 0.0 111.713 -6.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -49.93 141.38 29.26 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.199 2.6 . . . . 0.0 114.186 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.25 96.42 2.51 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 163.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.02 54.59 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.255 2.637 . . . . 0.0 112.852 -152.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.52 -35.11 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 -173.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -61.91 -46.57 93.85 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 118.595 0.634 . . . . 0.0 113.031 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -69.88 -36.69 75.66 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 121.281 -1.129 . . . . 0.0 112.636 178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.3 mt -62.94 -44.66 99.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.757 -0.589 . . . . 0.0 109.902 173.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -65.81 -40.37 91.78 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.265 -0.897 . . . . 0.0 112.497 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -55.89 -42.04 75.37 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.472 -0.767 . . . . 0.0 112.232 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.7 -45.22 81.93 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.892 0.769 . . . . 0.0 112.134 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.25 -40.66 86.3 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.242 178.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.55 -47.05 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.041 0.536 . . . . 0.0 110.283 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.33 -37.27 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.672 1.189 . . . . 0.0 112.261 177.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.86 -42.76 98.51 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.027 0.83 . . . . 0.0 111.235 171.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.49 -45.26 90.84 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 123.863 0.744 . . . . 0.0 113.176 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.41 -42.34 86.97 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 118.039 0.919 . . . . 0.0 111.112 173.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -55.34 -50.2 70.26 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.815 0.846 . . . . 0.0 112.473 173.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -55.95 -43.16 77.19 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 118.865 0.757 . . . . 0.0 111.971 175.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.3 mt -64.44 -48.06 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 C-N-CA 123.338 0.655 . . . . 0.0 111.448 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.52 -32.69 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.916 1.235 . . . . 0.0 112.952 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -60.3 -43.91 95.88 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.901 0.88 . . . . 0.0 111.498 171.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.7 ttp -76.99 -37.1 55.8 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.66 1.584 . . . . 0.0 113.48 -176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.4 t80 . . . . . 0 C--O 1.252 1.192 0 C-N-CA 128.377 2.671 . . . . 0.0 114.48 -172.057 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.2 mm -91.82 135.0 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.467 1.107 . . . . 0.0 108.402 163.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -125.99 154.92 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.686 170.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.62 116.68 32.48 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.57 0.748 . . . . 0.0 109.18 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.47 178.07 6.9 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.58 0.705 . . . . 0.0 112.451 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.95 -26.45 68.83 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.59 -2.19 57.9 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.776 1.231 . . . . 0.0 113.0 175.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.02 85.69 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.76 128.28 35.67 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.823 1.311 . . . . 0.0 109.745 174.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.89 125.62 29.62 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 168.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.99 123.4 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.07 1.348 . . . . 0.0 108.629 -174.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.7 38.54 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.71 141.15 48.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.5 1.92 . . . . 0.0 107.929 169.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 21.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.998 0.817 . . . . 0.0 111.191 170.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.53 136.84 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.607 -0.683 . . . . 0.0 111.544 176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.64 130.03 93.25 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.059 0.544 . . . . 0.0 111.169 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.09 -34.5 68.53 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.86 2.373 . . . . 0.0 113.575 167.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.53 -38.04 86.32 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 121.508 -0.745 . . . . 0.0 112.562 174.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.91 -44.31 97.34 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.767 0.712 . . . . 0.0 111.377 171.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.7 mt -63.53 -44.33 94.55 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 118.328 0.513 . . . . 0.0 112.321 175.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.17 -47.33 85.72 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.136 0.574 . . . . 0.0 111.359 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.0 -45.35 95.19 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.644 0.778 . . . . 0.0 111.883 176.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.7 t-105 -60.02 -47.42 85.93 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.855 0.862 . . . . 0.0 112.763 177.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.9 t -56.68 -55.0 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 118.465 0.575 . . . . 0.0 110.273 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.04 -37.82 77.89 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.396 1.079 . . . . 0.0 113.243 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.41 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.33 -51.9 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.031 1.332 . . . . 0.0 111.329 170.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.65 -35.88 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 118.989 -0.529 . . . . 0.0 111.435 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -58.98 -23.1 61.44 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 119.707 1.139 . . . . 0.0 114.038 174.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.73 -25.94 11.05 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -135.86 16.3 3.31 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -166.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.53 -37.68 2.57 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -118.25 14.73 13.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.392 1.077 . . . . 0.0 113.149 -172.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -113.93 152.94 46.13 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 124.01 0.924 . . . . 0.0 111.566 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.85 -30.75 59.21 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.257 2.638 . . . . 0.0 115.276 -172.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.05 -20.67 64.2 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 -177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.82 -31.97 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.376 0.989 . . . . 0.0 112.528 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.1 mt -71.34 -55.08 6.35 Favored Pre-proline 0 CA--C 1.543 0.709 0 C-N-CA 124.943 1.297 . . . . 0.0 112.961 -178.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.83 -30.12 49.72 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.688 1.639 . . . . 0.0 112.661 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.41 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.6 mtm -69.06 -40.22 78.64 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.86 1.209 . . . . 0.0 112.623 172.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.23 -46.53 82.87 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.816 0.735 . . . . 0.0 111.581 169.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.7 m -61.01 -44.52 97.3 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 175.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.82 -32.09 71.47 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.255 1.022 . . . . 0.0 113.207 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.29 4.44 53.47 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.39 1.476 . . . . 0.0 113.522 -178.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.4 p -132.98 22.83 4.18 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.62 120.3 6.0 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.47 -1.394 . . . . 0.0 111.491 168.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.54 60.16 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -177.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.42 130.84 47.06 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.565 1.682 . . . . 0.0 112.499 -178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.39 159.69 84.21 Favored Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 123.714 0.806 . . . . 0.0 110.661 167.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.28 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -60.4 -45.29 94.11 Favored 'General case' 0 N--CA 1.472 0.626 0 O-C-N 121.663 -0.648 . . . . 0.0 111.025 172.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.51 -44.34 94.57 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.35 1.06 . . . . 0.0 112.103 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -59.11 -41.58 88.5 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.635 0.652 . . . . 0.0 111.994 171.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.13 -45.31 93.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.594 0.633 . . . . 0.0 111.084 175.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.43 -48.81 78.15 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 119.209 0.913 . . . . 0.0 112.188 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.18 -38.27 90.53 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.98 -33.63 70.9 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -73.29 -12.76 60.96 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.8 m -121.15 9.21 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -174.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -62.23 -5.51 8.22 Favored Glycine 0 CA--C 1.541 1.712 0 N-CA-C 117.328 1.691 . . . . 0.0 117.328 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.36 -31.3 59.55 Favored Glycine 0 CA--C 1.537 1.432 0 CA-C-N 119.336 1.568 . . . . 0.0 115.563 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -93.61 78.12 4.32 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.003 1.402 . . . . 0.0 110.652 172.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -50.79 -35.78 33.68 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 -173.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.05 -41.02 74.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.123 1.328 . . . . 0.0 112.246 -179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.5 -43.5 85.14 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.164 0.585 . . . . 0.0 111.371 173.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.7 tpp -63.06 -40.14 96.82 Favored 'General case' 0 CA--C 1.541 0.61 0 O-C-N 121.521 -0.737 . . . . 0.0 112.263 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.99 -49.93 74.24 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.235 1.014 . . . . 0.0 111.521 173.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.02 -45.47 79.09 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.091 0.956 . . . . 0.0 112.188 174.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.7 tp -61.91 -48.72 79.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.277 0.631 . . . . 0.0 112.088 176.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.7 -38.28 90.52 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.876 0.87 . . . . 0.0 112.479 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.99 -45.49 92.54 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 112.02 170.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.6 m -62.61 -42.38 99.55 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.848 0.749 . . . . 0.0 112.149 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.9 -46.04 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 O-C-N 121.472 -0.768 . . . . 0.0 111.097 174.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.49 94.13 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 118.876 0.762 . . . . 0.0 112.684 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -60.78 -47.39 86.53 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.741 0.816 . . . . 0.0 111.94 174.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.13 -34.35 72.94 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.84 -41.53 91.62 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 121.484 -0.76 . . . . 0.0 112.322 173.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.11 98.61 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.224 0.61 . . . . 0.0 111.781 172.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.17 -42.11 99.33 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.84 -0.538 . . . . 0.0 112.207 174.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -57.88 -48.55 79.52 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.673 0.67 . . . . 0.0 111.694 173.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.01 -30.35 71.53 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.11 -39.06 79.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.354 1.062 . . . . 0.0 112.482 173.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.79 60.98 53.75 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.85 120.1 7.36 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.451 2.101 . . . . 0.0 110.341 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.29 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 125.351 1.461 . . . . 0.0 112.142 -169.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.7 m170 -80.0 160.47 25.88 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.053 0.541 . . . . 0.0 110.903 168.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.91 65.0 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.74 41.6 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 125.096 1.332 . . . . 0.0 112.631 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.56 169.2 14.73 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.601 2.867 . . . . 0.0 112.917 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.66 -39.2 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.904 1.282 . . . . 0.0 111.753 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.48 161.89 28.61 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.843 1.657 . . . . 0.0 110.585 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -47.94 133.42 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.479 2.786 . . . . 0.0 113.106 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.93 -14.96 60.48 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.567 1.08 . . . . 0.0 115.037 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.13 143.32 37.4 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.95 1.375 . . . . 0.0 110.214 173.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.11 145.48 54.35 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.654 -0.654 . . . . 0.0 110.843 168.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.47 152.82 44.86 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.27 131.69 84.83 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.916 -0.564 . . . . 0.0 109.872 170.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.35 140.36 44.03 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.107 1.871 . . . . 0.0 112.435 -177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.0 mtp85 -75.14 171.65 13.76 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.705 1.602 . . . . 0.0 111.805 163.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.6 -43.78 94.15 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.916 -0.49 . . . . 0.0 113.035 168.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.89 -25.78 64.78 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 175.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.65 65.03 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.989 -1.069 . . . . 0.0 111.749 171.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.65 -42.7 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.686 0.794 . . . . 0.0 110.812 173.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.06 -1.26 14.09 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 173.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.23 74.26 Favored Glycine 0 CA--C 1.535 1.288 0 O-C-N 120.865 -1.147 . . . . 0.0 115.444 174.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.31 -19.5 19.21 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.079 1.439 . . . . 0.0 113.263 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.2 p -126.13 -1.28 7.08 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.76 149.84 24.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.08 0.952 . . . . 0.0 111.789 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.5 p -81.81 162.32 22.91 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.288 0.566 . . . . 0.0 110.73 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.81 -39.37 74.04 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.529 -0.732 . . . . 0.0 111.438 169.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.5 -38.99 93.24 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.576 -0.702 . . . . 0.0 112.675 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.6 95.45 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.573 -0.705 . . . . 0.0 112.085 171.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.77 -46.47 90.36 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.626 0.77 . . . . 0.0 112.092 176.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.33 -46.35 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.126 0.971 . . . . 0.0 110.35 172.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.03 54.41 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 123.753 0.692 . . . . 0.0 112.945 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.12 72.98 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.79 0.795 . . . . 0.0 112.485 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.9 8.36 20.34 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.66 1.184 . . . . 0.0 113.033 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -55.46 162.31 1.62 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.029 1.332 . . . . 0.0 111.361 165.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.34 48.99 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.035 0.934 . . . . 0.0 110.811 176.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -76.14 163.78 89.25 Favored 'Cis proline' 0 CA--C 1.543 0.951 0 CA-C-N 119.466 0.845 . . . . 0.0 111.735 -6.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_exo -49.9 141.39 29.0 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.205 2.604 . . . . 0.0 114.171 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.19 96.38 2.46 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 163.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.96 54.56 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.27 2.647 . . . . 0.0 112.86 -152.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.57 -34.83 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -173.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.39 -46.26 94.22 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.638 0.654 . . . . 0.0 112.967 173.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.83 -36.86 75.94 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.4 mt -62.91 -44.56 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.732 -0.605 . . . . 0.0 110.004 173.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.37 91.6 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.307 -0.871 . . . . 0.0 112.557 176.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.83 -41.97 75.03 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.489 -0.757 . . . . 0.0 112.287 173.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.0 ttm-85 -56.71 -45.27 81.94 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.889 0.768 . . . . 0.0 112.08 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.32 -40.46 85.98 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.236 0.614 . . . . 0.0 112.315 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.9 mt -62.7 -46.98 95.04 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 123.044 0.538 . . . . 0.0 110.34 174.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.23 -37.39 78.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.686 1.195 . . . . 0.0 112.3 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.79 -42.81 98.3 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.011 0.823 . . . . 0.0 111.223 171.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.49 -45.19 91.19 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.796 0.712 . . . . 0.0 113.26 175.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -58.42 -42.26 86.87 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.003 0.901 . . . . 0.0 111.113 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.45 -50.22 70.41 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.772 0.829 . . . . 0.0 112.453 173.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.18 76.94 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 118.856 0.753 . . . . 0.0 111.973 175.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.48 -48.01 86.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.717 -0.658 . . . . 0.0 111.377 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.47 -32.84 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-N 119.988 1.267 . . . . 0.0 112.945 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.96 -43.23 95.18 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.877 0.871 . . . . 0.0 111.562 171.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 18.8 ttp -78.41 -36.71 45.37 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.72 1.608 . . . . 0.0 113.619 -176.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.3 t80 . . . . . 0 C--O 1.252 1.219 0 C-N-CA 128.423 2.689 . . . . 0.0 114.629 -171.91 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo . . . . . 0 N--CA 1.479 0.631 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.93 135.02 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.453 1.101 . . . . 0.0 108.425 163.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.92 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.62 116.7 32.52 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.521 0.729 . . . . 0.0 109.201 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.41 178.04 6.88 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.598 0.713 . . . . 0.0 112.441 177.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.94 -26.5 68.85 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.13 57.84 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.97 2.99 85.8 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.458 1.028 . . . . 0.0 114.12 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.73 128.3 35.75 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 118.801 1.301 . . . . 0.0 109.683 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.6 29.58 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 168.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -126.0 123.39 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.046 1.338 . . . . 0.0 108.659 -174.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.524 0.678 . . . . 0.0 111.213 170.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.65 141.14 48.49 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.491 1.916 . . . . 0.0 107.914 169.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 21.0 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.015 0.825 . . . . 0.0 111.191 170.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.47 136.83 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.601 -0.687 . . . . 0.0 111.58 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.7 130.06 93.18 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.11 0.564 . . . . 0.0 111.088 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.09 -34.54 68.73 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.86 2.373 . . . . 0.0 113.575 167.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.43 -38.03 86.5 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.526 -0.734 . . . . 0.0 112.622 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.94 -44.32 97.43 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.691 0.678 . . . . 0.0 111.373 171.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.55 -44.36 94.39 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.251 0.478 . . . . 0.0 112.266 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.19 -47.21 86.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.105 0.562 . . . . 0.0 111.432 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.14 95.91 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.683 0.793 . . . . 0.0 111.879 176.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.19 -47.23 86.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.861 0.864 . . . . 0.0 112.766 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.2 t -56.8 -54.44 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 CA-C-N 118.397 0.544 . . . . 0.0 110.369 174.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.71 -37.34 78.6 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.347 1.059 . . . . 0.0 113.2 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.54 -52.15 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.058 1.343 . . . . 0.0 111.288 170.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.75 -35.9 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-O 119.034 -0.508 . . . . 0.0 111.406 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -58.7 -23.86 60.34 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.001 1.111 . . . . 0.0 114.001 175.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.37 -25.65 11.35 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -135.93 16.12 3.3 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 -166.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.19 -38.22 2.41 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.433 2.012 . . . . 0.0 116.433 -175.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -117.56 13.97 14.43 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.415 1.086 . . . . 0.0 113.105 -172.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.5 p -113.2 152.97 45.54 Favored Pre-proline 0 CA--C 1.54 0.561 0 C-N-CA 124.027 0.931 . . . . 0.0 111.582 -178.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.9 -30.76 59.7 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.277 2.651 . . . . 0.0 115.229 -172.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.02 -20.69 64.19 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.85 -31.89 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.431 1.014 . . . . 0.0 112.548 176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.38 -55.07 6.31 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.957 1.303 . . . . 0.0 113.011 -178.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.88 -30.08 49.31 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.653 1.626 . . . . 0.0 112.641 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.403 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.06 -40.16 78.67 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.901 1.228 . . . . 0.0 112.673 172.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -57.27 -46.51 83.01 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 118.758 0.708 . . . . 0.0 111.583 169.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.3 m -61.05 -44.48 97.33 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.86 -31.98 71.42 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.284 1.034 . . . . 0.0 113.292 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.34 4.44 53.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.344 1.458 . . . . 0.0 113.508 -178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.6 p -132.91 22.75 4.2 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.54 120.31 5.98 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.474 -1.391 . . . . 0.0 111.47 168.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.66 60.1 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.362 0.905 . . . . 0.0 115.362 -177.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.51 130.82 46.87 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.554 1.677 . . . . 0.0 112.53 -178.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.33 159.66 84.35 Favored Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 123.696 0.798 . . . . 0.0 110.718 167.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -49.61 -35.31 37.27 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 122.15 1.9 . . . . 0.0 115.454 168.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.16 -40.19 86.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 113.059 0.762 . . . . 0.0 113.059 174.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.34 -45.3 93.95 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.6 -0.687 . . . . 0.0 111.1 172.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.52 -44.37 94.44 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.364 1.066 . . . . 0.0 112.134 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.13 -41.51 88.42 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.658 -0.651 . . . . 0.0 112.031 171.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.18 -45.35 93.41 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.622 0.646 . . . . 0.0 111.084 175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.36 -48.87 77.9 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.179 0.9 . . . . 0.0 112.19 174.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.8 mt -63.15 -38.44 91.17 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.95 -33.36 70.53 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.0 p -73.67 -12.5 60.75 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.0 m -122.25 7.77 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -174.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.87 -4.49 5.86 Favored Glycine 0 CA--C 1.541 1.689 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.82 -33.19 55.8 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-N 119.249 1.524 . . . . 0.0 115.425 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -91.23 78.63 5.78 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 118.84 1.32 . . . . 0.0 110.613 171.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.16 -35.86 38.06 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.39 -41.1 73.48 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 120.107 1.322 . . . . 0.0 112.299 -179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.28 -43.61 85.92 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.202 0.601 . . . . 0.0 111.335 173.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.05 -40.1 96.71 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 121.514 -0.741 . . . . 0.0 112.255 175.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -50.02 73.93 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.251 1.02 . . . . 0.0 111.539 173.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -56.0 -45.39 79.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.97 -48.72 79.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.338 0.655 . . . . 0.0 112.055 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.75 -38.27 90.49 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.411 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.95 -45.48 92.49 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.735 0.698 . . . . 0.0 112.046 170.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.64 -42.37 99.55 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.149 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.84 -46.07 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.507 -0.745 . . . . 0.0 111.093 174.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.19 -39.33 93.76 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.816 0.734 . . . . 0.0 112.738 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.89 -47.4 86.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.745 0.818 . . . . 0.0 111.964 174.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.16 -34.33 72.87 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.48 91.66 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.481 -0.762 . . . . 0.0 112.355 173.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.84 -42.16 98.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.2 0.6 . . . . 0.0 111.787 172.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.03 -42.28 99.74 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.888 -0.508 . . . . 0.0 112.166 174.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.676 0.671 . . . . 0.0 111.71 173.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.07 -30.2 71.41 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.22 -39.1 78.77 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.397 1.079 . . . . 0.0 112.45 173.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.6 42.27 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.817 1.247 . . . . 0.0 113.302 176.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.0 53.92 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.88 120.08 7.34 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.479 2.119 . . . . 0.0 110.312 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.33 136.26 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.35 1.46 . . . . 0.0 112.179 -169.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.98 160.47 25.9 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.079 0.552 . . . . 0.0 110.903 168.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.98 65.01 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.95 174.77 41.6 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.053 1.311 . . . . 0.0 112.647 174.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.62 169.16 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.944 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.61 -39.2 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.91 1.284 . . . . 0.0 111.799 -175.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.47 161.94 28.51 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.884 1.674 . . . . 0.0 110.587 176.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -47.94 133.42 22.99 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.479 2.786 . . . . 0.0 113.106 168.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.98 -15.08 60.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.567 1.08 . . . . 0.0 115.01 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.6 54.12 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.694 -0.629 . . . . 0.0 110.824 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.3 ptt85 -68.48 152.7 45.03 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.765 0.826 . . . . 0.0 111.626 171.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -72.25 131.7 84.85 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.912 -0.565 . . . . 0.0 109.835 170.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.38 140.43 44.06 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.074 1.849 . . . . 0.0 112.442 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.8 mtp85 -75.1 171.61 13.83 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.763 1.625 . . . . 0.0 111.871 163.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.87 94.1 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.895 -0.503 . . . . 0.0 113.035 168.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.0 p -68.81 -25.68 64.8 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.82 -41.6 64.72 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 121.03 -1.044 . . . . 0.0 111.733 171.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.67 -42.71 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 123.742 0.817 . . . . 0.0 110.787 173.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.23 13.99 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.893 1.071 . . . . 0.0 113.893 173.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.98 18.11 74.21 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.626 1.107 . . . . 0.0 115.413 174.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.21 -19.36 19.39 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.141 1.471 . . . . 0.0 113.312 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.25 -1.52 6.99 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 114.379 1.251 . . . . 0.0 114.379 177.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.56 150.01 24.34 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.063 0.945 . . . . 0.0 111.773 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 40.9 p -82.01 162.3 22.68 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-O 121.311 0.577 . . . . 0.0 110.806 169.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.66 -39.45 73.76 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.431 -0.793 . . . . 0.0 111.427 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.49 -38.93 93.03 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.533 -0.729 . . . . 0.0 112.701 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -64.67 -42.75 95.15 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 111.997 171.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.6 -46.41 90.36 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.575 0.75 . . . . 0.0 112.152 176.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.47 -46.29 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.106 0.962 . . . . 0.0 110.338 172.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.1 54.01 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 0.0 112.869 177.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.07 73.19 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.512 174.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.95 8.42 20.29 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.6 1.16 . . . . 0.0 113.046 178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.39 162.28 1.6 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.991 1.316 . . . . 0.0 111.403 165.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.54 103.37 48.97 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.035 0.934 . . . . 0.0 110.792 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -76.14 163.87 89.05 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.509 0.86 . . . . 0.0 111.676 -6.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -50.04 141.36 30.06 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 0.0 114.205 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.11 96.41 2.45 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.97 54.6 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.54 -34.89 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.24 94.26 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.633 0.652 . . . . 0.0 112.999 173.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.8 -36.87 76.02 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.348 -1.09 . . . . 0.0 112.723 178.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.92 -44.56 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.732 -0.605 . . . . 0.0 109.987 173.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.89 -40.39 91.53 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.307 -0.871 . . . . 0.0 112.521 176.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.83 -41.98 75.06 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.431 -0.793 . . . . 0.0 112.259 173.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.74 -45.23 82.12 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 118.956 0.798 . . . . 0.0 112.044 174.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.3 -40.57 86.06 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.257 178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.53 -47.22 93.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.065 0.546 . . . . 0.0 110.295 174.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.09 -37.39 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.68 1.192 . . . . 0.0 112.3 177.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.78 98.35 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.011 0.823 . . . . 0.0 111.224 171.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.07 91.47 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.844 0.735 . . . . 0.0 113.252 175.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.35 -42.42 86.86 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 117.988 0.894 . . . . 0.0 111.076 173.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.18 70.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.9 -43.23 77.07 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.83 0.741 . . . . 0.0 111.975 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.9 mt -64.51 -47.79 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 CA-C-O 118.744 -0.646 . . . . 0.0 111.43 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.56 -32.91 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.963 1.256 . . . . 0.0 112.911 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.23 -44.79 94.9 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.933 0.893 . . . . 0.0 111.487 171.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.2 ttp -75.42 -36.34 60.81 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.631 1.573 . . . . 0.0 113.442 -177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.252 1.196 0 C-N-CA 128.394 2.678 . . . . 0.0 114.54 -172.815 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 113.009 0.35 . . . . 0.0 113.009 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.76 135.02 28.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.472 1.109 . . . . 0.0 108.436 163.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.96 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.72 116.74 32.56 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.501 0.72 . . . . 0.0 109.195 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.452 177.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.89 -26.46 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 -173.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.64 -2.19 57.93 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.809 1.244 . . . . 0.0 112.988 175.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.04 2.94 85.67 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.504 1.05 . . . . 0.0 114.103 -175.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.64 128.29 35.68 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.866 1.333 . . . . 0.0 109.745 174.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.91 125.61 29.61 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 168.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.0 t -125.97 123.34 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 C-N-CA 125.045 1.338 . . . . 0.0 108.723 -174.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.5 139.73 38.64 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.512 0.672 . . . . 0.0 111.206 170.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.76 141.17 48.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.477 1.911 . . . . 0.0 107.897 169.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.38 20.94 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.804 . . . . 0.0 111.238 170.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.5 136.79 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 O-C-N 121.611 -0.681 . . . . 0.0 111.591 176.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.64 130.01 93.26 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 123.114 0.566 . . . . 0.0 111.151 177.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.887 2.391 . . . . 0.0 113.575 167.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.4 -38.09 86.69 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 112.579 174.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -61.0 -44.28 97.65 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 118.687 0.676 . . . . 0.0 111.347 171.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.8 mt -63.55 -44.23 94.77 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.328 0.513 . . . . 0.0 112.309 175.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.28 -47.28 85.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.124 0.569 . . . . 0.0 111.392 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.2 95.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.658 0.783 . . . . 0.0 111.9 176.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.17 -47.23 86.83 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.809 0.844 . . . . 0.0 112.77 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.6 t -56.76 -54.52 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.455 0.57 . . . . 0.0 110.397 174.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.59 -37.44 78.54 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.354 1.062 . . . . 0.0 113.191 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.405 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.59 -52.1 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.026 1.33 . . . . 0.0 111.295 170.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 76.7 t -64.64 -35.92 76.06 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 122.915 0.486 . . . . 0.0 111.399 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -58.72 -23.95 60.63 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.21 -25.73 11.39 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.88 16.13 3.31 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.312 1.227 . . . . 0.0 114.312 -166.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.16 -38.38 2.44 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.402 2.001 . . . . 0.0 116.402 -175.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -117.48 14.1 14.53 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.404 1.081 . . . . 0.0 113.115 -172.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.9 p -113.18 153.02 45.54 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 123.952 0.901 . . . . 0.0 111.565 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.89 -30.66 59.12 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.289 2.659 . . . . 0.0 115.27 -172.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.12 -20.74 64.37 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.19 1.181 . . . . 0.0 114.19 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.73 -32.01 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.387 0.994 . . . . 0.0 112.539 176.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.8 mt -71.33 -55.05 6.39 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.943 1.297 . . . . 0.0 113.011 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.89 -30.08 49.23 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.685 1.637 . . . . 0.0 112.655 174.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.405 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.08 -40.21 78.58 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.876 1.216 . . . . 0.0 112.598 172.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -57.28 -46.52 83.03 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.776 0.716 . . . . 0.0 111.522 169.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.2 m -61.11 -44.4 97.4 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 175.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.9 -32.02 71.5 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.268 1.027 . . . . 0.0 113.27 178.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.23 4.43 53.55 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.4 1.48 . . . . 0.0 113.536 -178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.7 p -133.03 22.8 4.16 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.62 120.34 6.06 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.491 168.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.69 60.06 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.375 0.91 . . . . 0.0 115.375 -177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.55 130.9 47.19 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.565 1.683 . . . . 0.0 112.481 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.37 159.66 84.33 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 123.748 0.819 . . . . 0.0 110.705 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -49.54 -35.48 37.11 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.3 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.36 -45.26 94.12 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.049 172.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.54 -44.37 94.37 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.386 1.074 . . . . 0.0 112.134 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -59.13 -41.51 88.42 Favored 'General case' 0 N--CA 1.466 0.35 0 O-C-N 121.658 -0.651 . . . . 0.0 112.031 171.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.5 m -60.23 -45.28 93.78 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.622 0.646 . . . . 0.0 111.073 175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.44 -48.85 78.06 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.254 0.934 . . . . 0.0 112.191 174.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 63.9 mt -63.13 -38.45 91.24 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.87 -33.43 70.48 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 177.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.1 p -73.66 -12.52 60.76 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.4 m -122.2 7.84 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -174.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.93 -4.54 6.0 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 117.193 1.637 . . . . 0.0 117.193 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.83 -33.22 55.93 Favored Glycine 0 CA--C 1.536 1.399 0 CA-C-N 119.257 1.528 . . . . 0.0 115.404 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -91.18 78.49 5.83 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 118.875 1.338 . . . . 0.0 110.605 171.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.06 -35.86 36.88 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 -173.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.35 -41.09 73.61 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 120.094 1.315 . . . . 0.0 112.242 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.54 85.74 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.174 0.59 . . . . 0.0 111.311 173.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.05 -40.13 96.77 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.514 -0.741 . . . . 0.0 112.265 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.96 -49.92 74.22 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.198 0.999 . . . . 0.0 111.58 173.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.99 -45.52 78.97 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.091 0.956 . . . . 0.0 112.199 174.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.2 tp -61.87 -48.81 78.87 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.326 0.65 . . . . 0.0 112.055 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.63 -38.28 90.53 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.842 0.857 . . . . 0.0 112.49 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -59.99 -45.55 92.37 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.668 0.667 . . . . 0.0 111.985 170.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.3 m -62.51 -42.45 99.51 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.87 0.759 . . . . 0.0 112.155 175.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.86 -46.08 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.478 -0.764 . . . . 0.0 111.059 174.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.18 -39.37 93.85 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.858 0.754 . . . . 0.0 112.752 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.81 -47.48 86.13 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.925 174.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.09 -34.32 73.0 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 121.582 -0.699 . . . . 0.0 112.85 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.85 -41.45 91.69 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.408 -0.808 . . . . 0.0 112.361 172.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.92 -42.09 98.7 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.215 0.606 . . . . 0.0 111.751 172.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.08 -42.25 99.58 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.86 -0.525 . . . . 0.0 112.218 174.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.77 -48.57 79.3 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.737 173.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.05 -30.23 71.43 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.24 -39.11 78.71 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.337 1.055 . . . . 0.0 112.482 173.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.24 -27.58 42.41 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.76 1.224 . . . . 0.0 113.327 176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.76 61.03 54.17 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.646 1.978 . . . . 0.0 111.247 -174.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.92 120.14 7.41 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.509 2.139 . . . . 0.0 110.261 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.42 136.3 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.298 1.439 . . . . 0.0 112.108 -169.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.97 160.37 25.95 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.116 0.567 . . . . 0.0 110.922 168.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.97 65.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.89 174.77 41.56 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.048 1.309 . . . . 0.0 112.656 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 169.16 14.85 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.66 2.907 . . . . 0.0 112.896 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.3 mt -57.64 -39.18 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.926 1.29 . . . . 0.0 111.762 -175.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.55 161.87 28.65 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.858 1.663 . . . . 0.0 110.561 176.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.93 133.44 22.94 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.403 2.735 . . . . 0.0 113.141 168.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.08 60.29 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.562 1.077 . . . . 0.0 114.978 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.22 145.5 54.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.694 -0.629 . . . . 0.0 110.815 168.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.6 ptt85 -68.54 152.83 44.83 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.658 0.783 . . . . 0.0 111.668 171.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.18 131.64 85.03 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.83 170.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.37 140.44 44.13 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.076 1.851 . . . . 0.0 112.426 -177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtp85 -75.12 171.58 13.89 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.74 1.616 . . . . 0.0 111.906 163.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.51 -43.87 93.96 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 121.971 -0.455 . . . . 0.0 113.049 168.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.3 p -68.85 -25.7 64.78 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.74 -41.68 64.88 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 121.068 -1.02 . . . . 0.0 111.727 171.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.63 -42.69 96.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 123.744 0.818 . . . . 0.0 110.817 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.07 -1.29 14.23 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 70.01 18.16 74.31 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.605 1.098 . . . . 0.0 115.447 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.31 -19.46 19.24 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.074 1.437 . . . . 0.0 113.263 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.1 p -126.14 -1.34 7.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 177.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.86 149.81 24.73 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.095 0.958 . . . . 0.0 111.752 173.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.6 p -81.73 162.27 23.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.303 0.573 . . . . 0.0 110.799 170.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.72 -39.38 73.81 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.466 -0.771 . . . . 0.0 111.445 169.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.58 -38.91 92.91 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.554 -0.716 . . . . 0.0 112.706 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.57 -42.79 95.41 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.542 -0.724 . . . . 0.0 112.011 171.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -60.62 -46.43 90.3 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.68 0.792 . . . . 0.0 112.144 176.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.46 -46.35 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.106 0.962 . . . . 0.0 110.301 172.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.39 -51.11 53.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.872 0.748 . . . . 0.0 112.882 177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.27 -50.08 73.13 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.799 0.799 . . . . 0.0 112.542 174.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.62 -18.56 64.33 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.8 p -111.86 8.42 20.43 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.624 1.17 . . . . 0.0 113.064 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.41 162.3 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.952 1.301 . . . . 0.0 111.461 165.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.39 48.92 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.035 0.934 . . . . 0.0 110.811 176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.07 163.84 89.16 Favored 'Cis proline' 0 CA--C 1.544 1.025 0 CA-C-N 119.429 0.832 . . . . 0.0 111.701 -6.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -50.04 141.35 30.07 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.136 2.558 . . . . 0.0 114.205 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.13 96.48 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -86.05 54.58 3.45 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.274 2.649 . . . . 0.0 112.827 -152.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.59 -34.77 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.48 -46.2 94.31 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.637 0.653 . . . . 0.0 112.996 173.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -69.8 -36.92 76.07 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.293 -1.122 . . . . 0.0 112.665 178.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.0 mt -62.93 -44.57 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.808 -0.557 . . . . 0.0 109.921 174.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.86 -40.42 91.66 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.303 -0.873 . . . . 0.0 112.489 176.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.84 -41.99 75.1 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.294 173.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -56.7 -45.24 81.95 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.926 0.784 . . . . 0.0 112.071 174.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.1 m0 -67.34 -40.48 85.9 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.266 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.62 -47.23 93.94 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.044 0.538 . . . . 0.0 110.291 174.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.2 mt -62.03 -37.35 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.683 1.193 . . . . 0.0 112.355 177.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.83 -42.77 98.4 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.03 0.832 . . . . 0.0 111.224 171.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.09 91.41 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.796 0.712 . . . . 0.0 113.242 175.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.38 -42.35 86.85 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 117.986 0.893 . . . . 0.0 111.097 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.55 -50.17 70.73 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.798 0.839 . . . . 0.0 112.445 173.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.26 77.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.86 0.755 . . . . 0.0 111.991 175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.4 -47.9 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 123.335 0.654 . . . . 0.0 111.44 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.92 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.924 1.238 . . . . 0.0 112.9 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.17 -44.54 94.94 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 123.884 0.874 . . . . 0.0 111.473 171.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.78 -35.86 59.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.655 1.582 . . . . 0.0 113.468 -177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.251 1.175 0 C-N-CA 128.39 2.676 . . . . 0.0 114.59 -172.737 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.998 0.345 . . . . 0.0 112.998 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.9 135.09 28.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 124.457 1.103 . . . . 0.0 108.402 163.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.13 154.83 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.063 1.345 . . . . 0.0 109.627 170.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.7 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.6 tp -62.9 -26.45 68.8 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -173.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.61 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.825 1.25 . . . . 0.0 113.03 175.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.98 3.02 85.77 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.5 1.048 . . . . 0.0 114.144 -175.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.7 128.22 35.43 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 118.801 1.301 . . . . 0.0 109.745 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.63 29.63 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 168.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 88.1 t -125.95 123.36 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.107 1.363 . . . . 0.0 108.669 -174.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.56 139.71 38.58 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 121.543 0.687 . . . . 0.0 111.191 170.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.72 141.11 48.4 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.465 1.906 . . . . 0.0 107.929 169.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.36 21.02 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.254 170.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.5 136.89 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.492 0.663 . . . . 0.0 111.572 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.69 129.96 93.22 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.068 0.547 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -53.01 -34.56 68.05 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.868 2.378 . . . . 0.0 113.56 167.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.41 -38.07 86.64 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 121.451 -0.78 . . . . 0.0 112.587 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -60.97 -44.3 97.55 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.779 0.718 . . . . 0.0 111.377 171.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.54 -44.37 94.41 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.29 0.496 . . . . 0.0 112.244 175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.22 -47.25 86.04 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.115 0.566 . . . . 0.0 111.37 176.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.24 95.61 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.651 0.78 . . . . 0.0 111.897 176.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.6 t-105 -60.24 -47.01 87.79 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.771 0.829 . . . . 0.0 112.812 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.78 -54.55 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.439 0.563 . . . . 0.0 110.344 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -59.66 -37.36 78.52 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.343 1.057 . . . . 0.0 113.219 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.4 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.38 -52.22 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 125.138 1.375 . . . . 0.0 111.253 170.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.82 -36.02 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.996 0.518 . . . . 0.0 111.407 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -58.66 -23.89 60.13 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.3 -25.62 11.39 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.98 16.08 3.29 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -165.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.37 -38.13 2.59 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 116.401 2.0 . . . . 0.0 116.401 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -117.44 13.8 14.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.345 1.058 . . . . 0.0 113.127 -172.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -112.99 153.0 45.38 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 123.96 0.904 . . . . 0.0 111.566 -178.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.88 -30.74 59.39 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.311 2.674 . . . . 0.0 115.218 -172.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.02 -20.74 64.25 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -177.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.88 -31.88 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 CA-C-N 119.414 1.006 . . . . 0.0 112.488 176.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.41 -55.01 6.32 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.957 1.303 . . . . 0.0 112.989 -178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.93 -30.08 48.9 Favored 'Trans proline' 0 C--N 1.35 0.657 0 CA-C-N 121.678 1.635 . . . . 0.0 112.641 174.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.4 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.06 -40.21 78.65 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.901 1.228 . . . . 0.0 112.673 172.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -57.27 -46.47 83.05 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.765 0.711 . . . . 0.0 111.569 169.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 71.8 m -61.09 -44.44 97.36 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 175.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.92 -32.0 71.51 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.268 1.027 . . . . 0.0 113.257 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.3 4.48 53.41 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.325 1.45 . . . . 0.0 113.511 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.8 p -133.03 22.8 4.16 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.54 120.31 5.97 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 120.478 -1.389 . . . . 0.0 111.468 168.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.63 60.04 Favored Glycine 0 CA--C 1.537 1.452 0 N-CA-C 115.358 0.903 . . . . 0.0 115.358 -177.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.46 130.88 47.16 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.573 1.687 . . . . 0.0 112.482 -178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.35 159.66 84.34 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.753 0.821 . . . . 0.0 110.666 167.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.54 -35.47 37.1 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.167 1.911 . . . . 0.0 115.415 168.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.22 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -60.41 -45.22 94.38 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 121.66 -0.65 . . . . 0.0 111.108 172.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.3 mt -63.57 -44.26 94.62 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 112.163 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -59.3 -41.35 88.78 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.696 -0.628 . . . . 0.0 111.989 171.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.4 m -60.26 -45.33 93.68 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.629 0.65 . . . . 0.0 111.091 175.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.33 -48.91 77.74 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.205 0.911 . . . . 0.0 112.179 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.1 mt -63.11 -38.49 91.38 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.91 -33.56 70.69 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 177.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.5 p -73.57 -12.46 60.77 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 30.2 m -122.34 7.73 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.57 -4.8 5.73 Favored Glycine 0 CA--C 1.541 1.702 0 N-CA-C 117.191 1.636 . . . . 0.0 117.191 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.71 -33.32 55.25 Favored Glycine 0 CA--C 1.537 1.433 0 CA-C-N 119.183 1.491 . . . . 0.0 115.462 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 51.9 t-80 -90.81 78.77 6.06 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.836 1.318 . . . . 0.0 110.634 171.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.32 -35.94 40.43 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -173.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.49 -41.2 73.01 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.094 1.315 . . . . 0.0 112.293 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.22 -43.57 86.32 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.155 0.582 . . . . 0.0 111.337 173.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.2 tpp -63.13 -40.04 96.44 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 121.555 -0.716 . . . . 0.0 112.224 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.99 -50.0 74.03 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.056 -1.028 . . . . 0.0 111.521 173.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.5 tpp -56.0 -45.42 79.05 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.059 0.944 . . . . 0.0 112.234 174.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.3 tp -61.88 -48.75 79.09 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.277 0.631 . . . . 0.0 112.105 176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.3 mmtt -63.77 -38.21 90.26 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.836 0.854 . . . . 0.0 112.463 179.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -59.97 -45.48 92.55 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.699 0.681 . . . . 0.0 112.075 170.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.8 m -62.65 -42.37 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.806 0.73 . . . . 0.0 112.118 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.4 mt -58.85 -46.14 91.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.477 -0.765 . . . . 0.0 111.03 174.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.09 -39.43 94.05 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.842 0.746 . . . . 0.0 112.757 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.1 mt-10 -60.75 -47.46 86.2 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.703 0.801 . . . . 0.0 111.975 174.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -70.09 -34.38 73.06 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.87 -41.42 91.63 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.467 -0.771 . . . . 0.0 112.341 173.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.08 98.7 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.184 0.594 . . . . 0.0 111.772 172.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -63.14 -42.21 99.44 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.924 -0.485 . . . . 0.0 112.135 174.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.6 t-105 -57.84 -48.58 79.38 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.682 0.674 . . . . 0.0 111.699 173.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -63.04 -30.19 71.4 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.16 -39.18 78.93 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.361 1.065 . . . . 0.0 112.499 173.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.7 mt -79.26 -27.61 42.34 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.78 1.232 . . . . 0.0 113.29 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.76 61.03 54.13 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 126.696 1.998 . . . . 0.0 111.225 -174.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -63.9 120.16 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.481 2.12 . . . . 0.0 110.277 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.46 136.23 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.318 1.447 . . . . 0.0 112.121 -169.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -79.92 160.49 25.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.05 0.54 . . . . 0.0 110.903 168.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.29 -19.9 64.99 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.98 174.71 41.62 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.099 1.333 . . . . 0.0 112.653 174.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.63 169.14 14.96 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.658 2.905 . . . . 0.0 112.915 177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.4 mt -57.6 -39.23 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.94 1.296 . . . . 0.0 111.762 -175.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.44 161.93 28.53 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.817 1.647 . . . . 0.0 110.573 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -47.95 133.47 23.07 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.441 2.761 . . . . 0.0 113.132 168.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.88 -14.99 60.33 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 124.613 1.101 . . . . 0.0 115.056 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.08 143.36 37.46 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.946 1.373 . . . . 0.0 110.198 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.11 145.54 54.29 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.693 -0.63 . . . . 0.0 110.858 168.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.51 152.7 45.02 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.728 0.811 . . . . 0.0 111.653 171.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.21 131.66 84.96 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-O 118.887 -0.578 . . . . 0.0 109.869 170.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.34 140.38 44.09 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.134 1.889 . . . . 0.0 112.416 -177.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -75.11 171.66 13.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.709 1.604 . . . . 0.0 111.89 163.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.59 -43.91 94.07 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.895 -0.503 . . . . 0.0 112.991 168.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.6 p -68.78 -25.77 64.87 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 175.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.76 -41.59 64.92 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.027 -1.046 . . . . 0.0 111.778 171.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.65 -42.69 97.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.718 0.807 . . . . 0.0 110.793 173.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.26 13.93 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 173.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.91 18.16 74.12 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.922 -1.111 . . . . 0.0 115.477 175.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.3 p -96.3 -19.35 19.33 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 119.131 1.466 . . . . 0.0 113.305 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.0 p -126.27 -1.51 6.98 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.6 149.97 24.41 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.103 0.961 . . . . 0.0 111.824 173.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.6 p -81.84 162.35 22.85 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.318 0.58 . . . . 0.0 110.807 170.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.81 -39.44 74.16 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.418 -0.801 . . . . 0.0 111.372 169.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.5 -38.93 93.03 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 121.576 -0.702 . . . . 0.0 112.685 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.8 95.31 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.602 -0.686 . . . . 0.0 112.008 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.61 -46.39 90.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.648 0.779 . . . . 0.0 112.097 176.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.35 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.301 172.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.05 54.33 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 123.85 0.738 . . . . 0.0 112.866 177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.14 72.91 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.828 0.814 . . . . 0.0 112.517 174.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.62 -18.48 64.31 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.4 p -111.88 8.36 20.39 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.688 1.195 . . . . 0.0 113.051 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.43 162.31 1.6 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.989 1.316 . . . . 0.0 111.434 165.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.57 103.34 48.97 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 124.035 0.934 . . . . 0.0 110.837 176.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.85 89.11 Favored 'Cis proline' 0 CA--C 1.543 0.956 0 CA-C-N 119.447 0.838 . . . . 0.0 111.701 -6.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -50.06 141.37 30.24 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.21 2.607 . . . . 0.0 114.135 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.1 mt -96.14 96.49 2.5 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 163.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -86.0 54.59 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.251 2.634 . . . . 0.0 112.86 -152.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.63 -34.81 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -173.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.26 94.21 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.61 0.641 . . . . 0.0 112.999 173.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -69.83 -36.87 75.95 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.347 -1.09 . . . . 0.0 112.634 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.91 -44.6 99.71 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 O-C-N 121.709 -0.62 . . . . 0.0 109.942 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.82 -40.46 91.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.307 -0.871 . . . . 0.0 112.54 176.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.79 -42.03 74.99 Favored 'General case' 0 N--CA 1.477 0.893 0 O-C-N 121.455 -0.778 . . . . 0.0 112.287 173.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.68 -45.21 81.9 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.865 0.757 . . . . 0.0 112.147 174.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.35 -40.47 85.83 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.271 0.628 . . . . 0.0 112.272 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.1 mt -62.64 -47.27 93.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 123.085 0.554 . . . . 0.0 110.206 174.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.05 -37.36 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.634 1.174 . . . . 0.0 112.322 177.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.74 -42.87 98.24 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 119.095 0.861 . . . . 0.0 111.233 171.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.55 -45.07 91.56 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 123.821 0.724 . . . . 0.0 113.252 175.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.3 mt -58.28 -42.49 86.68 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 117.988 0.894 . . . . 0.0 111.102 173.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -55.5 -50.16 70.67 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.772 0.829 . . . . 0.0 112.503 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.86 -43.27 76.95 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.864 0.756 . . . . 0.0 112.027 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.8 mt -64.46 -47.74 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 123.337 0.655 . . . . 0.0 111.467 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.64 -32.89 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.923 1.238 . . . . 0.0 112.874 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.34 -45.11 94.6 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.958 0.903 . . . . 0.0 111.463 171.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.3 ttp -74.74 -36.7 62.63 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.666 1.586 . . . . 0.0 113.362 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.251 1.162 0 C-N-CA 128.417 2.687 . . . . 0.0 114.655 -173.026 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.002 0.347 . . . . 0.0 113.002 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.81 135.01 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 124.458 1.103 . . . . 0.0 108.437 163.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.02 154.94 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.1 1.36 . . . . 0.0 109.648 170.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -104.66 116.69 32.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.516 0.726 . . . . 0.0 109.17 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.95 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.604 0.716 . . . . 0.0 112.452 177.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.89 -26.45 68.79 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.63 -2.19 57.92 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.767 1.227 . . . . 0.0 112.988 175.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.02 3.03 85.67 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.504 1.05 . . . . 0.0 114.091 -175.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -66.78 128.27 35.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.861 1.331 . . . . 0.0 109.664 174.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.61 29.61 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 168.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.97 123.35 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.046 1.338 . . . . 0.0 108.678 -174.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -78.52 139.65 38.63 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.236 170.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.13 48.4 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.468 1.907 . . . . 0.0 107.94 169.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.24 152.37 20.91 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 119.011 0.823 . . . . 0.0 111.221 170.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.54 136.9 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.65 -0.656 . . . . 0.0 111.509 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.71 130.01 93.19 Favored Pre-proline 0 CA--C 1.538 0.495 0 C-N-CA 123.098 0.559 . . . . 0.0 111.151 177.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -52.99 -34.6 67.96 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.907 2.405 . . . . 0.0 113.604 167.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -66.43 -38.06 86.57 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.49 -0.756 . . . . 0.0 112.594 174.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.94 -44.32 97.43 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.691 0.678 . . . . 0.0 111.373 171.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.57 -44.29 94.53 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 118.251 0.478 . . . . 0.0 112.254 175.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.23 -47.27 85.98 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.079 0.551 . . . . 0.0 111.399 176.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.02 -45.23 95.63 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.663 0.785 . . . . 0.0 111.882 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.11 -47.27 86.61 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.801 0.84 . . . . 0.0 112.801 177.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -56.8 -54.4 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-N 118.431 0.559 . . . . 0.0 110.397 174.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.7 -37.36 78.63 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.301 1.04 . . . . 0.0 113.218 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.403 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.55 -52.19 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.027 1.331 . . . . 0.0 111.318 170.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.61 -35.96 76.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-O 119.053 -0.498 . . . . 0.0 111.417 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -58.66 -23.96 60.27 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.037 1.125 . . . . 0.0 114.037 175.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.2 -25.73 11.39 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 -177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.83 15.91 3.33 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -166.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.05 -38.22 2.24 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -175.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -117.61 14.05 14.4 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.402 1.081 . . . . 0.0 113.141 -172.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.4 p -113.14 152.97 45.49 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 123.982 0.913 . . . . 0.0 111.523 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.74 -30.96 58.98 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.258 2.639 . . . . 0.0 115.203 -172.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.01 -21.01 64.51 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -177.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.16 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.41 1.005 . . . . 0.0 112.485 176.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.3 mt -70.36 -57.18 5.98 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.76 1.224 . . . . 0.0 112.561 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -64.84 -29.52 58.68 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.891 1.711 . . . . 0.0 112.814 175.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.403 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.25 -40.16 78.03 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 119.781 1.173 . . . . 0.0 112.705 172.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.09 -47.02 82.08 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 118.847 0.748 . . . . 0.0 111.53 169.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -60.92 -44.2 97.55 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 175.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.83 -31.68 71.09 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.227 1.011 . . . . 0.0 113.225 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.3 mt -95.76 4.53 52.85 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.373 1.469 . . . . 0.0 113.47 -178.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.5 p -133.08 22.79 4.14 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -53.56 120.33 6.01 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.508 -1.37 . . . . 0.0 111.454 168.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.62 60.02 Favored Glycine 0 CA--C 1.537 1.408 0 N-CA-C 115.447 0.939 . . . . 0.0 115.447 -177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.53 130.89 47.15 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.489 1.644 . . . . 0.0 112.515 -178.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.32 159.68 84.33 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.771 0.828 . . . . 0.0 110.665 167.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.57 -35.48 37.46 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.227 1.951 . . . . 0.0 115.381 168.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.0 -40.3 87.32 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.33 -45.3 93.9 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.596 -0.69 . . . . 0.0 111.062 172.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.2 mt -63.57 -44.29 94.51 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.354 1.062 . . . . 0.0 112.134 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -59.21 -41.49 88.74 Favored 'General case' 0 N--CA 1.467 0.38 0 O-C-N 121.682 -0.636 . . . . 0.0 111.973 171.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.25 -45.24 93.95 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.654 0.661 . . . . 0.0 111.08 175.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.38 -48.87 77.92 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 119.254 0.934 . . . . 0.0 112.202 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.0 mt -63.13 -38.47 91.32 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 178.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -58.91 -33.41 70.51 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 177.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 41.4 p -73.66 -12.52 60.76 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.647 1.351 . . . . 0.0 114.647 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.2 m -122.14 7.79 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 N-CA-C 114.012 1.115 . . . . 0.0 114.012 -174.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.77 -4.64 5.87 Favored Glycine 0 CA--C 1.542 1.73 0 N-CA-C 117.205 1.642 . . . . 0.0 117.205 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -54.85 -32.94 55.83 Favored Glycine 0 CA--C 1.537 1.407 0 CA-C-N 119.236 1.518 . . . . 0.0 115.411 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -91.57 78.62 5.56 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-N 118.875 1.337 . . . . 0.0 110.585 171.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.18 -35.92 38.59 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 -173.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.33 -41.06 73.73 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 120.12 1.327 . . . . 0.0 112.315 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.6 86.01 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.16 0.584 . . . . 0.0 111.361 173.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.4 tpp -63.04 -40.18 96.95 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 121.476 -0.765 . . . . 0.0 112.255 175.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -56.9 -50.0 73.88 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.237 1.015 . . . . 0.0 111.548 173.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.6 tpp -55.99 -45.42 79.02 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.095 0.958 . . . . 0.0 112.21 174.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.0 tp -61.97 -48.72 79.09 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.338 0.655 . . . . 0.0 112.055 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -63.75 -38.24 90.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.839 0.855 . . . . 0.0 112.448 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -59.98 -45.53 92.42 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.684 0.675 . . . . 0.0 112.046 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.4 m -62.54 -42.42 99.52 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.848 0.749 . . . . 0.0 112.164 175.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.5 mt -58.84 -46.1 91.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 O-C-N 121.507 -0.745 . . . . 0.0 111.093 174.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -64.13 -39.4 93.94 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.847 0.749 . . . . 0.0 112.759 177.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -60.8 -47.46 86.23 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.948 174.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -70.11 -34.32 72.96 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.83 -41.46 91.76 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.408 -0.808 . . . . 0.0 112.376 172.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.12 98.72 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.208 0.603 . . . . 0.0 111.772 172.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.0 -42.32 99.81 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.869 -0.519 . . . . 0.0 112.165 174.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.77 -48.63 79.11 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.645 0.657 . . . . 0.0 111.676 173.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -63.02 -30.25 71.45 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -39.1 78.79 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.326 1.05 . . . . 0.0 112.451 173.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.22 -27.61 42.5 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.785 1.234 . . . . 0.0 113.339 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -132.76 61.01 54.03 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.646 1.978 . . . . 0.0 111.247 -174.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -63.89 120.16 7.45 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.51 2.14 . . . . 0.0 110.261 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.45 136.24 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 125.383 1.473 . . . . 0.0 112.086 -169.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -79.94 160.43 25.97 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.082 0.553 . . . . 0.0 110.909 168.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.21 -19.98 65.02 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.75 41.58 Favored Glycine 0 CA--C 1.536 1.405 0 C-N-CA 125.016 1.293 . . . . 0.0 112.617 174.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.59 169.2 14.77 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.636 2.891 . . . . 0.0 112.917 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.1 mt -57.65 -39.17 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.897 1.279 . . . . 0.0 111.799 -175.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.51 161.9 28.59 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.911 1.684 . . . . 0.0 110.599 176.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.427 2.751 . . . . 0.0 113.132 168.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.97 -15.07 60.28 Favored Glycine 0 CA--C 1.536 1.35 0 C-N-CA 124.567 1.08 . . . . 0.0 115.005 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.021 1.41 . . . . 0.0 110.198 173.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.18 145.5 54.27 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.726 -0.608 . . . . 0.0 110.848 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.53 152.77 44.92 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.666 0.787 . . . . 0.0 111.664 171.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.24 131.73 84.85 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.883 -0.58 . . . . 0.0 109.821 170.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.42 140.44 43.95 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.037 1.825 . . . . 0.0 112.426 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -75.1 171.62 13.8 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.74 1.616 . . . . 0.0 111.898 163.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.55 -43.94 94.0 Favored Glycine 0 CA--C 1.536 1.352 0 O-C-N 121.895 -0.503 . . . . 0.0 112.986 168.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.5 p -68.77 -25.73 64.86 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.8 -41.61 64.76 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 121.068 -1.02 . . . . 0.0 111.721 171.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.75 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.784 0.834 . . . . 0.0 110.782 173.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.05 -1.25 14.05 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 173.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.97 18.13 74.21 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.879 -1.138 . . . . 0.0 115.485 175.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.34 -19.3 19.33 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.092 1.446 . . . . 0.0 113.313 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.26 -1.5 6.99 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 177.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.63 149.95 24.45 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.055 0.942 . . . . 0.0 111.799 173.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.1 p -81.79 162.42 22.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.309 0.576 . . . . 0.0 110.773 169.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.5 tp -56.81 -39.41 74.13 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 121.454 -0.778 . . . . 0.0 111.431 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.52 -38.91 92.93 Favored 'General case' 0 CA--C 1.539 0.528 0 O-C-N 121.518 -0.739 . . . . 0.0 112.674 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.62 -42.75 95.3 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.628 -0.67 . . . . 0.0 112.033 171.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.68 -46.35 90.7 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.62 0.768 . . . . 0.0 112.11 176.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.51 -46.33 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.151 0.981 . . . . 0.0 110.255 172.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.09 54.06 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.823 0.725 . . . . 0.0 112.884 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.22 -50.1 73.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.517 174.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.61 -18.58 64.34 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.9 p -111.9 8.41 20.37 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.581 1.153 . . . . 0.0 113.046 178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.41 162.3 1.59 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.935 1.294 . . . . 0.0 111.461 165.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.09 163.87 89.08 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.451 0.84 . . . . 0.0 111.713 -6.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -50.08 141.4 30.3 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.189 2.593 . . . . 0.0 114.135 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.16 96.43 2.48 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -85.97 54.63 3.5 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.248 2.632 . . . . 0.0 112.863 -152.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.66 -34.78 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 -173.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.44 -46.2 94.33 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.666 0.666 . . . . 0.0 112.996 173.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.84 -36.89 75.93 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.259 -1.142 . . . . 0.0 112.679 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.89 -44.58 99.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.802 -0.561 . . . . 0.0 109.98 173.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.9 -40.4 91.47 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.313 -0.867 . . . . 0.0 112.521 176.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.81 -42.04 75.07 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 121.418 -0.801 . . . . 0.0 112.246 173.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.8 ttm-85 -56.69 -45.28 81.88 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.924 0.784 . . . . 0.0 112.058 174.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -67.3 -40.54 86.04 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.305 0.642 . . . . 0.0 112.227 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.64 -47.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 123.005 0.522 . . . . 0.0 110.279 174.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.25 -37.29 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.685 1.194 . . . . 0.0 112.282 177.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.8 -42.78 98.31 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.112 0.869 . . . . 0.0 111.245 171.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.57 -45.06 91.55 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 123.796 0.712 . . . . 0.0 113.242 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.41 -42.4 87.1 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 118.019 0.91 . . . . 0.0 111.078 173.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.19 70.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.26 77.0 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 118.86 0.755 . . . . 0.0 111.991 175.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.43 -47.94 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 118.665 -0.683 . . . . 0.0 111.402 -179.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.48 -32.88 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 CA-C-N 119.951 1.251 . . . . 0.0 112.911 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.2 mtp180 -60.24 -44.55 95.14 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.902 0.881 . . . . 0.0 111.474 171.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.77 -36.2 59.9 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.69 1.596 . . . . 0.0 113.437 -177.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.5 t80 . . . . . 0 C--O 1.251 1.16 0 C-N-CA 128.415 2.686 . . . . 0.0 114.504 -172.665 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.85 135.0 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.504 1.121 . . . . 0.0 108.402 163.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.7 32.54 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.45 177.98 6.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.587 0.708 . . . . 0.0 112.444 177.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.88 -26.5 68.81 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.452 1.279 . . . . 0.0 114.452 -173.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.0 3.05 85.7 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 124.475 1.036 . . . . 0.0 114.092 -175.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.72 128.19 35.32 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.87 1.335 . . . . 0.0 109.741 174.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.85 125.52 29.47 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 168.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.9 t -125.9 123.36 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 C-N-CA 125.063 1.345 . . . . 0.0 108.659 -174.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.54 139.67 38.61 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-O 121.539 0.685 . . . . 0.0 111.177 170.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.73 141.16 48.41 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.465 1.906 . . . . 0.0 107.897 169.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.26 152.37 20.99 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 118.968 0.803 . . . . 0.0 111.191 170.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.53 136.91 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 121.472 0.653 . . . . 0.0 111.578 176.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.71 130.0 93.19 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.108 0.563 . . . . 0.0 111.137 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.06 -34.54 68.36 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.873 2.382 . . . . 0.0 113.575 167.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.44 -38.09 86.61 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.464 -0.773 . . . . 0.0 112.56 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 m -60.92 -44.32 97.35 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 0.0 111.373 171.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.53 -44.31 94.6 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 175.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.24 -47.26 86.02 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 123.079 0.551 . . . . 0.0 111.366 176.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.18 95.79 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.626 0.77 . . . . 0.0 111.91 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.11 -47.14 87.12 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.833 0.853 . . . . 0.0 112.786 176.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.0 t -56.89 -54.26 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 CA-C-N 118.381 0.537 . . . . 0.0 110.474 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.83 -37.26 78.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.358 1.063 . . . . 0.0 113.19 -179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.45 -52.3 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.096 1.358 . . . . 0.0 111.257 170.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.83 -35.85 76.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 CA-C-O 119.053 -0.499 . . . . 0.0 111.466 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -58.73 -23.71 60.31 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.49 -25.62 11.3 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -135.92 16.11 3.3 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -166.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.39 -37.5 2.34 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 116.493 2.034 . . . . 0.0 116.493 -175.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -118.23 13.84 13.79 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.475 1.11 . . . . 0.0 113.148 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.9 p -113.05 153.06 45.42 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.971 0.908 . . . . 0.0 111.568 -178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.89 -30.88 60.16 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.256 2.638 . . . . 0.0 115.182 -172.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.95 64.53 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.58 -32.17 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.41 1.005 . . . . 0.0 112.462 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.6 mt -70.35 -57.18 6.0 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 124.743 1.217 . . . . 0.0 112.561 -179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.88 -29.45 58.36 Favored 'Trans proline' 0 C--N 1.351 0.697 0 CA-C-N 121.891 1.711 . . . . 0.0 112.816 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.24 -40.17 78.04 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 119.831 1.196 . . . . 0.0 112.709 172.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -57.12 -47.01 82.13 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.83 0.741 . . . . 0.0 111.562 169.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.5 m -60.91 -44.2 97.49 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 175.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.73 -31.68 70.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.228 1.011 . . . . 0.0 113.251 178.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.2 mt -95.87 4.62 52.65 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.419 1.488 . . . . 0.0 113.458 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.1 p -133.11 22.86 4.14 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 59.9 mm-40 -53.61 120.3 6.0 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.453 -1.404 . . . . 0.0 111.465 168.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.51 11.71 60.16 Favored Glycine 0 CA--C 1.537 1.449 0 N-CA-C 115.403 0.921 . . . . 0.0 115.403 -177.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.59 130.91 47.18 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.478 1.639 . . . . 0.0 112.453 -178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.35 159.65 84.37 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 123.771 0.828 . . . . 0.0 110.653 167.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -49.58 -35.44 37.43 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.171 1.914 . . . . 0.0 115.372 168.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.07 -40.24 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -60.32 -45.32 93.81 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.662 -0.649 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.57 -44.27 94.59 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.318 1.047 . . . . 0.0 112.163 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -59.21 -41.43 88.58 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.682 -0.636 . . . . 0.0 111.996 171.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.6 m -60.25 -45.42 93.33 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.583 0.629 . . . . 0.0 111.028 175.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.28 -48.85 77.85 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 119.228 0.922 . . . . 0.0 112.179 174.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.8 mt -63.18 -38.29 90.6 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 178.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.07 -34.2 71.69 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -72.81 -12.93 61.18 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.5 m -119.4 13.11 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.267 1.027 . . . . 0.0 113.505 -175.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.48 -5.91 4.1 Favored Glycine 0 CA--C 1.543 1.835 0 N-CA-C 117.067 1.587 . . . . 0.0 117.067 178.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.67 -0.13 6.21 Favored Glycine 0 CA--C 1.54 1.597 0 C-N-CA 125.84 1.686 . . . . 0.0 116.919 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -124.78 79.79 1.81 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 119.339 1.57 . . . . 0.0 110.347 166.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.81 -36.08 46.59 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 -172.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.17 -41.01 74.33 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.118 1.326 . . . . 0.0 112.19 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.47 -43.68 84.82 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.19 0.596 . . . . 0.0 111.317 173.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.2 tpp -62.86 -40.3 97.04 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.508 -0.745 . . . . 0.0 112.2 175.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.97 74.18 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.296 1.038 . . . . 0.0 111.536 173.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -56.02 -45.43 79.1 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.101 0.961 . . . . 0.0 112.206 174.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 38.8 tp -61.88 -48.81 78.84 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.289 0.636 . . . . 0.0 112.055 176.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.63 -38.31 90.65 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.882 0.873 . . . . 0.0 112.455 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -60.02 -45.45 92.75 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 118.668 0.667 . . . . 0.0 112.013 170.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.61 -42.45 99.58 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 118.848 0.749 . . . . 0.0 112.094 175.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.8 -46.11 91.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 O-C-N 121.535 -0.728 . . . . 0.0 111.053 174.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.16 -39.4 93.94 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.865 0.757 . . . . 0.0 112.717 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -60.84 -47.44 86.35 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.964 174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.1 -34.3 72.96 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.8 -41.55 91.78 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.451 -0.781 . . . . 0.0 112.369 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.9 -42.01 98.58 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.201 0.6 . . . . 0.0 111.784 172.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.1 -42.28 99.54 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.864 -0.523 . . . . 0.0 112.19 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.88 -48.45 79.81 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.646 0.657 . . . . 0.0 111.687 173.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.09 -30.3 71.49 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.08 -39.12 79.26 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.361 1.064 . . . . 0.0 112.499 173.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.29 -27.6 42.21 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.776 1.23 . . . . 0.0 113.302 176.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.83 61.03 54.02 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.672 1.989 . . . . 0.0 111.241 -174.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.93 120.16 7.44 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.421 2.08 . . . . 0.0 110.258 179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.4 136.4 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.34 1.456 . . . . 0.0 112.152 -169.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.05 160.47 25.81 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.043 0.537 . . . . 0.0 110.909 168.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.26 -19.97 65.03 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.92 174.71 41.58 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.048 1.309 . . . . 0.0 112.61 174.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -66.45 169.17 14.61 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.668 2.912 . . . . 0.0 112.954 176.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.74 -39.17 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.909 1.284 . . . . 0.0 111.742 -175.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.94 28.52 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -47.91 133.42 22.84 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.479 2.786 . . . . 0.0 113.089 168.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 90.0 -15.06 60.35 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.562 1.077 . . . . 0.0 114.978 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -78.08 143.35 37.47 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.96 1.38 . . . . 0.0 110.198 173.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.17 145.57 54.21 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.717 -0.614 . . . . 0.0 110.826 168.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.56 152.73 44.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.709 0.804 . . . . 0.0 111.614 171.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -72.25 131.73 84.82 Favored Pre-proline 0 CA--C 1.546 0.806 0 CA-C-O 118.916 -0.564 . . . . 0.0 109.835 170.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.42 140.39 43.83 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.099 1.866 . . . . 0.0 112.442 -177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.7 mtp85 -75.02 171.63 13.76 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.737 1.615 . . . . 0.0 111.852 163.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.68 -43.82 94.27 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.942 -0.474 . . . . 0.0 112.954 168.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.77 -25.86 64.92 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.71 -41.56 65.11 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.041 -1.037 . . . . 0.0 111.756 171.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.3 mt -62.66 -42.69 97.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.731 0.812 . . . . 0.0 110.827 173.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.0 -1.29 14.03 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 173.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.11 74.16 Favored Glycine 0 CA--C 1.534 1.275 0 O-C-N 120.934 -1.104 . . . . 0.0 115.477 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.4 p -96.23 -19.39 19.35 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 119.11 1.455 . . . . 0.0 113.292 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.6 p -126.21 -1.54 7.02 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.5 p -103.57 149.99 24.37 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.067 0.947 . . . . 0.0 111.773 173.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 42.9 p -81.85 162.37 22.84 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.307 0.575 . . . . 0.0 110.794 169.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.81 -39.45 74.19 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.484 -0.76 . . . . 0.0 111.4 169.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.59 -38.83 92.62 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.556 -0.715 . . . . 0.0 112.683 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.63 -42.76 95.25 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 121.628 -0.67 . . . . 0.0 112.047 171.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -60.63 -46.42 90.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.61 0.764 . . . . 0.0 112.11 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.39 -46.33 92.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.142 0.977 . . . . 0.0 110.354 172.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.46 -51.12 53.81 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.81 0.719 . . . . 0.0 112.902 177.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.21 -50.07 73.24 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.778 0.789 . . . . 0.0 112.512 174.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.66 -18.46 64.28 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.1 p -111.95 8.42 20.29 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.6 1.16 . . . . 0.0 113.009 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -55.44 162.31 1.61 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.952 1.301 . . . . 0.0 111.441 165.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.58 103.34 48.95 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.029 0.932 . . . . 0.0 110.778 176.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.1 163.85 89.12 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.451 0.84 . . . . 0.0 111.762 -6.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -49.97 141.31 29.73 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.238 2.625 . . . . 0.0 114.174 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.12 96.48 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.814 -2.291 . . . . 0.0 104.814 163.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.6 -34.81 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 -173.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.42 -46.17 94.4 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-N 118.638 0.654 . . . . 0.0 113.011 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.2 mm-40 -69.89 -36.86 75.76 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.296 -1.12 . . . . 0.0 112.634 178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.6 mt -62.92 -44.58 99.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 O-C-N 121.785 -0.572 . . . . 0.0 109.954 173.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.89 -40.38 91.52 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.303 -0.873 . . . . 0.0 112.521 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.82 -42.05 75.1 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 121.418 -0.801 . . . . 0.0 112.275 173.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.65 -45.21 81.77 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.901 0.773 . . . . 0.0 112.147 174.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.28 -40.53 86.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.69 -47.04 94.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.05 0.54 . . . . 0.0 110.286 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.1 mt -62.29 -37.3 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 124.636 1.174 . . . . 0.0 112.282 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.82 -42.77 98.35 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.051 0.842 . . . . 0.0 111.215 171.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.58 -45.17 90.96 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 123.836 0.731 . . . . 0.0 113.184 175.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.43 -42.29 86.97 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.045 0.922 . . . . 0.0 111.073 173.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.26 70.4 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.424 173.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -55.77 -43.26 76.57 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 118.874 0.761 . . . . 0.0 111.961 175.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.2 mt -64.6 -47.76 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 118.692 -0.671 . . . . 0.0 111.431 -179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.56 -32.89 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.965 1.257 . . . . 0.0 112.9 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -60.25 -44.84 94.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.939 0.895 . . . . 0.0 111.468 171.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.39 -36.87 60.82 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.683 1.593 . . . . 0.0 113.428 -177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.251 1.171 0 C-N-CA 128.425 2.69 . . . . 0.0 114.577 -172.73 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo . . . . . 0 N--CA 1.48 0.679 0 N-CA-C 112.98 0.338 . . . . 0.0 112.98 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.1 mm -91.89 135.06 28.24 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 C-N-CA 124.482 1.113 . . . . 0.0 108.402 163.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.3 m -126.07 154.84 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.092 1.357 . . . . 0.0 109.688 170.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.56 116.7 32.53 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.519 0.728 . . . . 0.0 109.139 178.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -76.46 177.97 6.96 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-O 121.514 0.673 . . . . 0.0 112.474 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.85 -26.53 68.8 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 114.422 1.268 . . . . 0.0 114.422 -173.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.87 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.81 1.244 . . . . 0.0 113.019 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 85.94 3.09 85.81 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.458 1.028 . . . . 0.0 114.08 -175.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.74 128.21 35.39 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.823 1.312 . . . . 0.0 109.683 174.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.87 125.53 29.49 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 168.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.9 123.31 63.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.086 1.354 . . . . 0.0 108.698 -174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.58 139.66 38.57 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.555 0.693 . . . . 0.0 111.23 170.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.68 141.09 48.43 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.491 1.916 . . . . 0.0 107.921 169.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.25 152.4 20.9 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 118.98 0.809 . . . . 0.0 111.248 170.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.9 tt -56.56 136.85 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 O-C-N 121.605 -0.685 . . . . 0.0 111.555 176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.2 t -67.65 129.98 93.26 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.136 0.575 . . . . 0.0 111.149 177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.02 -34.58 68.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 122.907 2.405 . . . . 0.0 113.586 167.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.7 mtt180 -66.44 -38.08 86.6 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.513 -0.742 . . . . 0.0 112.588 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.87 -44.34 97.19 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 118.767 0.712 . . . . 0.0 111.386 171.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -63.52 -44.33 94.57 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 118.296 0.498 . . . . 0.0 112.267 175.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -59.23 -47.22 86.14 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.139 0.576 . . . . 0.0 111.4 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.24 95.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.664 0.786 . . . . 0.0 111.899 176.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.3 t-105 -60.14 -47.12 87.25 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.795 0.838 . . . . 0.0 112.772 177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 57.1 t -56.91 -54.3 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 CA-C-N 118.392 0.542 . . . . 0.0 110.41 174.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -59.81 -37.18 78.42 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.324 1.05 . . . . 0.0 113.247 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.2 t -57.57 -52.19 60.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 125.044 1.338 . . . . 0.0 111.286 170.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 77.2 t -64.91 -35.86 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 C-N-CA 122.972 0.509 . . . . 0.0 111.412 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -58.66 -23.79 59.96 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.073 1.138 . . . . 0.0 114.073 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -107.52 -25.58 11.31 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -135.94 16.12 3.29 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -166.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.42 -37.4 2.33 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 116.54 2.052 . . . . 0.0 116.54 -175.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -118.31 13.91 13.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.473 1.109 . . . . 0.0 113.148 -172.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.1 p -113.15 153.02 45.52 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 123.962 0.905 . . . . 0.0 111.515 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.82 -30.91 59.64 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 123.287 2.658 . . . . 0.0 115.218 -172.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.07 -20.91 64.49 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -56.61 -32.24 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 119.406 1.003 . . . . 0.0 112.422 176.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 52.6 mt -70.33 -57.15 6.05 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.684 1.194 . . . . 0.0 112.572 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -64.86 -29.45 58.49 Favored 'Trans proline' 0 C--N 1.351 0.668 0 CA-C-N 121.896 1.713 . . . . 0.0 112.816 175.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 76.5 mtm -69.29 -40.08 77.95 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.818 1.19 . . . . 0.0 112.694 172.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -57.17 -47.05 82.18 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 118.878 0.763 . . . . 0.0 111.537 169.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.4 m -60.88 -44.21 97.4 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.79 -31.61 70.97 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.193 0.997 . . . . 0.0 113.297 178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.88 4.74 52.54 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.368 1.467 . . . . 0.0 113.55 -178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 90.0 p -133.15 22.73 4.12 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.57 120.29 5.96 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 120.474 -1.391 . . . . 0.0 111.456 168.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.62 11.53 60.15 Favored Glycine 0 CA--C 1.537 1.411 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 -177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.47 130.82 46.91 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.528 1.664 . . . . 0.0 112.53 -178.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.1 p -73.28 159.66 84.43 Favored Pre-proline 0 N--CA 1.472 0.646 0 C-N-CA 123.718 0.807 . . . . 0.0 110.692 167.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -49.61 -35.37 37.49 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.144 1.896 . . . . 0.0 115.4 168.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 tt0 -67.03 -40.3 87.18 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 174.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.3 93.89 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.066 172.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.55 -44.28 94.62 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.329 1.051 . . . . 0.0 112.175 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.2 m-20 -59.24 -41.37 88.58 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.612 -0.68 . . . . 0.0 112.047 171.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.7 m -60.2 -45.41 93.26 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.597 0.635 . . . . 0.0 111.115 175.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.28 -48.85 77.84 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.187 0.903 . . . . 0.0 112.176 174.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 65.0 mt -63.18 -38.33 90.73 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.06 -34.16 71.62 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 43.0 p -72.78 -12.98 61.21 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.3 m -119.36 13.15 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 124.315 1.046 . . . . 0.0 113.557 -175.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -59.48 -5.92 4.11 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 117.055 1.582 . . . . 0.0 117.055 178.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -65.71 -0.2 6.38 Favored Glycine 0 CA--C 1.54 1.653 0 C-N-CA 125.909 1.719 . . . . 0.0 116.845 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -124.71 79.76 1.8 Allowed 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.347 1.574 . . . . 0.0 110.385 166.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -51.87 -36.03 47.07 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.718 1.607 . . . . 0.0 115.304 -172.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.2 -40.98 74.29 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 120.154 1.343 . . . . 0.0 112.191 -179.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.44 -43.75 84.73 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.254 0.622 . . . . 0.0 111.315 173.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 61.2 tpp -62.77 -40.3 96.87 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 121.491 -0.756 . . . . 0.0 112.257 175.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.05 -49.95 74.26 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.292 1.037 . . . . 0.0 111.544 173.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -56.0 -45.42 79.06 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.101 0.961 . . . . 0.0 112.234 174.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.0 tp -61.88 -48.84 78.69 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.308 0.643 . . . . 0.0 112.054 176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -63.69 -38.3 90.58 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.873 0.869 . . . . 0.0 112.424 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.95 -45.49 92.49 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.705 0.684 . . . . 0.0 112.034 170.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.7 m -62.65 -42.36 99.57 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.793 0.724 . . . . 0.0 112.118 175.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.2 mt -58.87 -46.08 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 O-C-N 121.507 -0.745 . . . . 0.0 111.045 174.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.13 -39.4 93.96 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 118.838 0.745 . . . . 0.0 112.717 177.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -60.84 -47.41 86.48 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.743 0.817 . . . . 0.0 111.958 174.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.4 mm-40 -70.12 -34.34 72.96 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.593 -0.692 . . . . 0.0 112.859 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.79 -41.56 91.81 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.484 -0.76 . . . . 0.0 112.371 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.81 -42.09 98.58 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.246 0.619 . . . . 0.0 111.766 172.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -63.17 -42.22 99.37 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.864 -0.523 . . . . 0.0 112.191 174.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.78 -48.58 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.646 0.657 . . . . 0.0 111.71 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -63.06 -30.22 71.43 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.7 ttp85 -69.19 -39.06 78.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.342 1.057 . . . . 0.0 112.488 173.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.28 -27.57 42.28 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.796 1.239 . . . . 0.0 113.354 176.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.79 61.0 53.92 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 126.672 1.989 . . . . 0.0 111.247 -174.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -63.94 120.15 7.43 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.452 2.101 . . . . 0.0 110.285 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.44 136.36 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.372 1.469 . . . . 0.0 112.077 -169.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.6 m170 -80.0 160.47 25.87 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.048 0.539 . . . . 0.0 110.909 168.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.24 -19.98 65.03 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.91 174.81 41.58 Favored Glycine 0 CA--C 1.537 1.446 0 C-N-CA 125.075 1.322 . . . . 0.0 112.625 174.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.64 169.18 14.9 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.635 2.89 . . . . 0.0 112.889 177.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.68 -39.19 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 124.903 1.281 . . . . 0.0 111.749 -175.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.46 161.89 28.6 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.842 1.657 . . . . 0.0 110.551 176.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -47.95 133.45 23.06 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.427 2.751 . . . . 0.0 113.132 168.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.98 -15.08 60.26 Favored Glycine 0 CA--C 1.537 1.411 0 C-N-CA 124.567 1.08 . . . . 0.0 115.01 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -78.05 143.38 37.49 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.975 1.387 . . . . 0.0 110.198 173.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.23 145.48 54.24 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 121.691 -0.631 . . . . 0.0 110.859 168.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.5 ptt85 -68.47 152.82 44.86 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.2 131.69 84.94 Favored Pre-proline 0 CA--C 1.546 0.824 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.83 170.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.44 140.36 43.69 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.097 1.864 . . . . 0.0 112.426 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.5 mtp85 -75.04 171.62 13.79 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.649 1.58 . . . . 0.0 111.89 163.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.55 -43.85 94.02 Favored Glycine 0 CA--C 1.534 1.266 0 O-C-N 121.949 -0.469 . . . . 0.0 113.035 168.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.7 p -68.76 -25.85 64.94 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 175.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.63 -41.63 65.32 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 121.061 -1.025 . . . . 0.0 111.795 171.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.64 -42.75 97.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 123.784 0.834 . . . . 0.0 110.782 173.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.03 -1.26 14.02 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 173.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.93 18.16 74.16 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 120.908 -1.12 . . . . 0.0 115.491 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.26 -19.46 19.28 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.053 1.426 . . . . 0.0 113.263 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 64.0 p -126.1 -1.49 7.09 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 177.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.67 149.89 24.53 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.052 0.941 . . . . 0.0 111.814 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.0 p -81.76 162.31 22.97 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.318 0.58 . . . . 0.0 110.827 170.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.4 tp -56.75 -39.43 73.97 Favored 'General case' 0 CA--C 1.537 0.456 0 O-C-N 121.446 -0.784 . . . . 0.0 111.43 169.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -63.56 -38.9 92.89 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.516 -0.74 . . . . 0.0 112.706 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -64.6 -42.76 95.34 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.628 -0.67 . . . . 0.0 112.008 171.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.68 -46.36 90.66 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.613 0.765 . . . . 0.0 112.156 176.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.47 -46.32 92.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.091 0.956 . . . . 0.0 110.288 172.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.47 -51.1 54.01 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.838 0.733 . . . . 0.0 112.869 177.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -62.25 -50.07 73.19 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 117.796 0.798 . . . . 0.0 112.512 174.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.1 mtp -68.61 -18.53 64.33 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -176.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 36.6 p -111.91 8.36 20.33 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.645 1.178 . . . . 0.0 112.996 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.44 162.33 1.6 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.995 1.318 . . . . 0.0 111.447 165.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.6 103.34 48.91 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 124.065 0.946 . . . . 0.0 110.778 176.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.1 163.82 89.19 Favored 'Cis proline' 0 CA--C 1.544 0.992 0 CA-C-N 119.451 0.84 . . . . 0.0 111.762 -6.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo -50.0 141.36 29.81 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 C-N-CA 123.155 2.57 . . . . 0.0 114.205 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.0 mt -96.11 96.46 2.47 Favored Pre-proline 0 CA--C 1.542 0.656 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 163.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -85.98 54.54 3.48 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.251 2.634 . . . . 0.0 112.882 -152.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.4 m -53.56 -34.84 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -173.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.45 -46.21 94.29 Favored Glycine 0 CA--C 1.532 1.14 0 CA-C-N 118.605 0.639 . . . . 0.0 112.996 173.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -69.84 -36.9 75.95 Favored 'General case' 0 N--CA 1.471 0.578 0 O-C-N 121.289 -1.124 . . . . 0.0 112.645 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.9 -44.57 99.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.745 -0.597 . . . . 0.0 109.914 173.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.91 -40.35 91.4 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.282 -0.886 . . . . 0.0 112.521 176.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.87 -42.07 75.34 Favored 'General case' 0 N--CA 1.476 0.868 0 O-C-N 121.439 -0.788 . . . . 0.0 112.204 173.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.7 ttm-85 -56.63 -45.25 81.66 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 118.899 0.772 . . . . 0.0 112.093 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.28 -40.53 86.13 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.275 0.63 . . . . 0.0 112.251 178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.66 -47.08 94.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 C-N-CA 123.085 0.554 . . . . 0.0 110.285 174.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.5 mt -62.26 -37.32 78.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.645 1.178 . . . . 0.0 112.298 177.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.81 -42.82 98.41 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 119.028 0.831 . . . . 0.0 111.185 171.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.48 -45.21 91.12 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 123.878 0.751 . . . . 0.0 113.228 175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.2 mt -58.38 -42.3 86.73 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.003 0.901 . . . . 0.0 111.14 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.49 -50.26 70.4 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.813 0.845 . . . . 0.0 112.424 173.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.83 -43.19 76.74 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 118.874 0.761 . . . . 0.0 111.975 175.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.6 -47.79 87.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 123.344 0.658 . . . . 0.0 111.431 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.3 m -69.53 -32.89 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 CA-C-N 119.961 1.255 . . . . 0.0 112.9 179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -60.26 -44.87 94.92 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.939 0.895 . . . . 0.0 111.461 171.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 20.1 ttp -75.33 -36.95 60.99 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.672 1.589 . . . . 0.0 113.45 -177.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.6 t80 . . . . . 0 C--O 1.252 1.201 0 C-N-CA 128.454 2.702 . . . . 0.0 114.562 -172.701 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo . . . . . 0 N--CA 1.479 0.624 0 N-CA-C 113.024 0.355 . . . . 0.0 113.024 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 19.0 mm -91.85 135.0 28.36 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.488 1.115 . . . . 0.0 108.482 163.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.4 m -126.01 154.85 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.106 1.362 . . . . 0.0 109.657 170.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -104.54 116.65 32.46 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.524 0.73 . . . . 0.0 109.201 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -76.43 178.06 6.88 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-O 121.529 0.68 . . . . 0.0 112.46 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 tp -62.88 -26.56 68.84 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.416 1.265 . . . . 0.0 114.416 -173.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 27.9 mp0 -85.6 -2.16 57.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.783 1.233 . . . . 0.0 113.03 175.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 86.03 3.02 85.65 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.475 1.036 . . . . 0.0 114.07 -175.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.71 128.2 35.35 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 118.893 1.347 . . . . 0.0 109.712 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.7 mmt -77.84 125.55 29.51 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 168.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 87.5 t -125.94 123.4 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.074 1.349 . . . . 0.0 108.629 -174.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -78.6 139.67 38.55 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.213 170.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -132.65 141.14 48.49 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.488 1.915 . . . . 0.0 107.89 169.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.22 152.29 21.03 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.023 0.829 . . . . 0.0 111.254 170.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 16.8 tt -56.48 136.85 18.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 121.523 0.678 . . . . 0.0 111.55 176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 29.1 t -67.69 130.0 93.21 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.068 0.547 . . . . 0.0 111.137 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -53.02 -34.58 68.22 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 122.894 2.396 . . . . 0.0 113.583 167.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -66.44 -38.06 86.55 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 121.437 -0.789 . . . . 0.0 112.588 174.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.1 m -60.95 -44.31 97.47 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 118.753 0.706 . . . . 0.0 111.349 171.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.57 -44.35 94.36 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 118.29 0.496 . . . . 0.0 112.309 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -59.12 -47.31 85.73 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.142 0.577 . . . . 0.0 111.388 176.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.01 -45.32 95.29 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.604 0.761 . . . . 0.0 111.896 176.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 51.8 t-105 -60.07 -47.29 86.47 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.849 0.859 . . . . 0.0 112.791 177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 66.6 t -56.74 -54.94 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 118.417 0.553 . . . . 0.0 110.254 174.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.15 -37.71 77.98 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.371 1.068 . . . . 0.0 113.237 -178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.404 HG13 ' CE ' ' A' ' 39' ' ' MET . 2.2 t -57.21 -51.96 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.064 1.346 . . . . 0.0 111.28 170.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.4 t -64.81 -35.87 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 122.993 0.517 . . . . 0.0 111.485 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -58.94 -23.29 61.29 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.709 1.141 . . . . 0.0 113.972 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -107.55 -25.91 11.15 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -177.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.3 mmtt -135.9 16.26 3.3 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -165.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -43.65 -37.47 2.6 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -118.3 14.58 13.86 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.39 1.076 . . . . 0.0 113.1 -172.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 26.8 p -113.77 153.02 46.05 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 124.004 0.922 . . . . 0.0 111.526 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.9 -30.79 59.87 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 123.274 2.649 . . . . 0.0 115.224 -172.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -62.09 -20.64 64.24 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.5 p -56.78 -31.96 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 119.397 0.998 . . . . 0.0 112.539 176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.38 -55.08 6.3 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 124.974 1.31 . . . . 0.0 112.944 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.85 -30.07 49.59 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 121.658 1.628 . . . . 0.0 112.669 174.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.404 ' CE ' HG13 ' A' ' 26' ' ' VAL . 76.5 mtm -69.04 -40.3 78.68 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.921 1.237 . . . . 0.0 112.606 172.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -57.25 -46.46 82.99 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.735 0.698 . . . . 0.0 111.576 169.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 70.6 m -61.1 -44.47 97.31 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.84 -31.95 71.37 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.317 1.047 . . . . 0.0 113.25 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 99.1 mt -95.47 4.58 53.13 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.333 1.453 . . . . 0.0 113.526 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 88.1 p -133.09 22.8 4.14 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -53.58 120.34 6.04 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 120.44 -1.413 . . . . 0.0 111.47 168.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.48 11.69 60.07 Favored Glycine 0 CA--C 1.537 1.418 0 N-CA-C 115.371 0.909 . . . . 0.0 115.371 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -62.54 130.89 47.14 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.565 1.683 . . . . 0.0 112.515 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 43.2 p -73.33 159.69 84.29 Favored Pre-proline 0 N--CA 1.471 0.577 0 C-N-CA 123.748 0.819 . . . . 0.0 110.718 167.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -49.61 -35.44 37.68 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.204 1.936 . . . . 0.0 115.372 168.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -67.07 -40.24 87.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -60.32 -45.35 93.71 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.63 -0.669 . . . . 0.0 111.039 172.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.4 mt -63.54 -44.26 94.73 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.35 1.06 . . . . 0.0 112.163 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -59.2 -41.49 88.66 Favored 'General case' 0 CA--C 1.534 0.357 0 O-C-N 121.696 -0.628 . . . . 0.0 112.024 171.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.1 m -60.22 -45.33 93.58 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 118.569 0.622 . . . . 0.0 111.091 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 98.1 mtp -57.33 -48.86 77.88 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 119.205 0.911 . . . . 0.0 112.164 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 64.5 mt -63.19 -38.33 90.76 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -59.06 -33.7 71.09 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 177.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 42.4 p -73.07 -12.92 61.09 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.9 m -121.17 8.9 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -174.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.86 -5.55 7.55 Favored Glycine 0 CA--C 1.542 1.728 0 N-CA-C 117.267 1.667 . . . . 0.0 117.267 -178.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . -56.23 -31.24 59.12 Favored Glycine 0 CA--C 1.536 1.402 0 CA-C-N 119.318 1.559 . . . . 0.0 115.648 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -93.42 78.44 4.41 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 118.962 1.381 . . . . 0.0 110.536 172.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -51.07 -35.8 36.64 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -173.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.03 73.96 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 120.154 1.343 . . . . 0.0 112.243 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -66.41 -43.58 85.35 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.199 0.599 . . . . 0.0 111.35 173.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.6 tpp -63.06 -40.08 96.64 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.53 -0.732 . . . . 0.0 112.238 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -57.03 -49.96 74.2 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.247 1.019 . . . . 0.0 111.529 173.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . . . . . . . . . 49.7 tpp -55.9 -45.5 78.63 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.1 0.96 . . . . 0.0 112.228 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 37.9 tp -61.92 -48.77 78.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.265 0.626 . . . . 0.0 112.035 177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.5 mmtt -63.69 -38.31 90.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.873 0.869 . . . . 0.0 112.49 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -59.96 -45.49 92.48 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.689 0.677 . . . . 0.0 112.02 170.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 62.9 m -62.6 -42.43 99.57 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 118.848 0.749 . . . . 0.0 112.13 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 72.3 mt -58.83 -46.08 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 121.535 -0.728 . . . . 0.0 111.059 174.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -64.21 -39.35 93.79 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 118.858 0.754 . . . . 0.0 112.731 177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.3 mt-10 -60.84 -47.39 86.59 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.757 0.823 . . . . 0.0 111.964 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -70.19 -34.27 72.74 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.865 0.691 . . . . 0.0 112.865 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.76 -41.6 91.91 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 121.451 -0.781 . . . . 0.0 112.333 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -42.04 98.54 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.224 0.61 . . . . 0.0 111.783 172.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -63.19 -42.26 99.33 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.855 -0.528 . . . . 0.0 112.191 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TRP . . . . . . . . . . . . . 52.5 t-105 -57.74 -48.55 79.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.625 0.648 . . . . 0.0 111.71 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -63.04 -30.3 71.49 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 63.8 ttp85 -69.22 -38.99 78.83 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.33 1.052 . . . . 0.0 112.458 173.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -79.36 -27.5 41.95 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.776 1.23 . . . . 0.0 113.313 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -132.84 61.02 53.98 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 126.622 1.969 . . . . 0.0 111.241 -174.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -63.91 120.12 7.38 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.479 2.119 . . . . 0.0 110.293 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -60.39 136.39 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.32 1.448 . . . . 0.0 112.135 -169.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -80.03 160.49 25.83 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.083 0.553 . . . . 0.0 110.897 168.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.28 -19.93 65.01 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 -179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.94 174.77 41.59 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 125.032 1.301 . . . . 0.0 112.656 174.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.57 169.17 14.81 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 123.66 2.907 . . . . 0.0 112.906 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 76.2 mt -57.69 -39.14 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.843 1.257 . . . . 0.0 111.824 -175.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.91 28.57 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 125.884 1.674 . . . . 0.0 110.597 176.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -47.83 133.41 22.44 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.519 2.812 . . . . 0.0 113.132 168.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.9 -15.0 60.33 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 124.607 1.099 . . . . 0.0 114.992 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -78.05 143.4 37.48 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 118.992 1.396 . . . . 0.0 110.198 173.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' MET . . . . . . . . . . . . . 75.7 mtm -68.25 145.52 54.19 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 121.694 -0.629 . . . . 0.0 110.787 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 37.4 ptt85 -68.47 152.84 44.83 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 0.0 111.67 171.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -72.3 131.73 84.73 Favored Pre-proline 0 CA--C 1.546 0.826 0 CA-C-O 118.945 -0.55 . . . . 0.0 109.824 170.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.38 140.38 43.93 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.074 1.849 . . . . 0.0 112.442 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 69.6 mtp85 -74.98 171.61 13.77 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.761 1.625 . . . . 0.0 111.872 163.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -57.64 -43.82 94.19 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.912 -0.493 . . . . 0.0 112.974 168.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 26.5 p -68.74 -25.85 64.95 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -72.72 -41.64 65.0 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.082 -1.011 . . . . 0.0 111.725 171.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 68.2 mt -62.63 -42.69 96.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 123.718 0.807 . . . . 0.0 110.827 173.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -71.96 -1.34 14.13 Favored 'General case' 0 CA--C 1.548 0.889 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 173.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.21 74.24 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 120.877 -1.139 . . . . 0.0 115.463 175.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 80.5 p -96.31 -19.46 19.24 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 119.099 1.449 . . . . 0.0 113.263 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.8 p -126.12 -1.42 7.08 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 177.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 89.6 p -103.7 149.87 24.57 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.073 0.949 . . . . 0.0 111.788 173.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 43.1 p -81.76 162.33 22.96 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.318 0.58 . . . . 0.0 110.827 169.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 67.3 tp -56.78 -39.47 74.14 Favored 'General case' 0 CA--C 1.538 0.502 0 O-C-N 121.418 -0.801 . . . . 0.0 111.347 169.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -63.52 -38.9 92.89 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.554 -0.716 . . . . 0.0 112.722 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -64.62 -42.76 95.3 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.584 -0.698 . . . . 0.0 112.033 171.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -60.65 -46.39 90.49 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.687 0.795 . . . . 0.0 112.097 176.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.49 -46.29 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.137 0.975 . . . . 0.0 110.338 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -54.51 -51.02 54.73 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.81 0.719 . . . . 0.0 112.927 177.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TRP . . . . . . . . . . . . . 13.1 m0 -62.27 -50.04 73.28 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.819 0.81 . . . . 0.0 112.542 174.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 92.0 mtp -68.69 -18.49 64.27 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 37.0 p -111.93 8.46 20.33 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.643 1.177 . . . . 0.0 113.062 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -55.45 162.31 1.62 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.989 1.316 . . . . 0.0 111.441 165.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -118.56 103.37 48.93 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.029 0.932 . . . . 0.0 110.758 176.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -76.06 163.81 89.24 Favored 'Cis proline' 0 CA--C 1.544 0.997 0 CA-C-N 119.494 0.855 . . . . 0.0 111.713 -6.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -49.93 141.36 29.3 Favored 'Trans proline' 0 CA--C 1.534 0.491 0 C-N-CA 123.199 2.6 . . . . 0.0 114.149 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.16 96.45 2.49 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 104.793 -2.299 . . . . 0.0 104.793 163.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -86.0 54.56 3.47 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.251 2.634 . . . . 0.0 112.86 -152.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.3 m -53.56 -34.86 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -173.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.22 94.31 Favored Glycine 0 CA--C 1.533 1.212 0 CA-C-N 118.638 0.654 . . . . 0.0 112.999 173.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -69.9 -36.83 75.72 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.327 -1.102 . . . . 0.0 112.688 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.7 mt -62.87 -44.64 99.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 O-C-N 121.795 -0.566 . . . . 0.0 109.912 173.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.88 -40.34 91.52 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.303 -0.873 . . . . 0.0 112.564 176.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.88 -41.98 75.26 Favored 'General case' 0 N--CA 1.476 0.856 0 O-C-N 121.412 -0.805 . . . . 0.0 112.253 173.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.9 ttm-85 -56.69 -45.16 81.95 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 118.924 0.784 . . . . 0.0 112.147 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TRP . . . . . . . . . . . . . 36.9 m0 -67.33 -40.53 85.94 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.29 0.636 . . . . 0.0 112.251 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 87.0 mt -62.67 -47.09 94.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 C-N-CA 123.085 0.554 . . . . 0.0 110.249 174.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 74.0 mt -62.19 -37.39 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.674 1.19 . . . . 0.0 112.3 177.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 14.5 tp -60.8 -42.79 98.31 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.011 0.823 . . . . 0.0 111.253 171.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -65.54 -45.11 91.4 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.796 0.712 . . . . 0.0 113.265 175.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.1 mt -58.46 -42.3 87.12 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 118.01 0.905 . . . . 0.0 111.092 173.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -55.47 -50.19 70.54 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.772 0.829 . . . . 0.0 112.478 173.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 81.0 mttt -55.88 -43.23 77.01 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.86 0.755 . . . . 0.0 111.986 175.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.41 -47.91 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-O 118.702 -0.666 . . . . 0.0 111.415 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 4.4 m -69.64 -32.8 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 120.0 1.273 . . . . 0.0 112.86 179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ARG . . . . . . . . . . . . . 55.3 mtp180 -60.11 -44.02 95.18 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.863 0.865 . . . . 0.0 111.505 171.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 19.3 ttp -77.04 -37.36 54.96 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.652 1.581 . . . . 0.0 113.558 -176.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 7.9 t80 . . . . . 0 C--O 1.251 1.177 0 C-N-CA 128.427 2.691 . . . . 0.0 114.649 -172.059 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' JPR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_